{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "name": "Extractive_Summarization_ofTEXT.ipynb",
      "provenance": [],
      "collapsed_sections": [],
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/kjapan87/ExtractiveSummarizationV1/blob/main/Extractive_Summarization_ofTEXT.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "wQuQ3rddSvFw",
        "outputId": "295f60b8-325a-4bcb-ac15-1f7dc7d0c912",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 34
        }
      },
      "source": [
        "pip install beautifulsoup4"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: beautifulsoup4 in /usr/local/lib/python3.6/dist-packages (4.6.3)\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "VTgc8JQrUCOW",
        "outputId": "23e590f3-e50e-454c-d153-5877ce6e9743",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 34
        }
      },
      "source": [
        "pip install lxml"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: lxml in /usr/local/lib/python3.6/dist-packages (4.2.6)\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "2ESWIqF-TpW3"
      },
      "source": [
        "import bs4\n",
        "import re #re= regular expression\n",
        "import nltk # a pre-developed library for data analysis techniques START PRE_PROCESSING\n",
        "import urllib.request"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "OlzNZIYYS2zM"
      },
      "source": [
        "text_data = urllib.request.urlopen('https://en.wikipedia.org/wiki/COVID-19_vaccine').read()"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "3GWlH9ueddz2",
        "outputId": "de222270-3355-4467-a09d-599be6d35158",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 54
        }
      },
      "source": [
        "print(text_data)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "b'<!DOCTYPE html>\\n<html class=\"client-nojs\" lang=\"en\" dir=\"ltr\">\\n<head>\\n<meta charset=\"UTF-8\"/>\\n<title>COVID-19 vaccine - Wikipedia</title>\\n<script>document.documentElement.className=\"client-js\";RLCONF={\"wgBreakFrames\":!1,\"wgSeparatorTransformTable\":[\"\",\"\"],\"wgDigitTransformTable\":[\"\",\"\"],\"wgDefaultDateFormat\":\"dmy\",\"wgMonthNames\":[\"\",\"January\",\"February\",\"March\",\"April\",\"May\",\"June\",\"July\",\"August\",\"September\",\"October\",\"November\",\"December\"],\"wgRequestId\":\"17df4ec9-e609-40dd-83b9-9161b22cde71\",\"wgCSPNonce\":!1,\"wgCanonicalNamespace\":\"\",\"wgCanonicalSpecialPageName\":!1,\"wgNamespaceNumber\":0,\"wgPageName\":\"COVID-19_vaccine\",\"wgTitle\":\"COVID-19 vaccine\",\"wgCurRevisionId\":983748222,\"wgRevisionId\":983748222,\"wgArticleId\":63319438,\"wgIsArticle\":!0,\"wgIsRedirect\":!1,\"wgAction\":\"view\",\"wgUserName\":null,\"wgUserGroups\":[\"*\"],\"wgCategories\":[\"Pages with non-numeric formatnum arguments\",\"CS1 maint: uses authors parameter\",\"CS1 German-language sources (de)\",\"CS1 Dutch-language sources (nl)\",\"CS1 Indonesian-language sources (id)\",\"CS1 errors: missing periodical\",\"Wikipedia indefinitely semi-protected pages\",\\n\"Articles with short description\",\"Short description is different from Wikidata\",\"Use dmy dates from March 2020\",\"Pages using left with no arguments\",\"COVID-19 vaccines\",\"Medical research\",\"Medical responses to the COVID-19 pandemic\"],\"wgPageContentLanguage\":\"en\",\"wgPageContentModel\":\"wikitext\",\"wgRelevantPageName\":\"COVID-19_vaccine\",\"wgRelevantArticleId\":63319438,\"wgIsProbablyEditable\":!1,\"wgRelevantPageIsProbablyEditable\":!1,\"wgRestrictionEdit\":[\"autoconfirmed\"],\"wgRestrictionMove\":[],\"wgMediaViewerOnClick\":!0,\"wgMediaViewerEnabledByDefault\":!0,\"wgPopupsReferencePreviews\":!1,\"wgPopupsConflictsWithNavPopupGadget\":!1,\"wgVisualEditor\":{\"pageLanguageCode\":\"en\",\"pageLanguageDir\":\"ltr\",\"pageVariantFallbacks\":\"en\"},\"wgMFDisplayWikibaseDescriptions\":{\"search\":!0,\"nearby\":!0,\"watchlist\":!0,\"tagline\":!1},\"wgWMESchemaEditAttemptStepOversample\":!1,\"wgULSCurrentAutonym\":\"English\",\"wgNoticeProject\":\"wikipedia\",\"wgCentralAuthMobileDomain\":!1,\\n\"wgEditSubmitButtonLabelPublish\":!0,\"wgULSPosition\":\"interlanguage\",\"wgWikibaseItemId\":\"Q87719492\"};RLSTATE={\"ext.globalCssJs.user.styles\":\"ready\",\"site.styles\":\"ready\",\"noscript\":\"ready\",\"user.styles\":\"ready\",\"ext.globalCssJs.user\":\"ready\",\"user\":\"ready\",\"user.options\":\"loading\",\"ext.cite.styles\":\"ready\",\"skins.vector.styles.legacy\":\"ready\",\"jquery.tablesorter.styles\":\"ready\",\"jquery.makeCollapsible.styles\":\"ready\",\"mediawiki.toc.styles\":\"ready\",\"ext.visualEditor.desktopArticleTarget.noscript\":\"ready\",\"ext.uls.interlanguage\":\"ready\",\"ext.wikimediaBadges\":\"ready\",\"wikibase.client.init\":\"ready\"};RLPAGEMODULES=[\"ext.cite.ux-enhancements\",\"ext.scribunto.logs\",\"site\",\"mediawiki.page.ready\",\"jquery.tablesorter\",\"jquery.makeCollapsible\",\"mediawiki.toc\",\"skins.vector.legacy.js\",\"ext.gadget.ReferenceTooltips\",\"ext.gadget.charinsert\",\"ext.gadget.extra-toolbar-buttons\",\"ext.gadget.refToolbar\",\"ext.gadget.switcher\",\"ext.centralauth.centralautologin\",\"mmv.head\",\"mmv.bootstrap.autostart\",\\n\"ext.popups\",\"ext.visualEditor.desktopArticleTarget.init\",\"ext.visualEditor.targetLoader\",\"ext.eventLogging\",\"ext.wikimediaEvents\",\"ext.navigationTiming\",\"ext.uls.compactlinks\",\"ext.uls.interface\",\"ext.cx.eventlogging.campaigns\",\"ext.quicksurveys.init\",\"ext.centralNotice.geoIP\",\"ext.centralNotice.startUp\"];</script>\\n<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement(\"user.options@1hzgi\",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({\"patrolToken\":\"+\\\\\\\\\",\"watchToken\":\"+\\\\\\\\\",\"csrfToken\":\"+\\\\\\\\\"});\\n});});</script>\\n<link rel=\"stylesheet\" href=\"/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cjquery.tablesorter.styles%7Cmediawiki.toc.styles%7Cskins.vector.styles.legacy%7Cwikibase.client.init&amp;only=styles&amp;skin=vector\"/>\\n<script async=\"\" src=\"/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector\"></script>\\n<meta name=\"ResourceLoaderDynamicStyles\" content=\"\"/>\\n<link rel=\"stylesheet\" href=\"/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector\"/>\\n<meta name=\"generator\" content=\"MediaWiki 1.36.0-wmf.13\"/>\\n<meta name=\"referrer\" content=\"origin\"/>\\n<meta name=\"referrer\" content=\"origin-when-crossorigin\"/>\\n<meta name=\"referrer\" content=\"origin-when-cross-origin\"/>\\n<meta property=\"og:image\" content=\"https://upload.wikimedia.org/wikipedia/commons/thumb/8/82/SARS-CoV-2_without_background.png/1200px-SARS-CoV-2_without_background.png\"/>\\n<link rel=\"alternate\" media=\"only screen and (max-width: 720px)\" href=\"//en.m.wikipedia.org/wiki/COVID-19_vaccine\"/>\\n<link rel=\"apple-touch-icon\" href=\"/static/apple-touch/wikipedia.png\"/>\\n<link rel=\"shortcut icon\" href=\"/static/favicon/wikipedia.ico\"/>\\n<link rel=\"search\" type=\"application/opensearchdescription+xml\" href=\"/w/opensearch_desc.php\" title=\"Wikipedia (en)\"/>\\n<link rel=\"EditURI\" type=\"application/rsd+xml\" href=\"//en.wikipedia.org/w/api.php?action=rsd\"/>\\n<link rel=\"license\" href=\"//creativecommons.org/licenses/by-sa/3.0/\"/>\\n<link rel=\"canonical\" href=\"https://en.wikipedia.org/wiki/COVID-19_vaccine\"/>\\n<link rel=\"dns-prefetch\" href=\"//login.wikimedia.org\"/>\\n<link rel=\"dns-prefetch\" href=\"//meta.wikimedia.org\" />\\n</head>\\n<body class=\"mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-COVID-19_vaccine rootpage-COVID-19_vaccine skin-vector action-view skin-vector-legacy\"><div id=\"mw-page-base\" class=\"noprint\"></div>\\n<div id=\"mw-head-base\" class=\"noprint\"></div>\\n<div id=\"content\" class=\"mw-body\" role=\"main\">\\n\\t<a id=\"top\"></a>\\n\\t<div id=\"siteNotice\" class=\"mw-body-content\"><!-- CentralNotice --></div>\\n\\t<div class=\"mw-indicators mw-body-content\">\\n\\t<div id=\"mw-indicator-pp-default\" class=\"mw-indicator\"><a href=\"/wiki/Wikipedia:Protection_policy#semi\" title=\"This article is semi-protected.\"><img alt=\"Page semi-protected\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/1/1b/Semi-protection-shackle.svg/20px-Semi-protection-shackle.svg.png\" decoding=\"async\" width=\"20\" height=\"20\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/1/1b/Semi-protection-shackle.svg/30px-Semi-protection-shackle.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/1/1b/Semi-protection-shackle.svg/40px-Semi-protection-shackle.svg.png 2x\" data-file-width=\"512\" data-file-height=\"512\" /></a></div>\\n\\t</div>\\n\\t<h1 id=\"firstHeading\" class=\"firstHeading\" lang=\"en\">COVID-19 vaccine</h1>\\n\\t<div id=\"bodyContent\" class=\"mw-body-content\">\\n\\t\\t<div id=\"siteSub\" class=\"noprint\">From Wikipedia, the free encyclopedia</div>\\n\\t\\t<div id=\"contentSub\"></div>\\n\\t\\t<div id=\"contentSub2\"></div>\\n\\t\\t\\n\\t\\t<div id=\"jump-to-nav\"></div>\\n\\t\\t<a class=\"mw-jump-link\" href=\"#mw-head\">Jump to navigation</a>\\n\\t\\t<a class=\"mw-jump-link\" href=\"#searchInput\">Jump to search</a>\\n\\t\\t<div id=\"mw-content-text\" lang=\"en\" dir=\"ltr\" class=\"mw-content-ltr\"><div class=\"mw-parser-output\"><p class=\"mw-empty-elt\">\\n</p>\\n<div class=\"shortdescription nomobile noexcerpt noprint searchaux\" style=\"display:none\">Hypothetical vaccine against COVID-19</div>\\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">This article is about ongoing research for potential COVID-19 vaccines. For potential therapeutic drugs for COVID-19, see <a href=\"/wiki/COVID-19_drug_development\" title=\"COVID-19 drug development\">COVID-19 drug development</a>. For drugs that may be repurposed for treating COVID-19, see <a href=\"/wiki/COVID-19_drug_repurposing_research\" title=\"COVID-19 drug repurposing research\">COVID-19 drug repurposing research</a>.</div>\\n<p class=\"mw-empty-elt\">\\n</p>\\n<table class=\"vertical-navbox nowraplinks hlist\" style=\"float:right;clear:right;width:22.0em;margin:0 0 1.0em 1.0em;background:#f8f9fa;border:1px solid #aaa;padding:0.2em;border-spacing:0.4em 0;text-align:center;line-height:1.4em;font-size:88%\"><tbody><tr><td style=\"padding-top:0.4em;line-height:1.2em\">Part of <a href=\"/wiki/Category:COVID-19_pandemic\" title=\"Category:COVID-19 pandemic\">a series</a> on the</td></tr><tr><th style=\"padding:0.2em 0.4em 0.2em;padding-top:0;font-size:145%;line-height:1.2em\"><a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a></th></tr><tr><td style=\"padding:0.2em 0 0.4em\"><div class=\"center\"><div class=\"floatnone\"><a href=\"/wiki/File:SARS-CoV-2_without_background.png\" class=\"image\"><img alt=\"SARS-CoV-2 without background.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/SARS-CoV-2_without_background.png/110px-SARS-CoV-2_without_background.png\" decoding=\"async\" width=\"110\" height=\"110\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/SARS-CoV-2_without_background.png/165px-SARS-CoV-2_without_background.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/82/SARS-CoV-2_without_background.png/220px-SARS-CoV-2_without_background.png 2x\" data-file-width=\"1956\" data-file-height=\"1958\" /></a></div></div></td></tr><tr><td style=\"padding:0.3em 0.4em 0.3em;font-weight:bold;border-top: 1px solid #aaa; border-bottom: 1px solid #aaa;\">\\n<div class=\"hlist hlist-separated\">\\n<ul><li><a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a> (virus)</li>\\n<li><a href=\"/wiki/Coronavirus_disease_2019\" title=\"Coronavirus disease 2019\">COVID-19</a> (disease)</li></ul>\\n</div></td></tr><tr><td style=\"padding:0 0.1em 0.4em\">\\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\"><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic\" title=\"Timeline of the COVID-19 pandemic\">Timeline</a></div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\">\\n<ul><li><b>2019</b></li></ul>\\n<div class=\"hlist hlist-separated\">\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_December_2019\" class=\"mw-redirect\" title=\"Timeline of the COVID-19 pandemic in December 2019\">December</a></li></ul>\\n</div>\\n<ul><li><b>2020</b></li></ul>\\n<div class=\"hlist hlist-separated\">\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_January_2020\" title=\"Timeline of the COVID-19 pandemic in January 2020\">January</a></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_February_2020\" title=\"Timeline of the COVID-19 pandemic in February 2020\">February</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_February_2020\" title=\"Responses to the COVID-19 pandemic in February 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_March_2020\" title=\"Timeline of the COVID-19 pandemic in March 2020\">March</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_March_2020\" title=\"Responses to the COVID-19 pandemic in March 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_April_2020\" title=\"Timeline of the COVID-19 pandemic in April 2020\">April</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_April_2020\" title=\"Responses to the COVID-19 pandemic in April 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_May_2020\" title=\"Timeline of the COVID-19 pandemic in May 2020\">May</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_May_2020\" title=\"Responses to the COVID-19 pandemic in May 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_June_2020\" title=\"Timeline of the COVID-19 pandemic in June 2020\">June</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_June_2020\" title=\"Responses to the COVID-19 pandemic in June 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_July_2020\" title=\"Timeline of the COVID-19 pandemic in July 2020\">July</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_July_2020\" title=\"Responses to the COVID-19 pandemic in July 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_August_2020\" title=\"Timeline of the COVID-19 pandemic in August 2020\">August</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_August_2020\" title=\"Responses to the COVID-19 pandemic in August 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_September_2020\" title=\"Timeline of the COVID-19 pandemic in September 2020\">September</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_September_2020\" title=\"Responses to the COVID-19 pandemic in September 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_October_2020\" title=\"Timeline of the COVID-19 pandemic in October 2020\">October</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_October_2020\" title=\"Responses to the COVID-19 pandemic in October 2020\">responses</a></li></ul></li></ul>\\n</div></div></div></td>\\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\"><a href=\"/wiki/COVID-19_pandemic_by_country_and_territory\" title=\"COVID-19 pandemic by country and territory\">Locations</a></div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\">\\n<ul><li><b>By continent</b></li></ul>\\n<div class=\"hlist hlist-separated\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Africa\" title=\"COVID-19 pandemic in Africa\">Africa</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Antarctica\" title=\"COVID-19 pandemic in Antarctica\">Antarctica</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Asia\" title=\"COVID-19 pandemic in Asia\">Asia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Europe\" title=\"COVID-19 pandemic in Europe\">Europe</a></li></ul>\\n</div>\\n<div class=\"hlist hlist-separated\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_North_America\" title=\"COVID-19 pandemic in North America\">North America</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Oceania\" title=\"COVID-19 pandemic in Oceania\">Oceania</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_South_America\" title=\"COVID-19 pandemic in South America\">South America</a></li></ul>\\n</div>\\n<ul><li><b>By conveyance</b></li></ul>\\n<div class=\"hlist hlist-separated\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_on_cruise_ships\" title=\"COVID-19 pandemic on cruise ships\">Cruise ships</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_on_naval_ships\" title=\"COVID-19 pandemic on naval ships\">Naval ships</a></li></ul>\\n</div>\\n<div class=\"hlist hlist-separated\">\\n<ul><li><b><a href=\"/wiki/COVID-19_pandemic_cases\" title=\"COVID-19 pandemic cases\">Cases</a></b></li>\\n<li><b><a href=\"/wiki/COVID-19_pandemic_deaths\" title=\"COVID-19 pandemic deaths\">Deaths</a></b></li></ul>\\n</div></div></div></td>\\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\">International response</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\">\\n<ul><li><a href=\"/wiki/United_Nations_response_to_the_COVID-19_pandemic\" title=\"United Nations response to the COVID-19 pandemic\">United Nations</a></li>\\n<li><a href=\"/wiki/National_responses_to_the_COVID-19_pandemic\" title=\"National responses to the COVID-19 pandemic\">National responses</a>\\n<ul><li><a href=\"/wiki/Indian_government_response_to_the_COVID-19_pandemic\" title=\"Indian government response to the COVID-19 pandemic\">India</a></li>\\n<li><a href=\"/wiki/Philippine_government_response_to_the_COVID-19_pandemic\" title=\"Philippine government response to the COVID-19 pandemic\">Philippines</a></li>\\n<li><a href=\"/wiki/Russian_government_responses_to_the_COVID-19_pandemic\" class=\"mw-redirect\" title=\"Russian government responses to the COVID-19 pandemic\">Russia</a></li>\\n<li><a href=\"/wiki/Swedish_government_response_to_the_COVID-19_pandemic\" title=\"Swedish government response to the COVID-19 pandemic\">Sweden</a></li>\\n<li><a href=\"/wiki/U.S._federal_government_response_to_the_COVID-19_pandemic\" title=\"U.S. federal government response to the COVID-19 pandemic\">U.S.</a></li></ul></li>\\n<li><a href=\"/wiki/European_Union_response_to_the_COVID-19_pandemic\" title=\"European Union response to the COVID-19 pandemic\">European Union response</a></li>\\n<li><a href=\"/wiki/Protests_over_responses_to_the_COVID-19_pandemic\" title=\"Protests over responses to the COVID-19 pandemic\">Protests</a>\\n<ul><li><a href=\"/wiki/2020_United_States_anti-lockdown_protests\" title=\"2020 United States anti-lockdown protests\">U.S.</a></li></ul></li>\\n<li><a href=\"/wiki/Curfews_and_lockdowns_related_to_the_COVID-19_pandemic\" class=\"mw-redirect\" title=\"Curfews and lockdowns related to the COVID-19 pandemic\">Lockdowns</a></li>\\n<li><a href=\"/wiki/Evacuations_related_to_the_COVID-19_pandemic\" title=\"Evacuations related to the COVID-19 pandemic\">Evacuations</a></li>\\n<li><a href=\"/wiki/Travel_restrictions_related_to_the_COVID-19_pandemic\" title=\"Travel restrictions related to the COVID-19 pandemic\">Travel restrictions</a></li>\\n<li><a href=\"/wiki/International_aid_related_to_the_COVID-19_pandemic\" title=\"International aid related to the COVID-19 pandemic\">International aid</a></li></ul></div></div></td>\\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\\n<div class=\"NavFrame\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\">Medical response</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><div class=\"hlist hlist-separated\">\\n<ul><li><a href=\"/wiki/COVID-19_testing\" title=\"COVID-19 testing\">Disease testing</a></li>\\n<li><a class=\"mw-selflink selflink\">Vaccine research</a></li></ul>\\n</div>\\n<ul><li><a href=\"/wiki/COVID-19_drug_development\" title=\"COVID-19 drug development\">Drug development</a></li>\\n<li><a href=\"/wiki/COVID-19_drug_repurposing_research\" title=\"COVID-19 drug repurposing research\">Drug repurposing</a></li></ul></div></div></td>\\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\"><a href=\"/wiki/Impact_of_the_COVID-19_pandemic\" title=\"Impact of the COVID-19 pandemic\">Impact</a></div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\">\\n<ul><li><b>Socio-economic</b></li></ul>\\n<div class=\"hlist hlist-separated\">\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_crime\" title=\"Impact of the COVID-19 pandemic on crime\">Crime</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_death_rates_by_country\" title=\"COVID-19 pandemic death rates by country\">Death rates by country</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_people_with_disabilities\" title=\"Impact of the COVID-19 pandemic on people with disabilities\">Disability</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_domestic_violence\" title=\"Impact of the COVID-19 pandemic on domestic violence\">Domestic violence</a></li>\\n<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic\" title=\"Economic impact of the COVID-19 pandemic\">Economic</a>\\n<ul><li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_Canada\" title=\"Economic impact of the COVID-19 pandemic in Canada\">Canada</a></li>\\n<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_India\" title=\"Economic impact of the COVID-19 pandemic in India\">India</a></li>\\n<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_the_United_Kingdom\" title=\"Economic impact of the COVID-19 pandemic in the United Kingdom\">U.K.</a></li>\\n<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Economic impact of the COVID-19 pandemic in the United States\">U.S.</a></li>\\n<li><a href=\"/wiki/COVID-19_recession\" title=\"COVID-19 recession\">Recession</a></li></ul></li>\\n<li><a href=\"/wiki/Emergency_evacuation_procedures_during_the_COVID-19_pandemic\" title=\"Emergency evacuation procedures during the COVID-19 pandemic\">Emergency evacuations</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_environment\" title=\"Impact of the COVID-19 pandemic on the environment\">Environment</a></li>\\n<li><a href=\"/wiki/List_of_unproven_methods_against_COVID-19\" title=\"List of unproven methods against COVID-19\">Fake treatments</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic%E2%80%93related_famines\" class=\"mw-redirect\" title=\"COVID-19 pandemic\\xe2\\x80\\x93related famines\">Famine</a></li>\\n<li><a href=\"/wiki/Financial_market_impact_of_the_COVID-19_pandemic\" title=\"Financial market impact of the COVID-19 pandemic\">Financial markets</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_hospitals\" title=\"Impact of the COVID-19 pandemic on hospitals\">Hospitals</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_long-term_care_facilities\" title=\"Impact of the COVID-19 pandemic on long-term care facilities\">Long-term care</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_migration\" title=\"Impact of the COVID-19 pandemic on migration\">Migration</a></li>\\n<li><a href=\"/wiki/Misinformation_related_to_the_COVID-19_pandemic\" title=\"Misinformation related to the COVID-19 pandemic\">Misinformation</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_military\" title=\"Impact of the COVID-19 pandemic on the military\">Military</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_other_health_issues\" title=\"Impact of the COVID-19 pandemic on other health issues\">Other health issues</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_politics\" title=\"Impact of the COVID-19 pandemic on politics\">Politics</a></li>\\n<li><a href=\"/wiki/COVID-19_in_pregnancy\" title=\"COVID-19 in pregnancy\">Pregnancy</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_prisons\" title=\"Impact of the COVID-19 pandemic on prisons\">Prisons</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_religion\" title=\"Impact of the COVID-19 pandemic on religion\">Religion</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_Catholic_Church\" title=\"Impact of the COVID-19 pandemic on the Catholic Church\">Catholic Church</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_Hajj\" title=\"Impact of the COVID-19 pandemic on Hajj\">Hajj</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_science_and_technology\" title=\"Impact of the COVID-19 pandemic on science and technology\">Science and technology</a></li>\\n<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic\" title=\"Social impact of the COVID-19 pandemic\">Social</a>\\n<ul><li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_Republic_of_Ireland\" title=\"Social impact of the COVID-19 pandemic in the Republic of Ireland\">Ireland</a></li>\\n<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_United_Kingdom\" title=\"Social impact of the COVID-19 pandemic in the United Kingdom\">U.K.</a></li>\\n<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Social impact of the COVID-19 pandemic in the United States\">U.S.</a></li></ul></li>\\n<li><a href=\"/wiki/Strikes_during_the_COVID-19_pandemic\" title=\"Strikes during the COVID-19 pandemic\">Strikes</a></li>\\n<li><a href=\"/wiki/List_of_incidents_of_xenophobia_and_racism_related_to_the_COVID-19_pandemic\" title=\"List of incidents of xenophobia and racism related to the COVID-19 pandemic\">Xenophobia and racism</a></li>\\n<li><a href=\"/wiki/List_of_deaths_due_to_COVID-19\" title=\"List of deaths due to COVID-19\">Notable deaths</a></li></ul>\\n</div>\\n<div class=\"hlist hlist-separated\">\\n<ul><li><b>By industry</b></li></ul>\\n</div>\\n<div class=\"hlist hlist-separated\">\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_arts_and_cultural_heritage\" title=\"Impact of the COVID-19 pandemic on the arts and cultural heritage\">Arts and culture</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_aviation\" title=\"Impact of the COVID-19 pandemic on aviation\">Aviation</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_cannabis_industry\" title=\"Impact of the COVID-19 pandemic on the cannabis industry\">Cannabis</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_cinema\" title=\"Impact of the COVID-19 pandemic on cinema\">Cinema</a>\\n<ul><li><a href=\"/wiki/List_of_films_impacted_by_the_COVID-19_pandemic\" title=\"List of films impacted by the COVID-19 pandemic\">films</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_education\" title=\"Impact of the COVID-19 pandemic on education\">Education</a></li>\\n<li><a href=\"/wiki/List_of_events_affected_by_the_COVID-19_pandemic\" title=\"List of events affected by the COVID-19 pandemic\">Event cancellations</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_fashion_industry\" title=\"Impact of the COVID-19 pandemic on the fashion industry\">Fashion</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_food_industry\" title=\"Impact of the COVID-19 pandemic on the food industry\">Food</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_meat_industry_in_Canada\" title=\"Impact of the COVID-19 pandemic on the meat industry in Canada\">Canada meat</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_meat_industry_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on the meat industry in the United States\">U.S. meat</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_journalism\" title=\"Impact of the COVID-19 pandemic on journalism\">Journalism</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_music_industry\" title=\"Impact of the COVID-19 pandemic on the music industry\">Music</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_performing_arts\" title=\"Impact of the COVID-19 pandemic on the performing arts\">Performing arts</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_retail\" title=\"Impact of the COVID-19 pandemic on retail\">Retail</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_sports\" title=\"Impact of the COVID-19 pandemic on sports\">Sports</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_television\" title=\"Impact of the COVID-19 pandemic on television\">Television</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_television_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on television in the United States\">U.S.</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_tourism\" title=\"Impact of the COVID-19 pandemic on tourism\">Tourism</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_video_game_industry\" title=\"Impact of the COVID-19 pandemic on the video game industry\">Video games</a></li></ul>\\n</div></div></div></td>\\n</tr><tr><td style=\"padding:0.3em 0.4em 0.3em;font-weight:bold;border-top: 1px solid #aaa; border-bottom: 1px solid #aaa;\">\\n<a href=\"/wiki/File:SARS-CoV-2_(Wikimedia_colors).svg\" class=\"image\"><img alt=\"SARS-CoV-2 (Wikimedia colors).svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/16px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png\" decoding=\"async\" width=\"16\" height=\"16\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/24px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/32px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 2x\" data-file-width=\"666\" data-file-height=\"666\" /></a>&#160;<a href=\"/wiki/Portal:Coronavirus_disease_2019\" title=\"Portal:Coronavirus disease 2019\">COVID-19 Portal</a></td></tr><tr><td style=\"text-align:right;font-size:115%;padding-top: 0.6em;\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:COVID-19_pandemic_sidebar\" title=\"Template:COVID-19 pandemic sidebar\"><abbr title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:COVID-19_pandemic_sidebar\" title=\"Template talk:COVID-19 pandemic sidebar\"><abbr title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:COVID-19_pandemic_sidebar&amp;action=edit\"><abbr title=\"Edit this template\">e</abbr></a></li></ul></div></td></tr></tbody></table>\\n<p>A <b>COVID\\xe2\\x80\\x9119 vaccine</b> is any of several different <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a> intended to  provide <a href=\"/wiki/Acquired_immunity\" class=\"mw-redirect\" title=\"Acquired immunity\">acquired immunity</a> against <a href=\"/wiki/Coronavirus_disease_2019\" title=\"Coronavirus disease 2019\">coronavirus disease 2019</a> (COVID\\xe2\\x80\\x9119). Previous work to develop a vaccine against the coronavirus diseases <a href=\"/wiki/Severe_acute_respiratory_syndrome\" title=\"Severe acute respiratory syndrome\">SARS</a> and <a href=\"/wiki/Middle_East_respiratory_syndrome\" title=\"Middle East respiratory syndrome\">MERS</a> established knowledge about the structure and function of coronaviruses&#160;&#8211;&#32;which accelerated development during early 2020 of varied technology platforms for a COVID\\xe2\\x80\\x9119 vaccine.<sup id=\"cite_ref-diamond_1-0\" class=\"reference\"><a href=\"#cite_note-diamond-1\">&#91;1&#93;</a></sup> As of October 2020, there were 321 vaccine candidates in development, a 2.5 fold increase since April. However, no candidate has completed <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trials</a> to <a href=\"/wiki/Vaccine_trial\" title=\"Vaccine trial\">prove its safety and efficacy</a>.<sup id=\"cite_ref-thanh2_2-0\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup> In October, some 42 vaccine candidates were in <a href=\"/wiki/Clinical_research\" title=\"Clinical research\">clinical research</a>: namely 33 in <a href=\"/wiki/Phases_of_clinical_research#Phase_II\" title=\"Phases of clinical research\">Phase I\\xe2\\x80\\x93II trials</a> and 9 in <a href=\"/wiki/Phases_of_clinical_research#Phase_III\" title=\"Phases of clinical research\">Phase II\\xe2\\x80\\x93III trials</a>.<sup id=\"cite_ref-thanh2_2-1\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-london_3-0\" class=\"reference\"><a href=\"#cite_note-london-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-milken_4-0\" class=\"reference\"><a href=\"#cite_note-milken-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-who-tracker_5-0\" class=\"reference\"><a href=\"#cite_note-who-tracker-5\">&#91;5&#93;</a></sup>\\n</p><p>The <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> (WHO), the <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">Coalition for Epidemic Preparedness Innovations</a> (CEPI), and the <a href=\"/wiki/Gates_Foundation\" class=\"mw-redirect\" title=\"Gates Foundation\">Gates Foundation</a> (GF) are committing money and organizational resources for the prospect that several vaccines will be needed to prevent continuing COVID\\xe2\\x80\\x9119 infection.<sup id=\"cite_ref-gates2_6-0\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup> The CEPI, which is organizing a <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\">&#160;</span>billion worldwide fund for rapid investment and development of vaccine candidates,<sup id=\"cite_ref-cepi-fund_7-0\" class=\"reference\"><a href=\"#cite_note-cepi-fund-7\">&#91;7&#93;</a></sup> indicated in September that clinical data to support licensure may be available by the end of 2020.<sup id=\"cite_ref-thanh2_2-2\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup> On 4<span class=\"nowrap\">&#160;</span>May 2020, the WHO organized a <a href=\"/wiki/Telethon\" title=\"Telethon\">telethon</a> which received <span style=\"white-space: nowrap\">US$8</span>.1<span class=\"nowrap\">&#160;</span>billion in pledges from forty countries to support rapid development of vaccines to prevent COVID\\xe2\\x80\\x9119 infections.<sup id=\"cite_ref-waked_8-0\" class=\"reference\"><a href=\"#cite_note-waked-8\">&#91;8&#93;</a></sup> At the same time, the WHO also announced the deployment of an international \"Solidarity trial\" for simultaneous evaluation of several vaccine candidates reaching <a href=\"/wiki/Phases_of_clinical_research#Phase_II\" title=\"Phases of clinical research\">Phase II\\xe2\\x80\\x93III clinical trials</a>.<sup id=\"cite_ref-who-accel_9-0\" class=\"reference\"><a href=\"#cite_note-who-accel-9\">&#91;9&#93;</a></sup>\\n</p>\\n<style data-mw-deduplicate=\"TemplateStyles:r886046785\">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class=\"toclimit-3\"><div id=\"toc\" class=\"toc\" role=\"navigation\" aria-labelledby=\"mw-toc-heading\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2 id=\"mw-toc-heading\">Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\\n<ul>\\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Synopsis_and_history\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Synopsis and history</span></a>\\n<ul>\\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#SARS_and_MERS\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">SARS and MERS</span></a></li>\\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#COVID-19_vaccine_development_in_2020\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">COVID-19 vaccine development in 2020</span></a></li>\\n</ul>\\n</li>\\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Global_development\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Global development</span></a>\\n<ul>\\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#International_organizations\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">International organizations</span></a></li>\\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#National_governments\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">National governments</span></a></li>\\n</ul>\\n</li>\\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#WHO_COVID-19_trials\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">WHO COVID-19 trials</span></a>\\n<ul>\\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Adaptive_design_for_the_Solidarity_trial\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Adaptive design for the Solidarity trial</span></a></li>\\n</ul>\\n</li>\\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#Partnerships,_competition,_and_distribution\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Partnerships, competition, and distribution</span></a></li>\\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Compressed_timelines\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Compressed timelines</span></a></li>\\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Technology_platforms\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Technology platforms</span></a></li>\\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#Vaccine_candidates\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Vaccine candidates</span></a>\\n<ul>\\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Clinical_trials_started_in_2020\"><span class=\"tocnumber\">7.1</span> <span class=\"toctext\">Clinical trials started in 2020</span></a></li>\\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Preclinical_research\"><span class=\"tocnumber\">7.2</span> <span class=\"toctext\">Preclinical research</span></a>\\n<ul>\\n<li class=\"toclevel-3 tocsection-15\"><a href=\"#Scheduled_Phase_I_trials_in_2020\"><span class=\"tocnumber\">7.2.1</span> <span class=\"toctext\">Scheduled Phase I trials in 2020</span></a></li>\\n</ul>\\n</li>\\n<li class=\"toclevel-2 tocsection-16\"><a href=\"#Non-specific_vaccines\"><span class=\"tocnumber\">7.3</span> <span class=\"toctext\">Non-specific vaccines</span></a></li>\\n<li class=\"toclevel-2 tocsection-17\"><a href=\"#Use_of_adjuvants\"><span class=\"tocnumber\">7.4</span> <span class=\"toctext\">Use of adjuvants</span></a></li>\\n</ul>\\n</li>\\n<li class=\"toclevel-1 tocsection-18\"><a href=\"#Potential_limitations\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Potential limitations</span></a>\\n<ul>\\n<li class=\"toclevel-2 tocsection-19\"><a href=\"#Biosafety_concern\"><span class=\"tocnumber\">8.1</span> <span class=\"toctext\">Biosafety concern</span></a></li>\\n<li class=\"toclevel-2 tocsection-20\"><a href=\"#Antibody-dependent_enhancement\"><span class=\"tocnumber\">8.2</span> <span class=\"toctext\">Antibody-dependent enhancement</span></a></li>\\n<li class=\"toclevel-2 tocsection-21\"><a href=\"#Efficacy\"><span class=\"tocnumber\">8.3</span> <span class=\"toctext\">Efficacy</span></a></li>\\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#Enrollment_of_participants_in_trials\"><span class=\"tocnumber\">8.4</span> <span class=\"toctext\">Enrollment of participants in trials</span></a></li>\\n<li class=\"toclevel-2 tocsection-23\"><a href=\"#Cost\"><span class=\"tocnumber\">8.5</span> <span class=\"toctext\">Cost</span></a></li>\\n<li class=\"toclevel-2 tocsection-24\"><a href=\"#Rollout\"><span class=\"tocnumber\">8.6</span> <span class=\"toctext\">Rollout</span></a></li>\\n</ul>\\n</li>\\n<li class=\"toclevel-1 tocsection-25\"><a href=\"#Proposed_challenge_studies\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Proposed challenge studies</span></a></li>\\n<li class=\"toclevel-1 tocsection-26\"><a href=\"#Licensure\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">Licensure</span></a>\\n<ul>\\n<li class=\"toclevel-2 tocsection-27\"><a href=\"#World_Health_Organization\"><span class=\"tocnumber\">10.1</span> <span class=\"toctext\">World Health Organization</span></a></li>\\n<li class=\"toclevel-2 tocsection-28\"><a href=\"#Europe\"><span class=\"tocnumber\">10.2</span> <span class=\"toctext\">Europe</span></a></li>\\n<li class=\"toclevel-2 tocsection-29\"><a href=\"#United_States\"><span class=\"tocnumber\">10.3</span> <span class=\"toctext\">United States</span></a></li>\\n<li class=\"toclevel-2 tocsection-30\"><a href=\"#Emergency_use_authorization\"><span class=\"tocnumber\">10.4</span> <span class=\"toctext\">Emergency use authorization</span></a></li>\\n<li class=\"toclevel-2 tocsection-31\"><a href=\"#Postmarketing_surveillance\"><span class=\"tocnumber\">10.5</span> <span class=\"toctext\">Postmarketing surveillance</span></a></li>\\n</ul>\\n</li>\\n<li class=\"toclevel-1 tocsection-32\"><a href=\"#Commercialization_and_equitable_access\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">Commercialization and equitable access</span></a>\\n<ul>\\n<li class=\"toclevel-2 tocsection-33\"><a href=\"#Commercialization_issues\"><span class=\"tocnumber\">11.1</span> <span class=\"toctext\">Commercialization issues</span></a></li>\\n<li class=\"toclevel-2 tocsection-34\"><a href=\"#Sovereignty\"><span class=\"tocnumber\">11.2</span> <span class=\"toctext\">Sovereignty</span></a></li>\\n<li class=\"toclevel-2 tocsection-35\"><a href=\"#Equitable_access\"><span class=\"tocnumber\">11.3</span> <span class=\"toctext\">Equitable access</span></a></li>\\n</ul>\\n</li>\\n<li class=\"toclevel-1 tocsection-36\"><a href=\"#Supply_chain\"><span class=\"tocnumber\">12</span> <span class=\"toctext\">Supply chain</span></a>\\n<ul>\\n<li class=\"toclevel-2 tocsection-37\"><a href=\"#Logistics\"><span class=\"tocnumber\">12.1</span> <span class=\"toctext\">Logistics</span></a></li>\\n<li class=\"toclevel-2 tocsection-38\"><a href=\"#Manufacturing_capacity\"><span class=\"tocnumber\">12.2</span> <span class=\"toctext\">Manufacturing capacity</span></a></li>\\n<li class=\"toclevel-2 tocsection-39\"><a href=\"#Cold_chain\"><span class=\"tocnumber\">12.3</span> <span class=\"toctext\">Cold chain</span></a></li>\\n<li class=\"toclevel-2 tocsection-40\"><a href=\"#Air_and_land_transport\"><span class=\"tocnumber\">12.4</span> <span class=\"toctext\">Air and land transport</span></a></li>\\n<li class=\"toclevel-2 tocsection-41\"><a href=\"#Security_and_corruption\"><span class=\"tocnumber\">12.5</span> <span class=\"toctext\">Security and corruption</span></a></li>\\n<li class=\"toclevel-2 tocsection-42\"><a href=\"#National_infrastructure\"><span class=\"tocnumber\">12.6</span> <span class=\"toctext\">National infrastructure</span></a></li>\\n</ul>\\n</li>\\n<li class=\"toclevel-1 tocsection-43\"><a href=\"#Liability\"><span class=\"tocnumber\">13</span> <span class=\"toctext\">Liability</span></a></li>\\n<li class=\"toclevel-1 tocsection-44\"><a href=\"#Misinformation\"><span class=\"tocnumber\">14</span> <span class=\"toctext\">Misinformation</span></a></li>\\n<li class=\"toclevel-1 tocsection-45\"><a href=\"#See_also\"><span class=\"tocnumber\">15</span> <span class=\"toctext\">See also</span></a></li>\\n<li class=\"toclevel-1 tocsection-46\"><a href=\"#References\"><span class=\"tocnumber\">16</span> <span class=\"toctext\">References</span></a></li>\\n<li class=\"toclevel-1 tocsection-47\"><a href=\"#Further_reading\"><span class=\"tocnumber\">17</span> <span class=\"toctext\">Further reading</span></a></li>\\n<li class=\"toclevel-1 tocsection-48\"><a href=\"#External_links\"><span class=\"tocnumber\">18</span> <span class=\"toctext\">External links</span></a></li>\\n</ul>\\n</div>\\n</div>\\n<h2><span class=\"mw-headline\" id=\"Synopsis_and_history\">Synopsis and history</span></h2>\\n<h3><span class=\"mw-headline\" id=\"SARS_and_MERS\">SARS and MERS</span></h3>\\n<p>Vaccines have been produced against several animal diseases caused by coronaviruses, including as of 2003 <a href=\"/wiki/Infectious_bronchitis_virus\" class=\"mw-redirect\" title=\"Infectious bronchitis virus\">infectious bronchitis virus</a> in birds, <a href=\"/wiki/Canine_coronavirus\" title=\"Canine coronavirus\">canine coronavirus</a>, and <a href=\"/wiki/Feline_coronavirus\" title=\"Feline coronavirus\">feline coronavirus</a>.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> Previous projects to develop vaccines for viruses in the family <i><a href=\"/wiki/Coronaviridae\" title=\"Coronaviridae\">Coronaviridae</a></i> that affect humans have been aimed at <a href=\"/wiki/Severe_acute_respiratory_syndrome\" title=\"Severe acute respiratory syndrome\">severe acute respiratory syndrome</a> (SARS) and <a href=\"/wiki/Middle_East_respiratory_syndrome\" title=\"Middle East respiratory syndrome\">Middle East respiratory syndrome</a> (MERS). Vaccines against SARS<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> and MERS<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> have been tested in non-human <a href=\"/wiki/Model_organism\" title=\"Model organism\">animals</a>.\\n</p><p>According to studies published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and <a href=\"/wiki/List_of_national_public_health_agencies\" title=\"List of national public health agencies\">public health agencies</a> around the world at that time.<sup id=\"cite_ref-&#80;MID_15655773_13-0\" class=\"reference\"><a href=\"#cite_note-PMID_15655773-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-&#80;MID_15885812_14-0\" class=\"reference\"><a href=\"#cite_note-PMID_15885812-14\">&#91;14&#93;</a></sup><sup id=\"cite_ref-&#80;MID_16453264_15-0\" class=\"reference\"><a href=\"#cite_note-PMID_16453264-15\">&#91;15&#93;</a></sup> As of 2020, there is no cure or protective vaccine proven to be safe and effective against SARS in humans.<sup id=\"cite_ref-JiangFutureVirology_16-0\" class=\"reference\"><a href=\"#cite_note-JiangFutureVirology-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\\n</p><p>There is also no proven vaccine against MERS.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.<sup id=\"cite_ref-JiangFutureVirology_16-1\" class=\"reference\"><a href=\"#cite_note-JiangFutureVirology-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-Butler3oct2013_19-0\" class=\"reference\"><a href=\"#cite_note-Butler3oct2013-19\">&#91;19&#93;</a></sup> As of March 2020, there was one (DNA based) MERS vaccine which completed Phase<span class=\"nowrap\">&#160;</span>I clinical trials in humans,<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> and three others in progress, all of which are viral-vectored vaccines: two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), and one MVA-vectored (MVA-MERS-S).<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"COVID-19_vaccine_development_in_2020\">COVID-19 vaccine development in 2020</span></h3>\\n<p>A vaccine for an infectious disease has never before been produced in less than several years, and no vaccine exists for preventing a <a href=\"/wiki/Coronavirus\" title=\"Coronavirus\">coronavirus</a> infection in humans.<sup id=\"cite_ref-gates2_6-1\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup> After the coronavirus was detected in December 2019,<sup id=\"cite_ref-who-time_22-0\" class=\"reference\"><a href=\"#cite_note-who-time-22\">&#91;22&#93;</a></sup> the <a href=\"/wiki/Nucleic_acid_sequence\" title=\"Nucleic acid sequence\">genetic sequence</a> of COVID\\xe2\\x80\\x9119 was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten development of a preventive vaccine.<sup id=\"cite_ref-thanh_23-0\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-gates1_24-0\" class=\"reference\"><a href=\"#cite_note-gates1-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-Fauci_25-0\" class=\"reference\"><a href=\"#cite_note-Fauci-25\">&#91;25&#93;</a></sup>\\n</p><p>In February 2020, the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> (WHO) said it did not expect a vaccine against <a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">severe acute respiratory syndrome coronavirus 2</a> (SARS-CoV-2), the causative virus, to become available in less than 18 months.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup> The rapidly growing infection rate of COVID\\xe2\\x80\\x9119 worldwide during early 2020 stimulated international alliances and government efforts to urgently organize resources to make multiple vaccines on shortened timelines,<sup id=\"cite_ref-who-accel_9-1\" class=\"reference\"><a href=\"#cite_note-who-accel-9\">&#91;9&#93;</a></sup> with four vaccine candidates entering human evaluation in March (see the table of <a href=\"#Clinical_trials_started_in_2020\">clinical trials started in 2020</a>, below).<sup id=\"cite_ref-thanh_23-1\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-yamey_27-0\" class=\"reference\"><a href=\"#cite_note-yamey-27\">&#91;27&#93;</a></sup>\\n</p><p>In April 2020, the WHO estimated a total cost of <span style=\"white-space: nowrap\">US$8</span><span class=\"nowrap\">&#160;</span>billion to develop a suite of three or more vaccines having different technologies and distribution.<sup id=\"cite_ref-who-accel_9-2\" class=\"reference\"><a href=\"#cite_note-who-accel-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-cepi-landmark_28-0\" class=\"reference\"><a href=\"#cite_note-cepi-landmark-28\">&#91;28&#93;</a></sup>\\nBy April 2020, \"almost 80 companies and institutes in 19 countries\" were working on this virtual gold rush.<sup id=\"cite_ref-cssa_29-0\" class=\"reference\"><a href=\"#cite_note-cssa-29\">&#91;29&#93;</a></sup> Also in April, CEPI estimated that as many as six of the vaccine candidates against COVID\\xe2\\x80\\x9119 should be chosen by international coalitions for development through Phase<span class=\"nowrap\">&#160;</span>II\\xe2\\x80\\x93III trials, and three should be streamlined through regulatory and quality assurance for eventual licensing at a total cost of at least <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\">&#160;</span>billion.<sup id=\"cite_ref-thanh2_2-3\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-yamey_27-1\" class=\"reference\"><a href=\"#cite_note-yamey-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-gates2_6-2\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup> Another analysis estimates 10 candidates will need simultaneous initial development, before a select few are chosen for the final path to licensing.<sup id=\"cite_ref-gates2_6-3\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup>\\n</p><p>In July 2020, Anglo-American intelligence and security organisations of the respective governments and armed forces, as the UK\\'s <a href=\"/wiki/National_Cyber_Security_Centre_(United_Kingdom)\" title=\"National Cyber Security Centre (United Kingdom)\">National Cyber Security Centre</a>, together with the Canadian <a href=\"/wiki/Communications_Security_Establishment\" title=\"Communications Security Establishment\">Communications Security Establishment</a>, the United States Department for Homeland Security <a href=\"/wiki/Cybersecurity_and_Infrastructure_Security_Agency\" title=\"Cybersecurity and Infrastructure Security Agency\">Cybersecurity Infrastructure Security Agency</a>, and the US <a href=\"/wiki/National_Security_Agency\" title=\"National Security Agency\">National Security Agency</a> (NSA) alleged that Russian state-backed hackers may have been trying to steal COVID-19 treatment and vaccine research from academic and pharmaceutical institutions in other countries; Russia has denied it.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Global_development\">Global development</span></h2>\\n<p>During 2020, major changes in the overall effort of developing COVID-19 vaccines since early in the year have been the increasing number of collaborations of the <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">multinational pharmaceutical industry</a> with national governments, and the diversity and growing number of <a href=\"/wiki/Biotechnology#Industrial\" title=\"Biotechnology\">biotechnology companies</a> in many countries focusing on a COVID-19 vaccine.<sup id=\"cite_ref-thanh2_2-4\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup> According to CEPI, the general geographic distribution of COVID\\xe2\\x80\\x9119 vaccine development involves organizations in North America having about 40% of the world\\'s COVID-19 vaccine research, compared with 30% in Asia and <a href=\"/wiki/Australia\" title=\"Australia\">Australia</a>, 26% in Europe, and a few projects in <a href=\"/wiki/South_America\" title=\"South America\">South America</a> and Africa.<sup id=\"cite_ref-thanh2_2-5\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-thanh_23-2\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"International_organizations\">International organizations</span></h3>\\n<p>Organizations have formed international alliances to expedite vaccine development and prepare for distribution, including the WHO which is facilitating collaboration, accelerated research, and international communications on a scale unprecedented in history, beginning in early May by raising <span style=\"white-space: nowrap\">US$8.1</span><span class=\"nowrap\">&#160;</span>billion in pledges.<sup id=\"cite_ref-waked_8-1\" class=\"reference\"><a href=\"#cite_note-waked-8\">&#91;8&#93;</a></sup> The WHO also implemented <i>Covid-19 Vaccines Global Access</i> (COVAX) for coordinating global vaccine development, the vaccine pillar of <i><a href=\"/wiki/Access_to_COVID-19_Tools_Accelerator\" title=\"Access to COVID-19 Tools Accelerator\">Access to COVID-19 Tools (ACT) Accelerator</a></i> in collaboration with <a href=\"/wiki/GAVI\" title=\"GAVI\">GAVI</a> and the <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">Coalition for Epidemic Preparedness Innovations</a> (CEPI).<sup id=\"cite_ref-thanh2_2-6\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-who-covax_31-0\" class=\"reference\"><a href=\"#cite_note-who-covax-31\">&#91;31&#93;</a></sup><sup id=\"cite_ref-covax-gavi_32-0\" class=\"reference\"><a href=\"#cite_note-covax-gavi-32\">&#91;32&#93;</a></sup> In July, the WHO announced that 165 countries, representing up to 60% of the world population, had agreed to a WHO COVAX plan for fair and equitable distribution of an eventual licensed vaccine, assuring that each participating country would receive a guaranteed share of doses to vaccinate the most vulnerable 20% of its population by the end of 2021.<sup id=\"cite_ref-covax_33-0\" class=\"reference\"><a href=\"#cite_note-covax-33\">&#91;33&#93;</a></sup> COVAX has the goal to accelerate the development and manufacturing of COVID-19 vaccines, and to assure that access to licensed vaccines is equitably provided to all countries.<sup id=\"cite_ref-covax-gavi_32-1\" class=\"reference\"><a href=\"#cite_note-covax-gavi-32\">&#91;32&#93;</a></sup>\\n</p><p>CEPI is working with international health authorities and vaccine developers to create another <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\">&#160;</span>billion fund in a global partnership between public, private, philanthropic, and civil society organizations for accelerated research and clinical testing of eight vaccine candidates, with the 2020\\xe2\\x80\\x9321 goal of supporting several candidates for full development to licensing.<sup id=\"cite_ref-thanh2_2-7\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-yamey_27-2\" class=\"reference\"><a href=\"#cite_note-yamey-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-cepi-landmark_28-1\" class=\"reference\"><a href=\"#cite_note-cepi-landmark-28\">&#91;28&#93;</a></sup> The United Kingdom, Canada, Belgium, Norway, Switzerland, Germany and the Netherlands had already donated <span style=\"white-space: nowrap\">US$915</span><span class=\"nowrap\">&#160;</span>million to CEPI by early May.<sup id=\"cite_ref-waked_8-2\" class=\"reference\"><a href=\"#cite_note-waked-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-reuters_34-0\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup> The <a href=\"/wiki/Bill_%26_Melinda_Gates_Foundation\" title=\"Bill &amp; Melinda Gates Foundation\">Bill &amp; Melinda Gates Foundation</a> (Gates Foundation), a private <a href=\"/wiki/Charitable_organization\" title=\"Charitable organization\">charitable organization</a> dedicated to vaccine research and distribution, is donating <span style=\"white-space: nowrap\">US$250</span><span class=\"nowrap\">&#160;</span>million in support of CEPI for research and public educational support on COVID\\xe2\\x80\\x9119 vaccines.<sup id=\"cite_ref-sanger_35-0\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup>\\n</p><p>The Global Research Collaboration for Infectious Disease Preparedness (GLoPID-R) is working closely with the WHO and member states to identify priorities for funding specific researches needed for a COVID\\xe2\\x80\\x9119 vaccine, coordinating among the international funding and research organizations to maintain updated information on vaccine progress and avoid duplicate funding.<sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup><sup id=\"cite_ref-can-research_38-0\" class=\"reference\"><a href=\"#cite_note-can-research-38\">&#91;38&#93;</a></sup>\\nThe International Severe Acute Respiratory and Emerging Infection Consortium is organizing and disseminating clinical information on COVID\\xe2\\x80\\x9119 research to inform public health policy on eventual vaccine distribution.<sup id=\"cite_ref-isaric_39-0\" class=\"reference\"><a href=\"#cite_note-isaric-39\">&#91;39&#93;</a></sup>\\n</p><p>On 4 June, a <a href=\"/wiki/Virtual_community\" title=\"Virtual community\">virtual</a> summit was coordinated from London, UK, among private and government representatives of 52 countries, including 35 <a href=\"/wiki/Head_of_state\" title=\"Head of state\">heads of state</a> from <a href=\"/wiki/Group_of_Seven\" title=\"Group of Seven\">G7</a> and <a href=\"/wiki/G20\" title=\"G20\">G20</a> nations, to raise <span style=\"white-space: nowrap\">US$8.8</span><span class=\"nowrap\">&#160;</span>billion in support of the <a href=\"/wiki/GAVI\" title=\"GAVI\">Global Alliance for Vaccines and Immunisation (GAVI)</a> to prepare for COVID\\xe2\\x80\\x9119 vaccinations of 300<span class=\"nowrap\">&#160;</span>million children in under-developed countries through 2025.<sup id=\"cite_ref-gavi-summit_40-0\" class=\"reference\"><a href=\"#cite_note-gavi-summit-40\">&#91;40&#93;</a></sup> Major contributions were <span style=\"white-space: nowrap\">US$1.6</span><span class=\"nowrap\">&#160;</span>billion from The Gates Foundation<sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup> and <span style=\"white-space: nowrap\">GB\\xc2\\xa3330</span><span class=\"nowrap\">&#160;</span>million per year over five years by the UK government (approximately <span style=\"white-space: nowrap\">US$2.1</span><span class=\"nowrap\">&#160;</span>billion in June 2020).<sup id=\"cite_ref-gavi-summit_40-1\" class=\"reference\"><a href=\"#cite_note-gavi-summit-40\">&#91;40&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"National_governments\">National governments</span></h3>\\n<p>National governments dedicating resources for national or international investments in vaccine research, development, and manufacturing beginning in 2020 included the <a href=\"/wiki/Government_of_Canada\" title=\"Government of Canada\">Canadian government</a> which announced <span style=\"white-space: nowrap\">CA$275</span><span class=\"nowrap\">&#160;</span>million in funding for 96 research vaccine research projects at Canadian companies and universities, with plans to establish a \"vaccine bank\" of several new vaccines that could be used if another coronavirus outbreak occurs.<sup id=\"cite_ref-abedi_42-0\" class=\"reference\"><a href=\"#cite_note-abedi-42\">&#91;42&#93;</a></sup><sup id=\"cite_ref-can-funding_43-0\" class=\"reference\"><a href=\"#cite_note-can-funding-43\">&#91;43&#93;</a></sup> A further investment of <span style=\"white-space: nowrap\">CA$1.1</span><span class=\"nowrap\">&#160;</span>billion was added to support clinical trials in Canada and develop manufacturing and supply chains for vaccines.<sup id=\"cite_ref-can-research_38-1\" class=\"reference\"><a href=\"#cite_note-can-research-38\">&#91;38&#93;</a></sup> On 4<span class=\"nowrap\">&#160;</span>May, the Canadian government committed <span style=\"white-space: nowrap\">CA$850</span><span class=\"nowrap\">&#160;</span>million to the WHO\\'s live streaming effort to raise <span style=\"white-space: nowrap\">US$8</span><span class=\"nowrap\">&#160;</span>billion for COVID\\xe2\\x80\\x9119 vaccines and preparedness.<sup id=\"cite_ref-aiello_44-0\" class=\"reference\"><a href=\"#cite_note-aiello-44\">&#91;44&#93;</a></sup>\\n</p><p>In <a href=\"/wiki/China\" title=\"China\">China</a>, the <a href=\"/wiki/Government_of_China\" title=\"Government of China\">government</a> is providing low-rate loans to a vaccine developer through its <a href=\"/wiki/People%27s_Bank_of_China\" title=\"People&#39;s Bank of China\">central bank</a>, and has \"quickly made land available for the company\" to build production plants.<sup id=\"cite_ref-reuters_34-1\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup> As of June 2020, six of the eleven COVID\\xe2\\x80\\x9119 vaccine candidates in early-stage human testing were developed by Chinese organizations.<sup id=\"cite_ref-sanger_35-1\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup> Three Chinese vaccine companies and research institutes are supported by the government for financing research, conducting clinical trials, and manufacturing the most promising vaccine candidates, while prioritizing rapid evidence of efficacy over safety.<sup id=\"cite_ref-takada_45-0\" class=\"reference\"><a href=\"#cite_note-takada-45\">&#91;45&#93;</a></sup> On 18 May, China had pledged <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\">&#160;</span>billion to support overall efforts by the WHO for programs against COVID\\xe2\\x80\\x9119.<sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup> On 22 July, China additionally announced that it plans to provide a US$1 billion loan to make its vaccine accessible for countries in <a href=\"/wiki/Latin_America\" title=\"Latin America\">Latin America</a> and the <a href=\"/wiki/Caribbean\" title=\"Caribbean\">Caribbean</a>.<sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup> On August 24, <a href=\"/wiki/Premier_of_the_People%27s_Republic_of_China\" title=\"Premier of the People&#39;s Republic of China\">Chinese Premier</a> <a href=\"/wiki/Li_Keqiang\" title=\"Li Keqiang\">Li Keqiang</a> announced it would provide five Southeast Asian countries of Cambodia, Laos, Myanmar, Thailand and Vietnam priority access to the vaccine once it was fully developed.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup>\\n</p><p>Among European Union countries, France announced a <span style=\"white-space: nowrap\">US$4.9</span><span class=\"nowrap\">&#160;</span>million investment in a COVID\\xe2\\x80\\x9119 vaccine research consortium via CEPI involving the <a href=\"/wiki/Institut_Pasteur\" class=\"mw-redirect\" title=\"Institut Pasteur\">Institut Pasteur</a>, Themis Bioscience (<a href=\"/wiki/Vienna\" title=\"Vienna\">Vienna</a>, <a href=\"/wiki/Austria\" title=\"Austria\">Austria</a>), and the <a href=\"/wiki/University_of_Pittsburgh\" title=\"University of Pittsburgh\">University of Pittsburgh</a>, bringing CEPI\\'s total investment in COVID\\xe2\\x80\\x9119 vaccine development to <span style=\"white-space: nowrap\">US$480</span><span class=\"nowrap\">&#160;</span>million by May.<sup id=\"cite_ref-cepi-4-30_49-0\" class=\"reference\"><a href=\"#cite_note-cepi-4-30-49\">&#91;49&#93;</a></sup><sup id=\"cite_ref-cepi3-19_50-0\" class=\"reference\"><a href=\"#cite_note-cepi3-19-50\">&#91;50&#93;</a></sup> In March, the <a href=\"/wiki/European_Commission\" title=\"European Commission\">European Commission</a> made an \\xe2\\x82\\xac80<span class=\"nowrap\">&#160;</span>million investment in <a href=\"/wiki/CureVac\" title=\"CureVac\">CureVac</a>, a German biotechnology company, to develop a <a href=\"/wiki/Messenger_RNA\" title=\"Messenger RNA\">mRNA</a> vaccine.<sup id=\"cite_ref-curevac_51-0\" class=\"reference\"><a href=\"#cite_note-curevac-51\">&#91;51&#93;</a></sup> The German government announced a separate \\xe2\\x82\\xac300<span class=\"nowrap\">&#160;</span>million investment in CureVac in June.<sup id=\"cite_ref-52\" class=\"reference\"><a href=\"#cite_note-52\">&#91;52&#93;</a></sup> Belgium, Norway, Switzerland, Germany, and the Netherlands have been major contributors to the CEPI effort for COVID\\xe2\\x80\\x9119 vaccine research in Europe.<sup id=\"cite_ref-reuters_34-2\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup>\\n</p><p>In April, the UK government formed a COVID\\xe2\\x80\\x9119 vaccine <a href=\"/wiki/Task_force\" title=\"Task force\">task force</a> to stimulate British efforts for rapidly developing a vaccine through collaborations of industry, universities, and government agencies across the vaccine development pipeline, including clinical trial placement at UK hospitals, regulations for approval, and eventual manufacturing.<sup id=\"cite_ref-morriss_53-0\" class=\"reference\"><a href=\"#cite_note-morriss-53\">&#91;53&#93;</a></sup> The vaccine development initiatives at the University of Oxford and <a href=\"/wiki/Imperial_College_London\" title=\"Imperial College London\">Imperial College of London</a> were financed with <span style=\"white-space: nowrap\">GB\\xc2\\xa344</span><span class=\"nowrap\">&#160;</span>million in April.<sup id=\"cite_ref-gartner_54-0\" class=\"reference\"><a href=\"#cite_note-gartner-54\">&#91;54&#93;</a></sup><sup id=\"cite_ref-oxford_55-0\" class=\"reference\"><a href=\"#cite_note-oxford-55\">&#91;55&#93;</a></sup>\\n</p>\\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:312px;\"><a href=\"/wiki/File:The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways,_such_as_Emergency_Use_Authorization,_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_(49948301848).jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/85/The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways%2C_such_as_Emergency_Use_Authorization%2C_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_%2849948301848%29.jpg/310px-thumbnail.jpg\" decoding=\"async\" width=\"310\" height=\"270\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/85/The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways%2C_such_as_Emergency_Use_Authorization%2C_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_%2849948301848%29.jpg/465px-thumbnail.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/85/The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways%2C_such_as_Emergency_Use_Authorization%2C_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_%2849948301848%29.jpg/620px-thumbnail.jpg 2x\" data-file-width=\"1051\" data-file-height=\"915\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways,_such_as_Emergency_Use_Authorization,_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_(49948301848).jpg\" class=\"internal\" title=\"Enlarge\"></a></div>US <a href=\"/wiki/Government_Accountability_Office\" title=\"Government Accountability Office\">Government Accountability Office</a> diagram comparing a traditional vaccine development timeline to a possible expedited timeline</div></div></div>\\n<p>The United States <a href=\"/wiki/Biomedical_Advanced_Research_and_Development_Authority\" title=\"Biomedical Advanced Research and Development Authority\">Biomedical Advanced Research and Development Authority</a> (BARDA), a federal agency that funds disease-fighting technology, announced investments of nearly <span style=\"white-space: nowrap\">US$1</span><span class=\"nowrap\">&#160;</span>billion to support American COVID\\xe2\\x80\\x9119 vaccine development, and preparation for manufacturing the most promising candidates. On 16 April, BARDA made a <span style=\"white-space: nowrap\">US$483</span><span class=\"nowrap\">&#160;</span>million investment in the vaccine developer, <a href=\"/wiki/Moderna\" title=\"Moderna\">Moderna</a> and its partner, <a href=\"/wiki/Johnson_%26_Johnson\" title=\"Johnson &amp; Johnson\">Johnson &amp; Johnson</a>.<sup id=\"cite_ref-reuters_34-3\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-kuznia_56-0\" class=\"reference\"><a href=\"#cite_note-kuznia-56\">&#91;56&#93;</a></sup> BARDA has an additional <span style=\"white-space: nowrap\">US$4</span><span class=\"nowrap\">&#160;</span>billion to spend on vaccine development, and will have roles in other American investment for development of six to eight vaccine candidates to be in clinical studies over 2020\\xe2\\x80\\x9321 by companies such as <a href=\"/wiki/Sanofi_Pasteur\" title=\"Sanofi Pasteur\">Sanofi Pasteur</a> and <a href=\"/wiki/Regeneron\" class=\"mw-redirect\" title=\"Regeneron\">Regeneron</a>.<sup id=\"cite_ref-kuznia_56-1\" class=\"reference\"><a href=\"#cite_note-kuznia-56\">&#91;56&#93;</a></sup><sup id=\"cite_ref-lee_57-0\" class=\"reference\"><a href=\"#cite_note-lee-57\">&#91;57&#93;</a></sup> On 15 May, the US government announced federal funding for a fast-track program called <a href=\"/wiki/Operation_Warp_Speed\" title=\"Operation Warp Speed\">Operation Warp Speed</a>, which has the goals of placing diverse vaccine candidates in clinical trials by the fall of 2020, and manufacturing 300<span class=\"nowrap\">&#160;</span>million doses of a licensed vaccine by January 2021. The project chief advisor is <a href=\"/wiki/Moncef_Slaoui\" title=\"Moncef Slaoui\">Moncef Slaoui</a> and its <a href=\"/wiki/Chief_Operating_Officer\" class=\"mw-redirect\" title=\"Chief Operating Officer\">Chief Operating Officer</a> is Army General <a href=\"/wiki/Gustave_F._Perna\" title=\"Gustave F. Perna\">Gustave Perna</a>.<sup id=\"cite_ref-58\" class=\"reference\"><a href=\"#cite_note-58\">&#91;58&#93;</a></sup><sup id=\"cite_ref-59\" class=\"reference\"><a href=\"#cite_note-59\">&#91;59&#93;</a></sup> In June, the Warp Speed team said it would work with seven companies developing COVID\\xe2\\x80\\x9119 vaccine candidates: <a href=\"/wiki/Moderna\" title=\"Moderna\">Moderna</a>, <a href=\"/wiki/Johnson_%26_Johnson_Pharmaceutical_Research_and_Development\" title=\"Johnson &amp; Johnson Pharmaceutical Research and Development\">Johnson &amp; Johnson</a>, <a href=\"/wiki/Merck_%26_Co.\" title=\"Merck &amp; Co.\">Merck</a>, <a href=\"/wiki/Pfizer\" title=\"Pfizer\">Pfizer</a>, and the <a href=\"/wiki/University_of_Oxford\" title=\"University of Oxford\">University of Oxford</a> in collaboration with <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a>, as well as two others.<sup id=\"cite_ref-60\" class=\"reference\"><a href=\"#cite_note-60\">&#91;60&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"WHO_COVID-19_trials\">WHO COVID-19 trials</span></h2>\\n<p>In April 2020, the WHO published an \"R&amp;D Blueprint (for the) novel Coronavirus\" (Blueprint). The Blueprint documented a \"large, international, multi-site, individually randomized controlled clinical trial\" to allow \"the concurrent evaluation of the benefits and risks of each promising candidate vaccine within 3-6 months of it being made available for the trial.\" The Blueprint listed a <i>Global Target Product Profile</i> (TPP) for COVID\\xe2\\x80\\x9119, identifying favorable attributes of safe and effective vaccines under two broad categories: \"vaccines for the long-term protection of people at higher risk of COVID\\xe2\\x80\\x9119, such as healthcare workers\", and other vaccines to provide rapid-response immunity for new outbreaks.<sup id=\"cite_ref-who-accel_9-3\" class=\"reference\"><a href=\"#cite_note-who-accel-9\">&#91;9&#93;</a></sup> The international TPP team was formed to 1) assess the development of the most promising candidate vaccines; 2) map candidate vaccines and their clinical trial worldwide, publishing a frequently-updated \"landscape\" of vaccines in development;<sup id=\"cite_ref-who-tracker_5-1\" class=\"reference\"><a href=\"#cite_note-who-tracker-5\">&#91;5&#93;</a></sup> 3) rapidly evaluate and screen for the most promising candidate vaccines simultaneously before they are tested in humans; and 4) design and coordinate a multiple-site, international <a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">randomized controlled trial</a>&#160;&#8211;&#32;the \"Solidarity trial\" for vaccines<sup id=\"cite_ref-who-accel_9-4\" class=\"reference\"><a href=\"#cite_note-who-accel-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-solidarity-vacc_61-0\" class=\"reference\"><a href=\"#cite_note-solidarity-vacc-61\">&#91;61&#93;</a></sup>&#160;&#8211;&#32;to enable simultaneous evaluation of the benefits and risks of different vaccine candidates under clinical trials in countries where there are high rates of COVID\\xe2\\x80\\x9119 disease, ensuring fast interpretation and sharing of results around the world.<sup id=\"cite_ref-who-accel_9-5\" class=\"reference\"><a href=\"#cite_note-who-accel-9\">&#91;9&#93;</a></sup> The WHO vaccine coalition will prioritize which vaccines should go into Phase<span class=\"nowrap\">&#160;</span>II and III clinical trials, and determine harmonized Phase<span class=\"nowrap\">&#160;</span>III protocols for all vaccines achieving the <a href=\"/wiki/Pivotal_trial\" title=\"Pivotal trial\">pivotal trial</a> stage.<sup id=\"cite_ref-who-accel_9-6\" class=\"reference\"><a href=\"#cite_note-who-accel-9\">&#91;9&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Adaptive_design_for_the_Solidarity_trial\">Adaptive design for the Solidarity trial</span></h3>\\n<p>A clinical trial design in progress may be modified as an <a href=\"/wiki/Adaptive_design_(medicine)\" title=\"Adaptive design (medicine)\">\"adaptive design\"</a> if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment.<sup id=\"cite_ref-pallmann_62-0\" class=\"reference\"><a href=\"#cite_note-pallmann-62\">&#91;62&#93;</a></sup><sup id=\"cite_ref-fda-adaptive_63-0\" class=\"reference\"><a href=\"#cite_note-fda-adaptive-63\">&#91;63&#93;</a></sup> The WHO Solidarity trial of multiple vaccines in clinical studies during 2020 will apply adaptive design to rapidly alter trial parameters across all study sites as results emerge.<sup id=\"cite_ref-solidarity-vacc_61-1\" class=\"reference\"><a href=\"#cite_note-solidarity-vacc-61\">&#91;61&#93;</a></sup> Candidate vaccines may be added to the Solidarity trial as they become available if priority criteria are met, while vaccine candidates showing poor evidence of safety or efficacy compared to placebo or other vaccines will be dropped from the international trial.<sup id=\"cite_ref-solidarity-vacc_61-2\" class=\"reference\"><a href=\"#cite_note-solidarity-vacc-61\">&#91;61&#93;</a></sup>\\n</p><p>Adaptive designs within ongoing Phase<span class=\"nowrap\">&#160;</span>II\\xe2\\x80\\x93III clinical trials on candidate vaccines may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, avoiding duplication of research efforts, and enhancing coordination of design changes for the Solidarity trial across its international locations.<sup id=\"cite_ref-solidarity-vacc_61-3\" class=\"reference\"><a href=\"#cite_note-solidarity-vacc-61\">&#91;61&#93;</a></sup><sup id=\"cite_ref-pallmann_62-1\" class=\"reference\"><a href=\"#cite_note-pallmann-62\">&#91;62&#93;</a></sup>\\n</p>\\n<h2><span id=\"Partnerships.2C_competition.2C_and_distribution\"></span><span class=\"mw-headline\" id=\"Partnerships,_competition,_and_distribution\">Partnerships, competition, and distribution</span></h2>\\n<p>Large pharmaceutical companies with experience in making vaccines at scale, including Johnson &amp; Johnson, AstraZeneca, and <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a> (GSK), are forming alliances with <a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">biotechnology</a> companies, national governments, and universities to accelerate progression to an effective vaccine.<sup id=\"cite_ref-reuters_34-4\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-sanger_35-2\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup> To combine financial and manufacturing capabilities for a pandemic <a href=\"/wiki/Adjuvant\" title=\"Adjuvant\">adjuvanted</a> vaccine technology, GSK joined with <a href=\"/wiki/Sanofi\" title=\"Sanofi\">Sanofi</a> in an uncommon partnership of <a href=\"/wiki/Multinational_corporation\" title=\"Multinational corporation\">multinational companies</a> to support accelerated vaccine development.<sup id=\"cite_ref-64\" class=\"reference\"><a href=\"#cite_note-64\">&#91;64&#93;</a></sup>\\n</p><p>During a pandemic on the rapid timeline and scale of COVID\\xe2\\x80\\x9119 infections during 2020, international organizations like the WHO and CEPI, vaccine developers, governments, and industry are evaluating distribution of the eventual vaccine(s).<sup id=\"cite_ref-who-accel_9-7\" class=\"reference\"><a href=\"#cite_note-who-accel-9\">&#91;9&#93;</a></sup> Individual countries producing a vaccine may be persuaded to favor the highest bidder for manufacturing or provide first-service to their own country.<sup id=\"cite_ref-gates2_6-4\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-gates1_24-1\" class=\"reference\"><a href=\"#cite_note-gates1-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-reuters_34-5\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup> Experts emphasize that licensed vaccines should be available and affordable for people at the frontline of <a href=\"/wiki/Healthcare\" class=\"mw-redirect\" title=\"Healthcare\">healthcare</a> and having the greatest need.<sup id=\"cite_ref-gates2_6-5\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-gates1_24-2\" class=\"reference\"><a href=\"#cite_note-gates1-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-reuters_34-6\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup> Under their agreement with AstraZeneca, the University of Oxford vaccine development team and UK government agreed that UK citizens would not get preferential access to a new COVID\\xe2\\x80\\x9119 vaccine developed by the taxpayer-funded university, but rather consented to having a licensed vaccine distributed multinationally in cooperation with the WHO.<sup id=\"cite_ref-gartner_54-1\" class=\"reference\"><a href=\"#cite_note-gartner-54\">&#91;54&#93;</a></sup> Several companies plan to initially manufacture a vaccine at low cost, then increase costs for <a href=\"/wiki/Profit_(economics)\" title=\"Profit (economics)\">profitability</a> later if annual vaccinations are needed and as countries build stock for future needs.<sup id=\"cite_ref-reuters_34-7\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup>\\n</p><p>The WHO and CEPI are developing financial resources and guidelines for global deployment of several safe, effective COVID\\xe2\\x80\\x9119 vaccines, recognizing the need is different across countries and population segments.<sup id=\"cite_ref-thanh2_2-8\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-who-accel_9-8\" class=\"reference\"><a href=\"#cite_note-who-accel-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-yamey_27-3\" class=\"reference\"><a href=\"#cite_note-yamey-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-solidarity-vacc_61-4\" class=\"reference\"><a href=\"#cite_note-solidarity-vacc-61\">&#91;61&#93;</a></sup> For example, successful COVID\\xe2\\x80\\x9119 vaccines would likely be allocated first to <a href=\"/wiki/Health_care\" title=\"Health care\">healthcare personnel</a> and populations at greatest risk of severe illness and death from COVID\\xe2\\x80\\x9119 infection, such as the elderly or <a href=\"/wiki/Poverty\" title=\"Poverty\">densely-populated impoverished people</a>.<sup id=\"cite_ref-covax-gavi_32-2\" class=\"reference\"><a href=\"#cite_note-covax-gavi-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-who-blueprint_65-0\" class=\"reference\"><a href=\"#cite_note-who-blueprint-65\">&#91;65&#93;</a></sup> The WHO, CEPI, and GAVI have expressed concerns that affluent countries should not receive priority access to the global supply of eventual COVID\\xe2\\x80\\x9119 vaccines, but rather protecting healthcare personnel and people at high risk of infection are needed to address public health concerns and reduce economic impact of the pandemic.<sup id=\"cite_ref-thanh_23-3\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-yamey_27-4\" class=\"reference\"><a href=\"#cite_note-yamey-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-covax-gavi_32-3\" class=\"reference\"><a href=\"#cite_note-covax-gavi-32\">&#91;32&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Compressed_timelines\">Compressed timelines</span></h2>\\n<p><a href=\"/wiki/Geopolitics\" title=\"Geopolitics\">Geopolitical</a> issues, safety concerns for vulnerable populations, and manufacturing challenges for producing billions of doses are compressing schedules to shorten the standard vaccine development timeline, in some cases combining clinical trial steps over months, a process typically conducted sequentially over years.<sup id=\"cite_ref-sanger_35-3\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup> As an example, Chinese vaccine developers and the government <a href=\"/wiki/Chinese_Center_for_Disease_Control_and_Prevention\" title=\"Chinese Center for Disease Control and Prevention\">Chinese Center for Disease Control and Prevention</a> began their efforts in January 2020,<sup id=\"cite_ref-66\" class=\"reference\"><a href=\"#cite_note-66\">&#91;66&#93;</a></sup> and by March were pursuing numerous candidates on short timelines, with the goal to showcase Chinese technology strengths over those of the United States, and to reassure the Chinese people about the quality of vaccines produced in China.<sup id=\"cite_ref-sanger_35-4\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-wee_67-0\" class=\"reference\"><a href=\"#cite_note-wee-67\">&#91;67&#93;</a></sup>\\n</p><p>In the haste to provide a vaccine on a rapid timeline for the COVID\\xe2\\x80\\x9119 pandemic, developers and governments are accepting a high risk of <a href=\"/wiki/Short-circuit_test\" title=\"Short-circuit test\">\"short-circuiting\"</a> the vaccine development process,<sup id=\"cite_ref-reuters_34-8\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup> with one industry executive saying: \"The crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop\".<sup id=\"cite_ref-reuters_34-9\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup> Multiple steps along the entire development path are evaluated, including the level of acceptable toxicity of the vaccine (its safety), targeting vulnerable populations, the need for vaccine efficacy breakthroughs, the duration of vaccination protection, special delivery systems (such as oral or nasal, rather than by injection), dose regimen, stability and storage characteristics, emergency use authorization before formal licensing, optimal manufacturing for scaling to billions of doses, and dissemination of the licensed vaccine.<sup id=\"cite_ref-gates2_6-6\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-simpson_68-0\" class=\"reference\"><a href=\"#cite_note-simpson-68\">&#91;68&#93;</a></sup> From Phase I clinical trials, 84\\xe2\\x80\\x9390%<sup id=\"cite_ref-thanh_23-4\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-bio_69-0\" class=\"reference\"><a href=\"#cite_note-bio-69\">&#91;69&#93;</a></sup>of vaccine candidates fail to make it to final approval during development, and from Phase III, 25.7% fail<sup id=\"cite_ref-bio_69-1\" class=\"reference\"><a href=\"#cite_note-bio-69\">&#91;69&#93;</a></sup>&#160;&#8211;&#32;the investment by a manufacturer in a vaccine candidate may exceed <span style=\"white-space: nowrap\">US$1</span><span class=\"nowrap\">&#160;</span>billion and end with millions of useless doses.<sup id=\"cite_ref-gates2_6-7\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-reuters_34-10\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-sanger_35-5\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup> In the case of COVID\\xe2\\x80\\x9119 specifically, a vaccine efficacy of 70% may be enough to stop the pandemic, but if it has only 60% efficacy, outbreaks may continue; an efficacy of less than 60% will not provide enough <a href=\"/wiki/Herd_immunity\" title=\"Herd immunity\">herd immunity</a> to stop the spread of the virus alone.<sup id=\"cite_ref-gates2_6-8\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup>\\n</p><p>As the pandemic expands during 2020, research at universities is obstructed by <a href=\"/wiki/Social_distancing\" title=\"Social distancing\">physical distancing</a> and closing of laboratories.<sup id=\"cite_ref-70\" class=\"reference\"><a href=\"#cite_note-70\">&#91;70&#93;</a></sup><sup id=\"cite_ref-71\" class=\"reference\"><a href=\"#cite_note-71\">&#91;71&#93;</a></sup> Globally, supplies critical to vaccine research and development are increasingly scarce due to international competition or national <a href=\"/wiki/Sequestration_(law)\" title=\"Sequestration (law)\">sequestration</a>.<sup id=\"cite_ref-takada_45-1\" class=\"reference\"><a href=\"#cite_note-takada-45\">&#91;45&#93;</a></sup> Timelines for conducting clinical research&#160;&#8211;&#32;normally a sequential process requiring years&#160;&#8211;&#32;are being compressed into safety, efficacy, and dosing trials running simultaneously over months, potentially compromising safety assurance.<sup id=\"cite_ref-reuters_34-11\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-sanger_35-6\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Technology_platforms\">Technology platforms</span></h2>\\n<p>CEPI scientists reported in September 2020 that nine different technology platforms &#160;&#8211;&#32; with the technology of numerous candidates remaining undefined &#160;&#8211;&#32; were under research and development during 2020 to create an effective vaccine against COVID\\xe2\\x80\\x9119.<sup id=\"cite_ref-thanh2_2-9\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup> According to CEPI, most of the platforms of vaccine candidates in clinical trials as of September are focused on the <a href=\"/wiki/Coronavirus#Microbiology\" title=\"Coronavirus\">coronavirus spike protein and its variants</a> as the primary <a href=\"/wiki/Antigen\" title=\"Antigen\">antigen</a> of COVID-19 infection.<sup id=\"cite_ref-thanh2_2-10\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup> Platforms being developed in 2020 involve <a href=\"/wiki/Nucleic_acid\" title=\"Nucleic acid\">nucleic acid</a> technologies (<a href=\"/wiki/RNA\" title=\"RNA\">RNA</a> and <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a>), <a href=\"/wiki/Viral_vector#Vaccines\" title=\"Viral vector\">non-replicating viral vectors</a>, <a href=\"/wiki/Peptide\" title=\"Peptide\">peptides</a>, <a href=\"/wiki/Recombinant_protein\" class=\"mw-redirect\" title=\"Recombinant protein\">recombinant proteins</a>, live <a href=\"/wiki/Attenuated_virus\" class=\"mw-redirect\" title=\"Attenuated virus\">attenuated viruses</a>, and <a href=\"/wiki/Virus_processing#Viral_inactivation\" class=\"mw-redirect\" title=\"Virus processing\">inactivated viruses</a>.<sup id=\"cite_ref-thanh2_2-11\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-diamond_1-1\" class=\"reference\"><a href=\"#cite_note-diamond-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-gates2_6-9\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-thanh_23-5\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup>\\n</p><p>Many vaccine technologies being developed for COVID\\xe2\\x80\\x9119 are not like vaccines already in use to prevent influenza, but rather are using \"next-generation\" strategies for precision on COVID\\xe2\\x80\\x9119 infection mechanisms.<sup id=\"cite_ref-thanh2_2-12\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-diamond_1-2\" class=\"reference\"><a href=\"#cite_note-diamond-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-thanh_23-6\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup> Vaccine platforms in development may improve flexibility for antigen manipulation and effectiveness for targeting mechanisms of COVID\\xe2\\x80\\x9119 infection in susceptible population subgroups, such as healthcare workers, the elderly, children, pregnant women, and people with existing weakened <a href=\"/wiki/Immune_system\" title=\"Immune system\">immune systems</a>.<sup id=\"cite_ref-thanh2_2-13\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-thanh_23-7\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup>\\n</p>\\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:402px;\"><a href=\"/wiki/File:Vaccine_candidate_mechanisms_for_SARS-CoV-2_(49948301838).jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg/400px-Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg\" decoding=\"async\" width=\"400\" height=\"158\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg/600px-Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg/800px-Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg 2x\" data-file-width=\"1051\" data-file-height=\"414\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Vaccine_candidate_mechanisms_for_SARS-CoV-2_(49948301838).jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Potential candidates for forming SARS-CoV-2 proteins to prompt an immune response</div></div></div>\\n<table class=\"wikitable\" style=\"text-align: right;\">\\n<caption>COVID\\xe2\\x80\\x9119: Vaccine technology platforms, September 2020<sup id=\"cite_ref-london_3-1\" class=\"reference\"><a href=\"#cite_note-london-3\">&#91;3&#93;</a></sup>\\n</caption>\\n<tbody><tr>\\n<th>Molecular platform ^\\n</th>\\n<th>Total number <br />of candidates\\n</th>\\n<th>Number of candidates <br />in human trials\\n</th></tr>\\n<tr>\\n<td style=\"text-align:left\"> Non-replicating viral vector\\n</td>\\n<td><center>31</center>\\n</td>\\n<td><center>4 <sup id=\"cite_ref-phase2orhigher_72-0\" class=\"reference\"><a href=\"#cite_note-phase2orhigher-72\">&#91;i&#93;</a></sup></center>\\n</td></tr>\\n<tr>\\n<td style=\"text-align:left\"> RNA-based\\n</td>\\n<td><center>31</center>\\n</td>\\n<td><center>3 <sup id=\"cite_ref-phase2orhigher_72-1\" class=\"reference\"><a href=\"#cite_note-phase2orhigher-72\">&#91;i&#93;</a></sup></center>\\n</td></tr>\\n<tr>\\n<td style=\"text-align:left\"> Inactivated virus\\n</td>\\n<td><center>14</center>\\n</td>\\n<td><center>3 <sup id=\"cite_ref-phase2orhigher_72-2\" class=\"reference\"><a href=\"#cite_note-phase2orhigher-72\">&#91;i&#93;</a></sup></center>\\n</td></tr>\\n<tr>\\n<td style=\"text-align:left\"> Protein subunit\\n</td>\\n<td><center>76</center>\\n</td>\\n<td><center>3 <sup id=\"cite_ref-phase2orhigher_72-3\" class=\"reference\"><a href=\"#cite_note-phase2orhigher-72\">&#91;i&#93;</a></sup></center>\\n</td></tr>\\n<tr>\\n<td style=\"text-align:left\"> DNA-based\\n</td>\\n<td><center>19</center>\\n</td>\\n<td><center>0 <sup id=\"cite_ref-phase2orhigher_72-4\" class=\"reference\"><a href=\"#cite_note-phase2orhigher-72\">&#91;i&#93;</a></sup></center>\\n</td></tr>\\n<tr>\\n<td style=\"text-align:left\"> Replicating viral vector\\n</td>\\n<td><center>21</center>\\n</td>\\n<td><center>0</center>\\n</td></tr>\\n<tr>\\n<td style=\"text-align:left\"> Virus-like particle\\n</td>\\n<td><center>13</center>\\n</td>\\n<td><center>0</center>\\n</td></tr>\\n<tr>\\n<td style=\"text-align:left\"> Live attenuated virus\\n</td>\\n<td><center>4</center>\\n</td>\\n<td><center>0</center>\\n</td></tr>\\n</tbody></table>\\n<div class=\"reflist\" style=\"list-style-type: lower-roman;\">\\n<div class=\"mw-references-wrap\"><ol class=\"references\">\\n<li id=\"cite_note-phase2orhigher-72\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-phase2orhigher_72-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-phase2orhigher_72-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-phase2orhigher_72-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-phase2orhigher_72-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-phase2orhigher_72-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\">One or more candidates in Phase II or Phase II\\xe2\\x80\\x93III trials</span>\\n</li>\\n</ol></div></div>\\n<p>^ <small>technologies for dozens of candidates are unannounced or \"unknown\"</small><sup id=\"cite_ref-london_3-2\" class=\"reference\"><a href=\"#cite_note-london-3\">&#91;3&#93;</a></sup>\\n</p><p><br />\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Vaccine_candidates\">Vaccine candidates</span></h2>\\n<p>CEPI classifies development stages for vaccines as \"exploratory\" (planning and designing a candidate, having no evaluation <a href=\"/wiki/In_vivo\" title=\"In vivo\">in vivo</a>), \"preclinical\" (in vivo evaluation with preparation for manufacturing a compound to test in humans), or <a href=\"/wiki/Phases_of_clinical_research#Phase_I\" title=\"Phases of clinical research\">initiation of Phase<span class=\"nowrap\">&#160;</span>I safety studies in healthy people</a>.<sup id=\"cite_ref-thanh2_2-14\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup> Some 321 total vaccine candidates are in development as either confirmed projects in clinical trials or in early-stage \"exploratory\" or \"preclinical\" development, as of September.<sup id=\"cite_ref-thanh2_2-15\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup>\\n</p><p>Phase<span class=\"nowrap\">&#160;</span>I trials test primarily for safety and preliminary dosing in a few dozen healthy subjects, while Phase<span class=\"nowrap\">&#160;</span>II trials&#160;&#8211;&#32;following success in Phase<span class=\"nowrap\">&#160;</span>I&#160;&#8211;&#32;evaluate <a href=\"/wiki/Immunogenicity\" title=\"Immunogenicity\">immunogenicity</a>, dose levels (efficacy based on <a href=\"/wiki/Biomarker\" title=\"Biomarker\">biomarkers</a>) and adverse effects of the candidate vaccine, typically in hundreds of people.<sup id=\"cite_ref-Vaccines.gov_73-0\" class=\"reference\"><a href=\"#cite_note-Vaccines.gov-73\">&#91;72&#93;</a></sup><sup id=\"cite_ref-fda-ddp_74-0\" class=\"reference\"><a href=\"#cite_note-fda-ddp-74\">&#91;73&#93;</a></sup> A Phase<span class=\"nowrap\">&#160;</span>I\\xe2\\x80\\x93II trial consists of preliminary safety and immunogenicity testing, is typically randomized, placebo-controlled, while determining more precise, effective doses.<sup id=\"cite_ref-fda-ddp_74-1\" class=\"reference\"><a href=\"#cite_note-fda-ddp-74\">&#91;73&#93;</a></sup>  Phase<span class=\"nowrap\">&#160;</span>III trials typically involve more participants at multiple sites, include a <a href=\"/wiki/Control_group\" class=\"mw-redirect\" title=\"Control group\">control group</a>, and test effectiveness of the vaccine to prevent the disease (an \"interventional\" or \"pivotal\" trial), while monitoring for <a href=\"/wiki/Adverse_effect\" title=\"Adverse effect\">adverse effects</a> at the optimal dose.<sup id=\"cite_ref-Vaccines.gov_73-1\" class=\"reference\"><a href=\"#cite_note-Vaccines.gov-73\">&#91;72&#93;</a></sup><sup id=\"cite_ref-fda-ddp_74-2\" class=\"reference\"><a href=\"#cite_note-fda-ddp-74\">&#91;73&#93;</a></sup> Definition of vaccine safety, efficacy, and <a href=\"/wiki/Clinical_endpoint\" title=\"Clinical endpoint\">clinical endpoints</a> in a Phase<span class=\"nowrap\">&#160;</span>III trial may vary between the trials of different companies, such as defining the degree of side effects, infection or amount of transmission, and whether the vaccine prevents moderate or severe COVID\\xe2\\x80\\x9119 infection.<sup id=\"cite_ref-cohen6-19_75-0\" class=\"reference\"><a href=\"#cite_note-cohen6-19-75\">&#91;74&#93;</a></sup><sup id=\"cite_ref-cdc-eff_76-0\" class=\"reference\"><a href=\"#cite_note-cdc-eff-76\">&#91;75&#93;</a></sup><sup id=\"cite_ref-77\" class=\"reference\"><a href=\"#cite_note-77\">&#91;76&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Clinical_trials_started_in_2020\">Clinical trials started in 2020</span></h3>\\n<table class=\"wikitable sortable\">\\n<caption>COVID\\xe2\\x80\\x9119: candidate vaccines in Phase I\\xe2\\x80\\x93III trials<sup id=\"cite_ref-london_3-3\" class=\"reference\"><a href=\"#cite_note-london-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-milken_4-1\" class=\"reference\"><a href=\"#cite_note-milken-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-who-tracker_5-2\" class=\"reference\"><a href=\"#cite_note-who-tracker-5\">&#91;5&#93;</a></sup>\\n</caption>\\n<tbody><tr>\\n<th>Vaccine candidates<br />Developers, sponsors\\n</th>\\n<th>Technology\\n</th>\\n<th>Current phase (participants)<br />Design\\n</th>\\n<th>Completed phase<sup id=\"cite_ref-78\" class=\"reference\"><a href=\"#cite_note-78\">&#91;a&#93;</a></sup> (participants)<br />Immune response, adverse effects\\n</th>\\n<th>Clinical trial site(s)\\n</th>\\n<th>Duration<sup id=\"cite_ref-79\" class=\"reference\"><a href=\"#cite_note-79\">&#91;b&#93;</a></sup>\\n</th></tr>\\n<tr>\\n<td><b>AZD1222</b><wbr /><sup id=\"cite_ref-81\" class=\"reference\"><a href=\"#cite_note-81\">&#91;c&#93;</a></sup><sup id=\"cite_ref-NCT04400838_82-0\" class=\"reference\"><a href=\"#cite_note-NCT04400838-82\">&#91;78&#93;</a></sup><sup id=\"cite_ref-EudraCT-2020-001228-32_83-0\" class=\"reference\"><a href=\"#cite_note-EudraCT-2020-001228-32-83\">&#91;79&#93;</a></sup><sup id=\"cite_ref-ISRCTN89951424_84-0\" class=\"reference\"><a href=\"#cite_note-ISRCTN89951424-84\">&#91;80&#93;</a></sup><br /><a href=\"/wiki/University_of_Oxford\" title=\"University of Oxford\">University of Oxford</a>, <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a>\\n</td>\\n<td>Modified <a href=\"/wiki/Chimpanzee\" title=\"Chimpanzee\">chimp</a> <a href=\"/wiki/Adenoviridae\" title=\"Adenoviridae\">adenovirus</a> <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">vector</a> (ChAdOx1)\\n</td>\\n<td data-sort-value=\"P3 30000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\" class=\"table-yes2\"><b>Phase III</b> (30,000)<wbr /><br />Interventional; <a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">randomized, placebo-controlled study</a> for efficacy, safety, and immunogenicity.<sup id=\"cite_ref-NCT04516746_85-0\" class=\"reference\"><a href=\"#cite_note-NCT04516746-85\">&#91;81&#93;</a></sup>  Brazil (5,000)<sup id=\"cite_ref-86\" class=\"reference\"><a href=\"#cite_note-86\">&#91;82&#93;</a></sup> International enrolment of the Phase III trial was paused on 8 September 2020 due to an adverse neurological event in one participant,<sup id=\"cite_ref-phillips_87-0\" class=\"reference\"><a href=\"#cite_note-phillips-87\">&#91;83&#93;</a></sup><sup id=\"cite_ref-88\" class=\"reference\"><a href=\"#cite_note-88\">&#91;84&#93;</a></sup> but resumed on 12 September after it was determined the symptoms were unrelated to the vaccine.<sup id=\"cite_ref-89\" class=\"reference\"><a href=\"#cite_note-89\">&#91;85&#93;</a></sup>\\n</td>\\n<td data-sort-value=\"P1-2 543\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I-II</b> (543)<wbr /><br />Spike-specific antibodies at day 28; <a href=\"/wiki/Neutralizing_antibody\" title=\"Neutralizing antibody\">neutralizing antibodies</a> after a <a href=\"/wiki/Booster_dose\" title=\"Booster dose\">booster dose</a> at day 56. <b>Adverse effects</b>: pain at the injection site, headache, fever, chills, <a href=\"/wiki/Myalgia\" title=\"Myalgia\">muscle ache</a>, <a href=\"/wiki/Malaise\" title=\"Malaise\">malaise</a> in more than 60% of participants; <a href=\"/wiki/Paracetamol\" title=\"Paracetamol\">paracetamol</a> allowed for some participants to increase tolerability<sup id=\"cite_ref-folegatti_90-0\" class=\"reference\"><a href=\"#cite_note-folegatti-90\">&#91;86&#93;</a></sup>\\n</td>\\n<td>20 in the UK, <a href=\"/wiki/S%C3%A3o_Paulo\" title=\"S\\xc3\\xa3o Paulo\">S\\xc3\\xa3o Paulo</a>\\n</td>\\n<td data-sort-value=\"2021-08\">May 2020&#160;&#8211;&#32;Aug 2021\\n</td></tr>\\n<tr>\\n<td><i>Unnamed</i><wbr /><sup id=\"cite_ref-ChiCTR2000034780_91-0\" class=\"reference\"><a href=\"#cite_note-ChiCTR2000034780-91\">&#91;87&#93;</a></sup><br /><a href=\"/wiki/China_National_Pharmaceutical_Group\" title=\"China National Pharmaceutical Group\">Sinopharm</a>: Beijing Institute of Biological Products, Wuhan Institute of Biological Products\\n</td>\\n<td><a href=\"/wiki/Inactivated_vaccine\" title=\"Inactivated vaccine\">Inactivated</a> <a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a> (<a href=\"/wiki/Vero_cell\" title=\"Vero cell\">vero cells</a>)\\n</td>\\n<td data-sort-value=\"P3 48000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\" class=\"table-yes2\"><b>Phase III</b> (48,000)<wbr /><br />Randomized, double-blind, parallel placebo-controlled, to evaluate safety and protective efficacy in the <a href=\"/wiki/United_Arab_Emirates\" title=\"United Arab Emirates\">United Arab Emirates</a>, <a href=\"/wiki/Bahrain\" title=\"Bahrain\">Bahrain</a>, <a href=\"/wiki/Jordan\" title=\"Jordan\">Jordan</a>,<sup id=\"cite_ref-92\" class=\"reference\"><a href=\"#cite_note-92\">&#91;88&#93;</a></sup> and <a href=\"/wiki/Argentina\" title=\"Argentina\">Argentina</a><sup id=\"cite_ref-93\" class=\"reference\"><a href=\"#cite_note-93\">&#91;89&#93;</a></sup>\\n<p>On September 14, UAE approved Sinopharm\\'s vaccine for emergency use by front-line healthcare workers following successful interim results in the Phase III trials.<sup id=\"cite_ref-UAE_approval_94-0\" class=\"reference\"><a href=\"#cite_note-UAE_approval-94\">&#91;90&#93;</a></sup> \\n</p>\\n</td>\\n<td data-sort-value=\"P1-2 320\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I-II</b> (320)<wbr /><br />Neutralizing antibodies at day 14 after 2 injections;  <b>Adverse effects</b>: injection site pain and fever, which were mild and self-limiting; no serious effects<sup id=\"cite_ref-95\" class=\"reference\"><a href=\"#cite_note-95\">&#91;91&#93;</a></sup>\\n</td>\\n<td><a href=\"/wiki/Jiaozuo\" title=\"Jiaozuo\">Jiaozuo</a>, <a href=\"/wiki/Abu_Dhabi\" title=\"Abu Dhabi\">Abu Dhabi</a>\\n</td>\\n<td data-sort-value=\"2021-11\">Jul 2020&#160;&#8211;&#32;Jul 2021 in Abu Dhabi\\n</td></tr>\\n<tr>\\n<td><b>Ad5-nCoV</b><wbr /><br /><a href=\"/wiki/CanSino_Biologics\" title=\"CanSino Biologics\">CanSinoBIO</a>, Beijing Institute of Biotechnology of the <a href=\"/wiki/Academy_of_Military_Medical_Sciences\" title=\"Academy of Military Medical Sciences\">Academy of Military Medical Sciences</a><sup id=\"cite_ref-Ad5-nCoV-manufacture_97-0\" class=\"reference\"><a href=\"#cite_note-Ad5-nCoV-manufacture-97\">&#91;d&#93;</a></sup>\\n</td>\\n<td><a href=\"/wiki/Recombinant_vaccine\" class=\"mw-redirect\" title=\"Recombinant vaccine\">Recombinant</a> <a href=\"/wiki/Adenoviridae\" title=\"Adenoviridae\">adenovirus</a> <a href=\"/wiki/Serotype\" title=\"Serotype\">type</a> 5 <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">vector</a>\\n</td>\\n<td data-sort-value=\"P3 40,000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\" class=\"table-yes2\"><b>Phase III</b> (40,000)<wbr /><br />global multi-center, randomized, double-blind, placebo-controlled to evaluate efficacy, safety and immunogenicity<sup id=\"cite_ref-98\" class=\"reference\"><a href=\"#cite_note-98\">&#91;93&#93;</a></sup>\\n</td>\\n<td data-sort-value=\"P2 508\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\" class=\"table-partial\"><b>Phase II</b> (508)<wbr /><br />Neutralizing antibody and <a href=\"/wiki/T_cell\" title=\"T cell\">T cell</a> responses. <b>Adverse effects</b>: moderate over 7 days: 74% had fever, pain, fatigue<sup id=\"cite_ref-zhu7-20_99-0\" class=\"reference\"><a href=\"#cite_note-zhu7-20-99\">&#91;94&#93;</a></sup>\\n</td>\\n<td><a href=\"/wiki/Wuhan\" title=\"Wuhan\">Wuhan</a>, China\\n<p><a href=\"/wiki/Pakistan\" title=\"Pakistan\">Pakistan</a>\\n</p>\\n</td>\\n<td data-sort-value=\"2020-12\">Mar \\xe2\\x80\\x93 Dec 2020 in China\\n<p>Sep 2020 \\xe2\\x80\\x93 December 2021 in Pakistan\\n</p>\\n</td></tr>\\n<tr>\\n<td><b><a href=\"/wiki/CoronaVac\" title=\"CoronaVac\">CoronaVac</a></b><sup id=\"cite_ref-NCT04383574_100-0\" class=\"reference\"><a href=\"#cite_note-NCT04383574-100\">&#91;95&#93;</a></sup><sup id=\"cite_ref-NCname=_nct04456595=_101-0\" class=\"reference\"><a href=\"#cite_note-NCname=_nct04456595=-101\">&#91;96&#93;</a></sup><sup id=\"cite_ref-102\" class=\"reference\"><a href=\"#cite_note-102\">&#91;97&#93;</a></sup><br /><a href=\"/wiki/Sinovac_Biotech\" title=\"Sinovac Biotech\">Sinovac</a>\\n</td>\\n<td><a href=\"/wiki/Inactivated_vaccine\" title=\"Inactivated vaccine\">Inactivated</a> <a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a>\\n</td>\\n<td data-sort-value=\"P3 23,490\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\" class=\"table-yes2\"><b>Phase III</b> (23,490)<wbr /><br />Double-blind, randomized, placebo-controlled to evaluate efficacy and safety in <a href=\"/wiki/Brazil\" title=\"Brazil\">Brazil</a> (8,870); <a href=\"/wiki/Indonesia\" title=\"Indonesia\">Indonesia</a> (1,620); <a href=\"/wiki/Turkey\" title=\"Turkey\">Turkey</a> (13,000)\\n</td>\\n<td data-sort-value=\"P2 600\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\" class=\"table-partial\"><b>Phase II</b> (600)<wbr /><br /><a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>. Immunogenicity eliciting 92% seroconversion at lower dose; <b>Adverse effects</b>: mild in severity, pain at injection site<sup id=\"cite_ref-103\" class=\"reference\"><a href=\"#cite_note-103\">&#91;98&#93;</a></sup>\\n</td>\\n<td>2 in China; 12 in Brazil; Bandung, Indonesia<sup id=\"cite_ref-104\" class=\"reference\"><a href=\"#cite_note-104\">&#91;99&#93;</a></sup>\\n</td>\\n<td data-sort-value=\"2020-07\"><div class=\"plainlist\"><ul><li style=\"margin-top:.3em\">Jul 2020&#160;&#8211;&#32;Oct 2021 in Brazil</li><li style=\"margin-top:.3em\">August 2020&#160;&#8211;&#32;January 2021 in Bandung, Indonesia</li></ul></div>\\n</td></tr>\\n<tr>\\n<td><b>BNT162 a1, b1, b2, c2</b><wbr /><sup id=\"cite_ref-105\" class=\"reference\"><a href=\"#cite_note-105\">&#91;e&#93;</a></sup><sup id=\"cite_ref-NCT04368728_106-0\" class=\"reference\"><a href=\"#cite_note-NCT04368728-106\">&#91;100&#93;</a></sup><sup id=\"cite_ref-EudraCT-2020-001038-36_107-0\" class=\"reference\"><a href=\"#cite_note-EudraCT-2020-001038-36-107\">&#91;101&#93;</a></sup><br /><a href=\"/wiki/BioNTech\" title=\"BioNTech\">BioNTech</a>, <a href=\"/wiki/Fosun_Pharma\" class=\"mw-redirect\" title=\"Fosun Pharma\">Fosun Pharma</a>, <a href=\"/wiki/Pfizer\" title=\"Pfizer\">Pfizer</a>\\n</td>\\n<td><a href=\"/wiki/RNA_vaccine\" title=\"RNA vaccine\">mRNA</a>\\n</td>\\n<td data-sort-value=\"P3 30000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\" class=\"table-yes2\"><b>Phase III</b> (30,000)<wbr /><sup id=\"cite_ref-108\" class=\"reference\"><a href=\"#cite_note-108\">&#91;102&#93;</a></sup><br />Randomized, placebo-controlled\\n</td>\\n<td data-sort-value=\"P1-2 60\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I-II</b> (60)<wbr /><br /><a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>. Strong RBD-binding <a href=\"/wiki/Immunoglobulin_G\" title=\"Immunoglobulin G\">IgG</a> and <a href=\"/wiki/Neutralizing_antibody\" title=\"Neutralizing antibody\">neutralizing antibody</a> response peaked 7 days after a <a href=\"/wiki/Booster_dose\" title=\"Booster dose\">booster dose</a>, robust CD4+ and CD8+ <a href=\"/wiki/T_cell\" title=\"T cell\">T cell</a> responses, undetermined durability. <b>Adverse effects</b>: dose-dependent and moderate including pain at the injection site, fatigue, headache, chills, muscle and join pain, fever<sup id=\"cite_ref-109\" class=\"reference\"><a href=\"#cite_note-109\">&#91;103&#93;</a></sup><sup id=\"cite_ref-110\" class=\"reference\"><a href=\"#cite_note-110\">&#91;104&#93;</a></sup>\\n</td>\\n<td>62 in the US, Germany\\n</td>\\n<td data-sort-value=\"2021-05\">Apr 2020&#160;&#8211;&#32;May 2021\\n</td></tr>\\n<tr>\\n<td><b>mRNA-1273</b><wbr /><sup id=\"cite_ref-NCT04470427_111-0\" class=\"reference\"><a href=\"#cite_note-NCT04470427-111\">&#91;105&#93;</a></sup><sup id=\"cite_ref-palca_112-0\" class=\"reference\"><a href=\"#cite_note-palca-112\">&#91;106&#93;</a></sup><br /><a href=\"/wiki/Moderna\" title=\"Moderna\">Moderna</a>, <a href=\"/wiki/National_Institute_of_Allergy_and_Infectious_Diseases\" title=\"National Institute of Allergy and Infectious Diseases\">NIAID</a>, <a href=\"/wiki/Biomedical_Advanced_Research_and_Development_Authority\" title=\"Biomedical Advanced Research and Development Authority\">BARDA</a>\\n</td>\\n<td><a href=\"/wiki/Lipid\" title=\"Lipid\">Lipid</a> <a href=\"/wiki/Nanoparticle\" title=\"Nanoparticle\">nanoparticle</a> dispersion containing <a href=\"/wiki/Messenger_RNA\" title=\"Messenger RNA\">mRNA</a>\\n</td>\\n<td data-sort-value=\"P3 30000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\" class=\"table-yes2\"><b>Phase III</b> (30,000)<wbr /><br />Interventional; randomized, placebo-controlled study for efficacy, safety, and immunogenicity\\n</td>\\n<td data-sort-value=\"P1 45\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (45)<wbr /><br />Dose-dependent neutralizing antibody response on two-dose schedule; undetermined durability. <b>Adverse effects</b>: fever, fatigue, headache, muscle ache, and pain at the injection site<sup id=\"cite_ref-jackson_113-0\" class=\"reference\"><a href=\"#cite_note-jackson-113\">&#91;107&#93;</a></sup><sup id=\"cite_ref-jackson-app_114-0\" class=\"reference\"><a href=\"#cite_note-jackson-app-114\">&#91;108&#93;</a></sup>\\n</td>\\n<td>89 in the US\\n</td>\\n<td data-sort-value=\"2022-10\">Jul 2020&#160;&#8211;&#32;Oct 2022\\n</td></tr>\\n<tr>\\n<td><a href=\"/wiki/Gam-COVID-Vac\" title=\"Gam-COVID-Vac\">Gam-COVID-Vac</a><br />Gamaleya Research Institute of Epidemiology and Microbiology; trade name: <i>Sputnik V</i>\\n</td>\\n<td>Non-<a href=\"/wiki/Viral_replication\" title=\"Viral replication\">replicating</a> <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">viral vector</a>\\n</td>\\n<td data-sort-value=\"P3 40,000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\" class=\"table-yes2\"><b>Phase III</b> (40,000)<wbr /><br />Randomized double-blind, placebo-controlled to evaluate efficacy, immunogenicity, and safety<sup id=\"cite_ref-115\" class=\"reference\"><a href=\"#cite_note-115\">&#91;109&#93;</a></sup>\\n</td>\\n<td data-sort-value=\"P1-2 76\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I-II</b> (76)<wbr />  <a href=\"/wiki/Neutralizing_antibody\" title=\"Neutralizing antibody\">Neutralizing antibody</a> and <a href=\"/wiki/T_cell\" title=\"T cell\">T cell</a> responses. <b>Adverse effects</b>: pain at injection site, fever, headache, weakness, and muscle/joint pain<sup id=\"cite_ref-logunov_116-0\" class=\"reference\"><a href=\"#cite_note-logunov-116\">&#91;110&#93;</a></sup>\\n</td>\\n<td><a href=\"/wiki/Moscow\" title=\"Moscow\">Moscow</a>\\n</td>\\n<td data-sort-value=\"2020-08\">Aug 2020&#160;&#8211;&#32;May 2021\\n</td></tr>\\n<tr>\\n<td><b>Ad26.COV2.S</b><sup id=\"cite_ref-117\" class=\"reference\"><a href=\"#cite_note-117\">&#91;111&#93;</a></sup><sup id=\"cite_ref-118\" class=\"reference\"><a href=\"#cite_note-118\">&#91;112&#93;</a></sup><sup id=\"cite_ref-119\" class=\"reference\"><a href=\"#cite_note-119\">&#91;113&#93;</a></sup>\\n<p><a href=\"/wiki/Janssen_Pharmaceutica\" title=\"Janssen Pharmaceutica\">Janssen Pharmaceutica</a> (Johnson &amp; Johnson), <a href=\"/wiki/Beth_Israel_Deaconess_Medical_Center\" title=\"Beth Israel Deaconess Medical Center\">BIDMC</a>\\n</p>\\n</td>\\n<td>Non-<a href=\"/wiki/Viral_replication\" title=\"Viral replication\">replicating</a> <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">viral vector</a>\\n</td>\\n<td data-sort-value=\"P3 60000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\" class=\"table-yes2\"><b>Phase III</b> (60,000)<wbr /><br />Randomized, double-blinded, placebo-controlled\\n<p>Temporarily paused on October 13 2020 due to an unexplained illness in a participant.<sup id=\"cite_ref-120\" class=\"reference\"><a href=\"#cite_note-120\">&#91;114&#93;</a></sup>\\n</p>\\n</td>\\n<td data-sort-value=\"P1-2 1045\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I-II</b> (1,045)<wbr />  Preprint. Seroconversion for S antibodies over 95%. <b>Adverse effects</b>: injection site pain, fatigue, headache and <a href=\"/wiki/Myalgia\" title=\"Myalgia\">myalgia</a>\\n</td>\\n<td>291 in US, Argentina, Brazil, Chile, Colombia, Mexico, Peru, Philippines, South Africa and Ukraine\\n</td>\\n<td data-sort-value=\"2023\">Jul 2020&#160;&#8211;&#32;2023\\n</td></tr>\\n<tr>\\n<td><i>Unnamed</i><wbr /><sup id=\"cite_ref-london_3-4\" class=\"reference\"><a href=\"#cite_note-london-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-milken_4-2\" class=\"reference\"><a href=\"#cite_note-milken-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-who-tracker_5-3\" class=\"reference\"><a href=\"#cite_note-who-tracker-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-NCT04445194_121-0\" class=\"reference\"><a href=\"#cite_note-NCT04445194-121\">&#91;115&#93;</a></sup><br />Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.\\n</td>\\n<td><a href=\"/wiki/Recombinant_vaccine\" class=\"mw-redirect\" title=\"Recombinant vaccine\">Recombinant</a> <a href=\"/wiki/Protein_subunit#Subunit_Vaccines\" title=\"Protein subunit\">protein subunit</a>\\n</td>\\n<td data-sort-value=\"P2 900\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\" class=\"table-partial\"><b>Phase II</b> (900)<wbr /><br />Interventional; randomized, double-blind, placebo-controlled <sup id=\"cite_ref-NCT04466085_122-0\" class=\"reference\"><a href=\"#cite_note-NCT04466085-122\">&#91;116&#93;</a></sup>\\n</td>\\n<td data-sort-value=\"P1 50\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (50)<wbr />\\n</td>\\n<td><a href=\"/wiki/Chongqing\" title=\"Chongqing\">Chongqing</a>\\n</td>\\n<td data-sort-value=\"2021-09\">Jun 2020&#160;&#8211;&#32;Sep 2021\\n</td></tr>\\n<tr>\\n<td><b>CVnCoV</b><wbr /><sup id=\"cite_ref-NCT04449276_123-0\" class=\"reference\"><a href=\"#cite_note-NCT04449276-123\">&#91;117&#93;</a></sup><br /><a href=\"/wiki/CureVac\" title=\"CureVac\">CureVac</a>, <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">CEPI</a>\\n</td>\\n<td><a href=\"/wiki/RNA_vaccine\" title=\"RNA vaccine\">mRNA</a>\\n</td>\\n<td data-sort-value=\"P2 691\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\" class=\"table-partial\"><b>Phase II</b> (691)<wbr /><br />Partially observer-blind, multicenter, controlled, dose-confirmation<sup id=\"cite_ref-NCT04515147_124-0\" class=\"reference\"><a href=\"#cite_note-NCT04515147-124\">&#91;118&#93;</a></sup>\\n</td>\\n<td data-sort-value=\"P1 168\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (168)<wbr />\\n</td>\\n<td><a href=\"/wiki/Ghent\" title=\"Ghent\">Ghent</a>, 3 in Germany\\n</td>\\n<td data-sort-value=\"2021-08\">Jun 2020&#160;&#8211;&#32;Aug 2021\\n</td></tr>\\n<tr>\\n<td><b>NVX-CoV2373</b><wbr /><sup id=\"cite_ref-NCT04368988_125-0\" class=\"reference\"><a href=\"#cite_note-NCT04368988-125\">&#91;119&#93;</a></sup><br /><a href=\"/wiki/Novavax\" title=\"Novavax\">Novavax</a>\\n</td>\\n<td><a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a> <a href=\"/wiki/Recombinant_vaccine\" class=\"mw-redirect\" title=\"Recombinant vaccine\">recombinant</a> <a href=\"/wiki/Peplomer\" title=\"Peplomer\">spike protein</a> <a href=\"/wiki/Nanoparticle\" title=\"Nanoparticle\">nanoparticle</a> with <a href=\"/wiki/Immunologic_adjuvant\" title=\"Immunologic adjuvant\">adjuvant</a>\\n</td>\\n<td data-sort-value=\"P2 131\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\" class=\"table-partial\"><b>Phase II</b> (131)<wbr />\\n</td>\\n<td data-sort-value=\"P1 131\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (131)<wbr /><br /><a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>. <a href=\"/wiki/Immunoglobulin_G\" title=\"Immunoglobulin G\">IgG</a> and <a href=\"/wiki/Neutralizing_antibody\" title=\"Neutralizing antibody\">neutralizing antibody</a> response with adjuvant after <a href=\"/wiki/Booster_dose\" title=\"Booster dose\">booster dose</a>. <b>Adverse effects</b>: short-duration, low grade, local pain, headache, fatigue, <a href=\"/wiki/Myalgia\" title=\"Myalgia\">myalgia</a><sup id=\"cite_ref-126\" class=\"reference\"><a href=\"#cite_note-126\">&#91;120&#93;</a></sup><sup id=\"cite_ref-127\" class=\"reference\"><a href=\"#cite_note-127\">&#91;121&#93;</a></sup>\\n</td>\\n<td>2 in Australia\\n</td>\\n<td data-sort-value=\"2021-07\">May 2020&#160;&#8211;&#32;Jul 2021\\n</td></tr>\\n<tr>\\n<td><b>INO-4800</b><wbr /><sup id=\"cite_ref-INO-4800-phase_128-0\" class=\"reference\"><a href=\"#cite_note-INO-4800-phase-128\">&#91;f&#93;</a></sup><sup id=\"cite_ref-NCT04336410_129-0\" class=\"reference\"><a href=\"#cite_note-NCT04336410-129\">&#91;122&#93;</a></sup><sup id=\"cite_ref-130\" class=\"reference\"><a href=\"#cite_note-130\">&#91;123&#93;</a></sup><br /><a href=\"/wiki/Inovio_Pharmaceuticals\" title=\"Inovio Pharmaceuticals\">Inovio</a>, <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">CEPI</a>, <a href=\"/wiki/Korea_Centers_for_Disease_Control_and_Prevention\" class=\"mw-redirect\" title=\"Korea Centers for Disease Control and Prevention\">Korea National Institute of Health</a>, <a href=\"/wiki/International_Vaccine_Institute\" title=\"International Vaccine Institute\">International Vaccine Institute</a>\\n</td>\\n<td><a href=\"/wiki/DNA_vaccination#Plasmid_vectors\" title=\"DNA vaccination\">DNA plasmid</a> delivered by <a href=\"/wiki/Electroporation\" title=\"Electroporation\">electroporation</a>\\n</td>\\n<td data-sort-value=\"P1-2 40\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I-II</b> (40)<wbr />\\n</td>\\n<td data-sort-value=\"0a\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">Pending Phase I report\\n</td>\\n<td>3 in the US, <a href=\"/wiki/Seoul\" title=\"Seoul\">Seoul</a>\\n</td>\\n<td data-sort-value=\"2020-11\">Apr\\xe2\\x80\\x93Nov 2020\\n</td></tr>\\n<tr>\\n<td><i>Unnamed</i><wbr /><sup id=\"cite_ref-NCT04412538_131-0\" class=\"reference\"><a href=\"#cite_note-NCT04412538-131\">&#91;124&#93;</a></sup><br /><a href=\"/wiki/Peking_Union_Medical_College\" title=\"Peking Union Medical College\">Chinese Academy of Medical Sciences</a>\\n</td>\\n<td><a href=\"/wiki/Inactivated_vaccine\" title=\"Inactivated vaccine\">Inactivated</a> <a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a>\\n</td>\\n<td data-sort-value=\"P1-2 942\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I-II</b> (942)<wbr /><br />Randomized, double-blinded, single-center, placebo-controlled\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td><a href=\"/wiki/Chengdu\" title=\"Chengdu\">Chengdu</a>\\n</td>\\n<td data-sort-value=\"2021-09\">Jun 2020&#160;&#8211;&#32;Sep 2021\\n</td></tr>\\n<tr>\\n<td><b>AG0301-COVID-19</b><wbr /><sup id=\"cite_ref-NCT04463472_132-0\" class=\"reference\"><a href=\"#cite_note-NCT04463472-132\">&#91;125&#93;</a></sup><br />AnGes Inc.,<sup id=\"cite_ref-anges-inc_133-0\" class=\"reference\"><a href=\"#cite_note-anges-inc-133\">&#91;126&#93;</a></sup> <a href=\"/wiki/Japan_Agency_for_Medical_Research_and_Development\" title=\"Japan Agency for Medical Research and Development\">AMED</a>\\n</td>\\n<td><a href=\"/wiki/DNA_vaccination#Plasmid_vectors\" title=\"DNA vaccination\">DNA plasmid</a>\\n</td>\\n<td data-sort-value=\"P1-2 30\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I-II</b> (30)<wbr /><br />Non-randomized, single-center, two doses\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td><a href=\"/wiki/Osaka\" title=\"Osaka\">Osaka</a>\\n</td>\\n<td data-sort-value=\"2021-07\">Jun 2020&#160;&#8211;&#32;Jul 2021\\n</td></tr>\\n<tr>\\n<td><b>Lunar-COV19/ARCT-021</b><sup id=\"cite_ref-134\" class=\"reference\"><a href=\"#cite_note-134\">&#91;127&#93;</a></sup><sup id=\"cite_ref-135\" class=\"reference\"><a href=\"#cite_note-135\">&#91;128&#93;</a></sup>\\n<p><a href=\"/wiki/Arcturus_Therapeutics\" title=\"Arcturus Therapeutics\">Arcturus Therapeutics</a>\\n</p>\\n</td>\\n<td><a href=\"/wiki/Messenger_RNA\" title=\"Messenger RNA\">mRNA</a>\\n</td>\\n<td data-sort-value=\"P1-2 92\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I-II</b> (92)<wbr /><br />Randomized, double-blinded\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td><a href=\"/wiki/Singapore\" title=\"Singapore\">Singapore</a>\\n</td>\\n<td>Aug 2020&#160;&#8211;&#32;?\\n</td></tr>\\n<tr>\\n<td><b>COVID\\xe2\\x80\\x9119/aAPC</b><wbr /><sup id=\"cite_ref-NCT04299724_136-0\" class=\"reference\"><a href=\"#cite_note-NCT04299724-136\">&#91;129&#93;</a></sup><br />Shenzhen Genoimmune Medical Institute<sup id=\"cite_ref-shenzhen-genoimmune-medical-institute_137-0\" class=\"reference\"><a href=\"#cite_note-shenzhen-genoimmune-medical-institute-137\">&#91;130&#93;</a></sup>\\n</td>\\n<td><a href=\"/wiki/Lentiviral_vector_in_gene_therapy\" title=\"Lentiviral vector in gene therapy\">Lentiviral vector</a> with <a href=\"/wiki/Minigene\" title=\"Minigene\">minigene</a> modifying <a href=\"/wiki/Artificial_antigen_presenting_cells\" title=\"Artificial antigen presenting cells\">aAPCs</a>\\n</td>\\n<td data-sort-value=\"P1 100\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (100)<wbr />\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td><a href=\"/wiki/Shenzhen\" title=\"Shenzhen\">Shenzhen</a>\\n</td>\\n<td data-sort-value=\"2023\">Mar 2020&#160;&#8211;&#32;2023\\n</td></tr>\\n<tr>\\n<td><b>LV-SMENP-DC</b><wbr /><sup id=\"cite_ref-NCT04276896_138-0\" class=\"reference\"><a href=\"#cite_note-NCT04276896-138\">&#91;131&#93;</a></sup><br />Shenzhen Genoimmune Medical Institute<sup id=\"cite_ref-shenzhen-genoimmune-medical-institute_137-1\" class=\"reference\"><a href=\"#cite_note-shenzhen-genoimmune-medical-institute-137\">&#91;130&#93;</a></sup>\\n</td>\\n<td><a href=\"/wiki/Lentiviral_vector_in_gene_therapy\" title=\"Lentiviral vector in gene therapy\">Lentiviral vector</a> with <a href=\"/wiki/Minigene\" title=\"Minigene\">minigene</a> modifying <a href=\"/wiki/Dendritic_cells\" class=\"mw-redirect\" title=\"Dendritic cells\">DCs</a>\\n</td>\\n<td data-sort-value=\"P1 100\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (100)<wbr />\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td><a href=\"/wiki/Shenzhen\" title=\"Shenzhen\">Shenzhen</a>\\n</td>\\n<td data-sort-value=\"2023\">Mar 2020&#160;&#8211;&#32;2023\\n</td></tr>\\n<tr>\\n<td><b>LNP-nCoVsaRNA</b><wbr /><sup id=\"cite_ref-ISRCTN17072692_139-0\" class=\"reference\"><a href=\"#cite_note-ISRCTN17072692-139\">&#91;132&#93;</a></sup><br /><a href=\"/wiki/Medical_Research_Council_(United_Kingdom)\" title=\"Medical Research Council (United Kingdom)\">MRC</a> <a href=\"/wiki/Clinical_trials_unit\" title=\"Clinical trials unit\">clinical trials unit</a> at <a href=\"/wiki/Imperial_College_London\" title=\"Imperial College London\">Imperial College London</a>\\n</td>\\n<td><a href=\"/wiki/RNA_vaccine\" title=\"RNA vaccine\">mRNA</a>\\n</td>\\n<td data-sort-value=\"P1 105\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (105)<wbr /><br />Randomized trial, with dose escalation study (15) and expanded safety study (at least 200)\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td>4 in the UK\\n</td>\\n<td data-sort-value=\"2021-07\">Jun 2020&#160;&#8211;&#32;Jul 2021\\n</td></tr>\\n<tr>\\n<td><b>GX-19</b><wbr /><sup id=\"cite_ref-NCT04445389_140-0\" class=\"reference\"><a href=\"#cite_note-NCT04445389-140\">&#91;133&#93;</a></sup><sup id=\"cite_ref-gen-reut_141-0\" class=\"reference\"><a href=\"#cite_note-gen-reut-141\">&#91;134&#93;</a></sup><br />Genexine consortium,<sup id=\"cite_ref-142\" class=\"reference\"><a href=\"#cite_note-142\">&#91;135&#93;</a></sup> <a href=\"/wiki/International_Vaccine_Institute\" title=\"International Vaccine Institute\">International Vaccine Institute</a>\\n</td>\\n<td><a href=\"/wiki/DNA_vaccination\" title=\"DNA vaccination\">DNA</a>\\n</td>\\n<td data-sort-value=\"P1 40\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (40)<wbr />\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td><a href=\"/wiki/Seoul\" title=\"Seoul\">Seoul</a>\\n</td>\\n<td data-sort-value=\"2022-06\">Jun 2020&#160;&#8211;&#32;Jun 2022\\n</td></tr>\\n<tr>\\n<td><b>SCB-2019</b><wbr /><sup id=\"cite_ref-NCT04405908_143-0\" class=\"reference\"><a href=\"#cite_note-NCT04405908-143\">&#91;136&#93;</a></sup><sup id=\"cite_ref-clover-cta_144-0\" class=\"reference\"><a href=\"#cite_note-clover-cta-144\">&#91;137&#93;</a></sup><br />Clover Biopharmaceuticals,<sup id=\"cite_ref-clover-biopharma_145-0\" class=\"reference\"><a href=\"#cite_note-clover-biopharma-145\">&#91;138&#93;</a></sup> <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GSK</a>\\n</td>\\n<td><a href=\"/wiki/Peplomer\" title=\"Peplomer\">Spike protein</a> <a href=\"/wiki/Protein_trimer\" title=\"Protein trimer\">trimeric</a> <a href=\"/wiki/Protein_subunit#Subunit_Vaccines\" title=\"Protein subunit\">subunit</a> with <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GSK</a> <a href=\"/wiki/Immunologic_adjuvant\" title=\"Immunologic adjuvant\">adjuvant</a>\\n</td>\\n<td data-sort-value=\"P1 150\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (150)<wbr />\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td><a href=\"/wiki/Perth\" title=\"Perth\">Perth</a>\\n</td>\\n<td data-sort-value=\"2021-03\">Jun 2020&#160;&#8211;&#32;Mar 2021\\n</td></tr>\\n<tr>\\n<td><b>COVAX-19</b><wbr /><sup id=\"cite_ref-NCT04453852_146-0\" class=\"reference\"><a href=\"#cite_note-NCT04453852-146\">&#91;139&#93;</a></sup><br />Vaxine Pty Ltd<sup id=\"cite_ref-vaxine-pty_147-0\" class=\"reference\"><a href=\"#cite_note-vaxine-pty-147\">&#91;140&#93;</a></sup>\\n</td>\\n<td><a href=\"/wiki/Recombinant_vaccine\" class=\"mw-redirect\" title=\"Recombinant vaccine\">Recombinant</a> <a href=\"/wiki/Protein\" title=\"Protein\">protein</a>\\n</td>\\n<td data-sort-value=\"P1 40\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (40)<wbr />\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td><a href=\"/wiki/Adelaide\" title=\"Adelaide\">Adelaide</a>\\n</td>\\n<td data-sort-value=\"2021-07\">Jun 2020&#160;&#8211;&#32;Jul 2021\\n</td></tr>\\n<tr>\\n<td><i>Unnamed</i><wbr /><sup id=\"cite_ref-ChiCTR2000034112_148-0\" class=\"reference\"><a href=\"#cite_note-ChiCTR2000034112-148\">&#91;141&#93;</a></sup><br /><a href=\"/wiki/PLA_Academy_of_Military_Science\" title=\"PLA Academy of Military Science\">PLA Academy of Military Science</a>, Walvax Biotech<sup id=\"cite_ref-walvax_149-0\" class=\"reference\"><a href=\"#cite_note-walvax-149\">&#91;142&#93;</a></sup>\\n</td>\\n<td><a href=\"/wiki/RNA_vaccine\" title=\"RNA vaccine\">mRNA</a>\\n</td>\\n<td data-sort-value=\"P1 168\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (168)<wbr />\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td>2 in China\\n</td>\\n<td data-sort-value=\"2021-12\">Jun 2020&#160;&#8211;&#32;Dec 2021\\n</td></tr>\\n<tr>\\n<td><i>Unnamed</i><wbr /><sup id=\"cite_ref-NCT04450004_150-0\" class=\"reference\"><a href=\"#cite_note-NCT04450004-150\">&#91;143&#93;</a></sup><sup id=\"cite_ref-ctv-medicago_151-0\" class=\"reference\"><a href=\"#cite_note-ctv-medicago-151\">&#91;144&#93;</a></sup><br /><a href=\"/wiki/Medicago_Inc.\" title=\"Medicago Inc.\">Medicago</a><sup id=\"cite_ref-medicago-about_152-0\" class=\"reference\"><a href=\"#cite_note-medicago-about-152\">&#91;145&#93;</a></sup> (governments of <a href=\"/wiki/Canada\" title=\"Canada\">Canada</a> and <a href=\"/wiki/Quebec\" title=\"Quebec\">Quebec</a>)\\n</td>\\n<td><a href=\"/wiki/Recombinant_vaccine\" class=\"mw-redirect\" title=\"Recombinant vaccine\">Recombinant</a> <a href=\"/wiki/Plant_expressed_vaccine\" title=\"Plant expressed vaccine\">plant-based</a> <a href=\"/wiki/Virus-like_particle\" title=\"Virus-like particle\">VLP</a><sup id=\"cite_ref-Medicago-technology_154-0\" class=\"reference\"><a href=\"#cite_note-Medicago-technology-154\">&#91;g&#93;</a></sup> with <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GSK</a> <a href=\"/wiki/Immunologic_adjuvant\" title=\"Immunologic adjuvant\">adjuvant</a>\\n</td>\\n<td data-sort-value=\"P1 180\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (180)<wbr /><br />Randomized, dose-ranging\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td>2 in Canada\\n</td>\\n<td data-sort-value=\"2021-04\">Jul 2020&#160;&#8211;&#32;Apr 2021\\n</td></tr>\\n<tr>\\n<td><b>SARS-CoV-2 Sclamp</b><wbr /><sup id=\"cite_ref-NCT04495933_155-0\" class=\"reference\"><a href=\"#cite_note-NCT04495933-155\">&#91;147&#93;</a></sup><br /><a href=\"/wiki/University_of_Queensland\" title=\"University of Queensland\">UQ</a>, <a href=\"/wiki/Syneos_Health\" title=\"Syneos Health\">Syneos Health</a>, <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">CEPI</a>, <a href=\"/wiki/CSL_Limited#Seqirus_(bioCSL)\" title=\"CSL Limited\">Seqirus</a>\\n</td>\\n<td><a href=\"/wiki/Molecular_clamp\" title=\"Molecular clamp\">Molecular clamp</a> stabilized <a href=\"/wiki/Peplomer\" title=\"Peplomer\">spike protein</a> with <a href=\"/wiki/MF59\" title=\"MF59\">MF59</a>\\n</td>\\n<td data-sort-value=\"P1 120\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\" class=\"table-depends\"><b>Phase I</b> (120)<wbr /><br />Randomised, double-blind, placebo-controlled, dose-ranging\\n</td>\\n<td data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\" class=\"table-na\">\\n</td>\\n<td><a href=\"/wiki/Brisbane\" title=\"Brisbane\">Brisbane</a>\\n</td>\\n<td data-sort-value=\"2020-10\">Jul\\xe2\\x80\\x93Oct 2020\\n</td></tr></tbody></table>\\n<div class=\"reflist\" style=\"list-style-type: lower-alpha;\">\\n<div class=\"mw-references-wrap\"><ol class=\"references\">\\n<li id=\"cite_note-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-78\">^</a></b></span> <span class=\"reference-text\">Latest Phase with published results.</span>\\n</li>\\n<li id=\"cite_note-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-79\">^</a></b></span> <span class=\"reference-text\">The range from the actual start date of Phase I to the estimated primary completion date of Phase III, when available.</span>\\n</li>\\n<li id=\"cite_note-81\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-81\">^</a></b></span> <span class=\"reference-text\">Oxford name: <i>ChAdOx1<span class=\"nowrap\">&#160;</span>nCoV-19</i>. Manufacturing in Brazil to be carried out by <a href=\"/wiki/Oswaldo_Cruz_Foundation\" title=\"Oswaldo Cruz Foundation\">Oswaldo Cruz Foundation</a>.<sup id=\"cite_ref-80\" class=\"reference\"><a href=\"#cite_note-80\">&#91;77&#93;</a></sup></span>\\n</li>\\n<li id=\"cite_note-Ad5-nCoV-manufacture-97\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ad5-nCoV-manufacture_97-0\">^</a></b></span> <span class=\"reference-text\">Manufacturing partnership with the <a href=\"/wiki/National_Research_Council_(Canada)\" title=\"National Research Council (Canada)\">National Research Council of Canada</a> and Canadian Center for Vaccinology, <a href=\"/wiki/Halifax,_Nova_Scotia\" title=\"Halifax, Nova Scotia\">Halifax, Nova Scotia</a><sup id=\"cite_ref-96\" class=\"reference\"><a href=\"#cite_note-96\">&#91;92&#93;</a></sup></span>\\n</li>\\n<li id=\"cite_note-105\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-105\">^</a></b></span> <span class=\"reference-text\">Four vaccines</span>\\n</li>\\n<li id=\"cite_note-INO-4800-phase-128\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-INO-4800-phase_128-0\">^</a></b></span> <span class=\"reference-text\">South Korean Phase I\\xe2\\x80\\x93II in parallel with Phase I in the US</span>\\n</li>\\n<li id=\"cite_note-Medicago-technology-154\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Medicago-technology_154-0\">^</a></b></span> <span class=\"reference-text\">Virus-like particles grown in <i><a href=\"/wiki/Nicotiana_benthamiana\" title=\"Nicotiana benthamiana\">Nicotiana benthamiana</a></i><sup id=\"cite_ref-np-medicago_153-0\" class=\"reference\"><a href=\"#cite_note-np-medicago-153\">&#91;146&#93;</a></sup></span>\\n</li>\\n</ol></div></div>\\n<h3><span class=\"mw-headline\" id=\"Preclinical_research\">Preclinical research</span></h3>\\n<p>In April 2020, the WHO issued a statement representing dozens of vaccine scientists around the world, pledging collaboration to speed development of a vaccine against COVID\\xe2\\x80\\x9119.<sup id=\"cite_ref-who-scientists_156-0\" class=\"reference\"><a href=\"#cite_note-who-scientists-156\">&#91;148&#93;</a></sup> The WHO coalition is encouraging international cooperation between organizations developing vaccine candidates, national regulatory and policy agencies, financial contributors, public health associations, and governments, for eventual manufacturing of a successful vaccine in quantities sufficient to supply all affected regions, particularly low-resource countries.<sup id=\"cite_ref-thanh_23-8\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup>\\n</p><p>Industry analysis of past vaccine development shows failure rates of 84\\xe2\\x80\\x9390%.<sup id=\"cite_ref-thanh_23-9\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-bio_69-2\" class=\"reference\"><a href=\"#cite_note-bio-69\">&#91;69&#93;</a></sup> Because COVID\\xe2\\x80\\x9119 is a novel virus target with properties still being discovered and requiring innovative vaccine technologies and development strategies, the risks associated with developing a successful vaccine across all steps of preclinical and clinical research are high.<sup id=\"cite_ref-thanh_23-10\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup>\\n</p><p>To assess potential for vaccine efficacy, unprecedented computer simulations and new COVID\\xe2\\x80\\x9119-specific animal models are being developed multinationally during 2020, but these methods remain untested by unknown characteristics of the COVID\\xe2\\x80\\x9119 virus.<sup id=\"cite_ref-thanh_23-11\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup> Of the confirmed active vaccine candidates, about 70% are being developed by private companies, with the remaining projects under development by academic, government coalitions, and health organizations.<sup id=\"cite_ref-thanh2_2-16\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup>\\n</p><p>Most of the vaccine developers are small firms or university research teams with little experience in successful vaccine design and limited capacity for advanced clinical trial costs and manufacturing without partnership by multinational pharmaceutical companies.<sup id=\"cite_ref-thanh2_2-17\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-thanh_23-12\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup>\\n</p>\\n<h4><span class=\"mw-headline\" id=\"Scheduled_Phase_I_trials_in_2020\">Scheduled Phase I trials in 2020</span></h4>\\n<p>Many vaccine candidates under design or preclinical development for COVID\\xe2\\x80\\x9119 will not gain approval for human studies in 2020 due to toxicity, ineffectiveness to induce immune responses or dosing failures in laboratory animals, or because of underfunding.<sup id=\"cite_ref-gouglas_157-0\" class=\"reference\"><a href=\"#cite_note-gouglas-157\">&#91;149&#93;</a></sup><sup id=\"cite_ref-strovel_158-0\" class=\"reference\"><a href=\"#cite_note-strovel-158\">&#91;150&#93;</a></sup> The probability of success for an infectious disease vaccine candidate to pass preclinical barriers and reach Phase<span class=\"nowrap\">&#160;</span>I of human testing is 41-57%.<sup id=\"cite_ref-gouglas_157-1\" class=\"reference\"><a href=\"#cite_note-gouglas-157\">&#91;149&#93;</a></sup>\\n</p><p>Commitment to first-in-human testing of a vaccine candidate represents a substantial capital cost for vaccine developers, estimated to be from <span style=\"white-space: nowrap\">US$14</span><span class=\"nowrap\">&#160;</span>million to <span style=\"white-space: nowrap\">US$25</span><span class=\"nowrap\">&#160;</span>million for a typical Phase<span class=\"nowrap\">&#160;</span>I trial program, but possibly as much as <span style=\"white-space: nowrap\">US$70</span><span class=\"nowrap\">&#160;</span>million.<sup id=\"cite_ref-gouglas_157-2\" class=\"reference\"><a href=\"#cite_note-gouglas-157\">&#91;149&#93;</a></sup><sup id=\"cite_ref-dimasi_159-0\" class=\"reference\"><a href=\"#cite_note-dimasi-159\">&#91;151&#93;</a></sup> For comparison, during the <a href=\"/wiki/Western_African_Ebola_virus_epidemic\" title=\"Western African Ebola virus epidemic\">Ebola virus epidemic of 2013-16</a>, there were 37 vaccine candidates in urgent development, but only one eventually succeeded as a licensed vaccine, involving a total cost to confirm efficacy in Phase<span class=\"nowrap\">&#160;</span>II\\xe2\\x80\\x93III trials of about <span style=\"white-space: nowrap\">US$1</span><span class=\"nowrap\">&#160;</span>billion.<sup id=\"cite_ref-gouglas_157-3\" class=\"reference\"><a href=\"#cite_note-gouglas-157\">&#91;149&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Non-specific_vaccines\">Non-specific vaccines</span></h3>\\n<p>Some vaccines have <a href=\"/wiki/Non-specific_effect_of_vaccines\" title=\"Non-specific effect of vaccines\">non-specific</a> effects beyond the disease they prevent.<sup id=\"cite_ref-Kleinnijenhuis_2015_160-0\" class=\"reference\"><a href=\"#cite_note-Kleinnijenhuis_2015-160\">&#91;152&#93;</a></sup>\\n</p><p>Assertions have been made that COVID\\xe2\\x80\\x9119 mortality has been lower in countries having routine <a href=\"/wiki/BCG_vaccine\" title=\"BCG vaccine\">BCG vaccine</a> administered against tuberculosis,<sup id=\"cite_ref-deVrieze-April_161-0\" class=\"reference\"><a href=\"#cite_note-deVrieze-April-161\">&#91;153&#93;</a></sup><sup id=\"cite_ref-162\" class=\"reference\"><a href=\"#cite_note-162\">&#91;154&#93;</a></sup><sup id=\"cite_ref-163\" class=\"reference\"><a href=\"#cite_note-163\">&#91;155&#93;</a></sup><sup id=\"cite_ref-164\" class=\"reference\"><a href=\"#cite_note-164\">&#91;156&#93;</a></sup> though the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> (WHO) has said there is no evidence that this vaccine is effective against the COVID\\xe2\\x80\\x9119 virus.<sup id=\"cite_ref-165\" class=\"reference\"><a href=\"#cite_note-165\">&#91;157&#93;</a></sup> In March 2020, a randomized trial of BCG vaccine to reduce COVID\\xe2\\x80\\x9119 illness began in the Netherlands, seeking to recruit 1,000 healthcare workers.<sup id=\"cite_ref-EudraCT-2020-000919-69_166-0\" class=\"reference\"><a href=\"#cite_note-EudraCT-2020-000919-69-166\">&#91;158&#93;</a></sup> A further randomized trial in Australia is seeking to enroll 4,170 healthcare workers.<sup id=\"cite_ref-MCRI-BCG-trial_167-0\" class=\"reference\"><a href=\"#cite_note-MCRI-BCG-trial-167\">&#91;159&#93;</a></sup><sup id=\"cite_ref-NCT04327206_168-0\" class=\"reference\"><a href=\"#cite_note-NCT04327206-168\">&#91;160&#93;</a></sup>\\n</p><p>In June 2020, a randomized placebo-controlled trial to test whether the <a href=\"/wiki/MMR_vaccine\" title=\"MMR vaccine\">measles-mumps-rubella vaccine</a> (MMR) can protect healthcare workers from COVID\\xe2\\x80\\x9119 began with 200 participants in Cairo.<sup id=\"cite_ref-NCT04357028_169-0\" class=\"reference\"><a href=\"#cite_note-NCT04357028-169\">&#91;161&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Use_of_adjuvants\">Use of adjuvants</span></h3>\\n<p>In September 2020, eleven of the vaccine candidates in clinical development used adjuvants to enhance immunogenicity.<sup id=\"cite_ref-thanh2_2-18\" class=\"reference\"><a href=\"#cite_note-thanh2-2\">&#91;2&#93;</a></sup> An <a href=\"/wiki/Immunological_adjuvant\" class=\"mw-redirect\" title=\"Immunological adjuvant\">immunological adjuvant</a> is a substance formulated with a vaccine to elevate the immune response to an <a href=\"/wiki/Antigen\" title=\"Antigen\">antigen</a>, such as the COVID-19 virus or influenza virus.<sup id=\"cite_ref-tregoning_170-0\" class=\"reference\"><a href=\"#cite_note-tregoning-170\">&#91;162&#93;</a></sup> Specifically, an adjuvant may be used in formulating a COVID-19 vaccine candidate to boost its immunogenicity and efficacy to reduce or prevent COVID-19 infection in vaccinated individuals.<sup id=\"cite_ref-tregoning_170-1\" class=\"reference\"><a href=\"#cite_note-tregoning-170\">&#91;162&#93;</a></sup><sup id=\"cite_ref-wang_171-0\" class=\"reference\"><a href=\"#cite_note-wang-171\">&#91;163&#93;</a></sup> Adjuvants used in COVID-19 vaccine formulation may be particularly effective for technologies using the inactivated COVID-19 virus and recombinant protein-based or vector-based vaccines.<sup id=\"cite_ref-wang_171-1\" class=\"reference\"><a href=\"#cite_note-wang-171\">&#91;163&#93;</a></sup> <a href=\"/wiki/Aluminium\" title=\"Aluminium\">Aluminum salts</a>, known as \"alum\", were the first adjuvant used for licensed vaccines, and are the adjuvant of choice in some 80% of adjuvanted vaccines.<sup id=\"cite_ref-wang_171-2\" class=\"reference\"><a href=\"#cite_note-wang-171\">&#91;163&#93;</a></sup> The alum adjuvant initiates diverse molecular and cellular mechanisms to enhance immunogenicity, including release of proinflammatory cytokines.<sup id=\"cite_ref-tregoning_170-2\" class=\"reference\"><a href=\"#cite_note-tregoning-170\">&#91;162&#93;</a></sup><sup id=\"cite_ref-wang_171-3\" class=\"reference\"><a href=\"#cite_note-wang-171\">&#91;163&#93;</a></sup> A potential drawback of adjuvanted vaccines is that the virus evolves in a way to avoid the induced vaccine response, making the adjuvant-vaccine technology misdesigned against a changed virus.<sup id=\"cite_ref-tregoning_170-3\" class=\"reference\"><a href=\"#cite_note-tregoning-170\">&#91;162&#93;</a></sup> Such a change would require revised manufacturing and increased costs that discourage the routine use of adjuvants.<sup id=\"cite_ref-tregoning_170-4\" class=\"reference\"><a href=\"#cite_note-tregoning-170\">&#91;162&#93;</a></sup><sup id=\"cite_ref-wang_171-4\" class=\"reference\"><a href=\"#cite_note-wang-171\">&#91;163&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Potential_limitations\">Potential limitations</span></h2>\\n<p>The rapid development and urgency of producing a vaccine for the COVID\\xe2\\x80\\x9119 pandemic may increase the risks and failure rate of delivering a safe, effective vaccine.<sup id=\"cite_ref-diamond_1-3\" class=\"reference\"><a href=\"#cite_note-diamond-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-thanh_23-13\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-Thorp_172-0\" class=\"reference\"><a href=\"#cite_note-Thorp-172\">&#91;164&#93;</a></sup> One study found that between 2006 and 2015, the success rate of obtaining approval from Phase<span class=\"nowrap\">&#160;</span>I to successful Phase<span class=\"nowrap\">&#160;</span>III trials was 16.2% for vaccines,<sup id=\"cite_ref-bio_69-3\" class=\"reference\"><a href=\"#cite_note-bio-69\">&#91;69&#93;</a></sup> and CEPI indicates a potential success rate of only 10% for vaccine candidates in 2020 development.<sup id=\"cite_ref-thanh_23-14\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup>\\n</p><p>An April 2020 CEPI report stated: \"Strong international coordination and cooperation between vaccine developers, regulators, policymakers, funders, public health bodies and governments will be needed to ensure that promising late-stage vaccine candidates can be manufactured in sufficient quantities and equitably supplied to all affected areas, particularly low-resource regions.\"<sup id=\"cite_ref-thanh_23-15\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup> However, some 10% of the public perceives vaccines as unsafe or unnecessary, refusing vaccination&#160;&#8211;&#32;a global health threat called <a href=\"/wiki/Vaccine_hesitancy\" title=\"Vaccine hesitancy\">vaccine hesitancy</a><sup id=\"cite_ref-who-threat_173-0\" class=\"reference\"><a href=\"#cite_note-who-threat-173\">&#91;165&#93;</a></sup>&#160;&#8211;&#32;which increases the risk of further <a href=\"/wiki/Viral_shedding\" title=\"Viral shedding\">viral spread</a> that could lead to COVID\\xe2\\x80\\x9119 outbreaks.<sup id=\"cite_ref-dube_174-0\" class=\"reference\"><a href=\"#cite_note-dube-174\">&#91;166&#93;</a></sup> In mid-2020, estimates from two surveys were that 67% or 80% of people in the U.S. would accept a new vaccination against COVID-19, with wide disparity by education level, employment status, race, and geography.<sup id=\"cite_ref-malik_175-0\" class=\"reference\"><a href=\"#cite_note-malik-175\">&#91;167&#93;</a></sup><sup id=\"cite_ref-176\" class=\"reference\"><a href=\"#cite_note-176\">&#91;168&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Biosafety_concern\">Biosafety concern</span></h3>\\n<p>Early research to assess vaccine efficacy using COVID\\xe2\\x80\\x9119-specific animal models, such as <a href=\"/wiki/ACE2\" class=\"mw-redirect\" title=\"ACE2\">ACE2</a>-<a href=\"/wiki/Transgenic\" class=\"mw-redirect\" title=\"Transgenic\">transgenic</a> mice, other laboratory animals, and non-human primates, indicates a need for <a href=\"/wiki/Biosafety\" title=\"Biosafety\">biosafety</a>-level<span class=\"nowrap\">&#160;</span>3 containment measures for handling live viruses, and international coordination to ensure standardized safety procedures.<sup id=\"cite_ref-diamond_1-4\" class=\"reference\"><a href=\"#cite_note-diamond-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-thanh_23-16\" class=\"reference\"><a href=\"#cite_note-thanh-23\">&#91;23&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Antibody-dependent_enhancement\">Antibody-dependent enhancement</span></h3>\\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Antibody-dependent_enhancement\" title=\"Antibody-dependent enhancement\">Antibody-dependent enhancement</a></div>\\n<p>Although the quality and quantity of <a href=\"/wiki/Antibody\" title=\"Antibody\">antibody</a> production by a potential vaccine is intended to neutralize the COVID\\xe2\\x80\\x9119 infection, a vaccine may have an unintended opposite effect by causing <a href=\"/wiki/Antibody-dependent_enhancement\" title=\"Antibody-dependent enhancement\">antibody-dependent disease enhancement</a> (ADE), which increases the virus attachment to its target cells and might trigger the <a href=\"/wiki/Cytokine_storm\" title=\"Cytokine storm\">cytokine storm</a> when the person will be infected by the virus after vaccination.<sup id=\"cite_ref-diamond_1-5\" class=\"reference\"><a href=\"#cite_note-diamond-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-iwasaki_177-0\" class=\"reference\"><a href=\"#cite_note-iwasaki-177\">&#91;169&#93;</a></sup> The vaccine technology platform (for example, <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">viral vector</a> vaccine, <a href=\"/wiki/Severe_acute_respiratory_syndrome-related_coronavirus#Morphology\" class=\"mw-redirect\" title=\"Severe acute respiratory syndrome-related coronavirus\">spike (S) protein</a> vaccine or <a href=\"/wiki/Protein_subunit\" title=\"Protein subunit\">protein subunit</a> vaccine), vaccine dose, timing of repeat vaccinations for the possible recurrence of COVID\\xe2\\x80\\x9119 infection, and elderly age are factors determining the risk and extent of ADE.<sup id=\"cite_ref-diamond_1-6\" class=\"reference\"><a href=\"#cite_note-diamond-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-iwasaki_177-1\" class=\"reference\"><a href=\"#cite_note-iwasaki-177\">&#91;169&#93;</a></sup> The antibody response to a vaccine is a variable of vaccine technologies in development, including whether the vaccine has precision in its mechanism,<sup id=\"cite_ref-diamond_1-7\" class=\"reference\"><a href=\"#cite_note-diamond-1\">&#91;1&#93;</a></sup> and choice of the route for how it is given (<a href=\"/wiki/Intramuscular_injection\" title=\"Intramuscular injection\">intramuscular</a>, <a href=\"/wiki/Intradermal_injection\" title=\"Intradermal injection\">intradermal</a>, oral, or nasal).<sup id=\"cite_ref-iwasaki_177-2\" class=\"reference\"><a href=\"#cite_note-iwasaki-177\">&#91;169&#93;</a></sup><sup id=\"cite_ref-wied_178-0\" class=\"reference\"><a href=\"#cite_note-wied-178\">&#91;170&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Efficacy\">Efficacy</span></h3>\\n<p>The effectiveness of new vaccine is defined by <a href=\"/wiki/Vaccine_efficacy\" title=\"Vaccine efficacy\">its efficacy</a>. The efficacy of less than 60% may result in failure to create <a href=\"/wiki/Herd_immunity\" title=\"Herd immunity\">herd immunity</a>.<sup id=\"cite_ref-gates2_6-10\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-wied_178-1\" class=\"reference\"><a href=\"#cite_note-wied-178\">&#91;170&#93;</a></sup> Host-(\"vaccinee\")-related determinants that render a person susceptible to infection, such as <a href=\"/wiki/Genetics\" title=\"Genetics\">genetics</a>, health status (underlying disease, nutrition, pregnancy, <a href=\"/wiki/Hypersensitivity\" title=\"Hypersensitivity\">sensitivities</a> or <a href=\"/wiki/Allergy\" title=\"Allergy\">allergies</a>), <a href=\"/wiki/Immunocompetence\" title=\"Immunocompetence\">immune competence</a>, age, and <a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic\" title=\"Economic impact of the COVID-19 pandemic\">economic impact</a> or <a href=\"/wiki/Synthetic_psychological_environment\" title=\"Synthetic psychological environment\">cultural environment</a> can be primary or secondary factors affecting the severity of infection and response to a vaccine.<sup id=\"cite_ref-wied_178-2\" class=\"reference\"><a href=\"#cite_note-wied-178\">&#91;170&#93;</a></sup> Elderly (above age 60), <a href=\"/wiki/Type_I_hypersensitivity\" title=\"Type I hypersensitivity\">allergen-hypersensitive</a>, and <a href=\"/wiki/Obesity\" title=\"Obesity\">obese</a> people have susceptibility to compromised <a href=\"/wiki/Immunogenicity\" title=\"Immunogenicity\">immunogenicity</a>, which prevents or inhibits vaccine effectiveness, possibly requiring separate vaccine technologies for these specific populations or repetitive <a href=\"/wiki/Booster_dose\" title=\"Booster dose\">booster vaccinations</a> to limit <a href=\"/wiki/Transmission_(medicine)\" title=\"Transmission (medicine)\">virus transmission</a>.<sup id=\"cite_ref-wied_178-3\" class=\"reference\"><a href=\"#cite_note-wied-178\">&#91;170&#93;</a></sup> Further, <a href=\"/wiki/Mutation\" title=\"Mutation\">mutations</a> of the virus can alter its structure targeted by the vaccine, thus making the vaccine ineffective.<sup id=\"cite_ref-zumla_179-0\" class=\"reference\"><a href=\"#cite_note-zumla-179\">&#91;171&#93;</a></sup><sup id=\"cite_ref-garcia_180-0\" class=\"reference\"><a href=\"#cite_note-garcia-180\">&#91;172&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Enrollment_of_participants_in_trials\">Enrollment of participants in trials</span></h3>\\n<p>Vaccine developers have to invest resources internationally to find enough participants for Phase<span class=\"nowrap\">&#160;</span>II\\xe2\\x80\\x93III clinical trials when the virus has proved to be a \"<a href=\"/wiki/Moving_target_indication\" title=\"Moving target indication\">moving target</a>\" of changing transmission rate across and within countries, forcing companies to compete for trial participants.<sup id=\"cite_ref-cohen6-19_75-1\" class=\"reference\"><a href=\"#cite_note-cohen6-19-75\">&#91;74&#93;</a></sup> As an example in June, the Chinese vaccine developer Sinovac formed alliances in <a href=\"/wiki/Malaysia\" title=\"Malaysia\">Malaysia</a>, Canada, the UK, and Brazil among its plans to recruit trial participants and manufacture enough vaccine doses for a possible Phase<span class=\"nowrap\">&#160;</span>III study in Brazil where COVID\\xe2\\x80\\x9119 transmission was accelerating during June.<sup id=\"cite_ref-cohen6-19_75-2\" class=\"reference\"><a href=\"#cite_note-cohen6-19-75\">&#91;74&#93;</a></sup> As the COVID\\xe2\\x80\\x9119 pandemic within China became more isolated and controlled, Chinese vaccine developers sought international relationships to conduct advanced human studies in several countries, creating competition for trial participants with other manufacturers and the international Solidarity trial organized by the WHO.<sup id=\"cite_ref-cohen6-19_75-3\" class=\"reference\"><a href=\"#cite_note-cohen6-19-75\">&#91;74&#93;</a></sup> In addition to competition over recruiting participants, clinical trial organizers may encounter  people unwilling to be vaccinated due to <a href=\"/wiki/Vaccine_hesitancy\" title=\"Vaccine hesitancy\">vaccine hesitancy</a><sup id=\"cite_ref-dube_174-1\" class=\"reference\"><a href=\"#cite_note-dube-174\">&#91;166&#93;</a></sup> or disbelieving the science of the vaccine technology and its ability to prevent infection.<sup id=\"cite_ref-howard-cnn_181-0\" class=\"reference\"><a href=\"#cite_note-howard-cnn-181\">&#91;173&#93;</a></sup>\\n</p><p>Having an insufficient number of skilled team members to administer vaccinations may hinder clinical trials that must overcome risks for trial failure, such as recruiting participants in rural or low-density geographic regions, and variations of age, race, ethnicity, or underlying medical conditions.<sup id=\"cite_ref-cohen6-19_75-4\" class=\"reference\"><a href=\"#cite_note-cohen6-19-75\">&#91;74&#93;</a></sup><sup id=\"cite_ref-winter_182-0\" class=\"reference\"><a href=\"#cite_note-winter-182\">&#91;174&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Cost\">Cost</span></h3>\\n<p>An effective vaccine for COVID-19 could save <a href=\"/wiki/Trillion\" title=\"Trillion\">trillions</a> of dollars in global economic impact, according to one expert, and would, therefore, make any price tag in the billions look small in comparison.<sup id=\"cite_ref-gates3_183-0\" class=\"reference\"><a href=\"#cite_note-gates3-183\">&#91;175&#93;</a></sup> It is not yet known if it is possible to create a safe, reliable and affordable vaccine for this virus, and it is not yet known exactly how much the vaccine development will cost.<sup id=\"cite_ref-gates2_6-11\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-gates1_24-3\" class=\"reference\"><a href=\"#cite_note-gates1-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-sanger_35-7\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup> It is possible that billions of dollars could be invested without success.<sup id=\"cite_ref-reuters_34-12\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup>\\n</p><p>The European Commission organized and held a video conference of world leaders on 4 May 2020, at which <span style=\"white-space: nowrap\">US$8</span><span class=\"nowrap\">&#160;</span>billion was raised for COVID-19 vaccine development.<sup id=\"cite_ref-184\" class=\"reference\"><a href=\"#cite_note-184\">&#91;176&#93;</a></sup>\\n</p><p>After a vaccine is created, billions of doses will need to be manufactured and distributed worldwide. In April 2020, the Gates Foundation estimated that manufacturing and distribution could cost as much as <span style=\"white-space: nowrap\">US$25</span><span class=\"nowrap\">&#160;</span>billion.<sup id=\"cite_ref-185\" class=\"reference\"><a href=\"#cite_note-185\">&#91;177&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Rollout\">Rollout</span></h3>\\n<p>Different vaccines have different shipping and handling requirements. For example, the Pfizer/BioNTech vaccine BNT162 must be shipped and stored at \\xe2\\x88\\x9270&#160;\\xc2\\xb0C (\\xe2\\x88\\x9294&#160;\\xc2\\xb0F), must be used within five days of thawing, and has a minimum order of 975 doses, making it unlikely to be rolled out in settings other than large, well-equipped hospitals.<sup id=\"cite_ref-186\" class=\"reference\"><a href=\"#cite_note-186\">&#91;178&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Proposed_challenge_studies\">Proposed challenge studies</span></h2>\\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Human_challenge_study\" title=\"Human challenge study\">Human challenge study</a></div>\\n<p>Strategies are being considered for fast-tracking the licensing of a vaccine against COVID\\xe2\\x80\\x9119, especially by compressing (to a few months) the usually lengthy duration of Phase<span class=\"nowrap\">&#160;</span>II\\xe2\\x80\\x93III trials (typically many years).<sup id=\"cite_ref-eyal_187-0\" class=\"reference\"><a href=\"#cite_note-eyal-187\">&#91;179&#93;</a></sup><sup id=\"cite_ref-callaway_188-0\" class=\"reference\"><a href=\"#cite_note-callaway-188\">&#91;180&#93;</a></sup><sup id=\"cite_ref-boodman_189-0\" class=\"reference\"><a href=\"#cite_note-boodman-189\">&#91;181&#93;</a></sup> <a href=\"/wiki/Human_challenge_study\" title=\"Human challenge study\">Challenge studies</a> have been implemented previously for diseases less deadly than COVID\\xe2\\x80\\x9119 infection, such as common influenza, <a href=\"/wiki/Typhoid_fever\" title=\"Typhoid fever\">typhoid fever</a>, <a href=\"/wiki/Cholera\" title=\"Cholera\">cholera</a>, and <a href=\"/wiki/Malaria\" title=\"Malaria\">malaria</a>.<sup id=\"cite_ref-callaway_188-1\" class=\"reference\"><a href=\"#cite_note-callaway-188\">&#91;180&#93;</a></sup><sup id=\"cite_ref-cohen_190-0\" class=\"reference\"><a href=\"#cite_note-cohen-190\">&#91;182&#93;</a></sup> Following preliminary proof of safety and efficacy of a candidate vaccine in laboratory animals and healthy humans, controlled challenge studies might be implemented to bypass typical Phase<span class=\"nowrap\">&#160;</span>III research, providing an accelerated path to license a COVID\\xe2\\x80\\x9119 vaccine.<sup id=\"cite_ref-eyal_187-1\" class=\"reference\"><a href=\"#cite_note-eyal-187\">&#91;179&#93;</a></sup><sup id=\"cite_ref-cohen_190-1\" class=\"reference\"><a href=\"#cite_note-cohen-190\">&#91;182&#93;</a></sup><sup id=\"cite_ref-callaway_188-2\" class=\"reference\"><a href=\"#cite_note-callaway-188\">&#91;180&#93;</a></sup>\\n</p><p>A challenge study begins by simultaneously testing a vaccine candidate for immunogenicity and safety in laboratory animals and healthy adult volunteers (100 or fewer), something normally a sequential process using animals first.<sup id=\"cite_ref-eyal_187-2\" class=\"reference\"><a href=\"#cite_note-eyal-187\">&#91;179&#93;</a></sup><sup id=\"cite_ref-callaway_188-3\" class=\"reference\"><a href=\"#cite_note-callaway-188\">&#91;180&#93;</a></sup> If the initial tests are promising, the study proceeds by rapidly advancing the effective dose into a large-scale Phase<span class=\"nowrap\">&#160;</span>II\\xe2\\x80\\x93III trial in previously-uninfected, low-risk volunteers (such as young adults), who would then be deliberately infected with COVID\\xe2\\x80\\x9119 for comparison with a <a href=\"/wiki/Placebo\" title=\"Placebo\">placebo</a> control group.<sup id=\"cite_ref-eyal_187-3\" class=\"reference\"><a href=\"#cite_note-eyal-187\">&#91;179&#93;</a></sup><sup id=\"cite_ref-callaway_188-4\" class=\"reference\"><a href=\"#cite_note-callaway-188\">&#91;180&#93;</a></sup><sup id=\"cite_ref-cohen_190-2\" class=\"reference\"><a href=\"#cite_note-cohen-190\">&#91;182&#93;</a></sup> Following the challenge, the volunteers would be monitored closely in clinics with life-saving resources, if needed.<sup id=\"cite_ref-eyal_187-4\" class=\"reference\"><a href=\"#cite_note-eyal-187\">&#91;179&#93;</a></sup><sup id=\"cite_ref-callaway_188-5\" class=\"reference\"><a href=\"#cite_note-callaway-188\">&#91;180&#93;</a></sup> Volunteering for a vaccine challenge study during the COVID\\xe2\\x80\\x9119 pandemic is likened to the emergency service of <a href=\"/wiki/Healthcare\" class=\"mw-redirect\" title=\"Healthcare\">healthcare</a> personnel for COVID\\xe2\\x80\\x9119-infected people, <a href=\"/wiki/Firefighter\" title=\"Firefighter\">firefighters</a>, or <a href=\"/wiki/Organ_donation\" title=\"Organ donation\">organ donors</a>.<sup id=\"cite_ref-eyal_187-5\" class=\"reference\"><a href=\"#cite_note-eyal-187\">&#91;179&#93;</a></sup>\\n</p><p>Although challenge studies are <a href=\"/wiki/Medical_ethics\" title=\"Medical ethics\">ethically questionable</a> due to the unknown hazards for the volunteers of possible COVID\\xe2\\x80\\x9119 <a href=\"/wiki/Disease_enhancement\" class=\"mw-redirect\" title=\"Disease enhancement\">disease enhancement</a> and whether the vaccine received has long-term safety (among other cautions), challenge studies may be the only option to rapidly produce an effective vaccine that will minimize the projected millions of deaths worldwide from COVID\\xe2\\x80\\x9119 infection,<sup id=\"cite_ref-eyal_187-6\" class=\"reference\"><a href=\"#cite_note-eyal-187\">&#91;179&#93;</a></sup><sup id=\"cite_ref-191\" class=\"reference\"><a href=\"#cite_note-191\">&#91;183&#93;</a></sup> according to some infectious disease experts.<sup id=\"cite_ref-eyal_187-7\" class=\"reference\"><a href=\"#cite_note-eyal-187\">&#91;179&#93;</a></sup><sup id=\"cite_ref-callaway_188-6\" class=\"reference\"><a href=\"#cite_note-callaway-188\">&#91;180&#93;</a></sup><sup id=\"cite_ref-cohen_190-3\" class=\"reference\"><a href=\"#cite_note-cohen-190\">&#91;182&#93;</a></sup> The World Health Organization has developed a guidance document with criteria for conducting COVID\\xe2\\x80\\x9119 challenge studies in healthy people, including scientific and ethical evaluation, public consultation and coordination, selection and <a href=\"/wiki/Informed_consent\" title=\"Informed consent\">informed consent</a> of the participants, and monitoring by independent experts.<sup id=\"cite_ref-who-challenge_192-0\" class=\"reference\"><a href=\"#cite_note-who-challenge-192\">&#91;184&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Licensure\">Licensure</span></h2>\\n<p>A <i>vaccine licensure</i> occurs after the successful conclusion of the clinical trials program through Phases I\\xe2\\x80\\x93III demonstrating safety, immunogenicity at a specific dose, effectiveness at preventing infection in target populations, and enduring preventive effect.<sup id=\"cite_ref-who-vacc_193-0\" class=\"reference\"><a href=\"#cite_note-who-vacc-193\">&#91;185&#93;</a></sup> As part of a multinational licensure for a vaccine, the World Health Organization <i>Expert Committee on Biological Standardization</i> developed guidelines of international standards for manufacturing and <a href=\"/wiki/Quality_control\" title=\"Quality control\">quality control</a> of vaccines, a process intended as a platform for national regulatory agencies to apply for their own licensure process.<sup id=\"cite_ref-who-vacc_193-1\" class=\"reference\"><a href=\"#cite_note-who-vacc-193\">&#91;185&#93;</a></sup> Vaccine manufacturers do not receive licensure until a complete clinical package proves the vaccine is safe and has long-term effectiveness, following scientific review by a multinational or national regulatory organization, such as the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA) or the US <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA).<sup id=\"cite_ref-wijnans_194-0\" class=\"reference\"><a href=\"#cite_note-wijnans-194\">&#91;186&#93;</a></sup><sup id=\"cite_ref-chop_195-0\" class=\"reference\"><a href=\"#cite_note-chop-195\">&#91;187&#93;</a></sup>\\n</p><p>Upon <a href=\"/wiki/Developing_country\" title=\"Developing country\">developing countries</a> adopting WHO guidelines for vaccine development and licensure, each country has its own responsibility to issue a national licensure, and to manage, deploy, and monitor the vaccine throughout its use in each nation.<sup id=\"cite_ref-who-vacc_193-2\" class=\"reference\"><a href=\"#cite_note-who-vacc-193\">&#91;185&#93;</a></sup> Building trust and acceptance of a licensed vaccine among the public is a task of communication by governments and healthcare personnel to ensure a vaccination campaign proceeds smoothly, saves lives, and enables economic recovery.<sup id=\"cite_ref-toner_196-0\" class=\"reference\"><a href=\"#cite_note-toner-196\">&#91;188&#93;</a></sup> When a vaccine is licensed, it will initially be in limited supply due to variable manufacturing, distribution, and logistical factors, requiring an allocation plan for the limited supply and which population segments should be prioritized to first receive the vaccine.<sup id=\"cite_ref-toner_196-1\" class=\"reference\"><a href=\"#cite_note-toner-196\">&#91;188&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"World_Health_Organization\">World Health Organization</span></h3>\\n<p>Vaccines developed for multinational distribution via the <a href=\"/wiki/UNICEF\" title=\"UNICEF\">United Nations Children\\'s Fund (UNICEF)</a> require pre-qualification by\\nWHO to ensure <a href=\"/wiki/International_standard\" title=\"International standard\">international standards</a> of quality, safety, immunogenicity, and efficacy for adoption by numerous countries.<sup id=\"cite_ref-who-vacc_193-3\" class=\"reference\"><a href=\"#cite_note-who-vacc-193\">&#91;185&#93;</a></sup>\\n</p><p>The process requires manufacturing consistency at WHO-contracted laboratories following <a href=\"/wiki/Good_Manufacturing_Practice\" class=\"mw-redirect\" title=\"Good Manufacturing Practice\">GMP practices</a>.<sup id=\"cite_ref-who-vacc_193-4\" class=\"reference\"><a href=\"#cite_note-who-vacc-193\">&#91;185&#93;</a></sup> When UN agencies are involved in vaccine licensure, individual nations collaborate by 1) issuing marketing authorization and a national license for the vaccine, its manufacturers, and distribution partners; and 2) conducting <a href=\"/wiki/Postmarketing_surveillance\" title=\"Postmarketing surveillance\">postmarketing surveillance</a>, including records for adverse events after the vaccination program. WHO works with national agencies to monitor inspections of manufacturing facilities and distributors for compliance with GMP and regulatory oversight.<sup id=\"cite_ref-who-vacc_193-5\" class=\"reference\"><a href=\"#cite_note-who-vacc-193\">&#91;185&#93;</a></sup>\\n</p><p>Some countries choose to buy vaccines licensed by reputable national organizations, such as EMA, FDA, or national agencies in other\\naffluent countries, but such purchases typically are more expensive and may not have distribution resources suitable to local conditions in developing countries.<sup id=\"cite_ref-who-vacc_193-6\" class=\"reference\"><a href=\"#cite_note-who-vacc-193\">&#91;185&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Europe\">Europe</span></h3>\\n<p>In the <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a> (EU), vaccines for pandemic pathogens, such as <a href=\"/wiki/Seasonal_influenza\" class=\"mw-redirect\" title=\"Seasonal influenza\">seasonal influenza</a>, are licensed EU-wide where all of the <a href=\"/wiki/Member_state_of_the_European_Union\" title=\"Member state of the European Union\">member states</a> comply (\"centralized\"), are licensed for only some member states (\"decentralized\"), or are licensed on an individual national level.<sup id=\"cite_ref-wijnans_194-1\" class=\"reference\"><a href=\"#cite_note-wijnans-194\">&#91;186&#93;</a></sup> Generally, all EU states follow regulatory guidance and clinical programs defined by the European <a href=\"/wiki/Committee_for_Medicinal_Products_for_Human_Use\" title=\"Committee for Medicinal Products for Human Use\">Committee for Medicinal Products for Human Use</a> (CHMP), a scientific panel of the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA) responsible for vaccine licensure.<sup id=\"cite_ref-wijnans_194-2\" class=\"reference\"><a href=\"#cite_note-wijnans-194\">&#91;186&#93;</a></sup> The CHMP is supported by several expert groups who assess and monitor the progress of a vaccine before and after licensure and distribution.<sup id=\"cite_ref-wijnans_194-3\" class=\"reference\"><a href=\"#cite_note-wijnans-194\">&#91;186&#93;</a></sup>\\n</p><p>In October 2020, the CHMP started \\'rolling reviews\\' of the vaccines known as <i>COVID-19 Vaccine AstraZeneca</i> and <i>BNT162b2</i>.<sup id=\"cite_ref-197\" class=\"reference\"><a href=\"#cite_note-197\">&#91;189&#93;</a></sup><sup id=\"cite_ref-198\" class=\"reference\"><a href=\"#cite_note-198\">&#91;190&#93;</a></sup><sup id=\"cite_ref-199\" class=\"reference\"><a href=\"#cite_note-199\">&#91;191&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"United_States\">United States</span></h3>\\n<p>Under the FDA, the process of establishing evidence for vaccine clinical safety and efficacy is the same as for <a href=\"/wiki/Drug_approval\" class=\"mw-redirect\" title=\"Drug approval\">the approval process for prescription drugs</a>.<sup id=\"cite_ref-fda-vacc_200-0\" class=\"reference\"><a href=\"#cite_note-fda-vacc-200\">&#91;192&#93;</a></sup> If successful through the stages of clinical development, the vaccine licensing process is followed by a <a href=\"/wiki/Biologics_License_Application\" class=\"mw-redirect\" title=\"Biologics License Application\">Biologics License Application</a> which must provide a scientific review team (from diverse disciplines, such as physicians, statisticians, microbiologists, chemists) a comprehensive documentation for the vaccine candidate having efficacy and safety throughout its development. Also during this stage, the proposed manufacturing facility is examined by expert reviewers for GMP compliance, and the label must have compliant description to enable health care providers definition of vaccine specific use, including its possible risks, to communicate and deliver the vaccine to the public.<sup id=\"cite_ref-fda-vacc_200-1\" class=\"reference\"><a href=\"#cite_note-fda-vacc-200\">&#91;192&#93;</a></sup>\\n</p><p>As of August 2020 in the United States, there is no national strategy for how a successful vaccine will be ethically prioritized or distributed to vulnerable population segments, such as <a href=\"/wiki/Homelessness_in_the_United_States\" title=\"Homelessness in the United States\">homeless</a> and <a href=\"/wiki/Incarceration_in_the_United_States\" title=\"Incarceration in the United States\">incarcerated people</a> and the elderly.<sup id=\"cite_ref-malik_175-1\" class=\"reference\"><a href=\"#cite_note-malik-175\">&#91;167&#93;</a></sup><sup id=\"cite_ref-toner_196-2\" class=\"reference\"><a href=\"#cite_note-toner-196\">&#91;188&#93;</a></sup><sup id=\"cite_ref-corey_201-0\" class=\"reference\"><a href=\"#cite_note-corey-201\">&#91;193&#93;</a></sup> After licensure, monitoring of the vaccine and its production, including periodic inspections for GMP compliance, continue as long as the manufacturer retains its license, which may include additional submissions to the FDA of tests for potency, safety, and purity for each vaccine manufacturing step.<sup id=\"cite_ref-fda-vacc_200-2\" class=\"reference\"><a href=\"#cite_note-fda-vacc-200\">&#91;192&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Emergency_use_authorization\">Emergency use authorization</span></h3>\\n<p>At the beginning of the COVID-19 pandemic in early 2020, the WHO issued a guideline as an Emergency Use Listing of new vaccines, a process derived from the 2013-16 <a href=\"/wiki/Western_African_Ebola_virus_epidemic\" title=\"Western African Ebola virus epidemic\">Ebola epidemic</a>.<sup id=\"cite_ref-who-eul_202-0\" class=\"reference\"><a href=\"#cite_note-who-eul-202\">&#91;194&#93;</a></sup> It required that a vaccine candidate developed for a life-threatening emergency be manufactured using GMP and that it complete development according to WHO prequalification procedures.<sup id=\"cite_ref-who-eul_202-1\" class=\"reference\"><a href=\"#cite_note-who-eul-202\">&#91;194&#93;</a></sup>\\n</p><p>Even as new vaccines are developed during the COVID-19 pandemic, licensure of COVID-19 vaccine candidates requires submission of a full dossier of information on development and manufacturing quality. In the EU, companies may use a rolling review process, supplying data as they become available during Phase III trials, rather than developing the full documentation over months or years at the end of clinical research, as is typical. This rolling process allows the European CHMP to evaluate clinical data in real time, enabling a promising vaccine candidate to be approved on a rapid timeline by the EMA.<sup id=\"cite_ref-ema-eau_203-0\" class=\"reference\"><a href=\"#cite_note-ema-eau-203\">&#91;195&#93;</a></sup>\\n</p><p>On June 24, 2020, China approved the CanSino vaccine for limited use in the military and two inactivated virus vaccines for emergency use in high-risk occupations.<sup id=\"cite_ref-204\" class=\"reference\"><a href=\"#cite_note-204\">&#91;196&#93;</a></sup> On August 11, 2020, Russia announced the approval of its Sputnik V vaccine for emergency use, though one month later only small amounts of the vaccine had been distributed for use outside of the phase 3 trial.<sup id=\"cite_ref-205\" class=\"reference\"><a href=\"#cite_note-205\">&#91;197&#93;</a></sup>\\n</p><p>In the United States, the FDA may grant <a href=\"/wiki/Emergency_Use_Authorization\" class=\"mw-redirect\" title=\"Emergency Use Authorization\">Emergency Use Authorization</a> for a promising COVID-19 vaccine before full evidence is available about its safety and efficacy, but this hastened process has been criticized for its political misuse, potential for lowered standards, and increased <a href=\"/wiki/Vaccine_hesitancy\" title=\"Vaccine hesitancy\">antivaccine sentiment</a> in the US population during 2020.<sup id=\"cite_ref-malik_175-2\" class=\"reference\"><a href=\"#cite_note-malik-175\">&#91;167&#93;</a></sup><sup id=\"cite_ref-206\" class=\"reference\"><a href=\"#cite_note-206\">&#91;198&#93;</a></sup><sup id=\"cite_ref-hoffman_207-0\" class=\"reference\"><a href=\"#cite_note-hoffman-207\">&#91;199&#93;</a></sup> On September 8, 2020, nine leading pharma companies involved in COVID-19 vaccine research signed a letter, pledging that they would submit their vaccines for emergency use authorization only after phase 3 trials had demonstrated safety and efficacy.<sup id=\"cite_ref-208\" class=\"reference\"><a href=\"#cite_note-208\">&#91;200&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Postmarketing_surveillance\">Postmarketing surveillance</span></h3>\\n<p>Until a vaccine is in use for the general population, all potential <a href=\"/wiki/Vaccine_adverse_event\" title=\"Vaccine adverse event\">adverse events</a> from the vaccine may not be known, requiring manufacturers to conduct <a href=\"/wiki/Phases_of_clinical_research#Phase_IV\" title=\"Phases of clinical research\">Phase IV studies</a> for <a href=\"/wiki/Postmarketing_surveillance\" title=\"Postmarketing surveillance\">postmarketing surveillance</a> of the vaccine while it is used widely in the public.<sup id=\"cite_ref-who-vacc_193-7\" class=\"reference\"><a href=\"#cite_note-who-vacc-193\">&#91;185&#93;</a></sup><sup id=\"cite_ref-fda-vacc_200-3\" class=\"reference\"><a href=\"#cite_note-fda-vacc-200\">&#91;192&#93;</a></sup> The WHO works with UN member states to implement postlicensing surveillance.<sup id=\"cite_ref-who-vacc_193-8\" class=\"reference\"><a href=\"#cite_note-who-vacc-193\">&#91;185&#93;</a></sup> The FDA relies on a <a href=\"/wiki/Vaccine_Adverse_Event_Reporting_System\" title=\"Vaccine Adverse Event Reporting System\">Vaccine Adverse Event Reporting System</a> to monitor safety concerns about a vaccine throughout its use in the American public.<sup id=\"cite_ref-fda-vacc_200-4\" class=\"reference\"><a href=\"#cite_note-fda-vacc-200\">&#91;192&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Commercialization_and_equitable_access\">Commercialization and equitable access</span></h2>\\n<h3><span class=\"mw-headline\" id=\"Commercialization_issues\">Commercialization issues</span></h3>\\n<p>By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID\\xe2\\x80\\x9119 infection.<sup id=\"cite_ref-gates1_24-4\" class=\"reference\"><a href=\"#cite_note-gates1-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-hbr_209-0\" class=\"reference\"><a href=\"#cite_note-hbr-209\">&#91;201&#93;</a></sup><sup id=\"cite_ref-cbcr_210-0\" class=\"reference\"><a href=\"#cite_note-cbcr-210\">&#91;202&#93;</a></sup><sup id=\"cite_ref-ahmed_211-0\" class=\"reference\"><a href=\"#cite_note-ahmed-211\">&#91;203&#93;</a></sup> The corporate investment and need to generate value for public shareholders raised concerns about a \"market-based approach\" in vaccine development, costly pricing of eventual licensed vaccines, preferred access for distribution first to affluent countries, and sparse or no distribution to where the pandemic is most aggressive, as predicted for densely-populated, impoverished countries unable to afford vaccinations.<sup id=\"cite_ref-gates1_24-5\" class=\"reference\"><a href=\"#cite_note-gates1-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-sanger_35-8\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-cbcr_210-1\" class=\"reference\"><a href=\"#cite_note-cbcr-210\">&#91;202&#93;</a></sup> The collaboration of the University of Oxford with AstraZeneca (a global pharmaceutical company based in the UK) raised concerns about price and sharing of eventual profits from international vaccine sales, arising from whether the UK government and university as public partners had commercialization rights.<sup id=\"cite_ref-ahmed_211-1\" class=\"reference\"><a href=\"#cite_note-ahmed-211\">&#91;203&#93;</a></sup> AstraZeneca stated that initial pricing of its vaccine would not include a <a href=\"/wiki/Profit_margin\" title=\"Profit margin\">profit margin</a> for the company while the pandemic was still expanding.<sup id=\"cite_ref-ahmed_211-2\" class=\"reference\"><a href=\"#cite_note-ahmed-211\">&#91;203&#93;</a></sup>\\n</p><p>In early June, AstraZeneca made a USD$750 millon deal allowing CEPI and GAVI to manufacture and distribute 300 million doses if its Oxford vaccine candidate proves safe and effective, reportedly increasing the company\\'s total production capacity to over 2 billion doses per year.<sup id=\"cite_ref-kyle_212-0\" class=\"reference\"><a href=\"#cite_note-kyle-212\">&#91;204&#93;</a></sup> Commercialization of pandemic vaccines is a high-risk business venture, potentially losing billions of dollars in development and pre-market manufacturing costs if the candidate vaccines fail to be safe and effective.<sup id=\"cite_ref-gates1_24-6\" class=\"reference\"><a href=\"#cite_note-gates1-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-reuters_34-13\" class=\"reference\"><a href=\"#cite_note-reuters-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-sanger_35-9\" class=\"reference\"><a href=\"#cite_note-sanger-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-hbr_209-1\" class=\"reference\"><a href=\"#cite_note-hbr-209\">&#91;201&#93;</a></sup> The multinational pharmaceutical company Pfizer indicated it was not interested in a government partnership, which would be a \"third party\" slowing progress in Pfizer\\'s vaccine program.<sup id=\"cite_ref-cohen6-4_213-0\" class=\"reference\"><a href=\"#cite_note-cohen6-4-213\">&#91;205&#93;</a></sup> Further, there are concerns that rapid-development programs \\xe2\\x80\\x93 like the Operation Warp Speed plan of the United States \\xe2\\x80\\x93 are choosing vaccine candidates mainly for their manufacturing advantages to shorten the development timeline, rather than for the most promising vaccine technology having safety and efficacy.<sup id=\"cite_ref-cohen6-4_213-1\" class=\"reference\"><a href=\"#cite_note-cohen6-4-213\">&#91;205&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Sovereignty\">Sovereignty</span></h3>\\n<p>Favored distribution of vaccines within one or a few select countries, called \"vaccine sovereignty\", is a criticism of some of the vaccine development partnerships,<sup id=\"cite_ref-cbcr_210-2\" class=\"reference\"><a href=\"#cite_note-cbcr-210\">&#91;202&#93;</a></sup><sup id=\"cite_ref-bolly_214-0\" class=\"reference\"><a href=\"#cite_note-bolly-214\">&#91;206&#93;</a></sup> such as for the AstraZeneca-University of Oxford vaccine candidate, concerning whether there may be prioritized distribution first within the UK and to the \"highest bidder\" \\xe2\\x80\\x93 the United States, which made an <a href=\"/wiki/Advance_payment\" title=\"Advance payment\">advance payment</a> of <span style=\"white-space: nowrap\">US$1.2</span><span class=\"nowrap\">&#160;</span>billion to secure 300<span class=\"nowrap\">&#160;</span>million vaccine doses for Americans, even before the AstraZeneca-Oxford vaccine or a <a href=\"/wiki/Sanofi\" title=\"Sanofi\">Sanofi</a> vaccine is proved safe or effective.<sup id=\"cite_ref-ahmed_211-3\" class=\"reference\"><a href=\"#cite_note-ahmed-211\">&#91;203&#93;</a></sup><sup id=\"cite_ref-215\" class=\"reference\"><a href=\"#cite_note-215\">&#91;207&#93;</a></sup><sup id=\"cite_ref-paton_216-0\" class=\"reference\"><a href=\"#cite_note-paton-216\">&#91;208&#93;</a></sup> Concerns exist about whether some countries producing vaccines may impose <a href=\"/wiki/Protectionism\" title=\"Protectionism\">protectionist controls</a> by export restrictions that would <a href=\"/wiki/Stockpile\" title=\"Stockpile\">stockpile</a> a COVID\\xe2\\x80\\x9119 vaccine for their own population.<sup id=\"cite_ref-bolly_214-1\" class=\"reference\"><a href=\"#cite_note-bolly-214\">&#91;206&#93;</a></sup>\\n</p><p>In June, the <a href=\"/wiki/Serum_Institute_of_India\" title=\"Serum Institute of India\">Serum Institute of India</a> (SII) \\xe2\\x80\\x93 a major manufacturer of global vaccines \\xe2\\x80\\x93 reached a licensing agreement with AstraZeneca to make <span class=\"nowrap\">1 billion doses</span> of vaccine for low-and-middle income countries;<sup id=\"cite_ref-kyle_212-1\" class=\"reference\"><a href=\"#cite_note-kyle-212\">&#91;204&#93;</a></sup> of which half of the doses would go to India.<sup id=\"cite_ref-unequal_217-0\" class=\"reference\"><a href=\"#cite_note-unequal-217\">&#91;209&#93;</a></sup> Similar preferential homeland distribution may exist if a vaccine is manufactured in Australia.<sup id=\"cite_ref-khamsi_218-0\" class=\"reference\"><a href=\"#cite_note-khamsi-218\">&#91;210&#93;</a></sup> The Chinese government pledged in May that a successful Chinese vaccine would become a \"global, public good,\" implying enough doses would be manufactured for both national and global distribution.<sup id=\"cite_ref-219\" class=\"reference\"><a href=\"#cite_note-219\">&#91;211&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Equitable_access\">Equitable access</span></h3>\\n<p>As many of the efforts on vaccine candidates have open-ended outcomes, including a high potential for failure during human testing, CEPI, WHO, and charitable vaccine organizations, such as the Gates Foundation and GAVI, raised over <span style=\"white-space: nowrap\">US$20</span><span class=\"nowrap\">&#160;</span>billion during the first half of 2020 to fund vaccine development and preparedness for vaccinations, particularly for children in <a href=\"/wiki/Least_developed_countries\" title=\"Least developed countries\">under-developed countries</a>.<sup id=\"cite_ref-cepi-fund_7-1\" class=\"reference\"><a href=\"#cite_note-cepi-fund-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-waked_8-3\" class=\"reference\"><a href=\"#cite_note-waked-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-gavi-summit_40-2\" class=\"reference\"><a href=\"#cite_note-gavi-summit-40\">&#91;40&#93;</a></sup><sup id=\"cite_ref-hbr_209-2\" class=\"reference\"><a href=\"#cite_note-hbr-209\">&#91;201&#93;</a></sup> CEPI had stated that governments should ensure implementation of a globally-fair allocation system for eventual vaccines, using a coordinated system of manufacturing capacity, financing and purchasing, and indemnification from liability to offset risks taken by vaccine developers.<sup id=\"cite_ref-yamey_27-5\" class=\"reference\"><a href=\"#cite_note-yamey-27\">&#91;27&#93;</a></sup>\\n</p><p>Having been created to monitor fair distribution of infectious disease vaccines to low- and middle-income countries,<sup id=\"cite_ref-bolly_214-2\" class=\"reference\"><a href=\"#cite_note-bolly-214\">&#91;206&#93;</a></sup><sup id=\"cite_ref-huney_220-0\" class=\"reference\"><a href=\"#cite_note-huney-220\">&#91;212&#93;</a></sup> CEPI revised its equitable access policy that was published in February to apply to its COVID-19 vaccine funding: 1) \"prices for vaccines will be set as low as possible for territories that are or may be affected by an outbreak of a disease for which CEPI funding was used to develop a vaccine;\" 2) \"information, know-how and materials related to vaccine development must be shared with (or transferred to) CEPI\" so that it can assume responsibility for vaccine development if a company discontinues expenditures for a promising vaccine candidate; 3) CEPI would have access to, and possible management of, <a href=\"/wiki/Intellectual_property\" title=\"Intellectual property\">intellectual property</a> rights (i.e., <a href=\"/wiki/Patent\" title=\"Patent\">patents</a>) for promising vaccines; 4) \"CEPI would receive a share of financial benefits that might accrue from CEPI-sponsored vaccine development, to re-invest in support of its mission to provide global public health benefit\"; and 5) data transparency among development partners should maintain the WHO Statement on Public Disclosure of Clinical Trial Results, and require results to be published in <a href=\"/wiki/Open_access\" title=\"Open access\">open-access</a> publications.<sup id=\"cite_ref-huney_220-1\" class=\"reference\"><a href=\"#cite_note-huney-220\">&#91;212&#93;</a></sup> Some vaccine manufacturers opposed parts of these proposals.<sup id=\"cite_ref-cbcr_210-3\" class=\"reference\"><a href=\"#cite_note-cbcr-210\">&#91;202&#93;</a></sup><sup id=\"cite_ref-huney_220-2\" class=\"reference\"><a href=\"#cite_note-huney-220\">&#91;212&#93;</a></sup>\\n</p><p>International groups, such as the Centre for Artistic Activism and <a href=\"/wiki/Universities_Allied_for_Essential_Medicines\" title=\"Universities Allied for Essential Medicines\">Universities Allied for Essential Medicines</a>, advocate for equitable access to licensed COVID\\xe2\\x80\\x9119 vaccines.<sup id=\"cite_ref-221\" class=\"reference\"><a href=\"#cite_note-221\">&#91;213&#93;</a></sup><sup id=\"cite_ref-222\" class=\"reference\"><a href=\"#cite_note-222\">&#91;214&#93;</a></sup> Scientists have encouraged that the WHO, CEPI, corporations, and governments collaborate to assure evidence-based allocation of eventual COVID\\xe2\\x80\\x9119 vaccines determined on infection risk,<sup id=\"cite_ref-bolly_214-3\" class=\"reference\"><a href=\"#cite_note-bolly-214\">&#91;206&#93;</a></sup><sup id=\"cite_ref-huney_220-3\" class=\"reference\"><a href=\"#cite_note-huney-220\">&#91;212&#93;</a></sup> particularly urgent vaccinations provided first for healthcare workers, vulnerable populations, and children.<sup id=\"cite_ref-gates1_24-7\" class=\"reference\"><a href=\"#cite_note-gates1-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-hbr_209-3\" class=\"reference\"><a href=\"#cite_note-hbr-209\">&#91;201&#93;</a></sup><sup id=\"cite_ref-cbcr_210-4\" class=\"reference\"><a href=\"#cite_note-cbcr-210\">&#91;202&#93;</a></sup>\\nDuring 2020, the WHO, GAVI, and CEPI combined resources to form COVAX \\xe2\\x80\\x93 a program for coordination of global equitable access to a licensed vaccine.<sup id=\"cite_ref-covax-gavi_32-4\" class=\"reference\"><a href=\"#cite_note-covax-gavi-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-covax_33-1\" class=\"reference\"><a href=\"#cite_note-covax-33\">&#91;33&#93;</a></sup>\\n</p><p>Over 100 international scientists and concerned individuals (including those associated with religious organizations) have called for releasing COVID\\xe2\\x80\\x9119 vaccines to the <a href=\"/wiki/Public_domain\" title=\"Public domain\">public domain</a>. Similar to the development of the first <a href=\"/wiki/Polio_vaccine\" title=\"Polio vaccine\">polio vaccine</a> that was never patented, an effective COVID-19 vaccine would be available for production and approval by a number of countries and pharmaceutical manufacturing centers worldwide, therefore allowing for a more even and cost-effective distribution on a global scale.<sup id=\"cite_ref-223\" class=\"reference\"><a href=\"#cite_note-223\">&#91;215&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Supply_chain\">Supply chain</span></h2>\\n<p>During and after 2021, deploying a COVID-19 vaccine may require worldwide transport and tracking of 10-19 billion vial doses, an effort readily becoming the largest <a href=\"/wiki/Supply_chain_management\" title=\"Supply chain management\">supply chain</a> challenge in history.<sup id=\"cite_ref-gates2_6-12\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-wef_224-0\" class=\"reference\"><a href=\"#cite_note-wef-224\">&#91;216&#93;</a></sup><sup id=\"cite_ref-unequal_217-1\" class=\"reference\"><a href=\"#cite_note-unequal-217\">&#91;209&#93;</a></sup> As of September 2020, supply chain and <a href=\"/wiki/Logistics\" title=\"Logistics\">logistics</a> experts expressed concern that international and national networks for distributing a licensed vaccine were not ready for the volume and urgency, due mainly to deterioration of resources during 2020 pandemic lockdowns and downsizing that degraded supply capabilities.<sup id=\"cite_ref-wef_224-1\" class=\"reference\"><a href=\"#cite_note-wef-224\">&#91;216&#93;</a></sup><sup id=\"cite_ref-murray_225-0\" class=\"reference\"><a href=\"#cite_note-murray-225\">&#91;217&#93;</a></sup><sup id=\"cite_ref-scott_226-0\" class=\"reference\"><a href=\"#cite_note-scott-226\">&#91;218&#93;</a></sup> Addressing the worldwide challenge faced by coordinating numerous organizations \\xe2\\x80\\x93 the COVAX partnership, global pharmaceutical companies, contract vaccine manufacturers, inter- and intranational transport, storage facilities, and health organizations in individual countries \\xe2\\x80\\x93 <a href=\"/wiki/Seth_Berkley\" title=\"Seth Berkley\">Seth Berkley</a>, <a href=\"/wiki/Chief_executive\" class=\"mw-redirect\" title=\"Chief executive\">chief executive</a> of GAVI, stated: \"Delivering billions of doses of vaccine to the entire world efficiently will involve hugely complex logistical and programmatic obstacles all the way along the supply chain.\"<sup id=\"cite_ref-unicef-now_227-0\" class=\"reference\"><a href=\"#cite_note-unicef-now-227\">&#91;219&#93;</a></sup>\\n</p><p>As an example highlighting the immensity of the challenge, the <a href=\"/wiki/International_Air_Transport_Association\" title=\"International Air Transport Association\">International Air Transport Association</a> stated that 8,000 <a href=\"/wiki/Boeing_747\" title=\"Boeing 747\">747 cargo planes</a> \\xe2\\x80\\x93 implemented with equipment for precision vaccine cold storage \\xe2\\x80\\x93 would be needed to transport just one dose for people in the more than 200 countries experiencing the COVID-19 pandemic.<sup id=\"cite_ref-desai_228-0\" class=\"reference\"><a href=\"#cite_note-desai-228\">&#91;220&#93;</a></sup> GAVI states that \"with a fast-moving pandemic, no one is safe, unless everyone is safe.\"<sup id=\"cite_ref-covax-gavi_32-5\" class=\"reference\"><a href=\"#cite_note-covax-gavi-32\">&#91;32&#93;</a></sup>\\n</p><p>In contrast to the multibillion dollar investment in vaccine technologies and early-stage clinical research, the post-licensing supply chain for a vaccine has not received the same planning, coordination, security or investment.<sup id=\"cite_ref-wef_224-2\" class=\"reference\"><a href=\"#cite_note-wef-224\">&#91;216&#93;</a></sup><sup id=\"cite_ref-murray_225-1\" class=\"reference\"><a href=\"#cite_note-murray-225\">&#91;217&#93;</a></sup><sup id=\"cite_ref-pharmiweb_229-0\" class=\"reference\"><a href=\"#cite_note-pharmiweb-229\">&#91;221&#93;</a></sup> A major concern is that resources for vaccine distribution in <a href=\"/wiki/Developing_country\" title=\"Developing country\">low- to middle-income countries</a>, particularly for vaccinating children, are inadequate or non-existent, but could be improved with cost efficiencies if procurement and distribution were centralized regionally or nationally.<sup id=\"cite_ref-covax-gavi_32-6\" class=\"reference\"><a href=\"#cite_note-covax-gavi-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-seidman_230-0\" class=\"reference\"><a href=\"#cite_note-seidman-230\">&#91;222&#93;</a></sup> In September, the COVAX partnership included 172 countries coordinating plans to optimize the supply chain for a COVID-19 vaccine,<sup id=\"cite_ref-gavi9-4_231-0\" class=\"reference\"><a href=\"#cite_note-gavi9-4-231\">&#91;223&#93;</a></sup> and <a href=\"/wiki/UNICEF\" title=\"UNICEF\">the United Nations Children\\'s Fund</a> joined with COVAX to prepare the financing and supply chain for vaccinations of children in 92 developing countries.<sup id=\"cite_ref-unicef_232-0\" class=\"reference\"><a href=\"#cite_note-unicef-232\">&#91;224&#93;</a></sup><sup id=\"cite_ref-cook_233-0\" class=\"reference\"><a href=\"#cite_note-cook-233\">&#91;225&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Logistics\">Logistics</span></h3>\\n<p>Logistics vaccination services assure necessary equipment, staff, and supply of licensed vaccines across international borders.<sup id=\"cite_ref-hessel_234-0\" class=\"reference\"><a href=\"#cite_note-hessel-234\">&#91;226&#93;</a></sup> Central logistics include vaccine handling and monitoring, cold chain management, and safety of distribution within the vaccination network.<sup id=\"cite_ref-who-log_235-0\" class=\"reference\"><a href=\"#cite_note-who-log-235\">&#91;227&#93;</a></sup> The purpose of the COVAX Facility is to centralize and equitably administer logistics resources among participating countries, merging manufacturing, transport, and overall supply chain infrastructure.<sup id=\"cite_ref-covax-gavi_32-7\" class=\"reference\"><a href=\"#cite_note-covax-gavi-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-pharmiweb_229-1\" class=\"reference\"><a href=\"#cite_note-pharmiweb-229\">&#91;221&#93;</a></sup> Included are logistics tools for vaccine forecasting and needs estimation, in-country vaccine management, potential for wastage, and stock management.<sup id=\"cite_ref-who-log_235-1\" class=\"reference\"><a href=\"#cite_note-who-log-235\">&#91;227&#93;</a></sup>\\n</p><p>Other logistics factors conducted internationally during distribution of a COVID-19 vaccine may include:<sup id=\"cite_ref-wef_224-3\" class=\"reference\"><a href=\"#cite_note-wef-224\">&#91;216&#93;</a></sup><sup id=\"cite_ref-jarrett_236-0\" class=\"reference\"><a href=\"#cite_note-jarrett-236\">&#91;228&#93;</a></sup><sup id=\"cite_ref-lloyd_237-0\" class=\"reference\"><a href=\"#cite_note-lloyd-237\">&#91;229&#93;</a></sup>\\n</p>\\n<ul><li>visibility and traceability by <a href=\"/wiki/Barcode\" title=\"Barcode\">barcodes</a> for each vaccine vial</li>\\n<li>sharing of supplier audits</li>\\n<li>sharing of <a href=\"/wiki/Chain_of_custody\" title=\"Chain of custody\">chain of custody</a> for a vaccine vial from manufacturer to the individual being vaccinated</li>\\n<li>use of vaccine temperature monitoring tools</li>\\n<li>temperature stability testing and assurance</li>\\n<li>new packaging and delivery technologies</li>\\n<li>stockpiling</li>\\n<li>coordination of supplies within each country (<a href=\"/wiki/Personal_protective_equipment\" title=\"Personal protective equipment\">personal protective equipment</a>, <a href=\"/wiki/Diluent\" title=\"Diluent\">diluent</a>, syringes, needles, rubber stoppers, refrigeration fuel or power sources, waste-handling, among others)</li>\\n<li>communications technology</li>\\n<li>environmental impacts in each country</li></ul>\\n<p>A logistics shortage in any one step may derail the whole supply chain, according to one vaccine developer.<sup id=\"cite_ref-wef-manuf_238-0\" class=\"reference\"><a href=\"#cite_note-wef-manuf-238\">&#91;230&#93;</a></sup> If the vaccine supply chain fails, the economic and human costs of the pandemic may be extended for years.<sup id=\"cite_ref-scott_226-1\" class=\"reference\"><a href=\"#cite_note-scott-226\">&#91;218&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Manufacturing_capacity\">Manufacturing capacity</span></h3>\\n<p>By August 2020 when only a few vaccine candidates were in Phase III trials many months from establishing safety and efficacy, numerous governments pre-ordered more than two billion doses at a cost of more than US$5 billion.<sup id=\"cite_ref-unequal_217-2\" class=\"reference\"><a href=\"#cite_note-unequal-217\">&#91;209&#93;</a></sup><sup id=\"cite_ref-wef-manuf_238-1\" class=\"reference\"><a href=\"#cite_note-wef-manuf-238\">&#91;230&#93;</a></sup><sup id=\"cite_ref-239\" class=\"reference\"><a href=\"#cite_note-239\">&#91;231&#93;</a></sup> Pre-orders from the UK government for 2021 were for five vaccine doses per person, a number dispiriting organizations like the WHO and GAVI which are promoting fair and equitable access worldwide, especially for developing countries.<sup id=\"cite_ref-unequal_217-3\" class=\"reference\"><a href=\"#cite_note-unequal-217\">&#91;209&#93;</a></sup> In September, CEPI was financially supporting basic and clinical research for nine vaccine candidates, with nine more in evaluation, under financing commitments to manufacture two billion doses of three licensed vaccines by the end of 2021.<sup id=\"cite_ref-gavi9-4_231-1\" class=\"reference\"><a href=\"#cite_note-gavi9-4-231\">&#91;223&#93;</a></sup> Overall before 2022, 7-10 billion COVID-19 vaccine doses may be manufactured worldwide, but the sizable pre-orders by affluent countries \\xe2\\x80\\x93 called \"vaccine nationalism\" \\xe2\\x80\\x93 threaten vaccine availability for poorer nations.<sup id=\"cite_ref-gates2_6-13\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-wef-manuf_238-2\" class=\"reference\"><a href=\"#cite_note-wef-manuf-238\">&#91;230&#93;</a></sup><sup id=\"cite_ref-unequal_217-4\" class=\"reference\"><a href=\"#cite_note-unequal-217\">&#91;209&#93;</a></sup> Brazil and Indonesia had pre-ordered millions of vaccine doses that are undergoing phase III trials in their countries The <a href=\"/wiki/Serum_Institute_of_India\" title=\"Serum Institute of India\">Serum Institute of India</a> plans to produce at least one billion vaccine doses, although the Institute has stated that half the doses will be used in India.<sup id=\"cite_ref-unequal_217-5\" class=\"reference\"><a href=\"#cite_note-unequal-217\">&#91;209&#93;</a></sup> After joining COVAX in October, China shared that it would produce 600 million vaccine doses before the end of 2020 and another one billion doses in 2021, although it was unsure how many would be for the country\\'s own population of 1.4 billion.<sup id=\"cite_ref-240\" class=\"reference\"><a href=\"#cite_note-240\">&#91;232&#93;</a></sup>\\n</p><p>AstraZeneca CEO, <a href=\"/wiki/Pascal_Soriot\" title=\"Pascal Soriot\">Pascal Soriot</a>, stated: \"The challenge is not making the vaccine itself, it\\'s filling vials. There just aren\\'t enough vials in the world.\"<sup id=\"cite_ref-molteni_241-0\" class=\"reference\"><a href=\"#cite_note-molteni-241\">&#91;233&#93;</a></sup> Preparing for high demand in manufacturing vials, an American glass producer invested $163 million in July for a vial factory.<sup id=\"cite_ref-glass_242-0\" class=\"reference\"><a href=\"#cite_note-glass-242\">&#91;234&#93;</a></sup> Glass availability for vial manufacturing and contaminant control are issues of concern,<sup id=\"cite_ref-burger_243-0\" class=\"reference\"><a href=\"#cite_note-burger-243\">&#91;235&#93;</a></sup> indicating higher production costs with lower profit potential for developers amid demands for vaccines to be affordable.<sup id=\"cite_ref-covax-gavi_32-8\" class=\"reference\"><a href=\"#cite_note-covax-gavi-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-unequal_217-6\" class=\"reference\"><a href=\"#cite_note-unequal-217\">&#91;209&#93;</a></sup><sup id=\"cite_ref-scott_226-2\" class=\"reference\"><a href=\"#cite_note-scott-226\">&#91;218&#93;</a></sup>\\n</p><p>Vaccines must be handled and transported using international regulations, be maintained at controlled temperatures that vary across vaccine technologies, and be used for immunization before deterioration in storage.<sup id=\"cite_ref-unequal_217-7\" class=\"reference\"><a href=\"#cite_note-unequal-217\">&#91;209&#93;</a></sup><sup id=\"cite_ref-wef-manuf_238-3\" class=\"reference\"><a href=\"#cite_note-wef-manuf-238\">&#91;230&#93;</a></sup> The scale of the COVID-19 vaccine supply chain is expected to be vast to ensure delivery worldwide to vulnerable populations.<sup id=\"cite_ref-gates2_6-14\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-murray_225-2\" class=\"reference\"><a href=\"#cite_note-murray-225\">&#91;217&#93;</a></sup> Priorities for preparing facilities for such distribution include temperature-controlled facilities and equipment, optimizing infrastructure, training immunization staff, and rigorous monitoring.<sup id=\"cite_ref-murray_225-3\" class=\"reference\"><a href=\"#cite_note-murray-225\">&#91;217&#93;</a></sup><sup id=\"cite_ref-unicef-now_227-1\" class=\"reference\"><a href=\"#cite_note-unicef-now-227\">&#91;219&#93;</a></sup><sup id=\"cite_ref-unicef_232-1\" class=\"reference\"><a href=\"#cite_note-unicef-232\">&#91;224&#93;</a></sup> <a href=\"/wiki/Radiofrequency_identification\" class=\"mw-redirect\" title=\"Radiofrequency identification\">RFID</a> technologies are being implemented to track and authenticate a vaccine dose from the manufacturer along the entire supply chain to the vaccination.<sup id=\"cite_ref-kaplan_244-0\" class=\"reference\"><a href=\"#cite_note-kaplan-244\">&#91;236&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Cold_chain\">Cold chain</span></h3>\\n<p>Vaccines (and adjuvants) are inherently unstable during temperature changes, requiring <a href=\"/wiki/Cold_chain\" title=\"Cold chain\">cold chain</a> management throughout the entire supply chain, typically at temperatures of 2\\xe2\\x80\\x938&#160;\\xc2\\xb0C (36\\xe2\\x80\\x9346&#160;\\xc2\\xb0F).<sup id=\"cite_ref-lloyd_237-1\" class=\"reference\"><a href=\"#cite_note-lloyd-237\">&#91;229&#93;</a></sup><sup id=\"cite_ref-karto_245-0\" class=\"reference\"><a href=\"#cite_note-karto-245\">&#91;237&#93;</a></sup> Because COVID-19 vaccine technologies are varied among several novel technologies, there are new challenges for cold chain management, with some vaccines that are stable while frozen but labile to heat, while others should not be frozen at all, and some are stable across temperatures.<sup id=\"cite_ref-karto_245-1\" class=\"reference\"><a href=\"#cite_note-karto-245\">&#91;237&#93;</a></sup> Freezing damage and inadequate training of personnel in the local vaccination process are major concerns.<sup id=\"cite_ref-hanson_246-0\" class=\"reference\"><a href=\"#cite_note-hanson-246\">&#91;238&#93;</a></sup> If more than one COVID-19 vaccine is approved, the vaccine cold chain may have to accommodate all these temperature sensitivities across different countries with variable climate conditions and local resources for temperature maintenance.<sup id=\"cite_ref-karto_245-2\" class=\"reference\"><a href=\"#cite_note-karto-245\">&#91;237&#93;</a></sup>\\n</p><p>DNA and RNA vaccine technologies are in development, but may be difficult to manufacture at scale and control degradation during cold storage and transport.<sup id=\"cite_ref-scott_226-3\" class=\"reference\"><a href=\"#cite_note-scott-226\">&#91;218&#93;</a></sup> As examples, Moderna\\'s RNA vaccine candidate requires cold chain management just above freezing temperatures with limited storage duration, but the BioNTech-Pfizer RNA candidate requires storage at -70\\xc2\\xb0C (-94\\xc2\\xb0F) or colder throughout deployment until vaccination.<sup id=\"cite_ref-gates2_6-15\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-weise_247-0\" class=\"reference\"><a href=\"#cite_note-weise-247\">&#91;239&#93;</a></sup>\\n</p><p>After a vaccine vial is punctured to administer a dose, it is viable for only six hours, then must be discarded, requiring attention to local management of cold storage and vaccination processes.<sup id=\"cite_ref-weise_247-1\" class=\"reference\"><a href=\"#cite_note-weise-247\">&#91;239&#93;</a></sup> Because the COVID-19 vaccine will likely be in short supply for many locations during early deployment, vaccination staff will have to avoid spoilage and waste, which typically are as much as 30% of the supply.<sup id=\"cite_ref-wef_224-4\" class=\"reference\"><a href=\"#cite_note-wef-224\">&#91;216&#93;</a></sup><sup id=\"cite_ref-weise_247-2\" class=\"reference\"><a href=\"#cite_note-weise-247\">&#91;239&#93;</a></sup> The cold chain is further challenged by the type of local transportation for the vaccines in rural communities, such as by motorcycle or <a href=\"/wiki/Delivery_drone\" title=\"Delivery drone\">delivery drone</a>, need for booster doses, use of diluents, and access to vulnerable populations, such as healthcare staff, children and the elderly.<sup id=\"cite_ref-gates2_6-16\" class=\"reference\"><a href=\"#cite_note-gates2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-unicef_232-2\" class=\"reference\"><a href=\"#cite_note-unicef-232\">&#91;224&#93;</a></sup><sup id=\"cite_ref-durbha_248-0\" class=\"reference\"><a href=\"#cite_note-durbha-248\">&#91;240&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Air_and_land_transport\">Air and land transport</span></h3>\\n<p>Coordination of international <a href=\"/wiki/Air_cargo\" title=\"Air cargo\">air cargo</a> is an essential component of time- and temperature-sensitive distribution of COVID-19 vaccines, but, as of September 2020, the air freight network is not prepared for multinational deployment.<sup id=\"cite_ref-murray_225-4\" class=\"reference\"><a href=\"#cite_note-murray-225\">&#91;217&#93;</a></sup><sup id=\"cite_ref-desai_228-1\" class=\"reference\"><a href=\"#cite_note-desai-228\">&#91;220&#93;</a></sup><sup id=\"cite_ref-iata_249-0\" class=\"reference\"><a href=\"#cite_note-iata-249\">&#91;241&#93;</a></sup> \"Safely delivering COVID-19 vaccines will be the mission of the century for the global air cargo industry. But it won\\'t happen without careful advance planning. And the time for that is now. We urge governments to take the lead in facilitating cooperation across the logistics chain so that the facilities, security arrangements and border processes are ready for the mammoth and complex task ahead,\" said IATA\\'s Director General and CEO, <a href=\"/wiki/Alexandre_de_Juniac\" title=\"Alexandre de Juniac\">Alexandre de Juniac</a>, in September 2020.<sup id=\"cite_ref-iata_249-1\" class=\"reference\"><a href=\"#cite_note-iata-249\">&#91;241&#93;</a></sup>\\n</p><p>For the severe reduction in passenger air traffic during 2020, airlines <a href=\"/wiki/Layoff\" title=\"Layoff\">downsized</a> personnel, trimmed destination networks, and put aircraft into long-term storage.<sup id=\"cite_ref-murray_225-5\" class=\"reference\"><a href=\"#cite_note-murray-225\">&#91;217&#93;</a></sup><sup id=\"cite_ref-iata_249-2\" class=\"reference\"><a href=\"#cite_note-iata-249\">&#91;241&#93;</a></sup> As the lead agencies for procurement and supply of the COVID-19 vaccine within the WHO COVAX Facility, GAVI and UNICEF are preparing for the largest and fastest vaccine deployment ever, necessitating international air freight collaboration, customs and border control, and possibly as many as 8,000 cargo planes to deliver just one vaccine dose to multiple countries.<sup id=\"cite_ref-unicef_232-3\" class=\"reference\"><a href=\"#cite_note-unicef-232\">&#91;224&#93;</a></sup><sup id=\"cite_ref-iata_249-3\" class=\"reference\"><a href=\"#cite_note-iata-249\">&#91;241&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"Security_and_corruption\">Security and corruption</span></h3>\\n<p>Medicines are the world\\'s largest fraud market, worth some $200 billion per year, making the widespread demand for a COVID-19 vaccine vulnerable to <a href=\"/wiki/Counterfeit\" title=\"Counterfeit\">counterfeit</a>, theft, <a href=\"/wiki/Confidence_trick\" title=\"Confidence trick\">scams</a>, and <a href=\"/wiki/Cyberattack\" title=\"Cyberattack\">cyberattacks</a> throughout the supply chain.<sup id=\"cite_ref-pharmiweb_229-2\" class=\"reference\"><a href=\"#cite_note-pharmiweb-229\">&#91;221&#93;</a></sup><sup id=\"cite_ref-unodc_250-0\" class=\"reference\"><a href=\"#cite_note-unodc-250\">&#91;242&#93;</a></sup> <a href=\"/wiki/Anticorruption\" class=\"mw-redirect\" title=\"Anticorruption\">Anticorruption</a>, transparency, and accountability  safeguards are being established to reduce and eliminate corruption of COVID-19 vaccine supplies.<sup id=\"cite_ref-unodc_250-1\" class=\"reference\"><a href=\"#cite_note-unodc-250\">&#91;242&#93;</a></sup><sup id=\"cite_ref-kohler_251-0\" class=\"reference\"><a href=\"#cite_note-kohler-251\">&#91;243&#93;</a></sup> Absence of harmonized regulatory frameworks among countries, including low technical capacity, constrained access, and ineffective capability to identify and track genuine vs. counterfeit vaccines, may be life-threatening for vaccine recipients, and would potentially perpetuate the COVID-19 pandemic.<sup id=\"cite_ref-unodc_250-2\" class=\"reference\"><a href=\"#cite_note-unodc-250\">&#91;242&#93;</a></sup> <a href=\"/wiki/Tracking_system\" title=\"Tracking system\">Tracking system</a> technologies for packaging are being used by manufacturers to trace vaccine vials across the supply chain,<sup id=\"cite_ref-pharmiweb_229-3\" class=\"reference\"><a href=\"#cite_note-pharmiweb-229\">&#91;221&#93;</a></sup> and to use digital and <a href=\"/wiki/Biometric\" class=\"mw-redirect\" title=\"Biometric\">biometric</a> tools to assure security for vaccination teams.<sup id=\"cite_ref-kaplan_244-1\" class=\"reference\"><a href=\"#cite_note-kaplan-244\">&#91;236&#93;</a></sup><sup id=\"cite_ref-subra_252-0\" class=\"reference\"><a href=\"#cite_note-subra-252\">&#91;244&#93;</a></sup>\\n</p>\\n<h3><span class=\"mw-headline\" id=\"National_infrastructure\">National infrastructure</span></h3>\\n<p>The WHO has implemented an \"Effective Vaccine Management\" system,<sup id=\"cite_ref-who-evm_253-0\" class=\"reference\"><a href=\"#cite_note-who-evm-253\">&#91;245&#93;</a></sup> which includes constructing priorities to prepare national and subnational personnel and facilities for vaccine distribution, including:\\n</p>\\n<ul><li>Trained staff to handle time- and temperature-sensitive vaccines</li>\\n<li>Robust monitoring capabilities to ensure optimal vaccine storage and transport</li>\\n<li>Temperature-controlled facilities and equipment</li>\\n<li>Traceability</li>\\n<li>Security</li></ul>\\n<p>Border processes for efficient handling and customs clearance within individual countries may include:<sup id=\"cite_ref-hessel_234-1\" class=\"reference\"><a href=\"#cite_note-hessel-234\">&#91;226&#93;</a></sup><sup id=\"cite_ref-who-evm_253-1\" class=\"reference\"><a href=\"#cite_note-who-evm-253\">&#91;245&#93;</a></sup>\\n</p>\\n<ul><li>Facilitating flight and landing permits</li>\\n<li>Exempting flight crews from <a href=\"/wiki/Quarantine\" title=\"Quarantine\">quarantine</a> requirements</li>\\n<li>Facilitating flexible operations for efficient national deployment</li>\\n<li>Granting arrival priority to maintain vaccine temperature requirements</li></ul>\\n<h2><span class=\"mw-headline\" id=\"Liability\">Liability</span></h2>\\n<p>On February 4, 2020, US Secretary of Health and Human Services <a href=\"/wiki/Alex_Azar\" title=\"Alex Azar\">Alex Azar</a> published a notice of declaration under the <a href=\"/wiki/Public_Readiness_and_Emergency_Preparedness_Act\" title=\"Public Readiness and Emergency Preparedness Act\">Public Readiness and Emergency Preparedness Act</a> for medical countermeasures against COVID\\xe2\\x80\\x9119, covering \"any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID\\xe2\\x80\\x9119, or the transmission of SARS-CoV-2 or a virus mutating therefrom\", and stating that the declaration precludes \"liability claims alleging negligence by a manufacturer in creating a vaccine, or negligence by a health care provider in prescribing the wrong dose, absent willful misconduct\".<sup id=\"cite_ref-254\" class=\"reference\"><a href=\"#cite_note-254\">&#91;246&#93;</a></sup> The declaration is effective in the United States through 1 October 2024.\\n</p>\\n<h2><span class=\"mw-headline\" id=\"Misinformation\">Misinformation</span></h2>\\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Misinformation_related_to_the_COVID-19_pandemic\" title=\"Misinformation related to the COVID-19 pandemic\">Misinformation related to the COVID-19 pandemic</a></div>\\n<p>Social media posts have promoted a <a href=\"/wiki/Conspiracy_theory\" title=\"Conspiracy theory\">conspiracy theory</a> that a COVID\\xe2\\x80\\x9119 vaccine is already available. The patents cited by various <a href=\"/wiki/Social_media\" title=\"Social media\">social media</a> posts have references to existing patents for <a href=\"/wiki/Genetic_sequence\" class=\"mw-redirect\" title=\"Genetic sequence\">genetic sequences</a> and vaccines for other strains such as the <a href=\"/wiki/Severe_acute_respiratory_syndrome-related_coronavirus\" class=\"mw-redirect\" title=\"Severe acute respiratory syndrome-related coronavirus\">SARS coronavirus</a>, but not for COVID\\xe2\\x80\\x9119.<sup id=\"cite_ref-255\" class=\"reference\"><a href=\"#cite_note-255\">&#91;247&#93;</a></sup><sup id=\"cite_ref-20200124factcheckA_256-0\" class=\"reference\"><a href=\"#cite_note-20200124factcheckA-256\">&#91;248&#93;</a></sup>\\n</p><p>On 21 May 2020, the FDA made public the cease-and-desist notice it had sent to North Coast Biologics, a Seattle-based company that had been selling a purported \"nCoV19 spike protein vaccine\".<sup id=\"cite_ref-257\" class=\"reference\"><a href=\"#cite_note-257\">&#91;249&#93;</a></sup>\\n</p>\\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span></h2>\\n<style data-mw-deduplicate=\"TemplateStyles:r936637989\">.mw-parser-output .portal{border:solid #aaa 1px;padding:0}.mw-parser-output .portal.tleft{margin:0.5em 1em 0.5em 0}.mw-parser-output .portal.tright{margin:0.5em 0 0.5em 1em}.mw-parser-output .portal>ul{display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold}.mw-parser-output .portal>ul>li{display:table-row}.mw-parser-output .portal>ul>li>span:first-child{display:table-cell;padding:0.2em;vertical-align:middle;text-align:center}.mw-parser-output .portal>ul>li>span:last-child{display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle}</style><div role=\"navigation\" aria-label=\"Portals\" class=\"noprint portal plainlist tright\">\\n<ul>\\n<li><span><a href=\"/wiki/File:SARS-CoV-2_(Wikimedia_colors).svg\" class=\"image\"><img alt=\"virus icon\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/28px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png\" decoding=\"async\" width=\"28\" height=\"28\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/42px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/56px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 2x\" data-file-width=\"666\" data-file-height=\"666\" /></a></span><span><a href=\"/wiki/Portal:Coronavirus_disease_2019\" title=\"Portal:Coronavirus disease 2019\">Coronavirus disease 2019 portal</a></span></li>\\n<li><span><img alt=\"icon\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/12px-WHO_Rod.svg.png\" decoding=\"async\" width=\"12\" height=\"28\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/18px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/24px-WHO_Rod.svg.png 2x\" data-file-width=\"107\" data-file-height=\"250\" /></span><span><a href=\"/wiki/Portal:Medicine\" title=\"Portal:Medicine\">Medicine portal</a></span></li>\\n<li><span><img alt=\"icon\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Klepsydra-pt.svg/25px-Klepsydra-pt.svg.png\" decoding=\"async\" width=\"25\" height=\"28\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Klepsydra-pt.svg/37px-Klepsydra-pt.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Klepsydra-pt.svg/50px-Klepsydra-pt.svg.png 2x\" data-file-width=\"244\" data-file-height=\"275\" /></span><span><a href=\"/wiki/Portal:Modern_history\" title=\"Portal:Modern history\">Modern history portal</a></span></li>\\n<li><span><a href=\"/wiki/File:Sida-aids.png\" class=\"image\"><img alt=\"icon\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Sida-aids.png/28px-Sida-aids.png\" decoding=\"async\" width=\"28\" height=\"28\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Sida-aids.png/42px-Sida-aids.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Sida-aids.png/56px-Sida-aids.png 2x\" data-file-width=\"290\" data-file-height=\"290\" /></a></span><span><a href=\"/wiki/Portal:Viruses\" title=\"Portal:Viruses\">Viruses portal</a></span></li>\\n<li><span><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e2/Ambox_globe.svg/28px-Ambox_globe.svg.png\" decoding=\"async\" width=\"28\" height=\"28\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e2/Ambox_globe.svg/42px-Ambox_globe.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e2/Ambox_globe.svg/56px-Ambox_globe.svg.png 2x\" data-file-width=\"512\" data-file-height=\"512\" /></span><span><a href=\"/wiki/Portal:Current_events\" title=\"Portal:Current events\">Current events portal</a></span></li></ul></div>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a></li>\\n<li><a href=\"/wiki/Coronavirus_disease_2019\" title=\"Coronavirus disease 2019\">Coronavirus disease 2019</a></li>\\n<li><a href=\"/wiki/COVID-19_drug_repurposing_research\" title=\"COVID-19 drug repurposing research\">COVID-19 drug repurposing research</a></li>\\n<li><a href=\"/wiki/COVID-19_drug_development\" title=\"COVID-19 drug development\">COVID-19 drug development</a></li>\\n<li><a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">Severe acute respiratory syndrome coronavirus 2</a></li>\\n<li><a href=\"/wiki/Respiratory_disease\" title=\"Respiratory disease\">Respiratory disease</a></li>\\n<li><a href=\"/wiki/Phases_of_clinical_research\" title=\"Phases of clinical research\">Phases of clinical research</a></li>\\n<li><a href=\"/wiki/2009_swine_flu_pandemic_vaccine\" title=\"2009 swine flu pandemic vaccine\">2009 swine flu pandemic vaccine</a></li></ul>\\n<h2><span class=\"mw-headline\" id=\"References\">References</span></h2>\\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\\n<li id=\"cite_note-diamond-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-diamond_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-diamond_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-diamond_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-diamond_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-diamond_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-diamond_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-diamond_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-diamond_1-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFDiamondPierson2020\" class=\"citation journal cs1\">Diamond MS, Pierson TC (13 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7219397\">\"The challenges of vaccine development against a new virus during a pandemic\"</a>. <i>Cell Host and Microbe</i>. <b>27</b> (5): 699\\xe2\\x80\\x93703. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.chom.2020.04.021\">10.1016/j.chom.2020.04.021</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7219397\">7219397</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32407708\">32407708</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Host+and+Microbe&amp;rft.atitle=The+challenges+of+vaccine+development+against+a+new+virus+during+a+pandemic&amp;rft.volume=27&amp;rft.issue=5&amp;rft.pages=699-703&amp;rft.date=2020-05-13&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7219397&amp;rft_id=info%3Apmid%2F32407708&amp;rft_id=info%3Adoi%2F10.1016%2Fj.chom.2020.04.021&amp;rft.aulast=Diamond&amp;rft.aufirst=Michael+S&amp;rft.au=Pierson%2C+Theodore+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7219397&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><style data-mw-deduplicate=\"TemplateStyles:r982806391\">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:\"\\\\\"\"\"\\\\\"\"\"\\'\"\"\\'\"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg\")right 0.1em center/12px no-repeat}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style></span>\\n</li>\\n<li id=\"cite_note-thanh2-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-thanh2_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-16\"><sup><i><b>q</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-17\"><sup><i><b>r</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-18\"><sup><i><b>s</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFLeCramerChenMayhew2020\" class=\"citation journal cs1\">Le, Tung Thanh; Cramer, Jakob P.; Chen, Robert; Mayhew, Stephen (4 September 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/d41573-020-00151-8\">\"Evolution of the COVID-19 vaccine development landscape\"</a>. <i>Nature Reviews Drug Discovery</i>. <b>19</b> (10): 667\\xe2\\x80\\x9368. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fd41573-020-00151-8\">10.1038/d41573-020-00151-8</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1474-1776\">1474-1776</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32887942\">32887942</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221503034\">221503034</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Drug+Discovery&amp;rft.atitle=Evolution+of+the+COVID-19+vaccine+development+landscape&amp;rft.volume=19&amp;rft.issue=10&amp;rft.pages=667-68&amp;rft.date=2020-09-04&amp;rft.issn=1474-1776&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221503034&amp;rft_id=info%3Apmid%2F32887942&amp;rft_id=info%3Adoi%2F10.1038%2Fd41573-020-00151-8&amp;rft.aulast=Le&amp;rft.aufirst=Tung+Thanh&amp;rft.au=Cramer%2C+Jakob+P.&amp;rft.au=Chen%2C+Robert&amp;rft.au=Mayhew%2C+Stephen&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41573-020-00151-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-london-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-london_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-london_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-london_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-london_3-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-london_3-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/\">\"COVID-19 vaccine development pipeline (Refresh URL to update)\"</a>. Vaccine Centre, London School of Hygiene and Tropical Medicine. 14 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVID-19+vaccine+development+pipeline+%28Refresh+URL+to+update%29&amp;rft.pub=Vaccine+Centre%2C+London+School+of+Hygiene+and+Tropical+Medicine&amp;rft.date=2020-09-14&amp;rft_id=https%3A%2F%2Fvac-lshtm.shinyapps.io%2Fncov_vaccine_landscape%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-milken-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-milken_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-milken_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-milken_4-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://airtable.com/shrSAi6t5WFwqo3GM/tblEzPQS5fnc0FHYR/viwDBH7b6FjmIBX5x?blocks=hide\">\"COVID-19 vaccine tracker (Choose vaccines tab, apply filters to view select data)\"</a>. Milken Institute. 17 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>. <a rel=\"nofollow\" class=\"external text\" href=\"https://milkeninstitute.org/covid-19-tracker\">Lay summary</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVID-19+vaccine+tracker+%28Choose+vaccines+tab%2C+apply+filters+to+view+select+data%29&amp;rft.pub=Milken+Institute&amp;rft.date=2020-09-17&amp;rft_id=https%3A%2F%2Fairtable.com%2FshrSAi6t5WFwqo3GM%2FtblEzPQS5fnc0FHYR%2FviwDBH7b6FjmIBX5x%3Fblocks%3Dhide&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-tracker-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-tracker_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-tracker_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-who-tracker_5-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-who-tracker_5-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines\">\"Draft landscape of COVID 19 candidate vaccines\"</a>. World Health Organization. 17 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Draft+landscape+of+COVID+19+candidate+vaccines&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-09-17&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fwho-documents-detail%2Fdraft-landscape-of-covid-19-candidate-vaccines&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-gates2-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gates2_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gates2_6-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-gates2_6-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-gates2_6-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-gates2_6-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-gates2_6-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-gates2_6-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-gates2_6-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-gates2_6-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-gates2_6-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-gates2_6-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-gates2_6-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-gates2_6-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-gates2_6-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-gates2_6-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-gates2_6-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-gates2_6-16\"><sup><i><b>q</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFGates2020\" class=\"citation web cs1\">Gates B (30 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.gatesnotes.com/Health/What-you-need-to-know-about-the-COVID-19-vaccine\">\"The vaccine race explained: What you need to know about the COVID-19 vaccine\"</a>. The Gates Notes. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200514010012/https://www.gatesnotes.com/Health/What-you-need-to-know-about-the-COVID-19-vaccine\">Archived</a> from the original on 14 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+vaccine+race+explained%3A+What+you+need+to+know+about+the+COVID-19+vaccine&amp;rft.pub=The+Gates+Notes&amp;rft.date=2020-04-30&amp;rft.aulast=Gates&amp;rft.aufirst=Bill&amp;rft_id=https%3A%2F%2Fwww.gatesnotes.com%2FHealth%2FWhat-you-need-to-know-about-the-COVID-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cepi-fund-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cepi-fund_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cepi-fund_7-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://cepi.net/news_cepi/2-billion-required-to-develop-a-vaccine-against-the-covid-19-virus/\">\"CEPI welcomes UK Government\\'s funding and highlights need for $2 billion to develop a vaccine against COVID-19\"</a>. Coalition for Epidemic Preparedness Innovations, Oslo, Norway. 6 March 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200322170547/https://cepi.net/news_cepi/2-billion-required-to-develop-a-vaccine-against-the-covid-19-virus/\">Archived</a> from the original on 22 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CEPI+welcomes+UK+Government%27s+funding+and+highlights+need+for+%242+billion+to+develop+a+vaccine+against+COVID-19&amp;rft.pub=Coalition+for+Epidemic+Preparedness+Innovations%2C+Oslo%2C+Norway&amp;rft.date=2020-03-06&amp;rft_id=https%3A%2F%2Fcepi.net%2Fnews_cepi%2F2-billion-required-to-develop-a-vaccine-against-the-covid-19-virus%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-waked-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-waked_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-waked_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-waked_8-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-waked_8-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFWake2020\" class=\"citation web cs1\">Wake D (4 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://finance.yahoo.com/news/eu-hosts-virus-telethon-seeking-first-7-5-003500556.html\">\"EU spearheads $8 billion virus fundraiser\"</a>. Yahoo Finance. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200629033556if_/https://finance.yahoo.com/news/eu-hosts-virus-telethon-seeking-first-7-5-003500556.html\">Archived</a> from the original on 29 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=EU+spearheads+%248+billion+virus+fundraiser&amp;rft.pub=Yahoo+Finance&amp;rft.date=2020-05-04&amp;rft.aulast=Wake&amp;rft.aufirst=Damon&amp;rft_id=https%3A%2F%2Ffinance.yahoo.com%2Fnews%2Feu-hosts-virus-telethon-seeking-first-7-5-003500556.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-accel-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-accel_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-trial-accelerating-a-safe-and-effective-covid-19-vaccine\">\"Update on WHO Solidarity Trial \\xe2\\x80\\x93 Accelerating a safe and effective COVID-19 vaccine\"</a>. World Health Organization. 27 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200430185550/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-trial-accelerating-a-safe-and-effective-covid-19-vaccine\">Archived</a> from the original on 30 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>. <q>It is vital that we evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success (given the high level of attrition during vaccine development), we must test all candidate vaccines until they fail. [The] WHO is working to ensure that all of them have the chance of being tested at the initial stage of development. The results for the efficacy of each vaccine are expected within three to six months and this evidence, combined with data on safety, will inform decisions about whether it can be used on a wider scale.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Update+on+WHO+Solidarity+Trial+%E2%80%93+Accelerating+a+safe+and+effective+COVID-19+vaccine&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-04-27&amp;rft_id=https%3A%2F%2Fwww.who.int%2Femergencies%2Fdiseases%2Fnovel-coronavirus-2019%2Fglobal-research-on-novel-coronavirus-2019-ncov%2Fsolidarity-trial-accelerating-a-safe-and-effective-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFCavanagh2003\" class=\"citation journal cs1\">Cavanagh D (December 2003). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7154303\">\"Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus\"</a>. <i>Avian Pathology</i>. <b>32</b> (6): 567\\xe2\\x80\\x9382. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1080%2F03079450310001621198\">10.1080/03079450310001621198</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7154303\">7154303</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/14676007\">14676007</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Avian+Pathology&amp;rft.atitle=Severe+acute+respiratory+syndrome+vaccine+development%3A+experiences+of+vaccination+against+avian+infectious+bronchitis+coronavirus&amp;rft.volume=32&amp;rft.issue=6&amp;rft.pages=567-82&amp;rft.date=2003-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7154303&amp;rft_id=info%3Apmid%2F14676007&amp;rft_id=info%3Adoi%2F10.1080%2F03079450310001621198&amp;rft.aulast=Cavanagh&amp;rft.aufirst=D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7154303&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFGaoTaminSoloffD&#39;Aiuto2003\" class=\"citation journal cs1\">Gao W, Tamin A, Soloff A, D\\'Aiuto L, Nwanegbo E, Robbins PD,  et al. (December 2003). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7112457\">\"Effects of a SARS-associated coronavirus vaccine in monkeys\"</a>. <i>Lancet</i>. <b>362</b> (9399): 1895\\xe2\\x80\\x9396. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0140-6736%2803%2914962-8\">10.1016/S0140-6736(03)14962-8</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7112457\">7112457</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/14667748\">14667748</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Effects+of+a+SARS-associated+coronavirus+vaccine+in+monkeys&amp;rft.volume=362&amp;rft.issue=9399&amp;rft.pages=1895-96&amp;rft.date=2003-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112457&amp;rft_id=info%3Apmid%2F14667748&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2803%2914962-8&amp;rft.aulast=Gao&amp;rft.aufirst=W&amp;rft.au=Tamin%2C+A&amp;rft.au=Soloff%2C+A&amp;rft.au=D%27Aiuto%2C+L&amp;rft.au=Nwanegbo%2C+E&amp;rft.au=Robbins%2C+PD&amp;rft.au=Bellini%2C+WJ&amp;rft.au=Barratt-Boyes%2C+S&amp;rft.au=Gambotto%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112457&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFKimOkadaKennistonRaj2014\" class=\"citation journal cs1\">Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA,  et al. (October 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7115510\">\"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice\"</a>. <i>Vaccine</i>. <b>32</b> (45): 5975\\xe2\\x80\\x9382. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.vaccine.2014.08.058\">10.1016/j.vaccine.2014.08.058</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7115510\">7115510</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/25192975\">25192975</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Immunogenicity+of+an+adenoviral-based+Middle+East+Respiratory+Syndrome+coronavirus+vaccine+in+BALB%2Fc+mice&amp;rft.volume=32&amp;rft.issue=45&amp;rft.pages=5975-82&amp;rft.date=2014-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7115510&amp;rft_id=info%3Apmid%2F25192975&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2014.08.058&amp;rft.aulast=Kim&amp;rft.aufirst=E&amp;rft.au=Okada%2C+K&amp;rft.au=Kenniston%2C+T&amp;rft.au=Raj%2C+VS&amp;rft.au=AlHajri%2C+MM&amp;rft.au=Farag%2C+EA&amp;rft.au=AlHajri%2C+F&amp;rft.au=Osterhaus%2C+AD&amp;rft.au=Haagmans%2C+BL&amp;rft.au=Gambotto%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7115510&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-&#80;MID_15655773-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PMID_15655773_13-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFGreenoughBabcockRobertsHernandez2005\" class=\"citation journal cs1\">Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA,  et al. (February 2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7110081\">\"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice\"</a>. <i>The Journal of Infectious Diseases</i>. <b>191</b> (4): 507\\xe2\\x80\\x9314. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1086%2F427242\">10.1086/427242</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7110081\">7110081</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/15655773\">15655773</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Infectious+Diseases&amp;rft.atitle=Development+and+characterization+of+a+severe+acute+respiratory+syndrome-associated+coronavirus-neutralizing+human+monoclonal+antibody+that+provides+effective+immunoprophylaxis+in+mice&amp;rft.volume=191&amp;rft.issue=4&amp;rft.pages=507-14&amp;rft.date=2005-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7110081&amp;rft_id=info%3Apmid%2F15655773&amp;rft_id=info%3Adoi%2F10.1086%2F427242&amp;rft.aulast=Greenough&amp;rft.aufirst=TC&amp;rft.au=Babcock%2C+GJ&amp;rft.au=Roberts%2C+A&amp;rft.au=Hernandez%2C+HJ&amp;rft.au=Thomas%2C+WD&amp;rft.au=Coccia%2C+JA&amp;rft.au=Graziano%2C+RF&amp;rft.au=Srinivasan%2C+M&amp;rft.au=Lowy%2C+I&amp;rft.au=Finberg%2C+RW&amp;rft.au=Subbarao%2C+K&amp;rft.au=Vogel%2C+L&amp;rft.au=Somasundaran%2C+M&amp;rft.au=Luzuriaga%2C+K&amp;rft.au=Sullivan%2C+JL&amp;rft.au=Ambrosino%2C+DM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7110081&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-&#80;MID_15885812-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PMID_15885812_14-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFTrippHaynesMooreAnderson2005\" class=\"citation journal cs1\">Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH,  et al. (September 2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7112802\">\"Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins\"</a>. <i>Journal of Virological Methods</i>. <b>128</b> (1\\xe2\\x80\\x932): 21\\xe2\\x80\\x9328. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.jviromet.2005.03.021\">10.1016/j.jviromet.2005.03.021</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7112802\">7112802</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/15885812\">15885812</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virological+Methods&amp;rft.atitle=Monoclonal+antibodies+to+SARS-associated+coronavirus+%28SARS-CoV%29%3A+identification+of+neutralizing+and+antibodies+reactive+to+S%2C+N%2C+M+and+E+viral+proteins&amp;rft.volume=128&amp;rft.issue=1%E2%80%932&amp;rft.pages=21-28&amp;rft.date=2005-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112802&amp;rft_id=info%3Apmid%2F15885812&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jviromet.2005.03.021&amp;rft.aulast=Tripp&amp;rft.aufirst=RA&amp;rft.au=Haynes%2C+LM&amp;rft.au=Moore%2C+D&amp;rft.au=Anderson%2C+B&amp;rft.au=Tamin%2C+A&amp;rft.au=Harcourt%2C+BH&amp;rft.au=Jones%2C+LP&amp;rft.au=Yilla%2C+M&amp;rft.au=Babcock%2C+GJ&amp;rft.au=Greenough%2C+T&amp;rft.au=Ambrosino%2C+DM&amp;rft.au=Alvarez%2C+R&amp;rft.au=Callaway%2C+J&amp;rft.au=Cavitt%2C+S&amp;rft.au=Kamrud%2C+K&amp;rft.au=Alterson%2C+H&amp;rft.au=Smith%2C+J&amp;rft.au=Harcourt%2C+JL&amp;rft.au=Miao%2C+C&amp;rft.au=Razdan%2C+R&amp;rft.au=Comer%2C+JA&amp;rft.au=Rollin%2C+PE&amp;rft.au=Ksiazek%2C+TG&amp;rft.au=Sanchez%2C+A&amp;rft.au=Rota%2C+PA&amp;rft.au=Bellini%2C+WJ&amp;rft.au=Anderson%2C+LJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112802&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-&#80;MID_16453264-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PMID_16453264_15-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFRobertsThomasGuarnerLamirande2006\" class=\"citation journal cs1\">Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC,  et al. (March 2006). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7109703\">\"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters\"</a>. <i>The Journal of Infectious Diseases</i>. <b>193</b> (5): 685\\xe2\\x80\\x9392. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1086%2F500143\">10.1086/500143</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7109703\">7109703</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/16453264\">16453264</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Infectious+Diseases&amp;rft.atitle=Therapy+with+a+severe+acute+respiratory+syndrome-associated+coronavirus-neutralizing+human+monoclonal+antibody+reduces+disease+severity+and+viral+burden+in+golden+Syrian+hamsters&amp;rft.volume=193&amp;rft.issue=5&amp;rft.pages=685-92&amp;rft.date=2006-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7109703&amp;rft_id=info%3Apmid%2F16453264&amp;rft_id=info%3Adoi%2F10.1086%2F500143&amp;rft.aulast=Roberts&amp;rft.aufirst=A&amp;rft.au=Thomas%2C+WD&amp;rft.au=Guarner%2C+J&amp;rft.au=Lamirande%2C+EW&amp;rft.au=Babcock%2C+GJ&amp;rft.au=Greenough%2C+TC&amp;rft.au=Vogel%2C+L&amp;rft.au=Hayes%2C+N&amp;rft.au=Sullivan%2C+JL&amp;rft.au=Zaki%2C+S&amp;rft.au=Subbarao%2C+K&amp;rft.au=Ambrosino%2C+DM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7109703&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-JiangFutureVirology-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-JiangFutureVirology_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-JiangFutureVirology_16-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFJiangLuDu2013\" class=\"citation journal cs1\">Jiang S, Lu L, Du L (January 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7079997\">\"Development of SARS vaccines and therapeutics is still needed\"</a>. <i>Future Virology</i>. <b>8</b> (1): 1\\xe2\\x80\\x932. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.2217%2Ffvl.12.126\">10.2217/fvl.12.126</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7079997\">7079997</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32201503\">32201503</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Future+Virology&amp;rft.atitle=Development+of+SARS+vaccines+and+therapeutics+is+still+needed&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=1-2&amp;rft.date=2013-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7079997&amp;rft_id=info%3Apmid%2F32201503&amp;rft_id=info%3Adoi%2F10.2217%2Ffvl.12.126&amp;rft.aulast=Jiang&amp;rft.aufirst=S&amp;rft.au=Lu%2C+L&amp;rft.au=Du%2C+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7079997&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nhs.uk/conditions/sars/\">\"SARS (severe acute respiratory syndrome)\"</a>. <a href=\"/wiki/National_Health_Service\" title=\"National Health Service\">National Health Service</a>. 5 March 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200309174230/https://www.nhs.uk/conditions/sars/\">Archived</a> from the original on 9 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">31 January</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=SARS+%28severe+acute+respiratory+syndrome%29&amp;rft.pub=National+Health+Service&amp;rft.date=2020-03-05&amp;rft_id=https%3A%2F%2Fwww.nhs.uk%2Fconditions%2Fsars%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFShehataGomaaAliKayali2016\" class=\"citation journal cs1\">Shehata MM, Gomaa MR, Ali MA, Kayali G (20 January 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7089261\">\"Middle East respiratory syndrome coronavirus: a comprehensive review\"</a>. <i>Frontiers of Medicine</i>. <b>10</b> (2): 120\\xe2\\x80\\x9336. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1007%2Fs11684-016-0430-6\">10.1007/s11684-016-0430-6</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7089261\">7089261</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26791756\">26791756</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+of+Medicine&amp;rft.atitle=Middle+East+respiratory+syndrome+coronavirus%3A+a+comprehensive+review&amp;rft.volume=10&amp;rft.issue=2&amp;rft.pages=120-36&amp;rft.date=2016-01-20&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7089261&amp;rft_id=info%3Apmid%2F26791756&amp;rft_id=info%3Adoi%2F10.1007%2Fs11684-016-0430-6&amp;rft.aulast=Shehata&amp;rft.aufirst=Mahmoud+M.&amp;rft.au=Gomaa%2C+Mokhtar+R.&amp;rft.au=Ali%2C+Mohamed+A.&amp;rft.au=Kayali%2C+Ghazi&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7089261&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-Butler3oct2013-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Butler3oct2013_19-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFButler2012\" class=\"citation journal cs1\">Butler D (October 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2F490020a\">\"SARS veterans tackle coronavirus\"</a>. <i>Nature</i>. <b>490</b> (7418): 20. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2012Natur.490...20B\">2012Natur.490...20B</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2F490020a\">10.1038/490020a</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/23038444\">23038444</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=SARS+veterans+tackle+coronavirus&amp;rft.volume=490&amp;rft.issue=7418&amp;rft.pages=20&amp;rft.date=2012-10&amp;rft_id=info%3Apmid%2F23038444&amp;rft_id=info%3Adoi%2F10.1038%2F490020a&amp;rft_id=info%3Abibcode%2F2012Natur.490...20B&amp;rft.aulast=Butler&amp;rft.aufirst=D&amp;rft_id=%2F%2Fdoi.org%2F10.1038%252F490020a&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFModjarradRobertsMillsCastellano2019\" class=\"citation journal cs1\">Modjarrad K, Roberts CC, Mills KT, Castellano AR, Paolino K, Muthumani K,  et al. (September 2019). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7185789\">\"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial\"</a>. <i>The Lancet. Infectious Diseases</i>. <b>19</b> (9): 1013\\xe2\\x80\\x9322. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1473-3099%2819%2930266-X\">10.1016/S1473-3099(19)30266-X</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7185789\">7185789</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/31351922\">31351922</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Infectious+Diseases&amp;rft.atitle=Safety+and+immunogenicity+of+an+anti-Middle+East+respiratory+syndrome+coronavirus+DNA+vaccine%3A+a+phase+1%2C+open-label%2C+single-arm%2C+dose-escalation+trial&amp;rft.volume=19&amp;rft.issue=9&amp;rft.pages=1013-22&amp;rft.date=2019-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7185789&amp;rft_id=info%3Apmid%2F31351922&amp;rft_id=info%3Adoi%2F10.1016%2FS1473-3099%2819%2930266-X&amp;rft.aulast=Modjarrad&amp;rft.aufirst=K&amp;rft.au=Roberts%2C+CC&amp;rft.au=Mills%2C+KT&amp;rft.au=Castellano%2C+AR&amp;rft.au=Paolino%2C+K&amp;rft.au=Muthumani%2C+K&amp;rft.au=Reuschel%2C+EL&amp;rft.au=Robb%2C+ML&amp;rft.au=Racine%2C+T&amp;rft.au=Oh%2C+MD&amp;rft.au=Lamarre%2C+C&amp;rft.au=Zaidi%2C+FI&amp;rft.au=Boyer%2C+J&amp;rft.au=Kudchodkar%2C+SB&amp;rft.au=Jeong%2C+M&amp;rft.au=Darden%2C+JM&amp;rft.au=Park%2C+YK&amp;rft.au=Scott%2C+PT&amp;rft.au=Remigio%2C+C&amp;rft.au=Parikh%2C+AP&amp;rft.au=Wise%2C+MC&amp;rft.au=Patel%2C+A&amp;rft.au=Duperret%2C+EK&amp;rft.au=Kim%2C+KY&amp;rft.au=Choi%2C+H&amp;rft.au=White%2C+S&amp;rft.au=Bagarazzi%2C+M&amp;rft.au=May%2C+JM&amp;rft.au=Kane%2C+D&amp;rft.au=Lee%2C+H&amp;rft.au=Kobinger%2C+G&amp;rft.au=Michael%2C+NL&amp;rft.au=Weiner%2C+DB&amp;rft.au=Thomas%2C+SJ&amp;rft.au=Maslow%2C+JN&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7185789&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFYongOngYeapHo2019\" class=\"citation journal cs1\">Yong CY, Ong HK, Yeap SK, Ho KL, Tan WS (2019). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6688523\">\"Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus\"</a>. <i>Frontiers in Microbiology</i>. <b>10</b>: 1781. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.3389%2Ffmicb.2019.01781\">10.3389/fmicb.2019.01781</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6688523\">6688523</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/31428074\">31428074</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Microbiology&amp;rft.atitle=Recent+Advances+in+the+Vaccine+Development+Against+Middle+East+Respiratory+Syndrome-Coronavirus&amp;rft.volume=10&amp;rft.pages=1781&amp;rft.date=2019&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6688523&amp;rft_id=info%3Apmid%2F31428074&amp;rft_id=info%3Adoi%2F10.3389%2Ffmicb.2019.01781&amp;rft.aulast=Yong&amp;rft.aufirst=CY&amp;rft.au=Ong%2C+HK&amp;rft.au=Yeap%2C+SK&amp;rft.au=Ho%2C+KL&amp;rft.au=Tan%2C+WS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6688523&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-time-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-time_22-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19\">\"World Health Organization timeline \\xe2\\x80\\x93 COVID-19\"</a>. World Health Organization. 27 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200429012212/https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19\">Archived</a> from the original on 29 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=World+Health+Organization+timeline+%E2%80%93+COVID-19&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-04-27&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fdetail%2F27-04-2020-who-timeline---covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-thanh-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-thanh_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-thanh_23-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-thanh_23-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-thanh_23-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-thanh_23-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-thanh_23-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-thanh_23-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-thanh_23-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-thanh_23-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-thanh_23-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-thanh_23-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-thanh_23-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-thanh_23-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-thanh_23-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-thanh_23-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-thanh_23-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-thanh_23-16\"><sup><i><b>q</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFThanh_LeAndreadakisKumarG\\xc3\\xb3mez_Rom\\xc3\\xa1n2020\" class=\"citation journal cs1\">Thanh Le T, Andreadakis Z, Kumar A, G\\xc3\\xb3mez Rom\\xc3\\xa1n R, Tollefsen S, Saville M,  et al. (9 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/d41573-020-00073-5\">\"The COVID-19 vaccine development landscape\"</a>. <i>Nature Reviews Drug Discovery</i>. <b>19</b> (5): 305\\xe2\\x80\\x9306. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fd41573-020-00073-5\">10.1038/d41573-020-00073-5</a></span>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1474-1776\">1474-1776</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32273591\">32273591</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200510135439/https://www.nature.com/articles/d41573-020-00073-5\">Archived</a> from the original on 10 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Drug+Discovery&amp;rft.atitle=The+COVID-19+vaccine+development+landscape&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=305-06&amp;rft.date=2020-04-09&amp;rft.issn=1474-1776&amp;rft_id=info%3Apmid%2F32273591&amp;rft_id=info%3Adoi%2F10.1038%2Fd41573-020-00073-5&amp;rft.aulast=Thanh+Le&amp;rft.aufirst=Tung&amp;rft.au=Andreadakis%2C+Zacharias&amp;rft.au=Kumar%2C+Arun&amp;rft.au=G%C3%B3mez+Rom%C3%A1n%2C+Ra%C3%BAl&amp;rft.au=Tollefsen%2C+Stig&amp;rft.au=Saville%2C+Melanie&amp;rft.au=Mayhew%2C+Stephen&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41573-020-00073-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-gates1-24\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gates1_24-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gates1_24-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-gates1_24-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-gates1_24-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-gates1_24-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-gates1_24-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-gates1_24-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-gates1_24-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFGates2020\" class=\"citation journal cs1\">Gates B (February 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1056%2Fnejmp2003762\">\"Responding to Covid-19: A once-in-a-century pandemic?\"</a>. <i>The New England Journal of Medicine</i>. <b>382</b> (18): 1677\\xe2\\x80\\x9379. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1056%2Fnejmp2003762\">10.1056/nejmp2003762</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32109012\">32109012</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Responding+to+Covid-19%3A+A+once-in-a-century+pandemic%3F&amp;rft.volume=382&amp;rft.issue=18&amp;rft.pages=1677-79&amp;rft.date=2020-02&amp;rft_id=info%3Adoi%2F10.1056%2Fnejmp2003762&amp;rft_id=info%3Apmid%2F32109012&amp;rft.aulast=Gates&amp;rft.aufirst=B&amp;rft_id=%2F%2Fdoi.org%2F10.1056%252Fnejmp2003762&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-Fauci-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Fauci_25-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFFauciLaneRedfield2020\" class=\"citation journal cs1\">Fauci AS, Lane HC, Redfield RR (March 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7121221\">\"Covid-19: Navigating the uncharted\"</a>. <i>The New England Journal of Medicine</i>. <b>382</b> (13): 1268\\xe2\\x80\\x9369. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1056%2Fnejme2002387\">10.1056/nejme2002387</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7121221\">7121221</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32109011\">32109011</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Covid-19%3A+Navigating+the+uncharted&amp;rft.volume=382&amp;rft.issue=13&amp;rft.pages=1268-69&amp;rft.date=2020-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7121221&amp;rft_id=info%3Apmid%2F32109011&amp;rft_id=info%3Adoi%2F10.1056%2Fnejme2002387&amp;rft.aulast=Fauci&amp;rft.aufirst=AS&amp;rft.au=Lane%2C+HC&amp;rft.au=Redfield%2C+RR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7121221&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFGrenfellDrew2020\" class=\"citation web cs1\">Grenfell R, Drew T (17 February 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away\">\"Here\\'s Why It\\'s Taking So Long to Develop a Vaccine for the New Coronavirus\"</a>. <i>ScienceAlert</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200228010631/https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away\">Archived</a> from the original on 28 February 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 February</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ScienceAlert&amp;rft.atitle=Here%27s+Why+It%27s+Taking+So+Long+to+Develop+a+Vaccine+for+the+New+Coronavirus&amp;rft.date=2020-02-17&amp;rft.aulast=Grenfell&amp;rft.aufirst=Rob&amp;rft.au=Drew%2C+Trevor&amp;rft_id=https%3A%2F%2Fwww.sciencealert.com%2Fwho-says-a-coronavirus-vaccine-is-18-months-away&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-yamey-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-yamey_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-yamey_27-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-yamey_27-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-yamey_27-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-yamey_27-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-yamey_27-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFYameySch\\xc3\\xa4ferhoffHatchettPate2020\" class=\"citation journal cs1\">Yamey G, Sch\\xc3\\xa4ferhoff M, Hatchett R, Pate M, Zhao F, McDade KK (May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7271264\">\"Ensuring global access to COVID-19 vaccines\"</a>. <i>Lancet</i>. <b>395</b> (10234): 1405\\xe2\\x80\\x9306. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0140-6736%2820%2930763-7\">10.1016/S0140-6736(20)30763-7</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7271264\">7271264</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32243778\">32243778</a>. <q>CEPI estimates that developing up to three vaccines in the next 12\\xe2\\x80\\x9318 months will require an investment of at least <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\">&#160;</span>billion. This estimate includes Phase<span class=\"nowrap\">&#160;</span>1 clinical trials of eight vaccine candidates, progression of up to six candidates through Phase<span class=\"nowrap\">&#160;</span>2 and<span class=\"nowrap\">&#160;</span>3 trials, completion of regulatory and quality requirements for at least three vaccines, and enhancing global manufacturing capacity for three vaccines.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Ensuring+global+access+to+COVID-19+vaccines&amp;rft.volume=395&amp;rft.issue=10234&amp;rft.pages=1405-06&amp;rft.date=2020-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7271264&amp;rft_id=info%3Apmid%2F32243778&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2820%2930763-7&amp;rft.aulast=Yamey&amp;rft.aufirst=G&amp;rft.au=Sch%C3%A4ferhoff%2C+M&amp;rft.au=Hatchett%2C+R&amp;rft.au=Pate%2C+M&amp;rft.au=Zhao%2C+F&amp;rft.au=McDade%2C+KK&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7271264&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cepi-landmark-28\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cepi-landmark_28-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cepi-landmark_28-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://cepi.net/news_cepi/landmark-global-collaboration-launched-to-defeat-covid-19-pandemic/\">\"Landmark global collaboration launched to defeat COVID-19 pandemic\"</a>. CEPI. 24 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200502023137/https://cepi.net/news_cepi/landmark-global-collaboration-launched-to-defeat-covid-19-pandemic/\">Archived</a> from the original on 2 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>. <q>The global nature of a pandemic means that any vaccine or medicine that is successfully developed will be needed immediately all over the world. That means that the challenge we face is not only one of R&amp;D but one of manufacturing at scale, and equitable access.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Landmark+global+collaboration+launched+to+defeat+COVID-19+pandemic&amp;rft.pub=CEPI&amp;rft.date=2020-04-24&amp;rft_id=https%3A%2F%2Fcepi.net%2Fnews_cepi%2Flandmark-global-collaboration-launched-to-defeat-covid-19-pandemic%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cssa-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cssa_29-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFSchmidt2020\" class=\"citation news cs1\">Schmidt, Charles (1 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scientificamerican.com/article/genetic-engineering-could-make-a-covid-19-vaccine-in-months-rather-than-years1/\">\"Genetic Engineering Could Make a COVID-19 Vaccine in Months Rather Than Years\"</a>. Scientific American.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Genetic+Engineering+Could+Make+a+COVID-19+Vaccine+in+Months+Rather+Than+Years&amp;rft.date=2020-06-01&amp;rft.aulast=Schmidt&amp;rft.aufirst=Charles&amp;rft_id=https%3A%2F%2Fwww.scientificamerican.com%2Farticle%2Fgenetic-engineering-could-make-a-covid-19-vaccine-in-months-rather-than-years1%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFFoxKelion2020\" class=\"citation news cs1\">Fox C, Kelion L (16 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.com/news/technology-53429506\">\"Russian spies \\'target coronavirus vaccine<span class=\"cs1-kern-right\">\\'</span>\"</a>. <i>BBC News Online</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News+Online&amp;rft.atitle=Russian+spies+%27target+coronavirus+vaccine%27&amp;rft.date=2020-07-16&amp;rft.aulast=Fox&amp;rft.aufirst=Chris&amp;rft.au=Kelion%2C+Leo&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Ftechnology-53429506&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-covax-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-covax_31-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/initiatives/act-accelerator\">\"The Access to COVID-19 Tools (ACT) Accelerator\"</a>. World Health Organization. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">29 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Access+to+COVID-19+Tools+%28ACT%29+Accelerator&amp;rft.pub=World+Health+Organization&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.who.int%2Finitiatives%2Fact-accelerator&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-covax-gavi-32\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-covax-gavi_32-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.gavi.org/covid19/covax-facility\">\"COVAX: Ensuring global equitable access to COVID-19 vaccines\"</a>. GAVI. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVAX%3A+Ensuring+global+equitable+access+to+COVID-19+vaccines&amp;rft.pub=GAVI&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.gavi.org%2Fcovid19%2Fcovax-facility&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-covax-33\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-covax_33-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-covax_33-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/news-room/detail/15-07-2020-more-than-150-countries-engaged-in-covid-19-vaccine-global-access-facility\">\"More than 150 countries engaged in COVID-19 vaccine global access facility\"</a>. World Health Organization. 15 July 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 July</span> 2020</span>. <q>COVAX is the only truly global solution to the COVID-19 pandemic. For the vast majority of countries, whether they can afford to pay for their own doses or require assistance, it means receiving a guaranteed share of doses and avoiding being pushed to the back of the queue, as we saw during the H1N1 pandemic a decade ago. Even for those countries that are able to secure their own agreements with vaccine manufacturers, this mechanism represents, through its world-leading portfolio of vaccine candidates, a means of reducing the risks associated with individual candidates failing to show efficacy or gain licensure.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=More+than+150+countries+engaged+in+COVID-19+vaccine+global+access+facility&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-07-15&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fdetail%2F15-07-2020-more-than-150-countries-engaged-in-covid-19-vaccine-global-access-facility&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-reuters-34\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-reuters_34-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-reuters_34-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-reuters_34-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-reuters_34-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-reuters_34-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-reuters_34-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-reuters_34-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-reuters_34-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-reuters_34-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-reuters_34-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-reuters_34-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-reuters_34-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-reuters_34-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-reuters_34-13\"><sup><i><b>n</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFSteenhuysenEislerMartellNebehay2020\" class=\"citation news cs1\">Steenhuysen J, Eisler P, Martell A, Nebehay S (27 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/health-coronavirus-vaccine-idUSL2N2CF0JG\">\"Special Report: Countries, companies risk billions in race for coronavirus vaccine\"</a>. <i>Reuters</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200515031817/https://www.reuters.com/article/health-coronavirus-vaccine-idUSL2N2CF0JG\">Archived</a> from the original on 15 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Special+Report%3A+Countries%2C+companies+risk+billions+in+race+for+coronavirus+vaccine&amp;rft.date=2020-04-27&amp;rft.aulast=Steenhuysen&amp;rft.aufirst=Julie&amp;rft.au=Eisler%2C+Peter&amp;rft.au=Martell%2C+Allison&amp;rft.au=Nebehay%2C+Stephanie&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fhealth-coronavirus-vaccine-idUSL2N2CF0JG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-sanger-35\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-sanger_35-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-sanger_35-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-sanger_35-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-sanger_35-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-sanger_35-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-sanger_35-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-sanger_35-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-sanger_35-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-sanger_35-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-sanger_35-9\"><sup><i><b>j</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFSangerKirkpatrickZimmerThomas2020\" class=\"citation news cs1\">Sanger DE, Kirkpatrick DD, Zimmer C, Thomas K, Wee S (2 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/05/02/us/politics/vaccines-coronavirus-research.html\">\"With Pressure Growing, Global Race for a Vaccine Intensifies\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200511003506/https://www.nytimes.com/2020/05/02/us/politics/vaccines-coronavirus-research.html\">Archived</a> from the original on 11 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=With+Pressure+Growing%2C+Global+Race+for+a+Vaccine+Intensifies&amp;rft.date=2020-05-02&amp;rft.issn=0362-4331&amp;rft.aulast=Sanger&amp;rft.aufirst=David+E.&amp;rft.au=Kirkpatrick%2C+David+D.&amp;rft.au=Zimmer%2C+Carl&amp;rft.au=Thomas%2C+Katie&amp;rft.au=Wee%2C+Sui-Lee&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F05%2F02%2Fus%2Fpolitics%2Fvaccines-coronavirus-research.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFHamilton2020\" class=\"citation news cs1\">Hamilton IA (1 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.businessinsider.com/bill-gates-10-promising-coronavirus-vaccine-candidates-2020-5\">\"Bill Gates thinks there are 8 to 10 promising coronavirus vaccine candidates and one could be ready in as little as 9 months\"</a>. <i>Business Insider</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200516101559/https://www.businessinsider.com/bill-gates-10-promising-coronavirus-vaccine-candidates-2020-5\">Archived</a> from the original on 16 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+Insider&amp;rft.atitle=Bill+Gates+thinks+there+are+8+to+10+promising+coronavirus+vaccine+candidates+and+one+could+be+ready+in+as+little+as+9+months&amp;rft.date=2020-05-01&amp;rft.aulast=Hamilton&amp;rft.aufirst=Isobel+Asher&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fbill-gates-10-promising-coronavirus-vaccine-candidates-2020-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.glopid-r.org/our-work/novel-coronavirus-covid-19\">\"GloPID: Novel coronavirus COVID-19\"</a>. <i>glopid-r.org</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200502035337/https://www.glopid-r.org/our-work/novel-coronavirus-covid-19/\">Archived</a> from the original on 2 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>. <q>GloPID-R Members and other major players involved in infectious disease outbreaks worldwide reacted rapidly to this emerging epidemic, working closely with WHO to identify the specific funding research priorities needed to tackle the disease.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=glopid-r.org&amp;rft.atitle=GloPID%3A+Novel+coronavirus+COVID-19&amp;rft_id=https%3A%2F%2Fwww.glopid-r.org%2Four-work%2Fnovel-coronavirus-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-can-research-38\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-can-research_38-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-can-research_38-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.canada.ca/en/public-health/services/publications/diseases-conditions/covid-19-government-canada-research-response.html\">\"Government of Canada\\'s research response to COVID-19\"</a>. Government of Canada. 23 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200513135919/https://www.canada.ca/en/public-health/services/publications/diseases-conditions/covid-19-government-canada-research-response.html\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Government+of+Canada%27s+research+response+to+COVID-19&amp;rft.pub=Government+of+Canada&amp;rft.date=2020-04-23&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Fpublic-health%2Fservices%2Fpublications%2Fdiseases-conditions%2Fcovid-19-government-canada-research-response.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-isaric-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-isaric_39-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://isaric.tghn.org/covid-19-clinical-research-resources/\">\"ISARIC: COVID-19 clinical research resources\"</a>. ISARIC. 27 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200330135638/https://isaric.tghn.org/covid-19-clinical-research-resources/\">Archived</a> from the original on 30 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ISARIC%3A+COVID-19+clinical+research+resources&amp;rft.pub=ISARIC&amp;rft.date=2020-04-27&amp;rft_id=https%3A%2F%2Fisaric.tghn.org%2Fcovid-19-clinical-research-resources%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-gavi-summit-40\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gavi-summit_40-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gavi-summit_40-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-gavi-summit_40-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.gavi.org/news/media-room/world-leaders-make-historic-commitments-provide-equal-access-vaccines-all\">\"Global Vaccine Summit 2020: World leaders make historic commitments to provide equal access to vaccines for all\"</a>. Global Alliance for Vaccines and Immunisation. 4 June 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200606161748/https://www.gavi.org/news/media-room/world-leaders-make-historic-commitments-provide-equal-access-vaccines-all\">Archived</a> from the original on 6 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Global+Vaccine+Summit+2020%3A+World+leaders+make+historic+commitments+to+provide+equal+access+to+vaccines+for+all&amp;rft.pub=Global+Alliance+for+Vaccines+and+Immunisation&amp;rft.date=2020-06-04&amp;rft_id=https%3A%2F%2Fwww.gavi.org%2Fnews%2Fmedia-room%2Fworld-leaders-make-historic-commitments-provide-equal-access-vaccines-all&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.prnewswire.com/news-releases/bill--melinda-gates-foundation-pledges-1-6-billion-to-gavi-the-vaccine-alliance-to-protect-the-next-generation-with-lifesaving-vaccines-301070878.html\">\"Bill &amp; Melinda Gates Foundation pledges <span style=\"white-space: nowrap\">US$1.6</span><span class=\"nowrap\">&#160;</span>billion to Gavi, the Vaccine Alliance, to protect the next generation with lifesaving vaccines\"</a> (Press release). The Bill &amp; Melinda Gates Foundation. 4 June 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200604165907/https://www.prnewswire.com/news-releases/bill--melinda-gates-foundation-pledges-1-6-billion-to-gavi-the-vaccine-alliance-to-protect-the-next-generation-with-lifesaving-vaccines-301070878.html\">Archived</a> from the original on 4 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 June</span> 2020</span> &#8211; via PR Newswire.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bill+%26+Melinda+Gates+Foundation+pledges+%3Cspan+style%3D%22white-space%3A+nowrap%22%3EUS%241.6%3C%2Fspan%3E%3Cspan+class%3D%22nowrap%22%3E+%3C%2Fspan%3Ebillion+to+Gavi%2C+the+Vaccine+Alliance%2C+to+protect+the+next+generation+with+lifesaving+vaccines&amp;rft.pub=The+Bill+%26+Melinda+Gates+Foundation&amp;rft.date=2020-06-04&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fbill--melinda-gates-foundation-pledges-1-6-billion-to-gavi-the-vaccine-alliance-to-protect-the-next-generation-with-lifesaving-vaccines-301070878.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-abedi-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-abedi_42-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFAbedi2020\" class=\"citation news cs1\">Abedi M (23 March 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://globalnews.ca/news/6717883/coronavirus-canada-vaccine-spending/\">\"Canada to spend $192M on developing COVID-19 vaccine\"</a>. <i>Global News</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200409200638/https://globalnews.ca/news/6717883/coronavirus-canada-vaccine-spending/\">Archived</a> from the original on 9 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 March</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Global+News&amp;rft.atitle=Canada+to+spend+%24192M+on+developing+COVID-19+vaccine&amp;rft.date=2020-03-23&amp;rft.aulast=Abedi&amp;rft.aufirst=Maham&amp;rft_id=https%3A%2F%2Fglobalnews.ca%2Fnews%2F6717883%2Fcoronavirus-canada-vaccine-spending%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-can-funding-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-can-funding_43-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html\">\"Government of Canada funds 49 additional COVID-19 research projects \\xe2\\x80\\x93 Details of the funded projects\"</a>. Government of Canada. 23 March 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200322163807/https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html\">Archived</a> from the original on 22 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Government+of+Canada+funds+49+additional+COVID-19+research+projects+%E2%80%93+Details+of+the+funded+projects&amp;rft.pub=Government+of+Canada&amp;rft.date=2020-03-23&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Finstitutes-health-research%2Fnews%2F2020%2F03%2Fgovernment-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-aiello-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-aiello_44-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFAiello2020\" class=\"citation news cs1\">Aiello R (4 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ctvnews.ca/health/coronavirus/a-global-challenge-pm-trudeau-commits-850-million-to-global-fight-against-covid-19-1.4923565\">\"<span class=\"cs1-kern-left\">\\'</span>A global challenge\\': PM Trudeau commits $850 million to global fight against COVID-19\"</a>. <i>CTV News</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200510070903/https://www.ctvnews.ca/health/coronavirus/a-global-challenge-pm-trudeau-commits-850-million-to-global-fight-against-covid-19-1.4923565\">Archived</a> from the original on 10 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CTV+News&amp;rft.atitle=%27A+global+challenge%27%3A+PM+Trudeau+commits+%24850+million+to+global+fight+against+COVID-19&amp;rft.date=2020-05-04&amp;rft.aulast=Aiello&amp;rft.aufirst=Rachel&amp;rft_id=https%3A%2F%2Fwww.ctvnews.ca%2Fhealth%2Fcoronavirus%2Fa-global-challenge-pm-trudeau-commits-850-million-to-global-fight-against-covid-19-1.4923565&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-takada-45\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-takada_45-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-takada_45-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFTakadaSatake2020\" class=\"citation news cs1\">Takada N, Satake M (2 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://asia.nikkei.com/Spotlight/Coronavirus/US-and-China-unleash-wallets-in-race-for-coronavirus-vaccine\">\"US and China unleash wallets in race for coronavirus vaccine\"</a>. <i>Nikkei Asian Review</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200510111134/https://asia.nikkei.com/Spotlight/Coronavirus/US-and-China-unleash-wallets-in-race-for-coronavirus-vaccine\">Archived</a> from the original on 10 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nikkei+Asian+Review&amp;rft.atitle=US+and+China+unleash+wallets+in+race+for+coronavirus+vaccine&amp;rft.date=2020-05-02&amp;rft.aulast=Takada&amp;rft.aufirst=Noriyuki&amp;rft.au=Satake%2C+Minoru&amp;rft_id=https%3A%2F%2Fasia.nikkei.com%2FSpotlight%2FCoronavirus%2FUS-and-China-unleash-wallets-in-race-for-coronavirus-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\">Yuliya Talmazan, Keir Simmons, Laura Saravia (18 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nbcnews.com/news/world/coronavirus-who-faces-global-call-investigation-general-assembly-n1209061\">\"China\\'s Xi announces $2B for coronavirus response as WHO faces calls for investigation\"</a>. <i>NBC News</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200518171737/https://www.nbcnews.com/news/world/coronavirus-who-faces-global-call-investigation-general-assembly-n1209061\">Archived</a> from the original on 18 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">18 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NBC+News&amp;rft.atitle=China%27s+Xi+announces+%242B+for+coronavirus+response+as+WHO+faces+calls+for+investigation&amp;rft.date=2020-05-18&amp;rft_id=https%3A%2F%2Fwww.nbcnews.com%2Fnews%2Fworld%2Fcoronavirus-who-faces-global-call-investigation-general-assembly-n1209061&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFOre2020\" class=\"citation news cs1\">Ore, Diego (23 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/us-health-coronavirus-mexico-china/mexico-says-china-plans-1-billion-loan-to-ease-latam-access-to-virus-vaccine-idUSKCN24O08L\">\"Mexico says China plans $1 billion loan to ease Latam access to virus vaccine\"</a>. <i>Reuters</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Mexico+says+China+plans+%241+billion+loan+to+ease+Latam+access+to+virus+vaccine&amp;rft.date=2020-07-23&amp;rft.aulast=Ore&amp;rft.aufirst=Diego&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-health-coronavirus-mexico-china%2Fmexico-says-china-plans-1-billion-loan-to-ease-latam-access-to-virus-vaccine-idUSKCN24O08L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.scmp.com/news/china/diplomacy/article/3098610/china-promises-its-mekong-neighbours-priority-access\">\"China promises Mekong neighbours access to Chinese Covid-19 vaccine\"</a>. <i>South China Morning Post</i>. 24 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=South+China+Morning+Post&amp;rft.atitle=China+promises+Mekong+neighbours+access+to+Chinese+Covid-19+vaccine&amp;rft.date=2020-08-24&amp;rft_id=https%3A%2F%2Fwww.scmp.com%2Fnews%2Fchina%2Fdiplomacy%2Farticle%2F3098610%2Fchina-promises-its-mekong-neighbours-priority-access&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cepi-4-30-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cepi-4-30_49-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://cepi.net/research_dev/our-portfolio/\">\"CEPI: Our vaccine and platform portfolio\"</a>. Coalition for Epidemic Preparedness Innovation (CEPI). 30 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200507133020/https://cepi.net/research_dev/our-portfolio/\">Archived</a> from the original on 7 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CEPI%3A+Our+vaccine+and+platform+portfolio&amp;rft.pub=Coalition+for+Epidemic+Preparedness+Innovation+%28CEPI%29&amp;rft.date=2020-04-30&amp;rft_id=https%3A%2F%2Fcepi.net%2Fresearch_dev%2Four-portfolio%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cepi3-19-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cepi3-19_50-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://cepi.net/news_cepi/cepi-collaborates-with-the-institut-pasteur-in-a-consortium-to-develop-covid-19-vaccine/\">\"CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine\"</a>. Coalition for Epidemic Preparedness Innovations. 19 March 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200322233816/https://cepi.net/news_cepi/cepi-collaborates-with-the-institut-pasteur-in-a-consortium-to-develop-covid-19-vaccine/\">Archived</a> from the original on 22 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CEPI+collaborates+with+the+Institut+Pasteur+in+a+consortium+to+develop+COVID-19+vaccine&amp;rft.pub=Coalition+for+Epidemic+Preparedness+Innovations&amp;rft.date=2020-03-19&amp;rft_id=https%3A%2F%2Fcepi.net%2Fnews_cepi%2Fcepi-collaborates-with-the-institut-pasteur-in-a-consortium-to-develop-covid-19-vaccine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-curevac-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-curevac_51-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://ec.europa.eu/commission/presscorner/detail/en/ip_20_474\">\"Coronavirus: Commission offers financing to innovative vaccines company CureVac\"</a>. European Commission. 16 March 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200319161432/https://ec.europa.eu/commission/presscorner/detail/en/ip_20_474\">Archived</a> from the original on 19 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 March</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus%3A+Commission+offers+financing+to+innovative+vaccines+company+CureVac&amp;rft.pub=European+Commission&amp;rft.date=2020-03-16&amp;rft_id=https%3A%2F%2Fec.europa.eu%2Fcommission%2Fpresscorner%2Fdetail%2Fen%2Fip_20_474&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.spiegel.de/wirtschaft/bundesregierung-beteiligt-sich-an-impfstoffhersteller-curevac-a-2c915a65-5e89-407c-91d0-8fa2200efa00\">\"Corona-Impfstoff: Bundesregierung beteiligt sich an Impfstoffhersteller CureVac\"</a>. <i>www.spiegel.de</i> (in German). Der Spiegel. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200616073818/https://www.spiegel.de/wirtschaft/bundesregierung-beteiligt-sich-an-impfstoffhersteller-curevac-a-2c915a65-5e89-407c-91d0-8fa2200efa00\">Archived</a> from the original on 16 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.spiegel.de&amp;rft.atitle=Corona-Impfstoff%3A+Bundesregierung+beteiligt+sich+an+Impfstoffhersteller+CureVac&amp;rft_id=https%3A%2F%2Fwww.spiegel.de%2Fwirtschaft%2Fbundesregierung-beteiligt-sich-an-impfstoffhersteller-curevac-a-2c915a65-5e89-407c-91d0-8fa2200efa00&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-morriss-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-morriss_53-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFMorriss2020\" class=\"citation web cs1\">Morriss E (22 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://pharmafield.co.uk/pharma_news/government-launches-coronavirus-vaccine-taskforce-as-human-clinical-trials-start/\">\"Government launches coronavirus vaccine taskforce as human clinical trials start\"</a>. Pharmafield<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Government+launches+coronavirus+vaccine+taskforce+as+human+clinical+trials+start&amp;rft.pub=Pharmafield&amp;rft.date=2020-04-22&amp;rft.aulast=Morriss&amp;rft.aufirst=Emma&amp;rft_id=https%3A%2F%2Fpharmafield.co.uk%2Fpharma_news%2Fgovernment-launches-coronavirus-vaccine-taskforce-as-human-clinical-trials-start%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-gartner-54\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gartner_54-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gartner_54-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFGartnerRoberts2020\" class=\"citation news cs1\">Gartner A, Roberts L (3 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-vaccine-uk-trials-news-latest-update-covid-19/\">\"How close are we to a coronavirus vaccine? Latest news on UK trials\"</a>. <i>The Telegraph</i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0307-1235\">0307-1235</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200504203335/https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-vaccine-uk-trials-news-latest-update-covid-19/\">Archived</a> from the original on 4 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Telegraph&amp;rft.atitle=How+close+are+we+to+a+coronavirus+vaccine%3F+Latest+news+on+UK+trials&amp;rft.date=2020-05-03&amp;rft.issn=0307-1235&amp;rft.aulast=Gartner&amp;rft.aufirst=Annelies&amp;rft.au=Roberts%2C+Lizzie&amp;rft_id=https%3A%2F%2Fwww.telegraph.co.uk%2Fglobal-health%2Fscience-and-disease%2Fcoronavirus-vaccine-uk-trials-news-latest-update-covid-19%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-oxford-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-oxford_55-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ox.ac.uk/news/2020-04-30-landmark-partnership-announced-development-covid-19-vaccine\">\"Landmark partnership announced for development of COVID-19 vaccine\"</a>. University of Oxford. 30 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200513010438/http://www.ox.ac.uk/news/2020-04-30-landmark-partnership-announced-development-covid-19-vaccine\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Landmark+partnership+announced+for+development+of+COVID-19+vaccine&amp;rft.pub=University+of+Oxford&amp;rft.date=2020-04-30&amp;rft_id=http%3A%2F%2Fwww.ox.ac.uk%2Fnews%2F2020-04-30-landmark-partnership-announced-development-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-kuznia-56\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-kuznia_56-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-kuznia_56-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFKuzniaPolglaseMezzofiore2020\" class=\"citation news cs1\">Kuznia R, Polglase K, Mezzofiore G (1 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cnn.com/2020/05/01/us/coronavirus-moderna-vaccine-invs/index.html\">\"In quest for vaccine, US makes \\'big bet\\' on company with unproven technology\"</a>. <i>CNN</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200513005730/https://www.cnn.com/2020/05/01/us/coronavirus-moderna-vaccine-invs/index.html\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=In+quest+for+vaccine%2C+US+makes+%27big+bet%27+on+company+with+unproven+technology&amp;rft.date=2020-05-01&amp;rft.aulast=Kuznia&amp;rft.aufirst=Robert&amp;rft.au=Polglase%2C+Katie&amp;rft.au=Mezzofiore%2C+Gianluca&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2020%2F05%2F01%2Fus%2Fcoronavirus-moderna-vaccine-invs%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-lee-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-lee_57-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFLeeWelkerPerlmutter-Gumbiner2020\" class=\"citation web cs1\">Lee CE, Welker K, Perlmutter-Gumbiner E (1 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nbcnews.com/politics/white-house/health-officials-eyeing-least-one-14-potential-coronavirus-vaccines-fast-n1198326\">\"Health officials eyeing at least one of 14 potential coronavirus vaccines to fast-track\"</a>. <i>NBC News</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200511104127/https://www.nbcnews.com/politics/white-house/health-officials-eyeing-least-one-14-potential-coronavirus-vaccines-fast-n1198326\">Archived</a> from the original on 11 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NBC+News&amp;rft.atitle=Health+officials+eyeing+at+least+one+of+14+potential+coronavirus+vaccines+to+fast-track&amp;rft.date=2020-05-01&amp;rft.aulast=Lee&amp;rft.aufirst=Carol+E&amp;rft.au=Welker%2C+Kristen&amp;rft.au=Perlmutter-Gumbiner%2C+Elyse&amp;rft_id=https%3A%2F%2Fwww.nbcnews.com%2Fpolitics%2Fwhite-house%2Fhealth-officials-eyeing-least-one-14-potential-coronavirus-vaccines-fast-n1198326&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-58\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFCohen2020\" class=\"citation journal cs1\">Cohen J (15 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://science.sciencemag.org/content/368/6492/692\">\"U.S. \\'Warp Speed\\' vaccine effort comes out of the shadows\"</a>. <i>Science</i>. <b>368</b> (6492): 692\\xe2\\x80\\x9393. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Sci...368..692C\">2020Sci...368..692C</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.368.6492.692\">10.1126/science.368.6492.692</a></span>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0036-8075\">0036-8075</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32409451\">32409451</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200519111116/https://science.sciencemag.org/content/368/6492/692\">Archived</a> from the original on 19 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=U.S.+%27Warp+Speed%27+vaccine+effort+comes+out+of+the+shadows&amp;rft.volume=368&amp;rft.issue=6492&amp;rft.pages=692-93&amp;rft.date=2020-05-15&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.368.6492.692&amp;rft.issn=0036-8075&amp;rft_id=info%3Apmid%2F32409451&amp;rft_id=info%3Abibcode%2F2020Sci...368..692C&amp;rft.aulast=Cohen&amp;rft.aufirst=Jon&amp;rft_id=https%3A%2F%2Fscience.sciencemag.org%2Fcontent%2F368%2F6492%2F692&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\">Justin Sink, Jordan Fabian, Riley Griffin (15 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2020-05-15/trump-to-introduce-warp-speed-leaders-after-vaccine-criticism\">\"Trump introduces \\'Warp Speed\\' leaders to hasten COVID-19 vaccine\"</a>. <i>Bloomberg</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200521231515/https://www.bloomberg.com/news/articles/2020-05-15/trump-to-introduce-warp-speed-leaders-after-vaccine-criticism\">Archived</a> from the original on 21 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=Trump+introduces+%27Warp+Speed%27+leaders+to+hasten+COVID-19+vaccine&amp;rft.date=2020-05-15&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2020-05-15%2Ftrump-to-introduce-warp-speed-leaders-after-vaccine-criticism&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-60\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\">Riley Griffith, Jennifer Jacobs (3 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2020-06-03/white-house-working-with-seven-drugmakers-in-warp-speed-push\">\"White House Works With Seven Drugmakers in \\'Warp Speed\\' Push\"</a>. <i>Bloomberg</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200603220008/https://www.bloomberg.com/news/articles/2020-06-03/white-house-working-with-seven-drugmakers-in-warp-speed-push\">Archived</a> from the original on 3 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=White+House+Works+With+Seven+Drugmakers+in+%27Warp+Speed%27+Push&amp;rft.date=2020-06-03&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2020-06-03%2Fwhite-house-working-with-seven-drugmakers-in-warp-speed-push&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-solidarity-vacc-61\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-solidarity-vacc_61-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-solidarity-vacc_61-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-solidarity-vacc_61-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-solidarity-vacc_61-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-solidarity-vacc_61-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/blueprint/priority-diseases/key-action/Outline_CoreProtocol_vaccine_trial_09042020.pdf\">\"An international randomised trial of candidate vaccines against COVID-19: Outline of Solidarity vaccine trial\"</a> <span class=\"cs1-format\">(PDF)</span>. World Health Organization. 9 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200512115627/https://www.who.int/blueprint/priority-diseases/key-action/Outline_CoreProtocol_vaccine_trial_09042020.pdf\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 12 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=An+international+randomised+trial+of+candidate+vaccines+against+COVID-19%3A+Outline+of+Solidarity+vaccine+trial&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-04-09&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fblueprint%2Fpriority-diseases%2Fkey-action%2FOutline_CoreProtocol_vaccine_trial_09042020.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-pallmann-62\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pallmann_62-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pallmann_62-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFPallmannBeddingChoodari-OskooeiDimairo2018\" class=\"citation journal cs1\">Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV,  et al. (February 2018). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5830330\">\"Adaptive designs in clinical trials: why use them, and how to run and report them\"</a>. <i>BMC Medicine</i>. <b>16</b> (1): 29. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186%2Fs12916-018-1017-7\">10.1186/s12916-018-1017-7</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5830330\">5830330</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/29490655\">29490655</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Medicine&amp;rft.atitle=Adaptive+designs+in+clinical+trials%3A+why+use+them%2C+and+how+to+run+and+report+them&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=29&amp;rft.date=2018-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5830330&amp;rft_id=info%3Apmid%2F29490655&amp;rft_id=info%3Adoi%2F10.1186%2Fs12916-018-1017-7&amp;rft.aulast=Pallmann&amp;rft.aufirst=P&amp;rft.au=Bedding%2C+AW&amp;rft.au=Choodari-Oskooei%2C+B&amp;rft.au=Dimairo%2C+M&amp;rft.au=Flight%2C+L&amp;rft.au=Hampson%2C+LV&amp;rft.au=Holmes%2C+J&amp;rft.au=Mander%2C+AP&amp;rft.au=Odondi%2C+L&amp;rft.au=Sydes%2C+MR&amp;rft.au=Villar%2C+SS&amp;rft.au=Wason%2C+JM&amp;rft.au=Weir%2C+CJ&amp;rft.au=Wheeler%2C+GM&amp;rft.au=Yap%2C+C&amp;rft.au=Jaki%2C+T&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5830330&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-fda-adaptive-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-fda-adaptive_63-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/media/78495/download\">\"Adaptive designs for clinical trials of drugs and biologics: Guidance for industry\"</a>. U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA). 1 November 2019. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20191213234438/https://www.fda.gov/media/78495/download\">Archived</a> from the original on 13 December 2019<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Adaptive+designs+for+clinical+trials+of+drugs+and+biologics%3A+Guidance+for+industry&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2019-11-01&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F78495%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-64\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFMcGrail2020\" class=\"citation web cs1\">McGrail S (15 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://pharmanewsintel.com/news/sanofi-gsk-partner-to-develop-adjuvanted-covid-19-vaccine\">\"Sanofi, GSK partner to develop adjuvanted COVID-19 vaccine\"</a>. PharmaNewsIntelligence. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200509223306/https://pharmanewsintel.com/news/sanofi-gsk-partner-to-develop-adjuvanted-covid-19-vaccine\">Archived</a> from the original on 9 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Sanofi%2C+GSK+partner+to+develop+adjuvanted+COVID-19+vaccine&amp;rft.pub=PharmaNewsIntelligence&amp;rft.date=2020-04-15&amp;rft.aulast=McGrail&amp;rft.aufirst=Samantha&amp;rft_id=https%3A%2F%2Fpharmanewsintel.com%2Fnews%2Fsanofi-gsk-partner-to-develop-adjuvanted-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-blueprint-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-blueprint_65-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/blueprint/priority-diseases/key-action/Coronavirus_Roadmap_V9.pdf?ua=1\">\"R&amp;D Blueprint: A coordinated global research roadmap \\xe2\\x80\\x93 2019 novel coronavirus\"</a> <span class=\"cs1-format\">(PDF)</span>. World Health Organization. 1 March 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200515101822/https://www.who.int/blueprint/priority-diseases/key-action/Coronavirus_Roadmap_V9.pdf?ua=1\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 15 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=R%26D+Blueprint%3A+A+coordinated+global+research+roadmap+%E2%80%93+2019+novel+coronavirus&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-03-01&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fblueprint%2Fpriority-diseases%2Fkey-action%2FCoronavirus_Roadmap_V9.pdf%3Fua%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-66\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFJeong-hoZhengZhou2020\" class=\"citation news cs1\">Jeong-ho L, Zheng W, Zhou L (26 January 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scmp.com/news/china/society/article/3047676/number-coronavirus-cases-china-doubles-spread-rate-accelerates\">\"Chinese scientists race to develop vaccine as coronavirus death toll jumps\"</a>. <i><a href=\"/wiki/South_China_Morning_Post\" title=\"South China Morning Post\">South China Morning Post</a></i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200126073453/https://www.scmp.com/news/china/society/article/3047676/number-coronavirus-cases-china-doubles-spread-rate-accelerates\">Archived</a> from the original on 26 January 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 January</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=South+China+Morning+Post&amp;rft.atitle=Chinese+scientists+race+to+develop+vaccine+as+coronavirus+death+toll+jumps&amp;rft.date=2020-01-26&amp;rft.aulast=Jeong-ho&amp;rft.aufirst=Lee&amp;rft.au=Zheng%2C+William&amp;rft.au=Zhou%2C+Laura&amp;rft_id=https%3A%2F%2Fwww.scmp.com%2Fnews%2Fchina%2Fsociety%2Farticle%2F3047676%2Fnumber-coronavirus-cases-china-doubles-spread-rate-accelerates&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-wee-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-wee_67-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFWee2020\" class=\"citation news cs1\">Wee S (4 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/05/04/business/coronavirus-china-vaccine.html\">\"China\\'s coronavirus vaccine drive empowers a troubled industry\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200504175312/https://www.nytimes.com/2020/05/04/business/coronavirus-china-vaccine.html\">Archived</a> from the original on 4 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=China%27s+coronavirus+vaccine+drive+empowers+a+troubled+industry&amp;rft.date=2020-05-04&amp;rft.issn=0362-4331&amp;rft.aulast=Wee&amp;rft.aufirst=Sui-Lee&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F05%2F04%2Fbusiness%2Fcoronavirus-china-vaccine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-simpson-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-simpson_68-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFSimpsonKaufmannGlozmanChakrabarti2020\" class=\"citation journal cs1\">Simpson S, Kaufmann MC, Glozman V, Chakrabarti A (May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7158580\">\"Disease X: accelerating the development of medical countermeasures for the next pandemic\"</a>. <i>The Lancet. Infectious Diseases</i>. <b>20</b> (5): e108\\xe2\\x80\\x9315. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1473-3099%2820%2930123-7\">10.1016/S1473-3099(20)30123-7</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1474-4457\">1474-4457</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7158580\">7158580</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32197097\">32197097</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Infectious+Diseases&amp;rft.atitle=Disease+X%3A+accelerating+the+development+of+medical+countermeasures+for+the+next+pandemic&amp;rft.volume=20&amp;rft.issue=5&amp;rft.pages=e108-15&amp;rft.date=2020-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7158580&amp;rft.issn=1474-4457&amp;rft_id=info%3Apmid%2F32197097&amp;rft_id=info%3Adoi%2F10.1016%2FS1473-3099%2820%2930123-7&amp;rft.aulast=Simpson&amp;rft.aufirst=Shmona&amp;rft.au=Kaufmann%2C+Michael+C.&amp;rft.au=Glozman%2C+Vitaly&amp;rft.au=Chakrabarti%2C+Ajoy&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7158580&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-bio-69\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-bio_69-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-bio_69-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-bio_69-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-bio_69-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf\">\"Clinical Development Success Rates 2006\\xe2\\x80\\x932015\"</a> <span class=\"cs1-format\">(PDF)</span>. BIO Industry Analysis. June 2016. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20190912220246/https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 12 September 2019<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Clinical+Development+Success+Rates+2006%E2%80%932015&amp;rft.pub=BIO+Industry+Analysis&amp;rft.date=2016-06&amp;rft_id=https%3A%2F%2Fwww.bio.org%2Fsites%2Fdefault%2Ffiles%2FClinical%2520Development%2520Success%2520Rates%25202006-2015%2520-%2520BIO%2C%2520Biomedtracker%2C%2520Amplion%25202016.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-70\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFBlackwell2020\" class=\"citation news cs1\">Blackwell T (20 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://nationalpost.com/news/covid-19-vaccine-researchers-say-pandemic-lockdown-placing-many-serious-obstacles-to-their-work\">\"COVID-19 vaccine researchers say pandemic lockdown placing many serious obstacles to their work\"</a>. <i>National Post</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=National+Post&amp;rft.atitle=COVID-19+vaccine+researchers+say+pandemic+lockdown+placing+many+serious+obstacles+to+their+work&amp;rft.date=2020-04-20&amp;rft.aulast=Blackwell&amp;rft.aufirst=Tom&amp;rft_id=https%3A%2F%2Fnationalpost.com%2Fnews%2Fcovid-19-vaccine-researchers-say-pandemic-lockdown-placing-many-serious-obstacles-to-their-work&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-71\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFChen2020\" class=\"citation web cs1\">Chen J (4 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/2020/05/04/coronavirus-lab-shutdowns-impact-on-scientists-research-delays/\">\"Covid-19 has shuttered labs. It could put a generation of researchers at risk\"</a>. STAT. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200506072301/https://www.statnews.com/2020/05/04/coronavirus-lab-shutdowns-impact-on-scientists-research-delays/\">Archived</a> from the original on 6 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Covid-19+has+shuttered+labs.+It+could+put+a+generation+of+researchers+at+risk&amp;rft.pub=STAT&amp;rft.date=2020-05-04&amp;rft.aulast=Chen&amp;rft.aufirst=Justin&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F05%2F04%2Fcoronavirus-lab-shutdowns-impact-on-scientists-research-delays%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-Vaccines.gov-73\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Vaccines.gov_73-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Vaccines.gov_73-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.vaccines.gov/basics/safety\">\"Vaccine Safety \\xe2\\x80\\x93 Vaccines\"</a>. <i>vaccines.gov</i>. US Department of Health and Human Services. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200422073442/https://www.vaccines.gov/basics/safety\">Archived</a> from the original on 22 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=vaccines.gov&amp;rft.atitle=Vaccine+Safety+%E2%80%93+Vaccines&amp;rft_id=https%3A%2F%2Fwww.vaccines.gov%2Fbasics%2Fsafety&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-fda-ddp-74\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-fda-ddp_74-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-fda-ddp_74-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-fda-ddp_74-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process\">\"The drug development process\"</a>. U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA). 4 January 2018. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200222182002/https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process\">Archived</a> from the original on 22 February 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">12 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+drug+development+process&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2018-01-04&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fpatients%2Flearn-about-drug-and-device-approvals%2Fdrug-development-process&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cohen6-19-75\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cohen6-19_75-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cohen6-19_75-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-cohen6-19_75-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-cohen6-19_75-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-cohen6-19_75-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFCohen2020\" class=\"citation journal cs1\">Cohen J (19 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://science.sciencemag.org/content/368/6497/1295\">\"Pandemic vaccines are about to face the real test\"</a>. <i>Science</i>. <b>368</b> (6497): 1295\\xe2\\x80\\x9396. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Sci...368.1295C\">2020Sci...368.1295C</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.368.6497.1295\">10.1126/science.368.6497.1295</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32554572\">32554572</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200621082652/https://science.sciencemag.org/content/368/6497/1295\">Archived</a> from the original on 21 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Pandemic+vaccines+are+about+to+face+the+real+test&amp;rft.volume=368&amp;rft.issue=6497&amp;rft.pages=1295-96&amp;rft.date=2020-06-19&amp;rft_id=info%3Apmid%2F32554572&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.368.6497.1295&amp;rft_id=info%3Abibcode%2F2020Sci...368.1295C&amp;rft.aulast=Cohen&amp;rft.aufirst=Jon&amp;rft_id=https%3A%2F%2Fscience.sciencemag.org%2Fcontent%2F368%2F6497%2F1295&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cdc-eff-76\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cdc-eff_76-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/flu/vaccines-work/effectivenessqa.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Fvaccination%2Feffectivenessqa.htm\">\"How flu vaccine effectiveness and efficacy are measured\"</a>. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, US Department of Health and Human Services. 29 January 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=How+flu+vaccine+effectiveness+and+efficacy+are+measured&amp;rft.pub=Centers+for+Disease+Control+and+Prevention%2C+National+Center+for+Immunization+and+Respiratory+Diseases%2C+US+Department+of+Health+and+Human+Services&amp;rft.date=2016-01-29&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fvaccines-work%2Feffectivenessqa.htm%3FCDC_AA_refVal%3Dhttps%253A%252F%252Fwww.cdc.gov%252Fflu%252Fprofessionals%252Fvaccination%252Feffectivenessqa.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-77\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section8.html\">\"Principles of epidemiology, Section 8: Concepts of disease occurrence\"</a>. Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services, US Department of Health and Human Services. 18 May 2012. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200406212227/https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section8.html\">Archived</a> from the original on 6 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Principles+of+epidemiology%2C+Section+8%3A+Concepts+of+disease+occurrence&amp;rft.pub=Centers+for+Disease+Control+and+Prevention%2C+Center+for+Surveillance%2C+Epidemiology%2C+and+Laboratory+Services%2C+US+Department+of+Health+and+Human+Services&amp;rft.date=2012-05-18&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fcsels%2Fdsepd%2Fss1978%2Flesson1%2Fsection8.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-80\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-80\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFWalshShelleyDuweBonnett2020\" class=\"citation news cs1\">Walsh N, Shelley J, Duwe E, Bonnett W (27 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://edition.cnn.com/2020/07/27/americas/brazil-covid-19-sinovac-vaccine-intl/index.html\">\"The world\\'s hopes for a coronavirus vaccine may run in these health care workers\\' veins\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>. <a href=\"/wiki/S%C3%A3o_Paulo\" title=\"S\\xc3\\xa3o Paulo\">S\\xc3\\xa3o Paulo</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=The+world%27s+hopes+for+a+coronavirus+vaccine+may+run+in+these+health+care+workers%27+veins&amp;rft.date=2020-07-27&amp;rft.aulast=Walsh&amp;rft.aufirst=Nick&amp;rft.au=Shelley%2C+Jo&amp;rft.au=Duwe%2C+Eduardo&amp;rft.au=Bonnett%2C+William&amp;rft_id=https%3A%2F%2Fedition.cnn.com%2F2020%2F07%2F27%2Famericas%2Fbrazil-covid-19-sinovac-vaccine-intl%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04400838-82\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04400838_82-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04400838\">\"Investigating a Vaccine Against COVID-19\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 26 May 2020. NCT04400838<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Investigating+a+Vaccine+Against+COVID-19&amp;rft.date=2020-05-26&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04400838&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-EudraCT-2020-001228-32-83\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EudraCT-2020-001228-32_83-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB\">\"A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19\"</a>. <i>EU Clinical Trials Register</i> (Registry). European Union. 21 April 2020. <a href=\"/wiki/EudraCT\" title=\"EudraCT\">EudraCT</a> 2020-001228-32<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EU+Clinical+Trials+Register&amp;rft.atitle=A+Phase+2%2F3+study+to+determine+the+efficacy%2C+safety+and+immunogenicity+of+the+candidate+Coronavirus+Disease+%28COVID-19%29+vaccine+ChAdOx1+nCoV-19&amp;rft.date=2020-04-21&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsregister.eu%2Fctr-search%2Ftrial%2F2020-001228-32%2FGB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-ISRCTN89951424-84\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ISRCTN89951424_84-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFO&#39;Reilly2020\" class=\"citation journal cs1\">O\\'Reilly P (26 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.isrctn.com/ISRCTN89951424\">\"A Phase III study to investigate a vaccine against COVID-19\"</a>. <i>ISRCTN</i> (Registry). <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186%2FISRCTN89951424\">10.1186/ISRCTN89951424</a>. ISRCTN89951424<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ISRCTN&amp;rft.atitle=A+Phase+III+study+to+investigate+a+vaccine+against+COVID-19&amp;rft.date=2020-05-26&amp;rft_id=info%3Adoi%2F10.1186%2FISRCTN89951424&amp;rft.aulast=O%27Reilly&amp;rft.aufirst=Peter&amp;rft_id=http%3A%2F%2Fwww.isrctn.com%2FISRCTN89951424&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04516746-85\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04516746_85-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04516746\">\"A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 12 May 2020. NCT04383574<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Phase+III+Randomized%2C+Double-blind%2C+Placebo-controlled+Multicenter+Study+in+Adults+to+Determine+the+Safety%2C+Efficacy%2C+and+Immunogenicity+of+AZD1222%2C+a+Non-replicating+ChAdOx1+Vector+Vaccine%2C+for+the+Prevention+of+COVID-19&amp;rft.date=2020-05-12&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04516746&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-86\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-86\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://covid19vaccinetrial.co.uk/brazil-trial-launch\">\"Trial of Oxford COVID-19 vaccine starts in Brazil\"</a>. <a href=\"/wiki/Jenner_Institute\" title=\"Jenner Institute\">Jenner Institute</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Trial+of+Oxford+COVID-19+vaccine+starts+in+Brazil&amp;rft.pub=Jenner+Institute&amp;rft_id=https%3A%2F%2Fcovid19vaccinetrial.co.uk%2Fbrazil-trial-launch&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-phillips-87\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-phillips_87-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFPhillipsCyranoskiMallapaty2020\" class=\"citation journal cs1\">Phillips, Nicky; Cyranoski, David; Mallapaty, Smriti (9 September 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/d41586-020-02594-w\">\"A leading coronavirus vaccine trial is on hold: scientists react\"</a>. <i>Nature</i>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fd41586-020-02594-w\">10.1038/d41586-020-02594-w</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0028-0836\">0028-0836</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32908295\">32908295</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221620587\">221620587</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=A+leading+coronavirus+vaccine+trial+is+on+hold%3A+scientists+react&amp;rft.date=2020-09-09&amp;rft.issn=0028-0836&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221620587&amp;rft_id=info%3Apmid%2F32908295&amp;rft_id=info%3Adoi%2F10.1038%2Fd41586-020-02594-w&amp;rft.aulast=Phillips&amp;rft.aufirst=Nicky&amp;rft.au=Cyranoski%2C+David&amp;rft.au=Mallapaty%2C+Smriti&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-02594-w&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-88\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-88\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFAdam_Feuerstein2020\" class=\"citation web cs1\">Adam Feuerstein (9 September 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/2020/09/09/astrazeneca-covid19-vaccine-trial-hold-patient-report/\">\"Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says\"</a>. STAT<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Covid-19+vaccine+trial+participant+had+serious+neurological+symptoms%2C+but+could+be+discharged+today%2C+AstraZeneca+CEO+says&amp;rft.pub=STAT&amp;rft.date=2020-09-09&amp;rft.au=Adam+Feuerstein&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F09%2F09%2Fastrazeneca-covid19-vaccine-trial-hold-patient-report%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-89\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-89\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://nos.nl/artikel/2347931-astrazeneca-en-universiteit-oxford-hervatten-vaccintest.html\">\"AstraZeneca en universiteit Oxford hervatten vaccintest\"</a>. <i><a href=\"/wiki/Nederlandse_Omroep_Stichting\" title=\"Nederlandse Omroep Stichting\">NOS</a></i> (in Dutch). 12 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">12 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NOS&amp;rft.atitle=AstraZeneca+en+universiteit+Oxford+hervatten+vaccintest&amp;rft.date=2020-09-12&amp;rft_id=https%3A%2F%2Fnos.nl%2Fartikel%2F2347931-astrazeneca-en-universiteit-oxford-hervatten-vaccintest.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-folegatti-90\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-folegatti_90-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFFolegattiEwerAleyAngus2020\" class=\"citation journal cs1\">Folegatti PM, <a href=\"/wiki/Katie_Ewer\" title=\"Katie Ewer\">Ewer KJ</a>, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S,  et al. (July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931604-4\">\"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Lancet</i>. <b>396</b> (10249): 467\\xe2\\x80\\x9378. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0140-6736%2820%2931604-4\">10.1016/S0140-6736(20)31604-4</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7445431\">7445431</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32702298\">32702298</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://blogs.sciencemag.org/pipeline/archives/2020/07/20/new-data-on-the-oxford-az-vaccine\">Lay summary</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Safety+and+immunogenicity+of+the+ChAdOx1+nCoV-19+vaccine+against+SARS-CoV-2%3A+a+preliminary+report+of+a+phase+1%2F2%2C+single-blind%2C+randomised+controlled+trial&amp;rft.volume=396&amp;rft.issue=10249&amp;rft.pages=467-78&amp;rft.date=2020-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7445431&amp;rft_id=info%3Apmid%2F32702298&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2820%2931604-4&amp;rft.aulast=Folegatti&amp;rft.aufirst=Pedro+M&amp;rft.au=Ewer%2C+Katie+J&amp;rft.au=Aley%2C+Parvinder+K&amp;rft.au=Angus%2C+Brian&amp;rft.au=Becker%2C+Stephan&amp;rft.au=Belij-Rammerstorfer%2C+Sandra&amp;rft.au=Bellamy%2C+Duncan&amp;rft.au=Bibi%2C+Sagida&amp;rft.au=Bittaye%2C+Mustapha&amp;rft.au=Clutterbuck%2C+Elizabeth+A&amp;rft.au=Dold%2C+Christina&amp;rft.au=Faust%2C+Saul+N&amp;rft.au=Finn%2C+Adam&amp;rft.au=Flaxman%2C+Amy+L&amp;rft.au=Hallis%2C+Bassam&amp;rft.au=Heath%2C+Paul&amp;rft.au=Jenkin%2C+Daniel&amp;rft.au=Lazarus%2C+Rajeka&amp;rft.au=Makinson%2C+Rebecca&amp;rft.au=Minassian%2C+Angela+M&amp;rft.au=Pollock%2C+Katrina+M&amp;rft.au=Ramasamy%2C+Maheshi&amp;rft.au=Robinson%2C+Hannah&amp;rft.au=Snape%2C+Matthew&amp;rft.au=Tarrant%2C+Richard&amp;rft.au=Voysey%2C+Merryn&amp;rft.au=Green%2C+Catherine&amp;rft.au=Douglas%2C+Alexander+D&amp;rft.au=Hill%2C+Adrian+V+S&amp;rft.au=Lambe%2C+Teresa&amp;rft.au=Gilbert%2C+Sarah+C&amp;rft.au=Pollard%2C+Andrew+J&amp;rft_id=https%3A%2F%2Fwww.thelancet.com%2Faction%2FshowPdf%3Fpii%3DS0140-6736%252820%252931604-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-ChiCTR2000034780-91\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ChiCTR2000034780_91-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFChenAl_Kaabi2020\" class=\"citation journal cs1\">Chen, Wei; Al Kaabi, Nawal (18 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.chictr.org.cn/showprojen.aspx?proj=56651\">\"A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)\"</a>. <i>Chinese Clinical Trial Registry</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chinese+Clinical+Trial+Registry&amp;rft.atitle=A+Phase+III+clinical+trial+for+inactivated+novel+coronavirus+pneumonia+%28COVID-19%29+vaccine+%28Vero+cells%29&amp;rft.date=2020-07-18&amp;rft.aulast=Chen&amp;rft.aufirst=Wei&amp;rft.au=Al+Kaabi%2C+Nawal&amp;rft_id=http%3A%2F%2Fwww.chictr.org.cn%2Fshowprojen.aspx%3Fproj%3D56651&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-92\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-92\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFYang\" class=\"citation web cs1\">Yang, Yunkai. <a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04510207\">\"A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above\"</a>. <i>clinicaltrials.gov</i>. Clinical Trials<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=A+Study+to+Evaluate+The+Efficacy%2C+Safety+and+Immunogenicity+of+Inactivated+SARS-CoV-2+Vaccines+%28Vero+Cell%29+in+Healthy+Population+Aged+18+Years+Old+and+Above&amp;rft.aulast=Yang&amp;rft.aufirst=Yunkai&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04510207&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-93\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-93\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04560881?term=vaccine&amp;cond=covid-19&amp;draw=2&amp;rank=3\">\"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)\"</a>. <i>clinicaltrials.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=Clinical+Trial+to+Evaluate+the+Efficacy%2C+Immunogenicity+and+Safety+of+the+Inactivated+SARS-CoV-2+Vaccine+%28COVID-19%29&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04560881%3Fterm%3Dvaccine%26cond%3Dcovid-19%26draw%3D2%26rank%3D3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-UAE_approval-94\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-UAE_approval_94-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFMaxwell\" class=\"citation web cs1\">Maxwell, Chris. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.thenational.ae/uae/health/coronavirus-uae-authorises-emergency-use-of-vaccine-for-frontline-workers-1.1077680\">\"Coronavirus: UAE authorises emergency use of vaccine for frontline workers\"</a>. The National<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus%3A+UAE+authorises+emergency+use+of+vaccine+for+frontline+workers&amp;rft.pub=The+National&amp;rft.aulast=Maxwell&amp;rft.aufirst=Chris&amp;rft_id=https%3A%2F%2Fwww.thenational.ae%2Fuae%2Fhealth%2Fcoronavirus-uae-authorises-emergency-use-of-vaccine-for-frontline-workers-1.1077680&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-95\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-95\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFXiaDuanZhangZhao2020\" class=\"citation journal cs1\">Xia S, Duan K, Zhang Y, Zhao D,  et al. (13 August 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://jamanetwork.com/journals/jama/fullarticle/2769612\">\"Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials\"</a>. <i>JAMA</i>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1001%2Fjama.2020.15543\">10.1001/jama.2020.15543</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7426884\">7426884</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32789505\">32789505</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Effect+of+an+Inactivated+Vaccine+Against+SARS-CoV-2+on+Safety+and+Immunogenicity+Outcomes%3A+Interim+Analysis+of+2+Randomized+Clinical+Trials&amp;rft.date=2020-08-13&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7426884&amp;rft_id=info%3Apmid%2F32789505&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2020.15543&amp;rft.aulast=Xia&amp;rft.aufirst=S&amp;rft.au=Duan%2C+K&amp;rft.au=Zhang%2C+Y&amp;rft.au=Zhao%2C+D&amp;rft_id=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjama%2Ffullarticle%2F2769612&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-96\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-96\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.canada.ca/en/national-research-council/news/2020/05/the-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19.html\">\"The National Research Council of Canada and CanSino Biologics Inc. announce collaboration to advance vaccine against COVID-19\"</a>. National Research Council, Government of Canada. 12 May 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200522153344/https://www.canada.ca/en/national-research-council/news/2020/05/the-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19.html\">Archived</a> from the original on 22 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+National+Research+Council+of+Canada+and+CanSino+Biologics+Inc.+announce+collaboration+to+advance+vaccine+against+COVID-19&amp;rft.pub=National+Research+Council%2C+Government+of+Canada&amp;rft.date=2020-05-12&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Fnational-research-council%2Fnews%2F2020%2F05%2Fthe-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-98\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-98\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFGou\" class=\"citation web cs1\">Gou, Jinbo. <a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04526990\">\"Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above\"</a>. clinicaltrials.gov<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Phase+III+Trial+of+A+COVID-19+Vaccine+of+Adenovirus+Vector+in+Adults+18+Years+Old+and+Above&amp;rft.pub=clinicaltrials.gov&amp;rft.aulast=Gou&amp;rft.aufirst=Jinbo&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04526990&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-zhu7-20-99\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-zhu7-20_99-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFZhuGuanLiHuang2020\" class=\"citation journal cs1\">Zhu F, Guan X, Li Y, Huang J, Jiang T, Hou L,  et al. (July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931605-6\">\"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Lancet</i>. <b>396</b> (10249): 479\\xe2\\x80\\x9388. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fs0140-6736%2820%2931605-6\">10.1016/s0140-6736(20)31605-6</a></span>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0140-6736\">0140-6736</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32702299\">32702299</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://blogs.sciencemag.org/pipeline/archives/2020/07/20/new-data-on-the-cansino-vaccine\">Lay summary</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Immunogenicity+and+safety+of+a+recombinant+adenovirus+type-5-vectored+COVID-19+vaccine+in+healthy+adults+aged+18+years+or+older%3A+a+randomised%2C+double-blind%2C+placebo-controlled%2C+phase+2+trial&amp;rft.volume=396&amp;rft.issue=10249&amp;rft.pages=479-88&amp;rft.date=2020-07&amp;rft.issn=0140-6736&amp;rft_id=info%3Apmid%2F32702299&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2820%2931605-6&amp;rft.aulast=Zhu&amp;rft.aufirst=Feng-Cai&amp;rft.au=Guan%2C+Xu-Hua&amp;rft.au=Li%2C+Yu-Hua&amp;rft.au=Huang%2C+Jian-Ying&amp;rft.au=Jiang%2C+Tao&amp;rft.au=Hou%2C+Li-Hua&amp;rft.au=Li%2C+Jing-Xin&amp;rft.au=Yang%2C+Bei-Fang&amp;rft.au=Wang%2C+Ling&amp;rft.au=Wang%2C+Wen-Juan&amp;rft.au=Wu%2C+Shi-Po&amp;rft.au=Wang%2C+Zhao&amp;rft.au=Wu%2C+Xiao-Hong&amp;rft.au=Xu%2C+Jun-Jie&amp;rft.au=Zhang%2C+Zhe&amp;rft.au=Jia%2C+Si-Yue&amp;rft.au=Wang%2C+Bu-Sen&amp;rft.au=Hu%2C+Yi&amp;rft.au=Liu%2C+Jing-Jing&amp;rft.au=Zhang%2C+Jun&amp;rft.au=Qian%2C+Xiao-Ai&amp;rft.au=Li%2C+Qiong&amp;rft.au=Pan%2C+Hong-Xing&amp;rft.au=Jiang%2C+Hu-Dachuan&amp;rft.au=Deng%2C+Peng&amp;rft.au=Gou%2C+Jin-Bo&amp;rft.au=Wang%2C+Xue-Wen&amp;rft.au=Wang%2C+Xing-Huan&amp;rft.au=Chen%2C+Wei&amp;rft_id=https%3A%2F%2Fwww.thelancet.com%2Faction%2FshowPdf%3Fpii%3DS0140-6736%252820%252931605-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04383574-100\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04383574_100-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04383574\">\"Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 12 May 2020. NCT04383574<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety+and+Immunogenicity+Study+of+Inactivated+Vaccine+for+Prevention+of+SARS-CoV-2+Infection+%28COVID-19%29+%28Renqiu%29&amp;rft.date=2020-05-12&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04383574&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCname=_nct04456595=-101\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCname=_nct04456595=_101-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04456595\">\"Clinical Trial of Efficacy and Safety of Sinovac\\'s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 2 July 2020. NCT04456595<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Clinical+Trial+of+Efficacy+and+Safety+of+Sinovac%27s+Adsorbed+COVID-19+%28Inactivated%29+Vaccine+in+Healthcare+Professionals+%28PROFISCOV%29&amp;rft.date=2020-07-02&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04456595&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-102\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-102\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFPT._Bio_Farma2020\" class=\"citation journal cs1\">PT. Bio Farma (10 August 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ina-registry.org/index.php?act=registry_trial_detail&amp;code_trial=16202009080721WXFM0YX\">\"A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18\\xe2\\x80\\x9359 years in Indonesia\"</a>. <i>Registri Penyakit Indonesia</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Registri+Penyakit+Indonesia&amp;rft.atitle=A+Phase+III%2C+observer-blind%2C+randomized%2C+placebo-controlled+study+of+the+efficacy%2C+safety%2C+and+immunogenicity+of+SARS-COV-2+inactivated+vaccine+in+healthy+adults+aged+18%E2%80%9359+years+in+Indonesia&amp;rft.date=2020-08-10&amp;rft.au=PT.+Bio+Farma&amp;rft_id=https%3A%2F%2Fwww.ina-registry.org%2Findex.php%3Fact%3Dregistry_trial_detail%26code_trial%3D16202009080721WXFM0YX&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-103\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-103\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\">Zhang Y-J, Zeng G, Pan H-X, Li C-G, others (10 August 2020). \"Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18\\xe2\\x80\\x9359 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial\". <i>MedRxiv</i>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2F2020.07.31.20161216\">10.1101/2020.07.31.20161216</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221089937\">221089937</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MedRxiv&amp;rft.atitle=Immunogenicity+and+Safety+of+a+SARS-CoV-2+Inactivated+Vaccine+in+Healthy+Adults+Aged+18%E2%80%9359+years%3A+Report+of+the+Randomized%2C+Double-blind%2C+and+Placebo-controlled+Phase+2+Clinical+Trial&amp;rft.date=2020-08-10&amp;rft_id=info%3Adoi%2F10.1101%2F2020.07.31.20161216&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221089937&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-104\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-104\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFIndonesia\" class=\"citation web cs1\">Indonesia, C. N. N. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cnnindonesia.com/teknologi/20200805023946-199-532230/fakta-terbaru-uji-klinis-vaksin-covid-19-di-bandung\">\"Fakta Terbaru Uji Klinis Vaksin Covid-19 di Bandung\"</a>. <i>teknologi</i> (in Indonesian)<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=teknologi&amp;rft.atitle=Fakta+Terbaru+Uji+Klinis+Vaksin+Covid-19+di+Bandung&amp;rft.aulast=Indonesia&amp;rft.aufirst=C.+N.+N.&amp;rft_id=https%3A%2F%2Fwww.cnnindonesia.com%2Fteknologi%2F20200805023946-199-532230%2Ffakta-terbaru-uji-klinis-vaksin-covid-19-di-bandung&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04368728-106\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04368728_106-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04368728\">\"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 30 April 2020. NCT04368728<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Study+to+Describe+the+Safety%2C+Tolerability%2C+Immunogenicity%2C+and+Efficacy+of+RNA+Vaccine+Candidates+Against+COVID-19+in+Healthy+Adults&amp;rft.date=2020-04-30&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04368728&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-EudraCT-2020-001038-36-107\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EudraCT-2020-001038-36_107-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE\">\"A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults\"</a>. <i>EU Clinical Trials Register</i> (Registry). European Union. 14 April 2020. <a href=\"/wiki/EudraCT\" title=\"EudraCT\">EudraCT</a> 2020-001038-36. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200422111024/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE\">Archived</a> from the original on 22 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EU+Clinical+Trials+Register&amp;rft.atitle=A+Multi-site+Phase+I%2FII%2C+2-Part%2C+Dose-Escalation+Trial+Investigating+the+Safety+and+Immunogenicity+of+four+Prophylactic+SARS-CoV-2+RNA+Vaccines+Against+COVID-19+Using+Different+Dosing+Regimens+in+Healthy+Adults&amp;rft.date=2020-04-14&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsregister.eu%2Fctr-search%2Ftrial%2F2020-001038-36%2FDE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-108\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-108\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFLovelace_Jr.2020\" class=\"citation news cs1\">Lovelace Jr B (27 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cnbc.com/2020/07/27/pfizer-and-biontech-began-late-stage-human-trial-for-coronavirus-vaccine-monday.html\">\"Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday\"</a>. <i><a href=\"/wiki/CNBC\" title=\"CNBC\">CNBC</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNBC&amp;rft.atitle=Pfizer+and+BioNTech+began+late-stage+human+trial+for+coronavirus+vaccine+Monday&amp;rft.date=2020-07-27&amp;rft.aulast=Lovelace+Jr.&amp;rft.aufirst=Berkeley&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2F2020%2F07%2F27%2Fpfizer-and-biontech-began-late-stage-human-trial-for-coronavirus-vaccine-monday.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-109\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-109\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFMulliganLykeKitchinAbsalon2020\" class=\"citation journal cs1\">Mulligan M, Lyke K, Kitchin N, Absalon J, Gurtman A, Lockhart S,  et al. (1 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.medrxiv.org/content/10.1101/2020.06.30.20142570v1.full.pdf\">\"Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>MedRxiv</i> (<a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>). <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2F2020.06.30.20142570\">10.1101/2020.06.30.20142570</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:220266992\">220266992</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MedRxiv&amp;rft.atitle=Phase+1%2F2+Study+to+Describe+the+Safety+and+Immunogenicity+of+a+COVID-19+RNA+Vaccine+Candidate+%28BNT162b1%29+in+Adults+18+to+55+Years+of+Age%3A+Interim+Report&amp;rft.date=2020-07-01&amp;rft_id=info%3Adoi%2F10.1101%2F2020.06.30.20142570&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A220266992&amp;rft.aulast=Mulligan&amp;rft.aufirst=Mark&amp;rft.au=Lyke%2C+Kirsten&amp;rft.au=Kitchin%2C+Nicholas&amp;rft.au=Absalon%2C+Judith&amp;rft.au=Gurtman%2C+Alejandra&amp;rft.au=Lockhart%2C+Stephen&amp;rft.au=Neuzil%2C+Kathleen&amp;rft.au=Raabe%2C+Vanessa&amp;rft.au=Bailey%2C+Ruth&amp;rft.au=Swanson%2C+Kena&amp;rft.au=Li%2C+Ping&amp;rft.au=Koury%2C+Kenneth&amp;rft.au=Kalina%2C+Warren&amp;rft.au=Cooper%2C+David&amp;rft.au=Fonter-Garfias%2C+Camila&amp;rft.au=Shi%2C+Pei-Yong&amp;rft.au=Tuereci%2C+Ozlem&amp;rft.au=Tompkins%2C+Kristin&amp;rft.au=Walsh%2C+Edward&amp;rft.au=Frenck%2C+Robert&amp;rft.au=Falsey%2C+Ann&amp;rft.au=Dormitzer%2C+Philip&amp;rft.au=Gruber%2C+William&amp;rft.au=Sahin%2C+Ugur&amp;rft.au=Jansen%2C+Kathrin&amp;rft_id=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2020.06.30.20142570v1.full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-110\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-110\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFSahinMuikDerhovanessianVogler2020\" class=\"citation journal cs1\">Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M,  et al. (2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.medrxiv.org/content/10.1101/2020.07.17.20140533v1.full.pdf\">\"Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>MedRxiv</i> (<a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>). <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2F2020.07.17.20140533\">10.1101/2020.07.17.20140533</a></span>. <a rel=\"nofollow\" class=\"external text\" href=\"https://blogs.sciencemag.org/pipeline/archives/2020/07/20/more-pfizer-phase-i-results-antibodies-viral-mutations-and-t-cells\">Lay summary</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MedRxiv&amp;rft.atitle=Concurrent+human+antibody+and+TH1+type+T-cell+responses+elicited+by+a+COVID-19+RNA+vaccine&amp;rft.date=2020&amp;rft_id=info%3Adoi%2F10.1101%2F2020.07.17.20140533&amp;rft.aulast=Sahin&amp;rft.aufirst=Ugur&amp;rft.au=Muik%2C+Alexander&amp;rft.au=Derhovanessian%2C+Evelyna&amp;rft.au=Vogler%2C+Isabel&amp;rft.au=Kranz%2C+Lena+M&amp;rft.au=Vormehr%2C+Mathias&amp;rft.au=Baum%2C+Alina&amp;rft.au=Pascal%2C+Kristen&amp;rft.au=Quandt%2C+Jasmin&amp;rft.au=Maurus%2C+Daniel&amp;rft.au=Brachtendorf%2C+Sebastian&amp;rft.au=Loerks%2C+Verena+L&amp;rft.au=Sikorski%2C+Julian&amp;rft.au=Hilker%2C+Rolf&amp;rft.au=Becker%2C+Dirk&amp;rft.au=Eller%2C+Ann-Kathrin&amp;rft.au=Gruetzner%2C+Jan&amp;rft.au=Boesler%2C+Carsten&amp;rft.au=Rosenbaum%2C+Corinna&amp;rft.au=Kuehnle%2C+Marie-Cristine&amp;rft.au=Luxemburger%2C+Ulrich&amp;rft.au=Kemmer-Brueck%2C+Alexandra&amp;rft.au=Langer%2C+David&amp;rft.au=Bexon%2C+Martin&amp;rft.au=Bolte%2C+Stefanie&amp;rft.au=Kariko%2C+Katalin&amp;rft.au=Palanche%2C+Tania&amp;rft.au=Fischer%2C+Boris&amp;rft.au=Schultz%2C+Armin&amp;rft.au=Shi%2C+Pei-Yong&amp;rft.au=Fontes-Garfias%2C+Camila&amp;rft.au=Perez%2C+John+L&amp;rft.au=Swanson%2C+Kena+A&amp;rft.au=Loschko%2C+Jakob&amp;rft.au=Scully%2C+Ingrid+L&amp;rft.au=Cutler%2C+Mark&amp;rft.au=Kalina%2C+Warren&amp;rft.au=Kyratsous%2C+Christos+A&amp;rft.au=Cooper%2C+David&amp;rft.au=Dormitzer%2C+Philip+R&amp;rft.au=Jansen%2C+Kathrin+U&amp;rft.au=Tuereci%2C+Oezlem&amp;rft_id=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2020.07.17.20140533v1.full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04470427-111\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04470427_111-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04470427\">\"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 14 July 2020. NCT04470427<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Study+to+Evaluate+Efficacy%2C+Safety%2C+and+Immunogenicity+of+mRNA-1273+Vaccine+in+Adults+Aged+18+Years+and+Older+to+Prevent+COVID-19&amp;rft.date=2020-07-14&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04470427&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-palca-112\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-palca_112-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFPalca2020\" class=\"citation news cs1\">Palca J (27 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people\">\"COVID-19 vaccine candidate heads to widespread testing in U.S.\"</a> <i>NPR</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NPR&amp;rft.atitle=COVID-19+vaccine+candidate+heads+to+widespread+testing+in+U.S.&amp;rft.date=2020-07-27&amp;rft.aulast=Palca&amp;rft.aufirst=Joe&amp;rft_id=https%3A%2F%2Fwww.npr.org%2Fsections%2Fcoronavirus-live-updates%2F2020%2F07%2F27%2F895672859%2Fus-vaccine-candidate-heads-to-widespread-testing-in-people&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-jackson-113\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-jackson_113-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFJacksonAndersonRouphaelRoberts2020\" class=\"citation journal cs1\">Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN,  et al. (mRNA-1273 Study Group) (July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7377258\">\"An mRNA Vaccine against SARS-CoV-2 \\xe2\\x80\\x93 Preliminary Report\"</a>. <i>New England Journal of Medicine</i>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1056%2FNEJMoa2022483\">10.1056/NEJMoa2022483</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7377258\">7377258</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32663912\">32663912</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/2020/07/14/moderna-covid19-vaccine-first-data-show-spurs-immune-response/\">Lay summary</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=An+mRNA+Vaccine+against+SARS-CoV-2+%E2%80%93+Preliminary+Report&amp;rft.date=2020-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7377258&amp;rft_id=info%3Apmid%2F32663912&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa2022483&amp;rft.aulast=Jackson&amp;rft.aufirst=LA&amp;rft.au=Anderson%2C+EJ&amp;rft.au=Rouphael%2C+NG&amp;rft.au=Roberts%2C+PC&amp;rft.au=Makhene%2C+M&amp;rft.au=Coler%2C+RN&amp;rft.au=McCullough%2C+MP&amp;rft.au=Chappell%2C+JD&amp;rft.au=Denison%2C+MR&amp;rft.au=Stevens%2C+LJ&amp;rft.au=Pruijssers%2C+AJ&amp;rft.au=McDermott%2C+A&amp;rft.au=Flach%2C+B&amp;rft.au=Doria-Rose%2C+NA&amp;rft.au=Corbett%2C+KS&amp;rft.au=Morabito%2C+KM&amp;rft.au=O%27Dell%2C+S&amp;rft.au=Schmidt%2C+SD&amp;rft.au=Swanson%2C+PA&amp;rft.au=Padilla%2C+M&amp;rft.au=Mascola%2C+JR&amp;rft.au=Neuzil%2C+KM&amp;rft.au=Bennett%2C+H&amp;rft.au=Sun%2C+W&amp;rft.au=Peters%2C+E&amp;rft.au=Makowski%2C+M&amp;rft.au=Albert%2C+J&amp;rft.au=Cross%2C+K&amp;rft.au=Buchanan%2C+W&amp;rft.au=Pikaart-Tautges%2C+R&amp;rft.au=Ledgerwood%2C+JE&amp;rft.au=Graham%2C+BS&amp;rft.au=Beigel%2C+JH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7377258&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-jackson-app-114\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-jackson-app_114-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFJacksonAndersonRouphaelRoberts2020\" class=\"citation journal cs1\">Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN,  et al. (mRNA-1273 Study Group) (July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nejm.org/doi/suppl/10.1056/NEJMoa2022483/suppl_file/nejmoa2022483_appendix.pdf\">\"An mRNA Vaccine against SARS-CoV-2 \\xe2\\x80\\x93 Preliminary Report Supplementary appendix\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>New England Journal of Medicine</i>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1056%2FNEJMoa2022483\">10.1056/NEJMoa2022483</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32663912\">32663912</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=An+mRNA+Vaccine+against+SARS-CoV-2+%E2%80%93+Preliminary+Report+Supplementary+appendix&amp;rft.date=2020-07&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa2022483&amp;rft_id=info%3Apmid%2F32663912&amp;rft.aulast=Jackson&amp;rft.aufirst=LA&amp;rft.au=Anderson%2C+EJ&amp;rft.au=Rouphael%2C+NG&amp;rft.au=Roberts%2C+PC&amp;rft.au=Makhene%2C+M&amp;rft.au=Coler%2C+RN&amp;rft.au=McCullough%2C+MP&amp;rft.au=Chappell%2C+JD&amp;rft.au=Denison%2C+MR&amp;rft.au=Stevens%2C+LJ&amp;rft.au=Pruijssers%2C+AJ&amp;rft.au=McDermott%2C+A&amp;rft.au=Flach%2C+B&amp;rft.au=Doria-Rose%2C+NA&amp;rft.au=Corbett%2C+KS&amp;rft.au=Morabito%2C+KM&amp;rft.au=O%27Dell%2C+S&amp;rft.au=Schmidt%2C+SD&amp;rft.au=Swanson%2C+PA&amp;rft.au=Padilla%2C+M&amp;rft.au=Mascola%2C+JR&amp;rft.au=Neuzil%2C+KM&amp;rft.au=Bennett%2C+H&amp;rft.au=Sun%2C+W&amp;rft.au=Peters%2C+E&amp;rft.au=Makowski%2C+M&amp;rft.au=Albert%2C+J&amp;rft.au=Cross%2C+K&amp;rft.au=Buchanan%2C+W&amp;rft.au=Pikaart-Tautges%2C+R&amp;rft.au=Ledgerwood%2C+JE&amp;rft.au=Graham%2C+BS&amp;rft.au=Beigel%2C+JH&amp;rft_id=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Fsuppl%2F10.1056%2FNEJMoa2022483%2Fsuppl_file%2Fnejmoa2022483_appendix.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-115\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-115\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04530396?term=vaccine&amp;cond=covid-19&amp;draw=3\">\"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19\"</a>. <i>clinicaltrials.gov</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=Clinical+Trial+of+Efficacy%2C+Safety%2C+and+Immunogenicity+of+Gam-COVID-Vac+Vaccine+Against+COVID-19&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04530396%3Fterm%3Dvaccine%26cond%3Dcovid-19%26draw%3D3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-logunov-116\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-logunov_116-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFLogunovDolzhikovaothers2020\" class=\"citation journal cs1\">Logunov, Denis Y; Dolzhikova, Inna V; others (2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31866-3/fulltext\">\"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia\"</a>. <i>The Lancet</i>. <b>396</b> (10255): 887\\xe2\\x80\\x9397. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fs0140-6736%2820%2931866-3\">10.1016/s0140-6736(20)31866-3</a></span>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0140-6736\">0140-6736</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32896291\">32896291</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221472251\">221472251</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Safety+and+immunogenicity+of+an+rAd26+and+rAd5+vector-based+heterologous+prime-boost+COVID-19+vaccine+in+two+formulations%3A+two+open%2C+non-randomised+phase+1%2F2+studies+from+Russia&amp;rft.volume=396&amp;rft.issue=10255&amp;rft.pages=887-97&amp;rft.date=2020&amp;rft.issn=0140-6736&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221472251&amp;rft_id=info%3Apmid%2F32896291&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2820%2931866-3&amp;rft.aulast=Logunov&amp;rft.aufirst=Denis+Y&amp;rft.au=Dolzhikova%2C+Inna+V&amp;rft.au=others&amp;rft_id=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2820%2931866-3%2Ffulltext&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-117\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-117\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04436276\">\"A Study of Ad26.COV2.S in Adults\"</a>. ClinicalTrials.gov, US National Library of Medicine. 4 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Study+of+Ad26.COV2.S+in+Adults&amp;rft.pub=ClinicalTrials.gov%2C+US+National+Library+of+Medicine&amp;rft.date=2020-08-04&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04436276&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-118\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-118\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFSadoffLe_GarsShukarevHeerwegh2020\" class=\"citation journal cs1\">Sadoff, Jerry; Le Gars, Mathieu; Shukarev, Georgi; Heerwegh, Dirk; Truyers, Carla; de Groot, Anna Marit; Stoop, Jeroen; Tete, Sarah; Van Damme, Wim; Leroux-Roels, Isabel; Berghmans, Pieter-Jan (25 September 2020). <a rel=\"nofollow\" class=\"external text\" href=\"http://medrxiv.org/lookup/doi/10.1101/2020.09.23.20199604\">\"Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial\"</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2F2020.09.23.20199604\">10.1101/2020.09.23.20199604</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221882008\">221882008</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Safety+and+immunogenicity+of+the+Ad26.COV2.S+COVID-19+vaccine+candidate%3A+interim+results+of+a+phase+1%2F2a%2C+double-blind%2C+randomized%2C+placebo-controlled+trial&amp;rft.date=2020-09-25&amp;rft_id=info%3Adoi%2F10.1101%2F2020.09.23.20199604&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221882008&amp;rft.aulast=Sadoff&amp;rft.aufirst=Jerry&amp;rft.au=Le+Gars%2C+Mathieu&amp;rft.au=Shukarev%2C+Georgi&amp;rft.au=Heerwegh%2C+Dirk&amp;rft.au=Truyers%2C+Carla&amp;rft.au=de+Groot%2C+Anna+Marit&amp;rft.au=Stoop%2C+Jeroen&amp;rft.au=Tete%2C+Sarah&amp;rft.au=Van+Damme%2C+Wim&amp;rft.au=Leroux-Roels%2C+Isabel&amp;rft.au=Berghmans%2C+Pieter-Jan&amp;rft_id=http%3A%2F%2Fmedrxiv.org%2Flookup%2Fdoi%2F10.1101%2F2020.09.23.20199604&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span> <span class=\"cs1-hidden-error error citation-comment\">Cite journal requires <code class=\"cs1-code\">&#124;journal=</code> (<a href=\"/wiki/Help:CS1_errors#missing_periodical\" title=\"Help:CS1 errors\">help</a>)</span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-119\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-119\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04505722\">\"A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants\"</a>. <i>ClinicalTrials.gov</i>. US National Library of Medicine.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Study+of+Ad26.COV2.S+for+the+Prevention+of+SARS-CoV-2-Mediated+COVID-19+in+Adult+Participants&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04505722&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-120\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-120\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.jnj.com/our-company/johnson-johnson-temporarily-pauses-all-dosing-in-our-janssen-covid-19-vaccine-candidate-clinical-trials\">\"Johnson &amp; Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+Temporarily+Pauses+All+Dosing+in+Our+Janssen+COVID-19+Vaccine+Candidate+Clinical+Trials&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Four-company%2Fjohnson-johnson-temporarily-pauses-all-dosing-in-our-janssen-covid-19-vaccine-candidate-clinical-trials&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04445194-121\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04445194_121-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04445194\">\"Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 24 June 2020. NCT04445194<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Phase+I+Clinical+Study+of+Recombinant+Novel+Coronavirus+Vaccine&amp;rft.date=2020-06-24&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04445194&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04466085-122\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04466085_122-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04466085\">\"A Randomized, Blinded, Placebo-controlled Trial to Evaluate the Immunogenicity and Safety of a Recombinant New Coronavirus Vaccine (CHO Cell) With Different Doses and Different Immunization Procedures in Healthy People Aged 18 to 59 Years\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 10 July 2020. NCT04466085<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Randomized%2C+Blinded%2C+Placebo-controlled+Trial+to+Evaluate+the+Immunogenicity+and+Safety+of+a+Recombinant+New+Coronavirus+Vaccine+%28CHO+Cell%29+With+Different+Doses+and+Different+Immunization+Procedures+in+Healthy+People+Aged+18+to+59+Years&amp;rft.date=2020-07-10&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04466085&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04449276-123\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04449276_123-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04449276\">\"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults\"</a>. ClinicalTrials.gov, US National Library of Medicine. 26 June 2020. NCT04449276<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Study+to+Evaluate+the+Safety%2C+Reactogenicity+and+Immunogenicity+of+Vaccine+CVnCoV+in+Healthy+Adults&amp;rft.pub=ClinicalTrials.gov%2C+US+National+Library+of+Medicine&amp;rft.date=2020-06-26&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04449276&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04515147-124\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04515147_124-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04515147\">\"A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults\"</a>. ClinicalTrials.gov, US National Library of Medicine. 17 August 2020. NCT04515147<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Dose-Confirmation+Study+to+Evaluate+the+Safety%2C+Reactogenicity+and+Immunogenicity+of+Vaccine+CVnCoV+in+Healthy+Adults&amp;rft.pub=ClinicalTrials.gov%2C+US+National+Library+of+Medicine&amp;rft.date=2020-08-17&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04515147&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04368988-125\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04368988_125-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04368988\">\"Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 30 April 2020. NCT04368988<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Evaluation+of+the+Safety+and+Immunogenicity+of+a+SARS-CoV-2+rS+%28COVID-19%29+Nanoparticle+Vaccine+With%2FWithout+Matrix-M+Adjuvant&amp;rft.date=2020-04-30&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04368988&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-126\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-126\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.novavax.com/download/files/2020.08.04NVXCoV2373Phase1ClinicalResults.pdf\">\"NVX-CoV2373 COVID-19 Vaccine Candidate Phase 1/2, Part 1, Clinical Trial Results\"</a> <span class=\"cs1-format\">(PDF)</span>. 4 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 August</span> 2020</span>. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/08/04/health/covid-19-vaccine-novavax.html?searchResultPosition=4\">Lay summary</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NVX-CoV2373+COVID-19+Vaccine+Candidate+Phase+1%2F2%2C+Part+1%2C+Clinical+Trial+Results&amp;rft.date=2020-08-04&amp;rft_id=https%3A%2F%2Fwww.novavax.com%2Fdownload%2Ffiles%2F2020.08.04NVXCoV2373Phase1ClinicalResults.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-127\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-127\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFKeechAlbertReedNeal2020\" class=\"citation journal cs1\">Keech, Cheryl; Albert, Gary; Reed, Patricia; Neal, Susan; Plested, Joyce; Zhu, Mingzhu;  et al. (6 August 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.medrxiv.org/content/10.1101/2020.08.05.20168435v1.full.pdf\">\"First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>MedRxiv</i> (<a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>). <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1101%2F2020.08.05.20168435\">10.1101/2020.08.05.20168435</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221004959\">221004959</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">7 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MedRxiv&amp;rft.atitle=First-in-Human+Trial+of+a+SARS+CoV+2+Recombinant+Spike+Protein+Nanoparticle+Vaccine&amp;rft.date=2020-08-06&amp;rft_id=info%3Adoi%2F10.1101%2F2020.08.05.20168435&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221004959&amp;rft.aulast=Keech&amp;rft.aufirst=Cheryl&amp;rft.au=Albert%2C+Gary&amp;rft.au=Reed%2C+Patricia&amp;rft.au=Neal%2C+Susan&amp;rft.au=Plested%2C+Joyce&amp;rft.au=Zhu%2C+Mingzhu&amp;rft.au=Cloney-Clark%2C+Shane&amp;rft.au=Zhou%2C+Haixia&amp;rft.au=Patel%2C+Nita&amp;rft.au=Frieman%2C+Matthew&amp;rft.au=Haupt%2C+Robert&amp;rft.au=Logue%2C+James&amp;rft.au=McGrath%2C+Marisa&amp;rft.au=Weston%2C+Stuart&amp;rft.au=Piedra%2C+Pedro&amp;rft.au=Cho%2C+Iksung&amp;rft.au=Robertson%2C+Andreana&amp;rft.au=Desai%2C+Chinar&amp;rft.au=Callahan%2C+Kathleen&amp;rft.au=Lewis%2C+Maggie&amp;rft.au=Price-Abbott%2C+Patricia&amp;rft.au=Formica%2C+Neil&amp;rft.au=Shinde%2C+Vivek&amp;rft.au=Fries%2C+Louis&amp;rft.au=Linkliter%2C+Jason&amp;rft.au=Griffin%2C+Paul&amp;rft.au=Wilkinson%2C+Bethanie&amp;rft.au=Smith%2C+Gale&amp;rft.au=Glenn%2C+Gregory&amp;rft_id=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2020.08.05.20168435v1.full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04336410-129\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04336410_129-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04336410\">\"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 7 April 2020. NCT04336410<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety%2C+Tolerability+and+Immunogenicity+of+INO-4800+for+COVID-19+in+Healthy+Volunteers&amp;rft.date=2020-04-07&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04336410&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-130\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-130\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ivi.int/ivi-inovio-and-knih-to-partner-with-cepi-in-a-phase-i-ii-clinical-trial-of-inovios-covid-19-dna-vaccine-in-south-korea/\">\"IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO\\'s COVID-19 DNA vaccine in South Korea\"</a>. International Vaccine Institute. 16 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=IVI%2C+INOVIO%2C+and+KNIH+to+partner+with+CEPI+in+a+Phase+I%2FII+clinical+trial+of+INOVIO%27s+COVID-19+DNA+vaccine+in+South+Korea&amp;rft.pub=International+Vaccine+Institute&amp;rft.date=2020-04-16&amp;rft_id=https%3A%2F%2Fwww.ivi.int%2Fivi-inovio-and-knih-to-partner-with-cepi-in-a-phase-i-ii-clinical-trial-of-inovios-covid-19-dna-vaccine-in-south-korea%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04412538-131\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04412538_131-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04412538\">\"Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 2 June 2020. NCT04412538<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety+and+Immunogenicity+Study+of+an+Inactivated+SARS-CoV-2+Vaccine+for+Preventing+Against+COVID-19&amp;rft.date=2020-06-02&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04412538&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04463472-132\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04463472_132-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04463472\">\"Study of COVID-19 DNA Vaccine (AG0301-COVID19)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 9 July 2020. NCT04463472<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Study+of+COVID-19+DNA+Vaccine+%28AG0301-COVID19%29&amp;rft.date=2020-07-09&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04463472&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-anges-inc-133\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-anges-inc_133-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.anges.co.jp/en/company/index.html\">\"About AnGes \\xe2\\x80\\x93 Introduction\"</a>. <i>AnGes, Inc</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=AnGes%2C+Inc.&amp;rft.atitle=About+AnGes+%E2%80%93+Introduction&amp;rft_id=https%3A%2F%2Fwww.anges.co.jp%2Fen%2Fcompany%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-134\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-134\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bioindustry.org/news-listing/cti-and-arcturus-therapeutics-announce-initiation-of-dosing-of-covid-19-starr-mrna-vaccine-candidate-lunar-cov19-arct-021-in-a-phase-12-study.html\">\"CTI and Arcturus Therapeutics Announce Initiation of Dosing of COVID-19 STARR\\xe2\\x84\\xa2 mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study\"</a>. UK BioIndustry Association. 13 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CTI+and+Arcturus+Therapeutics+Announce+Initiation+of+Dosing+of+COVID-19+STARR%E2%84%A2+mRNA+Vaccine+Candidate%2C+LUNAR-COV19+%28ARCT-021%29+in+a+Phase+1%2F2+study&amp;rft.pub=UK+BioIndustry+Association&amp;rft.date=2020-08-13&amp;rft_id=https%3A%2F%2Fwww.bioindustry.org%2Fnews-listing%2Fcti-and-arcturus-therapeutics-announce-initiation-of-dosing-of-covid-19-starr-mrna-vaccine-candidate-lunar-cov19-arct-021-in-a-phase-12-study.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-135\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-135\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04480957\">\"Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects\"</a>. <i>clinicaltrials.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=Ascending+Dose+Study+of+Investigational+SARS-CoV-2+Vaccine+ARCT-021+in+Healthy+Adult+Subjects&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04480957&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04299724-136\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04299724_136-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04299724\">\"Safety and Immunity of Covid-19 aAPC Vaccine\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 9 March 2020. NCT04299724<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety+and+Immunity+of+Covid-19+aAPC+Vaccine&amp;rft.date=2020-03-09&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04299724&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-shenzhen-genoimmune-medical-institute-137\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-shenzhen-genoimmune-medical-institute_137-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-shenzhen-genoimmune-medical-institute_137-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.szgimi.org/en/about.php\">\"About Us\"</a>. <i>Shenzhen Genoimmune Medical Institute</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Shenzhen+Genoimmune+Medical+Institute&amp;rft.atitle=About+Us&amp;rft_id=http%3A%2F%2Fwww.szgimi.org%2Fen%2Fabout.php&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04276896-138\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04276896_138-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04276896\">\"Immunity and Safety of Covid-19 Synthetic Minigene Vaccine\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 19 February 2020. NCT04276896<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Immunity+and+Safety+of+Covid-19+Synthetic+Minigene+Vaccine&amp;rft.date=2020-02-19&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04276896&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-ISRCTN17072692-139\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ISRCTN17072692_139-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFWardMcCormack2020\" class=\"citation journal cs1\">Ward D, McCormack S (22 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.isrctn.com/ISRCTN17072692\">\"Clinical trial to assess the safety of a coronavirus vaccine in healthy men and women\"</a>. <i>ISRCTN</i> (Registry). <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186%2FISRCTN17072692\">10.1186/ISRCTN17072692</a></span>. ISRCTN17072692<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ISRCTN&amp;rft.atitle=Clinical+trial+to+assess+the+safety+of+a+coronavirus+vaccine+in+healthy+men+and+women&amp;rft.date=2020-05-22&amp;rft_id=info%3Adoi%2F10.1186%2FISRCTN17072692&amp;rft.aulast=Ward&amp;rft.aufirst=Denise&amp;rft.au=McCormack%2C+Sheena&amp;rft_id=https%3A%2F%2Fwww.isrctn.com%2FISRCTN17072692&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04445389-140\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04445389_140-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04445389\">\"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 24 June 2020. NCT04445389<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety+and+Immunogenicity+Study+of+GX-19%2C+a+COVID-19+Preventive+DNA+Vaccine+in+Healthy+Adults&amp;rft.date=2020-06-24&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04445389&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-gen-reut-141\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-gen-reut_141-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/health-coronavirus-genexine-vaccine-idUSL4N2DW1T3\">\"S. Korea\\'s Genexine begins human trial of coronavirus vaccine\"</a>. <i>Reuters</i>. 19 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=S.+Korea%27s+Genexine+begins+human+trial+of+coronavirus+vaccine&amp;rft.date=2020-06-19&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fhealth-coronavirus-genexine-vaccine-idUSL4N2DW1T3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-142\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-142\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ivi.int/genexine-consortiums-covid-19-vaccine-acquires-approval-for-clinical-trails-in-korea/\">\"Genexine consortium\\'s Covid-19 vaccine acquires approval for clinical trails in Korea\"</a>. 11 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Genexine+consortium%27s+Covid-19+vaccine+acquires+approval+for+clinical+trails+in+Korea&amp;rft.date=2020-06-11&amp;rft_id=https%3A%2F%2Fwww.ivi.int%2Fgenexine-consortiums-covid-19-vaccine-acquires-approval-for-clinical-trails-in-korea%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04405908-143\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04405908_143-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04405908\">\"SCB-2019 as COVID-19 Vaccine\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 28 May 2020. NCT04405908<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=SCB-2019+as+COVID-19+Vaccine&amp;rft.date=2020-05-28&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04405908&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-clover-cta-144\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-clover-cta_144-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.clinicaltrialsarena.com/news/clover-vaccine-covid-19-trial/\">\"Clover Biopharmaceuticals starts Phase I Covid-19 vaccine trial\"</a>. Clinical Trials Arena. 20 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Clover+Biopharmaceuticals+starts+Phase+I+Covid-19+vaccine+trial&amp;rft.pub=Clinical+Trials+Arena&amp;rft.date=2020-06-20&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsarena.com%2Fnews%2Fclover-vaccine-covid-19-trial%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-clover-biopharma-145\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-clover-biopharma_145-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cloverbiopharma.com/index.php?m=content&amp;c=index&amp;a=lists&amp;catid=12\">\"About Us\"</a>. <i>Clover Biopharmaceuticals</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Clover+Biopharmaceuticals&amp;rft.atitle=About+Us&amp;rft_id=http%3A%2F%2Fwww.cloverbiopharma.com%2Findex.php%3Fm%3Dcontent%26c%3Dindex%26a%3Dlists%26catid%3D12&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04453852-146\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04453852_146-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04453852\">\"Monovalent Recombinant COVID19 Vaccine (COVAX19)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 1 July 2020. NCT04453852<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Monovalent+Recombinant+COVID19+Vaccine+%28COVAX19%29&amp;rft.date=2020-07-01&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04453852&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-vaxine-pty-147\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-vaxine-pty_147-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://vaxine.net/\">\"Vaxine\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaxine&amp;rft_id=http%3A%2F%2Fvaxine.net%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-ChiCTR2000034112-148\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ChiCTR2000034112_148-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.chictr.org.cn/showprojen.aspx?proj=55524\">\"A Phase I clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a SARS-CoV-2 mRNA vaccine in population aged 18\\xe2\\x80\\x9359 years and 60 years and above\"</a>. <i>Chinese Clinical Trial Register</i> (Registry). 24 June 2020. ChiCTR2000034112<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Chinese+Clinical+Trial+Register&amp;rft.atitle=A+Phase+I+clinical+trial+to+evaluate+the+safety%2C+tolerance+and+preliminary+immunogenicity+of+different+doses+of+a+SARS-CoV-2+mRNA+vaccine+in+population+aged+18%E2%80%9359+years+and+60+years+and+above&amp;rft.date=2020-06-24&amp;rft_id=http%3A%2F%2Fwww.chictr.org.cn%2Fshowprojen.aspx%3Fproj%3D55524&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-walvax-149\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-walvax_149-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.walvax.com/wosen/28.aspx\">\"Company introduction\"</a>. <i>Walvax Biotechnology</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Walvax+Biotechnology&amp;rft.atitle=Company+introduction&amp;rft_id=http%3A%2F%2Fwww.walvax.com%2Fwosen%2F28.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04450004-150\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04450004_150-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04450004\">\"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 29 June 2020. NCT04450004<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety%2C+Tolerability+and+Immunogenicinity+of+a+Coronavirus-Like+Particle+COVID-19+Vaccine+in+Adults+Aged+18-55+Years&amp;rft.date=2020-06-29&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04450004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-ctv-medicago-151\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ctv-medicago_151-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFSt._PhilipFavaroMacLeod2020\" class=\"citation news cs1\">St Philip E, Favaro A, MacLeod M (14 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ctvnews.ca/health/coronavirus/the-hunt-for-a-vaccine-canadian-company-begins-human-testing-of-covid-19-candidate-1.5022960\">\"The hunt for a vaccine: Canadian company begins human testing of COVID-19 candidate\"</a>. <i>CTV News</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CTV+News&amp;rft.atitle=The+hunt+for+a+vaccine%3A+Canadian+company+begins+human+testing+of+COVID-19+candidate&amp;rft.date=2020-07-14&amp;rft.aulast=St.+Philip&amp;rft.aufirst=Elizabeth&amp;rft.au=Favaro%2C+Avis&amp;rft.au=MacLeod%2C+Meredith&amp;rft_id=https%3A%2F%2Fwww.ctvnews.ca%2Fhealth%2Fcoronavirus%2Fthe-hunt-for-a-vaccine-canadian-company-begins-human-testing-of-covid-19-candidate-1.5022960&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-medicago-about-152\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-medicago-about_152-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.medicago.com/en/about-us/\">\"About Us\"</a>. <i>Medicago</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medicago&amp;rft.atitle=About+Us&amp;rft_id=https%3A%2F%2Fwww.medicago.com%2Fen%2Fabout-us%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-np-medicago-153\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-np-medicago_153-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFChander2020\" class=\"citation news cs1\">Chander V (14 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://nationalpost.com/news/canada/canadas-medicago-begins-human-trials-of-plant-based-covid-19-vaccine\">\"Canada\\'s Medicago begins human trials of plant-based COVID-19 vaccine\"</a>. <i>National Post</i>. Reuters<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=National+Post&amp;rft.atitle=Canada%27s+Medicago+begins+human+trials+of+plant-based+COVID-19+vaccine&amp;rft.date=2020-07-14&amp;rft.aulast=Chander&amp;rft.aufirst=Vishwadha&amp;rft_id=https%3A%2F%2Fnationalpost.com%2Fnews%2Fcanada%2Fcanadas-medicago-begins-human-trials-of-plant-based-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04495933-155\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04495933_155-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04495933\">\"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 3 August 2020. NCT04495933<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Study+on+the+Safety%2C+Tolerability+and+Immune+Response+of+SARS-CoV-2+Sclamp+%28COVID-19%29+Vaccine+in+Healthy+Adults&amp;rft.date=2020-08-03&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04495933&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-scientists-156\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-scientists_156-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development\">\"Public statement for collaboration on COVID-19 vaccine development\"</a>. World Health Organization. 13 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200420214124/https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development\">Archived</a> from the original on 20 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Public+statement+for+collaboration+on+COVID-19+vaccine+development&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-04-13&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fdetail%2F13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-gouglas-157\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gouglas_157-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gouglas_157-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-gouglas_157-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-gouglas_157-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFGouglasThanh_LeHendersonKaloudis2018\" class=\"citation journal cs1\">Gouglas D, Thanh Le T, Henderson K, Kaloudis A, Danielsen T, Hammersland NC, Robinson JM, Heaton PM, R\\xc3\\xb8ttingen JA (December 2018). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7164811\">\"Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study\"</a>. <i>Lancet Global Health</i>. <b>6</b> (12): e1386\\xe2\\x80\\x9396. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS2214-109X%2818%2930346-2\">10.1016/S2214-109X(18)30346-2</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7164811\">7164811</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/30342925\">30342925</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet+Global+Health&amp;rft.atitle=Estimating+the+cost+of+vaccine+development+against+epidemic+infectious+diseases%3A+a+cost+minimisation+study&amp;rft.volume=6&amp;rft.issue=12&amp;rft.pages=e1386-96&amp;rft.date=2018-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7164811&amp;rft_id=info%3Apmid%2F30342925&amp;rft_id=info%3Adoi%2F10.1016%2FS2214-109X%2818%2930346-2&amp;rft.aulast=Gouglas&amp;rft.aufirst=D&amp;rft.au=Thanh+Le%2C+T&amp;rft.au=Henderson%2C+K&amp;rft.au=Kaloudis%2C+A&amp;rft.au=Danielsen%2C+T&amp;rft.au=Hammersland%2C+NC&amp;rft.au=Robinson%2C+JM&amp;rft.au=Heaton%2C+PM&amp;rft.au=R%C3%B8ttingen%2C+JA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7164811&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-strovel-158\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-strovel_158-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFStrovelSittampalamCoussensHughes2016\" class=\"citation book cs1\">Strovel J, Sittampalam S, Coussens NP, Hughes M, Inglese J, Kurtz A,  et al. (1 July 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK92015/\">\"Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies\"</a>. <i>Assay Guidance Manual</i>. Eli Lilly &amp; Company and the National Center for Advancing Translational Sciences. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/22553881\">22553881</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Early+Drug+Discovery+and+Development+Guidelines%3A+For+Academic+Researchers%2C+Collaborators%2C+and+Start-up+Companies&amp;rft.btitle=Assay+Guidance+Manual&amp;rft.pub=Eli+Lilly+%26+Company+and+the+National+Center+for+Advancing+Translational+Sciences&amp;rft.date=2016-07-01&amp;rft_id=info%3Apmid%2F22553881&amp;rft.aulast=Strovel&amp;rft.aufirst=J&amp;rft.au=Sittampalam%2C+S&amp;rft.au=Coussens%2C+NP&amp;rft.au=Hughes%2C+M&amp;rft.au=Inglese%2C+J&amp;rft.au=Kurtz%2C+A&amp;rft.au=Andalibi%2C+A&amp;rft.au=Patton%2C+L&amp;rft.au=Austin%2C+C&amp;rft.au=Baltezor%2C+M&amp;rft.au=Beckloff%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK92015%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-dimasi-159\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-dimasi_159-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFDiMasiGrabowskiHansen2016\" class=\"citation journal cs1\">DiMasi JA, Grabowski HG, Hansen RW (May 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://dukespace.lib.duke.edu/dspace/bitstream/handle/10161/12742/DiMasi-Grabowski-Hansen-RnD-JHE-2016.pdf;sequence=1\">\"Innovation in the pharmaceutical industry: New estimates of R&amp;D costs\"</a>. <i>Journal of Health Economics</i>. <b>47</b>: 20\\xe2\\x80\\x9333. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.jhealeco.2016.01.012\">10.1016/j.jhealeco.2016.01.012</a>. <a href=\"/wiki/Hdl_(identifier)\" class=\"mw-redirect\" title=\"Hdl (identifier)\">hdl</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//hdl.handle.net/10161%2F12742\">10161/12742</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26928437\">26928437</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20191205042228/https://dukespace.lib.duke.edu/dspace/bitstream/handle/10161/12742/DiMasi-Grabowski-Hansen-RnD-JHE-2016.pdf;sequence=1\">Archived</a> from the original on 5 December 2019<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">21 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Health+Economics&amp;rft.atitle=Innovation+in+the+pharmaceutical+industry%3A+New+estimates+of+R%26D+costs&amp;rft.volume=47&amp;rft.pages=20-33&amp;rft.date=2016-05&amp;rft_id=info%3Ahdl%2F10161%2F12742&amp;rft_id=info%3Apmid%2F26928437&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhealeco.2016.01.012&amp;rft.aulast=DiMasi&amp;rft.aufirst=JA&amp;rft.au=Grabowski%2C+HG&amp;rft.au=Hansen%2C+RW&amp;rft_id=https%3A%2F%2Fdukespace.lib.duke.edu%2Fdspace%2Fbitstream%2Fhandle%2F10161%2F12742%2FDiMasi-Grabowski-Hansen-RnD-JHE-2016.pdf%3Bsequence%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-Kleinnijenhuis_2015-160\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Kleinnijenhuis_2015_160-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFKleinnijenhuisvan_CrevelNetea2015\" class=\"citation journal cs1\">Kleinnijenhuis J, van Crevel R, Netea MG (January 2015). \"Trained immunity: consequences for the heterologous effects of BCG vaccination\". <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>. <b>109</b> (1): 29\\xe2\\x80\\x9335. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Ftrstmh%2Ftru168\">10.1093/trstmh/tru168</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/25573107\">25573107</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transactions+of+the+Royal+Society+of+Tropical+Medicine+and+Hygiene&amp;rft.atitle=Trained+immunity%3A+consequences+for+the+heterologous+effects+of+BCG+vaccination.&amp;rft.volume=109&amp;rft.issue=1&amp;rft.pages=29-35&amp;rft.date=2015-01&amp;rft_id=info%3Adoi%2F10.1093%2Ftrstmh%2Ftru168&amp;rft_id=info%3Apmid%2F25573107&amp;rft.aulast=Kleinnijenhuis&amp;rft.aufirst=J&amp;rft.au=van+Crevel%2C+R&amp;rft.au=Netea%2C+MG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-deVrieze-April-161\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-deVrieze-April_161-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFde_Vrieze2020\" class=\"citation journal cs1\">de Vrieze J (23 March 2020). \"Can a century-old TB vaccine steel the immune system against the new coronavirus?\". <i>Science</i>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abb8297\">10.1126/science.abb8297</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:216359131\">216359131</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Can+a+century-old+TB+vaccine+steel+the+immune+system+against+the+new+coronavirus%3F&amp;rft.date=2020-03-23&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abb8297&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A216359131&amp;rft.aulast=de+Vrieze&amp;rft.aufirst=Jop&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-162\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-162\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFO&#39;NeillNetea2020\" class=\"citation journal cs1\">O\\'Neill LA, Netea MG (June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7212510\">\"BCG-induced trained immunity: can it offer protection against COVID-19?\"</a>. <i>Nat. Rev. Immunol</i>. <b>20</b> (6): 335\\xe2\\x80\\x9337. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fs41577-020-0337-y\">10.1038/s41577-020-0337-y</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7212510\">7212510</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32393823\">32393823</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Rev.+Immunol.&amp;rft.atitle=BCG-induced+trained+immunity%3A+can+it+offer+protection+against+COVID-19%3F&amp;rft.volume=20&amp;rft.issue=6&amp;rft.pages=335-37&amp;rft.date=2020-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7212510&amp;rft_id=info%3Apmid%2F32393823&amp;rft_id=info%3Adoi%2F10.1038%2Fs41577-020-0337-y&amp;rft.aulast=O%27Neill&amp;rft.aufirst=LA&amp;rft.au=Netea%2C+MG&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7212510&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-163\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-163\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFEscobarMolina-CruzBarillas-Mury2020\" class=\"citation journal cs1\">Escobar LE, Molina-Cruz A, Barillas-Mury C (July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7395502\">\"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>117</b> (30): 17720\\xe2\\x80\\x9326. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.2008410117\">10.1073/pnas.2008410117</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7395502\">7395502</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32647056\">32647056</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BCG+vaccine+protection+from+severe+coronavirus+disease+2019+%28COVID-19%29&amp;rft.volume=117&amp;rft.issue=30&amp;rft.pages=17720-26&amp;rft.date=2020-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7395502&amp;rft_id=info%3Apmid%2F32647056&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.2008410117&amp;rft.aulast=Escobar&amp;rft.aufirst=LE&amp;rft.au=Molina-Cruz%2C+A&amp;rft.au=Barillas-Mury%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7395502&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-164\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-164\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFKotiMoralesGrahamSiemens2020\" class=\"citation journal cs1\">Koti M, Morales A, Graham CH, Siemens DR (July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7342862\">\"BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy\"</a>. <i>J Immunother Cancer</i>. <b>8</b> (2): e001119. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1136%2Fjitc-2020-001119\">10.1136/jitc-2020-001119</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7342862\">7342862</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32636240\">32636240</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Immunother+Cancer&amp;rft.atitle=BCG+vaccine+and+COVID-19%3A+implications+for+infection+prophylaxis+and+cancer+immunotherapy&amp;rft.volume=8&amp;rft.issue=2&amp;rft.pages=e001119&amp;rft.date=2020-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7342862&amp;rft_id=info%3Apmid%2F32636240&amp;rft_id=info%3Adoi%2F10.1136%2Fjitc-2020-001119&amp;rft.aulast=Koti&amp;rft.aufirst=M&amp;rft.au=Morales%2C+A&amp;rft.au=Graham%2C+CH&amp;rft.au=Siemens%2C+DR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7342862&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-165\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-165\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/news-room/commentaries/detail/bacille-calmette-gu%C3%A9rin-(bcg)-vaccination-and-covid-19\">\"Bacille Calmette-Gu\\xc3\\xa9rin (BCG) vaccination and COVID-19\"</a>. <i><a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> (WHO)</i>. 12 April 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200430121126/https://www.who.int/news-room/commentaries/detail/bacille-calmette-gu%C3%A9rin-(bcg)-vaccination-and-covid-19\">Archived</a> from the original on 30 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization+%28WHO%29&amp;rft.atitle=Bacille+Calmette-Gu%C3%A9rin+%28BCG%29+vaccination+and+COVID-19&amp;rft.date=2020-04-12&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fcommentaries%2Fdetail%2Fbacille-calmette-gu%25C3%25A9rin-%28bcg%29-vaccination-and-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-EudraCT-2020-000919-69-166\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EudraCT-2020-000919-69_166-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000919-69/NL\">\"Reducing health care workers absenteeism in SARS-CoV-2 pandemic by enhanced trained immune responses through Bacillus Calmette-Gu\\xc3\\xa9rin vaccination, a randomized controlled trial (COVID-19)\"</a>. <i>EU Clinical Trials Register</i> (Registry). European Union. 17 March 2020. <a href=\"/wiki/EudraCT\" title=\"EudraCT\">EudraCT</a> 2020-000919-69. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200404104902/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000919-69/NL\">Archived</a> from the original on 4 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EU+Clinical+Trials+Register&amp;rft.atitle=Reducing+health+care+workers+absenteeism+in+SARS-CoV-2+pandemic+by+enhanced+trained+immune+responses+through+Bacillus+Calmette-Gu%C3%A9rin+vaccination%2C+a+randomized+controlled+trial+%28COVID-19%29&amp;rft.date=2020-03-17&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsregister.eu%2Fctr-search%2Ftrial%2F2020-000919-69%2FNL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-MCRI-BCG-trial-167\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-MCRI-BCG-trial_167-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.mcri.edu.au/news/murdoch-children%E2%80%99s-research-institute-trial-preventative-vaccine-covid-19-healthcare-workers\">\"Murdoch Children\\'s Research Institute to trial preventative vaccine for COVID-19 healthcare workers\"</a>. <i>Murdoch Children\\'s Research Institute</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200413230625/https://www.mcri.edu.au/news/murdoch-children%2525E2%252580%252599s-research-institute-trial-preventative-vaccine-covid-19-healthcare-workers\">Archived</a> from the original on 13 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Murdoch+Children%27s+Research+Institute&amp;rft.atitle=Murdoch+Children%27s+Research+Institute+to+trial+preventative+vaccine+for+COVID-19+healthcare+workers&amp;rft_id=https%3A%2F%2Fwww.mcri.edu.au%2Fnews%2Fmurdoch-children%25E2%2580%2599s-research-institute-trial-preventative-vaccine-covid-19-healthcare-workers&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04327206-168\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04327206_168-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04327206\">\"BCG Vaccination to Protect Healthcare Workers Against COVID-19 (BRACE)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 31 March 2020. NCT04327206. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200411045454/https://clinicaltrials.gov/ct2/show/NCT04327206\">Archived</a> from the original on 11 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=BCG+Vaccination+to+Protect+Healthcare+Workers+Against+COVID-19+%28BRACE%29&amp;rft.date=2020-03-31&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04327206&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-NCT04357028-169\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04357028_169-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04357028\">\"Measles Vaccine in HCW (MV-COVID19)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 22 April 2020. NCT04357028. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200507053436/https://clinicaltrials.gov/ct2/show/NCT04357028\">Archived</a> from the original on 7 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Measles+Vaccine+in+HCW+%28MV-COVID19%29&amp;rft.date=2020-04-22&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04357028&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-tregoning-170\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-tregoning_170-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-tregoning_170-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-tregoning_170-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-tregoning_170-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-tregoning_170-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFTregoningRussellKinnear2018\" class=\"citation journal cs1\">Tregoning, John S.; Russell, Ryan F.; Kinnear, Ekaterina (25 January 2018). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5861793\">\"Adjuvanted influenza vaccines\"</a>. <i>Human Vaccines and Immunotherapeutics</i>. <b>14</b> (3): 550\\xe2\\x80\\x9364. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1080%2F21645515.2017.1415684\">10.1080/21645515.2017.1415684</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2164-5515\">2164-5515</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5861793\">5861793</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/29232151\">29232151</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Vaccines+and+Immunotherapeutics&amp;rft.atitle=Adjuvanted+influenza+vaccines&amp;rft.volume=14&amp;rft.issue=3&amp;rft.pages=550-64&amp;rft.date=2018-01-25&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5861793&amp;rft.issn=2164-5515&amp;rft_id=info%3Apmid%2F29232151&amp;rft_id=info%3Adoi%2F10.1080%2F21645515.2017.1415684&amp;rft.aulast=Tregoning&amp;rft.aufirst=John+S.&amp;rft.au=Russell%2C+Ryan+F.&amp;rft.au=Kinnear%2C+Ekaterina&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5861793&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-wang-171\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wang_171-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wang_171-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wang_171-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wang_171-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-wang_171-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFWangPengXuCui2020\" class=\"citation journal cs1\">Wang, Jieliang; Peng, Ying; Xu, Haiyue; Cui, Zhengrong; Williams, Robert O. (5 August 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7405756\">\"The COVID-19 vaccine race: Challenges and opportunities in vaccine formulation\"</a>. <i>AAPS PharmSciTech</i>. <b>21</b> (6): 225. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1208%2Fs12249-020-01744-7\">10.1208/s12249-020-01744-7</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1530-9932\">1530-9932</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7405756\">7405756</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32761294\">32761294</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=AAPS+PharmSciTech&amp;rft.atitle=The+COVID-19+vaccine+race%3A+Challenges+and+opportunities+in+vaccine+formulation&amp;rft.volume=21&amp;rft.issue=6&amp;rft.pages=225&amp;rft.date=2020-08-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7405756&amp;rft.issn=1530-9932&amp;rft_id=info%3Apmid%2F32761294&amp;rft_id=info%3Adoi%2F10.1208%2Fs12249-020-01744-7&amp;rft.aulast=Wang&amp;rft.aufirst=Jieliang&amp;rft.au=Peng%2C+Ying&amp;rft.au=Xu%2C+Haiyue&amp;rft.au=Cui%2C+Zhengrong&amp;rft.au=Williams%2C+Robert+O.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7405756&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-Thorp-172\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Thorp_172-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFThorp2020\" class=\"citation journal cs1\">Thorp HH (27 March 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abb8492\">\"Underpromise, overdeliver\"</a>. <i>Science</i>. <b>367</b> (6485): 1405. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Sci...367.1405T\">2020Sci...367.1405T</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abb8492\">10.1126/science.abb8492</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32205459\">32205459</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Underpromise%2C+overdeliver&amp;rft.volume=367&amp;rft.issue=6485&amp;rft.pages=1405&amp;rft.date=2020-03-27&amp;rft_id=info%3Apmid%2F32205459&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abb8492&amp;rft_id=info%3Abibcode%2F2020Sci...367.1405T&amp;rft.aulast=Thorp&amp;rft.aufirst=H.+Holden&amp;rft_id=%2F%2Fdoi.org%2F10.1126%252Fscience.abb8492&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-threat-173\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-threat_173-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/emergencies/ten-threats-to-global-health-in-2019\">\"Ten health issues WHO will tackle this year\"</a>. World Health Organization. 2019. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20191111212640/https://www.who.int/emergencies/ten-threats-to-global-health-in-2019\">Archived</a> from the original on 11 November 2019<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Ten+health+issues+WHO+will+tackle+this+year&amp;rft.pub=World+Health+Organization&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.who.int%2Femergencies%2Ften-threats-to-global-health-in-2019&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-dube-174\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-dube_174-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-dube_174-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFDub\\xc3\\xa9LabergeGuayBramadat2013\" class=\"citation journal cs1\">Dub\\xc3\\xa9 E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J (1 August 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3906279\">\"Vaccine hesitancy: an overview\"</a>. <i>Human Vaccines and Immunotherapeutics</i>. <b>9</b> (8): 1763\\xe2\\x80\\x9373. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.4161%2Fhv.24657\">10.4161/hv.24657</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2164-554X\">2164-554X</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3906279\">3906279</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/23584253\">23584253</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Vaccines+and+Immunotherapeutics&amp;rft.atitle=Vaccine+hesitancy%3A+an+overview&amp;rft.volume=9&amp;rft.issue=8&amp;rft.pages=1763-73&amp;rft.date=2013-08-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3906279&amp;rft.issn=2164-554X&amp;rft_id=info%3Apmid%2F23584253&amp;rft_id=info%3Adoi%2F10.4161%2Fhv.24657&amp;rft.aulast=Dub%C3%A9&amp;rft.aufirst=Eve&amp;rft.au=Laberge%2C+Caroline&amp;rft.au=Guay%2C+Maryse&amp;rft.au=Bramadat%2C+Paul&amp;rft.au=Roy%2C+R%C3%A9al&amp;rft.au=Bettinger%2C+Julie&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3906279&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-malik-175\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-malik_175-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-malik_175-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-malik_175-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFMalikMcFaddenElharakeOmer2020\" class=\"citation journal cs1\">Malik, Amyn A; McFadden, SarahAnn M; Elharake, Jad; Omer, Saad B (2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30239-X/fulltext\">\"Determinants of COVID-19 vaccine acceptance in the US\"</a>. <i>EClinicalMedicine, the Lancet</i>. <b>26</b>: 100495. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.eclinm.2020.100495\">10.1016/j.eclinm.2020.100495</a></span>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2589-5370\">2589-5370</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7423333\">7423333</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32838242\">32838242</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EClinicalMedicine%2C+the+Lancet&amp;rft.atitle=Determinants+of+COVID-19+vaccine+acceptance+in+the+US&amp;rft.volume=26&amp;rft.pages=100495&amp;rft.date=2020&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7423333&amp;rft.issn=2589-5370&amp;rft_id=info%3Apmid%2F32838242&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eclinm.2020.100495&amp;rft.aulast=Malik&amp;rft.aufirst=Amyn+A&amp;rft.au=McFadden%2C+SarahAnn+M&amp;rft.au=Elharake%2C+Jad&amp;rft.au=Omer%2C+Saad+B&amp;rft_id=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Feclinm%2Farticle%2FPIIS2589-5370%2820%2930239-X%2Ffulltext&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-176\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-176\">^</a></b></span> <span class=\"reference-text\">Linda Thunstr\\xc3\\xb6m, Madison Ashworth, David Finnoff, and Stephen C. Newbold. 2020. Hesitancy towards a COVID-19 vaccine and prospects for herd immunity. <a rel=\"nofollow\" class=\"external text\" href=\"https://cepr.org/file/9287/download?token=Ba6cin7P\"><i>Covid Economics</i> 35</a>: 7 July 2020</span>\\n</li>\\n<li id=\"cite_note-iwasaki-177\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-iwasaki_177-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-iwasaki_177-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-iwasaki_177-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFIwasakiYang2020\" class=\"citation journal cs1\">Iwasaki A, Yang Y (21 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7187142\">\"The potential danger of suboptimal antibody responses in COVID-19\"</a>. <i>Nature Reviews Immunology</i>. <b>20</b> (6): 339\\xe2\\x80\\x9341. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fs41577-020-0321-6\">10.1038/s41577-020-0321-6</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1474-1733\">1474-1733</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7187142\">7187142</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32317716\">32317716</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Immunology&amp;rft.atitle=The+potential+danger+of+suboptimal+antibody+responses+in+COVID-19&amp;rft.volume=20&amp;rft.issue=6&amp;rft.pages=339-41&amp;rft.date=2020-04-21&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7187142&amp;rft.issn=1474-1733&amp;rft_id=info%3Apmid%2F32317716&amp;rft_id=info%3Adoi%2F10.1038%2Fs41577-020-0321-6&amp;rft.aulast=Iwasaki&amp;rft.aufirst=Akiko&amp;rft.au=Yang%2C+Yexin&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7187142&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-wied-178\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wied_178-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wied_178-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wied_178-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wied_178-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFWiedermannGarner-SpitzerWagner2016\" class=\"citation journal cs1\">Wiedermann U, Garner-Spitzer E, Wagner A (2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4962729\">\"Primary vaccine failure to routine vaccines: Why and what to do?\"</a>. <i>Human Vaccines and Immunotherapeutics</i>. <b>12</b> (1): 239\\xe2\\x80\\x9343. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1080%2F21645515.2015.1093263\">10.1080/21645515.2015.1093263</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2164-554X\">2164-554X</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4962729\">4962729</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26836329\">26836329</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Vaccines+and+Immunotherapeutics&amp;rft.atitle=Primary+vaccine+failure+to+routine+vaccines%3A+Why+and+what+to+do%3F&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=239-43&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4962729&amp;rft.issn=2164-554X&amp;rft_id=info%3Apmid%2F26836329&amp;rft_id=info%3Adoi%2F10.1080%2F21645515.2015.1093263&amp;rft.aulast=Wiedermann&amp;rft.aufirst=Ursula&amp;rft.au=Garner-Spitzer%2C+Erika&amp;rft.au=Wagner%2C+Angelika&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4962729&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-zumla-179\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-zumla_179-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFZumlaHuiPerlman2015\" class=\"citation journal cs1\">Zumla A, Hui DS, Perlman S (11 September 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4721578\">\"Middle East respiratory syndrome\"</a>. <i>Lancet</i>. <b>386</b> (9997): 995\\xe2\\x80\\x931007. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS0140-6736%2815%2960454-8\">10.1016/S0140-6736(15)60454-8</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4721578\">4721578</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26049252\">26049252</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Middle+East+respiratory+syndrome&amp;rft.volume=386&amp;rft.issue=9997&amp;rft.pages=995-1007&amp;rft.date=2015-09-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4721578&amp;rft_id=info%3Apmid%2F26049252&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2815%2960454-8&amp;rft.aulast=Zumla&amp;rft.aufirst=Alimuddin&amp;rft.au=Hui%2C+David+S&amp;rft.au=Perlman%2C+Stanley&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4721578&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-garcia-180\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-garcia_180-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFGarcia_de_Jesus2020\" class=\"citation web cs1\">Garcia de Jesus E (26 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencenews.org/article/coronavirus-covid19-mutations-strains-variants\">\"Is the coronavirus mutating? Yes. But here\\'s why you don\\'t need to panic\"</a>. Science News. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200621235243/https://www.sciencenews.org/article/coronavirus-covid19-mutations-strains-variants\">Archived</a> from the original on 21 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">21 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Is+the+coronavirus+mutating%3F+Yes.+But+here%27s+why+you+don%27t+need+to+panic&amp;rft.pub=Science+News&amp;rft.date=2020-05-26&amp;rft.aulast=Garcia+de+Jesus&amp;rft.aufirst=Erin&amp;rft_id=https%3A%2F%2Fwww.sciencenews.org%2Farticle%2Fcoronavirus-covid19-mutations-strains-variants&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-howard-cnn-181\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-howard-cnn_181-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFHowardStracqualursi2020\" class=\"citation news cs1\">Howard J, Stracqualursi V (18 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cnn.com/2020/06/18/politics/anthony-fauci-coronavirus-anti-science-bias/index.html\">\"Fauci warns of \\'anti-science bias\\' being a problem in US\"</a>. <i>CNN</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200621003117/https://www.cnn.com/2020/06/18/politics/anthony-fauci-coronavirus-anti-science-bias/index.html\">Archived</a> from the original on 21 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">21 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Fauci+warns+of+%27anti-science+bias%27+being+a+problem+in+US&amp;rft.date=2020-06-18&amp;rft.aulast=Howard&amp;rft.aufirst=Jacqueline&amp;rft.au=Stracqualursi%2C+Veronica&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2020%2F06%2F18%2Fpolitics%2Fanthony-fauci-coronavirus-anti-science-bias%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-winter-182\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-winter_182-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFWinterPage-ReevesPageHaozous2018\" class=\"citation journal cs1\">Winter, SS; Page-Reeves, JM; Page, KA; Haozous, E; Solares, A; Nicole Cordova, C; Larson, RS (28 May 2018). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6410628\">\"Inclusion of special populations in clinical research: important considerations and guidelines\"</a>. <i>Journal of Clinical and Translational Research</i> (Review). <b>4</b> (1): 56\\xe2\\x80\\x9369. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2382-6533\">2382-6533</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6410628\">6410628</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/30873495\">30873495</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+and+Translational+Research&amp;rft.atitle=Inclusion+of+special+populations+in+clinical+research%3A+important+considerations+and+guidelines&amp;rft.volume=4&amp;rft.issue=1&amp;rft.pages=56-69&amp;rft.date=2018-05-28&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6410628&amp;rft.issn=2382-6533&amp;rft_id=info%3Apmid%2F30873495&amp;rft.aulast=Winter&amp;rft.aufirst=SS&amp;rft.au=Page-Reeves%2C+JM&amp;rft.au=Page%2C+KA&amp;rft.au=Haozous%2C+E&amp;rft.au=Solares%2C+A&amp;rft.au=Nicole+Cordova%2C+C&amp;rft.au=Larson%2C+RS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6410628&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-gates3-183\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-gates3_183-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFGates2020\" class=\"citation web cs1\">Gates B (23 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.gatesnotes.com/Health/Pandemic-Innovation\">\"The first modern pandemic: The scientific advances we need to stop COVID-19\"</a>. The Gates Notes. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200513122415/https://www.gatesnotes.com/Health/Pandemic-Innovation\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+first+modern+pandemic%3A+The+scientific+advances+we+need+to+stop+COVID-19&amp;rft.pub=The+Gates+Notes&amp;rft.date=2020-04-23&amp;rft.aulast=Gates&amp;rft.aufirst=Bill&amp;rft_id=https%3A%2F%2Fwww.gatesnotes.com%2FHealth%2FPandemic-Innovation&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-184\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-184\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFStevis-GridneffJakes2020\" class=\"citation news cs1\">Stevis-Gridneff M, Jakes L (4 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/05/04/world/europe/eu-coronavirus-vaccine.html\">\"World Leaders Join to Pledge $8 Billion for Vaccine as U.S. Goes It Alone\"</a>. <i>The New York Times</i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200513041549/https://www.nytimes.com/2020/05/04/world/europe/eu-coronavirus-vaccine.html\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=World+Leaders+Join+to+Pledge+%248+Billion+for+Vaccine+as+U.S.+Goes+It+Alone&amp;rft.date=2020-05-04&amp;rft.issn=0362-4331&amp;rft.aulast=Stevis-Gridneff&amp;rft.aufirst=Matina&amp;rft.au=Jakes%2C+Lara&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F05%2F04%2Fworld%2Feurope%2Feu-coronavirus-vaccine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-185\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-185\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFBlanchfield2020\" class=\"citation news cs1\">Blanchfield M (30 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.thestar.com/news/canada/2020/04/30/global-philanthropists-experts-call-for-covid-19-vaccine-distribution-plan.html\">\"Global philanthropists, experts call for COVID-19 vaccine distribution plan\"</a>. <i>The Toronto Star</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200507230428/https://www.thestar.com/news/canada/2020/04/30/global-philanthropists-experts-call-for-covid-19-vaccine-distribution-plan.html\">Archived</a> from the original on 7 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Toronto+Star&amp;rft.atitle=Global+philanthropists%2C+experts+call+for+COVID-19+vaccine+distribution+plan&amp;rft.date=2020-04-30&amp;rft.aulast=Blanchfield&amp;rft.aufirst=Mike&amp;rft_id=https%3A%2F%2Fwww.thestar.com%2Fnews%2Fcanada%2F2020%2F04%2F30%2Fglobal-philanthropists-experts-call-for-covid-19-vaccine-distribution-plan.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-186\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-186\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/2020/10/09/7-looming-questions-about-the-rollout-of-a-covid-19-vaccine/\">\"7 looming questions about the rollout of a Covid-19 vaccine\"</a>. <i>STAT</i>. 9 October 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 October</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=STAT&amp;rft.atitle=7+looming+questions+about+the+rollout+of+a+Covid-19+vaccine&amp;rft.date=2020-10-09&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F10%2F09%2F7-looming-questions-about-the-rollout-of-a-covid-19-vaccine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-eyal-187\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-eyal_187-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-eyal_187-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-eyal_187-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-eyal_187-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-eyal_187-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-eyal_187-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-eyal_187-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-eyal_187-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFEyalLipsitchSmith2020\" class=\"citation journal cs1\">Eyal N, Lipsitch M, Smith PG (31 March 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa152/5814216\">\"Human challenge studies to accelerate coronavirus vaccine licensure\"</a>. <i>The Journal of Infectious Diseases</i>. <b>221</b> (11): 1752\\xe2\\x80\\x9356. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1093%2Finfdis%2Fjiaa152\">10.1093/infdis/jiaa152</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7184325\">7184325</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32232474\">32232474</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200424095527/https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa152/5814216\">Archived</a> from the original on 24 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Infectious+Diseases&amp;rft.atitle=Human+challenge+studies+to+accelerate+coronavirus+vaccine+licensure&amp;rft.volume=221&amp;rft.issue=11&amp;rft.pages=1752-56&amp;rft.date=2020-03-31&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7184325&amp;rft_id=info%3Apmid%2F32232474&amp;rft_id=info%3Adoi%2F10.1093%2Finfdis%2Fjiaa152&amp;rft.aulast=Eyal&amp;rft.aufirst=Nir&amp;rft.au=Lipsitch%2C+Marc&amp;rft.au=Smith%2C+Peter+G.&amp;rft_id=https%3A%2F%2Facademic.oup.com%2Fjid%2Fadvance-article%2Fdoi%2F10.1093%2Finfdis%2Fjiaa152%2F5814216&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-callaway-188\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-callaway_188-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-callaway_188-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-callaway_188-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-callaway_188-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-callaway_188-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-callaway_188-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-callaway_188-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFCallaway2020\" class=\"citation journal cs1\">Callaway E (April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/d41586-020-00927-3\">\"Should scientists infect healthy people with the coronavirus to test vaccines?\"</a>. <i>Nature</i>. <b>580</b> (7801): 17. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Natur.580...17C\">2020Natur.580...17C</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fd41586-020-00927-3\">10.1038/d41586-020-00927-3</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32218549\">32218549</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200414035045/https://www.nature.com/articles/d41586-020-00927-3\">Archived</a> from the original on 14 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Should+scientists+infect+healthy+people+with+the+coronavirus+to+test+vaccines%3F&amp;rft.volume=580&amp;rft.issue=7801&amp;rft.pages=17&amp;rft.date=2020-04&amp;rft_id=info%3Apmid%2F32218549&amp;rft_id=info%3Adoi%2F10.1038%2Fd41586-020-00927-3&amp;rft_id=info%3Abibcode%2F2020Natur.580...17C&amp;rft.aulast=Callaway&amp;rft.aufirst=E&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-00927-3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-boodman-189\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-boodman_189-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFBoodman2020\" class=\"citation web cs1\">Boodman E (13 March 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/2020/03/11/researchers-rush-to-start-moderna-coronavirus-vaccine-trial-without-usual-animal-testing/\">\"Coronavirus vaccine clinical trial starting without usual animal data\"</a>. STAT. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200417060301/https://www.statnews.com/2020/03/11/researchers-rush-to-start-moderna-coronavirus-vaccine-trial-without-usual-animal-testing/\">Archived</a> from the original on 17 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus+vaccine+clinical+trial+starting+without+usual+animal+data&amp;rft.pub=STAT&amp;rft.date=2020-03-13&amp;rft.aulast=Boodman&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F03%2F11%2Fresearchers-rush-to-start-moderna-coronavirus-vaccine-trial-without-usual-animal-testing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cohen-190\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cohen_190-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cohen_190-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-cohen_190-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-cohen_190-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFCohen2020\" class=\"citation journal cs1\">Cohen J (31 March 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencemag.org/news/2020/03/speed-coronavirus-vaccine-testing-deliberately-infecting-volunteers-not-so-fast-some\">\"Speed coronavirus vaccine testing by deliberately infecting volunteers? Not so fast, some scientists warn\"</a>. <i>Science</i>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abc0006\">10.1126/science.abc0006</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200414031310/https://www.sciencemag.org/news/2020/03/speed-coronavirus-vaccine-testing-deliberately-infecting-volunteers-not-so-fast-some\">Archived</a> from the original on 14 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Speed+coronavirus+vaccine+testing+by+deliberately+infecting+volunteers%3F+Not+so+fast%2C+some+scientists+warn&amp;rft.date=2020-03-31&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abc0006&amp;rft.aulast=Cohen&amp;rft.aufirst=Jon&amp;rft_id=https%3A%2F%2Fwww.sciencemag.org%2Fnews%2F2020%2F03%2Fspeed-coronavirus-vaccine-testing-deliberately-infecting-volunteers-not-so-fast-some&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-191\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-191\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFWalkerWhittakerWatsonBaguelin2020\" class=\"citation journal cs1\">Walker P, Whittaker C, Watson O, Baguelin M, Ainslie K, Bhatia S,  et al. (26 March 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://spiral.imperial.ac.uk:8443/bitstream/10044/1/77735/10/2020-03-26-COVID19-Report-12.pdf\">\"The global impact of COVID-19 and strategies for mitigation and suppression\"</a> <span class=\"cs1-format\">(PDF)</span>. Imperial College COVID-19 Response Team. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.25561%2F77735\">10.25561/77735</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200421013007/https://spiral.imperial.ac.uk:8443/bitstream/10044/1/77735/10/2020-03-26-COVID19-Report-12.pdf\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 21 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+global+impact+of+COVID-19+and+strategies+for+mitigation+and+suppression&amp;rft.date=2020-03-26&amp;rft_id=info%3Adoi%2F10.25561%2F77735&amp;rft.aulast=Walker&amp;rft.aufirst=P.&amp;rft.au=Whittaker%2C+C.&amp;rft.au=Watson%2C+O.&amp;rft.au=Baguelin%2C+M.&amp;rft.au=Ainslie%2C+K.&amp;rft.au=Bhatia%2C+S.&amp;rft.au=Bhatt%2C+S.&amp;rft.au=Boonyasiri%2C+A.&amp;rft.au=Boyd%2C+O.&amp;rft.au=Cattarino%2C+L.&amp;rft.au=Cucunuba+Perez%2C+Z.&amp;rft.au=Cuomo-Dannenburg%2C+G.&amp;rft.au=Dighe%2C+A.&amp;rft.au=Donnelly%2C+C.&amp;rft.au=Dorigatti%2C+I.&amp;rft.au=Van+Elsland%2C+S.&amp;rft.au=Fitzjohn%2C+R.&amp;rft.au=Flaxman%2C+S.&amp;rft.au=Fu%2C+H.&amp;rft.au=Gaythorpe%2C+K.&amp;rft.au=Geidelberg%2C+L.&amp;rft.au=Grassly%2C+N.&amp;rft.au=Green%2C+W.&amp;rft.au=Hamlet%2C+A.&amp;rft.au=Hauck%2C+K.&amp;rft.au=Haw%2C+D.&amp;rft.au=Hayes%2C+S.&amp;rft.au=Hinsley%2C+W.&amp;rft.au=Imai%2C+N.&amp;rft.au=Jorgensen%2C+D.&amp;rft_id=https%3A%2F%2Fspiral.imperial.ac.uk%3A8443%2Fbitstream%2F10044%2F1%2F77735%2F10%2F2020-03-26-COVID19-Report-12.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span> <span class=\"cs1-hidden-error error citation-comment\">Cite journal requires <code class=\"cs1-code\">&#124;journal=</code> (<a href=\"/wiki/Help:CS1_errors#missing_periodical\" title=\"Help:CS1 errors\">help</a>)</span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-challenge-192\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-challenge_192-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://apps.who.int/iris/bitstream/handle/10665/331976/WHO-2019-nCoV-Ethics_criteria-2020.1-eng.pdf\">\"Key criteria for the ethical acceptability of COVID-19 human challenge studies\"</a> <span class=\"cs1-format\">(PDF)</span>. World Health Organization. 6 May 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200508153855/https://apps.who.int/iris/bitstream/handle/10665/331976/WHO-2019-nCoV-Ethics_criteria-2020.1-eng.pdf\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 8 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">12 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Key+criteria+for+the+ethical+acceptability+of+COVID-19+human+challenge+studies&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-05-06&amp;rft_id=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F331976%2FWHO-2019-nCoV-Ethics_criteria-2020.1-eng.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-vacc-193\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-vacc_193-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://apps.who.int/iris/bitstream/handle/10665/111548/9789241506892_eng.pdf\">\"Principles and considerations for adding a vaccine to a national immunization programme\"</a> <span class=\"cs1-format\">(PDF)</span>. World Health Organization. 1 April 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Principles+and+considerations+for+adding+a+vaccine+to+a+national+immunization+programme&amp;rft.pub=World+Health+Organization&amp;rft.date=2014-04-01&amp;rft_id=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F111548%2F9789241506892_eng.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-wijnans-194\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wijnans_194-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wijnans_194-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wijnans_194-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wijnans_194-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFWijnansVoordouw2015\" class=\"citation journal cs1\">Wijnans, Leonoor; Voordouw, Bettie (11 December 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4687503\">\"A review of the changes to the licensing of influenza vaccines in Europe\"</a>. <i>Influenza and Other Respiratory Viruses</i>. <b>10</b> (1): 2\\xe2\\x80\\x938. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1111%2Firv.12351\">10.1111/irv.12351</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1750-2640\">1750-2640</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4687503\">4687503</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26439108\">26439108</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Influenza+and+Other+Respiratory+Viruses&amp;rft.atitle=A+review+of+the+changes+to+the+licensing+of+influenza+vaccines+in+Europe&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=2-8&amp;rft.date=2015-12-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4687503&amp;rft.issn=1750-2640&amp;rft_id=info%3Apmid%2F26439108&amp;rft_id=info%3Adoi%2F10.1111%2Firv.12351&amp;rft.aulast=Wijnans&amp;rft.aufirst=Leonoor&amp;rft.au=Voordouw%2C+Bettie&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4687503&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-chop-195\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-chop_195-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFPaul_A._Offit2020\" class=\"citation web cs1\">Paul A. Offit (2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.chop.edu/centers-programs/vaccine-education-center/making-vaccines/licensure-recommendations-and-requirements\">\"Making vaccines: Licensure, recommendations and requirements\"</a>. Children\\'s Hospital of Philadelphia<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Making+vaccines%3A+Licensure%2C+recommendations+and+requirements&amp;rft.pub=Children%27s+Hospital+of+Philadelphia&amp;rft.date=2020&amp;rft.au=Paul+A.+Offit&amp;rft_id=https%3A%2F%2Fwww.chop.edu%2Fcenters-programs%2Fvaccine-education-center%2Fmaking-vaccines%2Flicensure-recommendations-and-requirements&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-toner-196\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-toner_196-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-toner_196-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-toner_196-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFTonerBarnillKrubinerothers2020\" class=\"citation web cs1\">Toner E, Barnill A, Krubiner C, others (19 August 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200819-vaccine-allocation.pdf\">\"Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States\"</a> <span class=\"cs1-format\">(PDF)</span>. Baltimore, MD: Johns Hopkins University Center for Health Security<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Interim+Framework+for+COVID-19+Vaccine+Allocation+and+Distribution+in+the+United+States&amp;rft.place=Baltimore%2C+MD&amp;rft.pub=Johns+Hopkins+University+Center+for+Health+Security&amp;rft.date=2020-08-19&amp;rft.aulast=Toner&amp;rft.aufirst=E&amp;rft.au=Barnill%2C+A&amp;rft.au=Krubiner%2C+C&amp;rft.au=others&amp;rft_id=https%3A%2F%2Fwww.centerforhealthsecurity.org%2Four-work%2Fpubs_archive%2Fpubs-pdfs%2F2020%2F200819-vaccine-allocation.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-197\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-197\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ema.europa.eu/en/news/ema-starts-first-rolling-review-covid-19-vaccine-eu\">\"EMA starts first rolling review of a COVID-19 vaccine in the EU\"</a>. <i><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA)</i> (Press release). 1 October 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 October</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=EMA+starts+first+rolling+review+of+a+COVID-19+vaccine+in+the+EU&amp;rft.date=2020-10-01&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fnews%2Fema-starts-first-rolling-review-covid-19-vaccine-eu&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-198\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-198\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-vaccines-key-facts\">\"COVID-19 vaccines: key facts\"</a>. <i><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA)</i>. 14 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 October</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=European+Medicines+Agency+%28EMA%29&amp;rft.atitle=COVID-19+vaccines%3A+key+facts&amp;rft.date=2020-09-14&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fhuman-regulatory%2Foverview%2Fpublic-health-threats%2Fcoronavirus-disease-covid-19%2Fcovid-19-vaccines-key-facts&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-199\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-199\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ema.europa.eu/en/news/ema-starts-second-rolling-review-covid-19-vaccine\">\"EMA starts second rolling review of a COVID-19 vaccine\"</a>. <i><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA)</i> (Press release). 5 October 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 October</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=EMA+starts+second+rolling+review+of+a+COVID-19+vaccine&amp;rft.date=2020-10-05&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fnews%2Fema-starts-second-rolling-review-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-fda-vacc-200\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-fda-vacc_200-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-fda-vacc_200-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-fda-vacc_200-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-fda-vacc_200-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-fda-vacc_200-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/vaccine-product-approval-process\">\"Vaccine product approval process\"</a>. US Food and Drug Administration. 30 January 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccine+product+approval+process&amp;rft.pub=US+Food+and+Drug+Administration&amp;rft.date=2020-01-30&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fvaccines-blood-biologics%2Fdevelopment-approval-process-cber%2Fvaccine-product-approval-process&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-corey-201\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-corey_201-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFCoreyMascolaFauciCollins2020\" class=\"citation journal cs1\">Corey, Lawrence; Mascola, John R; Fauci, Anthony S; Collins, Francis S (11 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://science.sciencemag.org/content/368/6494/948.long\">\"A strategic approach to COVID-19 vaccine R&amp;D\"</a>. <i>Science</i>. <b>368</b> (6494): 948\\xe2\\x80\\x9350. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abc5312\">10.1126/science.abc5312</a></span>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0036-8075\">0036-8075</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32393526\">32393526</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=A+strategic+approach+to+COVID-19+vaccine+R%26D&amp;rft.volume=368&amp;rft.issue=6494&amp;rft.pages=948-50&amp;rft.date=2020-05-11&amp;rft.issn=0036-8075&amp;rft_id=info%3Apmid%2F32393526&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abc5312&amp;rft.aulast=Corey&amp;rft.aufirst=Lawrence&amp;rft.au=Mascola%2C+John+R&amp;rft.au=Fauci%2C+Anthony+S&amp;rft.au=Collins%2C+Francis+S&amp;rft_id=https%3A%2F%2Fscience.sciencemag.org%2Fcontent%2F368%2F6494%2F948.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-eul-202\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-eul_202-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-eul_202-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/news-room/detail/09-01-2020-emergency-use-listing-procedure-and-roadmap-health-emergencies\">\"WHO publishes Emergency Use Listing procedure and roadmap to make new medical products more readily available during health emergencies\"</a>. World Health Organization. 9 January 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=WHO+publishes+Emergency+Use+Listing+procedure+and+roadmap+to+make+new+medical+products+more+readily+available+during+health+emergencies&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-01-09&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fdetail%2F09-01-2020-emergency-use-listing-procedure-and-roadmap-health-emergencies&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-ema-eau-203\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ema-eau_203-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ema.europa.eu/en/authorisation-procedures\">\"Vaccines: The Emergency Authorisation Procedure\"</a>. European Medicines Agency. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">21 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccines%3A+The+Emergency+Authorisation+Procedure&amp;rft.pub=European+Medicines+Agency&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fauthorisation-procedures&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-204\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-204\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.scmp.com/news/china/society/article/3103121/coronavirus-who-backed-chinas-emergency-use-experimental\">\"WHO \\'backed China\\'s emergency use\\' of experimental Covid-19 vaccines\"</a>. <i>South China Morning Post</i>. 25 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=South+China+Morning+Post&amp;rft.atitle=WHO+%27backed+China%27s+emergency+use%27+of+experimental+Covid-19+vaccines&amp;rft.date=2020-09-25&amp;rft_id=https%3A%2F%2Fwww.scmp.com%2Fnews%2Fchina%2Fsociety%2Farticle%2F3103121%2Fcoronavirus-who-backed-chinas-emergency-use-experimental&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-205\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-205\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFKramer2020\" class=\"citation news cs1\">Kramer, Andrew E. (19 September 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/09/19/world/europe/russia-coronavirus-vaccine.html\">\"Russia Is Slow to Administer Virus Vaccine Despite Kremlin\\'s Approval\"</a>. <i>The New York Times</i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Russia+Is+Slow+to+Administer+Virus+Vaccine+Despite+Kremlin%27s+Approval&amp;rft.date=2020-09-19&amp;rft.issn=0362-4331&amp;rft.aulast=Kramer&amp;rft.aufirst=Andrew+E.&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F09%2F19%2Fworld%2Feurope%2Frussia-coronavirus-vaccine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-206\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-206\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.clinicaltrialsarena.com/comment/fda-covid-19-vaccines/\">\"FDA may be risk-averse to grant emergency use for a Covid-19 vaccine; political pressure and hazy EUA standards are factors\"</a>. ClinicalTrials Arena, Verdict Media, Ltd. 2 July 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+may+be+risk-averse+to+grant+emergency+use+for+a+Covid-19+vaccine%3B+political+pressure+and+hazy+EUA+standards+are+factors&amp;rft.pub=ClinicalTrials+Arena%2C+Verdict+Media%2C+Ltd.&amp;rft.date=2020-07-02&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsarena.com%2Fcomment%2Ffda-covid-19-vaccines%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-hoffman-207\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-hoffman_207-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFJan_Hoffman2020\" class=\"citation news cs1\">Jan Hoffman (18 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/07/18/health/coronavirus-anti-vaccine.html\">\"Mistrust of a coronavirus vaccine could imperil widespread immunity\"</a>. <i>The New York Times</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Mistrust+of+a+coronavirus+vaccine+could+imperil+widespread+immunity&amp;rft.date=2020-07-18&amp;rft.au=Jan+Hoffman&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F07%2F18%2Fhealth%2Fcoronavirus-anti-vaccine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-208\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-208\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.news.sanofi.us/2020-09-08-Biopharma-leaders-unite-to-stand-with-science\">\"Biopharma leaders unite to stand with science\"</a>. SANOFI. 8 September 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Biopharma+leaders+unite+to+stand+with+science&amp;rft.pub=SANOFI&amp;rft.date=2020-09-08&amp;rft_id=http%3A%2F%2Fwww.news.sanofi.us%2F2020-09-08-Biopharma-leaders-unite-to-stand-with-science&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-hbr-209\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-hbr_209-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-hbr_209-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-hbr_209-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-hbr_209-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFWeintraubYadavBerkley2020\" class=\"citation news cs1\">Weintraub R, Yadav P, Berkley S (2 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://hbr.org/2020/04/a-covid-19-vaccine-will-need-equitable-global-distribution\">\"A COVID-19 vaccine will need equitable, global distribution\"</a>. <i>Harvard Business Review</i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0017-8012\">0017-8012</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200609173105/https://hbr.org/2020/04/a-covid-19-vaccine-will-need-equitable-global-distribution\">Archived</a> from the original on 9 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Harvard+Business+Review&amp;rft.atitle=A+COVID-19+vaccine+will+need+equitable%2C+global+distribution&amp;rft.date=2020-04-02&amp;rft.issn=0017-8012&amp;rft.aulast=Weintraub&amp;rft.aufirst=Rebecca&amp;rft.au=Yadav%2C+Prashant&amp;rft.au=Berkley%2C+Seth&amp;rft_id=https%3A%2F%2Fhbr.org%2F2020%2F04%2Fa-covid-19-vaccine-will-need-equitable-global-distribution&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cbcr-210\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cbcr_210-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cbcr_210-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-cbcr_210-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-cbcr_210-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-cbcr_210-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cbc.ca/radio/thesundayedition/the-sunday-edition-for-may-10-2020-1.5554451/covid-19-pandemic-reveals-the-risks-of-relying-on-private-sector-for-life-saving-vaccines-says-expert-1.5554463\">\"COVID-19 pandemic reveals the risks of relying on private sector for life-saving vaccines, says expert\"</a>. <i>CBC Radio</i>. 8 May 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200513172525/https://www.cbc.ca/radio/thesundayedition/the-sunday-edition-for-may-10-2020-1.5554451/covid-19-pandemic-reveals-the-risks-of-relying-on-private-sector-for-life-saving-vaccines-says-expert-1.5554463\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBC+Radio&amp;rft.atitle=COVID-19+pandemic+reveals+the+risks+of+relying+on+private+sector+for+life-saving+vaccines%2C+says+expert&amp;rft.date=2020-05-08&amp;rft_id=https%3A%2F%2Fwww.cbc.ca%2Fradio%2Fthesundayedition%2Fthe-sunday-edition-for-may-10-2020-1.5554451%2Fcovid-19-pandemic-reveals-the-risks-of-relying-on-private-sector-for-life-saving-vaccines-says-expert-1.5554463&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-ahmed-211\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ahmed_211-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ahmed_211-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ahmed_211-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ahmed_211-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFAhmed2020\" class=\"citation web cs1\">Ahmed DD (4 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/2020/06/04/oxford-astrazeneca-covid-19-deal-reinforces-vaccine-sovereignty/\">\"Oxford, AstraZeneca COVID-19 deal reinforces \\'vaccine sovereignty<span class=\"cs1-kern-right\">\\'</span>\"</a>. STAT. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200612125335/https://www.statnews.com/2020/06/04/oxford-astrazeneca-covid-19-deal-reinforces-vaccine-sovereignty/\">Archived</a> from the original on 12 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Oxford%2C+AstraZeneca+COVID-19+deal+reinforces+%27vaccine+sovereignty%27&amp;rft.pub=STAT&amp;rft.date=2020-06-04&amp;rft.aulast=Ahmed&amp;rft.aufirst=Darius+D.&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F06%2F04%2Foxford-astrazeneca-covid-19-deal-reinforces-vaccine-sovereignty%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-kyle-212\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-kyle_212-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-kyle_212-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFBlankenship2020\" class=\"citation web cs1\">Blankenship K (4 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/manufacturing/astrazeneca-unveils-massive-750m-deal-effort-to-produce-billions-covid-19-shots\">\"AstraZeneca unveils massive $750M deal in effort to produce billions of COVID-19 shots\"</a>. FiercePharma. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200610191605/https://www.fiercepharma.com/manufacturing/astrazeneca-unveils-massive-750m-deal-effort-to-produce-billions-covid-19-shots\">Archived</a> from the original on 10 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=AstraZeneca+unveils+massive+%24750M+deal+in+effort+to+produce+billions+of+COVID-19+shots&amp;rft.pub=FiercePharma&amp;rft.date=2020-06-04&amp;rft.aulast=Blankenship&amp;rft.aufirst=Kyle&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fmanufacturing%2Fastrazeneca-unveils-massive-750m-deal-effort-to-produce-billions-covid-19-shots&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cohen6-4-213\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cohen6-4_213-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cohen6-4_213-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFCohen2020\" class=\"citation journal cs1\">Cohen J (4 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencemag.org/news/2020/06/top-us-scientists-left-out-white-house-selection-covid-19-vaccine-shortlist\">\"Top U.S. scientists left out of White House selection of COVID-19 vaccine short list\"</a>. <i>Science</i>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abd1719\">10.1126/science.abd1719</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0036-8075\">0036-8075</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200609203807/https://www.sciencemag.org/news/2020/06/top-us-scientists-left-out-white-house-selection-covid-19-vaccine-shortlist\">Archived</a> from the original on 9 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Top+U.S.+scientists+left+out+of+White+House+selection+of+COVID-19+vaccine+short+list&amp;rft.date=2020-06-04&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abd1719&amp;rft.issn=0036-8075&amp;rft.aulast=Cohen&amp;rft.aufirst=Jon&amp;rft_id=https%3A%2F%2Fwww.sciencemag.org%2Fnews%2F2020%2F06%2Ftop-us-scientists-left-out-white-house-selection-covid-19-vaccine-shortlist&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-bolly-214\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-bolly_214-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-bolly_214-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-bolly_214-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-bolly_214-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFBollykyGostinHamburg2020\" class=\"citation journal cs1\">Bollyky TJ, Gostin LO, Hamburg MA (7 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://jamanetwork.com/journals/jama/fullarticle/2765944\">\"The equitable distribution of COVID-19 therapeutics and vaccines\"</a>. <i>JAMA</i>. <b>323</b> (24): 2462\\xe2\\x80\\x9363. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1001%2Fjama.2020.6641\">10.1001/jama.2020.6641</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32379268\">32379268</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200512234709/https://jamanetwork.com/journals/jama/fullarticle/2765944\">Archived</a> from the original on 12 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=The+equitable+distribution+of+COVID-19+therapeutics+and+vaccines&amp;rft.volume=323&amp;rft.issue=24&amp;rft.pages=2462-63&amp;rft.date=2020-05-07&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2020.6641&amp;rft_id=info%3Apmid%2F32379268&amp;rft.aulast=Bollyky&amp;rft.aufirst=Thomas+J.&amp;rft.au=Gostin%2C+Lawrence+O.&amp;rft.au=Hamburg%2C+Margaret+A.&amp;rft_id=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjama%2Ffullarticle%2F2765944&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-215\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-215\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFAakashFaulconbridgeHolton2020\" class=\"citation web cs1\">Aakash B, Faulconbridge G, Holton K (22 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.pe.ca/news/world/astrazeneca-gets-first-supply-agreements-for-covid-19-vaccine-452225/\">\"U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine\"</a>. <i>The Guardian</i>. Reuters. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200610002524/http://www.theguardian.pe.ca/news/world/astrazeneca-gets-first-supply-agreements-for-covid-19-vaccine-452225/\">Archived</a> from the original on 10 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Guardian&amp;rft.atitle=U.S.+secures+300+million+doses+of+potential+AstraZeneca+COVID-19+vaccine&amp;rft.date=2020-05-22&amp;rft.aulast=Aakash&amp;rft.aufirst=B&amp;rft.au=Faulconbridge%2C+Guy&amp;rft.au=Holton%2C+Kate&amp;rft_id=https%3A%2F%2Fwww.theguardian.pe.ca%2Fnews%2Fworld%2Fastrazeneca-gets-first-supply-agreements-for-covid-19-vaccine-452225%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-paton-216\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-paton_216-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFPatonGriffinKoons\" class=\"citation news cs1\">Paton J, Griffin R, Koons C. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloombergquint.com/business/u-s-to-get-sanofi-covid-vaccine-first-if-it-succeeds-ceo-says\">\"U.S. likely to get Sanofi vaccine first if it succeeds\"</a>. <i>Bloomberg</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200608182905/https://www.bloombergquint.com/business/u-s-to-get-sanofi-covid-vaccine-first-if-it-succeeds-ceo-says\">Archived</a> from the original on 8 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=U.S.+likely+to+get+Sanofi+vaccine+first+if+it+succeeds&amp;rft.aulast=Paton&amp;rft.aufirst=James&amp;rft.au=Griffin%2C+Riley&amp;rft.au=Koons%2C+Cynthia&amp;rft_id=https%3A%2F%2Fwww.bloombergquint.com%2Fbusiness%2Fu-s-to-get-sanofi-covid-vaccine-first-if-it-succeeds-ceo-says&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-unequal-217\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-unequal_217-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-unequal_217-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-unequal_217-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-unequal_217-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-unequal_217-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-unequal_217-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-unequal_217-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-unequal_217-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFCallaway2020\" class=\"citation journal cs1\">Callaway, Ewen (27 August 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/d41586-020-02450-x\">\"The unequal scramble for coronavirus vaccines \\xe2\\x80\\x93 by the numbers\"</a>. <i>Nature</i>. <b>584</b> (7822): 506\\xe2\\x80\\x9307. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Natur.584..506C\">2020Natur.584..506C</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fd41586-020-02450-x\">10.1038/d41586-020-02450-x</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32839593\">32839593</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221285160\">221285160</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=The+unequal+scramble+for+coronavirus+vaccines+%E2%80%93+by+the+numbers&amp;rft.volume=584&amp;rft.issue=7822&amp;rft.pages=506-07&amp;rft.date=2020-08-27&amp;rft_id=info%3Adoi%2F10.1038%2Fd41586-020-02450-x&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221285160&amp;rft_id=info%3Apmid%2F32839593&amp;rft_id=info%3Abibcode%2F2020Natur.584..506C&amp;rft.aulast=Callaway&amp;rft.aufirst=Ewen&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-02450-x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-khamsi-218\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-khamsi_218-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFKhamsi2020\" class=\"citation journal cs1\">Khamsi R (9 April 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/d41586-020-01063-8\">\"If a coronavirus vaccine arrives, can the world make enough?\"</a>. <i>Nature</i>. <b>580</b> (7805): 578\\xe2\\x80\\x9380. <a href=\"/wiki/Bibcode_(identifier)\" class=\"mw-redirect\" title=\"Bibcode (identifier)\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Natur.580..578K\">2020Natur.580..578K</a>. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038%2Fd41586-020-01063-8\">10.1038/d41586-020-01063-8</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32273621\">32273621</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200513023042/https://www.nature.com/articles/d41586-020-01063-8\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=If+a+coronavirus+vaccine+arrives%2C+can+the+world+make+enough%3F&amp;rft.volume=580&amp;rft.issue=7805&amp;rft.pages=578-80&amp;rft.date=2020-04-09&amp;rft_id=info%3Apmid%2F32273621&amp;rft_id=info%3Adoi%2F10.1038%2Fd41586-020-01063-8&amp;rft_id=info%3Abibcode%2F2020Natur.580..578K&amp;rft.aulast=Khamsi&amp;rft.aufirst=Roxanne&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-01063-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-219\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-219\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFGretler2020\" class=\"citation news cs1\">Gretler C (18 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://nationalpost.com/news/world/china-pledges-to-make-its-coronavirus-vaccine-a-public-good\">\"China pledges to make its coronavirus vaccine a \\'public good<span class=\"cs1-kern-right\">\\'</span>\"</a>. <i>The National Post</i>. Bloomberg<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+National+Post&amp;rft.atitle=China+pledges+to+make+its+coronavirus+vaccine+a+%27public+good%27&amp;rft.date=2020-05-18&amp;rft.aulast=Gretler&amp;rft.aufirst=Corinne&amp;rft_id=https%3A%2F%2Fnationalpost.com%2Fnews%2Fworld%2Fchina-pledges-to-make-its-coronavirus-vaccine-a-public-good&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-huney-220\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-huney_220-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-huney_220-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-huney_220-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-huney_220-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFHuneycuttLurieRotenbergWilder2020\" class=\"citation journal cs1\">Huneycutt B, Lurie N, Rotenberg S, Wilder R, Hatchett R (24 February 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7130943\">\"Finding equipoise: CEPI revises its equitable access policy\"</a>. <i>Vaccine</i>. <b>38</b> (9): 2144\\xe2\\x80\\x9348. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.vaccine.2019.12.055\">10.1016/j.vaccine.2019.12.055</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7130943\">7130943</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32005536\">32005536</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Finding+equipoise%3A+CEPI+revises+its+equitable+access+policy&amp;rft.volume=38&amp;rft.issue=9&amp;rft.pages=2144-48&amp;rft.date=2020-02-24&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7130943&amp;rft_id=info%3Apmid%2F32005536&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2019.12.055&amp;rft.aulast=Huneycutt&amp;rft.aufirst=Brenda&amp;rft.au=Lurie%2C+Nicole&amp;rft.au=Rotenberg%2C+Sara&amp;rft.au=Wilder%2C+Richard&amp;rft.au=Hatchett%2C+Richard&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7130943&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-221\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-221\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://c4aa.org/2020/03/join-us-free-the-vaccine-for-covid-19\">\"Vaccine for COVID-19\"</a>. The Center for Artistic Activism. 22 March 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200609001355/https://c4aa.org/2020/03/join-us-free-the-vaccine-for-covid-19\">Archived</a> from the original on 9 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccine+for+COVID-19&amp;rft.pub=The+Center+for+Artistic+Activism&amp;rft.date=2020-03-22&amp;rft_id=https%3A%2F%2Fc4aa.org%2F2020%2F03%2Fjoin-us-free-the-vaccine-for-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-222\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-222\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://uaem.org/\">\"UAEM response to COVID-19\"</a>. Universities Allied for Essential Medicines. 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200421083204/https://uaem.org/\">Archived</a> from the original on 21 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 June</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=UAEM+response+to+COVID-19&amp;rft.pub=Universities+Allied+for+Essential+Medicines&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fuaem.org%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-223\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-223\">^</a></b></span> <span class=\"reference-text\">Ferrucci A. (05 MAY 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.edc-online.org/en/home-en/news/16033-more-than-100-scientists-call-for-covid-19-vaccines-to-be-in-the-public-domain.html\">\"More than 100 scientists call for Covid 19 vaccines to be in the public domain\"</a>. <i>edc.online.org.</i> Retrieved July 21, 2020.</span>\\n</li>\\n<li id=\"cite_note-wef-224\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wef_224-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wef_224-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wef_224-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wef_224-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-wef_224-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.weforum.org/agenda/2020/07/blockchain-role-in-distributing-covid-19-vaccine-could-make-history/\">\"How the massive plan to deliver the COVID-19 vaccine could make history \\xe2\\x80\\x93 and leverage blockchain like never before\"</a>. World Economic Forum. 17 July 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=How+the+massive+plan+to+deliver+the+COVID-19+vaccine+could+make+history+%E2%80%93+and+leverage+blockchain+like+never+before&amp;rft.pub=World+Economic+Forum&amp;rft.date=2020-07-17&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Fagenda%2F2020%2F07%2Fblockchain-role-in-distributing-covid-19-vaccine-could-make-history%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-murray-225\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-murray_225-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-murray_225-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-murray_225-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-murray_225-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-murray_225-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-murray_225-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\">Brendan Murray and Riley Griffin (24 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2020-07-25/the-supply-chain-to-save-the-world-is-unprepared-for-a-vaccine\">\"The world\\'s supply chain isn\\'t ready for a Covid-19 vaccine\"</a>. <i>Bloomberg World</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+World&amp;rft.atitle=The+world%27s+supply+chain+isn%27t+ready+for+a+Covid-19+vaccine&amp;rft.date=2020-07-24&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2020-07-25%2Fthe-supply-chain-to-save-the-world-is-unprepared-for-a-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-scott-226\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-scott_226-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-scott_226-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-scott_226-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-scott_226-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFScott_Duke_KominersAlex_Tabarrok2020\" class=\"citation news cs1\">Scott Duke Kominers; Alex Tabarrok (18 August 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/opinion/articles/2020-08-18/a-resilient-covid-19-vaccine-supply-chain-starts-now\">\"Vaccines use bizarre stuff. We need a supply chain now\"</a>. <i>Bloomberg Business</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Business&amp;rft.atitle=Vaccines+use+bizarre+stuff.+We+need+a+supply+chain+now&amp;rft.date=2020-08-18&amp;rft.au=Scott+Duke+Kominers&amp;rft.au=Alex+Tabarrok&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fopinion%2Farticles%2F2020-08-18%2Fa-resilient-covid-19-vaccine-supply-chain-starts-now&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-unicef-now-227\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-unicef-now_227-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-unicef-now_227-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.unicef.org/press-releases/time-prepare-covid-19-vaccine-transport-now\">\"The time to prepare for COVID-19 vaccine transport is now\"</a>. UNICEF. 10 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+time+to+prepare+for+COVID-19+vaccine+transport+is+now&amp;rft.pub=UNICEF&amp;rft.date=2020-09-10&amp;rft_id=https%3A%2F%2Fwww.unicef.org%2Fpress-releases%2Ftime-prepare-covid-19-vaccine-transport-now&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-desai-228\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-desai_228-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-desai_228-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFDevika_Desai2020\" class=\"citation news cs1\">Devika Desai (10 September 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://nationalpost.com/news/transporting-one-single-dose-of-covid-19-vaccine-could-take-up-to-8000-jumbo-planes-says-aviation-body\">\"Transporting one single dose of COVID-19 vaccine could take up to 8,000 jumbo planes, says aviation body\"</a>. <i>National Post</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>. <q>The IATA estimated that 8,000 747 cargo planes, at minimum, would be needed to transport a single dose of the vaccine worldwide, but more equipment could be required as administering the vaccine might mean several doses. Vaccines would also have to be stored at a temperature range between two and eight degrees Celsius, which could rule out the use of some types of planes.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=National+Post&amp;rft.atitle=Transporting+one+single+dose+of+COVID-19+vaccine+could+take+up+to+8%2C000+jumbo+planes%2C+says+aviation+body&amp;rft.date=2020-09-10&amp;rft.au=Devika+Desai&amp;rft_id=https%3A%2F%2Fnationalpost.com%2Fnews%2Ftransporting-one-single-dose-of-covid-19-vaccine-could-take-up-to-8000-jumbo-planes-says-aviation-body&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-pharmiweb-229\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pharmiweb_229-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pharmiweb_229-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pharmiweb_229-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pharmiweb_229-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFQuelch2020\" class=\"citation web cs1\">Quelch, Rich (14 August 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.pharmiweb.com/article/covid-19-vaccine-delivery-overcoming-the-supply-chain-challenges\">\"COVID-19 vaccine delivery \\xe2\\x80\\x93 overcoming the supply chain challenges\"</a>. PharmiWeb.com<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>. <q>Delivering a new vaccine for COVID-19 worldwide will be one of the greatest challenges faced by modern pharma. The difficulties are intensified by pre-existing shortcomings in the supply chain.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVID-19+vaccine+delivery+%E2%80%93+overcoming+the+supply+chain+challenges&amp;rft.pub=PharmiWeb.com&amp;rft.date=2020-08-14&amp;rft.aulast=Quelch&amp;rft.aufirst=Rich&amp;rft_id=https%3A%2F%2Fwww.pharmiweb.com%2Farticle%2Fcovid-19-vaccine-delivery-overcoming-the-supply-chain-challenges&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-seidman-230\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-seidman_230-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFSeidmanAtun2017\" class=\"citation journal cs1\">Seidman, Gabriel; Atun, Rifat (2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5435270\">\"Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries\"</a>. <i>BMJ Global Health</i>. <b>2</b> (2): e000243. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1136%2Fbmjgh-2016-000243\">10.1136/bmjgh-2016-000243</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2059-7908\">2059-7908</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5435270\">5435270</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/28589028\">28589028</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ+Global+Health&amp;rft.atitle=Do+changes+to+supply+chains+and+procurement+processes+yield+cost+savings+and+improve+availability+of+pharmaceuticals%2C+vaccines+or+health+products%3F+A+systematic+review+of+evidence+from+low-income+and+middle-income+countries&amp;rft.volume=2&amp;rft.issue=2&amp;rft.pages=e000243&amp;rft.date=2017&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5435270&amp;rft.issn=2059-7908&amp;rft_id=info%3Apmid%2F28589028&amp;rft_id=info%3Adoi%2F10.1136%2Fbmjgh-2016-000243&amp;rft.aulast=Seidman&amp;rft.aufirst=Gabriel&amp;rft.au=Atun%2C+Rifat&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5435270&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-gavi9-4-231\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gavi9-4_231-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gavi9-4_231-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.gavi.org/news/media-room/172-countries-multiple-candidate-vaccines-engaged-covid-19-vaccine-global-access\">\"172 countries and multiple candidate vaccines engaged in COVID-19 Vaccine Global Access Facility\"</a>. GAVI. 4 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=172+countries+and+multiple+candidate+vaccines+engaged+in+COVID-19+Vaccine+Global+Access+Facility&amp;rft.pub=GAVI&amp;rft.date=2020-09-04&amp;rft_id=https%3A%2F%2Fwww.gavi.org%2Fnews%2Fmedia-room%2F172-countries-multiple-candidate-vaccines-engaged-covid-19-vaccine-global-access&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-unicef-232\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-unicef_232-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-unicef_232-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-unicef_232-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-unicef_232-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.unicef.org/press-releases/unicef-lead-procurement-and-supply-covid-19-vaccines-worlds-largest-and-fastest-ever\">\"UNICEF to lead procurement and supply of COVID-19 vaccines in world\\'s largest and fastest ever operation of its kind\"</a>. UNICEF. 4 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=UNICEF+to+lead+procurement+and+supply+of+COVID-19+vaccines+in+world%27s+largest+and+fastest+ever+operation+of+its+kind&amp;rft.pub=UNICEF&amp;rft.date=2020-09-04&amp;rft_id=https%3A%2F%2Fwww.unicef.org%2Fpress-releases%2Funicef-lead-procurement-and-supply-covid-19-vaccines-worlds-largest-and-fastest-ever&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-cook-233\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cook_233-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFEmily_Cook2020\" class=\"citation web cs1\">Emily Cook (4 September 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.manufacturingglobal.com/procurement-and-supply-chain/unicef-lead-supply-chain-covid-19-vaccine\">\"UNICEF to lead supply chain for COVID-19 vaccine\"</a>. Manufacturing<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=UNICEF+to+lead+supply+chain+for+COVID-19+vaccine&amp;rft.pub=Manufacturing&amp;rft.date=2020-09-04&amp;rft.au=Emily+Cook&amp;rft_id=https%3A%2F%2Fwww.manufacturingglobal.com%2Fprocurement-and-supply-chain%2Funicef-lead-supply-chain-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-hessel-234\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-hessel_234-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-hessel_234-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFHessel2009\" class=\"citation journal cs1\">Hessel, Luc (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4634681\">\"Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges\"</a>. <i>Influenza and Other Respiratory Viruses</i>. <b>3</b> (4): 165\\xe2\\x80\\x9370. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1750-2659.2009.00085.x\">10.1111/j.1750-2659.2009.00085.x</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1750-2640\">1750-2640</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4634681\">4634681</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/19627373\">19627373</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Influenza+and+Other+Respiratory+Viruses&amp;rft.atitle=Pandemic+influenza+vaccines%3A+meeting+the+supply%2C+distribution+and+deployment+challenges&amp;rft.volume=3&amp;rft.issue=4&amp;rft.pages=165-70&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4634681&amp;rft.issn=1750-2640&amp;rft_id=info%3Apmid%2F19627373&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1750-2659.2009.00085.x&amp;rft.aulast=Hessel&amp;rft.aufirst=Luc&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4634681&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-log-235\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-log_235-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-log_235-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/immunization/programmes_systems/supply_chain/resources/tools/en/\">\"Vaccine management and logistics support\"</a>. World Health Organization. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccine+management+and+logistics+support&amp;rft.pub=World+Health+Organization&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fimmunization%2Fprogrammes_systems%2Fsupply_chain%2Fresources%2Ftools%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-jarrett-236\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-jarrett_236-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFJarrettYangPagliusi2020\" class=\"citation journal cs1\">Jarrett, Stephen; Yang, Lingjiang; Pagliusi, Sonia (9 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7394771\">\"Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers\\' perspectives\"</a>. <i>Vaccine X</i>. <b>5</b>: 100068. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.jvacx.2020.100068\">10.1016/j.jvacx.2020.100068</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2590-1362\">2590-1362</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7394771\">7394771</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32775997\">32775997</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine+X&amp;rft.atitle=Roadmap+for+strengthening+the+vaccine+supply+chain+in+emerging+countries%3A+Manufacturers%27+perspectives&amp;rft.volume=5&amp;rft.pages=100068&amp;rft.date=2020-06-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7394771&amp;rft.issn=2590-1362&amp;rft_id=info%3Apmid%2F32775997&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jvacx.2020.100068&amp;rft.aulast=Jarrett&amp;rft.aufirst=Stephen&amp;rft.au=Yang%2C+Lingjiang&amp;rft.au=Pagliusi%2C+Sonia&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7394771&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-lloyd-237\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-lloyd_237-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-lloyd_237-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFLloydCheyne2017\" class=\"citation journal cs1\">Lloyd, John; Cheyne, James (2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencedirect.com/science/article/pii/S0264410X17300476/\">\"The origins of the vaccine cold chain and a glimpse of the future\"</a>. <i>Vaccine</i>. <b>35</b> (17): 2115\\xe2\\x80\\x9320. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.vaccine.2016.11.097\">10.1016/j.vaccine.2016.11.097</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0264-410X\">0264-410X</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/28364918\">28364918</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=The+origins+of+the+vaccine+cold+chain+and+a+glimpse+of+the+future&amp;rft.volume=35&amp;rft.issue=17&amp;rft.pages=2115-20&amp;rft.date=2017&amp;rft.issn=0264-410X&amp;rft_id=info%3Apmid%2F28364918&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2016.11.097&amp;rft.aulast=Lloyd&amp;rft.aufirst=John&amp;rft.au=Cheyne%2C+James&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0264410X17300476%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-wef-manuf-238\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wef-manuf_238-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wef-manuf_238-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wef-manuf_238-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wef-manuf_238-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.weforum.org/agenda/2020/08/covid-vaccine-manufacture-distribute-2-billion-doses/\">\"How can we make enough vaccine for 2 billion people?\"</a>. World Economic Forum. 25 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=How+can+we+make+enough+vaccine+for+2+billion+people%3F&amp;rft.pub=World+Economic+Forum&amp;rft.date=2020-08-25&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Fagenda%2F2020%2F08%2Fcovid-vaccine-manufacture-distribute-2-billion-doses%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-239\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-239\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.japantimes.co.jp/news/2020/08/12/world/science-health-world/pre-orders-coronavirus-vaccines/\">\"Coronavirus vaccine pre-orders worldwide top 5 billion\"</a>. <i>The Japan Times</i>. 12 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Japan+Times&amp;rft.atitle=Coronavirus+vaccine+pre-orders+worldwide+top+5+billion&amp;rft.date=2020-08-12&amp;rft_id=https%3A%2F%2Fwww.japantimes.co.jp%2Fnews%2F2020%2F08%2F12%2Fworld%2Fscience-health-world%2Fpre-orders-coronavirus-vaccines%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-240\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-240\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFC2020\" class=\"citation web cs1\">C, Hannah (10 October 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencetimes.com/articles/27653/20201010/china-producing-600-million-vaccine-2020.htm\">\"China Commits to Producing 600 Million Vaccine Doses by the End of 2020\"</a>. <i>Science Times</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 October</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Science+Times&amp;rft.atitle=China+Commits+to+Producing+600+Million+Vaccine+Doses+by+the+End+of+2020&amp;rft.date=2020-10-10&amp;rft.aulast=C&amp;rft.aufirst=Hannah&amp;rft_id=https%3A%2F%2Fwww.sciencetimes.com%2Farticles%2F27653%2F20201010%2Fchina-producing-600-million-vaccine-2020.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-molteni-241\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-molteni_241-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFMegan_Molteni2020\" class=\"citation web cs1\">Megan Molteni (26 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.wired.com/story/vaccine-makers-turn-to-microchip-tech-to-beat-glass-shortages/\">\"Vaccine makers turn to microchip tech to beat glass shortages\"</a>. Wired<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccine+makers+turn+to+microchip+tech+to+beat+glass+shortages&amp;rft.pub=Wired&amp;rft.date=2020-06-26&amp;rft.au=Megan+Molteni&amp;rft_id=https%3A%2F%2Fwww.wired.com%2Fstory%2Fvaccine-makers-turn-to-microchip-tech-to-beat-glass-shortages%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-glass-242\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-glass_242-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFFraiser_Kansteiner2020\" class=\"citation web cs1\">Fraiser Kansteiner (8 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/manufacturing/sio2-injects-163-million-into-glass-vial-production-plant\">\"With COVID-19 vaccines coming, SiO2 injects $163M into vial production plant\"</a>. FiercePharma, Questex LLC<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=With+COVID-19+vaccines+coming%2C+SiO2+injects+%24163M+into+vial+production+plant&amp;rft.pub=FiercePharma%2C+Questex+LLC&amp;rft.date=2020-07-08&amp;rft.au=Fraiser+Kansteiner&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fmanufacturing%2Fsio2-injects-163-million-into-glass-vial-production-plant&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-burger-243\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-burger_243-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFLudwig_BurgerMatthias_Blamont2020\" class=\"citation news cs1\">Ludwig Burger; Matthias Blamont (11 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/us-health-coronavirus-schott-exclusive-idUSKBN23J0SN\">\"Bottlenecks? Glass vial makers prepare for COVID-19 vaccine\"</a>. <i>Reuters</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Bottlenecks%3F+Glass+vial+makers+prepare+for+COVID-19+vaccine&amp;rft.date=2020-06-11&amp;rft.au=Ludwig+Burger&amp;rft.au=Matthias+Blamont&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-health-coronavirus-schott-exclusive-idUSKBN23J0SN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-kaplan-244\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-kaplan_244-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-kaplan_244-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFDeborah_Abrams_Kaplan2020\" class=\"citation web cs1\">Deborah Abrams Kaplan (7 July 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.supplychaindive.com/news/coronavirus-rfid-sensor-tracking-hospital-supply-chain/581066/\">\"3 applications for RFID in the fight against COVID-19\"</a>. Supply Chain Dive<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=3+applications+for+RFID+in+the+fight+against+COVID-19&amp;rft.pub=Supply+Chain+Dive&amp;rft.date=2020-07-07&amp;rft.au=Deborah+Abrams+Kaplan&amp;rft_id=https%3A%2F%2Fwww.supplychaindive.com%2Fnews%2Fcoronavirus-rfid-sensor-tracking-hospital-supply-chain%2F581066%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-karto-245\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-karto_245-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-karto_245-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-karto_245-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFKartogluMilstien2014\" class=\"citation journal cs1\">Kartoglu, Umit; Milstien, Julie (28 May 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4743593\">\"Tools and approaches to ensure quality of vaccines throughout the cold chain\"</a>. <i>Expert Review of Vaccines</i>. <b>13</b> (7): 843\\xe2\\x80\\x9354. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1586%2F14760584.2014.923761\">10.1586/14760584.2014.923761</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1476-0584\">1476-0584</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4743593\">4743593</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/24865112\">24865112</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Review+of+Vaccines&amp;rft.atitle=Tools+and+approaches+to+ensure+quality+of+vaccines+throughout+the+cold+chain&amp;rft.volume=13&amp;rft.issue=7&amp;rft.pages=843-54&amp;rft.date=2014-05-28&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4743593&amp;rft.issn=1476-0584&amp;rft_id=info%3Apmid%2F24865112&amp;rft_id=info%3Adoi%2F10.1586%2F14760584.2014.923761&amp;rft.aulast=Kartoglu&amp;rft.aufirst=Umit&amp;rft.au=Milstien%2C+Julie&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4743593&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-hanson-246\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-hanson_246-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFHansonGeorgeSawadogoSchreiber2017\" class=\"citation journal cs1\">Hanson, Celina M.; George, Anupa M.; Sawadogo, Adama; Schreiber, Benjamin (19 April 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencedirect.com/science/article/pii/S0264410X16309471/\">\"Is freezing in the vaccine cold chain an ongoing issue? A literature review\"</a>. <i>Vaccine</i>. <b>35</b> (17): 2127\\xe2\\x80\\x9333. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2Fj.vaccine.2016.09.070\">10.1016/j.vaccine.2016.09.070</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0264-410X\">0264-410X</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/28364920\">28364920</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Is+freezing+in+the+vaccine+cold+chain+an+ongoing+issue%3F+A+literature+review&amp;rft.volume=35&amp;rft.issue=17&amp;rft.pages=2127-33&amp;rft.date=2017-04-19&amp;rft.issn=0264-410X&amp;rft_id=info%3Apmid%2F28364920&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2016.09.070&amp;rft.aulast=Hanson&amp;rft.aufirst=Celina+M.&amp;rft.au=George%2C+Anupa+M.&amp;rft.au=Sawadogo%2C+Adama&amp;rft.au=Schreiber%2C+Benjamin&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0264410X16309471%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-weise-247\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-weise_247-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-weise_247-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-weise_247-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFElizabeth_Weise2020\" class=\"citation news cs1\">Elizabeth Weise (6 September 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usatoday.com/story/news/health/2020/09/06/covid-vaccine-complex-distribution-supply-chain-follow-approval/5712053002/\">\"<span class=\"cs1-kern-left\">\\'</span>Mind-bogglingly complex\\': Here\\'s what we know about how COVID-19 vaccine will be distributed when it\\'s approved\"</a>. <i>USA Today</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=%27Mind-bogglingly+complex%27%3A+Here%27s+what+we+know+about+how+COVID-19+vaccine+will+be+distributed+when+it%27s+approved&amp;rft.date=2020-09-06&amp;rft.au=Elizabeth+Weise&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fhealth%2F2020%2F09%2F06%2Fcovid-vaccine-complex-distribution-supply-chain-follow-approval%2F5712053002%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-durbha-248\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-durbha_248-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFMadhav_Durbha2020\" class=\"citation web cs1\">Madhav Durbha (29 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.europeanpharmaceuticalreview.com/article/122358/the-extra-mile-preparing-a-supply-chain-for-a-covid-19-vaccine/\">\"The extra mile: preparing a supply chain for a COVID-19 vaccine\"</a>. European Pharmaceutical Review<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+extra+mile%3A+preparing+a+supply+chain+for+a+COVID-19+vaccine&amp;rft.pub=European+Pharmaceutical+Review&amp;rft.date=2020-06-29&amp;rft.au=Madhav+Durbha&amp;rft_id=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Farticle%2F122358%2Fthe-extra-mile-preparing-a-supply-chain-for-a-covid-19-vaccine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-iata-249\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-iata_249-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-iata_249-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-iata_249-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-iata_249-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.iata.org/en/pressroom/pr/2020-09-09-01/\">\"The time to prepare for COVID-19 vaccine transport is now\"</a>. International Air Transport Association. 9 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+time+to+prepare+for+COVID-19+vaccine+transport+is+now&amp;rft.pub=International+Air+Transport+Association&amp;rft.date=2020-09-09&amp;rft_id=https%3A%2F%2Fwww.iata.org%2Fen%2Fpressroom%2Fpr%2F2020-09-09-01%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-unodc-250\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-unodc_250-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-unodc_250-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-unodc_250-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.unodc.org/documents/data-and-analysis/covid/COVID-19_research_brief_trafficking_medical_products.pdf\">\"COVID-19-related trafficking of medical products as a threat to public health\"</a> <span class=\"cs1-format\">(PDF)</span>. United Nations Office on Drugs and Crime. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVID-19-related+trafficking+of+medical+products+as+a+threat+to+public+health&amp;rft.pub=United+Nations+Office+on+Drugs+and+Crime&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.unodc.org%2Fdocuments%2Fdata-and-analysis%2Fcovid%2FCOVID-19_research_brief_trafficking_medical_products.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-kohler-251\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-kohler_251-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFKohlerDimancesco2020\" class=\"citation journal cs1\">Kohler, Jillian Clare; Dimancesco, Deirdre (3 February 2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7170361\">\"The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk\"</a>. <i>Global Health Action</i>. <b>13</b> (sup1): 1694745. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1080%2F16549716.2019.1694745\">10.1080/16549716.2019.1694745</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1654-9716\">1654-9716</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7170361\">7170361</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32194011\">32194011</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Global+Health+Action&amp;rft.atitle=The+risk+of+corruption+in+public+pharmaceutical+procurement%3A+how+anti-corruption%2C+transparency+and+accountability+measures+may+reduce+this+risk&amp;rft.volume=13&amp;rft.issue=sup1&amp;rft.pages=1694745&amp;rft.date=2020-02-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7170361&amp;rft.issn=1654-9716&amp;rft_id=info%3Apmid%2F32194011&amp;rft_id=info%3Adoi%2F10.1080%2F16549716.2019.1694745&amp;rft.aulast=Kohler&amp;rft.aufirst=Jillian+Clare&amp;rft.au=Dimancesco%2C+Deirdre&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7170361&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-subra-252\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-subra_252-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFSamanth_Subramanian2020\" class=\"citation news cs1\">Samanth Subramanian (13 August 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/features/2020-covid-vaccine-tracking-biometric/\">\"Biometric tracking can ensure billions have immunity against Covid-19\"</a>. <i>Bloomberg Businessweek</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft.atitle=Biometric+tracking+can+ensure+billions+have+immunity+against+Covid-19&amp;rft.date=2020-08-13&amp;rft.au=Samanth+Subramanian&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Ffeatures%2F2020-covid-vaccine-tracking-biometric%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-who-evm-253\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-evm_253-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-evm_253-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who.int/immunization/programmes_systems/supply_chain/evm/en/index5.html\">\"Effective Vaccine Management (EVM) Initiative:Vaccine Management Handbook\"</a>. World Health Organization. 9 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Effective+Vaccine+Management+%28EVM%29+Initiative%3AVaccine+Management+Handbook&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-09-09&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fimmunization%2Fprogrammes_systems%2Fsupply_chain%2Fevm%2Fen%2Findex5.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-254\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-254\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFAzar2020\" class=\"citation web cs1\">Azar A (4 February 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.phe.gov/Preparedness/legal/prepact/Pages/COVID19.aspx\">\"Notice of Declaration under the Public Readiness and Emergency Preparedness Act for medical countermeasures against COVID-19\"</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200425015411/https://www.phe.gov/Preparedness/legal/prepact/Pages/COVID19.aspx\">Archived</a> from the original on 25 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 April</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Notice+of+Declaration+under+the+Public+Readiness+and+Emergency+Preparedness+Act+for+medical+countermeasures+against+COVID-19&amp;rft.date=2020-02-04&amp;rft.aulast=Azar&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.phe.gov%2FPreparedness%2Flegal%2Fprepact%2FPages%2FCOVID19.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-255\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-255\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFKertscher2020\" class=\"citation web cs1\">Kertscher T (23 January 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.politifact.com/factchecks/2020/jan/23/facebook-posts/there-outbreak-china-wuhan-coronavirus-there-not-v/\">\"No, there is no vaccine for the Wuhan coronavirus\"</a>. <i><a href=\"/wiki/PolitiFact\" title=\"PolitiFact\">PolitiFact</a></i>. <a href=\"/wiki/Poynter_Institute\" title=\"Poynter Institute\">Poynter Institute</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200207133056/https://www.politifact.com/factchecks/2020/jan/23/facebook-posts/there-outbreak-china-wuhan-coronavirus-there-not-v/\">Archived</a> from the original on 7 February 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">7 February</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PolitiFact&amp;rft.atitle=No%2C+there+is+no+vaccine+for+the+Wuhan+coronavirus&amp;rft.date=2020-01-23&amp;rft.aulast=Kertscher&amp;rft.aufirst=Tom&amp;rft_id=https%3A%2F%2Fwww.politifact.com%2Ffactchecks%2F2020%2Fjan%2F23%2Ffacebook-posts%2Fthere-outbreak-china-wuhan-coronavirus-there-not-v%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-20200124factcheckA-256\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20200124factcheckA_256-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFMcDonald2020\" class=\"citation web cs1\">McDonald J (24 January 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.factcheck.org/2020/01/social-media-posts-spread-bogus-coronavirus-conspiracy-theory/\">\"Social Media Posts Spread Bogus Coronavirus Conspiracy Theory\"</a>. <i><a href=\"/wiki/FactCheck.org\" title=\"FactCheck.org\">FactCheck.org</a></i>. <a href=\"/wiki/Annenberg_Public_Policy_Center\" title=\"Annenberg Public Policy Center\">Annenberg Public Policy Center</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200206102802/https://www.factcheck.org/2020/01/social-media-posts-spread-bogus-coronavirus-conspiracy-theory/\">Archived</a> from the original on 6 February 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 February</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FactCheck.org&amp;rft.atitle=Social+Media+Posts+Spread+Bogus+Coronavirus+Conspiracy+Theory&amp;rft.date=2020-01-24&amp;rft.aulast=McDonald&amp;rft.aufirst=Jessica&amp;rft_id=https%3A%2F%2Fwww.factcheck.org%2F2020%2F01%2Fsocial-media-posts-spread-bogus-coronavirus-conspiracy-theory%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n<li id=\"cite_note-257\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-257\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/north-coast-biologics-607532-05212020\">\"Warning Letter \\xe2\\x80\\x93 North Coast Biologics \\xe2\\x80\\x93 MARCS-CMS 607532\"</a>. U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA). 21 May 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20200526221432/https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/north-coast-biologics-607532-05212020\">Archived</a> from the original on 26 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 May</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Warning+Letter+%E2%80%93+North+Coast+Biologics+%E2%80%93+MARCS-CMS+607532&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2020-05-21&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Finspections-compliance-enforcement-and-criminal-investigations%2Fwarning-letters%2Fnorth-coast-biologics-607532-05212020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></span>\\n</li>\\n</ol></div></div>\\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span></h2>\\n<ul><li><cite id=\"CITEREFFunkLaferri\\xc3\\xa8reArdakani2020\" class=\"citation journal cs1\">Funk CD, Laferri\\xc3\\xa8re C, Ardakani A (2020). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7317023\">\"A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic\"</a>. <i>Front Pharmacol</i>. <b>11</b>: 937. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.3389%2Ffphar.2020.00937\">10.3389/fphar.2020.00937</a></span>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7317023\">7317023</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32636754\">32636754</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Front+Pharmacol&amp;rft.atitle=A+Snapshot+of+the+Global+Race+for+Vaccines+Targeting+SARS-CoV-2+and+the+COVID-19+Pandemic&amp;rft.volume=11&amp;rft.pages=937&amp;rft.date=2020&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7317023&amp;rft_id=info%3Apmid%2F32636754&amp;rft_id=info%3Adoi%2F10.3389%2Ffphar.2020.00937&amp;rft.aulast=Funk&amp;rft.aufirst=CD&amp;rft.au=Laferri%C3%A8re%2C+C&amp;rft.au=Ardakani%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7317023&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li>\\n<li><cite id=\"CITEREFJohnsonMufson2020\" class=\"citation web cs1\">Johnson CY, Mufson S (11 June 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.washingtonpost.com/health/2020/06/11/can-old-vaccines-sciences-medicine-cabinet-ward-off-coronavirus/\">\"Can old vaccines from science\\'s medicine cabinet ward off coronavirus?\"</a>. <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=Can+old+vaccines+from+science%27s+medicine+cabinet+ward+off+coronavirus%3F&amp;rft.date=2020-06-11&amp;rft.aulast=Johnson&amp;rft.aufirst=Carolyn+Y.&amp;rft.au=Mufson%2C+Steven&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fhealth%2F2020%2F06%2F11%2Fcan-old-vaccines-sciences-medicine-cabinet-ward-off-coronavirus%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li>\\n<li><cite id=\"CITEREFZimmerSheikhWeiland2020\" class=\"citation web cs1\">Zimmer C, Sheikh K, Weiland N (20 May 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/05/20/health/coronavirus-vaccines.html\">\"A New Entry in the Race for a Coronavirus Vaccine: Hope\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+New+Entry+in+the+Race+for+a+Coronavirus+Vaccine%3A+Hope&amp;rft.date=2020-05-20&amp;rft.aulast=Zimmer&amp;rft.aufirst=Carl&amp;rft.au=Sheikh%2C+Knvul&amp;rft.au=Weiland%2C+Noah&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F05%2F20%2Fhealth%2Fcoronavirus-vaccines.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li>\\n<li><cite class=\"citation journal cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/media/139638/download\">\"Development and Licensure of Vaccines to Prevent COVID-19\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA)</i>. June 2020. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19\">Lay summary</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=Development+and+Licensure+of+Vaccines+to+Prevent+COVID-19&amp;rft.date=2020-06&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F139638%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li></ul>\\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span></h2>\\n<table role=\"presentation\" class=\"mbox-small plainlinks sistersitebox\" style=\"background-color:#f9f9f9;border:1px solid #aaa;color:#000\">\\n<tbody><tr>\\n<td class=\"mbox-image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/34px-Wikiquote-logo.svg.png\" decoding=\"async\" width=\"34\" height=\"40\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/51px-Wikiquote-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/68px-Wikiquote-logo.svg.png 2x\" data-file-width=\"300\" data-file-height=\"355\" /></td>\\n<td class=\"mbox-text plainlist\">Wikiquote has quotations related to: <i><b><a href=\"https://en.wikiquote.org/wiki/Special:Search/COVID-19_vaccine\" class=\"extiw\" title=\"q:Special:Search/COVID-19 vaccine\">COVID-19 vaccine</a></b></i></td></tr>\\n</tbody></table>\\n<ul><li><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html\">\"Coronavirus Vaccine Tracker\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Coronavirus+Vaccine+Tracker&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2Finteractive%2F2020%2Fscience%2Fcoronavirus-vaccine-tracker.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li>\\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker\">COVID-19 vaccine tracker, Regulatory Focus</a></li>\\n<li><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/feature/coronavirus/drugs-vaccines-tracker/#vaccines\">\"STAT\\'s Covid-19 Drugs and Vaccines Tracker\"</a>. <i><a href=\"/wiki/Stat_(website)\" title=\"Stat (website)\">Stat</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Stat&amp;rft.atitle=STAT%27s+Covid-19+Drugs+and+Vaccines+Tracker&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2Ffeature%2Fcoronavirus%2Fdrugs-vaccines-tracker%2F%23vaccines&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li>\\n<li><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20200908005282/en/\">\"Biopharma Leaders Unite to Stand with Science\"</a> (Press release). 8 September 2020 &#8211; via Business Wire.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Biopharma+Leaders+Unite+to+Stand+with+Science&amp;rft.date=2020-09-08&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20200908005282%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li>\\n<li><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.modernatx.com/sites/default/files/mRNA-1273-P301-Protocol.pdf\">\"Protocol mRNA-1273-P301\"</a> <span class=\"cs1-format\">(PDF)</span>. <a href=\"/wiki/Moderna\" title=\"Moderna\">Moderna</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protocol+mRNA-1273-P301&amp;rft.pub=Moderna&amp;rft_id=https%3A%2F%2Fwww.modernatx.com%2Fsites%2Fdefault%2Ffiles%2FmRNA-1273-P301-Protocol.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li>\\n<li><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-09/C4591001_Clinical_Protocol.pdf\">\"Protocol C4591001 PF-07302048 (BNT162 RNA-Based COVID-19 Vaccines)\"</a> <span class=\"cs1-format\">(PDF)</span>. <a href=\"/wiki/Pfizer\" title=\"Pfizer\">Pfizer</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protocol+C4591001+PF-07302048+%28BNT162+RNA-Based+COVID-19+Vaccines%29&amp;rft.pub=Pfizer&amp;rft_id=https%3A%2F%2Fpfe-pfizercom-d8-prod.s3.amazonaws.com%2F2020-09%2FC4591001_Clinical_Protocol.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li>\\n<li><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://s3.amazonaws.com/ctr-med-7111/D8110C00001/52bec400-80f6-4c1b-8791-0483923d0867/c8070a4e-6a9d-46f9-8c32-cece903592b9/D8110C00001_CSP-v2.pdf\">\"Protocol AZD1222 \\xe2\\x80\\x93 D8110C00001\"</a> <span class=\"cs1-format\">(PDF)</span>. <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protocol+AZD1222+%E2%80%93+D8110C00001&amp;rft.pub=AstraZeneca&amp;rft_id=https%3A%2F%2Fs3.amazonaws.com%2Fctr-med-7111%2FD8110C00001%2F52bec400-80f6-4c1b-8791-0483923d0867%2Fc8070a4e-6a9d-46f9-8c32-cece903592b9%2FD8110C00001_CSP-v2.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li>\\n<li><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.jnj.com/coronavirus/covid-19-phase-3-study-clinical-protocol\">\"Protocol VAC31518COV3001; Phase 3\"</a> <span class=\"cs1-format\">(PDF)</span>. <a href=\"/wiki/Janssen_Pharmaceutica\" title=\"Janssen Pharmaceutica\">Janssen Vaccines &amp; Prevention</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protocol+VAC31518COV3001%3B+Phase+3&amp;rft.pub=Janssen+Vaccines+%26+Prevention&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fcoronavirus%2Fcovid-19-phase-3-study-clinical-protocol&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\" class=\"Z3988\"></span><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r982806391\"/></li></ul>\\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"COVID-19_pandemic\" style=\"padding:3px\"><table class=\"nowraplinks hlist mw-collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:COVID-19_pandemic\" title=\"Template:COVID-19 pandemic\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:COVID-19_pandemic\" title=\"Template talk:COVID-19 pandemic\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:COVID-19_pandemic&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"COVID-19_pandemic\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a></div></th></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div id=\"*_SARS-CoV-2_(virus)_*_COVID-19_(disease)\">\\n<ul><li><b><a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a> (virus)</b></li>\\n<li><b><a href=\"/wiki/Coronavirus_disease_2019\" title=\"Coronavirus disease 2019\">COVID-19</a> (disease)</b></li></ul>\\n</div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div id=\"Timeline\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic\" title=\"Timeline of the COVID-19 pandemic\">Timeline</a></div></th></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Pandemic_predictions_and_preparations_prior_to_the_COVID-19_pandemic\" title=\"Pandemic predictions and preparations prior to the COVID-19 pandemic\">Pre-pandemic</a>\\n<ul><li><a href=\"/wiki/Crimson_Contagion\" title=\"Crimson Contagion\">Crimson Contagion</a></li>\\n<li><a href=\"/wiki/Disease_X\" title=\"Disease X\">Disease X</a></li>\\n<li><a href=\"/wiki/Event_201\" class=\"mw-redirect\" title=\"Event 201\">Event 201</a></li>\\n<li><a href=\"/wiki/Exercise_Cygnus\" title=\"Exercise Cygnus\">Exercise Cygnus</a></li></ul></li></ul>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_2019\" title=\"Timeline of the COVID-19 pandemic in 2019\">2019</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_December_2019\" class=\"mw-redirect\" title=\"Timeline of the COVID-19 pandemic in December 2019\">December</a></li></ul></li>\\n<li>2020\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_January_2020\" title=\"Timeline of the COVID-19 pandemic in January 2020\">January</a></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_February_2020\" title=\"Timeline of the COVID-19 pandemic in February 2020\">February</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_February_2020\" title=\"Responses to the COVID-19 pandemic in February 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_March_2020\" title=\"Timeline of the COVID-19 pandemic in March 2020\">March</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_March_2020\" title=\"Responses to the COVID-19 pandemic in March 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_April_2020\" title=\"Timeline of the COVID-19 pandemic in April 2020\">April</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_April_2020\" title=\"Responses to the COVID-19 pandemic in April 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_May_2020\" title=\"Timeline of the COVID-19 pandemic in May 2020\">May</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_May_2020\" title=\"Responses to the COVID-19 pandemic in May 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_June_2020\" title=\"Timeline of the COVID-19 pandemic in June 2020\">June</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_June_2020\" title=\"Responses to the COVID-19 pandemic in June 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_July_2020\" title=\"Timeline of the COVID-19 pandemic in July 2020\">July</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_July_2020\" title=\"Responses to the COVID-19 pandemic in July 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_August_2020\" title=\"Timeline of the COVID-19 pandemic in August 2020\">August</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_August_2020\" title=\"Responses to the COVID-19 pandemic in August 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_September_2020\" title=\"Timeline of the COVID-19 pandemic in September 2020\">September</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_September_2020\" title=\"Responses to the COVID-19 pandemic in September 2020\">responses</a></li></ul></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_October_2020\" title=\"Timeline of the COVID-19 pandemic in October 2020\">October</a>\\n<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_October_2020\" title=\"Responses to the COVID-19 pandemic in October 2020\">responses</a></li></ul></li></ul></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div id=\"Locations\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/COVID-19_pandemic_by_country_and_territory\" title=\"COVID-19 pandemic by country and territory\">Locations</a></div></th></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Africa\" title=\"COVID-19 pandemic in Africa\">Africa</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">Northern</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Algeria\" title=\"COVID-19 pandemic in Algeria\">Algeria</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Canary_Islands\" title=\"COVID-19 pandemic in the Canary Islands\">Canary Islands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ceuta\" title=\"COVID-19 pandemic in Ceuta\">Ceuta</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Egypt\" title=\"COVID-19 pandemic in Egypt\">Egypt</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Libya\" title=\"COVID-19 pandemic in Libya\">Libya</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mauritania\" title=\"COVID-19 pandemic in Mauritania\">Mauritania</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Melilla\" title=\"COVID-19 pandemic in Melilla\">Melilla</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Morocco\" title=\"COVID-19 pandemic in Morocco\">Morocco</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sudan\" title=\"COVID-19 pandemic in Sudan\">Sudan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Tunisia\" title=\"COVID-19 pandemic in Tunisia\">Tunisia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Western_Sahara\" title=\"COVID-19 pandemic in Western Sahara\">Western Sahara</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Sahrawi_Arab_Democratic_Republic\" title=\"COVID-19 pandemic in the Sahrawi Arab Democratic Republic\">Sahrawi Arab Democratic Republic</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">Eastern</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Burundi\" title=\"COVID-19 pandemic in Burundi\">Burundi</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Comoros\" title=\"COVID-19 pandemic in the Comoros\">Comoros</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Djibouti\" title=\"COVID-19 pandemic in Djibouti\">Djibouti</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Eritrea\" title=\"COVID-19 pandemic in Eritrea\">Eritrea</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ethiopia\" title=\"COVID-19 pandemic in Ethiopia\">Ethiopia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Kenya\" title=\"COVID-19 pandemic in Kenya\">Kenya</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Madagascar\" title=\"COVID-19 pandemic in Madagascar\">Madagascar</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mauritius\" title=\"COVID-19 pandemic in Mauritius\">Mauritius</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mayotte\" title=\"COVID-19 pandemic in Mayotte\">Mayotte</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_R%C3%A9union\" title=\"COVID-19 pandemic in R\\xc3\\xa9union\">R\\xc3\\xa9union</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Rwanda\" title=\"COVID-19 pandemic in Rwanda\">Rwanda</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Seychelles\" title=\"COVID-19 pandemic in Seychelles\">Seychelles</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Somalia\" title=\"COVID-19 pandemic in Somalia\">Somalia</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Puntland\" title=\"COVID-19 pandemic in Puntland\">Puntland</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Somaliland\" title=\"COVID-19 pandemic in Somaliland\">Somaliland</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_South_Sudan\" title=\"COVID-19 pandemic in South Sudan\">South Sudan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Tanzania\" title=\"COVID-19 pandemic in Tanzania\">Tanzania</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Uganda\" title=\"COVID-19 pandemic in Uganda\">Uganda</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">Southern</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Angola\" title=\"COVID-19 pandemic in Angola\">Angola</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Botswana\" title=\"COVID-19 pandemic in Botswana\">Botswana</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Eswatini\" title=\"COVID-19 pandemic in Eswatini\">Eswatini</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Lesotho\" title=\"COVID-19 pandemic in Lesotho\">Lesotho</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Malawi\" title=\"COVID-19 pandemic in Malawi\">Malawi</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mozambique\" title=\"COVID-19 pandemic in Mozambique\">Mozambique</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Namibia\" title=\"COVID-19 pandemic in Namibia\">Namibia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_South_Africa\" title=\"COVID-19 pandemic in South Africa\">South Africa</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Zambia\" title=\"COVID-19 pandemic in Zambia\">Zambia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Zimbabwe\" title=\"COVID-19 pandemic in Zimbabwe\">Zimbabwe</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">Central</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Cameroon\" title=\"COVID-19 pandemic in Cameroon\">Cameroon</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Central_African_Republic\" title=\"COVID-19 pandemic in the Central African Republic\">Central African Republic</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Chad\" title=\"COVID-19 pandemic in Chad\">Chad</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Democratic_Republic_of_the_Congo\" title=\"COVID-19 pandemic in the Democratic Republic of the Congo\">Democratic Republic of the Congo</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Republic_of_the_Congo\" title=\"COVID-19 pandemic in the Republic of the Congo\">Republic of the Congo</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Gabon\" title=\"COVID-19 pandemic in Gabon\">Gabon</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_S%C3%A3o_Tom%C3%A9_and_Pr%C3%ADncipe\" title=\"COVID-19 pandemic in S\\xc3\\xa3o Tom\\xc3\\xa9 and Pr\\xc3\\xadncipe\">S\\xc3\\xa3o Tom\\xc3\\xa9 and Pr\\xc3\\xadncipe</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">Western</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Benin\" title=\"COVID-19 pandemic in Benin\">Benin</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Burkina_Faso\" title=\"COVID-19 pandemic in Burkina Faso\">Burkina Faso</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Cape_Verde\" title=\"COVID-19 pandemic in Cape Verde\">Cape Verde</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Equatorial_Guinea\" title=\"COVID-19 pandemic in Equatorial Guinea\">Equatorial Guinea</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Gambia\" title=\"COVID-19 pandemic in the Gambia\">Gambia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ghana\" title=\"COVID-19 pandemic in Ghana\">Ghana</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Ghana\" title=\"Timeline of the COVID-19 pandemic in Ghana\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Guinea\" title=\"COVID-19 pandemic in Guinea\">Guinea</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Guinea-Bissau\" title=\"COVID-19 pandemic in Guinea-Bissau\">Guinea-Bissau</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ivory_Coast\" title=\"COVID-19 pandemic in Ivory Coast\">Ivory Coast</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Liberia\" title=\"COVID-19 pandemic in Liberia\">Liberia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mali\" title=\"COVID-19 pandemic in Mali\">Mali</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Niger\" title=\"COVID-19 pandemic in Niger\">Niger</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Nigeria\" title=\"COVID-19 pandemic in Nigeria\">Nigeria</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Senegal\" title=\"COVID-19 pandemic in Senegal\">Senegal</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sierra_Leone\" title=\"COVID-19 pandemic in Sierra Leone\">Sierra Leone</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Togo\" title=\"COVID-19 pandemic in Togo\">Togo</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Asia\" title=\"COVID-19 pandemic in Asia\">Asia</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">Central / <a href=\"/wiki/COVID-19_pandemic_in_North_Asia\" title=\"COVID-19 pandemic in North Asia\">North</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Kazakhstan\" title=\"COVID-19 pandemic in Kazakhstan\">Kazakhstan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Kyrgyzstan\" title=\"COVID-19 pandemic in Kyrgyzstan\">Kyrgyzstan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Russia\" title=\"COVID-19 pandemic in Russia\">Russia</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Russia\" title=\"Timeline of the COVID-19 pandemic in Russia\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Tajikistan\" title=\"COVID-19 pandemic in Tajikistan\">Tajikistan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Turkmenistan\" title=\"COVID-19 pandemic in Turkmenistan\">Turkmenistan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Uzbekistan\" title=\"COVID-19 pandemic in Uzbekistan\">Uzbekistan</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">East</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Hong_Kong\" title=\"COVID-19 pandemic in Hong Kong\">Hong Kong</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Japan\" title=\"COVID-19 pandemic in Japan\">Japan</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Japan\" title=\"Timeline of the COVID-19 pandemic in Japan\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_North_Korea\" title=\"COVID-19 pandemic in North Korea\">North Korea</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_South_Korea\" title=\"COVID-19 pandemic in South Korea\">South Korea</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Macau\" title=\"COVID-19 pandemic in Macau\">Macau</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mongolia\" title=\"COVID-19 pandemic in Mongolia\">Mongolia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Taiwan\" title=\"COVID-19 pandemic in Taiwan\">Taiwan</a></li></ul>\\n</div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"China\" scope=\"row\" class=\"navbox-group\" style=\"width:6em\"><a href=\"/wiki/COVID-19_pandemic_in_mainland_China\" title=\"COVID-19 pandemic in mainland China\">China</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Beijing\" title=\"COVID-19 pandemic in Beijing\">Beijing</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Heilongjiang\" title=\"COVID-19 pandemic in Heilongjiang\">Heilongjiang</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Henan\" title=\"COVID-19 pandemic in Henan\">Henan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Hubei\" title=\"COVID-19 pandemic in Hubei\">Hubei</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_lockdown_in_Hubei\" title=\"COVID-19 pandemic lockdown in Hubei\">lockdown</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Inner_Mongolia\" title=\"COVID-19 pandemic in Inner Mongolia\">Inner Mongolia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Liaoning\" title=\"COVID-19 pandemic in Liaoning\">Liaoning</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Shanghai\" title=\"COVID-19 pandemic in Shanghai\">Shanghai</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sichuan\" title=\"COVID-19 pandemic in Sichuan\">Sichuan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Tibet\" title=\"COVID-19 pandemic in Tibet\">Tibet</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Xinjiang\" title=\"COVID-19 pandemic in Xinjiang\"> Xinjiang</a></li></ul>\\n</div></td></tr></tbody></table><div>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\"><a href=\"/wiki/COVID-19_pandemic_in_South_Asia\" title=\"COVID-19 pandemic in South Asia\">South</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Afghanistan\" title=\"COVID-19 pandemic in Afghanistan\">Afghanistan</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Afghanistan\" title=\"Timeline of the COVID-19 pandemic in Afghanistan\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Bangladesh\" title=\"COVID-19 pandemic in Bangladesh\">Bangladesh</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Bhutan\" title=\"COVID-19 pandemic in Bhutan\">Bhutan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Maldives\" title=\"COVID-19 pandemic in the Maldives\">Maldives</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Nepal\" title=\"COVID-19 pandemic in Nepal\">Nepal</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Nepal\" title=\"Timeline of the COVID-19 pandemic in Nepal\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Pakistan\" title=\"COVID-19 pandemic in Pakistan\">Pakistan</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Pakistan\" title=\"Timeline of the COVID-19 pandemic in Pakistan\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sri_Lanka\" title=\"COVID-19 pandemic in Sri Lanka\">Sri Lanka</a></li></ul>\\n</div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"India\" scope=\"row\" class=\"navbox-group\" style=\"width:6em\"><a href=\"/wiki/COVID-19_pandemic_in_India\" title=\"COVID-19 pandemic in India\">India</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li>(<a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_India\" class=\"mw-redirect\" title=\"Timeline of the COVID-19 pandemic in India\">timeline</a></li>\\n<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_India\" title=\"Economic impact of the COVID-19 pandemic in India\">economic impact</a></li>\\n<li><a href=\"/wiki/Evacuations_by_India_related_to_the_COVID-19_pandemic\" title=\"Evacuations by India related to the COVID-19 pandemic\">evacuations</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_lockdown_in_India\" title=\"COVID-19 pandemic lockdown in India\">lockdown</a></li>\\n<li><a href=\"/wiki/Indian_migrant_workers_during_the_COVID-19_pandemic\" title=\"Indian migrant workers during the COVID-19 pandemic\">migrant workers\\' crisis</a></li>\\n<li><a href=\"/wiki/Indian_government_response_to_the_COVID-19_pandemic\" title=\"Indian government response to the COVID-19 pandemic\">Indian government response</a>\\n<ul><li><a href=\"/wiki/Operation_Namaste\" title=\"Operation Namaste\">Operation Namaste</a></li></ul></li>\\n<li><a href=\"/wiki/Indian_state_government_responses_to_the_COVID-19_pandemic\" title=\"Indian state government responses to the COVID-19 pandemic\">state government responses</a>)</li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Andaman_and_Nicobar_Islands\" title=\"COVID-19 pandemic in the Andaman and Nicobar Islands\">Andaman and Nicobar Islands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Andhra_Pradesh\" title=\"COVID-19 pandemic in Andhra Pradesh\">Andhra Pradesh</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Arunachal_Pradesh\" title=\"COVID-19 pandemic in Arunachal Pradesh\">Arunachal Pradesh</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Assam\" title=\"COVID-19 pandemic in Assam\">Assam</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Bihar\" title=\"COVID-19 pandemic in Bihar\">Bihar</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Chandigarh\" title=\"COVID-19 pandemic in Chandigarh\">Chandigarh</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Chhattisgarh\" title=\"COVID-19 pandemic in Chhattisgarh\">Chhattisgarh</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Dadra_and_Nagar_Haveli_and_Daman_and_Diu\" title=\"COVID-19 pandemic in Dadra and Nagar Haveli and Daman and Diu\">Dadra and Nagar Haveli and Daman and Diu</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Delhi\" title=\"COVID-19 pandemic in Delhi\">Delhi</a>\\n<ul><li><a href=\"/wiki/2020_Tablighi_Jamaat_coronavirus_hotspot_in_Delhi\" title=\"2020 Tablighi Jamaat coronavirus hotspot in Delhi\">Tablighi Jamaat hotspot</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Goa\" title=\"COVID-19 pandemic in Goa\">Goa</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Gujarat\" title=\"COVID-19 pandemic in Gujarat\">Gujarat</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Haryana\" title=\"COVID-19 pandemic in Haryana\">Haryana</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Himachal_Pradesh\" title=\"COVID-19 pandemic in Himachal Pradesh\">Himachal Pradesh</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Jammu_and_Kashmir\" title=\"COVID-19 pandemic in Jammu and Kashmir\">Jammu and Kashmir</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Jharkhand\" title=\"COVID-19 pandemic in Jharkhand\">Jharkhand</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Karnataka\" title=\"COVID-19 pandemic in Karnataka\">Karnataka</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Kerala\" title=\"COVID-19 pandemic in Kerala\">Kerala</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ladakh\" title=\"COVID-19 pandemic in Ladakh\">Ladakh</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Madhya_Pradesh\" title=\"COVID-19 pandemic in Madhya Pradesh\">Madhya Pradesh</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Maharashtra\" title=\"COVID-19 pandemic in Maharashtra\">Maharashtra</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Manipur\" title=\"COVID-19 pandemic in Manipur\">Manipur</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Meghalaya\" title=\"COVID-19 pandemic in Meghalaya\">Meghalaya</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mizoram\" title=\"COVID-19 pandemic in Mizoram\">Mizoram</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Nagaland\" title=\"COVID-19 pandemic in Nagaland\">Nagaland</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Odisha\" title=\"COVID-19 pandemic in Odisha\">Odisha</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Puducherry\" title=\"COVID-19 pandemic in Puducherry\">Puducherry</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Punjab,_India\" title=\"COVID-19 pandemic in Punjab, India\">Punjab</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Rajasthan\" title=\"COVID-19 pandemic in Rajasthan\">Rajasthan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sikkim\" title=\"COVID-19 pandemic in Sikkim\">Sikkim</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Tamil_Nadu\" title=\"COVID-19 pandemic in Tamil Nadu\">Tamil Nadu</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Telangana\" title=\"COVID-19 pandemic in Telangana\">Telangana</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Tripura\" title=\"COVID-19 pandemic in Tripura\">Tripura</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Uttar_Pradesh\" title=\"COVID-19 pandemic in Uttar Pradesh\">Uttar Pradesh</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Uttarakhand\" title=\"COVID-19 pandemic in Uttarakhand\">Uttarakhand</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_West_Bengal\" title=\"COVID-19 pandemic in West Bengal\">West Bengal</a></li></ul>\\n</div></td></tr></tbody></table><div>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\"><a href=\"/wiki/COVID-19_pandemic_in_Southeast_Asia\" title=\"COVID-19 pandemic in Southeast Asia\">Southeast</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Brunei\" title=\"COVID-19 pandemic in Brunei\">Brunei</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Cambodia\" title=\"COVID-19 pandemic in Cambodia\">Cambodia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_East_Timor\" title=\"COVID-19 pandemic in East Timor\">East Timor</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Indonesia\" title=\"COVID-19 pandemic in Indonesia\">Indonesia</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Indonesia\" title=\"Timeline of the COVID-19 pandemic in Indonesia\">timeline</a></li>\\n<li><a href=\"/wiki/2020_Indonesia_large-scale_social_restrictions\" title=\"2020 Indonesia large-scale social restrictions\">social restrictions</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Laos\" title=\"COVID-19 pandemic in Laos\">Laos</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Malaysia\" title=\"COVID-19 pandemic in Malaysia\">Malaysia</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Malaysia\" title=\"Timeline of the COVID-19 pandemic in Malaysia\">timeline</a></li>\\n<li><a href=\"/wiki/2020_Malaysia_movement_control_order\" title=\"2020 Malaysia movement control order\">movement control order</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Johor\" title=\"COVID-19 pandemic in Johor\">Johor</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Kuala_Lumpur\" title=\"COVID-19 pandemic in Kuala Lumpur\">Kuala Lumpur</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sabah\" title=\"COVID-19 pandemic in Sabah\">Sabah</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sarawak\" title=\"COVID-19 pandemic in Sarawak\">Sarawak</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Selangor\" title=\"COVID-19 pandemic in Selangor\">Selangor</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Myanmar\" title=\"COVID-19 pandemic in Myanmar\">Myanmar</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Singapore\" title=\"COVID-19 pandemic in Singapore\">Singapore</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Singapore\" title=\"Timeline of the COVID-19 pandemic in Singapore\">timeline</a></li>\\n<li><a href=\"/wiki/2020_Singapore_circuit_breaker_measures\" title=\"2020 Singapore circuit breaker measures\">circuit breaker response</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Thailand\" title=\"COVID-19 pandemic in Thailand\">Thailand</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Nonthaburi_Province\" title=\"COVID-19 pandemic in Nonthaburi Province\">Nonthaburi</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Vietnam\" title=\"COVID-19 pandemic in Vietnam\">Vietnam</a></li></ul>\\n</div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"Philippines\" scope=\"row\" class=\"navbox-group\" style=\"width:6em\"><a href=\"/wiki/COVID-19_pandemic_in_the_Philippines\" title=\"COVID-19 pandemic in the Philippines\">Philippines</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li>(<a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_Philippines\" title=\"Timeline of the COVID-19 pandemic in the Philippines\">timeline</a></li>\\n<li><a href=\"/wiki/Philippine_government_response_to_the_COVID-19_pandemic\" title=\"Philippine government response to the COVID-19 pandemic\">government response</a>\\n<ul><li><a href=\"/wiki/COVID-19_community_quarantines_in_the_Philippines\" title=\"COVID-19 community quarantines in the Philippines\">community quarantines</a>\\n<ul><li><a href=\"/wiki/Enhanced_community_quarantine_in_Luzon\" title=\"Enhanced community quarantine in Luzon\">Luzon</a></li></ul></li>\\n<li><a href=\"/wiki/Evacuations_by_the_Philippines_related_to_the_COVID-19_pandemic\" title=\"Evacuations by the Philippines related to the COVID-19 pandemic\">evacuations</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_testing_controversy_in_the_Philippines\" title=\"COVID-19 testing controversy in the Philippines\">testing controversy</a>)</li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Bangsamoro\" title=\"COVID-19 pandemic in Bangsamoro\">Bangsamoro</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Bicol_Region\" title=\"COVID-19 pandemic in the Bicol Region\">Bicol Region</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Cagayan_Valley\" title=\"COVID-19 pandemic in Cagayan Valley\">Cagayan Valley</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Calabarzon\" title=\"COVID-19 pandemic in Calabarzon\">Calabarzon</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Caraga\" title=\"COVID-19 pandemic in Caraga\">Caraga</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Central_Luzon\" title=\"COVID-19 pandemic in Central Luzon\">Central Luzon</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Central_Visayas\" title=\"COVID-19 pandemic in Central Visayas\">Central Visayas</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Cordillera_Administrative_Region\" title=\"COVID-19 pandemic in the Cordillera Administrative Region\">Cordillera</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Davao_Region\" title=\"COVID-19 pandemic in the Davao Region\">Davao Region</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Eastern_Visayas\" title=\"COVID-19 pandemic in Eastern Visayas\">Eastern Visayas</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Ilocos_Region\" title=\"COVID-19 pandemic in the Ilocos Region\">Ilocos Region</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Metro_Manila\" title=\"COVID-19 pandemic in Metro Manila\">Metro Manila</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mimaropa\" title=\"COVID-19 pandemic in Mimaropa\">Mimaropa</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Northern_Mindanao\" title=\"COVID-19 pandemic in Northern Mindanao\">Northern Mindanao</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Soccsksargen\" title=\"COVID-19 pandemic in Soccsksargen\">Soccsksargen</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Western_Visayas\" title=\"COVID-19 pandemic in Western Visayas\">Western Visayas</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Zamboanga_Peninsula\" title=\"COVID-19 pandemic in Zamboanga Peninsula\">Zamboanga Peninsula</a></li>\\n<li><a href=\"/wiki/Overseas_Filipinos_during_the_COVID-19_pandemic\" title=\"Overseas Filipinos during the COVID-19 pandemic\">Overseas Filipinos</a></li></ul>\\n</div></td></tr></tbody></table><div>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">West</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Armenia\" title=\"COVID-19 pandemic in Armenia\">Armenia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Azerbaijan\" title=\"COVID-19 pandemic in Azerbaijan\">Azerbaijan</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Republic_of_Artsakh\" title=\"COVID-19 pandemic in the Republic of Artsakh\">Artsakh</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Bahrain\" title=\"COVID-19 pandemic in Bahrain\">Bahrain</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Georgia_(country)\" title=\"COVID-19 pandemic in Georgia (country)\">Georgia</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Abkhazia\" title=\"COVID-19 pandemic in Abkhazia\">Abkhazia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_South_Ossetia\" title=\"COVID-19 pandemic in South Ossetia\">South Ossetia</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Iran\" title=\"COVID-19 pandemic in Iran\">Iran</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Iraq\" title=\"COVID-19 pandemic in Iraq\">Iraq</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Kurdistan_Region\" title=\"COVID-19 pandemic in the Kurdistan Region\">Kurdistan</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Israel\" title=\"COVID-19 pandemic in Israel\">Israel</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Jordan\" title=\"COVID-19 pandemic in Jordan\">Jordan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Kuwait\" title=\"COVID-19 pandemic in Kuwait\">Kuwait</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Lebanon\" title=\"COVID-19 pandemic in Lebanon\">Lebanon</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Oman\" title=\"COVID-19 pandemic in Oman\">Oman</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_State_of_Palestine\" title=\"COVID-19 pandemic in the State of Palestine\">Palestine</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Qatar\" title=\"COVID-19 pandemic in Qatar\">Qatar</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Saudi_Arabia\" title=\"COVID-19 pandemic in Saudi Arabia\">Saudi Arabia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Syria\" title=\"COVID-19 pandemic in Syria\">Syria</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Turkey\" title=\"COVID-19 pandemic in Turkey\">Turkey</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Turkey\" title=\"Timeline of the COVID-19 pandemic in Turkey\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_United_Arab_Emirates\" title=\"COVID-19 pandemic in the United Arab Emirates\">United Arab Emirates</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Yemen\" title=\"COVID-19 pandemic in Yemen\">Yemen</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Europe\" title=\"COVID-19 pandemic in Europe\">Europe</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\"><a href=\"/wiki/COVID-19_pandemic_in_the_United_Kingdom\" title=\"COVID-19 pandemic in the United Kingdom\">United Kingdom</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li class=\"mw-empty-elt\"></li>\\n<li>timeline\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_United_Kingdom_(January%E2%80%93June_2020)\" title=\"Timeline of the COVID-19 pandemic in the United Kingdom (January\\xe2\\x80\\x93June 2020)\">January\\xe2\\x80\\x93June 2020</a></li>\\n<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_United_Kingdom_(July%E2%80%93December_2020)\" title=\"Timeline of the COVID-19 pandemic in the United Kingdom (July\\xe2\\x80\\x93December 2020)\">July\\xe2\\x80\\x93December 2020</a></li></ul></li>\\n<li><a href=\"/wiki/British_government_response_to_the_COVID-19_pandemic\" title=\"British government response to the COVID-19 pandemic\">government response</a>\\n<ul><li><a href=\"/wiki/Criticism_of_the_British_government_response_to_the_COVID-19_pandemic\" class=\"mw-redirect\" title=\"Criticism of the British government response to the COVID-19 pandemic\">criticism</a></li></ul></li>\\n<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_United_Kingdom\" title=\"Social impact of the COVID-19 pandemic in the United Kingdom\">social impact</a></li>\\n<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_the_United_Kingdom\" title=\"Economic impact of the COVID-19 pandemic in the United Kingdom\">economic impact</a></li>\\n<li><a href=\"/wiki/2020_United_Kingdom_education_shutdown\" title=\"2020 United Kingdom education shutdown\">education shutdown</a></li>\\n<li><a href=\"/wiki/Operation_Rescript\" title=\"Operation Rescript\">Operation Rescript</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_England\" title=\"COVID-19 pandemic in England\">England</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_England\" title=\"Timeline of the COVID-19 pandemic in England\">timeline</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_London\" title=\"COVID-19 pandemic in London\">London</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Northern_Ireland\" title=\"COVID-19 pandemic in Northern Ireland\">Northern Ireland</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Northern_Ireland\" title=\"Timeline of the COVID-19 pandemic in Northern Ireland\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Scotland\" title=\"COVID-19 pandemic in Scotland\">Scotland</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Scotland\" title=\"Timeline of the COVID-19 pandemic in Scotland\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Wales\" title=\"COVID-19 pandemic in Wales\">Wales</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Wales\" title=\"Timeline of the COVID-19 pandemic in Wales\">timeline</a></li></ul></li>\\n<li>Crown dependencies\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Isle_of_Man\" title=\"COVID-19 pandemic in the Isle of Man\">Isle of Man</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Jersey\" title=\"COVID-19 pandemic in Jersey\">Jersey</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Guernsey\" title=\"COVID-19 pandemic in Guernsey\">Guernsey</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_British_Overseas_Territories\" title=\"COVID-19 pandemic in the British Overseas Territories\">Overseas territories</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Akrotiri_and_Dhekelia\" title=\"COVID-19 pandemic in Akrotiri and Dhekelia\">Akrotiri and Dhekelia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Gibraltar\" title=\"COVID-19 pandemic in Gibraltar\">Gibraltar</a></li>\\n<li><a href=\"/wiki/Operation_Broadshare\" title=\"Operation Broadshare\">response</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">Eastern</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Armenia\" title=\"COVID-19 pandemic in Armenia\">Armenia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Azerbaijan\" title=\"COVID-19 pandemic in Azerbaijan\">Azerbaijan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Belarus\" title=\"COVID-19 pandemic in Belarus\">Belarus</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Georgia_(country)\" title=\"COVID-19 pandemic in Georgia (country)\">Georgia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Kazakhstan\" title=\"COVID-19 pandemic in Kazakhstan\">Kazakhstan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Moldova\" title=\"COVID-19 pandemic in Moldova\">Moldova</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Gagauzia\" title=\"COVID-19 pandemic in Gagauzia\">Gagauzia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Transnistria\" title=\"COVID-19 pandemic in Transnistria\">Transnistria</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Russia\" title=\"COVID-19 pandemic in Russia\">Russia</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Russia\" title=\"Timeline of the COVID-19 pandemic in Russia\">timeline</a></li>\\n<li><a href=\"/wiki/Russian_government_responses_to_the_COVID-19_pandemic\" class=\"mw-redirect\" title=\"Russian government responses to the COVID-19 pandemic\">government responses</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Crimea\" title=\"COVID-19 pandemic in Crimea\">Crimea</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sevastopol\" title=\"COVID-19 pandemic in Sevastopol\">Sevastopol</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ukraine\" title=\"COVID-19 pandemic in Ukraine\">Ukraine</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Crimea\" title=\"COVID-19 pandemic in Crimea\">Crimea</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sevastopol\" title=\"COVID-19 pandemic in Sevastopol\">Sevastopol</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Donetsk_People%27s_Republic\" title=\"COVID-19 pandemic in the Donetsk People&#39;s Republic\">Donetsk</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Luhansk_People%27s_Republic\" title=\"COVID-19 pandemic in the Luhansk People&#39;s Republic\">Luhansk</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">Balkans</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Albania\" title=\"COVID-19 pandemic in Albania\">Albania</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Bosnia_and_Herzegovina\" title=\"COVID-19 pandemic in Bosnia and Herzegovina\">Bosnia and Herzegovina</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Montenegro\" title=\"COVID-19 pandemic in Montenegro\">Montenegro</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_North_Macedonia\" title=\"COVID-19 pandemic in North Macedonia\">North Macedonia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Serbia\" title=\"COVID-19 pandemic in Serbia\">Serbia</a>\\n<ul><li><a href=\"/wiki/COVID-19_protests_and_riots_in_Serbia\" title=\"COVID-19 protests and riots in Serbia\">protests and riots</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Kosovo\" title=\"COVID-19 pandemic in Kosovo\">Kosovo</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Turkey\" title=\"COVID-19 pandemic in Turkey\">Turkey</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Turkey\" title=\"Timeline of the COVID-19 pandemic in Turkey\">timeline</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\">Microstates</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Andorra\" title=\"COVID-19 pandemic in Andorra\">Andorra</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_San_Marino\" title=\"COVID-19 pandemic in San Marino\">San Marino</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Vatican_City\" title=\"COVID-19 pandemic in Vatican City\">Vatican City</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Monaco\" title=\"COVID-19 pandemic in Monaco\">Monaco</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:8em\"><a href=\"/wiki/European_Union_response_to_the_COVID-19_pandemic\" title=\"European Union response to the COVID-19 pandemic\">European Union</a><br />EFTA countries</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Austria\" title=\"COVID-19 pandemic in Austria\">Austria</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Belgium\" title=\"COVID-19 pandemic in Belgium\">Belgium</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Bulgaria\" title=\"COVID-19 pandemic in Bulgaria\">Bulgaria</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Croatia\" title=\"COVID-19 pandemic in Croatia\">Croatia</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Croatia\" title=\"Timeline of the COVID-19 pandemic in Croatia\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Cyprus\" title=\"COVID-19 pandemic in Cyprus\">Cyprus</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Northern_Cyprus\" title=\"COVID-19 pandemic in Northern Cyprus\">Northern Cyprus</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Czech_Republic\" title=\"COVID-19 pandemic in the Czech Republic\">Czech Republic</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Denmark\" title=\"COVID-19 pandemic in Denmark\">Denmark</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Faroe_Islands\" title=\"COVID-19 pandemic in the Faroe Islands\">Faroe Islands</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Estonia\" title=\"COVID-19 pandemic in Estonia\">Estonia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Finland\" title=\"COVID-19 pandemic in Finland\">Finland</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_%C3%85land_Islands\" title=\"COVID-19 pandemic in the \\xc3\\x85land Islands\">\\xc3\\x85land Islands</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_France\" title=\"COVID-19 pandemic in France\">France</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Guadeloupe\" title=\"COVID-19 pandemic in Guadeloupe\">Guadeloupe</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_French_Guiana\" title=\"COVID-19 pandemic in French Guiana\">French Guiana</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_R%C3%A9union\" title=\"COVID-19 pandemic in R\\xc3\\xa9union\">R\\xc3\\xa9union</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Martinique\" title=\"COVID-19 pandemic in Martinique\">Martinique</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mayotte\" title=\"COVID-19 pandemic in Mayotte\">Mayotte</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_French_Saint_Martin\" title=\"COVID-19 pandemic in French Saint Martin\">Saint Martin</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Germany\" title=\"COVID-19 pandemic in Germany\">Germany</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_North_Rhine-Westphalia\" title=\"COVID-19 pandemic in North Rhine-Westphalia\">North Rhine-Westphalia</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Greece\" title=\"COVID-19 pandemic in Greece\">Greece</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Hungary\" title=\"COVID-19 pandemic in Hungary\">Hungary</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Iceland\" title=\"COVID-19 pandemic in Iceland\">Iceland</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Republic_of_Ireland\" title=\"COVID-19 pandemic in the Republic of Ireland\">Ireland</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_Republic_of_Ireland\" title=\"Timeline of the COVID-19 pandemic in the Republic of Ireland\">timeline</a></li>\\n<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_Republic_of_Ireland\" title=\"Social impact of the COVID-19 pandemic in the Republic of Ireland\">social impact</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Italy\" title=\"COVID-19 pandemic in Italy\">Italy</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_lockdown_in_Italy\" title=\"COVID-19 pandemic lockdown in Italy\">lockdown</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Latvia\" title=\"COVID-19 pandemic in Latvia\">Latvia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Liechtenstein\" title=\"COVID-19 pandemic in Liechtenstein\">Liechtenstein</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Lithuania\" title=\"COVID-19 pandemic in Lithuania\">Lithuania</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Luxembourg\" title=\"COVID-19 pandemic in Luxembourg\">Luxembourg</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Malta\" title=\"COVID-19 pandemic in Malta\">Malta</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Netherlands\" title=\"COVID-19 pandemic in the Netherlands\">Netherlands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Norway\" title=\"COVID-19 pandemic in Norway\">Norway</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Poland\" title=\"COVID-19 pandemic in Poland\">Poland</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Portugal\" title=\"COVID-19 pandemic in Portugal\">Portugal</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Romania\" title=\"COVID-19 pandemic in Romania\">Romania</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Romania\" title=\"Timeline of the COVID-19 pandemic in Romania\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Slovakia\" title=\"COVID-19 pandemic in Slovakia\">Slovakia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Slovenia\" title=\"COVID-19 pandemic in Slovenia\">Slovenia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Spain\" title=\"COVID-19 pandemic in Spain\">Spain</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Spain\" title=\"Timeline of the COVID-19 pandemic in Spain\">timeline</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Asturias\" title=\"COVID-19 pandemic in Asturias\">Asturias</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Canary_Islands\" title=\"COVID-19 pandemic in the Canary Islands\">Canary Islands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ceuta\" title=\"COVID-19 pandemic in Ceuta\">Ceuta</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Community_of_Madrid\" title=\"COVID-19 pandemic in the Community of Madrid\">Community of Madrid</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Melilla\" title=\"COVID-19 pandemic in Melilla\">Melilla</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sweden\" title=\"COVID-19 pandemic in Sweden\">Sweden</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Sweden\" title=\"Timeline of the COVID-19 pandemic in Sweden\">timeline</a></li>\\n<li><a href=\"/wiki/Swedish_government_response_to_the_COVID-19_pandemic\" title=\"Swedish government response to the COVID-19 pandemic\">government response</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Switzerland\" title=\"COVID-19 pandemic in Switzerland\">Switzerland</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_North_America\" title=\"COVID-19 pandemic in North America\">North America</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Mexico\" title=\"COVID-19 pandemic in Mexico\">Mexico</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Mexico\" title=\"Timeline of the COVID-19 pandemic in Mexico\">timeline</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Central America</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Belize\" title=\"COVID-19 pandemic in Belize\">Belize</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Costa_Rica\" title=\"COVID-19 pandemic in Costa Rica\">Costa Rica</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_El_Salvador\" title=\"COVID-19 pandemic in El Salvador\">El Salvador</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Guatemala\" title=\"COVID-19 pandemic in Guatemala\">Guatemala</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Honduras\" title=\"COVID-19 pandemic in Honduras\">Honduras</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Nicaragua\" title=\"COVID-19 pandemic in Nicaragua\">Nicaragua</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Panama\" title=\"COVID-19 pandemic in Panama\">Panama</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Canada\" title=\"COVID-19 pandemic in Canada\">Canada</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Canada\" title=\"Timeline of the COVID-19 pandemic in Canada\">timeline</a></li>\\n<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_Canada\" title=\"Economic impact of the COVID-19 pandemic in Canada\">economic impact</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Alberta\" title=\"COVID-19 pandemic in Alberta\">Alberta</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_British_Columbia\" title=\"COVID-19 pandemic in British Columbia\">British Columbia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Manitoba\" title=\"COVID-19 pandemic in Manitoba\">Manitoba</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_New_Brunswick\" title=\"COVID-19 pandemic in New Brunswick\">New Brunswick</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Newfoundland_and_Labrador\" title=\"COVID-19 pandemic in Newfoundland and Labrador\">Newfoundland and Labrador</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Northwest_Territories\" title=\"COVID-19 pandemic in the Northwest Territories\">Northwest Territories</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Nova_Scotia\" title=\"COVID-19 pandemic in Nova Scotia\">Nova Scotia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Nunavut\" title=\"COVID-19 pandemic in Nunavut\">Nunavut</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ontario\" title=\"COVID-19 pandemic in Ontario\">Ontario</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Regional_Municipality_of_Peel\" title=\"COVID-19 pandemic in the Regional Municipality of Peel\">Peel Region</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Toronto\" title=\"COVID-19 pandemic in Toronto\">Toronto</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Prince_Edward_Island\" title=\"COVID-19 pandemic in Prince Edward Island\">Prince Edward Island</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Quebec\" title=\"COVID-19 pandemic in Quebec\">Quebec</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Montreal\" title=\"COVID-19 pandemic in Montreal\">Montreal</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Saskatchewan\" title=\"COVID-19 pandemic in Saskatchewan\">Saskatchewan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Yukon\" title=\"COVID-19 pandemic in Yukon\">Yukon</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Caribbean</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Antigua_and_Barbuda\" title=\"COVID-19 pandemic in Antigua and Barbuda\">Antigua and Barbuda</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Bahamas\" title=\"COVID-19 pandemic in the Bahamas\">Bahamas</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Barbados\" title=\"COVID-19 pandemic in Barbados\">Barbados</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_British_Overseas_Territories\" title=\"COVID-19 pandemic in the British Overseas Territories\">British Overseas Territories</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Anguilla\" title=\"COVID-19 pandemic in Anguilla\">Anguilla</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_British_Virgin_Islands\" title=\"COVID-19 pandemic in the British Virgin Islands\">British Virgin Islands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Cayman_Islands\" title=\"COVID-19 pandemic in the Cayman Islands\">Cayman Islands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Montserrat\" title=\"COVID-19 pandemic in Montserrat\">Montserrat</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Turks_and_Caicos_Islands\" title=\"COVID-19 pandemic in the Turks and Caicos Islands\">Turks and Caicos Islands</a></li>\\n<li><a href=\"/wiki/Operation_Broadshare\" title=\"Operation Broadshare\">response</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Cuba\" title=\"COVID-19 pandemic in Cuba\">Cuba</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Guantanamo_Bay_Naval_Base\" title=\"COVID-19 pandemic in the Guantanamo Bay Naval Base\">Guantanamo Bay Naval Base</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Dominica\" title=\"COVID-19 pandemic in Dominica\">Dominica</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Dominican_Republic\" title=\"COVID-19 pandemic in the Dominican Republic\">Dominican Republic</a></li>\\n<li>Dutch Caribbean\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Aruba\" title=\"COVID-19 pandemic in Aruba\">Aruba</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Cura%C3%A7ao\" title=\"COVID-19 pandemic in Cura\\xc3\\xa7ao\">Cura\\xc3\\xa7ao</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sint_Maarten\" title=\"COVID-19 pandemic in Sint Maarten\">Sint Maarten</a></li>\\n<li>Caribbean Netherlands\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Bonaire\" title=\"COVID-19 pandemic in Bonaire\">Bonaire</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Saba\" title=\"COVID-19 pandemic in Saba\">Saba</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Sint_Eustatius\" title=\"COVID-19 pandemic in Sint Eustatius\">Sint Eustatius</a></li></ul></li></ul></li>\\n<li>French West Indies\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Guadeloupe\" title=\"COVID-19 pandemic in Guadeloupe\">Guadeloupe</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Martinique\" title=\"COVID-19 pandemic in Martinique\">Martinique</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Barth%C3%A9lemy\" title=\"COVID-19 pandemic in Saint Barth\\xc3\\xa9lemy\">Saint Barth\\xc3\\xa9lemy</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_French_Saint_Martin\" title=\"COVID-19 pandemic in French Saint Martin\">Saint Martin</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Grenada\" title=\"COVID-19 pandemic in Grenada\">Grenada</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Haiti\" title=\"COVID-19 pandemic in Haiti\">Haiti</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Jamaica\" title=\"COVID-19 pandemic in Jamaica\">Jamaica</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Kitts_and_Nevis\" title=\"COVID-19 pandemic in Saint Kitts and Nevis\">Saint Kitts and Nevis</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Lucia\" title=\"COVID-19 pandemic in Saint Lucia\">Saint Lucia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Vincent_and_the_Grenadines\" title=\"COVID-19 pandemic in Saint Vincent and the Grenadines\">Saint Vincent and the Grenadines</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Trinidad_and_Tobago\" title=\"COVID-19 pandemic in Trinidad and Tobago\">Trinidad and Tobago</a></li>\\n<li>US insular areas\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Puerto_Rico\" title=\"COVID-19 pandemic in Puerto Rico\">Puerto Rico</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_United_States_Virgin_Islands\" title=\"COVID-19 pandemic in the United States Virgin Islands\">U.S. Virgin Islands</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_the_United_States\" title=\"COVID-19 pandemic in the United States\">United States</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Timeline of the COVID-19 pandemic in the United States\">timeline</a></li>\\n<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Social impact of the COVID-19 pandemic in the United States\">social impact</a></li>\\n<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Economic impact of the COVID-19 pandemic in the United States\">economic impact</a></li>\\n<li><a href=\"/wiki/U.S._federal_government_response_to_the_COVID-19_pandemic\" title=\"U.S. federal government response to the COVID-19 pandemic\">federal government response</a></li>\\n<li><a href=\"/wiki/U.S._state_and_local_government_responses_to_the_COVID-19_pandemic\" title=\"U.S. state and local government responses to the COVID-19 pandemic\">state and local government responses</a></li>\\n<li>Regional responses\\n<ul><li><a href=\"/wiki/Eastern_States_Multi-state_Council\" title=\"Eastern States Multi-state Council\">Eastern States Multi-state Council</a></li>\\n<li><a href=\"/wiki/Midwest_Governors_Regional_Pact\" title=\"Midwest Governors Regional Pact\">Midwest Governors Regional Pact</a></li>\\n<li><a href=\"/wiki/Western_States_Pact\" title=\"Western States Pact\">Western States Pact</a></li></ul></li>\\n<li><a href=\"/wiki/Trump_administration_communication_during_the_COVID-19_pandemic\" title=\"Trump administration communication during the COVID-19 pandemic\">Trump administration communication</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Alabama\" title=\"COVID-19 pandemic in Alabama\">Alabama</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Alaska\" title=\"COVID-19 pandemic in Alaska\">Alaska</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Arizona\" title=\"COVID-19 pandemic in Arizona\">Arizona</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Navajo_Nation\" title=\"COVID-19 pandemic in the Navajo Nation\">Navajo Nation</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Arkansas\" title=\"COVID-19 pandemic in Arkansas\">Arkansas</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_California\" title=\"COVID-19 pandemic in California\">California</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_San_Francisco_Bay_Area\" title=\"COVID-19 pandemic in the San Francisco Bay Area\">S.F. Bay Area</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Colorado\" title=\"COVID-19 pandemic in Colorado\">Colorado</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Connecticut\" title=\"COVID-19 pandemic in Connecticut\">Connecticut</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Delaware\" title=\"COVID-19 pandemic in Delaware\">Delaware</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Florida\" title=\"COVID-19 pandemic in Florida\">Florida</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Georgia_(U.S._state)\" title=\"COVID-19 pandemic in Georgia (U.S. state)\">Georgia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Guam\" title=\"COVID-19 pandemic in Guam\">Guam</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Hawaii\" title=\"COVID-19 pandemic in Hawaii\">Hawaii</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Idaho\" title=\"COVID-19 pandemic in Idaho\">Idaho</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Illinois\" title=\"COVID-19 pandemic in Illinois\">Illinois</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Indiana\" title=\"COVID-19 pandemic in Indiana\">Indiana</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Iowa\" title=\"COVID-19 pandemic in Iowa\">Iowa</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Kansas\" title=\"COVID-19 pandemic in Kansas\">Kansas</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Kentucky\" title=\"COVID-19 pandemic in Kentucky\">Kentucky</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Louisiana\" title=\"COVID-19 pandemic in Louisiana\">Louisiana</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Maine\" title=\"COVID-19 pandemic in Maine\">Maine</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Maryland\" title=\"COVID-19 pandemic in Maryland\">Maryland</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Massachusetts\" title=\"COVID-19 pandemic in Massachusetts\">Massachusetts</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Massachusetts\" title=\"Timeline of the COVID-19 pandemic in Massachusetts\">timeline</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Boston\" title=\"COVID-19 pandemic in Boston\">Boston</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Boston\" title=\"Timeline of the COVID-19 pandemic in Boston\">timeline</a></li></ul></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Michigan\" title=\"COVID-19 pandemic in Michigan\">Michigan</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Minnesota\" title=\"COVID-19 pandemic in Minnesota\">Minnesota</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Mississippi\" title=\"COVID-19 pandemic in Mississippi\">Mississippi</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Missouri\" title=\"COVID-19 pandemic in Missouri\">Missouri</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Montana\" title=\"COVID-19 pandemic in Montana\">Montana</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Nebraska\" title=\"COVID-19 pandemic in Nebraska\">Nebraska</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Nevada\" title=\"COVID-19 pandemic in Nevada\">Nevada</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_New_Hampshire\" title=\"COVID-19 pandemic in New Hampshire\">New Hampshire</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_New_Jersey\" title=\"COVID-19 pandemic in New Jersey\">New Jersey</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_New_Mexico\" title=\"COVID-19 pandemic in New Mexico\">New Mexico</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_New_York_(state)\" title=\"COVID-19 pandemic in New York (state)\">New York</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_New_York_City\" title=\"COVID-19 pandemic in New York City\">New York City</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_North_Carolina\" title=\"COVID-19 pandemic in North Carolina\">North Carolina</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_North_Dakota\" title=\"COVID-19 pandemic in North Dakota\">North Dakota</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Northern_Mariana_Islands\" title=\"COVID-19 pandemic in the Northern Mariana Islands\">Northern Mariana Islands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ohio\" title=\"COVID-19 pandemic in Ohio\">Ohio</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_in_Ohio\" title=\"Impact of the COVID-19 pandemic in Ohio\">impact</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Columbus,_Ohio\" title=\"COVID-19 pandemic in Columbus, Ohio\">Columbus</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Oklahoma\" title=\"COVID-19 pandemic in Oklahoma\">Oklahoma</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Oregon\" title=\"COVID-19 pandemic in Oregon\">Oregon</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Portland,_Oregon\" title=\"COVID-19 pandemic in Portland, Oregon\">Portland</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Pennsylvania\" title=\"COVID-19 pandemic in Pennsylvania\">Pennsylvania</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Philadelphia\" title=\"COVID-19 pandemic in Philadelphia\">Philadelphia</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Puerto_Rico\" title=\"COVID-19 pandemic in Puerto Rico\">Puerto Rico</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Rhode_Island\" title=\"COVID-19 pandemic in Rhode Island\">Rhode Island</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_South_Carolina\" title=\"COVID-19 pandemic in South Carolina\">South Carolina</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_South_Dakota\" title=\"COVID-19 pandemic in South Dakota\">South Dakota</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Tennessee\" title=\"COVID-19 pandemic in Tennessee\">Tennessee</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Texas\" title=\"COVID-19 pandemic in Texas\">Texas</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_United_States_Virgin_Islands\" title=\"COVID-19 pandemic in the United States Virgin Islands\">U.S. Virgin Islands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Utah\" title=\"COVID-19 pandemic in Utah\">Utah</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Vermont\" title=\"COVID-19 pandemic in Vermont\">Vermont</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Virginia\" title=\"COVID-19 pandemic in Virginia\">Virginia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Washington_(state)\" title=\"COVID-19 pandemic in Washington (state)\">Washington</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Washington,_D.C.\" title=\"COVID-19 pandemic in Washington, D.C.\">Washington, D.C.</a>\\n<ul><li><a href=\"/wiki/White_House_COVID-19_outbreak\" title=\"White House COVID-19 outbreak\">White House</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_West_Virginia\" title=\"COVID-19 pandemic in West Virginia\">West Virginia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Wisconsin\" title=\"COVID-19 pandemic in Wisconsin\">Wisconsin</a>\\n<ul><li><a href=\"/wiki/Statistics_of_the_COVID-19_pandemic_in_Wisconsin\" title=\"Statistics of the COVID-19 pandemic in Wisconsin\">statistics</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Door_County,_Wisconsin\" title=\"COVID-19 pandemic in Door County, Wisconsin\">Door County</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Wyoming\" title=\"COVID-19 pandemic in Wyoming\">Wyoming</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Atlantic</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Bermuda\" title=\"COVID-19 pandemic in Bermuda\">Bermuda</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Greenland\" title=\"COVID-19 pandemic in Greenland\">Greenland</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Pierre_and_Miquelon\" title=\"COVID-19 pandemic in Saint Pierre and Miquelon\">Saint Pierre and Miquelon</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Oceania\" title=\"COVID-19 pandemic in Oceania\">Oceania</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Australia\" title=\"COVID-19 pandemic in Australia\">Australia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Easter_Island\" title=\"COVID-19 pandemic in Easter Island\">Easter Island</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Fiji\" title=\"COVID-19 pandemic in Fiji\">Fiji</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_French_Polynesia\" title=\"COVID-19 pandemic in French Polynesia\">French Polynesia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Guam\" title=\"COVID-19 pandemic in Guam\">Guam</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Hawaii\" title=\"COVID-19 pandemic in Hawaii\">Hawaii</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_New_Caledonia\" title=\"COVID-19 pandemic in New Caledonia\">New Caledonia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_New_Zealand\" title=\"COVID-19 pandemic in New Zealand\">New Zealand</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_New_Zealand\" title=\"Timeline of the COVID-19 pandemic in New Zealand\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Northern_Mariana_Islands\" title=\"COVID-19 pandemic in the Northern Mariana Islands\">Northern Mariana Islands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Papua_New_Guinea\" title=\"COVID-19 pandemic in Papua New Guinea\">Papua New Guinea</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Autonomous_Region_of_Bougainville\" title=\"COVID-19 pandemic in the Autonomous Region of Bougainville\">Bougainville</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Solomon_Islands\" title=\"COVID-19 pandemic in the Solomon Islands\">Solomon Islands</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_South_America\" title=\"COVID-19 pandemic in South America\">South America</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Argentina\" title=\"COVID-19 pandemic in Argentina\">Argentina</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Argentina\" title=\"Timeline of the COVID-19 pandemic in Argentina\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Bolivia\" title=\"COVID-19 pandemic in Bolivia\">Bolivia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Brazil\" title=\"COVID-19 pandemic in Brazil\">Brazil</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_S%C3%A3o_Paulo_(state)\" title=\"COVID-19 pandemic in S\\xc3\\xa3o Paulo (state)\">S\\xc3\\xa3o Paulo</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Chile\" title=\"COVID-19 pandemic in Chile\">Chile</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Easter_Island\" title=\"COVID-19 pandemic in Easter Island\">Easter Island</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Colombia\" title=\"COVID-19 pandemic in Colombia\">Colombia</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Ecuador\" title=\"COVID-19 pandemic in Ecuador\">Ecuador</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_the_Falkland_Islands\" title=\"COVID-19 pandemic in the Falkland Islands\">Falkland Islands</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_French_Guiana\" title=\"COVID-19 pandemic in French Guiana\">French Guiana</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Guyana\" title=\"COVID-19 pandemic in Guyana\">Guyana</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Paraguay\" title=\"COVID-19 pandemic in Paraguay\">Paraguay</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Peru\" title=\"COVID-19 pandemic in Peru\">Peru</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Suriname\" title=\"COVID-19 pandemic in Suriname\">Suriname</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Uruguay\" title=\"COVID-19 pandemic in Uruguay\">Uruguay</a>\\n<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Uruguay\" title=\"Timeline of the COVID-19 pandemic in Uruguay\">timeline</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_Venezuela\" title=\"COVID-19 pandemic in Venezuela\">Venezuela</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Antarctica\" title=\"COVID-19 pandemic in Antarctica\">Antarctica</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_on_cruise_ships\" title=\"COVID-19 pandemic on cruise ships\">Cruise ships</a>\\n<ul><li><i><a href=\"/wiki/COVID-19_pandemic_on_Diamond_Princess\" title=\"COVID-19 pandemic on Diamond Princess\">Diamond Princess</a></i></li>\\n<li><i><a href=\"/wiki/COVID-19_pandemic_on_Grand_Princess\" title=\"COVID-19 pandemic on Grand Princess\">Grand Princess</a></i></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_on_naval_ships\" title=\"COVID-19 pandemic on naval ships\">Naval ships</a>\\n<ul><li><i><a href=\"/wiki/COVID-19_pandemic_on_Charles_de_Gaulle\" title=\"COVID-19 pandemic on Charles de Gaulle\">Charles de Gaulle</a></i></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_on_USS_Theodore_Roosevelt\" title=\"COVID-19 pandemic on USS Theodore Roosevelt\">USS <i>Theodore Roosevelt</i></a></li></ul></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div id=\"Impacts\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Impact_of_the_COVID-19_pandemic\" title=\"Impact of the COVID-19 pandemic\">Impacts</a></div></th></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Culture and<br />entertainment</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_arts_and_cultural_heritage\" title=\"Impact of the COVID-19 pandemic on the arts and cultural heritage\">Arts and cultural heritage</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_cinema\" title=\"Impact of the COVID-19 pandemic on cinema\">Cinema</a>\\n<ul><li><a href=\"/wiki/List_of_films_impacted_by_the_COVID-19_pandemic\" title=\"List of films impacted by the COVID-19 pandemic\">films affected</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_The_Walt_Disney_Company\" title=\"Impact of the COVID-19 pandemic on The Walt Disney Company\">Disney</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_education\" title=\"Impact of the COVID-19 pandemic on education\">Education</a></li>\\n<li><a href=\"/wiki/List_of_events_affected_by_the_COVID-19_pandemic\" title=\"List of events affected by the COVID-19 pandemic\">Events affected</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_fashion_industry\" title=\"Impact of the COVID-19 pandemic on the fashion industry\">Fashion industry</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_music_industry\" title=\"Impact of the COVID-19 pandemic on the music industry\">Music industry</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_performing_arts\" title=\"Impact of the COVID-19 pandemic on the performing arts\">Performing arts</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_sports\" title=\"Impact of the COVID-19 pandemic on sports\">Sports</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_association_football\" title=\"Impact of the COVID-19 pandemic on association football\">association football</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_cricket\" title=\"Impact of the COVID-19 pandemic on cricket\">cricket</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_disc_golf\" title=\"Impact of the COVID-19 pandemic on disc golf\">disc golf</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_motorsport\" title=\"Impact of the COVID-19 pandemic on motorsport\">motorsport</a></li>\\n<li><a href=\"/wiki/Suspension_of_the_2019%E2%80%9320_NBA_season\" title=\"Suspension of the 2019\\xe2\\x80\\x9320 NBA season\">NBA</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_television\" title=\"Impact of the COVID-19 pandemic on television\">Television</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_television_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on television in the United States\">U.S.</a>\\n<ul><li><a href=\"/wiki/List_of_American_television_series_impacted_by_the_COVID-19_pandemic\" title=\"List of American television series impacted by the COVID-19 pandemic\">programs affected</a></li></ul></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_video_game_industry\" title=\"Impact of the COVID-19 pandemic on the video game industry\">Video games</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Society<br /> and rights</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic\" title=\"Social impact of the COVID-19 pandemic\">Social</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_social_media\" title=\"Impact of the COVID-19 pandemic on social media\">social media</a></li>\\n<li><a href=\"/wiki/Social_stigma_associated_with_COVID-19\" title=\"Social stigma associated with COVID-19\">stigma</a></li>\\n<li><a href=\"/wiki/Coronavirus_party\" title=\"Coronavirus party\">COVID-19 parties</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_children\" title=\"Impact of the COVID-19 pandemic on children\">Children</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_foster_care_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on foster care in the United States\">foster care in the United States</a></li></ul></li>\\n<li><a href=\"/wiki/Gendered_impact_of_the_COVID-19_pandemic\" title=\"Gendered impact of the COVID-19 pandemic\">Gender</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_healthcare_workers\" title=\"Impact of the COVID-19 pandemic on healthcare workers\">Healthcare workers</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_hospitals\" title=\"Impact of the COVID-19 pandemic on hospitals\">Hospitals</a></li>\\n<li><a href=\"/wiki/Human_rights_issues_related_to_the_COVID-19_pandemic\" title=\"Human rights issues related to the COVID-19 pandemic\">Human rights</a></li>\\n<li>Legal\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_abortion_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on abortion in the United States\">abortion in the U.S.</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_crime\" title=\"Impact of the COVID-19 pandemic on crime\">crime</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_domestic_violence\" title=\"Impact of the COVID-19 pandemic on domestic violence\">domestic violence</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_prisons\" title=\"Impact of the COVID-19 pandemic on prisons\">prisons</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_in_US_immigration_detention\" title=\"COVID-19 pandemic in US immigration detention\">U.S. immigration detention</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_LGBT_community\" title=\"Impact of the COVID-19 pandemic on the LGBT community\">LGBT community</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_long-term_care_facilities\" title=\"Impact of the COVID-19 pandemic on long-term care facilities\">Long-term care facilities</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_public_transport\" title=\"Impact of the COVID-19 pandemic on public transport\">Public transport</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_religion\" title=\"Impact of the COVID-19 pandemic on religion\">Religion</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_Catholic_Church\" title=\"Impact of the COVID-19 pandemic on the Catholic Church\">Catholic Church</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_Hajj\" title=\"Impact of the COVID-19 pandemic on Hajj\">Hajj</a></li></ul></li>\\n<li><a href=\"/wiki/Strikes_during_the_COVID-19_pandemic\" title=\"Strikes during the COVID-19 pandemic\">Strikes</a></li>\\n<li><a href=\"/wiki/List_of_incidents_of_xenophobia_and_racism_related_to_the_COVID-19_pandemic\" title=\"List of incidents of xenophobia and racism related to the COVID-19 pandemic\">Xenophobia and racism</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic\" title=\"Economic impact of the COVID-19 pandemic\">Economic</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_aviation\" title=\"Impact of the COVID-19 pandemic on aviation\">Aviation</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_airlines\" class=\"mw-redirect\" title=\"Impact of the COVID-19 pandemic on airlines\">Airlines</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_cannabis_industry\" title=\"Impact of the COVID-19 pandemic on the cannabis industry\">Cannabis industry</a></li>\\n<li><a href=\"/wiki/Charitable_activities_related_to_the_COVID-19_pandemic\" title=\"Charitable activities related to the COVID-19 pandemic\">Charitable activity</a></li>\\n<li><a href=\"/wiki/COVID-19_recession\" title=\"COVID-19 recession\">COVID-19 recession</a></li>\\n<li><a href=\"/wiki/Financial_market_impact_of_the_COVID-19_pandemic\" title=\"Financial market impact of the COVID-19 pandemic\">Financial markets</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_food_industry\" title=\"Impact of the COVID-19 pandemic on the food industry\">Food industry</a>\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_meat_industry_in_Canada\" title=\"Impact of the COVID-19 pandemic on the meat industry in Canada\">meat industry in Canada</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_meat_industry_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on the meat industry in the United States\">meat industry in the U.S.</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_restaurant_industry_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on the restaurant industry in the United States\">restaurant industry in the U.S.</a></li></ul></li>\\n<li><a href=\"/wiki/2020_stock_market_crash\" title=\"2020 stock market crash\">Global stock market crash</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_hospitals\" title=\"Impact of the COVID-19 pandemic on hospitals\">Hospitals</a></li>\\n<li><a href=\"/wiki/2020_Russia%E2%80%93Saudi_Arabia_oil_price_war\" title=\"2020 Russia\\xe2\\x80\\x93Saudi Arabia oil price war\">Oil price war</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_retail\" title=\"Impact of the COVID-19 pandemic on retail\">Retail</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_tourism\" title=\"Impact of the COVID-19 pandemic on tourism\">Tourism</a></li>\\n<li><a href=\"/wiki/Travel_restrictions_related_to_the_COVID-19_pandemic\" title=\"Travel restrictions related to the COVID-19 pandemic\">Travel restrictions</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Information</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_journalism\" title=\"Impact of the COVID-19 pandemic on journalism\">Journalism</a></li>\\n<li><a href=\"/wiki/Media_coverage_of_the_COVID-19_pandemic\" title=\"Media coverage of the COVID-19 pandemic\">Media coverage</a></li>\\n<li><a href=\"/wiki/Misinformation_related_to_the_COVID-19_pandemic\" title=\"Misinformation related to the COVID-19 pandemic\">Misinformation</a></li>\\n<li><a href=\"/wiki/Wikipedia%27s_response_to_the_COVID-19_pandemic\" title=\"Wikipedia&#39;s response to the COVID-19 pandemic\">Wikipedia\\'s response</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_politics\" title=\"Impact of the COVID-19 pandemic on politics\">Politics</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/National_responses_to_the_COVID-19_pandemic\" title=\"National responses to the COVID-19 pandemic\">National responses</a></li>\\n<li><a href=\"/wiki/List_of_COVID-19_pandemic_legislation\" title=\"List of COVID-19 pandemic legislation\">Legislation</a></li>\\n<li><a href=\"/wiki/Protests_over_responses_to_the_COVID-19_pandemic\" title=\"Protests over responses to the COVID-19 pandemic\">Protests</a>\\n<ul><li><a href=\"/wiki/2020_United_States_anti-lockdown_protests\" title=\"2020 United States anti-lockdown protests\">U.S.</a></li></ul></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_international_relations\" title=\"Impact of the COVID-19 pandemic on international relations\">International relations</a>\\n<ul><li><a href=\"/wiki/International_aid_related_to_the_COVID-19_pandemic\" title=\"International aid related to the COVID-19 pandemic\">Aid</a></li></ul></li>\\n<li><a href=\"/wiki/European_Union_response_to_the_COVID-19_pandemic\" title=\"European Union response to the COVID-19 pandemic\">European Union</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Others</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Anthropause\" title=\"Anthropause\">Anthropause</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_environment\" title=\"Impact of the COVID-19 pandemic on the environment\">Environment</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_military\" title=\"Impact of the COVID-19 pandemic on the military\">Military</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_science_and_technology\" title=\"Impact of the COVID-19 pandemic on science and technology\">Science and technology</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic-related_famines\" class=\"mw-redirect\" title=\"COVID-19 pandemic-related famines\">Famine</a></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div id=\"Health_issues\" style=\"font-size:114%;margin:0 4em\">Health issues</div></th></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Problems and<br />restrictions</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Transmission_of_COVID-19\" title=\"Transmission of COVID-19\">Transmission</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_death_rates_by_country\" title=\"COVID-19 pandemic death rates by country\">Death rates by country</a></li>\\n<li><a href=\"/wiki/COVID-19_and_cancer\" title=\"COVID-19 and cancer\">Cancer</a></li>\\n<li><a href=\"/wiki/Evacuations_related_to_the_COVID-19_pandemic\" title=\"Evacuations related to the COVID-19 pandemic\">Evacuations</a></li>\\n<li><a href=\"/wiki/List_of_unproven_methods_against_COVID-19\" title=\"List of unproven methods against COVID-19\">Falsified medical methods</a></li>\\n<li><a href=\"/wiki/Management_of_COVID-19\" title=\"Management of COVID-19\">Management</a></li>\\n<li><a href=\"/wiki/Mental_health_during_the_COVID-19_pandemic\" title=\"Mental health during the COVID-19 pandemic\">Mental health</a></li>\\n<li><a href=\"/wiki/Shortages_related_to_the_COVID-19_pandemic\" title=\"Shortages related to the COVID-19 pandemic\">Shortages</a>\\n<ul><li><a href=\"/wiki/Oxygen_therapy\" title=\"Oxygen therapy\">medical oxygen</a></li>\\n<li><a href=\"/wiki/Mechanical_ventilation\" title=\"Mechanical ventilation\">ventilator</a></li>\\n<li><a href=\"/wiki/Open-source_ventilator\" title=\"Open-source ventilator\">open-source ventilator</a></li>\\n<li><a href=\"/wiki/Extracorporeal_membrane_oxygenation\" title=\"Extracorporeal membrane oxygenation\">extracorporeal membrane oxygenation</a></li></ul></li>\\n<li><a href=\"/wiki/Flattening_the_curve#Raise_the_line\" title=\"Flattening the curve\">Raise the line</a></li>\\n<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_other_health_issues\" title=\"Impact of the COVID-19 pandemic on other health issues\">Non-COVID-19-related health issues</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Prevention</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Pandemic_Severity_Assessment_Framework\" title=\"Pandemic Severity Assessment Framework\">Pandemic Severity Assessment Framework</a></li>\\n<li><a href=\"/wiki/Public_Health_Emergency_of_International_Concern\" title=\"Public Health Emergency of International Concern\">Public Health Emergency of International Concern</a></li>\\n<li><a href=\"/wiki/Non-pharmaceutical_intervention\" title=\"Non-pharmaceutical intervention\">Non-pharmaceutical intervention</a>\\n<ul><li><a href=\"/wiki/Great_Barrington_Declaration\" title=\"Great Barrington Declaration\">Great Barrington Declaration</a></li></ul></li>\\n<li><a href=\"/wiki/Social_distancing\" title=\"Social distancing\">Social distancing</a>\\n<ul><li><a href=\"/wiki/Social_distancing_measures_related_to_the_COVID-19_pandemic\" title=\"Social distancing measures related to the COVID-19 pandemic\">Measures</a></li></ul></li>\\n<li><a href=\"/wiki/Face_masks_during_the_COVID-19_pandemic\" title=\"Face masks during the COVID-19 pandemic\">Face masks</a>\\n<ul><li><a href=\"/wiki/Face_masks_during_the_COVID-19_pandemic_in_the_United_States\" title=\"Face masks during the COVID-19 pandemic in the United States\">United States</a></li>\\n<li><a href=\"/wiki/N95_mask\" title=\"N95 mask\">N95</a></li></ul></li>\\n<li><a href=\"/wiki/Flattening_the_curve\" title=\"Flattening the curve\">Flattening the curve</a></li>\\n<li><a href=\"/wiki/COVID-19_testing\" title=\"COVID-19 testing\">Disease testing</a>\\n<ul><li><a href=\"/wiki/Coronavirus_breathalyzer\" title=\"Coronavirus breathalyzer\">breathalyzer</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_datasets\" title=\"COVID-19 datasets\">Datasets</a></li>\\n<li><a href=\"/wiki/COVID-19_apps\" title=\"COVID-19 apps\">Coronavirus apps</a>\\n<ul><li><a href=\"/wiki/COVID_Alert\" title=\"COVID Alert\">COVID Alert</a></li>\\n<li><a href=\"/wiki/COVIDSafe\" title=\"COVIDSafe\">COVIDSafe</a></li>\\n<li><a href=\"/wiki/COVID_Tracker_Ireland\" title=\"COVID Tracker Ireland\">COVID Tracker Ireland</a></li>\\n<li><a href=\"/wiki/Coronavirus_Australia\" title=\"Coronavirus Australia\">Coronavirus Australia</a></li>\\n<li><a href=\"/wiki/Aarogya_Setu\" title=\"Aarogya Setu\">Aarogya Setu</a></li>\\n<li><a href=\"/wiki/NZ_COVID_Tracer\" title=\"NZ COVID Tracer\">NZ COVID Tracer</a></li>\\n<li><a href=\"/wiki/TraceTogether\" title=\"TraceTogether\">TraceTogether</a></li>\\n<li><a href=\"/wiki/BlueTrace\" title=\"BlueTrace\">BlueTrace</a></li>\\n<li><a href=\"/wiki/Decentralized_Privacy-Preserving_Proximity_Tracing\" title=\"Decentralized Privacy-Preserving Proximity Tracing\">Decentralized Privacy-Preserving Proximity Tracing</a></li>\\n<li><a href=\"/wiki/NHS_COVID-19\" title=\"NHS COVID-19\">NHS COVID-19</a></li>\\n<li><a href=\"/wiki/Nearby_Spot\" class=\"mw-redirect\" title=\"Nearby Spot\">Nearby Spot</a></li>\\n<li><a href=\"/wiki/TCN_Protocol\" title=\"TCN Protocol\">TCN Protocol</a></li>\\n<li><a href=\"/wiki/Exposure_Notification\" title=\"Exposure Notification\">Exposure Notification</a></li></ul></li>\\n<li><a href=\"/wiki/Workplace_hazard_controls_for_COVID-19\" title=\"Workplace hazard controls for COVID-19\">Workplace hazard controls</a></li>\\n<li><a href=\"/wiki/COVID-19_surveillance\" title=\"COVID-19 surveillance\">Surveillance</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_lockdowns\" title=\"COVID-19 pandemic lockdowns\">Lockdowns</a></li>\\n<li><a href=\"/wiki/Immunity_passport\" title=\"Immunity passport\">Immunity passports</a></li>\\n<li><a href=\"/wiki/International_aid_related_to_the_COVID-19_pandemic\" title=\"International aid related to the COVID-19 pandemic\">International aid</a></li>\\n<li><a href=\"/wiki/Safe_Hands_Challenge\" title=\"Safe Hands Challenge\">Safe Hands Challenge</a></li>\\n<li><a href=\"/wiki/Wastewater_surveillance\" title=\"Wastewater surveillance\">Wastewater surveillance</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Treatments<br />and research</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_in_pregnancy\" title=\"COVID-19 in pregnancy\">Pregnancy</a></li>\\n<li><a href=\"/wiki/Coronavirus_disease_2019#Post-infection_treatments\" title=\"Coronavirus disease 2019\">Treatment research</a></li>\\n<li><a href=\"/wiki/COVID-19_drug_repurposing_research\" title=\"COVID-19 drug repurposing research\">Drug repurposing research</a>\\n<ul><li><a href=\"/wiki/Dexamethasone\" title=\"Dexamethasone\">Dexamethasone</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_drug_development\" title=\"COVID-19 drug development\">Drug development</a></li>\\n<li><a class=\"mw-selflink selflink\">Vaccine research</a>\\n<ul><li><a href=\"/wiki/Gam-COVID-Vac\" title=\"Gam-COVID-Vac\">Sputnik V</a> (Russia)</li>\\n<li><a href=\"/wiki/CoronaVac\" title=\"CoronaVac\">CoronaVac</a></li>\\n<li><a href=\"/wiki/Operation_Warp_Speed\" title=\"Operation Warp Speed\">Operation Warp Speed</a> (U.S.)</li>\\n<li><a href=\"/wiki/Solidarity_trial\" title=\"Solidarity trial\">Solidarity trial</a> (WHO)</li>\\n<li><a href=\"/wiki/RECOVERY_Trial\" title=\"RECOVERY Trial\">RECOVERY Trial</a> (UK)</li></ul></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div id=\"Institutions\" style=\"font-size:114%;margin:0 4em\">Institutions</div></th></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Hospitals and<br />related</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Hospital_ships_designated_for_the_COVID-19_pandemic\" title=\"Hospital ships designated for the COVID-19 pandemic\">Hospital ships</a></li>\\n<li><a href=\"/wiki/Central_Hospital_of_Wuhan\" title=\"Central Hospital of Wuhan\">Central Hospital of Wuhan</a></li>\\n<li><a href=\"/wiki/Dabie_Mountain_Regional_Medical_Centre\" title=\"Dabie Mountain Regional Medical Centre\">Dabie Mountain Regional Medical Centre</a></li>\\n<li><a href=\"/wiki/Fangcang_Hospital\" title=\"Fangcang Hospital\">Fangcang Hospitals</a></li>\\n<li><a href=\"/wiki/Huoshenshan_Hospital\" title=\"Huoshenshan Hospital\">Huoshenshan Hospital</a></li>\\n<li><a href=\"/wiki/Wuhan_Jinyintan_Hospital\" title=\"Wuhan Jinyintan Hospital\">Wuhan Jinyintan Hospital</a></li>\\n<li><a href=\"/wiki/Leishenshan_Hospital\" title=\"Leishenshan Hospital\">Leishenshan Hospital</a></li>\\n<li><a href=\"/wiki/Collapse_of_Xinjia_Express_Hotel\" title=\"Collapse of Xinjia Express Hotel\">Xinjia Express Hotel</a></li>\\n<li><a href=\"/wiki/SevenHills_Hospital#COVID-19_hospital\" title=\"SevenHills Hospital\">COVID-19 Hospital in Mumbai</a></li>\\n<li><a href=\"/wiki/Kemayoran_Athletes_Village\" title=\"Kemayoran Athletes Village\">Kemayoran Athletes Village</a></li>\\n<li><a href=\"/wiki/Malaysia_Agro_Exposition_Park_Serdang\" title=\"Malaysia Agro Exposition Park Serdang\">Malaysia Agro Exposition Park Serdang</a></li>\\n<li><a href=\"/wiki/COVID-19_hospitals_in_the_United_Kingdom\" title=\"COVID-19 hospitals in the United Kingdom\">COVID-19 hospitals in the United Kingdom</a></li>\\n<li><a href=\"/wiki/Canberra_Coronavirus_Field_Hospital\" title=\"Canberra Coronavirus Field Hospital\">Canberra Coronavirus Field Hospital</a></li>\\n<li><a href=\"/wiki/Hospital_El_Salvador\" title=\"Hospital El Salvador\">Hospital El Salvador</a></li>\\n<li><a href=\"/wiki/Pyongyang_General_Hospital\" title=\"Pyongyang General Hospital\">Pyongyang General Hospital</a></li>\\n<li><a href=\"/wiki/Sancaktepe_Prof._Dr._Feriha_%C3%96z_Emergency_Hospital\" title=\"Sancaktepe Prof. Dr. Feriha \\xc3\\x96z Emergency Hospital\">Sancaktepe Prof. Dr. Feriha \\xc3\\x96z Emergency Hospital</a></li>\\n<li><a href=\"/wiki/Ye%C5%9Filk%C3%B6y_Prof._Dr._Murat_Dilmener_Emergency_Hospital\" title=\"Ye\\xc5\\x9filk\\xc3\\xb6y Prof. Dr. Murat Dilmener Emergency Hospital\">Ye\\xc5\\x9filk\\xc3\\xb6y Prof. Dr. Murat Dilmener Emergency Hospital</a></li>\\n<li><a href=\"/wiki/We_Heal_As_One_Center\" class=\"mw-redirect\" title=\"We Heal As One Center\">We Heal As One Center</a></li>\\n<li><a href=\"/wiki/Dragon%27s_Heart_Hospital\" title=\"Dragon&#39;s Heart Hospital\">Dragon\\'s Heart Hospital</a></li>\\n<li><a href=\"/wiki/NHS_Nightingale_Hospitals\" title=\"NHS Nightingale Hospitals\">NHS Nightingale Hospitals</a>\\n<ul><li><a href=\"/wiki/NHS_Nightingale_Hospital_Birmingham\" title=\"NHS Nightingale Hospital Birmingham\">NHS Nightingale Hospital Birmingham</a></li>\\n<li><a href=\"/wiki/NHS_Nightingale_Hospital_London\" title=\"NHS Nightingale Hospital London\">NHS Nightingale Hospital London</a></li>\\n<li><a href=\"/wiki/NHS_Nightingale_Hospital_North_East\" title=\"NHS Nightingale Hospital North East\">NHS Nightingale Hospital North East</a></li>\\n<li><a href=\"/wiki/NHS_Nightingale_Hospital_North_West\" title=\"NHS Nightingale Hospital North West\">NHS Nightingale Hospital North West</a></li>\\n<li><a href=\"/wiki/NHS_Nightingale_Hospital_Yorkshire_and_the_Humber\" title=\"NHS Nightingale Hospital Yorkshire and the Humber\">NHS Nightingale Hospital Yorkshire and the Humber</a></li></ul></li>\\n<li><a href=\"/wiki/NHS_Louisa_Jordan_Hospital\" title=\"NHS Louisa Jordan Hospital\">NHS Louisa Jordan Hospital</a></li>\\n<li><a href=\"/wiki/Kandakadu_Treatment_and_Rehabilitation_Centre\" title=\"Kandakadu Treatment and Rehabilitation Centre\">Kandakadu Treatment and Rehabilitation Centre</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Organizations</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">Coalition for Epidemic Preparedness Innovations</a></li>\\n<li><a href=\"/wiki/World_Health_Organization%27s_response_to_the_COVID-19_pandemic\" title=\"World Health Organization&#39;s response to the COVID-19 pandemic\">World Health Organization</a></li>\\n<li><a href=\"/wiki/United_Nations%27_response_to_the_COVID-19_pandemic\" class=\"mw-redirect\" title=\"United Nations&#39; response to the COVID-19 pandemic\">United Nations</a>\\n<ul><li><a href=\"/wiki/List_of_United_Nations_resolutions_in_response_to_the_COVID-19_pandemic\" title=\"List of United Nations resolutions in response to the COVID-19 pandemic\">resolutions</a></li></ul></li>\\n<li><a href=\"/wiki/International_Committee_on_Taxonomy_of_Viruses\" title=\"International Committee on Taxonomy of Viruses\">International Committee on Taxonomy of Viruses</a></li>\\n<li><a href=\"/wiki/Wuhan_Institute_of_Virology\" title=\"Wuhan Institute of Virology\">Wuhan Institute of Virology</a> (China)</li>\\n<li><a href=\"/wiki/Central_Epidemic_Command_Center\" title=\"Central Epidemic Command Center\">Central Epidemic Command Center</a> (Taiwan)</li>\\n<li><a href=\"/wiki/Taiwan_Centers_for_Disease_Control\" title=\"Taiwan Centers for Disease Control\">Taiwan Centers for Disease Control</a> (Taiwan)</li>\\n<li><a href=\"/wiki/COVID-19_Response_Acceleration_Task_Force\" title=\"COVID-19 Response Acceleration Task Force\">COVID-19 Response Acceleration Task Force</a> (Indonesia)</li>\\n<li><a href=\"/wiki/White_House_Coronavirus_Task_Force\" title=\"White House Coronavirus Task Force\">White House Coronavirus Task Force</a> (United States)</li>\\n<li><a href=\"/wiki/Great_American_Economic_Revival_Industry_Groups\" title=\"Great American Economic Revival Industry Groups\">Great American Economic Revival Industry Groups</a> (United States)</li>\\n<li><a href=\"/wiki/Coronavirus_Tech_Handbook\" title=\"Coronavirus Tech Handbook\">Coronavirus Tech Handbook</a></li>\\n<li><a href=\"/wiki/Inter-Agency_Task_Force_on_Emerging_Infectious_Diseases\" title=\"Inter-Agency Task Force on Emerging Infectious Diseases\">Inter-Agency Task Force on Emerging Infectious Diseases</a> (Philippines)</li>\\n<li><a href=\"/wiki/PM_CARES_Fund\" title=\"PM CARES Fund\">PM CARES Fund</a> (India)</li>\\n<li><a href=\"/wiki/Artist_Relief\" title=\"Artist Relief\">Artist Relief</a> (United States)</li>\\n<li><a href=\"/wiki/Covid_Watch\" title=\"Covid Watch\">Covid Watch</a></li>\\n<li><a href=\"/wiki/SAARC_COVID-19_Emergency_Fund\" title=\"SAARC COVID-19 Emergency Fund\">SAARC COVID-19 Emergency Fund</a> (India)</li>\\n<li><a href=\"/wiki/COVID-19_Solidarity_Response_Fund\" title=\"COVID-19 Solidarity Response Fund\">COVID-19 Solidarity Response Fund</a></li>\\n<li><a href=\"/wiki/MusiCares_COVID-19_Relief_Fund\" title=\"MusiCares COVID-19 Relief Fund\">MusiCares COVID-19 Relief Fund</a></li>\\n<li><a href=\"/wiki/Imperial_College_COVID-19_Response_Team\" title=\"Imperial College COVID-19 Response Team\">Imperial College COVID-19 Response Team</a> (UK)</li>\\n<li><a href=\"/wiki/Scientific_Advisory_Group_for_Emergencies\" title=\"Scientific Advisory Group for Emergencies\">SAGE</a> (UK)</li>\\n<li><a href=\"/wiki/National_Cabinet_(Australia)\" title=\"National Cabinet (Australia)\">National Cabinet (Australia)</a></li>\\n<li><a href=\"/wiki/National_COVID-19_Coordination_Commission\" class=\"mw-redirect\" title=\"National COVID-19 Coordination Commission\">National COVID-19 Coordination Commission</a> (Australia)</li>\\n<li><a href=\"/wiki/UN_COVID-19_Supply_Chain_Task_Force\" title=\"UN COVID-19 Supply Chain Task Force\">UN COVID-19 Supply Chain Task Force</a> (WHO)</li>\\n<li><a href=\"/wiki/COVID-19_Supply_Council\" title=\"COVID-19 Supply Council\">COVID-19 Supply Council</a> (Canada)</li>\\n<li><a href=\"/wiki/PREPARE\" title=\"PREPARE\">PREPARE</a> (European Union)</li>\\n<li><a href=\"/wiki/National_Public_Health_Emergency_Team_(2020)\" title=\"National Public Health Emergency Team (2020)\">National Public Health Emergency Team</a> (Ireland)</li>\\n<li><a href=\"/wiki/Africa_Centres_for_Disease_Control_and_Prevention\" title=\"Africa Centres for Disease Control and Prevention\">Africa Centres for Disease Control and Prevention</a> (African Union)</li>\\n<li><a href=\"/wiki/Ghana_Infectious_Disease_Centre\" title=\"Ghana Infectious Disease Centre\">Ghana Infectious Disease Centre</a> (Ghana)</li>\\n<li><a href=\"/wiki/COVID-19_Immunity_Task_Force\" title=\"COVID-19 Immunity Task Force\">COVID-19 Immunity Task Force</a> (Canada)</li>\\n<li><a href=\"/wiki/Novel_Coronavirus_Expert_Meeting\" title=\"Novel Coronavirus Expert Meeting\">Novel Coronavirus Expert Meeting</a> (Japan)</li>\\n<li><a href=\"/wiki/Coronavirus_Scientific_Advisory_Board_(Turkey)\" title=\"Coronavirus Scientific Advisory Board (Turkey)\">Coronavirus Scientific Advisory Board (Turkey)</a></li>\\n<li><a href=\"/wiki/Crisis_Preparedness_and_Response_Centre\" title=\"Crisis Preparedness and Response Centre\">Crisis Preparedness and Response Centre</a> (Malaysia)</li>\\n<li><a href=\"/wiki/Korea_Disease_Control_and_Prevention_Agency\" title=\"Korea Disease Control and Prevention Agency\">Korea Disease Control and Prevention Agency</a> (Korea)</li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div id=\"People\" style=\"font-size:114%;margin:0 4em\">People</div></th></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Medical professionals</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Ai_Fen\" title=\"Ai Fen\">Ai Fen</a></li>\\n<li><a href=\"/wiki/Li_Wenliang\" title=\"Li Wenliang\">Li Wenliang</a></li>\\n<li><a href=\"/wiki/Liu_Wen_(doctor)\" title=\"Liu Wen (doctor)\">Liu Wen</a></li>\\n<li><a href=\"/wiki/Corona_Rintawan\" title=\"Corona Rintawan\">Corona Rintawan</a></li>\\n<li><a href=\"/wiki/Xie_Linka\" title=\"Xie Linka\">Xie Linka</a></li>\\n<li><a href=\"/wiki/Zhang_Wenhong\" title=\"Zhang Wenhong\">Zhang Wenhong</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Researchers</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Roberto_Burioni\" title=\"Roberto Burioni\">Roberto Burioni</a></li>\\n<li><a href=\"/wiki/Awang_Bulgiba_Awang_Mahmud\" title=\"Awang Bulgiba Awang Mahmud\">Awang Bulgiba Awang Mahmud</a></li>\\n<li><a href=\"/wiki/Chen_Wei_(medical_scientist)\" title=\"Chen Wei (medical scientist)\">Chen Wei</a></li>\\n<li><a href=\"/wiki/Andrea_Crisanti_(scientist)\" title=\"Andrea Crisanti (scientist)\">Andrea Crisanti</a></li>\\n<li><a href=\"/wiki/Christian_Drosten\" title=\"Christian Drosten\">Christian Drosten</a></li>\\n<li><a href=\"/wiki/Neil_Ferguson_(epidemiologist)\" title=\"Neil Ferguson (epidemiologist)\">Neil Ferguson</a></li>\\n<li><a href=\"/wiki/George_F._Gao\" title=\"George F. Gao\">George F. Gao</a></li>\\n<li><a href=\"/wiki/Azra_Ghani\" title=\"Azra Ghani\">Azra Ghani</a></li>\\n<li><a href=\"/wiki/Sarah_Gilbert\" title=\"Sarah Gilbert\">Sarah Gilbert</a></li>\\n<li><a href=\"/wiki/Guan_Yi\" title=\"Guan Yi\">Guan Yi</a></li>\\n<li><a href=\"/wiki/Kentaro_Iwata\" title=\"Kentaro Iwata\">Kentaro Iwata</a></li>\\n<li><a href=\"/wiki/Trudie_Lang\" title=\"Trudie Lang\">Trudie Lang</a></li>\\n<li><a href=\"/wiki/Li_Lanjuan\" title=\"Li Lanjuan\">Li Lanjuan</a></li>\\n<li><a href=\"/wiki/W._Ian_Lipkin\" title=\"W. Ian Lipkin\">W. Ian Lipkin</a></li>\\n<li><a href=\"/wiki/Ma_Xiaowei\" title=\"Ma Xiaowei\">Ma Xiaowei</a></li>\\n<li><a href=\"/wiki/Allison_McGeer\" title=\"Allison McGeer\">Allison McGeer</a></li>\\n<li><a href=\"/wiki/Luc_Montagnier\" title=\"Luc Montagnier\">Luc Montagnier</a></li>\\n<li><a href=\"/wiki/Shi_Zhengli\" title=\"Shi Zhengli\">Shi Zhengli</a></li>\\n<li><a href=\"/wiki/Moncef_Slaoui\" title=\"Moncef Slaoui\">Moncef Slaoui</a></li>\\n<li><a href=\"/wiki/John_Todd_(British_biologist)\" title=\"John Todd (British biologist)\">John Todd</a></li>\\n<li><a href=\"/wiki/Wang_Chen_(physician)\" title=\"Wang Chen (physician)\">Wang Chen</a></li>\\n<li><a href=\"/wiki/Wang_Guangfa\" title=\"Wang Guangfa\">Wang Guangfa</a></li></ul>\\n<ul><li><a href=\"/wiki/Yuen_Kwok-yung\" title=\"Yuen Kwok-yung\">Yuen Kwok-yung</a></li>\\n<li><a href=\"/wiki/Zeng_Guang\" title=\"Zeng Guang\">Zeng Guang</a></li>\\n<li><a href=\"/wiki/Zhong_Nanshan\" title=\"Zhong Nanshan\">Zhong Nanshan</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Officials</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">WHO</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Tedros_Adhanom\" title=\"Tedros Adhanom\">Tedros Adhanom</a> (Director-General of the WHO)</li>\\n<li><a href=\"/wiki/Bruce_Aylward\" title=\"Bruce Aylward\">Bruce Aylward</a> (Team lead of WHO-China COVID-19 mission)</li>\\n<li><a href=\"/wiki/Maria_Van_Kerkhove\" title=\"Maria Van Kerkhove\">Maria Van Kerkhove</a> (Technical Lead for COVID-19 response)</li>\\n<li><a href=\"/wiki/Michael_J._Ryan_(doctor)\" title=\"Michael J. Ryan (doctor)\">Michael J. Ryan</a> (Executive Director of the WHO Health Emergencies Programme)</li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Countries</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Frank_Atherton\" title=\"Frank Atherton\">Frank Atherton</a> (Wales)</li>\\n<li><a href=\"/wiki/Scott_Atlas\" title=\"Scott Atlas\">Scott Atlas</a> (United States)</li>\\n<li><a href=\"/wiki/Deborah_Birx\" title=\"Deborah Birx\">Deborah Birx</a> (United States)</li>\\n<li><a href=\"/wiki/Ashley_Bloomfield\" title=\"Ashley Bloomfield\">Ashley Bloomfield</a> (New Zealand)</li>\\n<li><a href=\"/wiki/Angelo_Borrelli\" title=\"Angelo Borrelli\">Angelo Borrelli</a> (Italy)</li>\\n<li><a href=\"/wiki/Catherine_Calderwood\" title=\"Catherine Calderwood\">Catherine Calderwood</a> (Scotland)</li>\\n<li><a href=\"/wiki/Carmen_Deseda\" title=\"Carmen Deseda\">Carmen Deseda</a> (Puerto Rico)</li>\\n<li><a href=\"/wiki/Jaap_van_Dissel\" title=\"Jaap van Dissel\">Jaap van Dissel</a> (the Netherlands)</li>\\n<li><a href=\"/wiki/Shan-chwen_Chang\" title=\"Shan-chwen Chang\">Shan-chwen Chang</a> (Taiwan)</li>\\n<li><a href=\"/wiki/Chen_Shih-chung\" title=\"Chen Shih-chung\">Chen Shih-chung</a> (Taiwan)</li>\\n<li><a href=\"/wiki/Chuang_Yin-ching\" title=\"Chuang Yin-ching\">Chuang Yin-ching</a> (Taiwan)</li>\\n<li><a href=\"/wiki/Francisco_Duque_III\" title=\"Francisco Duque III\">Francisco Duque</a> (Philippines)</li>\\n<li><a href=\"/wiki/Anthony_Fauci\" title=\"Anthony Fauci\">Anthony Fauci</a> (United States)</li>\\n<li><a href=\"/wiki/Ronan_Glynn\" title=\"Ronan Glynn\">Ronan Glynn</a> (Ireland)</li>\\n<li><a href=\"/wiki/Jeong_Eun-kyeong\" title=\"Jeong Eun-kyeong\">Jeong Eun-kyeong</a> (South Korea)</li>\\n<li><a href=\"/wiki/Fahrettin_Koca\" title=\"Fahrettin Koca\">Fahrettin Koca</a> (Turkey)</li>\\n<li><a href=\"/wiki/Li_Keqiang\" title=\"Li Keqiang\">Li Keqiang</a> (China)</li>\\n<li><a href=\"/wiki/Michael_McBride_(doctor)\" title=\"Michael McBride (doctor)\">Michael McBride</a> (Northern Ireland)</li>\\n<li><a href=\"/wiki/Oriol_Mitj%C3%A0\" title=\"Oriol Mitj\\xc3\\xa0\">Oriol Mitj\\xc3\\xa0</a> (Andorra)</li>\\n<li><a href=\"/wiki/Doni_Monardo\" title=\"Doni Monardo\">Doni Monardo</a> (Indonesia)</li>\\n<li><a href=\"/wiki/Noor_Hisham_Abdullah\" title=\"Noor Hisham Abdullah\">Noor Hisham Abdullah</a> (Malaysia)</li>\\n<li><a href=\"/wiki/J%C3%A9r%C3%B4me_Salomon\" title=\"J\\xc3\\xa9r\\xc3\\xb4me Salomon\">J\\xc3\\xa9r\\xc3\\xb4me Salomon</a> (France)</li>\\n<li><a href=\"/wiki/Fernando_Sim%C3%B3n\" title=\"Fernando Sim\\xc3\\xb3n\">Fernando Sim\\xc3\\xb3n</a> (Spain)</li>\\n<li><a href=\"/wiki/Gregor_Smith\" title=\"Gregor Smith\">Gregor Smith</a> (Scotland)</li>\\n<li><a href=\"/wiki/Ih-Jen_Su\" title=\"Ih-Jen Su\">Ih-Jen Su</a> (Taiwan)</li>\\n<li><a href=\"/wiki/%C5%81ukasz_Szumowski\" title=\"\\xc5\\x81ukasz Szumowski\">\\xc5\\x81ukasz Szumowski</a> (Poland)</li>\\n<li><a href=\"/wiki/Anders_Tegnell\" title=\"Anders Tegnell\">Anders Tegnell</a> (Sweden)</li>\\n<li><a href=\"/wiki/Theresa_Tam\" title=\"Theresa Tam\">Theresa Tam</a> (Canada)</li>\\n<li><a href=\"/wiki/Sotiris_Tsiodras\" title=\"Sotiris Tsiodras\">Sotiris Tsiodras</a> (Greece)</li>\\n<li><a href=\"/wiki/Chris_Whitty\" title=\"Chris Whitty\">Chris Whitty</a> (United Kingdom)</li>\\n<li><a href=\"/wiki/Lawrence_Wong\" title=\"Lawrence Wong\">Lawrence Wong</a> (Singapore)</li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Others</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Chen_Qiushi\" title=\"Chen Qiushi\">Chen Qiushi</a></li>\\n<li><a href=\"/wiki/Brett_Crozier\" title=\"Brett Crozier\">Brett Crozier</a></li>\\n<li><a href=\"/wiki/Fang_Bin\" title=\"Fang Bin\">Fang Bin</a></li>\\n<li><a href=\"/wiki/Fang_Fang\" title=\"Fang Fang\">Fang Fang</a></li>\\n<li><a href=\"/wiki/Li_Zehua\" title=\"Li Zehua\">Li Zehua</a></li>\\n<li><a href=\"/wiki/Qiu_Menghuang\" title=\"Qiu Menghuang\">Qiu Menghuang</a></li>\\n<li><a href=\"/wiki/Ren_Zhiqiang\" title=\"Ren Zhiqiang\">Ren Zhiqiang</a></li>\\n<li><a href=\"/wiki/Captain_Tom\" title=\"Captain Tom\">Captain Tom</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Deaths</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"><a href=\"/wiki/List_of_deaths_due_to_COVID-19\" title=\"List of deaths due to COVID-19\">List</a></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div id=\"Data_(templates)\" style=\"font-size:114%;margin:0 4em\">Data (templates)</div></th></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Global</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_by_country_and_territory#Statistics\" title=\"COVID-19 pandemic by country and territory\">Cases, deaths, recoveries by country</a></li>\\n<li><a href=\"/wiki/COVID-19_testing#Virus_testing_statistics_by_country\" title=\"COVID-19 testing\">Tests, cases, tests per capita, cases per capita by country</a></li>\\n<li><a href=\"/wiki/COVID-19_testing#Virus_testing_statistics_by_country_subdivision\" title=\"COVID-19 testing\">Tests, cases, tests per capita, cases per capita by country subdivision</a></li>\\n<li>WHO situation reports\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_cases\" title=\"COVID-19 pandemic cases\">cases</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_deaths\" title=\"COVID-19 pandemic deaths\">deaths</a></li></ul></li>\\n<li><a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">World map by countries: confirmed per capita</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_in_mainland_China#Graphics\" title=\"COVID-19 pandemic in mainland China\">China</a></li></ul></li>\\n<li><a href=\"/wiki/List_of_countries_by_hospital_beds#Numbers\" title=\"List of countries by hospital beds\">Hospital beds by country</a></li>\\n<li><a href=\"/wiki/COVID-19_pandemic_lockdowns#Table_of_pandemic_lockdowns\" title=\"COVID-19 pandemic lockdowns\">Lockdowns</a>\\n<ul><li><a href=\"/wiki/COVID-19_pandemic_lockdowns#China\" title=\"COVID-19 pandemic lockdowns\">Mainland China</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Africa</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Algeria_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Algeria medical cases (page does not exist)\">Algeria</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Algeria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Algeria medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Angola_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Angola medical cases (page does not exist)\">Angola</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Angola_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Angola medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Burkina_Faso_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Burkina Faso medical cases (page does not exist)\">Burkina Faso</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Burkina_Faso_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Burkina Faso medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Burundi_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Burundi medical cases (page does not exist)\">Burundi</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Burundi_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Burundi medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Cameroon_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Cameroon medical cases (page does not exist)\">Cameroon</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cameroon_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Cameroon medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Egypt_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Egypt medical cases (page does not exist)\">Egypt</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Egypt_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Egypt medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Eswatini_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Eswatini medical cases (page does not exist)\">Eswatini</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Eswatini_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Eswatini medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Ethiopia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Ethiopia medical cases (page does not exist)\">Ethiopia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ethiopia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ethiopia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ghana_medical_cases\" title=\"Template:COVID-19 pandemic data/Ghana medical cases\">Ghana</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ghana_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ghana medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Ivory_Coast_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Ivory Coast medical cases (page does not exist)\">Ivory Coast</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ivory_Coast_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ivory Coast medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Kenya_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Kenya medical cases (page does not exist)\">Kenya</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kenya_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kenya medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Libya_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Libya medical cases (page does not exist)\">Libya</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Libya_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Libya medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Malawi_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Malawi medical cases (page does not exist)\">Malawi</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Malawi_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Malawi medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Mali_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Mali medical cases (page does not exist)\">Mali</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mali_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mali medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Mauritania_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Mauritania medical cases (page does not exist)\">Mauritania</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mauritania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mauritania medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Mauritius_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Mauritius medical cases (page does not exist)\">Mauritius</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mauritius_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mauritius medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Morocco_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Morocco medical cases (page does not exist)\">Morocco</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Morocco_medical_cases_chart\" class=\"mw-redirect\" title=\"Template:COVID-19 pandemic data/Morocco medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nigeria_medical_cases\" title=\"Template:COVID-19 pandemic data/Nigeria medical cases\">Nigeria</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nigeria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Nigeria medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Senegal_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Senegal medical cases (page does not exist)\">Senegal</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Senegal_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Senegal medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Sierra_Leone_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Sierra Leone medical cases (page does not exist)\">Sierra Leone</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sierra_Leone_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Sierra Leone medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Africa_medical_cases\" title=\"Template:COVID-19 pandemic data/South Africa medical cases\">South Africa</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Africa_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/South Africa medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/South_Sudan_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/South Sudan medical cases (page does not exist)\">South Sudan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Sudan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/South Sudan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Sudan_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Sudan medical cases (page does not exist)\">Sudan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sudan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Sudan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Tanzania_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Tanzania medical cases (page does not exist)\">Tanzania</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Tanzania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Tanzania medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Togo_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Togo medical cases (page does not exist)\">Togo</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Togo_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Togo medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Tunisia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Tunisia medical cases (page does not exist)\">Tunisia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Tunisia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Tunisia medical cases chart\">chart</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Americas</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Argentina_medical_cases\" title=\"Template:COVID-19 pandemic data/Argentina medical cases\">Argentina</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Argentina_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Argentina medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bolivia_medical_cases\" title=\"Template:COVID-19 pandemic data/Bolivia medical cases\">Bolivia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bolivia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bolivia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Brazil_medical_cases\" title=\"Template:COVID-19 pandemic data/Brazil medical cases\">Brazil</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Brazil_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Brazil medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Canada_medical_cases\" title=\"Template:COVID-19 pandemic data/Canada medical cases\">Canada</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Canada_medical_cases_by_province\" title=\"Template:COVID-19 pandemic data/Canada medical cases by province\">by province</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Canada_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Canada medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Chile_medical_cases\" title=\"Template:COVID-19 pandemic data/Chile medical cases\">Chile</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Chile_medical_cases_by_commune\" title=\"Template:COVID-19 pandemic data/Chile medical cases by commune\">by commune</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Chile_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Chile medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Colombia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Colombia medical cases (page does not exist)\">Colombia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Colombia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Colombia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Costa_Rica_medical_cases\" title=\"Template:COVID-19 pandemic data/Costa Rica medical cases\">Costa Rica</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Costa_Rica_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Costa Rica medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Cuba_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Cuba medical cases (page does not exist)\">Cuba</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cuba_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Cuba medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Dominican_Republic_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Dominican Republic medical cases (page does not exist)\">Dominican Republic</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Dominican_Republic_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Dominican Republic medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Ecuador_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Ecuador medical cases (page does not exist)\">Ecuador</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ecuador_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ecuador medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/El_Salvador_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/El Salvador medical cases (page does not exist)\">El Salvador</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/El_Salvador_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/El Salvador medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Guatemala_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Guatemala medical cases (page does not exist)\">Guatemala</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Guatemala_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Guatemala medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Haiti_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Haiti medical cases (page does not exist)\">Haiti</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Haiti_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Haiti medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Honduras_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Honduras medical cases (page does not exist)\">Honduras</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Honduras_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Honduras medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mexico_medical_cases\" title=\"Template:COVID-19 pandemic data/Mexico medical cases\">Mexico</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mexico_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mexico medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Nicaragua_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Nicaragua medical cases (page does not exist)\">Nicaragua</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nicaragua_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Nicaragua medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Panama_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Panama medical cases (page does not exist)\">Panama</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Panama_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Panama medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Paraguay_medical_cases\" title=\"Template:COVID-19 pandemic data/Paraguay medical cases\">Paraguay</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Paraguay_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Paraguay medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Peru_medical_cases\" title=\"Template:COVID-19 pandemic data/Peru medical cases\">Peru</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Peru_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Peru medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_States_medical_cases\" title=\"Template:COVID-19 pandemic data/United States medical cases\">United States</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_States_medical_cases_by_state\" title=\"Template:COVID-19 pandemic data/United States medical cases by state\">by state</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_States_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/United States medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Uruguay_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Uruguay medical cases (page does not exist)\">Uruguay</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Uruguay_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Uruguay medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Venezuela_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Venezuela medical cases (page does not exist)\">Venezuela</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Venezuela_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Venezuela medical cases chart\">chart</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Asia</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Afghanistan_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Afghanistan medical cases (page does not exist)\">Afghanistan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Afghanistan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Afghanistan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Armenia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Armenia medical cases (page does not exist)\">Armenia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Armenia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Armenia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Azerbaijan_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Azerbaijan medical cases (page does not exist)\">Azerbaijan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Azerbaijan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Azerbaijan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Bahrain_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Bahrain medical cases (page does not exist)\">Bahrain</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bahrain_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bahrain medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Bangladesh_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Bangladesh medical cases (page does not exist)\">Bangladesh</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bangladesh_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bangladesh medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bhutan_medical_cases\" title=\"Template:COVID-19 pandemic data/Bhutan medical cases\">Bhutan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bhutan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bhutan medical cases chart\">chart</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bhutan_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/Bhutan medical cases summary\">summary</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Brunei_medical_cases\" class=\"mw-redirect\" title=\"Template:COVID-19 pandemic data/Brunei medical cases\">Brunei</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Brunei_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Brunei medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Cambodia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Cambodia medical cases (page does not exist)\">Cambodia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cambodia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Cambodia medical cases chart\">chart</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cambodia_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/Cambodia medical cases summary\">summary</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/China_medical_cases_by_province\" title=\"Template:COVID-19 pandemic data/China medical cases by province\">Mainland China</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mainland_China_medical_cases\" title=\"Template:COVID-19 pandemic data/Mainland China medical cases\">aggregate</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mainland_China_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mainland China medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Georgia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Georgia medical cases (page does not exist)\">Georgia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Georgia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Georgia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Hong_Kong_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Hong Kong medical cases (page does not exist)\">Hong Kong</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Hong_Kong_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Hong Kong medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/India_medical_cases_by_state_and_union_territory\" title=\"Template:COVID-19 pandemic data/India medical cases by state and union territory\">India</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/India_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/India medical cases chart\">chart</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/India_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/India medical cases summary\">summary</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Indonesia_medical_cases\" title=\"Template:COVID-19 pandemic data/Indonesia medical cases\">Indonesia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Indonesia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Indonesia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iran_medical_cases\" title=\"Template:COVID-19 pandemic data/Iran medical cases\">Iran</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iran_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Iran medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Iraq_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Iraq medical cases (page does not exist)\">Iraq</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iraq_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Iraq medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Israel_medical_cases\" title=\"Template:COVID-19 pandemic data/Israel medical cases\">Israel</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Israel_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Israel medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Japan_medical_cases\" title=\"Template:COVID-19 pandemic data/Japan medical cases\">Japan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Japan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Japan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Jordan_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Jordan medical cases (page does not exist)\">Jordan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Jordan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Jordan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_dat/Kazakhstan_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic dat/Kazakhstan medical cases (page does not exist)\">Kazakhstan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kazakhstan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kazakhstan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Korea_medical_cases\" title=\"Template:COVID-19 pandemic data/South Korea medical cases\">South Korea</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Korea_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/South Korea medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kuwait_medical_cases\" title=\"Template:COVID-19 pandemic data/Kuwait medical cases\">Kuwait</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data_in_Kuwait/Charts\" title=\"Template:COVID-19 pandemic data in Kuwait/Charts\">graph</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kuwait_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kuwait medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Kyrgyzstan_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Kyrgyzstan medical cases (page does not exist)\">Kyrgyzstan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kyrgyzstan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kyrgyzstan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Laos_medical_cases\" title=\"Template:COVID-19 pandemic data/Laos medical cases\">Laos</a>\\n<ul><li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Laos_medical_cases_chart&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Laos medical cases chart (page does not exist)\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Lebanon_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Lebanon medical cases (page does not exist)\">Lebanon</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Lebanon_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Lebanon medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Malaysia_medical_cases\" title=\"Template:COVID-19 pandemic data/Malaysia medical cases\">Malaysia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Malaysia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Malaysia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Myanmar_medical_cases\" title=\"Template:COVID-19 pandemic data/Myanmar medical cases\">Myanmar</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Myanmar_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Myanmar medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nepal_medical_cases\" title=\"Template:COVID-19 pandemic data/Nepal medical cases\">Nepal</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nepal_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Nepal medical cases chart\">chart</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nepal_medical_cases_by_province_and_district\" title=\"Template:COVID-19 pandemic data/Nepal medical cases by province and district\">by district</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nepal_PCR_tests_by_laboratory\" title=\"Template:COVID-19 pandemic data/Nepal PCR tests by laboratory\">PCR tests</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Oman_medical_cases\" title=\"Template:COVID-19 pandemic data/Oman medical cases\">Oman</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Oman_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Oman medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Pakistan_medical_cases\" title=\"Template:COVID-19 pandemic data/Pakistan medical cases\">Pakistan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Pakistan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Pakistan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Palestine_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Palestine medical cases (page does not exist)\">Palestine</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Palestine_medical_cases_chart\" class=\"mw-redirect\" title=\"Template:COVID-19 pandemic data/Palestine medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Philippines_medical_cases\" title=\"Template:COVID-19 pandemic data/Philippines medical cases\">Philippines</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Philippines_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Philippines medical cases chart\">chart</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Philippines_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/Philippines medical cases summary\">summary</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Philippines_coronavirus_quarantines\" class=\"mw-redirect\" title=\"Template:COVID-19 pandemic data/Philippines coronavirus quarantines\">areas of quarantine</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Qatar_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Qatar medical cases (page does not exist)\">Qatar</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Qatar_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Qatar medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/North_Asia_medical_cases\" title=\"Template:COVID-19 pandemic data/North Asia medical cases\">Russia/North Asia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases_by_federal_subject\" title=\"Template:COVID-19 pandemic data/Russia medical cases by federal subject\">by federal subject</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Russia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Saudi_Arabia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Saudi Arabia medical cases (page does not exist)\">Saudi Arabia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Saudi_Arabia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Saudi Arabia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Singapore_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Singapore medical cases (page does not exist)\">Singapore</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Singapore_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Singapore medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Sri_Lanka_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Sri Lanka medical cases (page does not exist)\">Sri Lanka</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sri_Lanka_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Sri Lanka medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Syria_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Syria medical cases (page does not exist)\">Syria</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Syria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Syria medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Taiwan_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Taiwan medical cases (page does not exist)\">Taiwan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Taiwan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Taiwan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Tajikistan_medical_cases\" title=\"Template:COVID-19 pandemic data/Tajikistan medical cases\">Tajikistan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Tajikistan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Tajikistan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Thailand_medical_cases\" title=\"Template:COVID-19 pandemic data/Thailand medical cases\">Thailand</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Thailand_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Thailand medical cases chart\">chart</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Thailand_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/Thailand medical cases summary\">summary</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases\" title=\"Template:COVID-19 pandemic data/Turkey medical cases\">Turkey</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases_by_province\" title=\"Template:COVID-19 pandemic data/Turkey medical cases by province\">by province</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Turkey medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Arab_Emirates_medical_cases\" title=\"Template:COVID-19 pandemic data/United Arab Emirates medical cases\">United Arab Emirates</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Arab_Emirates_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/United Arab Emirates medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Uzbekistan_medical_cases\" title=\"Template:COVID-19 pandemic data/Uzbekistan medical cases\">Uzbekistan</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Uzbekistan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Uzbekistan medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Vietnam_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Vietnam medical cases (page does not exist)\">Vietnam</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Vietnam_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Vietnam medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Yemen_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Yemen medical cases (page does not exist)\">Yemen</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Yemen_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Yemen medical cases chart\">chart</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Template:COVID-19_pandemic_data/Europe_medical_cases\" title=\"Template:COVID-19 pandemic data/Europe medical cases\">Europe</a><br /><span style=\"font-weight:normal;\">(<a href=\"/wiki/Template:COVID-19_pandemic_data/Europe_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Europe medical cases chart\">chart</a>)</span></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Albania_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Albania medical cases (page does not exist)\">Albania</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Albania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Albania medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Austria_medical_cases\" title=\"Template:COVID-19 pandemic data/Austria medical cases\">Austria</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Austria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Austria medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Belarus_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Belarus medical cases (page does not exist)\">Belarus</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Belarus_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Belarus medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Belgium_medical_cases\" title=\"Template:COVID-19 pandemic data/Belgium medical cases\">Belgium</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Belgium_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Belgium medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Bosnia_and_Herzegovina_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Bosnia and Herzegovina medical cases (page does not exist)\">Bosnia and Herzegovina</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bosnia_and_Herzegovina_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bosnia and Herzegovina medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bulgaria_medical_cases\" title=\"Template:COVID-19 pandemic data/Bulgaria medical cases\">Bulgaria</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bulgaria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bulgaria medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Croatia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Croatia medical cases (page does not exist)\">Croatia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Croatia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Croatia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Cyprus_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Cyprus medical cases (page does not exist)\">Cyprus</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cyprus_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Cyprus medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Czech_Republic_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Czech Republic medical cases (page does not exist)\">Czech Republic</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Czech_Republic_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Czech Republic medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Denmark_medical_cases\" title=\"Template:COVID-19 pandemic data/Denmark medical cases\">Denmark</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Denmark_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Denmark medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Estonia_medical_cases\" title=\"Template:COVID-19 pandemic data/Estonia medical cases\">Estonia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Estonia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Estonia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Faroe_Islands_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Faroe Islands medical cases (page does not exist)\">Faroe Islands</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Faroe_Islands_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Faroe Islands medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Finland_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Finland medical cases (page does not exist)\">Finland</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Finland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Finland medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/France_medical_cases\" title=\"Template:COVID-19 pandemic data/France medical cases\">France</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/France_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/France medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Germany_medical_cases\" title=\"Template:COVID-19 pandemic data/Germany medical cases\">Germany</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Germany_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Germany medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Greece_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Greece medical cases (page does not exist)\">Greece</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Greece_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Greece medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Hungary_medical_cases\" title=\"Template:COVID-19 pandemic data/Hungary medical cases\">Hungary</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Hungary_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Hungary medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iceland_medical_cases\" title=\"Template:COVID-19 pandemic data/Iceland medical cases\">Iceland</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iceland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Iceland medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Republic_of_Ireland_medical_cases\" title=\"Template:COVID-19 pandemic data/Republic of Ireland medical cases\">Ireland</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Republic_of_Ireland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Republic of Ireland medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Italy_medical_cases\" title=\"Template:COVID-19 pandemic data/Italy medical cases\">Italy</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Italy_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Italy medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Kosovo_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Kosovo medical cases (page does not exist)\">Kosovo</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kosovo_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kosovo medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Latvia_medical_cases\" title=\"Template:COVID-19 pandemic data/Latvia medical cases\">Latvia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Latvia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Latvia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Lithuania_medical_cases\" title=\"Template:COVID-19 pandemic data/Lithuania medical cases\">Lithuania</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Lithuania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Lithuania medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Luxembourg_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Luxembourg medical cases (page does not exist)\">Luxembourg</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Luxembourg_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Luxembourg medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Malta_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Malta medical cases (page does not exist)\">Malta</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Malta_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Malta medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Moldova_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Moldova medical cases (page does not exist)\">Moldova</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Moldova_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Moldova medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Monaco_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Monaco medical cases (page does not exist)\">Monaco</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Monaco_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Monaco medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Montenegro_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Montenegro medical cases (page does not exist)\">Montenegro</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Montenegro_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Montenegro medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Netherlands_medical_cases\" title=\"Template:COVID-19 pandemic data/Netherlands medical cases\">Netherlands</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Netherlands_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Netherlands medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/North_Macedonia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/North Macedonia medical cases (page does not exist)\">North Macedonia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/North_Macedonia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/North Macedonia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Norway_medical_cases\" title=\"Template:COVID-19 pandemic data/Norway medical cases\">Norway</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Norway_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Norway medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Poland_medical_cases\" title=\"Template:COVID-19 pandemic data/Poland medical cases\">Poland</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Poland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Poland medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Portugal_medical_cases\" title=\"Template:COVID-19 pandemic data/Portugal medical cases\">Portugal</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Portugal_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Portugal medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Romania_medical_cases\" title=\"Template:COVID-19 pandemic data/Romania medical cases\">Romania</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Romania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Romania medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases\" title=\"Template:COVID-19 pandemic data/Russia medical cases\">Russia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases_by_federal_subject\" title=\"Template:COVID-19 pandemic data/Russia medical cases by federal subject\">by federal subject</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Russia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/San_Marino_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/San Marino medical cases (page does not exist)\">San Marino</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/San_Marino_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/San Marino medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Serbia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Serbia medical cases (page does not exist)\">Serbia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Serbia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Serbia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovakia_medical_cases\" title=\"Template:COVID-19 pandemic data/Slovakia medical cases\">Slovakia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovakia_medical_cases_by_region\" title=\"Template:COVID-19 pandemic data/Slovakia medical cases by region\">by region</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovakia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Slovakia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovenia_medical_cases\" title=\"Template:COVID-19 pandemic data/Slovenia medical cases\">Slovenia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovenia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Slovenia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Spain_medical_cases\" title=\"Template:COVID-19 pandemic data/Spain medical cases\">Spain</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Spain_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Spain medical cases chart\">chart</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Asturias_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Asturias medical cases chart\">Asturias</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Community_of_Madrid_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Community of Madrid medical cases chart\">Community of Madrid</a></li></ul></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sweden_medical_cases\" title=\"Template:COVID-19 pandemic data/Sweden medical cases\">Sweden</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sweden_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Sweden medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Switzerland_medical_cases\" title=\"Template:COVID-19 pandemic data/Switzerland medical cases\">Switzerland</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Switzerland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Switzerland medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases\" title=\"Template:COVID-19 pandemic data/Turkey medical cases\">Turkey</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases_by_province\" title=\"Template:COVID-19 pandemic data/Turkey medical cases by province\">by province</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Turkey medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Ukraine_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Ukraine medical cases (page does not exist)\">Ukraine</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ukraine_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ukraine medical cases chart\">chart</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Donetsk_People%27s_Republic_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Donetsk People&#39;s Republic medical cases chart\">Donetsk People\\'s Republic</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Luhansk_People%27s_Republic_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Luhansk People&#39;s Republic medical cases chart\">Luhansk People\\'s Republic</a></li></ul></li></ul></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Kingdom_medical_cases\" title=\"Template:COVID-19 pandemic data/United Kingdom medical cases\">United Kingdom</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Kingdom/Scotland_medical_cases\" title=\"Template:COVID-19 pandemic data/United Kingdom/Scotland medical cases\">Scotland</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Kingdom_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/United Kingdom medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Vatican_City_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Vatican City medical cases (page does not exist)\">Vatican City</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Vatican_City_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Vatican City medical cases chart\">chart</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Oceania</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Australia_medical_cases\" title=\"Template:COVID-19 pandemic data/Australia medical cases\">Australia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Australia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Australia medical cases chart\">chart</a></li>\\n<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Australia_cases_by_state/territory\" title=\"Template:COVID-19 pandemic data/Australia cases by state/territory\">by state/territory</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Fiji_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Fiji medical cases (page does not exist)\">Fiji</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Fiji_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Fiji medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/French_Polynesia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/French Polynesia medical cases (page does not exist)\">French Polynesia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/French_Polynesia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/French Polynesia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/New_Caledonia_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/New Caledonia medical cases (page does not exist)\">New Caledonia</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/New_Caledonia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/New Caledonia medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/New_Zealand_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/New Zealand medical cases (page does not exist)\">New Zealand</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/New_Zealand_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/New Zealand medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Papua_New_Guinea_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Papua New Guinea medical cases (page does not exist)\">Papua New Guinea</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Papua_New_Guinea_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Papua New Guinea medical cases chart\">chart</a></li></ul></li>\\n<li><a href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Solomon_Islands_medical_cases&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Template:COVID-19 pandemic data/Solomon Islands medical cases (page does not exist)\">Solomon Islands</a>\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Solomon_Islands_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Solomon Islands medical cases chart\">Solomon Islands</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Others</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li>Cruise ships\\n<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Diamond_Princess_medical_cases\" title=\"Template:COVID-19 pandemic data/Diamond Princess medical cases\">Diamond Princess</a></li></ul></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\\n<ul><li><img alt=\"Category\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png\" decoding=\"async\" title=\"Category\" width=\"16\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/24px-Folder_Hexagonal_Icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/32px-Folder_Hexagonal_Icon.svg.png 2x\" data-file-width=\"36\" data-file-height=\"31\" /> <b><a href=\"/wiki/Category:COVID-19_pandemic\" title=\"Category:COVID-19 pandemic\">Category</a></b></li>\\n<li><img alt=\"Portal\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/16px-Portal-puzzle.svg.png\" decoding=\"async\" title=\"Portal\" width=\"16\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/24px-Portal-puzzle.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/32px-Portal-puzzle.svg.png 2x\" data-file-width=\"32\" data-file-height=\"28\" /> <b><a href=\"/wiki/Portal:Coronavirus_disease_2019\" title=\"Portal:Coronavirus disease 2019\">Portal</a></b></li></ul>\\n</div></td></tr></tbody></table></div>\\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Artificial_induction_of_immunity_/_Immunization:_Vaccines,_Vaccination,_Infection,_Inoculation_(J07)\" style=\"padding:3px\"><table class=\"nowraplinks hlist mw-collapsible mw-collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Vaccines\" title=\"Template:Vaccines\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Vaccines\" title=\"Template talk:Vaccines\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:Vaccines&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Artificial_induction_of_immunity_/_Immunization:_Vaccines,_Vaccination,_Infection,_Inoculation_(J07)\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Artificial_induction_of_immunity\" title=\"Artificial induction of immunity\">Artificial induction of immunity</a> / <a href=\"/wiki/Immunization\" title=\"Immunization\">Immunization</a>: <a href=\"/wiki/Vaccine\" title=\"Vaccine\">Vaccines</a>, <a href=\"/wiki/Vaccination\" title=\"Vaccination\">Vaccination</a>, <a href=\"/wiki/Infection\" title=\"Infection\">Infection</a>, <a href=\"/wiki/Inoculation\" title=\"Inoculation\">Inoculation</a> (<a href=\"/wiki/ATC_code_J07\" title=\"ATC code J07\">J07</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Development</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Immunologic_adjuvant\" title=\"Immunologic adjuvant\">Adjuvants</a></li>\\n<li><a href=\"/wiki/List_of_vaccine_ingredients\" title=\"List of vaccine ingredients\">List of vaccine ingredients</a></li>\\n<li><a href=\"/wiki/Mathematical_modelling_of_infectious_disease\" title=\"Mathematical modelling of infectious disease\">Mathematical modelling</a></li>\\n<li><a href=\"/wiki/Timeline_of_vaccines\" class=\"mw-redirect\" title=\"Timeline of vaccines\">Timeline</a></li>\\n<li><a href=\"/wiki/Vaccine_trial\" title=\"Vaccine trial\">Trials</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Classes</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Conjugate_vaccine\" title=\"Conjugate vaccine\">Conjugate vaccine</a></li>\\n<li><a href=\"/wiki/DNA_vaccination\" title=\"DNA vaccination\">DNA vaccination</a></li>\\n<li><a href=\"/wiki/Inactivated_vaccine\" title=\"Inactivated vaccine\">Inactivated vaccine</a></li>\\n<li><a href=\"/wiki/Live_vector_vaccine\" class=\"mw-redirect\" title=\"Live vector vaccine\">Live vector vaccine</a>\\n<ul><li><a href=\"/wiki/Attenuated_vaccine\" title=\"Attenuated vaccine\">Attenuated vaccine</a></li>\\n<li><a href=\"/wiki/Heterologous_vaccine\" title=\"Heterologous vaccine\">Heterologous vaccine</a></li></ul></li>\\n<li><a href=\"/wiki/Protein_subunit\" title=\"Protein subunit\">Subunit/component</a> / <a href=\"/wiki/Peptide_vaccine\" title=\"Peptide vaccine\">Peptide</a> / <a href=\"/wiki/Virus-like_particle\" title=\"Virus-like particle\">Virus-like particle</a></li>\\n<li><a href=\"/wiki/Toxoid\" title=\"Toxoid\">Toxoid</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Administration</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li>Global:\\n<ul><li><a href=\"/wiki/GAVI_Alliance\" class=\"mw-redirect\" title=\"GAVI Alliance\">GAVI Alliance</a></li>\\n<li><a href=\"/wiki/National_Immunization_Technical_Advisory_Group\" title=\"National Immunization Technical Advisory Group\">NITAG</a></li>\\n<li><a href=\"/wiki/Vaccination_policy\" title=\"Vaccination policy\">Policy</a></li>\\n<li><a href=\"/wiki/Vaccination_schedule\" title=\"Vaccination schedule\">Schedule</a></li>\\n<li><a href=\"/wiki/Vaccine_injury\" class=\"mw-redirect\" title=\"Vaccine injury\">Vaccine injury</a></li></ul></li>\\n<li>USA:\\n<ul><li><a href=\"/wiki/Advisory_Committee_on_Immunization_Practices\" title=\"Advisory Committee on Immunization Practices\">ACIP</a></li>\\n<li><a href=\"/wiki/Vaccine_court\" class=\"mw-redirect\" title=\"Vaccine court\">Vaccine court</a></li>\\n<li><a href=\"/wiki/Vaccines_for_Children_Program\" title=\"Vaccines for Children Program\">Vaccines for Children Program</a></li>\\n<li><a href=\"/wiki/Vaccine_Adverse_Event_Reporting_System\" title=\"Vaccine Adverse Event Reporting System\">VAERS</a></li>\\n<li><a href=\"/wiki/Vaccine_Safety_Datalink\" title=\"Vaccine Safety Datalink\">VSD</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Vaccines</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Bacterial</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Anthrax_vaccines\" title=\"Anthrax vaccines\">Anthrax</a></li>\\n<li><a href=\"/wiki/Brucellosis_vaccine\" title=\"Brucellosis vaccine\">Brucellosis</a></li>\\n<li><a href=\"/wiki/Cholera_vaccine\" title=\"Cholera vaccine\">Cholera</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Diphtheria_vaccine\" title=\"Diphtheria vaccine\">Diphtheria</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Hib_vaccine\" title=\"Hib vaccine\">Hib</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Leptospirosis_vaccine\" class=\"mw-redirect\" title=\"Leptospirosis vaccine\">Leptospirosis</a></li>\\n<li><a href=\"/wiki/Lyme_disease_vaccine\" class=\"mw-redirect\" title=\"Lyme disease vaccine\">Lyme disease</a><sup>\\xe2\\x80\\xa1</sup></li>\\n<li><a href=\"/wiki/Meningococcal_vaccine\" title=\"Meningococcal vaccine\">Meningococcus</a><sup>#</sup>\\n<ul><li><a href=\"/wiki/MeNZB\" title=\"MeNZB\">MeNZB</a></li>\\n<li><a href=\"/wiki/NmVac4-A/C/Y/W-135\" title=\"NmVac4-A/C/Y/W-135\">NmVac4-A/C/Y/W-135</a></li></ul></li>\\n<li><a href=\"/wiki/Pertussis_vaccine\" title=\"Pertussis vaccine\">Pertussis</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Plague_vaccine\" title=\"Plague vaccine\">Plague</a></li>\\n<li><a href=\"/wiki/Pneumococcal_vaccine\" title=\"Pneumococcal vaccine\">Pneumococcal</a><sup>#</sup>\\n<ul><li><a href=\"/wiki/Pneumococcal_conjugate_vaccine\" title=\"Pneumococcal conjugate vaccine\">PCV</a></li>\\n<li><a href=\"/wiki/Pneumococcal_polysaccharide_vaccine\" title=\"Pneumococcal polysaccharide vaccine\">PPSV</a></li></ul></li>\\n<li><a href=\"/wiki/Q_fever_vaccine\" class=\"mw-redirect\" title=\"Q fever vaccine\">Q fever</a></li>\\n<li><a href=\"/wiki/Tetanus_vaccine\" title=\"Tetanus vaccine\">Tetanus</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Tuberculosis_vaccines\" title=\"Tuberculosis vaccines\">Tuberculosis</a>\\n<ul><li><a href=\"/wiki/BCG_vaccine\" title=\"BCG vaccine\">BCG</a><sup>#</sup></li></ul></li>\\n<li><a href=\"/wiki/Typhoid_vaccine\" title=\"Typhoid vaccine\">Typhoid</a><sup>#</sup>\\n<ul><li><a href=\"/wiki/Ty21a\" title=\"Ty21a\">Ty21a</a></li>\\n<li><a href=\"/wiki/Vi_capsular_polysaccharide_vaccine\" title=\"Vi capsular polysaccharide vaccine\">ViCPS</a></li></ul></li>\\n<li><a href=\"/wiki/Typhus_vaccine\" title=\"Typhus vaccine\">Typhus</a></li>\\n<li>combination: <a href=\"/wiki/DPT_vaccine\" title=\"DPT vaccine\">DTwP/DTaP</a></li>\\n<li>research:\\n<ul><li><a href=\"/wiki/Clostridioides_difficile_infection#Research\" title=\"Clostridioides difficile infection\">Clostridioides difficile</a></li>\\n<li><a href=\"/wiki/Group_B_streptococcal_infection#Vaccine\" title=\"Group B streptococcal infection\">Group B streptococcal disease</a></li>\\n<li><a href=\"/wiki/Shigellosis#Vaccine\" title=\"Shigellosis\">Shigellosis</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Viral</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Adenovirus_vaccine\" title=\"Adenovirus vaccine\">Adenovirus</a></li>\\n<li><a href=\"/wiki/RVSV-ZEBOV_vaccine\" title=\"RVSV-ZEBOV vaccine\">Ebola</a></li>\\n<li><a href=\"/wiki/Influenza_vaccine\" title=\"Influenza vaccine\">Flu</a><sup>#</sup>\\n<ul><li><a href=\"/wiki/2009_flu_pandemic_vaccine\" class=\"mw-redirect\" title=\"2009 flu pandemic vaccine\">H1N1</a> (<a href=\"/wiki/Pandemrix\" title=\"Pandemrix\">Pandemrix</a>)</li>\\n<li><a href=\"/wiki/Live_attenuated_influenza_vaccine\" title=\"Live attenuated influenza vaccine\">LAIV</a></li></ul></li>\\n<li><a href=\"/wiki/Hantavirus_vaccine\" title=\"Hantavirus vaccine\">Hantavirus</a></li>\\n<li><a href=\"/wiki/Hepatitis_A_vaccine\" title=\"Hepatitis A vaccine\">Hepatitis A</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Hepatitis_B_vaccine\" title=\"Hepatitis B vaccine\">Hepatitis B</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Hepatitis_E_vaccine\" class=\"mw-redirect\" title=\"Hepatitis E vaccine\">Hepatitis E</a></li>\\n<li><a href=\"/wiki/HPV_vaccines\" class=\"mw-redirect\" title=\"HPV vaccines\">HPV</a>\\n<ul><li><a href=\"/wiki/Cervarix\" title=\"Cervarix\">Cervarix</a></li>\\n<li><a href=\"/wiki/Gardasil\" title=\"Gardasil\">Gardasil</a></li></ul></li>\\n<li><a href=\"/wiki/Japanese_encephalitis_vaccine\" title=\"Japanese encephalitis vaccine\">Japanese encephalitis</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Measles_vaccine\" title=\"Measles vaccine\">Measles</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Mumps_vaccine\" title=\"Mumps vaccine\">Mumps</a><sup>#</sup>\\n<ul><li><a href=\"/wiki/Mumpsvax\" class=\"mw-redirect\" title=\"Mumpsvax\">Mumpsvax</a></li></ul></li>\\n<li><a href=\"/wiki/Polio_vaccine\" title=\"Polio vaccine\">Polio</a><sup>#</sup>\\n<ul><li><a href=\"/wiki/Sabin_polio_vaccine\" class=\"mw-redirect\" title=\"Sabin polio vaccine\">Sabin</a></li>\\n<li><a href=\"/wiki/Salk_polio_vaccine\" class=\"mw-redirect\" title=\"Salk polio vaccine\">Salk</a></li></ul></li>\\n<li><a href=\"/wiki/Rabies_vaccine\" title=\"Rabies vaccine\">Rabies</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Rotavirus_vaccine\" title=\"Rotavirus vaccine\">Rotavirus</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Rubella_vaccine\" title=\"Rubella vaccine\">Rubella</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Smallpox_vaccine\" title=\"Smallpox vaccine\">Smallpox</a>\\n<ul><li><a href=\"/wiki/Dryvax\" class=\"mw-redirect\" title=\"Dryvax\">Dryvax</a></li></ul></li>\\n<li><a href=\"/wiki/Tick-borne_encephalitis_vaccine\" title=\"Tick-borne encephalitis vaccine\">Tick-borne encephalitis</a></li>\\n<li>Varicella zoster\\n<ul><li><a href=\"/wiki/Varicella_vaccine\" title=\"Varicella vaccine\">chicken pox</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Zoster_vaccine\" title=\"Zoster vaccine\">Zoster vaccine</a></li></ul></li>\\n<li><a href=\"/wiki/Yellow_fever_vaccine\" title=\"Yellow fever vaccine\">Yellow fever</a><sup>#</sup></li>\\n<li>combination:\\n<ul><li><a href=\"/wiki/MMR_vaccine\" title=\"MMR vaccine\">MMR</a></li>\\n<li><a href=\"/wiki/MMRV_vaccine\" title=\"MMRV vaccine\">MMRV</a></li></ul></li>\\n<li>research:\\n<ul><li><a href=\"/wiki/Chikungunya#Vaccine\" title=\"Chikungunya\">Chikungunya</a></li>\\n<li><a class=\"mw-selflink selflink\">COVID-19</a></li>\\n<li><a href=\"/wiki/Cytomegalovirus_vaccine\" title=\"Cytomegalovirus vaccine\">Cytomegalovirus</a></li>\\n<li><a href=\"/wiki/Dengue_vaccine\" title=\"Dengue vaccine\">Dengue</a></li>\\n<li><a href=\"/wiki/Ebola_vaccine\" title=\"Ebola vaccine\">Ebola</a></li>\\n<li><a href=\"/wiki/Epstein%E2%80%93Barr_virus_vaccine\" title=\"Epstein\\xe2\\x80\\x93Barr virus vaccine\">Epstein\\xe2\\x80\\x93Barr virus</a></li>\\n<li><a href=\"/wiki/Hepatitis_C_vaccine\" title=\"Hepatitis C vaccine\">Hepatitis C</a></li>\\n<li><a href=\"/wiki/Herpes_simplex_research\" title=\"Herpes simplex research\">Herpes simplex</a></li>\\n<li><a href=\"/wiki/HIV_vaccine\" title=\"HIV vaccine\">HIV</a></li>\\n<li><a href=\"/wiki/Respiratory_syncytial_virus_vaccine\" title=\"Respiratory syncytial virus vaccine\">Respiratory syncytial virus</a></li>\\n<li><a href=\"/wiki/Zika_virus_vaccine\" title=\"Zika virus vaccine\">Zika</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Protozoan</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Malaria_vaccine\" title=\"Malaria vaccine\">Malaria</a>\\n<ul><li><a href=\"/wiki/RTS,S\" title=\"RTS,S\">RTS,S</a></li></ul></li>\\n<li>research:\\n<ul><li><a href=\"/wiki/Trypanosomiasis_vaccine\" title=\"Trypanosomiasis vaccine\">Trypanosomiasis</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Helminthiasis\" title=\"Helminthiasis\">Helminthiasis</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li>research:\\n<ul><li><a href=\"/wiki/Hookworm_vaccine\" title=\"Hookworm vaccine\">Hookworm</a></li>\\n<li><a href=\"/wiki/Schistosomiasis_vaccine\" title=\"Schistosomiasis vaccine\">Schistosomiasis</a></li></ul></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Androvax\" title=\"Androvax\">Androvax (androstenedione albumin)</a></li>\\n<li><a href=\"/wiki/Cancer_vaccine\" title=\"Cancer vaccine\">Cancer vaccines</a>\\n<ul><li><a href=\"/wiki/ALVAC-CEA_vaccine\" title=\"ALVAC-CEA vaccine\">ALVAC-CEA</a></li>\\n<li><a href=\"/wiki/BCG_vaccine\" title=\"BCG vaccine\">BCG</a><sup>#</sup></li>\\n<li><a href=\"/wiki/Hepatitis_B_vaccine\" title=\"Hepatitis B vaccine\">Hepatitis B</a><sup>#</sup></li>\\n<li><a href=\"/wiki/HPV_vaccines\" class=\"mw-redirect\" title=\"HPV vaccines\">HPV</a>\\n<ul><li><a href=\"/wiki/Cervarix\" title=\"Cervarix\">Cervarix</a></li>\\n<li><a href=\"/wiki/Gardasil\" title=\"Gardasil\">Gardasil</a></li></ul></li>\\n<li><a href=\"/wiki/PROSTVAC\" class=\"mw-redirect\" title=\"PROSTVAC\">PROSTVAC</a></li></ul></li>\\n<li><a href=\"/wiki/NicVAX\" title=\"NicVAX\">NicVAX</a></li>\\n<li><a href=\"/wiki/Ovandrotone_albumin\" title=\"Ovandrotone albumin\">Ovandrotone albumin (Fecundin)</a></li>\\n<li><a href=\"/wiki/TA-CD\" title=\"TA-CD\">TA-CD</a></li>\\n<li><a href=\"/wiki/TA-NIC\" title=\"TA-NIC\">TA-NIC</a></li>\\n<li>combination\\n<ul><li><a href=\"/wiki/DTaP-IPV/Hib\" class=\"mw-redirect\" title=\"DTaP-IPV/Hib\">DTaP-IPV/Hib</a></li>\\n<li><a href=\"/wiki/DTaP-IPV-HepB\" class=\"mw-redirect\" title=\"DTaP-IPV-HepB\">DTaP-IPV-HepB</a></li>\\n<li><a href=\"/wiki/Hexavalent_vaccine\" title=\"Hexavalent vaccine\">Hexavalent vaccine</a></li>\\n<li><a href=\"/wiki/Pentavalent_vaccine\" title=\"Pentavalent vaccine\">Pentavalent vaccine</a></li></ul></li></ul>\\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Inventors/researchers</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Edward_Jenner\" title=\"Edward Jenner\">Edward Jenner</a></li>\\n<li><a href=\"/wiki/Louis_Pasteur\" title=\"Louis Pasteur\">Louis Pasteur</a></li>\\n<li><a href=\"/wiki/Hilary_Koprowski\" title=\"Hilary Koprowski\">Hilary Koprowski</a></li>\\n<li><a href=\"/wiki/Jonas_Salk\" title=\"Jonas Salk\">Jonas Salk</a></li>\\n<li><a href=\"/wiki/John_Franklin_Enders\" title=\"John Franklin Enders\">John Franklin Enders</a></li>\\n<li><a href=\"/wiki/Stanley_Plotkin\" title=\"Stanley Plotkin\">Stanley Plotkin</a></li>\\n<li><a href=\"/wiki/H._Fred_Clark\" title=\"H. Fred Clark\">H. Fred Clark</a></li>\\n<li><a href=\"/wiki/Paul_Offit\" title=\"Paul Offit\">Paul Offit</a></li>\\n<li><a href=\"/wiki/Anthony_Fauci\" title=\"Anthony Fauci\">Anthony Fauci</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Controversy</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Vaccine_controversies\" class=\"mw-redirect\" title=\"Vaccine controversies\">General</a></li>\\n<li><a href=\"/wiki/MMR_vaccine_and_autism\" title=\"MMR vaccine and autism\">MMR</a></li>\\n<li><a href=\"/wiki/National_Childhood_Vaccine_Injury_Act\" title=\"National Childhood Vaccine Injury Act\">NCVIA</a></li>\\n<li>Infection party\\n<ul><li><a href=\"/wiki/Pox_party\" title=\"Pox party\">Pox</a></li>\\n<li><a href=\"/wiki/Flu_party\" class=\"mw-redirect\" title=\"Flu party\">Flu</a></li>\\n<li><a href=\"/wiki/Coronavirus_party\" title=\"Coronavirus party\">CoV</a></li></ul></li>\\n<li><a href=\"/wiki/Thiomersal_controversy\" class=\"mw-redirect\" title=\"Thiomersal controversy\">Thiomersal</a></li>\\n<li><a href=\"/wiki/Vaccines_and_SIDS\" title=\"Vaccines and SIDS\">Vaccines and SIDS</a></li>\\n<li><a href=\"/wiki/Lancet_MMR_autism_fraud\" title=\"Lancet MMR autism fraud\"><i>Lancet</i> MMR autism fraud</a></li>\\n<li><i><a href=\"/wiki/Cedillo_v._Secretary_of_Health_and_Human_Services\" title=\"Cedillo v. Secretary of Health and Human Services\">Cedillo v. Secretary of Health and Human Services</a></i></li>\\n<li><a href=\"/wiki/Alternative_vaccination_schedule\" title=\"Alternative vaccination schedule\">Alternative vaccination schedule</a></li></ul>\\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Related</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\\n<ul><li><a href=\"/wiki/Epidemiology\" title=\"Epidemiology\">Epidemiology</a></li>\\n<li><a href=\"/wiki/Eradication_of_infectious_diseases\" title=\"Eradication of infectious diseases\">Eradication of infectious diseases</a></li>\\n<li><a href=\"/wiki/Every_Child_by_Two\" class=\"mw-redirect\" title=\"Every Child by Two\">Every Child by Two</a></li>\\n<li><a href=\"/wiki/List_of_vaccine_topics\" title=\"List of vaccine topics\">List of vaccine topics</a></li></ul>\\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\" style=\"background: transparent; padding: 0px;\"><div><div class=\"hlist\">\\n<ul><li><sup>#</sup><a href=\"/wiki/WHO_Model_List_of_Essential_Medicines\" title=\"WHO Model List of Essential Medicines\">WHO-EM</a></li>\\n<li><sup>\\xe2\\x80\\xa1</sup><a href=\"/wiki/List_of_withdrawn_drugs\" title=\"List of withdrawn drugs\">Withdrawn</a> from market</li>\\n<li><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trials</a>:\\n<ul><li><sup>\\xe2\\x80\\xa0</sup><a href=\"/wiki/Phases_of_clinical_research#Phase_III\" title=\"Phases of clinical research\">Phase III</a></li>\\n<li><sup>\\xc2\\xa7</sup>Never to phase III</li></ul></li></ul>\\n</div></div></td></tr></tbody></table></div>\\n<!-- \\nNewPP limit report\\nParsed by mw2365\\nCached time: 20201017063903\\nCache expiry: 2592000\\nDynamic content: false\\nComplications: [vary\\xe2\\x80\\x90revision\\xe2\\x80\\x90sha1]\\nCPU time usage: 2.708 seconds\\nReal time usage: 2.979 seconds\\nPreprocessor visited node count: 21382/1000000\\nPost\\xe2\\x80\\x90expand include size: 1041476/2097152 bytes\\nTemplate argument size: 22318/2097152 bytes\\nHighest expansion depth: 13/40\\nExpensive parser function count: 9/500\\nUnstrip recursion depth: 1/20\\nUnstrip post\\xe2\\x80\\x90expand size: 958437/5000000 bytes\\nLua time usage: 1.378/10.000 seconds\\nLua memory usage: 10.61 MB/50 MB\\nLua Profile:\\n    ?                                                                220 ms       15.3%\\n    Scribunto_LuaSandboxCallback::match                              160 ms       11.1%\\n    Scribunto_LuaSandboxCallback::find                               140 ms        9.7%\\n    Scribunto_LuaSandboxCallback::gsub                               120 ms        8.3%\\n    dataWrapper <mw.lua:661>                                         120 ms        8.3%\\n    Scribunto_LuaSandboxCallback::callParserFunction                 120 ms        8.3%\\n    recursiveClone <mwInit.lua:41>                                    80 ms        5.6%\\n    <mw.lua:683>                                                      60 ms        4.2%\\n    Scribunto_LuaSandboxCallback::plain                               60 ms        4.2%\\n    <Module:Citation/CS1:815>                                         40 ms        2.8%\\n    [others]                                                         320 ms       22.2%\\nNumber of Wikibase entities loaded: 0/400\\n-->\\n<!--\\nTransclusion expansion time report (%,ms,calls,template)\\n100.00% 2364.278      1 -total\\n 63.72% 1506.406      3 Template:Reflist\\n 24.40%  576.900    138 Template:Cite_web\\n 21.55%  509.472     71 Template:Cite_journal\\n  7.62%  180.272     41 Template:Cite_news\\n  3.95%   93.432      1 Template:Pp-semi\\n  2.99%   70.710      1 Template:COVID-19_pandemic\\n  2.34%   55.234      1 Template:Short_description\\n  2.29%   54.155     48 Template:ClinicalStudyInfo\\n  1.53%   36.071     28 Template:US$\\n-->\\n\\n<!-- Saved in parser cache with key enwiki:pcache:idhash:63319438-0!canonical and timestamp 20201017063900 and revision id 983748222\\n -->\\n</div><noscript><img src=\"//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1\" alt=\"\" title=\"\" width=\"1\" height=\"1\" style=\"border: none; position: absolute;\" /></noscript>\\n<div class=\"printfooter\">Retrieved from \"<a dir=\"ltr\" href=\"https://en.wikipedia.org/w/index.php?title=COVID-19_vaccine&amp;oldid=983748222\">https://en.wikipedia.org/w/index.php?title=COVID-19_vaccine&amp;oldid=983748222</a>\"</div></div>\\n\\t\\t<div id=\"catlinks\" class=\"catlinks\" data-mw=\"interface\"><div id=\"mw-normal-catlinks\" class=\"mw-normal-catlinks\"><a href=\"/wiki/Help:Category\" title=\"Help:Category\">Categories</a>: <ul><li><a href=\"/wiki/Category:COVID-19_vaccines\" title=\"Category:COVID-19 vaccines\">COVID-19 vaccines</a></li><li><a href=\"/wiki/Category:Medical_research\" title=\"Category:Medical research\">Medical research</a></li><li><a href=\"/wiki/Category:Medical_responses_to_the_COVID-19_pandemic\" title=\"Category:Medical responses to the COVID-19 pandemic\">Medical responses to the COVID-19 pandemic</a></li></ul></div><div id=\"mw-hidden-catlinks\" class=\"mw-hidden-catlinks mw-hidden-cats-hidden\">Hidden categories: <ul><li><a href=\"/wiki/Category:Pages_with_non-numeric_formatnum_arguments\" title=\"Category:Pages with non-numeric formatnum arguments\">Pages with non-numeric formatnum arguments</a></li><li><a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">CS1 maint: uses authors parameter</a></li><li><a href=\"/wiki/Category:CS1_German-language_sources_(de)\" title=\"Category:CS1 German-language sources (de)\">CS1 German-language sources (de)</a></li><li><a href=\"/wiki/Category:CS1_Dutch-language_sources_(nl)\" title=\"Category:CS1 Dutch-language sources (nl)\">CS1 Dutch-language sources (nl)</a></li><li><a href=\"/wiki/Category:CS1_Indonesian-language_sources_(id)\" title=\"Category:CS1 Indonesian-language sources (id)\">CS1 Indonesian-language sources (id)</a></li><li><a href=\"/wiki/Category:CS1_errors:_missing_periodical\" title=\"Category:CS1 errors: missing periodical\">CS1 errors: missing periodical</a></li><li><a href=\"/wiki/Category:Wikipedia_indefinitely_semi-protected_pages\" title=\"Category:Wikipedia indefinitely semi-protected pages\">Wikipedia indefinitely semi-protected pages</a></li><li><a href=\"/wiki/Category:Articles_with_short_description\" title=\"Category:Articles with short description\">Articles with short description</a></li><li><a href=\"/wiki/Category:Short_description_is_different_from_Wikidata\" title=\"Category:Short description is different from Wikidata\">Short description is different from Wikidata</a></li><li><a href=\"/wiki/Category:Use_dmy_dates_from_March_2020\" title=\"Category:Use dmy dates from March 2020\">Use dmy dates from March 2020</a></li><li><a href=\"/wiki/Category:Pages_using_left_with_no_arguments\" title=\"Category:Pages using left with no arguments\">Pages using left with no arguments</a></li></ul></div></div>\\n\\t</div>\\n</div>\\n<div id=\\'mw-data-after-content\\'>\\n\\t<div class=\"read-more-container\"></div>\\n</div>\\n\\n<div id=\"mw-navigation\">\\n\\t<h2>Navigation menu</h2>\\n\\t<div id=\"mw-head\">\\n\\t\\t<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-personal\" class=\"mw-portlet mw-portlet-personal vector-menu\" aria-labelledby=\"p-personal-label\" role=\"navigation\" \\n\\t >\\n\\t<h3 id=\"p-personal-label\">\\n\\t\\t<span>Personal tools</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"pt-anonuserpage\">Not logged in</li><li id=\"pt-anontalk\"><a href=\"/wiki/Special:MyTalk\" title=\"Discussion about edits from this IP address [n]\" accesskey=\"n\">Talk</a></li><li id=\"pt-anoncontribs\"><a href=\"/wiki/Special:MyContributions\" title=\"A list of edits made from this IP address [y]\" accesskey=\"y\">Contributions</a></li><li id=\"pt-createaccount\"><a href=\"/w/index.php?title=Special:CreateAccount&amp;returnto=COVID-19+vaccine\" title=\"You are encouraged to create an account and log in; however, it is not mandatory\">Create account</a></li><li id=\"pt-login\"><a href=\"/w/index.php?title=Special:UserLogin&amp;returnto=COVID-19+vaccine\" title=\"You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]\" accesskey=\"o\">Log in</a></li></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n\\n\\t\\t<div id=\"left-navigation\">\\n\\t\\t\\t<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-namespaces\" class=\"mw-portlet mw-portlet-namespaces vector-menu vector-menu-tabs\" aria-labelledby=\"p-namespaces-label\" role=\"navigation\" \\n\\t >\\n\\t<h3 id=\"p-namespaces-label\">\\n\\t\\t<span>Namespaces</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"ca-nstab-main\" class=\"selected\"><a href=\"/wiki/COVID-19_vaccine\" title=\"View the content page [c]\" accesskey=\"c\">Article</a></li><li id=\"ca-talk\"><a href=\"/wiki/Talk:COVID-19_vaccine\" rel=\"discussion\" title=\"Discuss improvements to the content page [t]\" accesskey=\"t\">Talk</a></li></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n\\n\\t\\t\\t<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-variants\" class=\"mw-portlet mw-portlet-variants emptyPortlet vector-menu vector-menu-dropdown\" aria-labelledby=\"p-variants-label\" role=\"navigation\" \\n\\t >\\n\\t<input type=\"checkbox\" class=\"vector-menu-checkbox\" aria-labelledby=\"p-variants-label\" />\\n\\t<h3 id=\"p-variants-label\">\\n\\t\\t<span>Variants</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n\\n\\t\\t</div>\\n\\t\\t<div id=\"right-navigation\">\\n\\t\\t\\t<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-views\" class=\"mw-portlet mw-portlet-views vector-menu vector-menu-tabs\" aria-labelledby=\"p-views-label\" role=\"navigation\" \\n\\t >\\n\\t<h3 id=\"p-views-label\">\\n\\t\\t<span>Views</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"ca-view\" class=\"selected\"><a href=\"/wiki/COVID-19_vaccine\">Read</a></li><li id=\"ca-viewsource\"><a href=\"/w/index.php?title=COVID-19_vaccine&amp;action=edit\" title=\"This page is protected.&#10;You can view its source [e]\" accesskey=\"e\">View source</a></li><li id=\"ca-history\"><a href=\"/w/index.php?title=COVID-19_vaccine&amp;action=history\" title=\"Past revisions of this page [h]\" accesskey=\"h\">View history</a></li></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n\\n\\t\\t\\t<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-cactions\" class=\"mw-portlet mw-portlet-cactions emptyPortlet vector-menu vector-menu-dropdown\" aria-labelledby=\"p-cactions-label\" role=\"navigation\" \\n\\t >\\n\\t<input type=\"checkbox\" class=\"vector-menu-checkbox\" aria-labelledby=\"p-cactions-label\" />\\n\\t<h3 id=\"p-cactions-label\">\\n\\t\\t<span>More</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n\\n\\t\\t\\t<div id=\"p-search\" role=\"search\">\\n\\t<h3 >\\n\\t\\t<label for=\"searchInput\">Search</label>\\n\\t</h3>\\n\\t<form action=\"/w/index.php\" id=\"searchform\">\\n\\t\\t<div id=\"simpleSearch\" data-search-loc=\"header-navigation\">\\n\\t\\t\\t<input type=\"search\" name=\"search\" placeholder=\"Search Wikipedia\" title=\"Search Wikipedia [f]\" accesskey=\"f\" id=\"searchInput\"/>\\n\\t\\t\\t<input type=\"hidden\" name=\"title\" value=\"Special:Search\">\\n\\t\\t\\t<input type=\"submit\" name=\"fulltext\" value=\"Search\" title=\"Search Wikipedia for this text\" id=\"mw-searchButton\" class=\"searchButton mw-fallbackSearchButton\"/>\\n\\t\\t\\t<input type=\"submit\" name=\"go\" value=\"Go\" title=\"Go to a page with this exact name if it exists\" id=\"searchButton\" class=\"searchButton\"/>\\n\\t\\t</div>\\n\\t</form>\\n</div>\\n\\n\\t\\t</div>\\n\\t</div>\\n\\t\\n<div id=\"mw-panel\">\\n\\t<div id=\"p-logo\" role=\"banner\">\\n\\t\\t<a  title=\"Visit the main page\" class=\"mw-wiki-logo\" href=\"/wiki/Main_Page\"></a>\\n\\t</div>\\n\\t<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-navigation\" class=\"mw-portlet mw-portlet-navigation vector-menu vector-menu-portal portal portal-first\" aria-labelledby=\"p-navigation-label\" role=\"navigation\" \\n\\t >\\n\\t<h3 id=\"p-navigation-label\">\\n\\t\\t<span>Navigation</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"n-mainpage-description\"><a href=\"/wiki/Main_Page\" title=\"Visit the main page [z]\" accesskey=\"z\">Main page</a></li><li id=\"n-contents\"><a href=\"/wiki/Wikipedia:Contents\" title=\"Guides to browsing Wikipedia\">Contents</a></li><li id=\"n-currentevents\"><a href=\"/wiki/Portal:Current_events\" title=\"Articles related to current events\">Current events</a></li><li id=\"n-randompage\"><a href=\"/wiki/Special:Random\" title=\"Visit a randomly selected article [x]\" accesskey=\"x\">Random article</a></li><li id=\"n-aboutsite\"><a href=\"/wiki/Wikipedia:About\" title=\"Learn about Wikipedia and how it works\">About Wikipedia</a></li><li id=\"n-contactpage\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\" title=\"How to contact Wikipedia\">Contact us</a></li><li id=\"n-sitesupport\"><a href=\"https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en\" title=\"Support us by donating to the Wikimedia Foundation\">Donate</a></li></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n\\n\\t<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-interaction\" class=\"mw-portlet mw-portlet-interaction vector-menu vector-menu-portal portal\" aria-labelledby=\"p-interaction-label\" role=\"navigation\" \\n\\t >\\n\\t<h3 id=\"p-interaction-label\">\\n\\t\\t<span>Contribute</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"n-help\"><a href=\"/wiki/Help:Contents\" title=\"Guidance on how to use and edit Wikipedia\">Help</a></li><li id=\"n-introduction\"><a href=\"/wiki/Help:Introduction\" title=\"Learn how to edit Wikipedia\">Learn to edit</a></li><li id=\"n-portal\"><a href=\"/wiki/Wikipedia:Community_portal\" title=\"The hub for editors\">Community portal</a></li><li id=\"n-recentchanges\"><a href=\"/wiki/Special:RecentChanges\" title=\"A list of recent changes to Wikipedia [r]\" accesskey=\"r\">Recent changes</a></li><li id=\"n-upload\"><a href=\"/wiki/Wikipedia:File_Upload_Wizard\" title=\"Add images or other media for use on Wikipedia\">Upload file</a></li></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-tb\" class=\"mw-portlet mw-portlet-tb vector-menu vector-menu-portal portal\" aria-labelledby=\"p-tb-label\" role=\"navigation\" \\n\\t >\\n\\t<h3 id=\"p-tb-label\">\\n\\t\\t<span>Tools</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"t-whatlinkshere\"><a href=\"/wiki/Special:WhatLinksHere/COVID-19_vaccine\" title=\"List of all English Wikipedia pages containing links to this page [j]\" accesskey=\"j\">What links here</a></li><li id=\"t-recentchangeslinked\"><a href=\"/wiki/Special:RecentChangesLinked/COVID-19_vaccine\" rel=\"nofollow\" title=\"Recent changes in pages linked from this page [k]\" accesskey=\"k\">Related changes</a></li><li id=\"t-upload\"><a href=\"/wiki/Wikipedia:File_Upload_Wizard\" title=\"Upload files [u]\" accesskey=\"u\">Upload file</a></li><li id=\"t-specialpages\"><a href=\"/wiki/Special:SpecialPages\" title=\"A list of all special pages [q]\" accesskey=\"q\">Special pages</a></li><li id=\"t-permalink\"><a href=\"/w/index.php?title=COVID-19_vaccine&amp;oldid=983748222\" title=\"Permanent link to this revision of this page\">Permanent link</a></li><li id=\"t-info\"><a href=\"/w/index.php?title=COVID-19_vaccine&amp;action=info\" title=\"More information about this page\">Page information</a></li><li id=\"t-cite\"><a href=\"/w/index.php?title=Special:CiteThisPage&amp;page=COVID-19_vaccine&amp;id=983748222&amp;wpFormIdentifier=titleform\" title=\"Information on how to cite this page\">Cite this page</a></li><li id=\"t-wikibase\"><a href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q87719492\" title=\"Structured data on this page hosted by Wikidata [g]\" accesskey=\"g\">Wikidata item</a></li></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-coll-print_export\" class=\"mw-portlet mw-portlet-coll-print_export vector-menu vector-menu-portal portal\" aria-labelledby=\"p-coll-print_export-label\" role=\"navigation\" \\n\\t >\\n\\t<h3 id=\"p-coll-print_export-label\">\\n\\t\\t<span>Print/export</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"><li id=\"coll-download-as-rl\"><a href=\"/w/index.php?title=Special:DownloadAsPdf&amp;page=COVID-19_vaccine&amp;action=show-download-screen\" title=\"Download this page as a PDF file\">Download as PDF</a></li><li id=\"t-print\"><a href=\"/w/index.php?title=COVID-19_vaccine&amp;printable=yes\" title=\"Printable version of this page [p]\" accesskey=\"p\">Printable version</a></li></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-wikibase-otherprojects\" class=\"mw-portlet mw-portlet-wikibase-otherprojects vector-menu vector-menu-portal portal\" aria-labelledby=\"p-wikibase-otherprojects-label\" role=\"navigation\" \\n\\t >\\n\\t<h3 id=\"p-wikibase-otherprojects-label\">\\n\\t\\t<span>In other projects</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"><li class=\"wb-otherproject-link wb-otherproject-commons\"><a href=\"https://commons.wikimedia.org/wiki/Category:COVID-19_vaccines\" hreflang=\"en\">Wikimedia Commons</a></li></ul>\\n\\t\\t\\n\\t</div>\\n</nav>\\n\\n\\t<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\\n<nav id=\"p-lang\" class=\"mw-portlet mw-portlet-lang vector-menu vector-menu-portal portal\" aria-labelledby=\"p-lang-label\" role=\"navigation\" \\n\\t >\\n\\t<h3 id=\"p-lang-label\">\\n\\t\\t<span>Languages</span>\\n\\t</h3>\\n\\t<div class=\"vector-menu-content\">\\n\\t\\t<ul class=\"vector-menu-content-list\"><li class=\"interlanguage-link interwiki-ar\"><a href=\"https://ar.wikipedia.org/wiki/%D9%84%D9%82%D8%A7%D8%AD_%D9%83%D9%88%D9%81%D9%8A%D8%AF-19\" title=\"\\xd9\\x84\\xd9\\x82\\xd8\\xa7\\xd8\\xad \\xd9\\x83\\xd9\\x88\\xd9\\x81\\xd9\\x8a\\xd8\\xaf-19 \\xe2\\x80\\x93 Arabic\" lang=\"ar\" hreflang=\"ar\" class=\"interlanguage-link-target\">\\xd8\\xa7\\xd9\\x84\\xd8\\xb9\\xd8\\xb1\\xd8\\xa8\\xd9\\x8a\\xd8\\xa9</a></li><li class=\"interlanguage-link interwiki-bn\"><a href=\"https://bn.wikipedia.org/wiki/%E0%A6%95%E0%A7%8B%E0%A6%AD%E0%A6%BF%E0%A6%A1-%E0%A7%A7%E0%A7%AF_%E0%A6%9F%E0%A6%BF%E0%A6%95%E0%A6%BE\" title=\"\\xe0\\xa6\\x95\\xe0\\xa7\\x8b\\xe0\\xa6\\xad\\xe0\\xa6\\xbf\\xe0\\xa6\\xa1-\\xe0\\xa7\\xa7\\xe0\\xa7\\xaf \\xe0\\xa6\\x9f\\xe0\\xa6\\xbf\\xe0\\xa6\\x95\\xe0\\xa6\\xbe \\xe2\\x80\\x93 Bangla\" lang=\"bn\" hreflang=\"bn\" class=\"interlanguage-link-target\">\\xe0\\xa6\\xac\\xe0\\xa6\\xbe\\xe0\\xa6\\x82\\xe0\\xa6\\xb2\\xe0\\xa6\\xbe</a></li><li class=\"interlanguage-link interwiki-bs\"><a href=\"https://bs.wikipedia.org/wiki/Vakcina_protiv_bolesti_COVID-19\" title=\"Vakcina protiv bolesti COVID-19 \\xe2\\x80\\x93 Bosnian\" lang=\"bs\" hreflang=\"bs\" class=\"interlanguage-link-target\">Bosanski</a></li><li class=\"interlanguage-link interwiki-ca\"><a href=\"https://ca.wikipedia.org/wiki/Vacuna_contra_la_COVID-19\" title=\"Vacuna contra la COVID-19 \\xe2\\x80\\x93 Catalan\" lang=\"ca\" hreflang=\"ca\" class=\"interlanguage-link-target\">Catal\\xc3\\xa0</a></li><li class=\"interlanguage-link interwiki-da\"><a href=\"https://da.wikipedia.org/wiki/COVID-19-vaccine\" title=\"COVID-19-vaccine \\xe2\\x80\\x93 Danish\" lang=\"da\" hreflang=\"da\" class=\"interlanguage-link-target\">Dansk</a></li><li class=\"interlanguage-link interwiki-de\"><a href=\"https://de.wikipedia.org/wiki/SARS-CoV-2-Impfstoff\" title=\"SARS-CoV-2-Impfstoff \\xe2\\x80\\x93 German\" lang=\"de\" hreflang=\"de\" class=\"interlanguage-link-target\">Deutsch</a></li><li class=\"interlanguage-link interwiki-el\"><a href=\"https://el.wikipedia.org/wiki/%CE%95%CE%BC%CE%B2%CF%8C%CE%BB%CE%B9%CE%BF_COVID-19\" title=\"\\xce\\x95\\xce\\xbc\\xce\\xb2\\xcf\\x8c\\xce\\xbb\\xce\\xb9\\xce\\xbf COVID-19 \\xe2\\x80\\x93 Greek\" lang=\"el\" hreflang=\"el\" class=\"interlanguage-link-target\">\\xce\\x95\\xce\\xbb\\xce\\xbb\\xce\\xb7\\xce\\xbd\\xce\\xb9\\xce\\xba\\xce\\xac</a></li><li class=\"interlanguage-link interwiki-es\"><a href=\"https://es.wikipedia.org/wiki/Vacuna_contra_COVID-19\" title=\"Vacuna contra COVID-19 \\xe2\\x80\\x93 Spanish\" lang=\"es\" hreflang=\"es\" class=\"interlanguage-link-target\">Espa\\xc3\\xb1ol</a></li><li class=\"interlanguage-link interwiki-eu\"><a href=\"https://eu.wikipedia.org/wiki/COVID-19aren_aurkako_txertoa\" title=\"COVID-19aren aurkako txertoa \\xe2\\x80\\x93 Basque\" lang=\"eu\" hreflang=\"eu\" class=\"interlanguage-link-target\">Euskara</a></li><li class=\"interlanguage-link interwiki-fa\"><a href=\"https://fa.wikipedia.org/wiki/%D9%88%D8%A7%DA%A9%D8%B3%D9%86_%DA%A9%D9%88%D9%88%DB%8C%D8%AF-%DB%B1%DB%B9\" title=\"\\xd9\\x88\\xd8\\xa7\\xda\\xa9\\xd8\\xb3\\xd9\\x86 \\xda\\xa9\\xd9\\x88\\xd9\\x88\\xdb\\x8c\\xd8\\xaf-\\xdb\\xb1\\xdb\\xb9 \\xe2\\x80\\x93 Persian\" lang=\"fa\" hreflang=\"fa\" class=\"interlanguage-link-target\">\\xd9\\x81\\xd8\\xa7\\xd8\\xb1\\xd8\\xb3\\xdb\\x8c</a></li><li class=\"interlanguage-link interwiki-fr\"><a href=\"https://fr.wikipedia.org/wiki/Vaccin_contre_la_Covid-19\" title=\"Vaccin contre la Covid-19 \\xe2\\x80\\x93 French\" lang=\"fr\" hreflang=\"fr\" class=\"interlanguage-link-target\">Fran\\xc3\\xa7ais</a></li><li class=\"interlanguage-link interwiki-gl\"><a href=\"https://gl.wikipedia.org/wiki/Vacina_da_COVID-19\" title=\"Vacina da COVID-19 \\xe2\\x80\\x93 Galician\" lang=\"gl\" hreflang=\"gl\" class=\"interlanguage-link-target\">Galego</a></li><li class=\"interlanguage-link interwiki-ko\"><a href=\"https://ko.wikipedia.org/wiki/%EC%BD%94%EB%A1%9C%EB%82%9819_%EB%B0%B1%EC%8B%A0\" title=\"\\xec\\xbd\\x94\\xeb\\xa1\\x9c\\xeb\\x82\\x9819 \\xeb\\xb0\\xb1\\xec\\x8b\\xa0 \\xe2\\x80\\x93 Korean\" lang=\"ko\" hreflang=\"ko\" class=\"interlanguage-link-target\">\\xed\\x95\\x9c\\xea\\xb5\\xad\\xec\\x96\\xb4</a></li><li class=\"interlanguage-link interwiki-hi\"><a href=\"https://hi.wikipedia.org/wiki/%E0%A4%95%E0%A5%8B%E0%A4%B5%E0%A4%BF%E0%A4%A1-19_%E0%A4%95%E0%A4%BE_%E0%A4%9F%E0%A5%80%E0%A4%95%E0%A4%BE\" title=\"\\xe0\\xa4\\x95\\xe0\\xa5\\x8b\\xe0\\xa4\\xb5\\xe0\\xa4\\xbf\\xe0\\xa4\\xa1-19 \\xe0\\xa4\\x95\\xe0\\xa4\\xbe \\xe0\\xa4\\x9f\\xe0\\xa5\\x80\\xe0\\xa4\\x95\\xe0\\xa4\\xbe \\xe2\\x80\\x93 Hindi\" lang=\"hi\" hreflang=\"hi\" class=\"interlanguage-link-target\">\\xe0\\xa4\\xb9\\xe0\\xa4\\xbf\\xe0\\xa4\\xa8\\xe0\\xa5\\x8d\\xe0\\xa4\\xa6\\xe0\\xa5\\x80</a></li><li class=\"interlanguage-link interwiki-hr\"><a href=\"https://hr.wikipedia.org/wiki/Cjepivo_protiv_COVID-19\" title=\"Cjepivo protiv COVID-19 \\xe2\\x80\\x93 Croatian\" lang=\"hr\" hreflang=\"hr\" class=\"interlanguage-link-target\">Hrvatski</a></li><li class=\"interlanguage-link interwiki-id\"><a href=\"https://id.wikipedia.org/wiki/Vaksin_COVID-19\" title=\"Vaksin COVID-19 \\xe2\\x80\\x93 Indonesian\" lang=\"id\" hreflang=\"id\" class=\"interlanguage-link-target\">Bahasa Indonesia</a></li><li class=\"interlanguage-link interwiki-it\"><a href=\"https://it.wikipedia.org/wiki/Vaccino_contro_il_COVID-19\" title=\"Vaccino contro il COVID-19 \\xe2\\x80\\x93 Italian\" lang=\"it\" hreflang=\"it\" class=\"interlanguage-link-target\">Italiano</a></li><li class=\"interlanguage-link interwiki-kn\"><a href=\"https://kn.wikipedia.org/wiki/%E0%B2%95%E0%B3%8B%E0%B2%B5%E0%B2%BF%E0%B2%A1%E0%B3%8D-%E0%B3%A7%E0%B3%AF_%E0%B2%B2%E0%B2%B8%E0%B2%BF%E0%B2%95%E0%B3%86\" title=\"\\xe0\\xb2\\x95\\xe0\\xb3\\x8b\\xe0\\xb2\\xb5\\xe0\\xb2\\xbf\\xe0\\xb2\\xa1\\xe0\\xb3\\x8d-\\xe0\\xb3\\xa7\\xe0\\xb3\\xaf \\xe0\\xb2\\xb2\\xe0\\xb2\\xb8\\xe0\\xb2\\xbf\\xe0\\xb2\\x95\\xe0\\xb3\\x86 \\xe2\\x80\\x93 Kannada\" lang=\"kn\" hreflang=\"kn\" class=\"interlanguage-link-target\">\\xe0\\xb2\\x95\\xe0\\xb2\\xa8\\xe0\\xb3\\x8d\\xe0\\xb2\\xa8\\xe0\\xb2\\xa1</a></li><li class=\"interlanguage-link interwiki-lt\"><a href=\"https://lt.wikipedia.org/wiki/COVID-19_vakcina\" title=\"COVID-19 vakcina \\xe2\\x80\\x93 Lithuanian\" lang=\"lt\" hreflang=\"lt\" class=\"interlanguage-link-target\">Lietuvi\\xc5\\xb3</a></li><li class=\"interlanguage-link interwiki-hu\"><a href=\"https://hu.wikipedia.org/wiki/COVID%E2%80%9319-vakcina\" title=\"COVID\\xe2\\x80\\x9319-vakcina \\xe2\\x80\\x93 Hungarian\" lang=\"hu\" hreflang=\"hu\" class=\"interlanguage-link-target\">Magyar</a></li><li class=\"interlanguage-link interwiki-ml\"><a href=\"https://ml.wikipedia.org/wiki/%E0%B4%95%E0%B5%8A%E0%B4%B1%E0%B5%8B%E0%B4%A3%E0%B4%B5%E0%B5%88%E0%B4%B1%E0%B4%B8%E0%B5%8D_%E0%B4%B0%E0%B5%8B%E0%B4%97%E0%B4%82_2019_%E0%B4%B5%E0%B4%BE%E0%B4%95%E0%B5%8D%E0%B4%B8%E0%B4%BF%E0%B5%BB\" title=\"\\xe0\\xb4\\x95\\xe0\\xb5\\x8a\\xe0\\xb4\\xb1\\xe0\\xb5\\x8b\\xe0\\xb4\\xa3\\xe0\\xb4\\xb5\\xe0\\xb5\\x88\\xe0\\xb4\\xb1\\xe0\\xb4\\xb8\\xe0\\xb5\\x8d \\xe0\\xb4\\xb0\\xe0\\xb5\\x8b\\xe0\\xb4\\x97\\xe0\\xb4\\x82 2019 \\xe0\\xb4\\xb5\\xe0\\xb4\\xbe\\xe0\\xb4\\x95\\xe0\\xb5\\x8d\\xe0\\xb4\\xb8\\xe0\\xb4\\xbf\\xe0\\xb5\\xbb \\xe2\\x80\\x93 Malayalam\" lang=\"ml\" hreflang=\"ml\" class=\"interlanguage-link-target\">\\xe0\\xb4\\xae\\xe0\\xb4\\xb2\\xe0\\xb4\\xaf\\xe0\\xb4\\xbe\\xe0\\xb4\\xb3\\xe0\\xb4\\x82</a></li><li class=\"interlanguage-link interwiki-ms\"><a href=\"https://ms.wikipedia.org/wiki/Vaksin_COVID-19\" title=\"Vaksin COVID-19 \\xe2\\x80\\x93 Malay\" lang=\"ms\" hreflang=\"ms\" class=\"interlanguage-link-target\">Bahasa Melayu</a></li><li class=\"interlanguage-link interwiki-nl\"><a href=\"https://nl.wikipedia.org/wiki/COVID-19-vaccin\" title=\"COVID-19-vaccin \\xe2\\x80\\x93 Dutch\" lang=\"nl\" hreflang=\"nl\" class=\"interlanguage-link-target\">Nederlands</a></li><li class=\"interlanguage-link interwiki-ja\"><a href=\"https://ja.wikipedia.org/wiki/COVID-19%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3\" title=\"COVID-19\\xe3\\x83\\xaf\\xe3\\x82\\xaf\\xe3\\x83\\x81\\xe3\\x83\\xb3 \\xe2\\x80\\x93 Japanese\" lang=\"ja\" hreflang=\"ja\" class=\"interlanguage-link-target\">\\xe6\\x97\\xa5\\xe6\\x9c\\xac\\xe8\\xaa\\x9e</a></li><li class=\"interlanguage-link interwiki-no\"><a href=\"https://no.wikipedia.org/wiki/Covid-19-vaksiner\" title=\"Covid-19-vaksiner \\xe2\\x80\\x93 Norwegian Bokm\\xc3\\xa5l\" lang=\"nb\" hreflang=\"nb\" class=\"interlanguage-link-target\">Norsk bokm\\xc3\\xa5l</a></li><li class=\"interlanguage-link interwiki-pt\"><a href=\"https://pt.wikipedia.org/wiki/Pesquisa_de_vacina_para_COVID-19\" title=\"Pesquisa de vacina para COVID-19 \\xe2\\x80\\x93 Portuguese\" lang=\"pt\" hreflang=\"pt\" class=\"interlanguage-link-target\">Portugu\\xc3\\xaas</a></li><li class=\"interlanguage-link interwiki-ro\"><a href=\"https://ro.wikipedia.org/wiki/Vaccin_anti-COVID-19\" title=\"Vaccin anti-COVID-19 \\xe2\\x80\\x93 Romanian\" lang=\"ro\" hreflang=\"ro\" class=\"interlanguage-link-target\">Rom\\xc3\\xa2n\\xc4\\x83</a></li><li class=\"interlanguage-link interwiki-ru\"><a href=\"https://ru.wikipedia.org/wiki/%D0%92%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D0%B0_%D0%BF%D1%80%D0%BE%D1%82%D0%B8%D0%B2_COVID-19\" title=\"\\xd0\\x92\\xd0\\xb0\\xd0\\xba\\xd1\\x86\\xd0\\xb8\\xd0\\xbd\\xd0\\xb0 \\xd0\\xbf\\xd1\\x80\\xd0\\xbe\\xd1\\x82\\xd0\\xb8\\xd0\\xb2 COVID-19 \\xe2\\x80\\x93 Russian\" lang=\"ru\" hreflang=\"ru\" class=\"interlanguage-link-target\">\\xd0\\xa0\\xd1\\x83\\xd1\\x81\\xd1\\x81\\xd0\\xba\\xd0\\xb8\\xd0\\xb9</a></li><li class=\"interlanguage-link interwiki-sq\"><a href=\"https://sq.wikipedia.org/wiki/Vaksina_p%C3%ABr_COVID-19\" title=\"Vaksina p\\xc3\\xabr COVID-19 \\xe2\\x80\\x93 Albanian\" lang=\"sq\" hreflang=\"sq\" class=\"interlanguage-link-target\">Shqip</a></li><li class=\"interlanguage-link interwiki-si\"><a href=\"https://si.wikipedia.org/wiki/%E0%B6%9A%E0%B7%9C%E0%B7%80%E0%B7%92%E0%B6%A9%E0%B7%8A-19_%E0%B6%91%E0%B6%B1%E0%B7%8A%E0%B6%B1%E0%B6%AD\" title=\"\\xe0\\xb6\\x9a\\xe0\\xb7\\x9c\\xe0\\xb7\\x80\\xe0\\xb7\\x92\\xe0\\xb6\\xa9\\xe0\\xb7\\x8a-19 \\xe0\\xb6\\x91\\xe0\\xb6\\xb1\\xe0\\xb7\\x8a\\xe0\\xb6\\xb1\\xe0\\xb6\\xad \\xe2\\x80\\x93 Sinhala\" lang=\"si\" hreflang=\"si\" class=\"interlanguage-link-target\">\\xe0\\xb7\\x83\\xe0\\xb7\\x92\\xe0\\xb6\\x82\\xe0\\xb7\\x84\\xe0\\xb6\\xbd</a></li><li class=\"interlanguage-link interwiki-simple\"><a href=\"https://simple.wikipedia.org/wiki/COVID-19_vaccine\" title=\"COVID-19 vaccine \\xe2\\x80\\x93 Simple English\" lang=\"en-simple\" hreflang=\"en-simple\" class=\"interlanguage-link-target\">Simple English</a></li><li class=\"interlanguage-link interwiki-sd\"><a href=\"https://sd.wikipedia.org/wiki/%DA%AA%D9%88%D9%88%DA%8A-%D9%A1%D9%A9_%D9%88%D9%8A%DA%AA%D8%B3%D9%8A%D9%86\" title=\"\\xda\\xaa\\xd9\\x88\\xd9\\x88\\xda\\x8a-\\xd9\\xa1\\xd9\\xa9 \\xd9\\x88\\xd9\\x8a\\xda\\xaa\\xd8\\xb3\\xd9\\x8a\\xd9\\x86 \\xe2\\x80\\x93 Sindhi\" lang=\"sd\" hreflang=\"sd\" class=\"interlanguage-link-target\">\\xd8\\xb3\\xd9\\x86\\xda\\x8c\\xd9\\x8a</a></li><li class=\"interlanguage-link interwiki-sk\"><a href=\"https://sk.wikipedia.org/wiki/Vakc%C3%ADna_proti_chorobe_COVID-19\" title=\"Vakc\\xc3\\xadna proti chorobe COVID-19 \\xe2\\x80\\x93 Slovak\" lang=\"sk\" hreflang=\"sk\" class=\"interlanguage-link-target\">Sloven\\xc4\\x8dina</a></li><li class=\"interlanguage-link interwiki-sr\"><a href=\"https://sr.wikipedia.org/wiki/%D0%98%D1%81%D1%82%D1%80%D0%B0%D0%B6%D0%B8%D0%B2%D0%B0%D1%9A%D0%B5_%D0%B2%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D0%B5_%D0%BF%D1%80%D0%BE%D1%82%D0%B8%D0%B2_%D0%BA%D0%BE%D0%B2%D0%B8%D0%B4%D0%B0_19\" title=\"\\xd0\\x98\\xd1\\x81\\xd1\\x82\\xd1\\x80\\xd0\\xb0\\xd0\\xb6\\xd0\\xb8\\xd0\\xb2\\xd0\\xb0\\xd1\\x9a\\xd0\\xb5 \\xd0\\xb2\\xd0\\xb0\\xd0\\xba\\xd1\\x86\\xd0\\xb8\\xd0\\xbd\\xd0\\xb5 \\xd0\\xbf\\xd1\\x80\\xd0\\xbe\\xd1\\x82\\xd0\\xb8\\xd0\\xb2 \\xd0\\xba\\xd0\\xbe\\xd0\\xb2\\xd0\\xb8\\xd0\\xb4\\xd0\\xb0 19 \\xe2\\x80\\x93 Serbian\" lang=\"sr\" hreflang=\"sr\" class=\"interlanguage-link-target\">\\xd0\\xa1\\xd1\\x80\\xd0\\xbf\\xd1\\x81\\xd0\\xba\\xd0\\xb8 / srpski</a></li><li class=\"interlanguage-link interwiki-fi\"><a href=\"https://fi.wikipedia.org/wiki/SARS-CoV-2-rokote\" title=\"SARS-CoV-2-rokote \\xe2\\x80\\x93 Finnish\" lang=\"fi\" hreflang=\"fi\" class=\"interlanguage-link-target\">Suomi</a></li><li class=\"interlanguage-link interwiki-sv\"><a href=\"https://sv.wikipedia.org/wiki/Covid-19-vaccin\" title=\"Covid-19-vaccin \\xe2\\x80\\x93 Swedish\" lang=\"sv\" hreflang=\"sv\" class=\"interlanguage-link-target\">Svenska</a></li><li class=\"interlanguage-link interwiki-ta\"><a href=\"https://ta.wikipedia.org/wiki/%E0%AE%95%E0%AF%8A%E0%AE%B0%E0%AF%8B%E0%AE%A9%E0%AE%BE%E0%AE%B5%E0%AF%88%E0%AE%B0%E0%AE%9A%E0%AF%81%E0%AE%A4%E0%AF%8D_%E0%AE%A4%E0%AF%8A%E0%AE%B1%E0%AF%8D%E0%AE%B1%E0%AF%81_2019_%E0%AE%A4%E0%AE%9F%E0%AF%81%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%82%E0%AE%9A%E0%AE%BF_%E0%AE%86%E0%AE%AF%E0%AF%8D%E0%AE%B5%E0%AF%81\" title=\"\\xe0\\xae\\x95\\xe0\\xaf\\x8a\\xe0\\xae\\xb0\\xe0\\xaf\\x8b\\xe0\\xae\\xa9\\xe0\\xae\\xbe\\xe0\\xae\\xb5\\xe0\\xaf\\x88\\xe0\\xae\\xb0\\xe0\\xae\\x9a\\xe0\\xaf\\x81\\xe0\\xae\\xa4\\xe0\\xaf\\x8d \\xe0\\xae\\xa4\\xe0\\xaf\\x8a\\xe0\\xae\\xb1\\xe0\\xaf\\x8d\\xe0\\xae\\xb1\\xe0\\xaf\\x81 2019 \\xe0\\xae\\xa4\\xe0\\xae\\x9f\\xe0\\xaf\\x81\\xe0\\xae\\xaa\\xe0\\xaf\\x8d\\xe0\\xae\\xaa\\xe0\\xaf\\x82\\xe0\\xae\\x9a\\xe0\\xae\\xbf \\xe0\\xae\\x86\\xe0\\xae\\xaf\\xe0\\xaf\\x8d\\xe0\\xae\\xb5\\xe0\\xaf\\x81 \\xe2\\x80\\x93 Tamil\" lang=\"ta\" hreflang=\"ta\" class=\"interlanguage-link-target\">\\xe0\\xae\\xa4\\xe0\\xae\\xae\\xe0\\xae\\xbf\\xe0\\xae\\xb4\\xe0\\xaf\\x8d</a></li><li class=\"interlanguage-link interwiki-kab\"><a href=\"https://kab.wikipedia.org/wiki/Tigezt_mgal_Covid-19\" title=\"Tigezt mgal Covid-19 \\xe2\\x80\\x93 Kabyle\" lang=\"kab\" hreflang=\"kab\" class=\"interlanguage-link-target\">Taqbaylit</a></li><li class=\"interlanguage-link interwiki-th\"><a href=\"https://th.wikipedia.org/wiki/%E0%B8%A7%E0%B8%B1%E0%B8%84%E0%B8%8B%E0%B8%B5%E0%B8%99%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B8%95%E0%B8%B4%E0%B8%94%E0%B9%80%E0%B8%8A%E0%B8%B7%E0%B9%89%E0%B8%AD%E0%B9%84%E0%B8%A7%E0%B8%A3%E0%B8%B1%E0%B8%AA%E0%B9%82%E0%B8%84%E0%B9%82%E0%B8%A3%E0%B8%99%E0%B8%B2_2019\" title=\"\\xe0\\xb8\\xa7\\xe0\\xb8\\xb1\\xe0\\xb8\\x84\\xe0\\xb8\\x8b\\xe0\\xb8\\xb5\\xe0\\xb8\\x99\\xe0\\xb9\\x82\\xe0\\xb8\\xa3\\xe0\\xb8\\x84\\xe0\\xb8\\x95\\xe0\\xb8\\xb4\\xe0\\xb8\\x94\\xe0\\xb9\\x80\\xe0\\xb8\\x8a\\xe0\\xb8\\xb7\\xe0\\xb9\\x89\\xe0\\xb8\\xad\\xe0\\xb9\\x84\\xe0\\xb8\\xa7\\xe0\\xb8\\xa3\\xe0\\xb8\\xb1\\xe0\\xb8\\xaa\\xe0\\xb9\\x82\\xe0\\xb8\\x84\\xe0\\xb9\\x82\\xe0\\xb8\\xa3\\xe0\\xb8\\x99\\xe0\\xb8\\xb2 2019 \\xe2\\x80\\x93 Thai\" lang=\"th\" hreflang=\"th\" class=\"interlanguage-link-target\">\\xe0\\xb9\\x84\\xe0\\xb8\\x97\\xe0\\xb8\\xa2</a></li><li class=\"interlanguage-link interwiki-tr\"><a href=\"https://tr.wikipedia.org/wiki/COVID-19_a%C5%9F%C4%B1s%C4%B1\" title=\"COVID-19 a\\xc5\\x9f\\xc4\\xb1s\\xc4\\xb1 \\xe2\\x80\\x93 Turkish\" lang=\"tr\" hreflang=\"tr\" class=\"interlanguage-link-target\">T\\xc3\\xbcrk\\xc3\\xa7e</a></li><li class=\"interlanguage-link interwiki-uk\"><a href=\"https://uk.wikipedia.org/wiki/%D0%92%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D0%B0_%D0%BF%D1%80%D0%BE%D1%82%D0%B8_COVID-19\" title=\"\\xd0\\x92\\xd0\\xb0\\xd0\\xba\\xd1\\x86\\xd0\\xb8\\xd0\\xbd\\xd0\\xb0 \\xd0\\xbf\\xd1\\x80\\xd0\\xbe\\xd1\\x82\\xd0\\xb8 COVID-19 \\xe2\\x80\\x93 Ukrainian\" lang=\"uk\" hreflang=\"uk\" class=\"interlanguage-link-target\">\\xd0\\xa3\\xd0\\xba\\xd1\\x80\\xd0\\xb0\\xd1\\x97\\xd0\\xbd\\xd1\\x81\\xd1\\x8c\\xd0\\xba\\xd0\\xb0</a></li><li class=\"interlanguage-link interwiki-ur\"><a href=\"https://ur.wikipedia.org/wiki/%DA%A9%D9%88%D9%88%DA%88-%D9%A1%D9%A9_%D9%88%DB%8C%DA%A9%D8%B3%DB%8C%D9%86\" title=\"\\xda\\xa9\\xd9\\x88\\xd9\\x88\\xda\\x88-\\xd9\\xa1\\xd9\\xa9 \\xd9\\x88\\xdb\\x8c\\xda\\xa9\\xd8\\xb3\\xdb\\x8c\\xd9\\x86 \\xe2\\x80\\x93 Urdu\" lang=\"ur\" hreflang=\"ur\" class=\"interlanguage-link-target\">\\xd8\\xa7\\xd8\\xb1\\xd8\\xaf\\xd9\\x88</a></li><li class=\"interlanguage-link interwiki-ug\"><a href=\"https://ug.wikipedia.org/wiki/%D9%8A%DB%90%DA%AD%D9%89_%D8%AA%D9%89%D9%BE%D8%AA%D9%89%D9%83%D9%89_%D8%AA%D8%A7%D8%AC%D8%B3%D9%89%D9%85%D8%A7%D9%86_%DB%8B%D9%89%D8%B1%DB%87%D8%B3_%D9%83%DB%90%D8%B3%D9%89%D9%84%D9%89_%DB%8B%D8%A7%D9%83%D8%B3%D9%89%D9%86%D9%89%D8%B3%D9%89(%D9%83%D9%88%DB%8B%D9%89%D8%AF-19_%D9%83%DB%90%D8%B3%D9%89%D9%84%D9%89_%DB%8B%D8%A7%D9%83%D8%B3%D9%89%D9%86%D9%89%D8%B3%D9%89)\" title=\"\\xd9\\x8a\\xdb\\x90\\xda\\xad\\xd9\\x89 \\xd8\\xaa\\xd9\\x89\\xd9\\xbe\\xd8\\xaa\\xd9\\x89\\xd9\\x83\\xd9\\x89 \\xd8\\xaa\\xd8\\xa7\\xd8\\xac\\xd8\\xb3\\xd9\\x89\\xd9\\x85\\xd8\\xa7\\xd9\\x86 \\xdb\\x8b\\xd9\\x89\\xd8\\xb1\\xdb\\x87\\xd8\\xb3 \\xd9\\x83\\xdb\\x90\\xd8\\xb3\\xd9\\x89\\xd9\\x84\\xd9\\x89 \\xdb\\x8b\\xd8\\xa7\\xd9\\x83\\xd8\\xb3\\xd9\\x89\\xd9\\x86\\xd9\\x89\\xd8\\xb3\\xd9\\x89(\\xd9\\x83\\xd9\\x88\\xdb\\x8b\\xd9\\x89\\xd8\\xaf-19 \\xd9\\x83\\xdb\\x90\\xd8\\xb3\\xd9\\x89\\xd9\\x84\\xd9\\x89 \\xdb\\x8b\\xd8\\xa7\\xd9\\x83\\xd8\\xb3\\xd9\\x89\\xd9\\x86\\xd9\\x89\\xd8\\xb3\\xd9\\x89) \\xe2\\x80\\x93 Uyghur\" lang=\"ug\" hreflang=\"ug\" class=\"interlanguage-link-target\">\\xd8\\xa6\\xdb\\x87\\xd9\\x8a\\xd8\\xba\\xdb\\x87\\xd8\\xb1\\xda\\x86\\xdb\\x95 / Uyghurche</a></li><li class=\"interlanguage-link interwiki-vi\"><a href=\"https://vi.wikipedia.org/wiki/V%E1%BA%AFc-xin_COVID-19\" title=\"V\\xe1\\xba\\xafc-xin COVID-19 \\xe2\\x80\\x93 Vietnamese\" lang=\"vi\" hreflang=\"vi\" class=\"interlanguage-link-target\">Ti\\xe1\\xba\\xbfng Vi\\xe1\\xbb\\x87t</a></li><li class=\"interlanguage-link interwiki-zh\"><a href=\"https://zh.wikipedia.org/wiki/2019%E5%86%A0%E7%8A%B6%E7%97%85%E6%AF%92%E7%97%85%E7%96%AB%E8%8B%97\" title=\"2019\\xe5\\x86\\xa0\\xe7\\x8a\\xb6\\xe7\\x97\\x85\\xe6\\xaf\\x92\\xe7\\x97\\x85\\xe7\\x96\\xab\\xe8\\x8b\\x97 \\xe2\\x80\\x93 Chinese\" lang=\"zh\" hreflang=\"zh\" class=\"interlanguage-link-target\">\\xe4\\xb8\\xad\\xe6\\x96\\x87</a></li></ul>\\n\\t\\t<div class=\"after-portlet after-portlet-lang\"><span class=\"wb-langlinks-edit wb-langlinks-link\"><a href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q87719492#sitelinks-wikipedia\" title=\"Edit interlanguage links\" class=\"wbc-editpage\">Edit links</a></span></div>\\n\\t</div>\\n</nav>\\n\\n</div>\\n\\n</div>\\n<footer id=\"footer\" class=\"mw-footer\" role=\"contentinfo\" >\\n\\t<ul id=\"footer-info\" >\\n\\t<li id=\"footer-info-lastmod\"> This page was last edited on 16 October 2020, at 01:04<span class=\"anonymous-show\">&#160;(UTC)</span>.</li>\\n\\t<li id=\"footer-info-copyright\">Text is available under the <a rel=\"license\" href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License\">Creative Commons Attribution-ShareAlike License</a><a rel=\"license\" href=\"//creativecommons.org/licenses/by-sa/3.0/\" style=\"display:none;\"></a>;\\nadditional terms may apply.  By using this site, you agree to the <a href=\"//foundation.wikimedia.org/wiki/Terms_of_Use\">Terms of Use</a> and <a href=\"//foundation.wikimedia.org/wiki/Privacy_policy\">Privacy Policy</a>. Wikipedia\\xc2\\xae is a registered trademark of the <a href=\"//www.wikimediafoundation.org/\">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>\\n</ul>\\n\\n\\t<ul id=\"footer-places\" >\\n\\t<li id=\"footer-places-privacy\"><a href=\"https://foundation.wikimedia.org/wiki/Privacy_policy\" class=\"extiw\" title=\"wmf:Privacy policy\">Privacy policy</a></li>\\n\\t<li id=\"footer-places-about\"><a href=\"/wiki/Wikipedia:About\" title=\"Wikipedia:About\">About Wikipedia</a></li>\\n\\t<li id=\"footer-places-disclaimer\"><a href=\"/wiki/Wikipedia:General_disclaimer\" title=\"Wikipedia:General disclaimer\">Disclaimers</a></li>\\n\\t<li id=\"footer-places-contact\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\">Contact Wikipedia</a></li>\\n\\t<li id=\"footer-places-mobileview\"><a href=\"//en.m.wikipedia.org/w/index.php?title=COVID-19_vaccine&amp;mobileaction=toggle_view_mobile\" class=\"noprint stopMobileRedirectToggle\">Mobile view</a></li>\\n\\t<li id=\"footer-places-developers\"><a href=\"https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute\">Developers</a></li>\\n\\t<li id=\"footer-places-statslink\"><a href=\"https://stats.wikimedia.org/#/en.wikipedia.org\">Statistics</a></li>\\n\\t<li id=\"footer-places-cookiestatement\"><a href=\"https://foundation.wikimedia.org/wiki/Cookie_statement\">Cookie statement</a></li>\\n</ul>\\n\\n\\t<ul id=\"footer-icons\" class=\"noprint\">\\n\\t<li id=\"footer-copyrightico\"><a href=\"https://wikimediafoundation.org/\"><img src=\"/static/images/footer/wikimedia-button.png\" srcset=\"/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x\" width=\"88\" height=\"31\" alt=\"Wikimedia Foundation\" loading=\"lazy\" /></a></li>\\n\\t<li id=\"footer-poweredbyico\"><a href=\"https://www.mediawiki.org/\"><img src=\"/static/images/footer/poweredby_mediawiki_88x31.png\" alt=\"Powered by MediaWiki\" srcset=\"/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x\" width=\"88\" height=\"31\" loading=\"lazy\"/></a></li>\\n</ul>\\n\\n\\t<div style=\"clear: both;\"></div>\\n</footer>\\n\\n\\n<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgPageParseReport\":{\"limitreport\":{\"cputime\":\"2.708\",\"walltime\":\"2.979\",\"ppvisitednodes\":{\"value\":21382,\"limit\":1000000},\"postexpandincludesize\":{\"value\":1041476,\"limit\":2097152},\"templateargumentsize\":{\"value\":22318,\"limit\":2097152},\"expansiondepth\":{\"value\":13,\"limit\":40},\"expensivefunctioncount\":{\"value\":9,\"limit\":500},\"unstrip-depth\":{\"value\":1,\"limit\":20},\"unstrip-size\":{\"value\":958437,\"limit\":5000000},\"entityaccesscount\":{\"value\":0,\"limit\":400},\"timingprofile\":[\"100.00% 2364.278      1 -total\",\" 63.72% 1506.406      3 Template:Reflist\",\" 24.40%  576.900    138 Template:Cite_web\",\" 21.55%  509.472     71 Template:Cite_journal\",\"  7.62%  180.272     41 Template:Cite_news\",\"  3.95%   93.432      1 Template:Pp-semi\",\"  2.99%   70.710      1 Template:COVID-19_pandemic\",\"  2.34%   55.234      1 Template:Short_description\",\"  2.29%   54.155     48 Template:ClinicalStudyInfo\",\"  1.53%   36.071     28 Template:US$\"]},\"scribunto\":{\"limitreport-timeusage\":{\"value\":\"1.378\",\"limit\":\"10.000\"},\"limitreport-memusage\":{\"value\":11127045,\"limit\":52428800},\"limitreport-logs\":\"table#1 {\\\\n  [\\\\\"size\\\\\"] = \\\\\"tiny\\\\\",\\\\n  [\\\\\"text\\\\\"] = \\\\\"COVID-19 Portal\\\\\",\\\\n}\\\\n\",\"limitreport-profile\":[[\"?\",\"220\",\"15.3\"],[\"Scribunto_LuaSandboxCallback::match\",\"160\",\"11.1\"],[\"Scribunto_LuaSandboxCallback::find\",\"140\",\"9.7\"],[\"Scribunto_LuaSandboxCallback::gsub\",\"120\",\"8.3\"],[\"dataWrapper \\\\u003Cmw.lua:661\\\\u003E\",\"120\",\"8.3\"],[\"Scribunto_LuaSandboxCallback::callParserFunction\",\"120\",\"8.3\"],[\"recursiveClone \\\\u003CmwInit.lua:41\\\\u003E\",\"80\",\"5.6\"],[\"\\\\u003Cmw.lua:683\\\\u003E\",\"60\",\"4.2\"],[\"Scribunto_LuaSandboxCallback::plain\",\"60\",\"4.2\"],[\"\\\\u003CModule:Citation/CS1:815\\\\u003E\",\"40\",\"2.8\"],[\"[others]\",\"320\",\"22.2\"]]},\"cachereport\":{\"origin\":\"mw2365\",\"timestamp\":\"20201017063903\",\"ttl\":2592000,\"transientcontent\":false}}});});</script>\\n<script type=\"application/ld+json\">{\"@context\":\"https:\\\\/\\\\/schema.org\",\"@type\":\"Article\",\"name\":\"COVID-19 vaccine\",\"url\":\"https:\\\\/\\\\/en.wikipedia.org\\\\/wiki\\\\/COVID-19_vaccine\",\"sameAs\":\"http:\\\\/\\\\/www.wikidata.org\\\\/entity\\\\/Q87719492\",\"mainEntity\":\"http:\\\\/\\\\/www.wikidata.org\\\\/entity\\\\/Q87719492\",\"author\":{\"@type\":\"Organization\",\"name\":\"Contributors to Wikimedia projects\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Wikimedia Foundation, Inc.\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\\/\\\\/www.wikimedia.org\\\\/static\\\\/images\\\\/wmf-hor-googpub.png\"}},\"datePublished\":\"2020-03-08T17:51:40Z\",\"dateModified\":\"2020-10-16T01:04:52Z\",\"image\":\"https:\\\\/\\\\/upload.wikimedia.org\\\\/wikipedia\\\\/commons\\\\/8\\\\/82\\\\/SARS-CoV-2_without_background.png\",\"headline\":\"hypothetical vaccine against coronavirus\"}</script>\\n<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgBackendResponseTime\":152,\"wgHostname\":\"mw2355\"});});</script>\\n</body></html>'\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "wTKuiU9kS5JT"
      },
      "source": [
        "obj2 = bs4.BeautifulSoup(text_data,\"lxml\") #parsing the url document, creating the object for beautiful soup "
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "bCYpr5sXdiLl",
        "outputId": "701d5881-9ef4-4fce-d4a1-f05819cba955",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        }
      },
      "source": [
        "print(obj2)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "<!DOCTYPE html>\n",
            "<html class=\"client-nojs\" dir=\"ltr\" lang=\"en\">\n",
            "<head>\n",
            "<meta charset=\"utf-8\"/>\n",
            "<title>COVID-19 vaccine - Wikipedia</title>\n",
            "<script>document.documentElement.className=\"client-js\";RLCONF={\"wgBreakFrames\":!1,\"wgSeparatorTransformTable\":[\"\",\"\"],\"wgDigitTransformTable\":[\"\",\"\"],\"wgDefaultDateFormat\":\"dmy\",\"wgMonthNames\":[\"\",\"January\",\"February\",\"March\",\"April\",\"May\",\"June\",\"July\",\"August\",\"September\",\"October\",\"November\",\"December\"],\"wgRequestId\":\"17df4ec9-e609-40dd-83b9-9161b22cde71\",\"wgCSPNonce\":!1,\"wgCanonicalNamespace\":\"\",\"wgCanonicalSpecialPageName\":!1,\"wgNamespaceNumber\":0,\"wgPageName\":\"COVID-19_vaccine\",\"wgTitle\":\"COVID-19 vaccine\",\"wgCurRevisionId\":983748222,\"wgRevisionId\":983748222,\"wgArticleId\":63319438,\"wgIsArticle\":!0,\"wgIsRedirect\":!1,\"wgAction\":\"view\",\"wgUserName\":null,\"wgUserGroups\":[\"*\"],\"wgCategories\":[\"Pages with non-numeric formatnum arguments\",\"CS1 maint: uses authors parameter\",\"CS1 German-language sources (de)\",\"CS1 Dutch-language sources (nl)\",\"CS1 Indonesian-language sources (id)\",\"CS1 errors: missing periodical\",\"Wikipedia indefinitely semi-protected pages\",\n",
            "\"Articles with short description\",\"Short description is different from Wikidata\",\"Use dmy dates from March 2020\",\"Pages using left with no arguments\",\"COVID-19 vaccines\",\"Medical research\",\"Medical responses to the COVID-19 pandemic\"],\"wgPageContentLanguage\":\"en\",\"wgPageContentModel\":\"wikitext\",\"wgRelevantPageName\":\"COVID-19_vaccine\",\"wgRelevantArticleId\":63319438,\"wgIsProbablyEditable\":!1,\"wgRelevantPageIsProbablyEditable\":!1,\"wgRestrictionEdit\":[\"autoconfirmed\"],\"wgRestrictionMove\":[],\"wgMediaViewerOnClick\":!0,\"wgMediaViewerEnabledByDefault\":!0,\"wgPopupsReferencePreviews\":!1,\"wgPopupsConflictsWithNavPopupGadget\":!1,\"wgVisualEditor\":{\"pageLanguageCode\":\"en\",\"pageLanguageDir\":\"ltr\",\"pageVariantFallbacks\":\"en\"},\"wgMFDisplayWikibaseDescriptions\":{\"search\":!0,\"nearby\":!0,\"watchlist\":!0,\"tagline\":!1},\"wgWMESchemaEditAttemptStepOversample\":!1,\"wgULSCurrentAutonym\":\"English\",\"wgNoticeProject\":\"wikipedia\",\"wgCentralAuthMobileDomain\":!1,\n",
            "\"wgEditSubmitButtonLabelPublish\":!0,\"wgULSPosition\":\"interlanguage\",\"wgWikibaseItemId\":\"Q87719492\"};RLSTATE={\"ext.globalCssJs.user.styles\":\"ready\",\"site.styles\":\"ready\",\"noscript\":\"ready\",\"user.styles\":\"ready\",\"ext.globalCssJs.user\":\"ready\",\"user\":\"ready\",\"user.options\":\"loading\",\"ext.cite.styles\":\"ready\",\"skins.vector.styles.legacy\":\"ready\",\"jquery.tablesorter.styles\":\"ready\",\"jquery.makeCollapsible.styles\":\"ready\",\"mediawiki.toc.styles\":\"ready\",\"ext.visualEditor.desktopArticleTarget.noscript\":\"ready\",\"ext.uls.interlanguage\":\"ready\",\"ext.wikimediaBadges\":\"ready\",\"wikibase.client.init\":\"ready\"};RLPAGEMODULES=[\"ext.cite.ux-enhancements\",\"ext.scribunto.logs\",\"site\",\"mediawiki.page.ready\",\"jquery.tablesorter\",\"jquery.makeCollapsible\",\"mediawiki.toc\",\"skins.vector.legacy.js\",\"ext.gadget.ReferenceTooltips\",\"ext.gadget.charinsert\",\"ext.gadget.extra-toolbar-buttons\",\"ext.gadget.refToolbar\",\"ext.gadget.switcher\",\"ext.centralauth.centralautologin\",\"mmv.head\",\"mmv.bootstrap.autostart\",\n",
            "\"ext.popups\",\"ext.visualEditor.desktopArticleTarget.init\",\"ext.visualEditor.targetLoader\",\"ext.eventLogging\",\"ext.wikimediaEvents\",\"ext.navigationTiming\",\"ext.uls.compactlinks\",\"ext.uls.interface\",\"ext.cx.eventlogging.campaigns\",\"ext.quicksurveys.init\",\"ext.centralNotice.geoIP\",\"ext.centralNotice.startUp\"];</script>\n",
            "<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement(\"user.options@1hzgi\",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({\"patrolToken\":\"+\\\\\",\"watchToken\":\"+\\\\\",\"csrfToken\":\"+\\\\\"});\n",
            "});});</script>\n",
            "<link href=\"/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cjquery.tablesorter.styles%7Cmediawiki.toc.styles%7Cskins.vector.styles.legacy%7Cwikibase.client.init&amp;only=styles&amp;skin=vector\" rel=\"stylesheet\"/>\n",
            "<script async=\"\" src=\"/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector\"></script>\n",
            "<meta content=\"\" name=\"ResourceLoaderDynamicStyles\"/>\n",
            "<link href=\"/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector\" rel=\"stylesheet\"/>\n",
            "<meta content=\"MediaWiki 1.36.0-wmf.13\" name=\"generator\"/>\n",
            "<meta content=\"origin\" name=\"referrer\"/>\n",
            "<meta content=\"origin-when-crossorigin\" name=\"referrer\"/>\n",
            "<meta content=\"origin-when-cross-origin\" name=\"referrer\"/>\n",
            "<meta content=\"https://upload.wikimedia.org/wikipedia/commons/thumb/8/82/SARS-CoV-2_without_background.png/1200px-SARS-CoV-2_without_background.png\" property=\"og:image\"/>\n",
            "<link href=\"//en.m.wikipedia.org/wiki/COVID-19_vaccine\" media=\"only screen and (max-width: 720px)\" rel=\"alternate\"/>\n",
            "<link href=\"/static/apple-touch/wikipedia.png\" rel=\"apple-touch-icon\"/>\n",
            "<link href=\"/static/favicon/wikipedia.ico\" rel=\"shortcut icon\"/>\n",
            "<link href=\"/w/opensearch_desc.php\" rel=\"search\" title=\"Wikipedia (en)\" type=\"application/opensearchdescription+xml\"/>\n",
            "<link href=\"//en.wikipedia.org/w/api.php?action=rsd\" rel=\"EditURI\" type=\"application/rsd+xml\"/>\n",
            "<link href=\"//creativecommons.org/licenses/by-sa/3.0/\" rel=\"license\"/>\n",
            "<link href=\"https://en.wikipedia.org/wiki/COVID-19_vaccine\" rel=\"canonical\"/>\n",
            "<link href=\"//login.wikimedia.org\" rel=\"dns-prefetch\"/>\n",
            "<link href=\"//meta.wikimedia.org\" rel=\"dns-prefetch\"/>\n",
            "</head>\n",
            "<body class=\"mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-COVID-19_vaccine rootpage-COVID-19_vaccine skin-vector action-view skin-vector-legacy\"><div class=\"noprint\" id=\"mw-page-base\"></div>\n",
            "<div class=\"noprint\" id=\"mw-head-base\"></div>\n",
            "<div class=\"mw-body\" id=\"content\" role=\"main\">\n",
            "<a id=\"top\"></a>\n",
            "<div class=\"mw-body-content\" id=\"siteNotice\"><!-- CentralNotice --></div>\n",
            "<div class=\"mw-indicators mw-body-content\">\n",
            "<div class=\"mw-indicator\" id=\"mw-indicator-pp-default\"><a href=\"/wiki/Wikipedia:Protection_policy#semi\" title=\"This article is semi-protected.\"><img alt=\"Page semi-protected\" data-file-height=\"512\" data-file-width=\"512\" decoding=\"async\" height=\"20\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/1/1b/Semi-protection-shackle.svg/20px-Semi-protection-shackle.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/1/1b/Semi-protection-shackle.svg/30px-Semi-protection-shackle.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/1/1b/Semi-protection-shackle.svg/40px-Semi-protection-shackle.svg.png 2x\" width=\"20\"/></a></div>\n",
            "</div>\n",
            "<h1 class=\"firstHeading\" id=\"firstHeading\" lang=\"en\">COVID-19 vaccine</h1>\n",
            "<div class=\"mw-body-content\" id=\"bodyContent\">\n",
            "<div class=\"noprint\" id=\"siteSub\">From Wikipedia, the free encyclopedia</div>\n",
            "<div id=\"contentSub\"></div>\n",
            "<div id=\"contentSub2\"></div>\n",
            "<div id=\"jump-to-nav\"></div>\n",
            "<a class=\"mw-jump-link\" href=\"#mw-head\">Jump to navigation</a>\n",
            "<a class=\"mw-jump-link\" href=\"#searchInput\">Jump to search</a>\n",
            "<div class=\"mw-content-ltr\" dir=\"ltr\" id=\"mw-content-text\" lang=\"en\"><div class=\"mw-parser-output\"><p class=\"mw-empty-elt\">\n",
            "</p>\n",
            "<div class=\"shortdescription nomobile noexcerpt noprint searchaux\" style=\"display:none\">Hypothetical vaccine against COVID-19</div>\n",
            "<div class=\"hatnote navigation-not-searchable\" role=\"note\">This article is about ongoing research for potential COVID-19 vaccines. For potential therapeutic drugs for COVID-19, see <a href=\"/wiki/COVID-19_drug_development\" title=\"COVID-19 drug development\">COVID-19 drug development</a>. For drugs that may be repurposed for treating COVID-19, see <a href=\"/wiki/COVID-19_drug_repurposing_research\" title=\"COVID-19 drug repurposing research\">COVID-19 drug repurposing research</a>.</div>\n",
            "<p class=\"mw-empty-elt\">\n",
            "</p>\n",
            "<table class=\"vertical-navbox nowraplinks hlist\" style=\"float:right;clear:right;width:22.0em;margin:0 0 1.0em 1.0em;background:#f8f9fa;border:1px solid #aaa;padding:0.2em;border-spacing:0.4em 0;text-align:center;line-height:1.4em;font-size:88%\"><tbody><tr><td style=\"padding-top:0.4em;line-height:1.2em\">Part of <a href=\"/wiki/Category:COVID-19_pandemic\" title=\"Category:COVID-19 pandemic\">a series</a> on the</td></tr><tr><th style=\"padding:0.2em 0.4em 0.2em;padding-top:0;font-size:145%;line-height:1.2em\"><a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a></th></tr><tr><td style=\"padding:0.2em 0 0.4em\"><div class=\"center\"><div class=\"floatnone\"><a class=\"image\" href=\"/wiki/File:SARS-CoV-2_without_background.png\"><img alt=\"SARS-CoV-2 without background.png\" data-file-height=\"1958\" data-file-width=\"1956\" decoding=\"async\" height=\"110\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/SARS-CoV-2_without_background.png/110px-SARS-CoV-2_without_background.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/SARS-CoV-2_without_background.png/165px-SARS-CoV-2_without_background.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/82/SARS-CoV-2_without_background.png/220px-SARS-CoV-2_without_background.png 2x\" width=\"110\"/></a></div></div></td></tr><tr><td style=\"padding:0.3em 0.4em 0.3em;font-weight:bold;border-top: 1px solid #aaa; border-bottom: 1px solid #aaa;\">\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a> (virus)</li>\n",
            "<li><a href=\"/wiki/Coronavirus_disease_2019\" title=\"Coronavirus disease 2019\">COVID-19</a> (disease)</li></ul>\n",
            "</div></td></tr><tr><td style=\"padding:0 0.1em 0.4em\">\n",
            "<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\"><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic\" title=\"Timeline of the COVID-19 pandemic\">Timeline</a></div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\">\n",
            "<ul><li><b>2019</b></li></ul>\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_December_2019\" title=\"Timeline of the COVID-19 pandemic in December 2019\">December</a></li></ul>\n",
            "</div>\n",
            "<ul><li><b>2020</b></li></ul>\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_January_2020\" title=\"Timeline of the COVID-19 pandemic in January 2020\">January</a></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_February_2020\" title=\"Timeline of the COVID-19 pandemic in February 2020\">February</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_February_2020\" title=\"Responses to the COVID-19 pandemic in February 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_March_2020\" title=\"Timeline of the COVID-19 pandemic in March 2020\">March</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_March_2020\" title=\"Responses to the COVID-19 pandemic in March 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_April_2020\" title=\"Timeline of the COVID-19 pandemic in April 2020\">April</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_April_2020\" title=\"Responses to the COVID-19 pandemic in April 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_May_2020\" title=\"Timeline of the COVID-19 pandemic in May 2020\">May</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_May_2020\" title=\"Responses to the COVID-19 pandemic in May 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_June_2020\" title=\"Timeline of the COVID-19 pandemic in June 2020\">June</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_June_2020\" title=\"Responses to the COVID-19 pandemic in June 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_July_2020\" title=\"Timeline of the COVID-19 pandemic in July 2020\">July</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_July_2020\" title=\"Responses to the COVID-19 pandemic in July 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_August_2020\" title=\"Timeline of the COVID-19 pandemic in August 2020\">August</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_August_2020\" title=\"Responses to the COVID-19 pandemic in August 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_September_2020\" title=\"Timeline of the COVID-19 pandemic in September 2020\">September</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_September_2020\" title=\"Responses to the COVID-19 pandemic in September 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_October_2020\" title=\"Timeline of the COVID-19 pandemic in October 2020\">October</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_October_2020\" title=\"Responses to the COVID-19 pandemic in October 2020\">responses</a></li></ul></li></ul>\n",
            "</div></div></div></td>\n",
            "</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n",
            "<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\"><a href=\"/wiki/COVID-19_pandemic_by_country_and_territory\" title=\"COVID-19 pandemic by country and territory\">Locations</a></div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\">\n",
            "<ul><li><b>By continent</b></li></ul>\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Africa\" title=\"COVID-19 pandemic in Africa\">Africa</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Antarctica\" title=\"COVID-19 pandemic in Antarctica\">Antarctica</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Asia\" title=\"COVID-19 pandemic in Asia\">Asia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Europe\" title=\"COVID-19 pandemic in Europe\">Europe</a></li></ul>\n",
            "</div>\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_North_America\" title=\"COVID-19 pandemic in North America\">North America</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Oceania\" title=\"COVID-19 pandemic in Oceania\">Oceania</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_South_America\" title=\"COVID-19 pandemic in South America\">South America</a></li></ul>\n",
            "</div>\n",
            "<ul><li><b>By conveyance</b></li></ul>\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_on_cruise_ships\" title=\"COVID-19 pandemic on cruise ships\">Cruise ships</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_on_naval_ships\" title=\"COVID-19 pandemic on naval ships\">Naval ships</a></li></ul>\n",
            "</div>\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><b><a href=\"/wiki/COVID-19_pandemic_cases\" title=\"COVID-19 pandemic cases\">Cases</a></b></li>\n",
            "<li><b><a href=\"/wiki/COVID-19_pandemic_deaths\" title=\"COVID-19 pandemic deaths\">Deaths</a></b></li></ul>\n",
            "</div></div></div></td>\n",
            "</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n",
            "<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\">International response</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\">\n",
            "<ul><li><a href=\"/wiki/United_Nations_response_to_the_COVID-19_pandemic\" title=\"United Nations response to the COVID-19 pandemic\">United Nations</a></li>\n",
            "<li><a href=\"/wiki/National_responses_to_the_COVID-19_pandemic\" title=\"National responses to the COVID-19 pandemic\">National responses</a>\n",
            "<ul><li><a href=\"/wiki/Indian_government_response_to_the_COVID-19_pandemic\" title=\"Indian government response to the COVID-19 pandemic\">India</a></li>\n",
            "<li><a href=\"/wiki/Philippine_government_response_to_the_COVID-19_pandemic\" title=\"Philippine government response to the COVID-19 pandemic\">Philippines</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Russian_government_responses_to_the_COVID-19_pandemic\" title=\"Russian government responses to the COVID-19 pandemic\">Russia</a></li>\n",
            "<li><a href=\"/wiki/Swedish_government_response_to_the_COVID-19_pandemic\" title=\"Swedish government response to the COVID-19 pandemic\">Sweden</a></li>\n",
            "<li><a href=\"/wiki/U.S._federal_government_response_to_the_COVID-19_pandemic\" title=\"U.S. federal government response to the COVID-19 pandemic\">U.S.</a></li></ul></li>\n",
            "<li><a href=\"/wiki/European_Union_response_to_the_COVID-19_pandemic\" title=\"European Union response to the COVID-19 pandemic\">European Union response</a></li>\n",
            "<li><a href=\"/wiki/Protests_over_responses_to_the_COVID-19_pandemic\" title=\"Protests over responses to the COVID-19 pandemic\">Protests</a>\n",
            "<ul><li><a href=\"/wiki/2020_United_States_anti-lockdown_protests\" title=\"2020 United States anti-lockdown protests\">U.S.</a></li></ul></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Curfews_and_lockdowns_related_to_the_COVID-19_pandemic\" title=\"Curfews and lockdowns related to the COVID-19 pandemic\">Lockdowns</a></li>\n",
            "<li><a href=\"/wiki/Evacuations_related_to_the_COVID-19_pandemic\" title=\"Evacuations related to the COVID-19 pandemic\">Evacuations</a></li>\n",
            "<li><a href=\"/wiki/Travel_restrictions_related_to_the_COVID-19_pandemic\" title=\"Travel restrictions related to the COVID-19 pandemic\">Travel restrictions</a></li>\n",
            "<li><a href=\"/wiki/International_aid_related_to_the_COVID-19_pandemic\" title=\"International aid related to the COVID-19 pandemic\">International aid</a></li></ul></div></div></td>\n",
            "</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n",
            "<div class=\"NavFrame\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\">Medical response</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><div class=\"hlist hlist-separated\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_testing\" title=\"COVID-19 testing\">Disease testing</a></li>\n",
            "<li><a class=\"mw-selflink selflink\">Vaccine research</a></li></ul>\n",
            "</div>\n",
            "<ul><li><a href=\"/wiki/COVID-19_drug_development\" title=\"COVID-19 drug development\">Drug development</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_drug_repurposing_research\" title=\"COVID-19 drug repurposing research\">Drug repurposing</a></li></ul></div></div></td>\n",
            "</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n",
            "<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;background:#ccccff; border-top:1px solid #aaaaaa; border-bottom:1px solid #aaaaaa; padding:0 5px 0 5px;\"><a href=\"/wiki/Impact_of_the_COVID-19_pandemic\" title=\"Impact of the COVID-19 pandemic\">Impact</a></div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\">\n",
            "<ul><li><b>Socio-economic</b></li></ul>\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_crime\" title=\"Impact of the COVID-19 pandemic on crime\">Crime</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_death_rates_by_country\" title=\"COVID-19 pandemic death rates by country\">Death rates by country</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_people_with_disabilities\" title=\"Impact of the COVID-19 pandemic on people with disabilities\">Disability</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_domestic_violence\" title=\"Impact of the COVID-19 pandemic on domestic violence\">Domestic violence</a></li>\n",
            "<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic\" title=\"Economic impact of the COVID-19 pandemic\">Economic</a>\n",
            "<ul><li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_Canada\" title=\"Economic impact of the COVID-19 pandemic in Canada\">Canada</a></li>\n",
            "<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_India\" title=\"Economic impact of the COVID-19 pandemic in India\">India</a></li>\n",
            "<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_the_United_Kingdom\" title=\"Economic impact of the COVID-19 pandemic in the United Kingdom\">U.K.</a></li>\n",
            "<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Economic impact of the COVID-19 pandemic in the United States\">U.S.</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_recession\" title=\"COVID-19 recession\">Recession</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Emergency_evacuation_procedures_during_the_COVID-19_pandemic\" title=\"Emergency evacuation procedures during the COVID-19 pandemic\">Emergency evacuations</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_environment\" title=\"Impact of the COVID-19 pandemic on the environment\">Environment</a></li>\n",
            "<li><a href=\"/wiki/List_of_unproven_methods_against_COVID-19\" title=\"List of unproven methods against COVID-19\">Fake treatments</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/COVID-19_pandemic%E2%80%93related_famines\" title=\"COVID-19 pandemic–related famines\">Famine</a></li>\n",
            "<li><a href=\"/wiki/Financial_market_impact_of_the_COVID-19_pandemic\" title=\"Financial market impact of the COVID-19 pandemic\">Financial markets</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_hospitals\" title=\"Impact of the COVID-19 pandemic on hospitals\">Hospitals</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_long-term_care_facilities\" title=\"Impact of the COVID-19 pandemic on long-term care facilities\">Long-term care</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_migration\" title=\"Impact of the COVID-19 pandemic on migration\">Migration</a></li>\n",
            "<li><a href=\"/wiki/Misinformation_related_to_the_COVID-19_pandemic\" title=\"Misinformation related to the COVID-19 pandemic\">Misinformation</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_military\" title=\"Impact of the COVID-19 pandemic on the military\">Military</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_other_health_issues\" title=\"Impact of the COVID-19 pandemic on other health issues\">Other health issues</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_politics\" title=\"Impact of the COVID-19 pandemic on politics\">Politics</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_in_pregnancy\" title=\"COVID-19 in pregnancy\">Pregnancy</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_prisons\" title=\"Impact of the COVID-19 pandemic on prisons\">Prisons</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_religion\" title=\"Impact of the COVID-19 pandemic on religion\">Religion</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_Catholic_Church\" title=\"Impact of the COVID-19 pandemic on the Catholic Church\">Catholic Church</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_Hajj\" title=\"Impact of the COVID-19 pandemic on Hajj\">Hajj</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_science_and_technology\" title=\"Impact of the COVID-19 pandemic on science and technology\">Science and technology</a></li>\n",
            "<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic\" title=\"Social impact of the COVID-19 pandemic\">Social</a>\n",
            "<ul><li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_Republic_of_Ireland\" title=\"Social impact of the COVID-19 pandemic in the Republic of Ireland\">Ireland</a></li>\n",
            "<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_United_Kingdom\" title=\"Social impact of the COVID-19 pandemic in the United Kingdom\">U.K.</a></li>\n",
            "<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Social impact of the COVID-19 pandemic in the United States\">U.S.</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Strikes_during_the_COVID-19_pandemic\" title=\"Strikes during the COVID-19 pandemic\">Strikes</a></li>\n",
            "<li><a href=\"/wiki/List_of_incidents_of_xenophobia_and_racism_related_to_the_COVID-19_pandemic\" title=\"List of incidents of xenophobia and racism related to the COVID-19 pandemic\">Xenophobia and racism</a></li>\n",
            "<li><a href=\"/wiki/List_of_deaths_due_to_COVID-19\" title=\"List of deaths due to COVID-19\">Notable deaths</a></li></ul>\n",
            "</div>\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><b>By industry</b></li></ul>\n",
            "</div>\n",
            "<div class=\"hlist hlist-separated\">\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_arts_and_cultural_heritage\" title=\"Impact of the COVID-19 pandemic on the arts and cultural heritage\">Arts and culture</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_aviation\" title=\"Impact of the COVID-19 pandemic on aviation\">Aviation</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_cannabis_industry\" title=\"Impact of the COVID-19 pandemic on the cannabis industry\">Cannabis</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_cinema\" title=\"Impact of the COVID-19 pandemic on cinema\">Cinema</a>\n",
            "<ul><li><a href=\"/wiki/List_of_films_impacted_by_the_COVID-19_pandemic\" title=\"List of films impacted by the COVID-19 pandemic\">films</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_education\" title=\"Impact of the COVID-19 pandemic on education\">Education</a></li>\n",
            "<li><a href=\"/wiki/List_of_events_affected_by_the_COVID-19_pandemic\" title=\"List of events affected by the COVID-19 pandemic\">Event cancellations</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_fashion_industry\" title=\"Impact of the COVID-19 pandemic on the fashion industry\">Fashion</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_food_industry\" title=\"Impact of the COVID-19 pandemic on the food industry\">Food</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_meat_industry_in_Canada\" title=\"Impact of the COVID-19 pandemic on the meat industry in Canada\">Canada meat</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_meat_industry_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on the meat industry in the United States\">U.S. meat</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_journalism\" title=\"Impact of the COVID-19 pandemic on journalism\">Journalism</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_music_industry\" title=\"Impact of the COVID-19 pandemic on the music industry\">Music</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_performing_arts\" title=\"Impact of the COVID-19 pandemic on the performing arts\">Performing arts</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_retail\" title=\"Impact of the COVID-19 pandemic on retail\">Retail</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_sports\" title=\"Impact of the COVID-19 pandemic on sports\">Sports</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_television\" title=\"Impact of the COVID-19 pandemic on television\">Television</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_television_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on television in the United States\">U.S.</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_tourism\" title=\"Impact of the COVID-19 pandemic on tourism\">Tourism</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_video_game_industry\" title=\"Impact of the COVID-19 pandemic on the video game industry\">Video games</a></li></ul>\n",
            "</div></div></div></td>\n",
            "</tr><tr><td style=\"padding:0.3em 0.4em 0.3em;font-weight:bold;border-top: 1px solid #aaa; border-bottom: 1px solid #aaa;\">\n",
            "<a class=\"image\" href=\"/wiki/File:SARS-CoV-2_(Wikimedia_colors).svg\"><img alt=\"SARS-CoV-2 (Wikimedia colors).svg\" class=\"noviewer\" data-file-height=\"666\" data-file-width=\"666\" decoding=\"async\" height=\"16\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/16px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/24px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/32px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 2x\" width=\"16\"/></a> <a href=\"/wiki/Portal:Coronavirus_disease_2019\" title=\"Portal:Coronavirus disease 2019\">COVID-19 Portal</a></td></tr><tr><td style=\"text-align:right;font-size:115%;padding-top: 0.6em;\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:COVID-19_pandemic_sidebar\" title=\"Template:COVID-19 pandemic sidebar\"><abbr title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:COVID-19_pandemic_sidebar\" title=\"Template talk:COVID-19 pandemic sidebar\"><abbr title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:COVID-19_pandemic_sidebar&amp;action=edit\"><abbr title=\"Edit this template\">e</abbr></a></li></ul></div></td></tr></tbody></table>\n",
            "<p>A <b>COVID‑19 vaccine</b> is any of several different <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a> intended to  provide <a class=\"mw-redirect\" href=\"/wiki/Acquired_immunity\" title=\"Acquired immunity\">acquired immunity</a> against <a href=\"/wiki/Coronavirus_disease_2019\" title=\"Coronavirus disease 2019\">coronavirus disease 2019</a> (COVID‑19). Previous work to develop a vaccine against the coronavirus diseases <a href=\"/wiki/Severe_acute_respiratory_syndrome\" title=\"Severe acute respiratory syndrome\">SARS</a> and <a href=\"/wiki/Middle_East_respiratory_syndrome\" title=\"Middle East respiratory syndrome\">MERS</a> established knowledge about the structure and function of coronaviruses – which accelerated development during early 2020 of varied technology platforms for a COVID‑19 vaccine.<sup class=\"reference\" id=\"cite_ref-diamond_1-0\"><a href=\"#cite_note-diamond-1\">[1]</a></sup> As of October 2020, there were 321 vaccine candidates in development, a 2.5 fold increase since April. However, no candidate has completed <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trials</a> to <a href=\"/wiki/Vaccine_trial\" title=\"Vaccine trial\">prove its safety and efficacy</a>.<sup class=\"reference\" id=\"cite_ref-thanh2_2-0\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup> In October, some 42 vaccine candidates were in <a href=\"/wiki/Clinical_research\" title=\"Clinical research\">clinical research</a>: namely 33 in <a href=\"/wiki/Phases_of_clinical_research#Phase_II\" title=\"Phases of clinical research\">Phase I–II trials</a> and 9 in <a href=\"/wiki/Phases_of_clinical_research#Phase_III\" title=\"Phases of clinical research\">Phase II–III trials</a>.<sup class=\"reference\" id=\"cite_ref-thanh2_2-1\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-london_3-0\"><a href=\"#cite_note-london-3\">[3]</a></sup><sup class=\"reference\" id=\"cite_ref-milken_4-0\"><a href=\"#cite_note-milken-4\">[4]</a></sup><sup class=\"reference\" id=\"cite_ref-who-tracker_5-0\"><a href=\"#cite_note-who-tracker-5\">[5]</a></sup>\n",
            "</p><p>The <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> (WHO), the <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">Coalition for Epidemic Preparedness Innovations</a> (CEPI), and the <a class=\"mw-redirect\" href=\"/wiki/Gates_Foundation\" title=\"Gates Foundation\">Gates Foundation</a> (GF) are committing money and organizational resources for the prospect that several vaccines will be needed to prevent continuing COVID‑19 infection.<sup class=\"reference\" id=\"cite_ref-gates2_6-0\"><a href=\"#cite_note-gates2-6\">[6]</a></sup> The CEPI, which is organizing a <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\"> </span>billion worldwide fund for rapid investment and development of vaccine candidates,<sup class=\"reference\" id=\"cite_ref-cepi-fund_7-0\"><a href=\"#cite_note-cepi-fund-7\">[7]</a></sup> indicated in September that clinical data to support licensure may be available by the end of 2020.<sup class=\"reference\" id=\"cite_ref-thanh2_2-2\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup> On 4<span class=\"nowrap\"> </span>May 2020, the WHO organized a <a href=\"/wiki/Telethon\" title=\"Telethon\">telethon</a> which received <span style=\"white-space: nowrap\">US$8</span>.1<span class=\"nowrap\"> </span>billion in pledges from forty countries to support rapid development of vaccines to prevent COVID‑19 infections.<sup class=\"reference\" id=\"cite_ref-waked_8-0\"><a href=\"#cite_note-waked-8\">[8]</a></sup> At the same time, the WHO also announced the deployment of an international \"Solidarity trial\" for simultaneous evaluation of several vaccine candidates reaching <a href=\"/wiki/Phases_of_clinical_research#Phase_II\" title=\"Phases of clinical research\">Phase II–III clinical trials</a>.<sup class=\"reference\" id=\"cite_ref-who-accel_9-0\"><a href=\"#cite_note-who-accel-9\">[9]</a></sup>\n",
            "</p>\n",
            "<style data-mw-deduplicate=\"TemplateStyles:r886046785\">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class=\"toclimit-3\"><div aria-labelledby=\"mw-toc-heading\" class=\"toc\" id=\"toc\" role=\"navigation\"><input class=\"toctogglecheckbox\" id=\"toctogglecheckbox\" role=\"button\" style=\"display:none\" type=\"checkbox\"/><div class=\"toctitle\" dir=\"ltr\" lang=\"en\"><h2 id=\"mw-toc-heading\">Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n",
            "<ul>\n",
            "<li class=\"toclevel-1 tocsection-1\"><a href=\"#Synopsis_and_history\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Synopsis and history</span></a>\n",
            "<ul>\n",
            "<li class=\"toclevel-2 tocsection-2\"><a href=\"#SARS_and_MERS\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">SARS and MERS</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-3\"><a href=\"#COVID-19_vaccine_development_in_2020\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">COVID-19 vaccine development in 2020</span></a></li>\n",
            "</ul>\n",
            "</li>\n",
            "<li class=\"toclevel-1 tocsection-4\"><a href=\"#Global_development\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Global development</span></a>\n",
            "<ul>\n",
            "<li class=\"toclevel-2 tocsection-5\"><a href=\"#International_organizations\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">International organizations</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-6\"><a href=\"#National_governments\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">National governments</span></a></li>\n",
            "</ul>\n",
            "</li>\n",
            "<li class=\"toclevel-1 tocsection-7\"><a href=\"#WHO_COVID-19_trials\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">WHO COVID-19 trials</span></a>\n",
            "<ul>\n",
            "<li class=\"toclevel-2 tocsection-8\"><a href=\"#Adaptive_design_for_the_Solidarity_trial\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Adaptive design for the Solidarity trial</span></a></li>\n",
            "</ul>\n",
            "</li>\n",
            "<li class=\"toclevel-1 tocsection-9\"><a href=\"#Partnerships,_competition,_and_distribution\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Partnerships, competition, and distribution</span></a></li>\n",
            "<li class=\"toclevel-1 tocsection-10\"><a href=\"#Compressed_timelines\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Compressed timelines</span></a></li>\n",
            "<li class=\"toclevel-1 tocsection-11\"><a href=\"#Technology_platforms\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Technology platforms</span></a></li>\n",
            "<li class=\"toclevel-1 tocsection-12\"><a href=\"#Vaccine_candidates\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Vaccine candidates</span></a>\n",
            "<ul>\n",
            "<li class=\"toclevel-2 tocsection-13\"><a href=\"#Clinical_trials_started_in_2020\"><span class=\"tocnumber\">7.1</span> <span class=\"toctext\">Clinical trials started in 2020</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-14\"><a href=\"#Preclinical_research\"><span class=\"tocnumber\">7.2</span> <span class=\"toctext\">Preclinical research</span></a>\n",
            "<ul>\n",
            "<li class=\"toclevel-3 tocsection-15\"><a href=\"#Scheduled_Phase_I_trials_in_2020\"><span class=\"tocnumber\">7.2.1</span> <span class=\"toctext\">Scheduled Phase I trials in 2020</span></a></li>\n",
            "</ul>\n",
            "</li>\n",
            "<li class=\"toclevel-2 tocsection-16\"><a href=\"#Non-specific_vaccines\"><span class=\"tocnumber\">7.3</span> <span class=\"toctext\">Non-specific vaccines</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-17\"><a href=\"#Use_of_adjuvants\"><span class=\"tocnumber\">7.4</span> <span class=\"toctext\">Use of adjuvants</span></a></li>\n",
            "</ul>\n",
            "</li>\n",
            "<li class=\"toclevel-1 tocsection-18\"><a href=\"#Potential_limitations\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Potential limitations</span></a>\n",
            "<ul>\n",
            "<li class=\"toclevel-2 tocsection-19\"><a href=\"#Biosafety_concern\"><span class=\"tocnumber\">8.1</span> <span class=\"toctext\">Biosafety concern</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-20\"><a href=\"#Antibody-dependent_enhancement\"><span class=\"tocnumber\">8.2</span> <span class=\"toctext\">Antibody-dependent enhancement</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-21\"><a href=\"#Efficacy\"><span class=\"tocnumber\">8.3</span> <span class=\"toctext\">Efficacy</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-22\"><a href=\"#Enrollment_of_participants_in_trials\"><span class=\"tocnumber\">8.4</span> <span class=\"toctext\">Enrollment of participants in trials</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-23\"><a href=\"#Cost\"><span class=\"tocnumber\">8.5</span> <span class=\"toctext\">Cost</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-24\"><a href=\"#Rollout\"><span class=\"tocnumber\">8.6</span> <span class=\"toctext\">Rollout</span></a></li>\n",
            "</ul>\n",
            "</li>\n",
            "<li class=\"toclevel-1 tocsection-25\"><a href=\"#Proposed_challenge_studies\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Proposed challenge studies</span></a></li>\n",
            "<li class=\"toclevel-1 tocsection-26\"><a href=\"#Licensure\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">Licensure</span></a>\n",
            "<ul>\n",
            "<li class=\"toclevel-2 tocsection-27\"><a href=\"#World_Health_Organization\"><span class=\"tocnumber\">10.1</span> <span class=\"toctext\">World Health Organization</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-28\"><a href=\"#Europe\"><span class=\"tocnumber\">10.2</span> <span class=\"toctext\">Europe</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-29\"><a href=\"#United_States\"><span class=\"tocnumber\">10.3</span> <span class=\"toctext\">United States</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-30\"><a href=\"#Emergency_use_authorization\"><span class=\"tocnumber\">10.4</span> <span class=\"toctext\">Emergency use authorization</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-31\"><a href=\"#Postmarketing_surveillance\"><span class=\"tocnumber\">10.5</span> <span class=\"toctext\">Postmarketing surveillance</span></a></li>\n",
            "</ul>\n",
            "</li>\n",
            "<li class=\"toclevel-1 tocsection-32\"><a href=\"#Commercialization_and_equitable_access\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">Commercialization and equitable access</span></a>\n",
            "<ul>\n",
            "<li class=\"toclevel-2 tocsection-33\"><a href=\"#Commercialization_issues\"><span class=\"tocnumber\">11.1</span> <span class=\"toctext\">Commercialization issues</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-34\"><a href=\"#Sovereignty\"><span class=\"tocnumber\">11.2</span> <span class=\"toctext\">Sovereignty</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-35\"><a href=\"#Equitable_access\"><span class=\"tocnumber\">11.3</span> <span class=\"toctext\">Equitable access</span></a></li>\n",
            "</ul>\n",
            "</li>\n",
            "<li class=\"toclevel-1 tocsection-36\"><a href=\"#Supply_chain\"><span class=\"tocnumber\">12</span> <span class=\"toctext\">Supply chain</span></a>\n",
            "<ul>\n",
            "<li class=\"toclevel-2 tocsection-37\"><a href=\"#Logistics\"><span class=\"tocnumber\">12.1</span> <span class=\"toctext\">Logistics</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-38\"><a href=\"#Manufacturing_capacity\"><span class=\"tocnumber\">12.2</span> <span class=\"toctext\">Manufacturing capacity</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-39\"><a href=\"#Cold_chain\"><span class=\"tocnumber\">12.3</span> <span class=\"toctext\">Cold chain</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-40\"><a href=\"#Air_and_land_transport\"><span class=\"tocnumber\">12.4</span> <span class=\"toctext\">Air and land transport</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-41\"><a href=\"#Security_and_corruption\"><span class=\"tocnumber\">12.5</span> <span class=\"toctext\">Security and corruption</span></a></li>\n",
            "<li class=\"toclevel-2 tocsection-42\"><a href=\"#National_infrastructure\"><span class=\"tocnumber\">12.6</span> <span class=\"toctext\">National infrastructure</span></a></li>\n",
            "</ul>\n",
            "</li>\n",
            "<li class=\"toclevel-1 tocsection-43\"><a href=\"#Liability\"><span class=\"tocnumber\">13</span> <span class=\"toctext\">Liability</span></a></li>\n",
            "<li class=\"toclevel-1 tocsection-44\"><a href=\"#Misinformation\"><span class=\"tocnumber\">14</span> <span class=\"toctext\">Misinformation</span></a></li>\n",
            "<li class=\"toclevel-1 tocsection-45\"><a href=\"#See_also\"><span class=\"tocnumber\">15</span> <span class=\"toctext\">See also</span></a></li>\n",
            "<li class=\"toclevel-1 tocsection-46\"><a href=\"#References\"><span class=\"tocnumber\">16</span> <span class=\"toctext\">References</span></a></li>\n",
            "<li class=\"toclevel-1 tocsection-47\"><a href=\"#Further_reading\"><span class=\"tocnumber\">17</span> <span class=\"toctext\">Further reading</span></a></li>\n",
            "<li class=\"toclevel-1 tocsection-48\"><a href=\"#External_links\"><span class=\"tocnumber\">18</span> <span class=\"toctext\">External links</span></a></li>\n",
            "</ul>\n",
            "</div>\n",
            "</div>\n",
            "<h2><span class=\"mw-headline\" id=\"Synopsis_and_history\">Synopsis and history</span></h2>\n",
            "<h3><span class=\"mw-headline\" id=\"SARS_and_MERS\">SARS and MERS</span></h3>\n",
            "<p>Vaccines have been produced against several animal diseases caused by coronaviruses, including as of 2003 <a class=\"mw-redirect\" href=\"/wiki/Infectious_bronchitis_virus\" title=\"Infectious bronchitis virus\">infectious bronchitis virus</a> in birds, <a href=\"/wiki/Canine_coronavirus\" title=\"Canine coronavirus\">canine coronavirus</a>, and <a href=\"/wiki/Feline_coronavirus\" title=\"Feline coronavirus\">feline coronavirus</a>.<sup class=\"reference\" id=\"cite_ref-10\"><a href=\"#cite_note-10\">[10]</a></sup> Previous projects to develop vaccines for viruses in the family <i><a href=\"/wiki/Coronaviridae\" title=\"Coronaviridae\">Coronaviridae</a></i> that affect humans have been aimed at <a href=\"/wiki/Severe_acute_respiratory_syndrome\" title=\"Severe acute respiratory syndrome\">severe acute respiratory syndrome</a> (SARS) and <a href=\"/wiki/Middle_East_respiratory_syndrome\" title=\"Middle East respiratory syndrome\">Middle East respiratory syndrome</a> (MERS). Vaccines against SARS<sup class=\"reference\" id=\"cite_ref-11\"><a href=\"#cite_note-11\">[11]</a></sup> and MERS<sup class=\"reference\" id=\"cite_ref-12\"><a href=\"#cite_note-12\">[12]</a></sup> have been tested in non-human <a href=\"/wiki/Model_organism\" title=\"Model organism\">animals</a>.\n",
            "</p><p>According to studies published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and <a href=\"/wiki/List_of_national_public_health_agencies\" title=\"List of national public health agencies\">public health agencies</a> around the world at that time.<sup class=\"reference\" id=\"cite_ref-PMID_15655773_13-0\"><a href=\"#cite_note-PMID_15655773-13\">[13]</a></sup><sup class=\"reference\" id=\"cite_ref-PMID_15885812_14-0\"><a href=\"#cite_note-PMID_15885812-14\">[14]</a></sup><sup class=\"reference\" id=\"cite_ref-PMID_16453264_15-0\"><a href=\"#cite_note-PMID_16453264-15\">[15]</a></sup> As of 2020, there is no cure or protective vaccine proven to be safe and effective against SARS in humans.<sup class=\"reference\" id=\"cite_ref-JiangFutureVirology_16-0\"><a href=\"#cite_note-JiangFutureVirology-16\">[16]</a></sup><sup class=\"reference\" id=\"cite_ref-17\"><a href=\"#cite_note-17\">[17]</a></sup>\n",
            "</p><p>There is also no proven vaccine against MERS.<sup class=\"reference\" id=\"cite_ref-18\"><a href=\"#cite_note-18\">[18]</a></sup> When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.<sup class=\"reference\" id=\"cite_ref-JiangFutureVirology_16-1\"><a href=\"#cite_note-JiangFutureVirology-16\">[16]</a></sup><sup class=\"reference\" id=\"cite_ref-Butler3oct2013_19-0\"><a href=\"#cite_note-Butler3oct2013-19\">[19]</a></sup> As of March 2020, there was one (DNA based) MERS vaccine which completed Phase<span class=\"nowrap\"> </span>I clinical trials in humans,<sup class=\"reference\" id=\"cite_ref-20\"><a href=\"#cite_note-20\">[20]</a></sup> and three others in progress, all of which are viral-vectored vaccines: two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), and one MVA-vectored (MVA-MERS-S).<sup class=\"reference\" id=\"cite_ref-21\"><a href=\"#cite_note-21\">[21]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"COVID-19_vaccine_development_in_2020\">COVID-19 vaccine development in 2020</span></h3>\n",
            "<p>A vaccine for an infectious disease has never before been produced in less than several years, and no vaccine exists for preventing a <a href=\"/wiki/Coronavirus\" title=\"Coronavirus\">coronavirus</a> infection in humans.<sup class=\"reference\" id=\"cite_ref-gates2_6-1\"><a href=\"#cite_note-gates2-6\">[6]</a></sup> After the coronavirus was detected in December 2019,<sup class=\"reference\" id=\"cite_ref-who-time_22-0\"><a href=\"#cite_note-who-time-22\">[22]</a></sup> the <a href=\"/wiki/Nucleic_acid_sequence\" title=\"Nucleic acid sequence\">genetic sequence</a> of COVID‑19 was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten development of a preventive vaccine.<sup class=\"reference\" id=\"cite_ref-thanh_23-0\"><a href=\"#cite_note-thanh-23\">[23]</a></sup><sup class=\"reference\" id=\"cite_ref-gates1_24-0\"><a href=\"#cite_note-gates1-24\">[24]</a></sup><sup class=\"reference\" id=\"cite_ref-Fauci_25-0\"><a href=\"#cite_note-Fauci-25\">[25]</a></sup>\n",
            "</p><p>In February 2020, the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> (WHO) said it did not expect a vaccine against <a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">severe acute respiratory syndrome coronavirus 2</a> (SARS-CoV-2), the causative virus, to become available in less than 18 months.<sup class=\"reference\" id=\"cite_ref-26\"><a href=\"#cite_note-26\">[26]</a></sup> The rapidly growing infection rate of COVID‑19 worldwide during early 2020 stimulated international alliances and government efforts to urgently organize resources to make multiple vaccines on shortened timelines,<sup class=\"reference\" id=\"cite_ref-who-accel_9-1\"><a href=\"#cite_note-who-accel-9\">[9]</a></sup> with four vaccine candidates entering human evaluation in March (see the table of <a href=\"#Clinical_trials_started_in_2020\">clinical trials started in 2020</a>, below).<sup class=\"reference\" id=\"cite_ref-thanh_23-1\"><a href=\"#cite_note-thanh-23\">[23]</a></sup><sup class=\"reference\" id=\"cite_ref-yamey_27-0\"><a href=\"#cite_note-yamey-27\">[27]</a></sup>\n",
            "</p><p>In April 2020, the WHO estimated a total cost of <span style=\"white-space: nowrap\">US$8</span><span class=\"nowrap\"> </span>billion to develop a suite of three or more vaccines having different technologies and distribution.<sup class=\"reference\" id=\"cite_ref-who-accel_9-2\"><a href=\"#cite_note-who-accel-9\">[9]</a></sup><sup class=\"reference\" id=\"cite_ref-cepi-landmark_28-0\"><a href=\"#cite_note-cepi-landmark-28\">[28]</a></sup>\n",
            "By April 2020, \"almost 80 companies and institutes in 19 countries\" were working on this virtual gold rush.<sup class=\"reference\" id=\"cite_ref-cssa_29-0\"><a href=\"#cite_note-cssa-29\">[29]</a></sup> Also in April, CEPI estimated that as many as six of the vaccine candidates against COVID‑19 should be chosen by international coalitions for development through Phase<span class=\"nowrap\"> </span>II–III trials, and three should be streamlined through regulatory and quality assurance for eventual licensing at a total cost of at least <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\"> </span>billion.<sup class=\"reference\" id=\"cite_ref-thanh2_2-3\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-yamey_27-1\"><a href=\"#cite_note-yamey-27\">[27]</a></sup><sup class=\"reference\" id=\"cite_ref-gates2_6-2\"><a href=\"#cite_note-gates2-6\">[6]</a></sup> Another analysis estimates 10 candidates will need simultaneous initial development, before a select few are chosen for the final path to licensing.<sup class=\"reference\" id=\"cite_ref-gates2_6-3\"><a href=\"#cite_note-gates2-6\">[6]</a></sup>\n",
            "</p><p>In July 2020, Anglo-American intelligence and security organisations of the respective governments and armed forces, as the UK's <a href=\"/wiki/National_Cyber_Security_Centre_(United_Kingdom)\" title=\"National Cyber Security Centre (United Kingdom)\">National Cyber Security Centre</a>, together with the Canadian <a href=\"/wiki/Communications_Security_Establishment\" title=\"Communications Security Establishment\">Communications Security Establishment</a>, the United States Department for Homeland Security <a href=\"/wiki/Cybersecurity_and_Infrastructure_Security_Agency\" title=\"Cybersecurity and Infrastructure Security Agency\">Cybersecurity Infrastructure Security Agency</a>, and the US <a href=\"/wiki/National_Security_Agency\" title=\"National Security Agency\">National Security Agency</a> (NSA) alleged that Russian state-backed hackers may have been trying to steal COVID-19 treatment and vaccine research from academic and pharmaceutical institutions in other countries; Russia has denied it.<sup class=\"reference\" id=\"cite_ref-30\"><a href=\"#cite_note-30\">[30]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Global_development\">Global development</span></h2>\n",
            "<p>During 2020, major changes in the overall effort of developing COVID-19 vaccines since early in the year have been the increasing number of collaborations of the <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">multinational pharmaceutical industry</a> with national governments, and the diversity and growing number of <a href=\"/wiki/Biotechnology#Industrial\" title=\"Biotechnology\">biotechnology companies</a> in many countries focusing on a COVID-19 vaccine.<sup class=\"reference\" id=\"cite_ref-thanh2_2-4\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup> According to CEPI, the general geographic distribution of COVID‑19 vaccine development involves organizations in North America having about 40% of the world's COVID-19 vaccine research, compared with 30% in Asia and <a href=\"/wiki/Australia\" title=\"Australia\">Australia</a>, 26% in Europe, and a few projects in <a href=\"/wiki/South_America\" title=\"South America\">South America</a> and Africa.<sup class=\"reference\" id=\"cite_ref-thanh2_2-5\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-thanh_23-2\"><a href=\"#cite_note-thanh-23\">[23]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"International_organizations\">International organizations</span></h3>\n",
            "<p>Organizations have formed international alliances to expedite vaccine development and prepare for distribution, including the WHO which is facilitating collaboration, accelerated research, and international communications on a scale unprecedented in history, beginning in early May by raising <span style=\"white-space: nowrap\">US$8.1</span><span class=\"nowrap\"> </span>billion in pledges.<sup class=\"reference\" id=\"cite_ref-waked_8-1\"><a href=\"#cite_note-waked-8\">[8]</a></sup> The WHO also implemented <i>Covid-19 Vaccines Global Access</i> (COVAX) for coordinating global vaccine development, the vaccine pillar of <i><a href=\"/wiki/Access_to_COVID-19_Tools_Accelerator\" title=\"Access to COVID-19 Tools Accelerator\">Access to COVID-19 Tools (ACT) Accelerator</a></i> in collaboration with <a href=\"/wiki/GAVI\" title=\"GAVI\">GAVI</a> and the <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">Coalition for Epidemic Preparedness Innovations</a> (CEPI).<sup class=\"reference\" id=\"cite_ref-thanh2_2-6\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-who-covax_31-0\"><a href=\"#cite_note-who-covax-31\">[31]</a></sup><sup class=\"reference\" id=\"cite_ref-covax-gavi_32-0\"><a href=\"#cite_note-covax-gavi-32\">[32]</a></sup> In July, the WHO announced that 165 countries, representing up to 60% of the world population, had agreed to a WHO COVAX plan for fair and equitable distribution of an eventual licensed vaccine, assuring that each participating country would receive a guaranteed share of doses to vaccinate the most vulnerable 20% of its population by the end of 2021.<sup class=\"reference\" id=\"cite_ref-covax_33-0\"><a href=\"#cite_note-covax-33\">[33]</a></sup> COVAX has the goal to accelerate the development and manufacturing of COVID-19 vaccines, and to assure that access to licensed vaccines is equitably provided to all countries.<sup class=\"reference\" id=\"cite_ref-covax-gavi_32-1\"><a href=\"#cite_note-covax-gavi-32\">[32]</a></sup>\n",
            "</p><p>CEPI is working with international health authorities and vaccine developers to create another <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\"> </span>billion fund in a global partnership between public, private, philanthropic, and civil society organizations for accelerated research and clinical testing of eight vaccine candidates, with the 2020–21 goal of supporting several candidates for full development to licensing.<sup class=\"reference\" id=\"cite_ref-thanh2_2-7\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-yamey_27-2\"><a href=\"#cite_note-yamey-27\">[27]</a></sup><sup class=\"reference\" id=\"cite_ref-cepi-landmark_28-1\"><a href=\"#cite_note-cepi-landmark-28\">[28]</a></sup> The United Kingdom, Canada, Belgium, Norway, Switzerland, Germany and the Netherlands had already donated <span style=\"white-space: nowrap\">US$915</span><span class=\"nowrap\"> </span>million to CEPI by early May.<sup class=\"reference\" id=\"cite_ref-waked_8-2\"><a href=\"#cite_note-waked-8\">[8]</a></sup><sup class=\"reference\" id=\"cite_ref-reuters_34-0\"><a href=\"#cite_note-reuters-34\">[34]</a></sup> The <a href=\"/wiki/Bill_%26_Melinda_Gates_Foundation\" title=\"Bill &amp; Melinda Gates Foundation\">Bill &amp; Melinda Gates Foundation</a> (Gates Foundation), a private <a href=\"/wiki/Charitable_organization\" title=\"Charitable organization\">charitable organization</a> dedicated to vaccine research and distribution, is donating <span style=\"white-space: nowrap\">US$250</span><span class=\"nowrap\"> </span>million in support of CEPI for research and public educational support on COVID‑19 vaccines.<sup class=\"reference\" id=\"cite_ref-sanger_35-0\"><a href=\"#cite_note-sanger-35\">[35]</a></sup><sup class=\"reference\" id=\"cite_ref-36\"><a href=\"#cite_note-36\">[36]</a></sup>\n",
            "</p><p>The Global Research Collaboration for Infectious Disease Preparedness (GLoPID-R) is working closely with the WHO and member states to identify priorities for funding specific researches needed for a COVID‑19 vaccine, coordinating among the international funding and research organizations to maintain updated information on vaccine progress and avoid duplicate funding.<sup class=\"reference\" id=\"cite_ref-37\"><a href=\"#cite_note-37\">[37]</a></sup><sup class=\"reference\" id=\"cite_ref-can-research_38-0\"><a href=\"#cite_note-can-research-38\">[38]</a></sup>\n",
            "The International Severe Acute Respiratory and Emerging Infection Consortium is organizing and disseminating clinical information on COVID‑19 research to inform public health policy on eventual vaccine distribution.<sup class=\"reference\" id=\"cite_ref-isaric_39-0\"><a href=\"#cite_note-isaric-39\">[39]</a></sup>\n",
            "</p><p>On 4 June, a <a href=\"/wiki/Virtual_community\" title=\"Virtual community\">virtual</a> summit was coordinated from London, UK, among private and government representatives of 52 countries, including 35 <a href=\"/wiki/Head_of_state\" title=\"Head of state\">heads of state</a> from <a href=\"/wiki/Group_of_Seven\" title=\"Group of Seven\">G7</a> and <a href=\"/wiki/G20\" title=\"G20\">G20</a> nations, to raise <span style=\"white-space: nowrap\">US$8.8</span><span class=\"nowrap\"> </span>billion in support of the <a href=\"/wiki/GAVI\" title=\"GAVI\">Global Alliance for Vaccines and Immunisation (GAVI)</a> to prepare for COVID‑19 vaccinations of 300<span class=\"nowrap\"> </span>million children in under-developed countries through 2025.<sup class=\"reference\" id=\"cite_ref-gavi-summit_40-0\"><a href=\"#cite_note-gavi-summit-40\">[40]</a></sup> Major contributions were <span style=\"white-space: nowrap\">US$1.6</span><span class=\"nowrap\"> </span>billion from The Gates Foundation<sup class=\"reference\" id=\"cite_ref-41\"><a href=\"#cite_note-41\">[41]</a></sup> and <span style=\"white-space: nowrap\">GB£330</span><span class=\"nowrap\"> </span>million per year over five years by the UK government (approximately <span style=\"white-space: nowrap\">US$2.1</span><span class=\"nowrap\"> </span>billion in June 2020).<sup class=\"reference\" id=\"cite_ref-gavi-summit_40-1\"><a href=\"#cite_note-gavi-summit-40\">[40]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"National_governments\">National governments</span></h3>\n",
            "<p>National governments dedicating resources for national or international investments in vaccine research, development, and manufacturing beginning in 2020 included the <a href=\"/wiki/Government_of_Canada\" title=\"Government of Canada\">Canadian government</a> which announced <span style=\"white-space: nowrap\">CA$275</span><span class=\"nowrap\"> </span>million in funding for 96 research vaccine research projects at Canadian companies and universities, with plans to establish a \"vaccine bank\" of several new vaccines that could be used if another coronavirus outbreak occurs.<sup class=\"reference\" id=\"cite_ref-abedi_42-0\"><a href=\"#cite_note-abedi-42\">[42]</a></sup><sup class=\"reference\" id=\"cite_ref-can-funding_43-0\"><a href=\"#cite_note-can-funding-43\">[43]</a></sup> A further investment of <span style=\"white-space: nowrap\">CA$1.1</span><span class=\"nowrap\"> </span>billion was added to support clinical trials in Canada and develop manufacturing and supply chains for vaccines.<sup class=\"reference\" id=\"cite_ref-can-research_38-1\"><a href=\"#cite_note-can-research-38\">[38]</a></sup> On 4<span class=\"nowrap\"> </span>May, the Canadian government committed <span style=\"white-space: nowrap\">CA$850</span><span class=\"nowrap\"> </span>million to the WHO's live streaming effort to raise <span style=\"white-space: nowrap\">US$8</span><span class=\"nowrap\"> </span>billion for COVID‑19 vaccines and preparedness.<sup class=\"reference\" id=\"cite_ref-aiello_44-0\"><a href=\"#cite_note-aiello-44\">[44]</a></sup>\n",
            "</p><p>In <a href=\"/wiki/China\" title=\"China\">China</a>, the <a href=\"/wiki/Government_of_China\" title=\"Government of China\">government</a> is providing low-rate loans to a vaccine developer through its <a href=\"/wiki/People%27s_Bank_of_China\" title=\"People's Bank of China\">central bank</a>, and has \"quickly made land available for the company\" to build production plants.<sup class=\"reference\" id=\"cite_ref-reuters_34-1\"><a href=\"#cite_note-reuters-34\">[34]</a></sup> As of June 2020, six of the eleven COVID‑19 vaccine candidates in early-stage human testing were developed by Chinese organizations.<sup class=\"reference\" id=\"cite_ref-sanger_35-1\"><a href=\"#cite_note-sanger-35\">[35]</a></sup> Three Chinese vaccine companies and research institutes are supported by the government for financing research, conducting clinical trials, and manufacturing the most promising vaccine candidates, while prioritizing rapid evidence of efficacy over safety.<sup class=\"reference\" id=\"cite_ref-takada_45-0\"><a href=\"#cite_note-takada-45\">[45]</a></sup> On 18 May, China had pledged <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\"> </span>billion to support overall efforts by the WHO for programs against COVID‑19.<sup class=\"reference\" id=\"cite_ref-46\"><a href=\"#cite_note-46\">[46]</a></sup> On 22 July, China additionally announced that it plans to provide a US$1 billion loan to make its vaccine accessible for countries in <a href=\"/wiki/Latin_America\" title=\"Latin America\">Latin America</a> and the <a href=\"/wiki/Caribbean\" title=\"Caribbean\">Caribbean</a>.<sup class=\"reference\" id=\"cite_ref-47\"><a href=\"#cite_note-47\">[47]</a></sup> On August 24, <a href=\"/wiki/Premier_of_the_People%27s_Republic_of_China\" title=\"Premier of the People's Republic of China\">Chinese Premier</a> <a href=\"/wiki/Li_Keqiang\" title=\"Li Keqiang\">Li Keqiang</a> announced it would provide five Southeast Asian countries of Cambodia, Laos, Myanmar, Thailand and Vietnam priority access to the vaccine once it was fully developed.<sup class=\"reference\" id=\"cite_ref-48\"><a href=\"#cite_note-48\">[48]</a></sup>\n",
            "</p><p>Among European Union countries, France announced a <span style=\"white-space: nowrap\">US$4.9</span><span class=\"nowrap\"> </span>million investment in a COVID‑19 vaccine research consortium via CEPI involving the <a class=\"mw-redirect\" href=\"/wiki/Institut_Pasteur\" title=\"Institut Pasteur\">Institut Pasteur</a>, Themis Bioscience (<a href=\"/wiki/Vienna\" title=\"Vienna\">Vienna</a>, <a href=\"/wiki/Austria\" title=\"Austria\">Austria</a>), and the <a href=\"/wiki/University_of_Pittsburgh\" title=\"University of Pittsburgh\">University of Pittsburgh</a>, bringing CEPI's total investment in COVID‑19 vaccine development to <span style=\"white-space: nowrap\">US$480</span><span class=\"nowrap\"> </span>million by May.<sup class=\"reference\" id=\"cite_ref-cepi-4-30_49-0\"><a href=\"#cite_note-cepi-4-30-49\">[49]</a></sup><sup class=\"reference\" id=\"cite_ref-cepi3-19_50-0\"><a href=\"#cite_note-cepi3-19-50\">[50]</a></sup> In March, the <a href=\"/wiki/European_Commission\" title=\"European Commission\">European Commission</a> made an €80<span class=\"nowrap\"> </span>million investment in <a href=\"/wiki/CureVac\" title=\"CureVac\">CureVac</a>, a German biotechnology company, to develop a <a href=\"/wiki/Messenger_RNA\" title=\"Messenger RNA\">mRNA</a> vaccine.<sup class=\"reference\" id=\"cite_ref-curevac_51-0\"><a href=\"#cite_note-curevac-51\">[51]</a></sup> The German government announced a separate €300<span class=\"nowrap\"> </span>million investment in CureVac in June.<sup class=\"reference\" id=\"cite_ref-52\"><a href=\"#cite_note-52\">[52]</a></sup> Belgium, Norway, Switzerland, Germany, and the Netherlands have been major contributors to the CEPI effort for COVID‑19 vaccine research in Europe.<sup class=\"reference\" id=\"cite_ref-reuters_34-2\"><a href=\"#cite_note-reuters-34\">[34]</a></sup>\n",
            "</p><p>In April, the UK government formed a COVID‑19 vaccine <a href=\"/wiki/Task_force\" title=\"Task force\">task force</a> to stimulate British efforts for rapidly developing a vaccine through collaborations of industry, universities, and government agencies across the vaccine development pipeline, including clinical trial placement at UK hospitals, regulations for approval, and eventual manufacturing.<sup class=\"reference\" id=\"cite_ref-morriss_53-0\"><a href=\"#cite_note-morriss-53\">[53]</a></sup> The vaccine development initiatives at the University of Oxford and <a href=\"/wiki/Imperial_College_London\" title=\"Imperial College London\">Imperial College of London</a> were financed with <span style=\"white-space: nowrap\">GB£44</span><span class=\"nowrap\"> </span>million in April.<sup class=\"reference\" id=\"cite_ref-gartner_54-0\"><a href=\"#cite_note-gartner-54\">[54]</a></sup><sup class=\"reference\" id=\"cite_ref-oxford_55-0\"><a href=\"#cite_note-oxford-55\">[55]</a></sup>\n",
            "</p>\n",
            "<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:312px;\"><a class=\"image\" href=\"/wiki/File:The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways,_such_as_Emergency_Use_Authorization,_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_(49948301848).jpg\"><img alt=\"\" class=\"thumbimage\" data-file-height=\"915\" data-file-width=\"1051\" decoding=\"async\" height=\"270\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/85/The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways%2C_such_as_Emergency_Use_Authorization%2C_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_%2849948301848%29.jpg/310px-thumbnail.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/85/The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways%2C_such_as_Emergency_Use_Authorization%2C_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_%2849948301848%29.jpg/465px-thumbnail.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/85/The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways%2C_such_as_Emergency_Use_Authorization%2C_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_%2849948301848%29.jpg/620px-thumbnail.jpg 2x\" width=\"310\"/></a> <div class=\"thumbcaption\"><div class=\"magnify\"><a class=\"internal\" href=\"/wiki/File:The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways,_such_as_Emergency_Use_Authorization,_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_(49948301848).jpg\" title=\"Enlarge\"></a></div>US <a href=\"/wiki/Government_Accountability_Office\" title=\"Government Accountability Office\">Government Accountability Office</a> diagram comparing a traditional vaccine development timeline to a possible expedited timeline</div></div></div>\n",
            "<p>The United States <a href=\"/wiki/Biomedical_Advanced_Research_and_Development_Authority\" title=\"Biomedical Advanced Research and Development Authority\">Biomedical Advanced Research and Development Authority</a> (BARDA), a federal agency that funds disease-fighting technology, announced investments of nearly <span style=\"white-space: nowrap\">US$1</span><span class=\"nowrap\"> </span>billion to support American COVID‑19 vaccine development, and preparation for manufacturing the most promising candidates. On 16 April, BARDA made a <span style=\"white-space: nowrap\">US$483</span><span class=\"nowrap\"> </span>million investment in the vaccine developer, <a href=\"/wiki/Moderna\" title=\"Moderna\">Moderna</a> and its partner, <a href=\"/wiki/Johnson_%26_Johnson\" title=\"Johnson &amp; Johnson\">Johnson &amp; Johnson</a>.<sup class=\"reference\" id=\"cite_ref-reuters_34-3\"><a href=\"#cite_note-reuters-34\">[34]</a></sup><sup class=\"reference\" id=\"cite_ref-kuznia_56-0\"><a href=\"#cite_note-kuznia-56\">[56]</a></sup> BARDA has an additional <span style=\"white-space: nowrap\">US$4</span><span class=\"nowrap\"> </span>billion to spend on vaccine development, and will have roles in other American investment for development of six to eight vaccine candidates to be in clinical studies over 2020–21 by companies such as <a href=\"/wiki/Sanofi_Pasteur\" title=\"Sanofi Pasteur\">Sanofi Pasteur</a> and <a class=\"mw-redirect\" href=\"/wiki/Regeneron\" title=\"Regeneron\">Regeneron</a>.<sup class=\"reference\" id=\"cite_ref-kuznia_56-1\"><a href=\"#cite_note-kuznia-56\">[56]</a></sup><sup class=\"reference\" id=\"cite_ref-lee_57-0\"><a href=\"#cite_note-lee-57\">[57]</a></sup> On 15 May, the US government announced federal funding for a fast-track program called <a href=\"/wiki/Operation_Warp_Speed\" title=\"Operation Warp Speed\">Operation Warp Speed</a>, which has the goals of placing diverse vaccine candidates in clinical trials by the fall of 2020, and manufacturing 300<span class=\"nowrap\"> </span>million doses of a licensed vaccine by January 2021. The project chief advisor is <a href=\"/wiki/Moncef_Slaoui\" title=\"Moncef Slaoui\">Moncef Slaoui</a> and its <a class=\"mw-redirect\" href=\"/wiki/Chief_Operating_Officer\" title=\"Chief Operating Officer\">Chief Operating Officer</a> is Army General <a href=\"/wiki/Gustave_F._Perna\" title=\"Gustave F. Perna\">Gustave Perna</a>.<sup class=\"reference\" id=\"cite_ref-58\"><a href=\"#cite_note-58\">[58]</a></sup><sup class=\"reference\" id=\"cite_ref-59\"><a href=\"#cite_note-59\">[59]</a></sup> In June, the Warp Speed team said it would work with seven companies developing COVID‑19 vaccine candidates: <a href=\"/wiki/Moderna\" title=\"Moderna\">Moderna</a>, <a href=\"/wiki/Johnson_%26_Johnson_Pharmaceutical_Research_and_Development\" title=\"Johnson &amp; Johnson Pharmaceutical Research and Development\">Johnson &amp; Johnson</a>, <a href=\"/wiki/Merck_%26_Co.\" title=\"Merck &amp; Co.\">Merck</a>, <a href=\"/wiki/Pfizer\" title=\"Pfizer\">Pfizer</a>, and the <a href=\"/wiki/University_of_Oxford\" title=\"University of Oxford\">University of Oxford</a> in collaboration with <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a>, as well as two others.<sup class=\"reference\" id=\"cite_ref-60\"><a href=\"#cite_note-60\">[60]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"WHO_COVID-19_trials\">WHO COVID-19 trials</span></h2>\n",
            "<p>In April 2020, the WHO published an \"R&amp;D Blueprint (for the) novel Coronavirus\" (Blueprint). The Blueprint documented a \"large, international, multi-site, individually randomized controlled clinical trial\" to allow \"the concurrent evaluation of the benefits and risks of each promising candidate vaccine within 3-6 months of it being made available for the trial.\" The Blueprint listed a <i>Global Target Product Profile</i> (TPP) for COVID‑19, identifying favorable attributes of safe and effective vaccines under two broad categories: \"vaccines for the long-term protection of people at higher risk of COVID‑19, such as healthcare workers\", and other vaccines to provide rapid-response immunity for new outbreaks.<sup class=\"reference\" id=\"cite_ref-who-accel_9-3\"><a href=\"#cite_note-who-accel-9\">[9]</a></sup> The international TPP team was formed to 1) assess the development of the most promising candidate vaccines; 2) map candidate vaccines and their clinical trial worldwide, publishing a frequently-updated \"landscape\" of vaccines in development;<sup class=\"reference\" id=\"cite_ref-who-tracker_5-1\"><a href=\"#cite_note-who-tracker-5\">[5]</a></sup> 3) rapidly evaluate and screen for the most promising candidate vaccines simultaneously before they are tested in humans; and 4) design and coordinate a multiple-site, international <a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">randomized controlled trial</a> – the \"Solidarity trial\" for vaccines<sup class=\"reference\" id=\"cite_ref-who-accel_9-4\"><a href=\"#cite_note-who-accel-9\">[9]</a></sup><sup class=\"reference\" id=\"cite_ref-solidarity-vacc_61-0\"><a href=\"#cite_note-solidarity-vacc-61\">[61]</a></sup> – to enable simultaneous evaluation of the benefits and risks of different vaccine candidates under clinical trials in countries where there are high rates of COVID‑19 disease, ensuring fast interpretation and sharing of results around the world.<sup class=\"reference\" id=\"cite_ref-who-accel_9-5\"><a href=\"#cite_note-who-accel-9\">[9]</a></sup> The WHO vaccine coalition will prioritize which vaccines should go into Phase<span class=\"nowrap\"> </span>II and III clinical trials, and determine harmonized Phase<span class=\"nowrap\"> </span>III protocols for all vaccines achieving the <a href=\"/wiki/Pivotal_trial\" title=\"Pivotal trial\">pivotal trial</a> stage.<sup class=\"reference\" id=\"cite_ref-who-accel_9-6\"><a href=\"#cite_note-who-accel-9\">[9]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Adaptive_design_for_the_Solidarity_trial\">Adaptive design for the Solidarity trial</span></h3>\n",
            "<p>A clinical trial design in progress may be modified as an <a href=\"/wiki/Adaptive_design_(medicine)\" title=\"Adaptive design (medicine)\">\"adaptive design\"</a> if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment.<sup class=\"reference\" id=\"cite_ref-pallmann_62-0\"><a href=\"#cite_note-pallmann-62\">[62]</a></sup><sup class=\"reference\" id=\"cite_ref-fda-adaptive_63-0\"><a href=\"#cite_note-fda-adaptive-63\">[63]</a></sup> The WHO Solidarity trial of multiple vaccines in clinical studies during 2020 will apply adaptive design to rapidly alter trial parameters across all study sites as results emerge.<sup class=\"reference\" id=\"cite_ref-solidarity-vacc_61-1\"><a href=\"#cite_note-solidarity-vacc-61\">[61]</a></sup> Candidate vaccines may be added to the Solidarity trial as they become available if priority criteria are met, while vaccine candidates showing poor evidence of safety or efficacy compared to placebo or other vaccines will be dropped from the international trial.<sup class=\"reference\" id=\"cite_ref-solidarity-vacc_61-2\"><a href=\"#cite_note-solidarity-vacc-61\">[61]</a></sup>\n",
            "</p><p>Adaptive designs within ongoing Phase<span class=\"nowrap\"> </span>II–III clinical trials on candidate vaccines may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, avoiding duplication of research efforts, and enhancing coordination of design changes for the Solidarity trial across its international locations.<sup class=\"reference\" id=\"cite_ref-solidarity-vacc_61-3\"><a href=\"#cite_note-solidarity-vacc-61\">[61]</a></sup><sup class=\"reference\" id=\"cite_ref-pallmann_62-1\"><a href=\"#cite_note-pallmann-62\">[62]</a></sup>\n",
            "</p>\n",
            "<h2><span id=\"Partnerships.2C_competition.2C_and_distribution\"></span><span class=\"mw-headline\" id=\"Partnerships,_competition,_and_distribution\">Partnerships, competition, and distribution</span></h2>\n",
            "<p>Large pharmaceutical companies with experience in making vaccines at scale, including Johnson &amp; Johnson, AstraZeneca, and <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a> (GSK), are forming alliances with <a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">biotechnology</a> companies, national governments, and universities to accelerate progression to an effective vaccine.<sup class=\"reference\" id=\"cite_ref-reuters_34-4\"><a href=\"#cite_note-reuters-34\">[34]</a></sup><sup class=\"reference\" id=\"cite_ref-sanger_35-2\"><a href=\"#cite_note-sanger-35\">[35]</a></sup> To combine financial and manufacturing capabilities for a pandemic <a href=\"/wiki/Adjuvant\" title=\"Adjuvant\">adjuvanted</a> vaccine technology, GSK joined with <a href=\"/wiki/Sanofi\" title=\"Sanofi\">Sanofi</a> in an uncommon partnership of <a href=\"/wiki/Multinational_corporation\" title=\"Multinational corporation\">multinational companies</a> to support accelerated vaccine development.<sup class=\"reference\" id=\"cite_ref-64\"><a href=\"#cite_note-64\">[64]</a></sup>\n",
            "</p><p>During a pandemic on the rapid timeline and scale of COVID‑19 infections during 2020, international organizations like the WHO and CEPI, vaccine developers, governments, and industry are evaluating distribution of the eventual vaccine(s).<sup class=\"reference\" id=\"cite_ref-who-accel_9-7\"><a href=\"#cite_note-who-accel-9\">[9]</a></sup> Individual countries producing a vaccine may be persuaded to favor the highest bidder for manufacturing or provide first-service to their own country.<sup class=\"reference\" id=\"cite_ref-gates2_6-4\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-gates1_24-1\"><a href=\"#cite_note-gates1-24\">[24]</a></sup><sup class=\"reference\" id=\"cite_ref-reuters_34-5\"><a href=\"#cite_note-reuters-34\">[34]</a></sup> Experts emphasize that licensed vaccines should be available and affordable for people at the frontline of <a class=\"mw-redirect\" href=\"/wiki/Healthcare\" title=\"Healthcare\">healthcare</a> and having the greatest need.<sup class=\"reference\" id=\"cite_ref-gates2_6-5\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-gates1_24-2\"><a href=\"#cite_note-gates1-24\">[24]</a></sup><sup class=\"reference\" id=\"cite_ref-reuters_34-6\"><a href=\"#cite_note-reuters-34\">[34]</a></sup> Under their agreement with AstraZeneca, the University of Oxford vaccine development team and UK government agreed that UK citizens would not get preferential access to a new COVID‑19 vaccine developed by the taxpayer-funded university, but rather consented to having a licensed vaccine distributed multinationally in cooperation with the WHO.<sup class=\"reference\" id=\"cite_ref-gartner_54-1\"><a href=\"#cite_note-gartner-54\">[54]</a></sup> Several companies plan to initially manufacture a vaccine at low cost, then increase costs for <a href=\"/wiki/Profit_(economics)\" title=\"Profit (economics)\">profitability</a> later if annual vaccinations are needed and as countries build stock for future needs.<sup class=\"reference\" id=\"cite_ref-reuters_34-7\"><a href=\"#cite_note-reuters-34\">[34]</a></sup>\n",
            "</p><p>The WHO and CEPI are developing financial resources and guidelines for global deployment of several safe, effective COVID‑19 vaccines, recognizing the need is different across countries and population segments.<sup class=\"reference\" id=\"cite_ref-thanh2_2-8\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-who-accel_9-8\"><a href=\"#cite_note-who-accel-9\">[9]</a></sup><sup class=\"reference\" id=\"cite_ref-yamey_27-3\"><a href=\"#cite_note-yamey-27\">[27]</a></sup><sup class=\"reference\" id=\"cite_ref-solidarity-vacc_61-4\"><a href=\"#cite_note-solidarity-vacc-61\">[61]</a></sup> For example, successful COVID‑19 vaccines would likely be allocated first to <a href=\"/wiki/Health_care\" title=\"Health care\">healthcare personnel</a> and populations at greatest risk of severe illness and death from COVID‑19 infection, such as the elderly or <a href=\"/wiki/Poverty\" title=\"Poverty\">densely-populated impoverished people</a>.<sup class=\"reference\" id=\"cite_ref-covax-gavi_32-2\"><a href=\"#cite_note-covax-gavi-32\">[32]</a></sup><sup class=\"reference\" id=\"cite_ref-who-blueprint_65-0\"><a href=\"#cite_note-who-blueprint-65\">[65]</a></sup> The WHO, CEPI, and GAVI have expressed concerns that affluent countries should not receive priority access to the global supply of eventual COVID‑19 vaccines, but rather protecting healthcare personnel and people at high risk of infection are needed to address public health concerns and reduce economic impact of the pandemic.<sup class=\"reference\" id=\"cite_ref-thanh_23-3\"><a href=\"#cite_note-thanh-23\">[23]</a></sup><sup class=\"reference\" id=\"cite_ref-yamey_27-4\"><a href=\"#cite_note-yamey-27\">[27]</a></sup><sup class=\"reference\" id=\"cite_ref-covax-gavi_32-3\"><a href=\"#cite_note-covax-gavi-32\">[32]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Compressed_timelines\">Compressed timelines</span></h2>\n",
            "<p><a href=\"/wiki/Geopolitics\" title=\"Geopolitics\">Geopolitical</a> issues, safety concerns for vulnerable populations, and manufacturing challenges for producing billions of doses are compressing schedules to shorten the standard vaccine development timeline, in some cases combining clinical trial steps over months, a process typically conducted sequentially over years.<sup class=\"reference\" id=\"cite_ref-sanger_35-3\"><a href=\"#cite_note-sanger-35\">[35]</a></sup> As an example, Chinese vaccine developers and the government <a href=\"/wiki/Chinese_Center_for_Disease_Control_and_Prevention\" title=\"Chinese Center for Disease Control and Prevention\">Chinese Center for Disease Control and Prevention</a> began their efforts in January 2020,<sup class=\"reference\" id=\"cite_ref-66\"><a href=\"#cite_note-66\">[66]</a></sup> and by March were pursuing numerous candidates on short timelines, with the goal to showcase Chinese technology strengths over those of the United States, and to reassure the Chinese people about the quality of vaccines produced in China.<sup class=\"reference\" id=\"cite_ref-sanger_35-4\"><a href=\"#cite_note-sanger-35\">[35]</a></sup><sup class=\"reference\" id=\"cite_ref-wee_67-0\"><a href=\"#cite_note-wee-67\">[67]</a></sup>\n",
            "</p><p>In the haste to provide a vaccine on a rapid timeline for the COVID‑19 pandemic, developers and governments are accepting a high risk of <a href=\"/wiki/Short-circuit_test\" title=\"Short-circuit test\">\"short-circuiting\"</a> the vaccine development process,<sup class=\"reference\" id=\"cite_ref-reuters_34-8\"><a href=\"#cite_note-reuters-34\">[34]</a></sup> with one industry executive saying: \"The crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop\".<sup class=\"reference\" id=\"cite_ref-reuters_34-9\"><a href=\"#cite_note-reuters-34\">[34]</a></sup> Multiple steps along the entire development path are evaluated, including the level of acceptable toxicity of the vaccine (its safety), targeting vulnerable populations, the need for vaccine efficacy breakthroughs, the duration of vaccination protection, special delivery systems (such as oral or nasal, rather than by injection), dose regimen, stability and storage characteristics, emergency use authorization before formal licensing, optimal manufacturing for scaling to billions of doses, and dissemination of the licensed vaccine.<sup class=\"reference\" id=\"cite_ref-gates2_6-6\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-simpson_68-0\"><a href=\"#cite_note-simpson-68\">[68]</a></sup> From Phase I clinical trials, 84–90%<sup class=\"reference\" id=\"cite_ref-thanh_23-4\"><a href=\"#cite_note-thanh-23\">[23]</a></sup><sup class=\"reference\" id=\"cite_ref-bio_69-0\"><a href=\"#cite_note-bio-69\">[69]</a></sup>of vaccine candidates fail to make it to final approval during development, and from Phase III, 25.7% fail<sup class=\"reference\" id=\"cite_ref-bio_69-1\"><a href=\"#cite_note-bio-69\">[69]</a></sup> – the investment by a manufacturer in a vaccine candidate may exceed <span style=\"white-space: nowrap\">US$1</span><span class=\"nowrap\"> </span>billion and end with millions of useless doses.<sup class=\"reference\" id=\"cite_ref-gates2_6-7\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-reuters_34-10\"><a href=\"#cite_note-reuters-34\">[34]</a></sup><sup class=\"reference\" id=\"cite_ref-sanger_35-5\"><a href=\"#cite_note-sanger-35\">[35]</a></sup> In the case of COVID‑19 specifically, a vaccine efficacy of 70% may be enough to stop the pandemic, but if it has only 60% efficacy, outbreaks may continue; an efficacy of less than 60% will not provide enough <a href=\"/wiki/Herd_immunity\" title=\"Herd immunity\">herd immunity</a> to stop the spread of the virus alone.<sup class=\"reference\" id=\"cite_ref-gates2_6-8\"><a href=\"#cite_note-gates2-6\">[6]</a></sup>\n",
            "</p><p>As the pandemic expands during 2020, research at universities is obstructed by <a href=\"/wiki/Social_distancing\" title=\"Social distancing\">physical distancing</a> and closing of laboratories.<sup class=\"reference\" id=\"cite_ref-70\"><a href=\"#cite_note-70\">[70]</a></sup><sup class=\"reference\" id=\"cite_ref-71\"><a href=\"#cite_note-71\">[71]</a></sup> Globally, supplies critical to vaccine research and development are increasingly scarce due to international competition or national <a href=\"/wiki/Sequestration_(law)\" title=\"Sequestration (law)\">sequestration</a>.<sup class=\"reference\" id=\"cite_ref-takada_45-1\"><a href=\"#cite_note-takada-45\">[45]</a></sup> Timelines for conducting clinical research – normally a sequential process requiring years – are being compressed into safety, efficacy, and dosing trials running simultaneously over months, potentially compromising safety assurance.<sup class=\"reference\" id=\"cite_ref-reuters_34-11\"><a href=\"#cite_note-reuters-34\">[34]</a></sup><sup class=\"reference\" id=\"cite_ref-sanger_35-6\"><a href=\"#cite_note-sanger-35\">[35]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Technology_platforms\">Technology platforms</span></h2>\n",
            "<p>CEPI scientists reported in September 2020 that nine different technology platforms  –  with the technology of numerous candidates remaining undefined  –  were under research and development during 2020 to create an effective vaccine against COVID‑19.<sup class=\"reference\" id=\"cite_ref-thanh2_2-9\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup> According to CEPI, most of the platforms of vaccine candidates in clinical trials as of September are focused on the <a href=\"/wiki/Coronavirus#Microbiology\" title=\"Coronavirus\">coronavirus spike protein and its variants</a> as the primary <a href=\"/wiki/Antigen\" title=\"Antigen\">antigen</a> of COVID-19 infection.<sup class=\"reference\" id=\"cite_ref-thanh2_2-10\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup> Platforms being developed in 2020 involve <a href=\"/wiki/Nucleic_acid\" title=\"Nucleic acid\">nucleic acid</a> technologies (<a href=\"/wiki/RNA\" title=\"RNA\">RNA</a> and <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a>), <a href=\"/wiki/Viral_vector#Vaccines\" title=\"Viral vector\">non-replicating viral vectors</a>, <a href=\"/wiki/Peptide\" title=\"Peptide\">peptides</a>, <a class=\"mw-redirect\" href=\"/wiki/Recombinant_protein\" title=\"Recombinant protein\">recombinant proteins</a>, live <a class=\"mw-redirect\" href=\"/wiki/Attenuated_virus\" title=\"Attenuated virus\">attenuated viruses</a>, and <a class=\"mw-redirect\" href=\"/wiki/Virus_processing#Viral_inactivation\" title=\"Virus processing\">inactivated viruses</a>.<sup class=\"reference\" id=\"cite_ref-thanh2_2-11\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-diamond_1-1\"><a href=\"#cite_note-diamond-1\">[1]</a></sup><sup class=\"reference\" id=\"cite_ref-gates2_6-9\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-thanh_23-5\"><a href=\"#cite_note-thanh-23\">[23]</a></sup>\n",
            "</p><p>Many vaccine technologies being developed for COVID‑19 are not like vaccines already in use to prevent influenza, but rather are using \"next-generation\" strategies for precision on COVID‑19 infection mechanisms.<sup class=\"reference\" id=\"cite_ref-thanh2_2-12\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-diamond_1-2\"><a href=\"#cite_note-diamond-1\">[1]</a></sup><sup class=\"reference\" id=\"cite_ref-thanh_23-6\"><a href=\"#cite_note-thanh-23\">[23]</a></sup> Vaccine platforms in development may improve flexibility for antigen manipulation and effectiveness for targeting mechanisms of COVID‑19 infection in susceptible population subgroups, such as healthcare workers, the elderly, children, pregnant women, and people with existing weakened <a href=\"/wiki/Immune_system\" title=\"Immune system\">immune systems</a>.<sup class=\"reference\" id=\"cite_ref-thanh2_2-13\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-thanh_23-7\"><a href=\"#cite_note-thanh-23\">[23]</a></sup>\n",
            "</p>\n",
            "<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:402px;\"><a class=\"image\" href=\"/wiki/File:Vaccine_candidate_mechanisms_for_SARS-CoV-2_(49948301838).jpg\"><img alt=\"\" class=\"thumbimage\" data-file-height=\"414\" data-file-width=\"1051\" decoding=\"async\" height=\"158\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg/400px-Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg/600px-Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg/800px-Vaccine_candidate_mechanisms_for_SARS-CoV-2_%2849948301838%29.jpg 2x\" width=\"400\"/></a> <div class=\"thumbcaption\"><div class=\"magnify\"><a class=\"internal\" href=\"/wiki/File:Vaccine_candidate_mechanisms_for_SARS-CoV-2_(49948301838).jpg\" title=\"Enlarge\"></a></div>Potential candidates for forming SARS-CoV-2 proteins to prompt an immune response</div></div></div>\n",
            "<table class=\"wikitable\" style=\"text-align: right;\">\n",
            "<caption>COVID‑19: Vaccine technology platforms, September 2020<sup class=\"reference\" id=\"cite_ref-london_3-1\"><a href=\"#cite_note-london-3\">[3]</a></sup>\n",
            "</caption>\n",
            "<tbody><tr>\n",
            "<th>Molecular platform ^\n",
            "</th>\n",
            "<th>Total number <br/>of candidates\n",
            "</th>\n",
            "<th>Number of candidates <br/>in human trials\n",
            "</th></tr>\n",
            "<tr>\n",
            "<td style=\"text-align:left\"> Non-replicating viral vector\n",
            "</td>\n",
            "<td><center>31</center>\n",
            "</td>\n",
            "<td><center>4 <sup class=\"reference\" id=\"cite_ref-phase2orhigher_72-0\"><a href=\"#cite_note-phase2orhigher-72\">[i]</a></sup></center>\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td style=\"text-align:left\"> RNA-based\n",
            "</td>\n",
            "<td><center>31</center>\n",
            "</td>\n",
            "<td><center>3 <sup class=\"reference\" id=\"cite_ref-phase2orhigher_72-1\"><a href=\"#cite_note-phase2orhigher-72\">[i]</a></sup></center>\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td style=\"text-align:left\"> Inactivated virus\n",
            "</td>\n",
            "<td><center>14</center>\n",
            "</td>\n",
            "<td><center>3 <sup class=\"reference\" id=\"cite_ref-phase2orhigher_72-2\"><a href=\"#cite_note-phase2orhigher-72\">[i]</a></sup></center>\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td style=\"text-align:left\"> Protein subunit\n",
            "</td>\n",
            "<td><center>76</center>\n",
            "</td>\n",
            "<td><center>3 <sup class=\"reference\" id=\"cite_ref-phase2orhigher_72-3\"><a href=\"#cite_note-phase2orhigher-72\">[i]</a></sup></center>\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td style=\"text-align:left\"> DNA-based\n",
            "</td>\n",
            "<td><center>19</center>\n",
            "</td>\n",
            "<td><center>0 <sup class=\"reference\" id=\"cite_ref-phase2orhigher_72-4\"><a href=\"#cite_note-phase2orhigher-72\">[i]</a></sup></center>\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td style=\"text-align:left\"> Replicating viral vector\n",
            "</td>\n",
            "<td><center>21</center>\n",
            "</td>\n",
            "<td><center>0</center>\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td style=\"text-align:left\"> Virus-like particle\n",
            "</td>\n",
            "<td><center>13</center>\n",
            "</td>\n",
            "<td><center>0</center>\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td style=\"text-align:left\"> Live attenuated virus\n",
            "</td>\n",
            "<td><center>4</center>\n",
            "</td>\n",
            "<td><center>0</center>\n",
            "</td></tr>\n",
            "</tbody></table>\n",
            "<div class=\"reflist\" style=\"list-style-type: lower-roman;\">\n",
            "<div class=\"mw-references-wrap\"><ol class=\"references\">\n",
            "<li id=\"cite_note-phase2orhigher-72\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-phase2orhigher_72-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-phase2orhigher_72-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-phase2orhigher_72-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-phase2orhigher_72-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-phase2orhigher_72-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\">One or more candidates in Phase II or Phase II–III trials</span>\n",
            "</li>\n",
            "</ol></div></div>\n",
            "<p>^ <small>technologies for dozens of candidates are unannounced or \"unknown\"</small><sup class=\"reference\" id=\"cite_ref-london_3-2\"><a href=\"#cite_note-london-3\">[3]</a></sup>\n",
            "</p><p><br/>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Vaccine_candidates\">Vaccine candidates</span></h2>\n",
            "<p>CEPI classifies development stages for vaccines as \"exploratory\" (planning and designing a candidate, having no evaluation <a href=\"/wiki/In_vivo\" title=\"In vivo\">in vivo</a>), \"preclinical\" (in vivo evaluation with preparation for manufacturing a compound to test in humans), or <a href=\"/wiki/Phases_of_clinical_research#Phase_I\" title=\"Phases of clinical research\">initiation of Phase<span class=\"nowrap\"> </span>I safety studies in healthy people</a>.<sup class=\"reference\" id=\"cite_ref-thanh2_2-14\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup> Some 321 total vaccine candidates are in development as either confirmed projects in clinical trials or in early-stage \"exploratory\" or \"preclinical\" development, as of September.<sup class=\"reference\" id=\"cite_ref-thanh2_2-15\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup>\n",
            "</p><p>Phase<span class=\"nowrap\"> </span>I trials test primarily for safety and preliminary dosing in a few dozen healthy subjects, while Phase<span class=\"nowrap\"> </span>II trials – following success in Phase<span class=\"nowrap\"> </span>I – evaluate <a href=\"/wiki/Immunogenicity\" title=\"Immunogenicity\">immunogenicity</a>, dose levels (efficacy based on <a href=\"/wiki/Biomarker\" title=\"Biomarker\">biomarkers</a>) and adverse effects of the candidate vaccine, typically in hundreds of people.<sup class=\"reference\" id=\"cite_ref-Vaccines.gov_73-0\"><a href=\"#cite_note-Vaccines.gov-73\">[72]</a></sup><sup class=\"reference\" id=\"cite_ref-fda-ddp_74-0\"><a href=\"#cite_note-fda-ddp-74\">[73]</a></sup> A Phase<span class=\"nowrap\"> </span>I–II trial consists of preliminary safety and immunogenicity testing, is typically randomized, placebo-controlled, while determining more precise, effective doses.<sup class=\"reference\" id=\"cite_ref-fda-ddp_74-1\"><a href=\"#cite_note-fda-ddp-74\">[73]</a></sup>  Phase<span class=\"nowrap\"> </span>III trials typically involve more participants at multiple sites, include a <a class=\"mw-redirect\" href=\"/wiki/Control_group\" title=\"Control group\">control group</a>, and test effectiveness of the vaccine to prevent the disease (an \"interventional\" or \"pivotal\" trial), while monitoring for <a href=\"/wiki/Adverse_effect\" title=\"Adverse effect\">adverse effects</a> at the optimal dose.<sup class=\"reference\" id=\"cite_ref-Vaccines.gov_73-1\"><a href=\"#cite_note-Vaccines.gov-73\">[72]</a></sup><sup class=\"reference\" id=\"cite_ref-fda-ddp_74-2\"><a href=\"#cite_note-fda-ddp-74\">[73]</a></sup> Definition of vaccine safety, efficacy, and <a href=\"/wiki/Clinical_endpoint\" title=\"Clinical endpoint\">clinical endpoints</a> in a Phase<span class=\"nowrap\"> </span>III trial may vary between the trials of different companies, such as defining the degree of side effects, infection or amount of transmission, and whether the vaccine prevents moderate or severe COVID‑19 infection.<sup class=\"reference\" id=\"cite_ref-cohen6-19_75-0\"><a href=\"#cite_note-cohen6-19-75\">[74]</a></sup><sup class=\"reference\" id=\"cite_ref-cdc-eff_76-0\"><a href=\"#cite_note-cdc-eff-76\">[75]</a></sup><sup class=\"reference\" id=\"cite_ref-77\"><a href=\"#cite_note-77\">[76]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Clinical_trials_started_in_2020\">Clinical trials started in 2020</span></h3>\n",
            "<table class=\"wikitable sortable\">\n",
            "<caption>COVID‑19: candidate vaccines in Phase I–III trials<sup class=\"reference\" id=\"cite_ref-london_3-3\"><a href=\"#cite_note-london-3\">[3]</a></sup><sup class=\"reference\" id=\"cite_ref-milken_4-1\"><a href=\"#cite_note-milken-4\">[4]</a></sup><sup class=\"reference\" id=\"cite_ref-who-tracker_5-2\"><a href=\"#cite_note-who-tracker-5\">[5]</a></sup>\n",
            "</caption>\n",
            "<tbody><tr>\n",
            "<th>Vaccine candidates<br/>Developers, sponsors\n",
            "</th>\n",
            "<th>Technology\n",
            "</th>\n",
            "<th>Current phase (participants)<br/>Design\n",
            "</th>\n",
            "<th>Completed phase<sup class=\"reference\" id=\"cite_ref-78\"><a href=\"#cite_note-78\">[a]</a></sup> (participants)<br/>Immune response, adverse effects\n",
            "</th>\n",
            "<th>Clinical trial site(s)\n",
            "</th>\n",
            "<th>Duration<sup class=\"reference\" id=\"cite_ref-79\"><a href=\"#cite_note-79\">[b]</a></sup>\n",
            "</th></tr>\n",
            "<tr>\n",
            "<td><b>AZD1222</b><wbr/><sup class=\"reference\" id=\"cite_ref-81\"><a href=\"#cite_note-81\">[c]</a></sup><sup class=\"reference\" id=\"cite_ref-NCT04400838_82-0\"><a href=\"#cite_note-NCT04400838-82\">[78]</a></sup><sup class=\"reference\" id=\"cite_ref-EudraCT-2020-001228-32_83-0\"><a href=\"#cite_note-EudraCT-2020-001228-32-83\">[79]</a></sup><sup class=\"reference\" id=\"cite_ref-ISRCTN89951424_84-0\"><a href=\"#cite_note-ISRCTN89951424-84\">[80]</a></sup><br/><a href=\"/wiki/University_of_Oxford\" title=\"University of Oxford\">University of Oxford</a>, <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a>\n",
            "</td>\n",
            "<td>Modified <a href=\"/wiki/Chimpanzee\" title=\"Chimpanzee\">chimp</a> <a href=\"/wiki/Adenoviridae\" title=\"Adenoviridae\">adenovirus</a> <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">vector</a> (ChAdOx1)\n",
            "</td>\n",
            "<td class=\"table-yes2\" data-sort-value=\"P3 30000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\"><b>Phase III</b> (30,000)<wbr/><br/>Interventional; <a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">randomized, placebo-controlled study</a> for efficacy, safety, and immunogenicity.<sup class=\"reference\" id=\"cite_ref-NCT04516746_85-0\"><a href=\"#cite_note-NCT04516746-85\">[81]</a></sup>  Brazil (5,000)<sup class=\"reference\" id=\"cite_ref-86\"><a href=\"#cite_note-86\">[82]</a></sup> International enrolment of the Phase III trial was paused on 8 September 2020 due to an adverse neurological event in one participant,<sup class=\"reference\" id=\"cite_ref-phillips_87-0\"><a href=\"#cite_note-phillips-87\">[83]</a></sup><sup class=\"reference\" id=\"cite_ref-88\"><a href=\"#cite_note-88\">[84]</a></sup> but resumed on 12 September after it was determined the symptoms were unrelated to the vaccine.<sup class=\"reference\" id=\"cite_ref-89\"><a href=\"#cite_note-89\">[85]</a></sup>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1-2 543\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I-II</b> (543)<wbr/><br/>Spike-specific antibodies at day 28; <a href=\"/wiki/Neutralizing_antibody\" title=\"Neutralizing antibody\">neutralizing antibodies</a> after a <a href=\"/wiki/Booster_dose\" title=\"Booster dose\">booster dose</a> at day 56. <b>Adverse effects</b>: pain at the injection site, headache, fever, chills, <a href=\"/wiki/Myalgia\" title=\"Myalgia\">muscle ache</a>, <a href=\"/wiki/Malaise\" title=\"Malaise\">malaise</a> in more than 60% of participants; <a href=\"/wiki/Paracetamol\" title=\"Paracetamol\">paracetamol</a> allowed for some participants to increase tolerability<sup class=\"reference\" id=\"cite_ref-folegatti_90-0\"><a href=\"#cite_note-folegatti-90\">[86]</a></sup>\n",
            "</td>\n",
            "<td>20 in the UK, <a href=\"/wiki/S%C3%A3o_Paulo\" title=\"São Paulo\">São Paulo</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2021-08\">May 2020 – Aug 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><i>Unnamed</i><wbr/><sup class=\"reference\" id=\"cite_ref-ChiCTR2000034780_91-0\"><a href=\"#cite_note-ChiCTR2000034780-91\">[87]</a></sup><br/><a href=\"/wiki/China_National_Pharmaceutical_Group\" title=\"China National Pharmaceutical Group\">Sinopharm</a>: Beijing Institute of Biological Products, Wuhan Institute of Biological Products\n",
            "</td>\n",
            "<td><a href=\"/wiki/Inactivated_vaccine\" title=\"Inactivated vaccine\">Inactivated</a> <a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a> (<a href=\"/wiki/Vero_cell\" title=\"Vero cell\">vero cells</a>)\n",
            "</td>\n",
            "<td class=\"table-yes2\" data-sort-value=\"P3 48000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\"><b>Phase III</b> (48,000)<wbr/><br/>Randomized, double-blind, parallel placebo-controlled, to evaluate safety and protective efficacy in the <a href=\"/wiki/United_Arab_Emirates\" title=\"United Arab Emirates\">United Arab Emirates</a>, <a href=\"/wiki/Bahrain\" title=\"Bahrain\">Bahrain</a>, <a href=\"/wiki/Jordan\" title=\"Jordan\">Jordan</a>,<sup class=\"reference\" id=\"cite_ref-92\"><a href=\"#cite_note-92\">[88]</a></sup> and <a href=\"/wiki/Argentina\" title=\"Argentina\">Argentina</a><sup class=\"reference\" id=\"cite_ref-93\"><a href=\"#cite_note-93\">[89]</a></sup>\n",
            "<p>On September 14, UAE approved Sinopharm's vaccine for emergency use by front-line healthcare workers following successful interim results in the Phase III trials.<sup class=\"reference\" id=\"cite_ref-UAE_approval_94-0\"><a href=\"#cite_note-UAE_approval-94\">[90]</a></sup>\n",
            "</p>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1-2 320\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I-II</b> (320)<wbr/><br/>Neutralizing antibodies at day 14 after 2 injections;  <b>Adverse effects</b>: injection site pain and fever, which were mild and self-limiting; no serious effects<sup class=\"reference\" id=\"cite_ref-95\"><a href=\"#cite_note-95\">[91]</a></sup>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Jiaozuo\" title=\"Jiaozuo\">Jiaozuo</a>, <a href=\"/wiki/Abu_Dhabi\" title=\"Abu Dhabi\">Abu Dhabi</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2021-11\">Jul 2020 – Jul 2021 in Abu Dhabi\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>Ad5-nCoV</b><wbr/><br/><a href=\"/wiki/CanSino_Biologics\" title=\"CanSino Biologics\">CanSinoBIO</a>, Beijing Institute of Biotechnology of the <a href=\"/wiki/Academy_of_Military_Medical_Sciences\" title=\"Academy of Military Medical Sciences\">Academy of Military Medical Sciences</a><sup class=\"reference\" id=\"cite_ref-Ad5-nCoV-manufacture_97-0\"><a href=\"#cite_note-Ad5-nCoV-manufacture-97\">[d]</a></sup>\n",
            "</td>\n",
            "<td><a class=\"mw-redirect\" href=\"/wiki/Recombinant_vaccine\" title=\"Recombinant vaccine\">Recombinant</a> <a href=\"/wiki/Adenoviridae\" title=\"Adenoviridae\">adenovirus</a> <a href=\"/wiki/Serotype\" title=\"Serotype\">type</a> 5 <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">vector</a>\n",
            "</td>\n",
            "<td class=\"table-yes2\" data-sort-value=\"P3 40,000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\"><b>Phase III</b> (40,000)<wbr/><br/>global multi-center, randomized, double-blind, placebo-controlled to evaluate efficacy, safety and immunogenicity<sup class=\"reference\" id=\"cite_ref-98\"><a href=\"#cite_note-98\">[93]</a></sup>\n",
            "</td>\n",
            "<td class=\"table-partial\" data-sort-value=\"P2 508\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\"><b>Phase II</b> (508)<wbr/><br/>Neutralizing antibody and <a href=\"/wiki/T_cell\" title=\"T cell\">T cell</a> responses. <b>Adverse effects</b>: moderate over 7 days: 74% had fever, pain, fatigue<sup class=\"reference\" id=\"cite_ref-zhu7-20_99-0\"><a href=\"#cite_note-zhu7-20-99\">[94]</a></sup>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Wuhan\" title=\"Wuhan\">Wuhan</a>, China\n",
            "<p><a href=\"/wiki/Pakistan\" title=\"Pakistan\">Pakistan</a>\n",
            "</p>\n",
            "</td>\n",
            "<td data-sort-value=\"2020-12\">Mar – Dec 2020 in China\n",
            "<p>Sep 2020 – December 2021 in Pakistan\n",
            "</p>\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b><a href=\"/wiki/CoronaVac\" title=\"CoronaVac\">CoronaVac</a></b><sup class=\"reference\" id=\"cite_ref-NCT04383574_100-0\"><a href=\"#cite_note-NCT04383574-100\">[95]</a></sup><sup class=\"reference\" id=\"cite_ref-NCname=_nct04456595=_101-0\"><a href=\"#cite_note-NCname=_nct04456595=-101\">[96]</a></sup><sup class=\"reference\" id=\"cite_ref-102\"><a href=\"#cite_note-102\">[97]</a></sup><br/><a href=\"/wiki/Sinovac_Biotech\" title=\"Sinovac Biotech\">Sinovac</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Inactivated_vaccine\" title=\"Inactivated vaccine\">Inactivated</a> <a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a>\n",
            "</td>\n",
            "<td class=\"table-yes2\" data-sort-value=\"P3 23,490\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\"><b>Phase III</b> (23,490)<wbr/><br/>Double-blind, randomized, placebo-controlled to evaluate efficacy and safety in <a href=\"/wiki/Brazil\" title=\"Brazil\">Brazil</a> (8,870); <a href=\"/wiki/Indonesia\" title=\"Indonesia\">Indonesia</a> (1,620); <a href=\"/wiki/Turkey\" title=\"Turkey\">Turkey</a> (13,000)\n",
            "</td>\n",
            "<td class=\"table-partial\" data-sort-value=\"P2 600\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\"><b>Phase II</b> (600)<wbr/><br/><a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>. Immunogenicity eliciting 92% seroconversion at lower dose; <b>Adverse effects</b>: mild in severity, pain at injection site<sup class=\"reference\" id=\"cite_ref-103\"><a href=\"#cite_note-103\">[98]</a></sup>\n",
            "</td>\n",
            "<td>2 in China; 12 in Brazil; Bandung, Indonesia<sup class=\"reference\" id=\"cite_ref-104\"><a href=\"#cite_note-104\">[99]</a></sup>\n",
            "</td>\n",
            "<td data-sort-value=\"2020-07\"><div class=\"plainlist\"><ul><li style=\"margin-top:.3em\">Jul 2020 – Oct 2021 in Brazil</li><li style=\"margin-top:.3em\">August 2020 – January 2021 in Bandung, Indonesia</li></ul></div>\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>BNT162 a1, b1, b2, c2</b><wbr/><sup class=\"reference\" id=\"cite_ref-105\"><a href=\"#cite_note-105\">[e]</a></sup><sup class=\"reference\" id=\"cite_ref-NCT04368728_106-0\"><a href=\"#cite_note-NCT04368728-106\">[100]</a></sup><sup class=\"reference\" id=\"cite_ref-EudraCT-2020-001038-36_107-0\"><a href=\"#cite_note-EudraCT-2020-001038-36-107\">[101]</a></sup><br/><a href=\"/wiki/BioNTech\" title=\"BioNTech\">BioNTech</a>, <a class=\"mw-redirect\" href=\"/wiki/Fosun_Pharma\" title=\"Fosun Pharma\">Fosun Pharma</a>, <a href=\"/wiki/Pfizer\" title=\"Pfizer\">Pfizer</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/RNA_vaccine\" title=\"RNA vaccine\">mRNA</a>\n",
            "</td>\n",
            "<td class=\"table-yes2\" data-sort-value=\"P3 30000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\"><b>Phase III</b> (30,000)<wbr/><sup class=\"reference\" id=\"cite_ref-108\"><a href=\"#cite_note-108\">[102]</a></sup><br/>Randomized, placebo-controlled\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1-2 60\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I-II</b> (60)<wbr/><br/><a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>. Strong RBD-binding <a href=\"/wiki/Immunoglobulin_G\" title=\"Immunoglobulin G\">IgG</a> and <a href=\"/wiki/Neutralizing_antibody\" title=\"Neutralizing antibody\">neutralizing antibody</a> response peaked 7 days after a <a href=\"/wiki/Booster_dose\" title=\"Booster dose\">booster dose</a>, robust CD4+ and CD8+ <a href=\"/wiki/T_cell\" title=\"T cell\">T cell</a> responses, undetermined durability. <b>Adverse effects</b>: dose-dependent and moderate including pain at the injection site, fatigue, headache, chills, muscle and join pain, fever<sup class=\"reference\" id=\"cite_ref-109\"><a href=\"#cite_note-109\">[103]</a></sup><sup class=\"reference\" id=\"cite_ref-110\"><a href=\"#cite_note-110\">[104]</a></sup>\n",
            "</td>\n",
            "<td>62 in the US, Germany\n",
            "</td>\n",
            "<td data-sort-value=\"2021-05\">Apr 2020 – May 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>mRNA-1273</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04470427_111-0\"><a href=\"#cite_note-NCT04470427-111\">[105]</a></sup><sup class=\"reference\" id=\"cite_ref-palca_112-0\"><a href=\"#cite_note-palca-112\">[106]</a></sup><br/><a href=\"/wiki/Moderna\" title=\"Moderna\">Moderna</a>, <a href=\"/wiki/National_Institute_of_Allergy_and_Infectious_Diseases\" title=\"National Institute of Allergy and Infectious Diseases\">NIAID</a>, <a href=\"/wiki/Biomedical_Advanced_Research_and_Development_Authority\" title=\"Biomedical Advanced Research and Development Authority\">BARDA</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Lipid\" title=\"Lipid\">Lipid</a> <a href=\"/wiki/Nanoparticle\" title=\"Nanoparticle\">nanoparticle</a> dispersion containing <a href=\"/wiki/Messenger_RNA\" title=\"Messenger RNA\">mRNA</a>\n",
            "</td>\n",
            "<td class=\"table-yes2\" data-sort-value=\"P3 30000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\"><b>Phase III</b> (30,000)<wbr/><br/>Interventional; randomized, placebo-controlled study for efficacy, safety, and immunogenicity\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 45\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (45)<wbr/><br/>Dose-dependent neutralizing antibody response on two-dose schedule; undetermined durability. <b>Adverse effects</b>: fever, fatigue, headache, muscle ache, and pain at the injection site<sup class=\"reference\" id=\"cite_ref-jackson_113-0\"><a href=\"#cite_note-jackson-113\">[107]</a></sup><sup class=\"reference\" id=\"cite_ref-jackson-app_114-0\"><a href=\"#cite_note-jackson-app-114\">[108]</a></sup>\n",
            "</td>\n",
            "<td>89 in the US\n",
            "</td>\n",
            "<td data-sort-value=\"2022-10\">Jul 2020 – Oct 2022\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><a href=\"/wiki/Gam-COVID-Vac\" title=\"Gam-COVID-Vac\">Gam-COVID-Vac</a><br/>Gamaleya Research Institute of Epidemiology and Microbiology; trade name: <i>Sputnik V</i>\n",
            "</td>\n",
            "<td>Non-<a href=\"/wiki/Viral_replication\" title=\"Viral replication\">replicating</a> <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">viral vector</a>\n",
            "</td>\n",
            "<td class=\"table-yes2\" data-sort-value=\"P3 40,000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\"><b>Phase III</b> (40,000)<wbr/><br/>Randomized double-blind, placebo-controlled to evaluate efficacy, immunogenicity, and safety<sup class=\"reference\" id=\"cite_ref-115\"><a href=\"#cite_note-115\">[109]</a></sup>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1-2 76\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I-II</b> (76)<wbr/> <a href=\"/wiki/Neutralizing_antibody\" title=\"Neutralizing antibody\">Neutralizing antibody</a> and <a href=\"/wiki/T_cell\" title=\"T cell\">T cell</a> responses. <b>Adverse effects</b>: pain at injection site, fever, headache, weakness, and muscle/joint pain<sup class=\"reference\" id=\"cite_ref-logunov_116-0\"><a href=\"#cite_note-logunov-116\">[110]</a></sup>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Moscow\" title=\"Moscow\">Moscow</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2020-08\">Aug 2020 – May 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>Ad26.COV2.S</b><sup class=\"reference\" id=\"cite_ref-117\"><a href=\"#cite_note-117\">[111]</a></sup><sup class=\"reference\" id=\"cite_ref-118\"><a href=\"#cite_note-118\">[112]</a></sup><sup class=\"reference\" id=\"cite_ref-119\"><a href=\"#cite_note-119\">[113]</a></sup>\n",
            "<p><a href=\"/wiki/Janssen_Pharmaceutica\" title=\"Janssen Pharmaceutica\">Janssen Pharmaceutica</a> (Johnson &amp; Johnson), <a href=\"/wiki/Beth_Israel_Deaconess_Medical_Center\" title=\"Beth Israel Deaconess Medical Center\">BIDMC</a>\n",
            "</p>\n",
            "</td>\n",
            "<td>Non-<a href=\"/wiki/Viral_replication\" title=\"Viral replication\">replicating</a> <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">viral vector</a>\n",
            "</td>\n",
            "<td class=\"table-yes2\" data-sort-value=\"P3 60000\" style=\"background: #dfd; color: black; vertical-align: middle; text-align: left;\"><b>Phase III</b> (60,000)<wbr/><br/>Randomized, double-blinded, placebo-controlled\n",
            "<p>Temporarily paused on October 13 2020 due to an unexplained illness in a participant.<sup class=\"reference\" id=\"cite_ref-120\"><a href=\"#cite_note-120\">[114]</a></sup>\n",
            "</p>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1-2 1045\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I-II</b> (1,045)<wbr/>  Preprint. Seroconversion for S antibodies over 95%. <b>Adverse effects</b>: injection site pain, fatigue, headache and <a href=\"/wiki/Myalgia\" title=\"Myalgia\">myalgia</a>\n",
            "</td>\n",
            "<td>291 in US, Argentina, Brazil, Chile, Colombia, Mexico, Peru, Philippines, South Africa and Ukraine\n",
            "</td>\n",
            "<td data-sort-value=\"2023\">Jul 2020 – 2023\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><i>Unnamed</i><wbr/><sup class=\"reference\" id=\"cite_ref-london_3-4\"><a href=\"#cite_note-london-3\">[3]</a></sup><sup class=\"reference\" id=\"cite_ref-milken_4-2\"><a href=\"#cite_note-milken-4\">[4]</a></sup><sup class=\"reference\" id=\"cite_ref-who-tracker_5-3\"><a href=\"#cite_note-who-tracker-5\">[5]</a></sup><sup class=\"reference\" id=\"cite_ref-NCT04445194_121-0\"><a href=\"#cite_note-NCT04445194-121\">[115]</a></sup><br/>Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.\n",
            "</td>\n",
            "<td><a class=\"mw-redirect\" href=\"/wiki/Recombinant_vaccine\" title=\"Recombinant vaccine\">Recombinant</a> <a href=\"/wiki/Protein_subunit#Subunit_Vaccines\" title=\"Protein subunit\">protein subunit</a>\n",
            "</td>\n",
            "<td class=\"table-partial\" data-sort-value=\"P2 900\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\"><b>Phase II</b> (900)<wbr/><br/>Interventional; randomized, double-blind, placebo-controlled <sup class=\"reference\" id=\"cite_ref-NCT04466085_122-0\"><a href=\"#cite_note-NCT04466085-122\">[116]</a></sup>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 50\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (50)<wbr/>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Chongqing\" title=\"Chongqing\">Chongqing</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2021-09\">Jun 2020 – Sep 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>CVnCoV</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04449276_123-0\"><a href=\"#cite_note-NCT04449276-123\">[117]</a></sup><br/><a href=\"/wiki/CureVac\" title=\"CureVac\">CureVac</a>, <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">CEPI</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/RNA_vaccine\" title=\"RNA vaccine\">mRNA</a>\n",
            "</td>\n",
            "<td class=\"table-partial\" data-sort-value=\"P2 691\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\"><b>Phase II</b> (691)<wbr/><br/>Partially observer-blind, multicenter, controlled, dose-confirmation<sup class=\"reference\" id=\"cite_ref-NCT04515147_124-0\"><a href=\"#cite_note-NCT04515147-124\">[118]</a></sup>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 168\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (168)<wbr/>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Ghent\" title=\"Ghent\">Ghent</a>, 3 in Germany\n",
            "</td>\n",
            "<td data-sort-value=\"2021-08\">Jun 2020 – Aug 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>NVX-CoV2373</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04368988_125-0\"><a href=\"#cite_note-NCT04368988-125\">[119]</a></sup><br/><a href=\"/wiki/Novavax\" title=\"Novavax\">Novavax</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a> <a class=\"mw-redirect\" href=\"/wiki/Recombinant_vaccine\" title=\"Recombinant vaccine\">recombinant</a> <a href=\"/wiki/Peplomer\" title=\"Peplomer\">spike protein</a> <a href=\"/wiki/Nanoparticle\" title=\"Nanoparticle\">nanoparticle</a> with <a href=\"/wiki/Immunologic_adjuvant\" title=\"Immunologic adjuvant\">adjuvant</a>\n",
            "</td>\n",
            "<td class=\"table-partial\" data-sort-value=\"P2 131\" style=\"background: #ffd; color: black; vertical-align: middle; text-align: left;\"><b>Phase II</b> (131)<wbr/>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 131\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (131)<wbr/><br/><a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>. <a href=\"/wiki/Immunoglobulin_G\" title=\"Immunoglobulin G\">IgG</a> and <a href=\"/wiki/Neutralizing_antibody\" title=\"Neutralizing antibody\">neutralizing antibody</a> response with adjuvant after <a href=\"/wiki/Booster_dose\" title=\"Booster dose\">booster dose</a>. <b>Adverse effects</b>: short-duration, low grade, local pain, headache, fatigue, <a href=\"/wiki/Myalgia\" title=\"Myalgia\">myalgia</a><sup class=\"reference\" id=\"cite_ref-126\"><a href=\"#cite_note-126\">[120]</a></sup><sup class=\"reference\" id=\"cite_ref-127\"><a href=\"#cite_note-127\">[121]</a></sup>\n",
            "</td>\n",
            "<td>2 in Australia\n",
            "</td>\n",
            "<td data-sort-value=\"2021-07\">May 2020 – Jul 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>INO-4800</b><wbr/><sup class=\"reference\" id=\"cite_ref-INO-4800-phase_128-0\"><a href=\"#cite_note-INO-4800-phase-128\">[f]</a></sup><sup class=\"reference\" id=\"cite_ref-NCT04336410_129-0\"><a href=\"#cite_note-NCT04336410-129\">[122]</a></sup><sup class=\"reference\" id=\"cite_ref-130\"><a href=\"#cite_note-130\">[123]</a></sup><br/><a href=\"/wiki/Inovio_Pharmaceuticals\" title=\"Inovio Pharmaceuticals\">Inovio</a>, <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">CEPI</a>, <a class=\"mw-redirect\" href=\"/wiki/Korea_Centers_for_Disease_Control_and_Prevention\" title=\"Korea Centers for Disease Control and Prevention\">Korea National Institute of Health</a>, <a href=\"/wiki/International_Vaccine_Institute\" title=\"International Vaccine Institute\">International Vaccine Institute</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/DNA_vaccination#Plasmid_vectors\" title=\"DNA vaccination\">DNA plasmid</a> delivered by <a href=\"/wiki/Electroporation\" title=\"Electroporation\">electroporation</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1-2 40\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I-II</b> (40)<wbr/>\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"0a\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">Pending Phase I report\n",
            "</td>\n",
            "<td>3 in the US, <a href=\"/wiki/Seoul\" title=\"Seoul\">Seoul</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2020-11\">Apr–Nov 2020\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><i>Unnamed</i><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04412538_131-0\"><a href=\"#cite_note-NCT04412538-131\">[124]</a></sup><br/><a href=\"/wiki/Peking_Union_Medical_College\" title=\"Peking Union Medical College\">Chinese Academy of Medical Sciences</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Inactivated_vaccine\" title=\"Inactivated vaccine\">Inactivated</a> <a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1-2 942\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I-II</b> (942)<wbr/><br/>Randomized, double-blinded, single-center, placebo-controlled\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td><a href=\"/wiki/Chengdu\" title=\"Chengdu\">Chengdu</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2021-09\">Jun 2020 – Sep 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>AG0301-COVID-19</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04463472_132-0\"><a href=\"#cite_note-NCT04463472-132\">[125]</a></sup><br/>AnGes Inc.,<sup class=\"reference\" id=\"cite_ref-anges-inc_133-0\"><a href=\"#cite_note-anges-inc-133\">[126]</a></sup> <a href=\"/wiki/Japan_Agency_for_Medical_Research_and_Development\" title=\"Japan Agency for Medical Research and Development\">AMED</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/DNA_vaccination#Plasmid_vectors\" title=\"DNA vaccination\">DNA plasmid</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1-2 30\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I-II</b> (30)<wbr/><br/>Non-randomized, single-center, two doses\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td><a href=\"/wiki/Osaka\" title=\"Osaka\">Osaka</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2021-07\">Jun 2020 – Jul 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>Lunar-COV19/ARCT-021</b><sup class=\"reference\" id=\"cite_ref-134\"><a href=\"#cite_note-134\">[127]</a></sup><sup class=\"reference\" id=\"cite_ref-135\"><a href=\"#cite_note-135\">[128]</a></sup>\n",
            "<p><a href=\"/wiki/Arcturus_Therapeutics\" title=\"Arcturus Therapeutics\">Arcturus Therapeutics</a>\n",
            "</p>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Messenger_RNA\" title=\"Messenger RNA\">mRNA</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1-2 92\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I-II</b> (92)<wbr/><br/>Randomized, double-blinded\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td><a href=\"/wiki/Singapore\" title=\"Singapore\">Singapore</a>\n",
            "</td>\n",
            "<td>Aug 2020 – ?\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>COVID‑19/aAPC</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04299724_136-0\"><a href=\"#cite_note-NCT04299724-136\">[129]</a></sup><br/>Shenzhen Genoimmune Medical Institute<sup class=\"reference\" id=\"cite_ref-shenzhen-genoimmune-medical-institute_137-0\"><a href=\"#cite_note-shenzhen-genoimmune-medical-institute-137\">[130]</a></sup>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Lentiviral_vector_in_gene_therapy\" title=\"Lentiviral vector in gene therapy\">Lentiviral vector</a> with <a href=\"/wiki/Minigene\" title=\"Minigene\">minigene</a> modifying <a href=\"/wiki/Artificial_antigen_presenting_cells\" title=\"Artificial antigen presenting cells\">aAPCs</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 100\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (100)<wbr/>\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td><a href=\"/wiki/Shenzhen\" title=\"Shenzhen\">Shenzhen</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2023\">Mar 2020 – 2023\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>LV-SMENP-DC</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04276896_138-0\"><a href=\"#cite_note-NCT04276896-138\">[131]</a></sup><br/>Shenzhen Genoimmune Medical Institute<sup class=\"reference\" id=\"cite_ref-shenzhen-genoimmune-medical-institute_137-1\"><a href=\"#cite_note-shenzhen-genoimmune-medical-institute-137\">[130]</a></sup>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Lentiviral_vector_in_gene_therapy\" title=\"Lentiviral vector in gene therapy\">Lentiviral vector</a> with <a href=\"/wiki/Minigene\" title=\"Minigene\">minigene</a> modifying <a class=\"mw-redirect\" href=\"/wiki/Dendritic_cells\" title=\"Dendritic cells\">DCs</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 100\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (100)<wbr/>\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td><a href=\"/wiki/Shenzhen\" title=\"Shenzhen\">Shenzhen</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2023\">Mar 2020 – 2023\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>LNP-nCoVsaRNA</b><wbr/><sup class=\"reference\" id=\"cite_ref-ISRCTN17072692_139-0\"><a href=\"#cite_note-ISRCTN17072692-139\">[132]</a></sup><br/><a href=\"/wiki/Medical_Research_Council_(United_Kingdom)\" title=\"Medical Research Council (United Kingdom)\">MRC</a> <a href=\"/wiki/Clinical_trials_unit\" title=\"Clinical trials unit\">clinical trials unit</a> at <a href=\"/wiki/Imperial_College_London\" title=\"Imperial College London\">Imperial College London</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/RNA_vaccine\" title=\"RNA vaccine\">mRNA</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 105\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (105)<wbr/><br/>Randomized trial, with dose escalation study (15) and expanded safety study (at least 200)\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td>4 in the UK\n",
            "</td>\n",
            "<td data-sort-value=\"2021-07\">Jun 2020 – Jul 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>GX-19</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04445389_140-0\"><a href=\"#cite_note-NCT04445389-140\">[133]</a></sup><sup class=\"reference\" id=\"cite_ref-gen-reut_141-0\"><a href=\"#cite_note-gen-reut-141\">[134]</a></sup><br/>Genexine consortium,<sup class=\"reference\" id=\"cite_ref-142\"><a href=\"#cite_note-142\">[135]</a></sup> <a href=\"/wiki/International_Vaccine_Institute\" title=\"International Vaccine Institute\">International Vaccine Institute</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/DNA_vaccination\" title=\"DNA vaccination\">DNA</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 40\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (40)<wbr/>\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td><a href=\"/wiki/Seoul\" title=\"Seoul\">Seoul</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2022-06\">Jun 2020 – Jun 2022\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>SCB-2019</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04405908_143-0\"><a href=\"#cite_note-NCT04405908-143\">[136]</a></sup><sup class=\"reference\" id=\"cite_ref-clover-cta_144-0\"><a href=\"#cite_note-clover-cta-144\">[137]</a></sup><br/>Clover Biopharmaceuticals,<sup class=\"reference\" id=\"cite_ref-clover-biopharma_145-0\"><a href=\"#cite_note-clover-biopharma-145\">[138]</a></sup> <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GSK</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Peplomer\" title=\"Peplomer\">Spike protein</a> <a href=\"/wiki/Protein_trimer\" title=\"Protein trimer\">trimeric</a> <a href=\"/wiki/Protein_subunit#Subunit_Vaccines\" title=\"Protein subunit\">subunit</a> with <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GSK</a> <a href=\"/wiki/Immunologic_adjuvant\" title=\"Immunologic adjuvant\">adjuvant</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 150\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (150)<wbr/>\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td><a href=\"/wiki/Perth\" title=\"Perth\">Perth</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2021-03\">Jun 2020 – Mar 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>COVAX-19</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04453852_146-0\"><a href=\"#cite_note-NCT04453852-146\">[139]</a></sup><br/>Vaxine Pty Ltd<sup class=\"reference\" id=\"cite_ref-vaxine-pty_147-0\"><a href=\"#cite_note-vaxine-pty-147\">[140]</a></sup>\n",
            "</td>\n",
            "<td><a class=\"mw-redirect\" href=\"/wiki/Recombinant_vaccine\" title=\"Recombinant vaccine\">Recombinant</a> <a href=\"/wiki/Protein\" title=\"Protein\">protein</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 40\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (40)<wbr/>\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td><a href=\"/wiki/Adelaide\" title=\"Adelaide\">Adelaide</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2021-07\">Jun 2020 – Jul 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><i>Unnamed</i><wbr/><sup class=\"reference\" id=\"cite_ref-ChiCTR2000034112_148-0\"><a href=\"#cite_note-ChiCTR2000034112-148\">[141]</a></sup><br/><a href=\"/wiki/PLA_Academy_of_Military_Science\" title=\"PLA Academy of Military Science\">PLA Academy of Military Science</a>, Walvax Biotech<sup class=\"reference\" id=\"cite_ref-walvax_149-0\"><a href=\"#cite_note-walvax-149\">[142]</a></sup>\n",
            "</td>\n",
            "<td><a href=\"/wiki/RNA_vaccine\" title=\"RNA vaccine\">mRNA</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 168\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (168)<wbr/>\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td>2 in China\n",
            "</td>\n",
            "<td data-sort-value=\"2021-12\">Jun 2020 – Dec 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><i>Unnamed</i><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04450004_150-0\"><a href=\"#cite_note-NCT04450004-150\">[143]</a></sup><sup class=\"reference\" id=\"cite_ref-ctv-medicago_151-0\"><a href=\"#cite_note-ctv-medicago-151\">[144]</a></sup><br/><a href=\"/wiki/Medicago_Inc.\" title=\"Medicago Inc.\">Medicago</a><sup class=\"reference\" id=\"cite_ref-medicago-about_152-0\"><a href=\"#cite_note-medicago-about-152\">[145]</a></sup> (governments of <a href=\"/wiki/Canada\" title=\"Canada\">Canada</a> and <a href=\"/wiki/Quebec\" title=\"Quebec\">Quebec</a>)\n",
            "</td>\n",
            "<td><a class=\"mw-redirect\" href=\"/wiki/Recombinant_vaccine\" title=\"Recombinant vaccine\">Recombinant</a> <a href=\"/wiki/Plant_expressed_vaccine\" title=\"Plant expressed vaccine\">plant-based</a> <a href=\"/wiki/Virus-like_particle\" title=\"Virus-like particle\">VLP</a><sup class=\"reference\" id=\"cite_ref-Medicago-technology_154-0\"><a href=\"#cite_note-Medicago-technology-154\">[g]</a></sup> with <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GSK</a> <a href=\"/wiki/Immunologic_adjuvant\" title=\"Immunologic adjuvant\">adjuvant</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 180\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (180)<wbr/><br/>Randomized, dose-ranging\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td>2 in Canada\n",
            "</td>\n",
            "<td data-sort-value=\"2021-04\">Jul 2020 – Apr 2021\n",
            "</td></tr>\n",
            "<tr>\n",
            "<td><b>SARS-CoV-2 Sclamp</b><wbr/><sup class=\"reference\" id=\"cite_ref-NCT04495933_155-0\"><a href=\"#cite_note-NCT04495933-155\">[147]</a></sup><br/><a href=\"/wiki/University_of_Queensland\" title=\"University of Queensland\">UQ</a>, <a href=\"/wiki/Syneos_Health\" title=\"Syneos Health\">Syneos Health</a>, <a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">CEPI</a>, <a href=\"/wiki/CSL_Limited#Seqirus_(bioCSL)\" title=\"CSL Limited\">Seqirus</a>\n",
            "</td>\n",
            "<td><a href=\"/wiki/Molecular_clamp\" title=\"Molecular clamp\">Molecular clamp</a> stabilized <a href=\"/wiki/Peplomer\" title=\"Peplomer\">spike protein</a> with <a href=\"/wiki/MF59\" title=\"MF59\">MF59</a>\n",
            "</td>\n",
            "<td class=\"table-depends\" data-sort-value=\"P1 120\" style=\"background: #fed; color: black; vertical-align: middle; text-align: left;\"><b>Phase I</b> (120)<wbr/><br/>Randomised, double-blind, placebo-controlled, dose-ranging\n",
            "</td>\n",
            "<td class=\"table-na\" data-sort-value=\"A0\" style=\"background: #eee; color: black; vertical-align: middle; text-align: left;\">\n",
            "</td>\n",
            "<td><a href=\"/wiki/Brisbane\" title=\"Brisbane\">Brisbane</a>\n",
            "</td>\n",
            "<td data-sort-value=\"2020-10\">Jul–Oct 2020\n",
            "</td></tr></tbody></table>\n",
            "<div class=\"reflist\" style=\"list-style-type: lower-alpha;\">\n",
            "<div class=\"mw-references-wrap\"><ol class=\"references\">\n",
            "<li id=\"cite_note-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-78\">^</a></b></span> <span class=\"reference-text\">Latest Phase with published results.</span>\n",
            "</li>\n",
            "<li id=\"cite_note-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-79\">^</a></b></span> <span class=\"reference-text\">The range from the actual start date of Phase I to the estimated primary completion date of Phase III, when available.</span>\n",
            "</li>\n",
            "<li id=\"cite_note-81\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-81\">^</a></b></span> <span class=\"reference-text\">Oxford name: <i>ChAdOx1<span class=\"nowrap\"> </span>nCoV-19</i>. Manufacturing in Brazil to be carried out by <a href=\"/wiki/Oswaldo_Cruz_Foundation\" title=\"Oswaldo Cruz Foundation\">Oswaldo Cruz Foundation</a>.<sup class=\"reference\" id=\"cite_ref-80\"><a href=\"#cite_note-80\">[77]</a></sup></span>\n",
            "</li>\n",
            "<li id=\"cite_note-Ad5-nCoV-manufacture-97\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ad5-nCoV-manufacture_97-0\">^</a></b></span> <span class=\"reference-text\">Manufacturing partnership with the <a href=\"/wiki/National_Research_Council_(Canada)\" title=\"National Research Council (Canada)\">National Research Council of Canada</a> and Canadian Center for Vaccinology, <a href=\"/wiki/Halifax,_Nova_Scotia\" title=\"Halifax, Nova Scotia\">Halifax, Nova Scotia</a><sup class=\"reference\" id=\"cite_ref-96\"><a href=\"#cite_note-96\">[92]</a></sup></span>\n",
            "</li>\n",
            "<li id=\"cite_note-105\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-105\">^</a></b></span> <span class=\"reference-text\">Four vaccines</span>\n",
            "</li>\n",
            "<li id=\"cite_note-INO-4800-phase-128\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-INO-4800-phase_128-0\">^</a></b></span> <span class=\"reference-text\">South Korean Phase I–II in parallel with Phase I in the US</span>\n",
            "</li>\n",
            "<li id=\"cite_note-Medicago-technology-154\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Medicago-technology_154-0\">^</a></b></span> <span class=\"reference-text\">Virus-like particles grown in <i><a href=\"/wiki/Nicotiana_benthamiana\" title=\"Nicotiana benthamiana\">Nicotiana benthamiana</a></i><sup class=\"reference\" id=\"cite_ref-np-medicago_153-0\"><a href=\"#cite_note-np-medicago-153\">[146]</a></sup></span>\n",
            "</li>\n",
            "</ol></div></div>\n",
            "<h3><span class=\"mw-headline\" id=\"Preclinical_research\">Preclinical research</span></h3>\n",
            "<p>In April 2020, the WHO issued a statement representing dozens of vaccine scientists around the world, pledging collaboration to speed development of a vaccine against COVID‑19.<sup class=\"reference\" id=\"cite_ref-who-scientists_156-0\"><a href=\"#cite_note-who-scientists-156\">[148]</a></sup> The WHO coalition is encouraging international cooperation between organizations developing vaccine candidates, national regulatory and policy agencies, financial contributors, public health associations, and governments, for eventual manufacturing of a successful vaccine in quantities sufficient to supply all affected regions, particularly low-resource countries.<sup class=\"reference\" id=\"cite_ref-thanh_23-8\"><a href=\"#cite_note-thanh-23\">[23]</a></sup>\n",
            "</p><p>Industry analysis of past vaccine development shows failure rates of 84–90%.<sup class=\"reference\" id=\"cite_ref-thanh_23-9\"><a href=\"#cite_note-thanh-23\">[23]</a></sup><sup class=\"reference\" id=\"cite_ref-bio_69-2\"><a href=\"#cite_note-bio-69\">[69]</a></sup> Because COVID‑19 is a novel virus target with properties still being discovered and requiring innovative vaccine technologies and development strategies, the risks associated with developing a successful vaccine across all steps of preclinical and clinical research are high.<sup class=\"reference\" id=\"cite_ref-thanh_23-10\"><a href=\"#cite_note-thanh-23\">[23]</a></sup>\n",
            "</p><p>To assess potential for vaccine efficacy, unprecedented computer simulations and new COVID‑19-specific animal models are being developed multinationally during 2020, but these methods remain untested by unknown characteristics of the COVID‑19 virus.<sup class=\"reference\" id=\"cite_ref-thanh_23-11\"><a href=\"#cite_note-thanh-23\">[23]</a></sup> Of the confirmed active vaccine candidates, about 70% are being developed by private companies, with the remaining projects under development by academic, government coalitions, and health organizations.<sup class=\"reference\" id=\"cite_ref-thanh2_2-16\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup>\n",
            "</p><p>Most of the vaccine developers are small firms or university research teams with little experience in successful vaccine design and limited capacity for advanced clinical trial costs and manufacturing without partnership by multinational pharmaceutical companies.<sup class=\"reference\" id=\"cite_ref-thanh2_2-17\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup><sup class=\"reference\" id=\"cite_ref-thanh_23-12\"><a href=\"#cite_note-thanh-23\">[23]</a></sup>\n",
            "</p>\n",
            "<h4><span class=\"mw-headline\" id=\"Scheduled_Phase_I_trials_in_2020\">Scheduled Phase I trials in 2020</span></h4>\n",
            "<p>Many vaccine candidates under design or preclinical development for COVID‑19 will not gain approval for human studies in 2020 due to toxicity, ineffectiveness to induce immune responses or dosing failures in laboratory animals, or because of underfunding.<sup class=\"reference\" id=\"cite_ref-gouglas_157-0\"><a href=\"#cite_note-gouglas-157\">[149]</a></sup><sup class=\"reference\" id=\"cite_ref-strovel_158-0\"><a href=\"#cite_note-strovel-158\">[150]</a></sup> The probability of success for an infectious disease vaccine candidate to pass preclinical barriers and reach Phase<span class=\"nowrap\"> </span>I of human testing is 41-57%.<sup class=\"reference\" id=\"cite_ref-gouglas_157-1\"><a href=\"#cite_note-gouglas-157\">[149]</a></sup>\n",
            "</p><p>Commitment to first-in-human testing of a vaccine candidate represents a substantial capital cost for vaccine developers, estimated to be from <span style=\"white-space: nowrap\">US$14</span><span class=\"nowrap\"> </span>million to <span style=\"white-space: nowrap\">US$25</span><span class=\"nowrap\"> </span>million for a typical Phase<span class=\"nowrap\"> </span>I trial program, but possibly as much as <span style=\"white-space: nowrap\">US$70</span><span class=\"nowrap\"> </span>million.<sup class=\"reference\" id=\"cite_ref-gouglas_157-2\"><a href=\"#cite_note-gouglas-157\">[149]</a></sup><sup class=\"reference\" id=\"cite_ref-dimasi_159-0\"><a href=\"#cite_note-dimasi-159\">[151]</a></sup> For comparison, during the <a href=\"/wiki/Western_African_Ebola_virus_epidemic\" title=\"Western African Ebola virus epidemic\">Ebola virus epidemic of 2013-16</a>, there were 37 vaccine candidates in urgent development, but only one eventually succeeded as a licensed vaccine, involving a total cost to confirm efficacy in Phase<span class=\"nowrap\"> </span>II–III trials of about <span style=\"white-space: nowrap\">US$1</span><span class=\"nowrap\"> </span>billion.<sup class=\"reference\" id=\"cite_ref-gouglas_157-3\"><a href=\"#cite_note-gouglas-157\">[149]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Non-specific_vaccines\">Non-specific vaccines</span></h3>\n",
            "<p>Some vaccines have <a href=\"/wiki/Non-specific_effect_of_vaccines\" title=\"Non-specific effect of vaccines\">non-specific</a> effects beyond the disease they prevent.<sup class=\"reference\" id=\"cite_ref-Kleinnijenhuis_2015_160-0\"><a href=\"#cite_note-Kleinnijenhuis_2015-160\">[152]</a></sup>\n",
            "</p><p>Assertions have been made that COVID‑19 mortality has been lower in countries having routine <a href=\"/wiki/BCG_vaccine\" title=\"BCG vaccine\">BCG vaccine</a> administered against tuberculosis,<sup class=\"reference\" id=\"cite_ref-deVrieze-April_161-0\"><a href=\"#cite_note-deVrieze-April-161\">[153]</a></sup><sup class=\"reference\" id=\"cite_ref-162\"><a href=\"#cite_note-162\">[154]</a></sup><sup class=\"reference\" id=\"cite_ref-163\"><a href=\"#cite_note-163\">[155]</a></sup><sup class=\"reference\" id=\"cite_ref-164\"><a href=\"#cite_note-164\">[156]</a></sup> though the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> (WHO) has said there is no evidence that this vaccine is effective against the COVID‑19 virus.<sup class=\"reference\" id=\"cite_ref-165\"><a href=\"#cite_note-165\">[157]</a></sup> In March 2020, a randomized trial of BCG vaccine to reduce COVID‑19 illness began in the Netherlands, seeking to recruit 1,000 healthcare workers.<sup class=\"reference\" id=\"cite_ref-EudraCT-2020-000919-69_166-0\"><a href=\"#cite_note-EudraCT-2020-000919-69-166\">[158]</a></sup> A further randomized trial in Australia is seeking to enroll 4,170 healthcare workers.<sup class=\"reference\" id=\"cite_ref-MCRI-BCG-trial_167-0\"><a href=\"#cite_note-MCRI-BCG-trial-167\">[159]</a></sup><sup class=\"reference\" id=\"cite_ref-NCT04327206_168-0\"><a href=\"#cite_note-NCT04327206-168\">[160]</a></sup>\n",
            "</p><p>In June 2020, a randomized placebo-controlled trial to test whether the <a href=\"/wiki/MMR_vaccine\" title=\"MMR vaccine\">measles-mumps-rubella vaccine</a> (MMR) can protect healthcare workers from COVID‑19 began with 200 participants in Cairo.<sup class=\"reference\" id=\"cite_ref-NCT04357028_169-0\"><a href=\"#cite_note-NCT04357028-169\">[161]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Use_of_adjuvants\">Use of adjuvants</span></h3>\n",
            "<p>In September 2020, eleven of the vaccine candidates in clinical development used adjuvants to enhance immunogenicity.<sup class=\"reference\" id=\"cite_ref-thanh2_2-18\"><a href=\"#cite_note-thanh2-2\">[2]</a></sup> An <a class=\"mw-redirect\" href=\"/wiki/Immunological_adjuvant\" title=\"Immunological adjuvant\">immunological adjuvant</a> is a substance formulated with a vaccine to elevate the immune response to an <a href=\"/wiki/Antigen\" title=\"Antigen\">antigen</a>, such as the COVID-19 virus or influenza virus.<sup class=\"reference\" id=\"cite_ref-tregoning_170-0\"><a href=\"#cite_note-tregoning-170\">[162]</a></sup> Specifically, an adjuvant may be used in formulating a COVID-19 vaccine candidate to boost its immunogenicity and efficacy to reduce or prevent COVID-19 infection in vaccinated individuals.<sup class=\"reference\" id=\"cite_ref-tregoning_170-1\"><a href=\"#cite_note-tregoning-170\">[162]</a></sup><sup class=\"reference\" id=\"cite_ref-wang_171-0\"><a href=\"#cite_note-wang-171\">[163]</a></sup> Adjuvants used in COVID-19 vaccine formulation may be particularly effective for technologies using the inactivated COVID-19 virus and recombinant protein-based or vector-based vaccines.<sup class=\"reference\" id=\"cite_ref-wang_171-1\"><a href=\"#cite_note-wang-171\">[163]</a></sup> <a href=\"/wiki/Aluminium\" title=\"Aluminium\">Aluminum salts</a>, known as \"alum\", were the first adjuvant used for licensed vaccines, and are the adjuvant of choice in some 80% of adjuvanted vaccines.<sup class=\"reference\" id=\"cite_ref-wang_171-2\"><a href=\"#cite_note-wang-171\">[163]</a></sup> The alum adjuvant initiates diverse molecular and cellular mechanisms to enhance immunogenicity, including release of proinflammatory cytokines.<sup class=\"reference\" id=\"cite_ref-tregoning_170-2\"><a href=\"#cite_note-tregoning-170\">[162]</a></sup><sup class=\"reference\" id=\"cite_ref-wang_171-3\"><a href=\"#cite_note-wang-171\">[163]</a></sup> A potential drawback of adjuvanted vaccines is that the virus evolves in a way to avoid the induced vaccine response, making the adjuvant-vaccine technology misdesigned against a changed virus.<sup class=\"reference\" id=\"cite_ref-tregoning_170-3\"><a href=\"#cite_note-tregoning-170\">[162]</a></sup> Such a change would require revised manufacturing and increased costs that discourage the routine use of adjuvants.<sup class=\"reference\" id=\"cite_ref-tregoning_170-4\"><a href=\"#cite_note-tregoning-170\">[162]</a></sup><sup class=\"reference\" id=\"cite_ref-wang_171-4\"><a href=\"#cite_note-wang-171\">[163]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Potential_limitations\">Potential limitations</span></h2>\n",
            "<p>The rapid development and urgency of producing a vaccine for the COVID‑19 pandemic may increase the risks and failure rate of delivering a safe, effective vaccine.<sup class=\"reference\" id=\"cite_ref-diamond_1-3\"><a href=\"#cite_note-diamond-1\">[1]</a></sup><sup class=\"reference\" id=\"cite_ref-thanh_23-13\"><a href=\"#cite_note-thanh-23\">[23]</a></sup><sup class=\"reference\" id=\"cite_ref-Thorp_172-0\"><a href=\"#cite_note-Thorp-172\">[164]</a></sup> One study found that between 2006 and 2015, the success rate of obtaining approval from Phase<span class=\"nowrap\"> </span>I to successful Phase<span class=\"nowrap\"> </span>III trials was 16.2% for vaccines,<sup class=\"reference\" id=\"cite_ref-bio_69-3\"><a href=\"#cite_note-bio-69\">[69]</a></sup> and CEPI indicates a potential success rate of only 10% for vaccine candidates in 2020 development.<sup class=\"reference\" id=\"cite_ref-thanh_23-14\"><a href=\"#cite_note-thanh-23\">[23]</a></sup>\n",
            "</p><p>An April 2020 CEPI report stated: \"Strong international coordination and cooperation between vaccine developers, regulators, policymakers, funders, public health bodies and governments will be needed to ensure that promising late-stage vaccine candidates can be manufactured in sufficient quantities and equitably supplied to all affected areas, particularly low-resource regions.\"<sup class=\"reference\" id=\"cite_ref-thanh_23-15\"><a href=\"#cite_note-thanh-23\">[23]</a></sup> However, some 10% of the public perceives vaccines as unsafe or unnecessary, refusing vaccination – a global health threat called <a href=\"/wiki/Vaccine_hesitancy\" title=\"Vaccine hesitancy\">vaccine hesitancy</a><sup class=\"reference\" id=\"cite_ref-who-threat_173-0\"><a href=\"#cite_note-who-threat-173\">[165]</a></sup> – which increases the risk of further <a href=\"/wiki/Viral_shedding\" title=\"Viral shedding\">viral spread</a> that could lead to COVID‑19 outbreaks.<sup class=\"reference\" id=\"cite_ref-dube_174-0\"><a href=\"#cite_note-dube-174\">[166]</a></sup> In mid-2020, estimates from two surveys were that 67% or 80% of people in the U.S. would accept a new vaccination against COVID-19, with wide disparity by education level, employment status, race, and geography.<sup class=\"reference\" id=\"cite_ref-malik_175-0\"><a href=\"#cite_note-malik-175\">[167]</a></sup><sup class=\"reference\" id=\"cite_ref-176\"><a href=\"#cite_note-176\">[168]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Biosafety_concern\">Biosafety concern</span></h3>\n",
            "<p>Early research to assess vaccine efficacy using COVID‑19-specific animal models, such as <a class=\"mw-redirect\" href=\"/wiki/ACE2\" title=\"ACE2\">ACE2</a>-<a class=\"mw-redirect\" href=\"/wiki/Transgenic\" title=\"Transgenic\">transgenic</a> mice, other laboratory animals, and non-human primates, indicates a need for <a href=\"/wiki/Biosafety\" title=\"Biosafety\">biosafety</a>-level<span class=\"nowrap\"> </span>3 containment measures for handling live viruses, and international coordination to ensure standardized safety procedures.<sup class=\"reference\" id=\"cite_ref-diamond_1-4\"><a href=\"#cite_note-diamond-1\">[1]</a></sup><sup class=\"reference\" id=\"cite_ref-thanh_23-16\"><a href=\"#cite_note-thanh-23\">[23]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Antibody-dependent_enhancement\">Antibody-dependent enhancement</span></h3>\n",
            "<div class=\"hatnote navigation-not-searchable\" role=\"note\">Main article: <a href=\"/wiki/Antibody-dependent_enhancement\" title=\"Antibody-dependent enhancement\">Antibody-dependent enhancement</a></div>\n",
            "<p>Although the quality and quantity of <a href=\"/wiki/Antibody\" title=\"Antibody\">antibody</a> production by a potential vaccine is intended to neutralize the COVID‑19 infection, a vaccine may have an unintended opposite effect by causing <a href=\"/wiki/Antibody-dependent_enhancement\" title=\"Antibody-dependent enhancement\">antibody-dependent disease enhancement</a> (ADE), which increases the virus attachment to its target cells and might trigger the <a href=\"/wiki/Cytokine_storm\" title=\"Cytokine storm\">cytokine storm</a> when the person will be infected by the virus after vaccination.<sup class=\"reference\" id=\"cite_ref-diamond_1-5\"><a href=\"#cite_note-diamond-1\">[1]</a></sup><sup class=\"reference\" id=\"cite_ref-iwasaki_177-0\"><a href=\"#cite_note-iwasaki-177\">[169]</a></sup> The vaccine technology platform (for example, <a href=\"/wiki/Viral_vector\" title=\"Viral vector\">viral vector</a> vaccine, <a class=\"mw-redirect\" href=\"/wiki/Severe_acute_respiratory_syndrome-related_coronavirus#Morphology\" title=\"Severe acute respiratory syndrome-related coronavirus\">spike (S) protein</a> vaccine or <a href=\"/wiki/Protein_subunit\" title=\"Protein subunit\">protein subunit</a> vaccine), vaccine dose, timing of repeat vaccinations for the possible recurrence of COVID‑19 infection, and elderly age are factors determining the risk and extent of ADE.<sup class=\"reference\" id=\"cite_ref-diamond_1-6\"><a href=\"#cite_note-diamond-1\">[1]</a></sup><sup class=\"reference\" id=\"cite_ref-iwasaki_177-1\"><a href=\"#cite_note-iwasaki-177\">[169]</a></sup> The antibody response to a vaccine is a variable of vaccine technologies in development, including whether the vaccine has precision in its mechanism,<sup class=\"reference\" id=\"cite_ref-diamond_1-7\"><a href=\"#cite_note-diamond-1\">[1]</a></sup> and choice of the route for how it is given (<a href=\"/wiki/Intramuscular_injection\" title=\"Intramuscular injection\">intramuscular</a>, <a href=\"/wiki/Intradermal_injection\" title=\"Intradermal injection\">intradermal</a>, oral, or nasal).<sup class=\"reference\" id=\"cite_ref-iwasaki_177-2\"><a href=\"#cite_note-iwasaki-177\">[169]</a></sup><sup class=\"reference\" id=\"cite_ref-wied_178-0\"><a href=\"#cite_note-wied-178\">[170]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Efficacy\">Efficacy</span></h3>\n",
            "<p>The effectiveness of new vaccine is defined by <a href=\"/wiki/Vaccine_efficacy\" title=\"Vaccine efficacy\">its efficacy</a>. The efficacy of less than 60% may result in failure to create <a href=\"/wiki/Herd_immunity\" title=\"Herd immunity\">herd immunity</a>.<sup class=\"reference\" id=\"cite_ref-gates2_6-10\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-wied_178-1\"><a href=\"#cite_note-wied-178\">[170]</a></sup> Host-(\"vaccinee\")-related determinants that render a person susceptible to infection, such as <a href=\"/wiki/Genetics\" title=\"Genetics\">genetics</a>, health status (underlying disease, nutrition, pregnancy, <a href=\"/wiki/Hypersensitivity\" title=\"Hypersensitivity\">sensitivities</a> or <a href=\"/wiki/Allergy\" title=\"Allergy\">allergies</a>), <a href=\"/wiki/Immunocompetence\" title=\"Immunocompetence\">immune competence</a>, age, and <a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic\" title=\"Economic impact of the COVID-19 pandemic\">economic impact</a> or <a href=\"/wiki/Synthetic_psychological_environment\" title=\"Synthetic psychological environment\">cultural environment</a> can be primary or secondary factors affecting the severity of infection and response to a vaccine.<sup class=\"reference\" id=\"cite_ref-wied_178-2\"><a href=\"#cite_note-wied-178\">[170]</a></sup> Elderly (above age 60), <a href=\"/wiki/Type_I_hypersensitivity\" title=\"Type I hypersensitivity\">allergen-hypersensitive</a>, and <a href=\"/wiki/Obesity\" title=\"Obesity\">obese</a> people have susceptibility to compromised <a href=\"/wiki/Immunogenicity\" title=\"Immunogenicity\">immunogenicity</a>, which prevents or inhibits vaccine effectiveness, possibly requiring separate vaccine technologies for these specific populations or repetitive <a href=\"/wiki/Booster_dose\" title=\"Booster dose\">booster vaccinations</a> to limit <a href=\"/wiki/Transmission_(medicine)\" title=\"Transmission (medicine)\">virus transmission</a>.<sup class=\"reference\" id=\"cite_ref-wied_178-3\"><a href=\"#cite_note-wied-178\">[170]</a></sup> Further, <a href=\"/wiki/Mutation\" title=\"Mutation\">mutations</a> of the virus can alter its structure targeted by the vaccine, thus making the vaccine ineffective.<sup class=\"reference\" id=\"cite_ref-zumla_179-0\"><a href=\"#cite_note-zumla-179\">[171]</a></sup><sup class=\"reference\" id=\"cite_ref-garcia_180-0\"><a href=\"#cite_note-garcia-180\">[172]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Enrollment_of_participants_in_trials\">Enrollment of participants in trials</span></h3>\n",
            "<p>Vaccine developers have to invest resources internationally to find enough participants for Phase<span class=\"nowrap\"> </span>II–III clinical trials when the virus has proved to be a \"<a href=\"/wiki/Moving_target_indication\" title=\"Moving target indication\">moving target</a>\" of changing transmission rate across and within countries, forcing companies to compete for trial participants.<sup class=\"reference\" id=\"cite_ref-cohen6-19_75-1\"><a href=\"#cite_note-cohen6-19-75\">[74]</a></sup> As an example in June, the Chinese vaccine developer Sinovac formed alliances in <a href=\"/wiki/Malaysia\" title=\"Malaysia\">Malaysia</a>, Canada, the UK, and Brazil among its plans to recruit trial participants and manufacture enough vaccine doses for a possible Phase<span class=\"nowrap\"> </span>III study in Brazil where COVID‑19 transmission was accelerating during June.<sup class=\"reference\" id=\"cite_ref-cohen6-19_75-2\"><a href=\"#cite_note-cohen6-19-75\">[74]</a></sup> As the COVID‑19 pandemic within China became more isolated and controlled, Chinese vaccine developers sought international relationships to conduct advanced human studies in several countries, creating competition for trial participants with other manufacturers and the international Solidarity trial organized by the WHO.<sup class=\"reference\" id=\"cite_ref-cohen6-19_75-3\"><a href=\"#cite_note-cohen6-19-75\">[74]</a></sup> In addition to competition over recruiting participants, clinical trial organizers may encounter  people unwilling to be vaccinated due to <a href=\"/wiki/Vaccine_hesitancy\" title=\"Vaccine hesitancy\">vaccine hesitancy</a><sup class=\"reference\" id=\"cite_ref-dube_174-1\"><a href=\"#cite_note-dube-174\">[166]</a></sup> or disbelieving the science of the vaccine technology and its ability to prevent infection.<sup class=\"reference\" id=\"cite_ref-howard-cnn_181-0\"><a href=\"#cite_note-howard-cnn-181\">[173]</a></sup>\n",
            "</p><p>Having an insufficient number of skilled team members to administer vaccinations may hinder clinical trials that must overcome risks for trial failure, such as recruiting participants in rural or low-density geographic regions, and variations of age, race, ethnicity, or underlying medical conditions.<sup class=\"reference\" id=\"cite_ref-cohen6-19_75-4\"><a href=\"#cite_note-cohen6-19-75\">[74]</a></sup><sup class=\"reference\" id=\"cite_ref-winter_182-0\"><a href=\"#cite_note-winter-182\">[174]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Cost\">Cost</span></h3>\n",
            "<p>An effective vaccine for COVID-19 could save <a href=\"/wiki/Trillion\" title=\"Trillion\">trillions</a> of dollars in global economic impact, according to one expert, and would, therefore, make any price tag in the billions look small in comparison.<sup class=\"reference\" id=\"cite_ref-gates3_183-0\"><a href=\"#cite_note-gates3-183\">[175]</a></sup> It is not yet known if it is possible to create a safe, reliable and affordable vaccine for this virus, and it is not yet known exactly how much the vaccine development will cost.<sup class=\"reference\" id=\"cite_ref-gates2_6-11\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-gates1_24-3\"><a href=\"#cite_note-gates1-24\">[24]</a></sup><sup class=\"reference\" id=\"cite_ref-sanger_35-7\"><a href=\"#cite_note-sanger-35\">[35]</a></sup> It is possible that billions of dollars could be invested without success.<sup class=\"reference\" id=\"cite_ref-reuters_34-12\"><a href=\"#cite_note-reuters-34\">[34]</a></sup>\n",
            "</p><p>The European Commission organized and held a video conference of world leaders on 4 May 2020, at which <span style=\"white-space: nowrap\">US$8</span><span class=\"nowrap\"> </span>billion was raised for COVID-19 vaccine development.<sup class=\"reference\" id=\"cite_ref-184\"><a href=\"#cite_note-184\">[176]</a></sup>\n",
            "</p><p>After a vaccine is created, billions of doses will need to be manufactured and distributed worldwide. In April 2020, the Gates Foundation estimated that manufacturing and distribution could cost as much as <span style=\"white-space: nowrap\">US$25</span><span class=\"nowrap\"> </span>billion.<sup class=\"reference\" id=\"cite_ref-185\"><a href=\"#cite_note-185\">[177]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Rollout\">Rollout</span></h3>\n",
            "<p>Different vaccines have different shipping and handling requirements. For example, the Pfizer/BioNTech vaccine BNT162 must be shipped and stored at −70 °C (−94 °F), must be used within five days of thawing, and has a minimum order of 975 doses, making it unlikely to be rolled out in settings other than large, well-equipped hospitals.<sup class=\"reference\" id=\"cite_ref-186\"><a href=\"#cite_note-186\">[178]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Proposed_challenge_studies\">Proposed challenge studies</span></h2>\n",
            "<div class=\"hatnote navigation-not-searchable\" role=\"note\">Main article: <a href=\"/wiki/Human_challenge_study\" title=\"Human challenge study\">Human challenge study</a></div>\n",
            "<p>Strategies are being considered for fast-tracking the licensing of a vaccine against COVID‑19, especially by compressing (to a few months) the usually lengthy duration of Phase<span class=\"nowrap\"> </span>II–III trials (typically many years).<sup class=\"reference\" id=\"cite_ref-eyal_187-0\"><a href=\"#cite_note-eyal-187\">[179]</a></sup><sup class=\"reference\" id=\"cite_ref-callaway_188-0\"><a href=\"#cite_note-callaway-188\">[180]</a></sup><sup class=\"reference\" id=\"cite_ref-boodman_189-0\"><a href=\"#cite_note-boodman-189\">[181]</a></sup> <a href=\"/wiki/Human_challenge_study\" title=\"Human challenge study\">Challenge studies</a> have been implemented previously for diseases less deadly than COVID‑19 infection, such as common influenza, <a href=\"/wiki/Typhoid_fever\" title=\"Typhoid fever\">typhoid fever</a>, <a href=\"/wiki/Cholera\" title=\"Cholera\">cholera</a>, and <a href=\"/wiki/Malaria\" title=\"Malaria\">malaria</a>.<sup class=\"reference\" id=\"cite_ref-callaway_188-1\"><a href=\"#cite_note-callaway-188\">[180]</a></sup><sup class=\"reference\" id=\"cite_ref-cohen_190-0\"><a href=\"#cite_note-cohen-190\">[182]</a></sup> Following preliminary proof of safety and efficacy of a candidate vaccine in laboratory animals and healthy humans, controlled challenge studies might be implemented to bypass typical Phase<span class=\"nowrap\"> </span>III research, providing an accelerated path to license a COVID‑19 vaccine.<sup class=\"reference\" id=\"cite_ref-eyal_187-1\"><a href=\"#cite_note-eyal-187\">[179]</a></sup><sup class=\"reference\" id=\"cite_ref-cohen_190-1\"><a href=\"#cite_note-cohen-190\">[182]</a></sup><sup class=\"reference\" id=\"cite_ref-callaway_188-2\"><a href=\"#cite_note-callaway-188\">[180]</a></sup>\n",
            "</p><p>A challenge study begins by simultaneously testing a vaccine candidate for immunogenicity and safety in laboratory animals and healthy adult volunteers (100 or fewer), something normally a sequential process using animals first.<sup class=\"reference\" id=\"cite_ref-eyal_187-2\"><a href=\"#cite_note-eyal-187\">[179]</a></sup><sup class=\"reference\" id=\"cite_ref-callaway_188-3\"><a href=\"#cite_note-callaway-188\">[180]</a></sup> If the initial tests are promising, the study proceeds by rapidly advancing the effective dose into a large-scale Phase<span class=\"nowrap\"> </span>II–III trial in previously-uninfected, low-risk volunteers (such as young adults), who would then be deliberately infected with COVID‑19 for comparison with a <a href=\"/wiki/Placebo\" title=\"Placebo\">placebo</a> control group.<sup class=\"reference\" id=\"cite_ref-eyal_187-3\"><a href=\"#cite_note-eyal-187\">[179]</a></sup><sup class=\"reference\" id=\"cite_ref-callaway_188-4\"><a href=\"#cite_note-callaway-188\">[180]</a></sup><sup class=\"reference\" id=\"cite_ref-cohen_190-2\"><a href=\"#cite_note-cohen-190\">[182]</a></sup> Following the challenge, the volunteers would be monitored closely in clinics with life-saving resources, if needed.<sup class=\"reference\" id=\"cite_ref-eyal_187-4\"><a href=\"#cite_note-eyal-187\">[179]</a></sup><sup class=\"reference\" id=\"cite_ref-callaway_188-5\"><a href=\"#cite_note-callaway-188\">[180]</a></sup> Volunteering for a vaccine challenge study during the COVID‑19 pandemic is likened to the emergency service of <a class=\"mw-redirect\" href=\"/wiki/Healthcare\" title=\"Healthcare\">healthcare</a> personnel for COVID‑19-infected people, <a href=\"/wiki/Firefighter\" title=\"Firefighter\">firefighters</a>, or <a href=\"/wiki/Organ_donation\" title=\"Organ donation\">organ donors</a>.<sup class=\"reference\" id=\"cite_ref-eyal_187-5\"><a href=\"#cite_note-eyal-187\">[179]</a></sup>\n",
            "</p><p>Although challenge studies are <a href=\"/wiki/Medical_ethics\" title=\"Medical ethics\">ethically questionable</a> due to the unknown hazards for the volunteers of possible COVID‑19 <a class=\"mw-redirect\" href=\"/wiki/Disease_enhancement\" title=\"Disease enhancement\">disease enhancement</a> and whether the vaccine received has long-term safety (among other cautions), challenge studies may be the only option to rapidly produce an effective vaccine that will minimize the projected millions of deaths worldwide from COVID‑19 infection,<sup class=\"reference\" id=\"cite_ref-eyal_187-6\"><a href=\"#cite_note-eyal-187\">[179]</a></sup><sup class=\"reference\" id=\"cite_ref-191\"><a href=\"#cite_note-191\">[183]</a></sup> according to some infectious disease experts.<sup class=\"reference\" id=\"cite_ref-eyal_187-7\"><a href=\"#cite_note-eyal-187\">[179]</a></sup><sup class=\"reference\" id=\"cite_ref-callaway_188-6\"><a href=\"#cite_note-callaway-188\">[180]</a></sup><sup class=\"reference\" id=\"cite_ref-cohen_190-3\"><a href=\"#cite_note-cohen-190\">[182]</a></sup> The World Health Organization has developed a guidance document with criteria for conducting COVID‑19 challenge studies in healthy people, including scientific and ethical evaluation, public consultation and coordination, selection and <a href=\"/wiki/Informed_consent\" title=\"Informed consent\">informed consent</a> of the participants, and monitoring by independent experts.<sup class=\"reference\" id=\"cite_ref-who-challenge_192-0\"><a href=\"#cite_note-who-challenge-192\">[184]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Licensure\">Licensure</span></h2>\n",
            "<p>A <i>vaccine licensure</i> occurs after the successful conclusion of the clinical trials program through Phases I–III demonstrating safety, immunogenicity at a specific dose, effectiveness at preventing infection in target populations, and enduring preventive effect.<sup class=\"reference\" id=\"cite_ref-who-vacc_193-0\"><a href=\"#cite_note-who-vacc-193\">[185]</a></sup> As part of a multinational licensure for a vaccine, the World Health Organization <i>Expert Committee on Biological Standardization</i> developed guidelines of international standards for manufacturing and <a href=\"/wiki/Quality_control\" title=\"Quality control\">quality control</a> of vaccines, a process intended as a platform for national regulatory agencies to apply for their own licensure process.<sup class=\"reference\" id=\"cite_ref-who-vacc_193-1\"><a href=\"#cite_note-who-vacc-193\">[185]</a></sup> Vaccine manufacturers do not receive licensure until a complete clinical package proves the vaccine is safe and has long-term effectiveness, following scientific review by a multinational or national regulatory organization, such as the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA) or the US <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA).<sup class=\"reference\" id=\"cite_ref-wijnans_194-0\"><a href=\"#cite_note-wijnans-194\">[186]</a></sup><sup class=\"reference\" id=\"cite_ref-chop_195-0\"><a href=\"#cite_note-chop-195\">[187]</a></sup>\n",
            "</p><p>Upon <a href=\"/wiki/Developing_country\" title=\"Developing country\">developing countries</a> adopting WHO guidelines for vaccine development and licensure, each country has its own responsibility to issue a national licensure, and to manage, deploy, and monitor the vaccine throughout its use in each nation.<sup class=\"reference\" id=\"cite_ref-who-vacc_193-2\"><a href=\"#cite_note-who-vacc-193\">[185]</a></sup> Building trust and acceptance of a licensed vaccine among the public is a task of communication by governments and healthcare personnel to ensure a vaccination campaign proceeds smoothly, saves lives, and enables economic recovery.<sup class=\"reference\" id=\"cite_ref-toner_196-0\"><a href=\"#cite_note-toner-196\">[188]</a></sup> When a vaccine is licensed, it will initially be in limited supply due to variable manufacturing, distribution, and logistical factors, requiring an allocation plan for the limited supply and which population segments should be prioritized to first receive the vaccine.<sup class=\"reference\" id=\"cite_ref-toner_196-1\"><a href=\"#cite_note-toner-196\">[188]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"World_Health_Organization\">World Health Organization</span></h3>\n",
            "<p>Vaccines developed for multinational distribution via the <a href=\"/wiki/UNICEF\" title=\"UNICEF\">United Nations Children's Fund (UNICEF)</a> require pre-qualification by\n",
            "WHO to ensure <a href=\"/wiki/International_standard\" title=\"International standard\">international standards</a> of quality, safety, immunogenicity, and efficacy for adoption by numerous countries.<sup class=\"reference\" id=\"cite_ref-who-vacc_193-3\"><a href=\"#cite_note-who-vacc-193\">[185]</a></sup>\n",
            "</p><p>The process requires manufacturing consistency at WHO-contracted laboratories following <a class=\"mw-redirect\" href=\"/wiki/Good_Manufacturing_Practice\" title=\"Good Manufacturing Practice\">GMP practices</a>.<sup class=\"reference\" id=\"cite_ref-who-vacc_193-4\"><a href=\"#cite_note-who-vacc-193\">[185]</a></sup> When UN agencies are involved in vaccine licensure, individual nations collaborate by 1) issuing marketing authorization and a national license for the vaccine, its manufacturers, and distribution partners; and 2) conducting <a href=\"/wiki/Postmarketing_surveillance\" title=\"Postmarketing surveillance\">postmarketing surveillance</a>, including records for adverse events after the vaccination program. WHO works with national agencies to monitor inspections of manufacturing facilities and distributors for compliance with GMP and regulatory oversight.<sup class=\"reference\" id=\"cite_ref-who-vacc_193-5\"><a href=\"#cite_note-who-vacc-193\">[185]</a></sup>\n",
            "</p><p>Some countries choose to buy vaccines licensed by reputable national organizations, such as EMA, FDA, or national agencies in other\n",
            "affluent countries, but such purchases typically are more expensive and may not have distribution resources suitable to local conditions in developing countries.<sup class=\"reference\" id=\"cite_ref-who-vacc_193-6\"><a href=\"#cite_note-who-vacc-193\">[185]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Europe\">Europe</span></h3>\n",
            "<p>In the <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a> (EU), vaccines for pandemic pathogens, such as <a class=\"mw-redirect\" href=\"/wiki/Seasonal_influenza\" title=\"Seasonal influenza\">seasonal influenza</a>, are licensed EU-wide where all of the <a href=\"/wiki/Member_state_of_the_European_Union\" title=\"Member state of the European Union\">member states</a> comply (\"centralized\"), are licensed for only some member states (\"decentralized\"), or are licensed on an individual national level.<sup class=\"reference\" id=\"cite_ref-wijnans_194-1\"><a href=\"#cite_note-wijnans-194\">[186]</a></sup> Generally, all EU states follow regulatory guidance and clinical programs defined by the European <a href=\"/wiki/Committee_for_Medicinal_Products_for_Human_Use\" title=\"Committee for Medicinal Products for Human Use\">Committee for Medicinal Products for Human Use</a> (CHMP), a scientific panel of the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA) responsible for vaccine licensure.<sup class=\"reference\" id=\"cite_ref-wijnans_194-2\"><a href=\"#cite_note-wijnans-194\">[186]</a></sup> The CHMP is supported by several expert groups who assess and monitor the progress of a vaccine before and after licensure and distribution.<sup class=\"reference\" id=\"cite_ref-wijnans_194-3\"><a href=\"#cite_note-wijnans-194\">[186]</a></sup>\n",
            "</p><p>In October 2020, the CHMP started 'rolling reviews' of the vaccines known as <i>COVID-19 Vaccine AstraZeneca</i> and <i>BNT162b2</i>.<sup class=\"reference\" id=\"cite_ref-197\"><a href=\"#cite_note-197\">[189]</a></sup><sup class=\"reference\" id=\"cite_ref-198\"><a href=\"#cite_note-198\">[190]</a></sup><sup class=\"reference\" id=\"cite_ref-199\"><a href=\"#cite_note-199\">[191]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"United_States\">United States</span></h3>\n",
            "<p>Under the FDA, the process of establishing evidence for vaccine clinical safety and efficacy is the same as for <a class=\"mw-redirect\" href=\"/wiki/Drug_approval\" title=\"Drug approval\">the approval process for prescription drugs</a>.<sup class=\"reference\" id=\"cite_ref-fda-vacc_200-0\"><a href=\"#cite_note-fda-vacc-200\">[192]</a></sup> If successful through the stages of clinical development, the vaccine licensing process is followed by a <a class=\"mw-redirect\" href=\"/wiki/Biologics_License_Application\" title=\"Biologics License Application\">Biologics License Application</a> which must provide a scientific review team (from diverse disciplines, such as physicians, statisticians, microbiologists, chemists) a comprehensive documentation for the vaccine candidate having efficacy and safety throughout its development. Also during this stage, the proposed manufacturing facility is examined by expert reviewers for GMP compliance, and the label must have compliant description to enable health care providers definition of vaccine specific use, including its possible risks, to communicate and deliver the vaccine to the public.<sup class=\"reference\" id=\"cite_ref-fda-vacc_200-1\"><a href=\"#cite_note-fda-vacc-200\">[192]</a></sup>\n",
            "</p><p>As of August 2020 in the United States, there is no national strategy for how a successful vaccine will be ethically prioritized or distributed to vulnerable population segments, such as <a href=\"/wiki/Homelessness_in_the_United_States\" title=\"Homelessness in the United States\">homeless</a> and <a href=\"/wiki/Incarceration_in_the_United_States\" title=\"Incarceration in the United States\">incarcerated people</a> and the elderly.<sup class=\"reference\" id=\"cite_ref-malik_175-1\"><a href=\"#cite_note-malik-175\">[167]</a></sup><sup class=\"reference\" id=\"cite_ref-toner_196-2\"><a href=\"#cite_note-toner-196\">[188]</a></sup><sup class=\"reference\" id=\"cite_ref-corey_201-0\"><a href=\"#cite_note-corey-201\">[193]</a></sup> After licensure, monitoring of the vaccine and its production, including periodic inspections for GMP compliance, continue as long as the manufacturer retains its license, which may include additional submissions to the FDA of tests for potency, safety, and purity for each vaccine manufacturing step.<sup class=\"reference\" id=\"cite_ref-fda-vacc_200-2\"><a href=\"#cite_note-fda-vacc-200\">[192]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Emergency_use_authorization\">Emergency use authorization</span></h3>\n",
            "<p>At the beginning of the COVID-19 pandemic in early 2020, the WHO issued a guideline as an Emergency Use Listing of new vaccines, a process derived from the 2013-16 <a href=\"/wiki/Western_African_Ebola_virus_epidemic\" title=\"Western African Ebola virus epidemic\">Ebola epidemic</a>.<sup class=\"reference\" id=\"cite_ref-who-eul_202-0\"><a href=\"#cite_note-who-eul-202\">[194]</a></sup> It required that a vaccine candidate developed for a life-threatening emergency be manufactured using GMP and that it complete development according to WHO prequalification procedures.<sup class=\"reference\" id=\"cite_ref-who-eul_202-1\"><a href=\"#cite_note-who-eul-202\">[194]</a></sup>\n",
            "</p><p>Even as new vaccines are developed during the COVID-19 pandemic, licensure of COVID-19 vaccine candidates requires submission of a full dossier of information on development and manufacturing quality. In the EU, companies may use a rolling review process, supplying data as they become available during Phase III trials, rather than developing the full documentation over months or years at the end of clinical research, as is typical. This rolling process allows the European CHMP to evaluate clinical data in real time, enabling a promising vaccine candidate to be approved on a rapid timeline by the EMA.<sup class=\"reference\" id=\"cite_ref-ema-eau_203-0\"><a href=\"#cite_note-ema-eau-203\">[195]</a></sup>\n",
            "</p><p>On June 24, 2020, China approved the CanSino vaccine for limited use in the military and two inactivated virus vaccines for emergency use in high-risk occupations.<sup class=\"reference\" id=\"cite_ref-204\"><a href=\"#cite_note-204\">[196]</a></sup> On August 11, 2020, Russia announced the approval of its Sputnik V vaccine for emergency use, though one month later only small amounts of the vaccine had been distributed for use outside of the phase 3 trial.<sup class=\"reference\" id=\"cite_ref-205\"><a href=\"#cite_note-205\">[197]</a></sup>\n",
            "</p><p>In the United States, the FDA may grant <a class=\"mw-redirect\" href=\"/wiki/Emergency_Use_Authorization\" title=\"Emergency Use Authorization\">Emergency Use Authorization</a> for a promising COVID-19 vaccine before full evidence is available about its safety and efficacy, but this hastened process has been criticized for its political misuse, potential for lowered standards, and increased <a href=\"/wiki/Vaccine_hesitancy\" title=\"Vaccine hesitancy\">antivaccine sentiment</a> in the US population during 2020.<sup class=\"reference\" id=\"cite_ref-malik_175-2\"><a href=\"#cite_note-malik-175\">[167]</a></sup><sup class=\"reference\" id=\"cite_ref-206\"><a href=\"#cite_note-206\">[198]</a></sup><sup class=\"reference\" id=\"cite_ref-hoffman_207-0\"><a href=\"#cite_note-hoffman-207\">[199]</a></sup> On September 8, 2020, nine leading pharma companies involved in COVID-19 vaccine research signed a letter, pledging that they would submit their vaccines for emergency use authorization only after phase 3 trials had demonstrated safety and efficacy.<sup class=\"reference\" id=\"cite_ref-208\"><a href=\"#cite_note-208\">[200]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Postmarketing_surveillance\">Postmarketing surveillance</span></h3>\n",
            "<p>Until a vaccine is in use for the general population, all potential <a href=\"/wiki/Vaccine_adverse_event\" title=\"Vaccine adverse event\">adverse events</a> from the vaccine may not be known, requiring manufacturers to conduct <a href=\"/wiki/Phases_of_clinical_research#Phase_IV\" title=\"Phases of clinical research\">Phase IV studies</a> for <a href=\"/wiki/Postmarketing_surveillance\" title=\"Postmarketing surveillance\">postmarketing surveillance</a> of the vaccine while it is used widely in the public.<sup class=\"reference\" id=\"cite_ref-who-vacc_193-7\"><a href=\"#cite_note-who-vacc-193\">[185]</a></sup><sup class=\"reference\" id=\"cite_ref-fda-vacc_200-3\"><a href=\"#cite_note-fda-vacc-200\">[192]</a></sup> The WHO works with UN member states to implement postlicensing surveillance.<sup class=\"reference\" id=\"cite_ref-who-vacc_193-8\"><a href=\"#cite_note-who-vacc-193\">[185]</a></sup> The FDA relies on a <a href=\"/wiki/Vaccine_Adverse_Event_Reporting_System\" title=\"Vaccine Adverse Event Reporting System\">Vaccine Adverse Event Reporting System</a> to monitor safety concerns about a vaccine throughout its use in the American public.<sup class=\"reference\" id=\"cite_ref-fda-vacc_200-4\"><a href=\"#cite_note-fda-vacc-200\">[192]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Commercialization_and_equitable_access\">Commercialization and equitable access</span></h2>\n",
            "<h3><span class=\"mw-headline\" id=\"Commercialization_issues\">Commercialization issues</span></h3>\n",
            "<p>By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection.<sup class=\"reference\" id=\"cite_ref-gates1_24-4\"><a href=\"#cite_note-gates1-24\">[24]</a></sup><sup class=\"reference\" id=\"cite_ref-hbr_209-0\"><a href=\"#cite_note-hbr-209\">[201]</a></sup><sup class=\"reference\" id=\"cite_ref-cbcr_210-0\"><a href=\"#cite_note-cbcr-210\">[202]</a></sup><sup class=\"reference\" id=\"cite_ref-ahmed_211-0\"><a href=\"#cite_note-ahmed-211\">[203]</a></sup> The corporate investment and need to generate value for public shareholders raised concerns about a \"market-based approach\" in vaccine development, costly pricing of eventual licensed vaccines, preferred access for distribution first to affluent countries, and sparse or no distribution to where the pandemic is most aggressive, as predicted for densely-populated, impoverished countries unable to afford vaccinations.<sup class=\"reference\" id=\"cite_ref-gates1_24-5\"><a href=\"#cite_note-gates1-24\">[24]</a></sup><sup class=\"reference\" id=\"cite_ref-sanger_35-8\"><a href=\"#cite_note-sanger-35\">[35]</a></sup><sup class=\"reference\" id=\"cite_ref-cbcr_210-1\"><a href=\"#cite_note-cbcr-210\">[202]</a></sup> The collaboration of the University of Oxford with AstraZeneca (a global pharmaceutical company based in the UK) raised concerns about price and sharing of eventual profits from international vaccine sales, arising from whether the UK government and university as public partners had commercialization rights.<sup class=\"reference\" id=\"cite_ref-ahmed_211-1\"><a href=\"#cite_note-ahmed-211\">[203]</a></sup> AstraZeneca stated that initial pricing of its vaccine would not include a <a href=\"/wiki/Profit_margin\" title=\"Profit margin\">profit margin</a> for the company while the pandemic was still expanding.<sup class=\"reference\" id=\"cite_ref-ahmed_211-2\"><a href=\"#cite_note-ahmed-211\">[203]</a></sup>\n",
            "</p><p>In early June, AstraZeneca made a USD$750 millon deal allowing CEPI and GAVI to manufacture and distribute 300 million doses if its Oxford vaccine candidate proves safe and effective, reportedly increasing the company's total production capacity to over 2 billion doses per year.<sup class=\"reference\" id=\"cite_ref-kyle_212-0\"><a href=\"#cite_note-kyle-212\">[204]</a></sup> Commercialization of pandemic vaccines is a high-risk business venture, potentially losing billions of dollars in development and pre-market manufacturing costs if the candidate vaccines fail to be safe and effective.<sup class=\"reference\" id=\"cite_ref-gates1_24-6\"><a href=\"#cite_note-gates1-24\">[24]</a></sup><sup class=\"reference\" id=\"cite_ref-reuters_34-13\"><a href=\"#cite_note-reuters-34\">[34]</a></sup><sup class=\"reference\" id=\"cite_ref-sanger_35-9\"><a href=\"#cite_note-sanger-35\">[35]</a></sup><sup class=\"reference\" id=\"cite_ref-hbr_209-1\"><a href=\"#cite_note-hbr-209\">[201]</a></sup> The multinational pharmaceutical company Pfizer indicated it was not interested in a government partnership, which would be a \"third party\" slowing progress in Pfizer's vaccine program.<sup class=\"reference\" id=\"cite_ref-cohen6-4_213-0\"><a href=\"#cite_note-cohen6-4-213\">[205]</a></sup> Further, there are concerns that rapid-development programs – like the Operation Warp Speed plan of the United States – are choosing vaccine candidates mainly for their manufacturing advantages to shorten the development timeline, rather than for the most promising vaccine technology having safety and efficacy.<sup class=\"reference\" id=\"cite_ref-cohen6-4_213-1\"><a href=\"#cite_note-cohen6-4-213\">[205]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Sovereignty\">Sovereignty</span></h3>\n",
            "<p>Favored distribution of vaccines within one or a few select countries, called \"vaccine sovereignty\", is a criticism of some of the vaccine development partnerships,<sup class=\"reference\" id=\"cite_ref-cbcr_210-2\"><a href=\"#cite_note-cbcr-210\">[202]</a></sup><sup class=\"reference\" id=\"cite_ref-bolly_214-0\"><a href=\"#cite_note-bolly-214\">[206]</a></sup> such as for the AstraZeneca-University of Oxford vaccine candidate, concerning whether there may be prioritized distribution first within the UK and to the \"highest bidder\" – the United States, which made an <a href=\"/wiki/Advance_payment\" title=\"Advance payment\">advance payment</a> of <span style=\"white-space: nowrap\">US$1.2</span><span class=\"nowrap\"> </span>billion to secure 300<span class=\"nowrap\"> </span>million vaccine doses for Americans, even before the AstraZeneca-Oxford vaccine or a <a href=\"/wiki/Sanofi\" title=\"Sanofi\">Sanofi</a> vaccine is proved safe or effective.<sup class=\"reference\" id=\"cite_ref-ahmed_211-3\"><a href=\"#cite_note-ahmed-211\">[203]</a></sup><sup class=\"reference\" id=\"cite_ref-215\"><a href=\"#cite_note-215\">[207]</a></sup><sup class=\"reference\" id=\"cite_ref-paton_216-0\"><a href=\"#cite_note-paton-216\">[208]</a></sup> Concerns exist about whether some countries producing vaccines may impose <a href=\"/wiki/Protectionism\" title=\"Protectionism\">protectionist controls</a> by export restrictions that would <a href=\"/wiki/Stockpile\" title=\"Stockpile\">stockpile</a> a COVID‑19 vaccine for their own population.<sup class=\"reference\" id=\"cite_ref-bolly_214-1\"><a href=\"#cite_note-bolly-214\">[206]</a></sup>\n",
            "</p><p>In June, the <a href=\"/wiki/Serum_Institute_of_India\" title=\"Serum Institute of India\">Serum Institute of India</a> (SII) – a major manufacturer of global vaccines – reached a licensing agreement with AstraZeneca to make <span class=\"nowrap\">1 billion doses</span> of vaccine for low-and-middle income countries;<sup class=\"reference\" id=\"cite_ref-kyle_212-1\"><a href=\"#cite_note-kyle-212\">[204]</a></sup> of which half of the doses would go to India.<sup class=\"reference\" id=\"cite_ref-unequal_217-0\"><a href=\"#cite_note-unequal-217\">[209]</a></sup> Similar preferential homeland distribution may exist if a vaccine is manufactured in Australia.<sup class=\"reference\" id=\"cite_ref-khamsi_218-0\"><a href=\"#cite_note-khamsi-218\">[210]</a></sup> The Chinese government pledged in May that a successful Chinese vaccine would become a \"global, public good,\" implying enough doses would be manufactured for both national and global distribution.<sup class=\"reference\" id=\"cite_ref-219\"><a href=\"#cite_note-219\">[211]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Equitable_access\">Equitable access</span></h3>\n",
            "<p>As many of the efforts on vaccine candidates have open-ended outcomes, including a high potential for failure during human testing, CEPI, WHO, and charitable vaccine organizations, such as the Gates Foundation and GAVI, raised over <span style=\"white-space: nowrap\">US$20</span><span class=\"nowrap\"> </span>billion during the first half of 2020 to fund vaccine development and preparedness for vaccinations, particularly for children in <a href=\"/wiki/Least_developed_countries\" title=\"Least developed countries\">under-developed countries</a>.<sup class=\"reference\" id=\"cite_ref-cepi-fund_7-1\"><a href=\"#cite_note-cepi-fund-7\">[7]</a></sup><sup class=\"reference\" id=\"cite_ref-waked_8-3\"><a href=\"#cite_note-waked-8\">[8]</a></sup><sup class=\"reference\" id=\"cite_ref-gavi-summit_40-2\"><a href=\"#cite_note-gavi-summit-40\">[40]</a></sup><sup class=\"reference\" id=\"cite_ref-hbr_209-2\"><a href=\"#cite_note-hbr-209\">[201]</a></sup> CEPI had stated that governments should ensure implementation of a globally-fair allocation system for eventual vaccines, using a coordinated system of manufacturing capacity, financing and purchasing, and indemnification from liability to offset risks taken by vaccine developers.<sup class=\"reference\" id=\"cite_ref-yamey_27-5\"><a href=\"#cite_note-yamey-27\">[27]</a></sup>\n",
            "</p><p>Having been created to monitor fair distribution of infectious disease vaccines to low- and middle-income countries,<sup class=\"reference\" id=\"cite_ref-bolly_214-2\"><a href=\"#cite_note-bolly-214\">[206]</a></sup><sup class=\"reference\" id=\"cite_ref-huney_220-0\"><a href=\"#cite_note-huney-220\">[212]</a></sup> CEPI revised its equitable access policy that was published in February to apply to its COVID-19 vaccine funding: 1) \"prices for vaccines will be set as low as possible for territories that are or may be affected by an outbreak of a disease for which CEPI funding was used to develop a vaccine;\" 2) \"information, know-how and materials related to vaccine development must be shared with (or transferred to) CEPI\" so that it can assume responsibility for vaccine development if a company discontinues expenditures for a promising vaccine candidate; 3) CEPI would have access to, and possible management of, <a href=\"/wiki/Intellectual_property\" title=\"Intellectual property\">intellectual property</a> rights (i.e., <a href=\"/wiki/Patent\" title=\"Patent\">patents</a>) for promising vaccines; 4) \"CEPI would receive a share of financial benefits that might accrue from CEPI-sponsored vaccine development, to re-invest in support of its mission to provide global public health benefit\"; and 5) data transparency among development partners should maintain the WHO Statement on Public Disclosure of Clinical Trial Results, and require results to be published in <a href=\"/wiki/Open_access\" title=\"Open access\">open-access</a> publications.<sup class=\"reference\" id=\"cite_ref-huney_220-1\"><a href=\"#cite_note-huney-220\">[212]</a></sup> Some vaccine manufacturers opposed parts of these proposals.<sup class=\"reference\" id=\"cite_ref-cbcr_210-3\"><a href=\"#cite_note-cbcr-210\">[202]</a></sup><sup class=\"reference\" id=\"cite_ref-huney_220-2\"><a href=\"#cite_note-huney-220\">[212]</a></sup>\n",
            "</p><p>International groups, such as the Centre for Artistic Activism and <a href=\"/wiki/Universities_Allied_for_Essential_Medicines\" title=\"Universities Allied for Essential Medicines\">Universities Allied for Essential Medicines</a>, advocate for equitable access to licensed COVID‑19 vaccines.<sup class=\"reference\" id=\"cite_ref-221\"><a href=\"#cite_note-221\">[213]</a></sup><sup class=\"reference\" id=\"cite_ref-222\"><a href=\"#cite_note-222\">[214]</a></sup> Scientists have encouraged that the WHO, CEPI, corporations, and governments collaborate to assure evidence-based allocation of eventual COVID‑19 vaccines determined on infection risk,<sup class=\"reference\" id=\"cite_ref-bolly_214-3\"><a href=\"#cite_note-bolly-214\">[206]</a></sup><sup class=\"reference\" id=\"cite_ref-huney_220-3\"><a href=\"#cite_note-huney-220\">[212]</a></sup> particularly urgent vaccinations provided first for healthcare workers, vulnerable populations, and children.<sup class=\"reference\" id=\"cite_ref-gates1_24-7\"><a href=\"#cite_note-gates1-24\">[24]</a></sup><sup class=\"reference\" id=\"cite_ref-hbr_209-3\"><a href=\"#cite_note-hbr-209\">[201]</a></sup><sup class=\"reference\" id=\"cite_ref-cbcr_210-4\"><a href=\"#cite_note-cbcr-210\">[202]</a></sup>\n",
            "During 2020, the WHO, GAVI, and CEPI combined resources to form COVAX – a program for coordination of global equitable access to a licensed vaccine.<sup class=\"reference\" id=\"cite_ref-covax-gavi_32-4\"><a href=\"#cite_note-covax-gavi-32\">[32]</a></sup><sup class=\"reference\" id=\"cite_ref-covax_33-1\"><a href=\"#cite_note-covax-33\">[33]</a></sup>\n",
            "</p><p>Over 100 international scientists and concerned individuals (including those associated with religious organizations) have called for releasing COVID‑19 vaccines to the <a href=\"/wiki/Public_domain\" title=\"Public domain\">public domain</a>. Similar to the development of the first <a href=\"/wiki/Polio_vaccine\" title=\"Polio vaccine\">polio vaccine</a> that was never patented, an effective COVID-19 vaccine would be available for production and approval by a number of countries and pharmaceutical manufacturing centers worldwide, therefore allowing for a more even and cost-effective distribution on a global scale.<sup class=\"reference\" id=\"cite_ref-223\"><a href=\"#cite_note-223\">[215]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Supply_chain\">Supply chain</span></h2>\n",
            "<p>During and after 2021, deploying a COVID-19 vaccine may require worldwide transport and tracking of 10-19 billion vial doses, an effort readily becoming the largest <a href=\"/wiki/Supply_chain_management\" title=\"Supply chain management\">supply chain</a> challenge in history.<sup class=\"reference\" id=\"cite_ref-gates2_6-12\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-wef_224-0\"><a href=\"#cite_note-wef-224\">[216]</a></sup><sup class=\"reference\" id=\"cite_ref-unequal_217-1\"><a href=\"#cite_note-unequal-217\">[209]</a></sup> As of September 2020, supply chain and <a href=\"/wiki/Logistics\" title=\"Logistics\">logistics</a> experts expressed concern that international and national networks for distributing a licensed vaccine were not ready for the volume and urgency, due mainly to deterioration of resources during 2020 pandemic lockdowns and downsizing that degraded supply capabilities.<sup class=\"reference\" id=\"cite_ref-wef_224-1\"><a href=\"#cite_note-wef-224\">[216]</a></sup><sup class=\"reference\" id=\"cite_ref-murray_225-0\"><a href=\"#cite_note-murray-225\">[217]</a></sup><sup class=\"reference\" id=\"cite_ref-scott_226-0\"><a href=\"#cite_note-scott-226\">[218]</a></sup> Addressing the worldwide challenge faced by coordinating numerous organizations – the COVAX partnership, global pharmaceutical companies, contract vaccine manufacturers, inter- and intranational transport, storage facilities, and health organizations in individual countries – <a href=\"/wiki/Seth_Berkley\" title=\"Seth Berkley\">Seth Berkley</a>, <a class=\"mw-redirect\" href=\"/wiki/Chief_executive\" title=\"Chief executive\">chief executive</a> of GAVI, stated: \"Delivering billions of doses of vaccine to the entire world efficiently will involve hugely complex logistical and programmatic obstacles all the way along the supply chain.\"<sup class=\"reference\" id=\"cite_ref-unicef-now_227-0\"><a href=\"#cite_note-unicef-now-227\">[219]</a></sup>\n",
            "</p><p>As an example highlighting the immensity of the challenge, the <a href=\"/wiki/International_Air_Transport_Association\" title=\"International Air Transport Association\">International Air Transport Association</a> stated that 8,000 <a href=\"/wiki/Boeing_747\" title=\"Boeing 747\">747 cargo planes</a> – implemented with equipment for precision vaccine cold storage – would be needed to transport just one dose for people in the more than 200 countries experiencing the COVID-19 pandemic.<sup class=\"reference\" id=\"cite_ref-desai_228-0\"><a href=\"#cite_note-desai-228\">[220]</a></sup> GAVI states that \"with a fast-moving pandemic, no one is safe, unless everyone is safe.\"<sup class=\"reference\" id=\"cite_ref-covax-gavi_32-5\"><a href=\"#cite_note-covax-gavi-32\">[32]</a></sup>\n",
            "</p><p>In contrast to the multibillion dollar investment in vaccine technologies and early-stage clinical research, the post-licensing supply chain for a vaccine has not received the same planning, coordination, security or investment.<sup class=\"reference\" id=\"cite_ref-wef_224-2\"><a href=\"#cite_note-wef-224\">[216]</a></sup><sup class=\"reference\" id=\"cite_ref-murray_225-1\"><a href=\"#cite_note-murray-225\">[217]</a></sup><sup class=\"reference\" id=\"cite_ref-pharmiweb_229-0\"><a href=\"#cite_note-pharmiweb-229\">[221]</a></sup> A major concern is that resources for vaccine distribution in <a href=\"/wiki/Developing_country\" title=\"Developing country\">low- to middle-income countries</a>, particularly for vaccinating children, are inadequate or non-existent, but could be improved with cost efficiencies if procurement and distribution were centralized regionally or nationally.<sup class=\"reference\" id=\"cite_ref-covax-gavi_32-6\"><a href=\"#cite_note-covax-gavi-32\">[32]</a></sup><sup class=\"reference\" id=\"cite_ref-seidman_230-0\"><a href=\"#cite_note-seidman-230\">[222]</a></sup> In September, the COVAX partnership included 172 countries coordinating plans to optimize the supply chain for a COVID-19 vaccine,<sup class=\"reference\" id=\"cite_ref-gavi9-4_231-0\"><a href=\"#cite_note-gavi9-4-231\">[223]</a></sup> and <a href=\"/wiki/UNICEF\" title=\"UNICEF\">the United Nations Children's Fund</a> joined with COVAX to prepare the financing and supply chain for vaccinations of children in 92 developing countries.<sup class=\"reference\" id=\"cite_ref-unicef_232-0\"><a href=\"#cite_note-unicef-232\">[224]</a></sup><sup class=\"reference\" id=\"cite_ref-cook_233-0\"><a href=\"#cite_note-cook-233\">[225]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Logistics\">Logistics</span></h3>\n",
            "<p>Logistics vaccination services assure necessary equipment, staff, and supply of licensed vaccines across international borders.<sup class=\"reference\" id=\"cite_ref-hessel_234-0\"><a href=\"#cite_note-hessel-234\">[226]</a></sup> Central logistics include vaccine handling and monitoring, cold chain management, and safety of distribution within the vaccination network.<sup class=\"reference\" id=\"cite_ref-who-log_235-0\"><a href=\"#cite_note-who-log-235\">[227]</a></sup> The purpose of the COVAX Facility is to centralize and equitably administer logistics resources among participating countries, merging manufacturing, transport, and overall supply chain infrastructure.<sup class=\"reference\" id=\"cite_ref-covax-gavi_32-7\"><a href=\"#cite_note-covax-gavi-32\">[32]</a></sup><sup class=\"reference\" id=\"cite_ref-pharmiweb_229-1\"><a href=\"#cite_note-pharmiweb-229\">[221]</a></sup> Included are logistics tools for vaccine forecasting and needs estimation, in-country vaccine management, potential for wastage, and stock management.<sup class=\"reference\" id=\"cite_ref-who-log_235-1\"><a href=\"#cite_note-who-log-235\">[227]</a></sup>\n",
            "</p><p>Other logistics factors conducted internationally during distribution of a COVID-19 vaccine may include:<sup class=\"reference\" id=\"cite_ref-wef_224-3\"><a href=\"#cite_note-wef-224\">[216]</a></sup><sup class=\"reference\" id=\"cite_ref-jarrett_236-0\"><a href=\"#cite_note-jarrett-236\">[228]</a></sup><sup class=\"reference\" id=\"cite_ref-lloyd_237-0\"><a href=\"#cite_note-lloyd-237\">[229]</a></sup>\n",
            "</p>\n",
            "<ul><li>visibility and traceability by <a href=\"/wiki/Barcode\" title=\"Barcode\">barcodes</a> for each vaccine vial</li>\n",
            "<li>sharing of supplier audits</li>\n",
            "<li>sharing of <a href=\"/wiki/Chain_of_custody\" title=\"Chain of custody\">chain of custody</a> for a vaccine vial from manufacturer to the individual being vaccinated</li>\n",
            "<li>use of vaccine temperature monitoring tools</li>\n",
            "<li>temperature stability testing and assurance</li>\n",
            "<li>new packaging and delivery technologies</li>\n",
            "<li>stockpiling</li>\n",
            "<li>coordination of supplies within each country (<a href=\"/wiki/Personal_protective_equipment\" title=\"Personal protective equipment\">personal protective equipment</a>, <a href=\"/wiki/Diluent\" title=\"Diluent\">diluent</a>, syringes, needles, rubber stoppers, refrigeration fuel or power sources, waste-handling, among others)</li>\n",
            "<li>communications technology</li>\n",
            "<li>environmental impacts in each country</li></ul>\n",
            "<p>A logistics shortage in any one step may derail the whole supply chain, according to one vaccine developer.<sup class=\"reference\" id=\"cite_ref-wef-manuf_238-0\"><a href=\"#cite_note-wef-manuf-238\">[230]</a></sup> If the vaccine supply chain fails, the economic and human costs of the pandemic may be extended for years.<sup class=\"reference\" id=\"cite_ref-scott_226-1\"><a href=\"#cite_note-scott-226\">[218]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Manufacturing_capacity\">Manufacturing capacity</span></h3>\n",
            "<p>By August 2020 when only a few vaccine candidates were in Phase III trials many months from establishing safety and efficacy, numerous governments pre-ordered more than two billion doses at a cost of more than US$5 billion.<sup class=\"reference\" id=\"cite_ref-unequal_217-2\"><a href=\"#cite_note-unequal-217\">[209]</a></sup><sup class=\"reference\" id=\"cite_ref-wef-manuf_238-1\"><a href=\"#cite_note-wef-manuf-238\">[230]</a></sup><sup class=\"reference\" id=\"cite_ref-239\"><a href=\"#cite_note-239\">[231]</a></sup> Pre-orders from the UK government for 2021 were for five vaccine doses per person, a number dispiriting organizations like the WHO and GAVI which are promoting fair and equitable access worldwide, especially for developing countries.<sup class=\"reference\" id=\"cite_ref-unequal_217-3\"><a href=\"#cite_note-unequal-217\">[209]</a></sup> In September, CEPI was financially supporting basic and clinical research for nine vaccine candidates, with nine more in evaluation, under financing commitments to manufacture two billion doses of three licensed vaccines by the end of 2021.<sup class=\"reference\" id=\"cite_ref-gavi9-4_231-1\"><a href=\"#cite_note-gavi9-4-231\">[223]</a></sup> Overall before 2022, 7-10 billion COVID-19 vaccine doses may be manufactured worldwide, but the sizable pre-orders by affluent countries – called \"vaccine nationalism\" – threaten vaccine availability for poorer nations.<sup class=\"reference\" id=\"cite_ref-gates2_6-13\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-wef-manuf_238-2\"><a href=\"#cite_note-wef-manuf-238\">[230]</a></sup><sup class=\"reference\" id=\"cite_ref-unequal_217-4\"><a href=\"#cite_note-unequal-217\">[209]</a></sup> Brazil and Indonesia had pre-ordered millions of vaccine doses that are undergoing phase III trials in their countries The <a href=\"/wiki/Serum_Institute_of_India\" title=\"Serum Institute of India\">Serum Institute of India</a> plans to produce at least one billion vaccine doses, although the Institute has stated that half the doses will be used in India.<sup class=\"reference\" id=\"cite_ref-unequal_217-5\"><a href=\"#cite_note-unequal-217\">[209]</a></sup> After joining COVAX in October, China shared that it would produce 600 million vaccine doses before the end of 2020 and another one billion doses in 2021, although it was unsure how many would be for the country's own population of 1.4 billion.<sup class=\"reference\" id=\"cite_ref-240\"><a href=\"#cite_note-240\">[232]</a></sup>\n",
            "</p><p>AstraZeneca CEO, <a href=\"/wiki/Pascal_Soriot\" title=\"Pascal Soriot\">Pascal Soriot</a>, stated: \"The challenge is not making the vaccine itself, it's filling vials. There just aren't enough vials in the world.\"<sup class=\"reference\" id=\"cite_ref-molteni_241-0\"><a href=\"#cite_note-molteni-241\">[233]</a></sup> Preparing for high demand in manufacturing vials, an American glass producer invested $163 million in July for a vial factory.<sup class=\"reference\" id=\"cite_ref-glass_242-0\"><a href=\"#cite_note-glass-242\">[234]</a></sup> Glass availability for vial manufacturing and contaminant control are issues of concern,<sup class=\"reference\" id=\"cite_ref-burger_243-0\"><a href=\"#cite_note-burger-243\">[235]</a></sup> indicating higher production costs with lower profit potential for developers amid demands for vaccines to be affordable.<sup class=\"reference\" id=\"cite_ref-covax-gavi_32-8\"><a href=\"#cite_note-covax-gavi-32\">[32]</a></sup><sup class=\"reference\" id=\"cite_ref-unequal_217-6\"><a href=\"#cite_note-unequal-217\">[209]</a></sup><sup class=\"reference\" id=\"cite_ref-scott_226-2\"><a href=\"#cite_note-scott-226\">[218]</a></sup>\n",
            "</p><p>Vaccines must be handled and transported using international regulations, be maintained at controlled temperatures that vary across vaccine technologies, and be used for immunization before deterioration in storage.<sup class=\"reference\" id=\"cite_ref-unequal_217-7\"><a href=\"#cite_note-unequal-217\">[209]</a></sup><sup class=\"reference\" id=\"cite_ref-wef-manuf_238-3\"><a href=\"#cite_note-wef-manuf-238\">[230]</a></sup> The scale of the COVID-19 vaccine supply chain is expected to be vast to ensure delivery worldwide to vulnerable populations.<sup class=\"reference\" id=\"cite_ref-gates2_6-14\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-murray_225-2\"><a href=\"#cite_note-murray-225\">[217]</a></sup> Priorities for preparing facilities for such distribution include temperature-controlled facilities and equipment, optimizing infrastructure, training immunization staff, and rigorous monitoring.<sup class=\"reference\" id=\"cite_ref-murray_225-3\"><a href=\"#cite_note-murray-225\">[217]</a></sup><sup class=\"reference\" id=\"cite_ref-unicef-now_227-1\"><a href=\"#cite_note-unicef-now-227\">[219]</a></sup><sup class=\"reference\" id=\"cite_ref-unicef_232-1\"><a href=\"#cite_note-unicef-232\">[224]</a></sup> <a class=\"mw-redirect\" href=\"/wiki/Radiofrequency_identification\" title=\"Radiofrequency identification\">RFID</a> technologies are being implemented to track and authenticate a vaccine dose from the manufacturer along the entire supply chain to the vaccination.<sup class=\"reference\" id=\"cite_ref-kaplan_244-0\"><a href=\"#cite_note-kaplan-244\">[236]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Cold_chain\">Cold chain</span></h3>\n",
            "<p>Vaccines (and adjuvants) are inherently unstable during temperature changes, requiring <a href=\"/wiki/Cold_chain\" title=\"Cold chain\">cold chain</a> management throughout the entire supply chain, typically at temperatures of 2–8 °C (36–46 °F).<sup class=\"reference\" id=\"cite_ref-lloyd_237-1\"><a href=\"#cite_note-lloyd-237\">[229]</a></sup><sup class=\"reference\" id=\"cite_ref-karto_245-0\"><a href=\"#cite_note-karto-245\">[237]</a></sup> Because COVID-19 vaccine technologies are varied among several novel technologies, there are new challenges for cold chain management, with some vaccines that are stable while frozen but labile to heat, while others should not be frozen at all, and some are stable across temperatures.<sup class=\"reference\" id=\"cite_ref-karto_245-1\"><a href=\"#cite_note-karto-245\">[237]</a></sup> Freezing damage and inadequate training of personnel in the local vaccination process are major concerns.<sup class=\"reference\" id=\"cite_ref-hanson_246-0\"><a href=\"#cite_note-hanson-246\">[238]</a></sup> If more than one COVID-19 vaccine is approved, the vaccine cold chain may have to accommodate all these temperature sensitivities across different countries with variable climate conditions and local resources for temperature maintenance.<sup class=\"reference\" id=\"cite_ref-karto_245-2\"><a href=\"#cite_note-karto-245\">[237]</a></sup>\n",
            "</p><p>DNA and RNA vaccine technologies are in development, but may be difficult to manufacture at scale and control degradation during cold storage and transport.<sup class=\"reference\" id=\"cite_ref-scott_226-3\"><a href=\"#cite_note-scott-226\">[218]</a></sup> As examples, Moderna's RNA vaccine candidate requires cold chain management just above freezing temperatures with limited storage duration, but the BioNTech-Pfizer RNA candidate requires storage at -70°C (-94°F) or colder throughout deployment until vaccination.<sup class=\"reference\" id=\"cite_ref-gates2_6-15\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-weise_247-0\"><a href=\"#cite_note-weise-247\">[239]</a></sup>\n",
            "</p><p>After a vaccine vial is punctured to administer a dose, it is viable for only six hours, then must be discarded, requiring attention to local management of cold storage and vaccination processes.<sup class=\"reference\" id=\"cite_ref-weise_247-1\"><a href=\"#cite_note-weise-247\">[239]</a></sup> Because the COVID-19 vaccine will likely be in short supply for many locations during early deployment, vaccination staff will have to avoid spoilage and waste, which typically are as much as 30% of the supply.<sup class=\"reference\" id=\"cite_ref-wef_224-4\"><a href=\"#cite_note-wef-224\">[216]</a></sup><sup class=\"reference\" id=\"cite_ref-weise_247-2\"><a href=\"#cite_note-weise-247\">[239]</a></sup> The cold chain is further challenged by the type of local transportation for the vaccines in rural communities, such as by motorcycle or <a href=\"/wiki/Delivery_drone\" title=\"Delivery drone\">delivery drone</a>, need for booster doses, use of diluents, and access to vulnerable populations, such as healthcare staff, children and the elderly.<sup class=\"reference\" id=\"cite_ref-gates2_6-16\"><a href=\"#cite_note-gates2-6\">[6]</a></sup><sup class=\"reference\" id=\"cite_ref-unicef_232-2\"><a href=\"#cite_note-unicef-232\">[224]</a></sup><sup class=\"reference\" id=\"cite_ref-durbha_248-0\"><a href=\"#cite_note-durbha-248\">[240]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Air_and_land_transport\">Air and land transport</span></h3>\n",
            "<p>Coordination of international <a href=\"/wiki/Air_cargo\" title=\"Air cargo\">air cargo</a> is an essential component of time- and temperature-sensitive distribution of COVID-19 vaccines, but, as of September 2020, the air freight network is not prepared for multinational deployment.<sup class=\"reference\" id=\"cite_ref-murray_225-4\"><a href=\"#cite_note-murray-225\">[217]</a></sup><sup class=\"reference\" id=\"cite_ref-desai_228-1\"><a href=\"#cite_note-desai-228\">[220]</a></sup><sup class=\"reference\" id=\"cite_ref-iata_249-0\"><a href=\"#cite_note-iata-249\">[241]</a></sup> \"Safely delivering COVID-19 vaccines will be the mission of the century for the global air cargo industry. But it won't happen without careful advance planning. And the time for that is now. We urge governments to take the lead in facilitating cooperation across the logistics chain so that the facilities, security arrangements and border processes are ready for the mammoth and complex task ahead,\" said IATA's Director General and CEO, <a href=\"/wiki/Alexandre_de_Juniac\" title=\"Alexandre de Juniac\">Alexandre de Juniac</a>, in September 2020.<sup class=\"reference\" id=\"cite_ref-iata_249-1\"><a href=\"#cite_note-iata-249\">[241]</a></sup>\n",
            "</p><p>For the severe reduction in passenger air traffic during 2020, airlines <a href=\"/wiki/Layoff\" title=\"Layoff\">downsized</a> personnel, trimmed destination networks, and put aircraft into long-term storage.<sup class=\"reference\" id=\"cite_ref-murray_225-5\"><a href=\"#cite_note-murray-225\">[217]</a></sup><sup class=\"reference\" id=\"cite_ref-iata_249-2\"><a href=\"#cite_note-iata-249\">[241]</a></sup> As the lead agencies for procurement and supply of the COVID-19 vaccine within the WHO COVAX Facility, GAVI and UNICEF are preparing for the largest and fastest vaccine deployment ever, necessitating international air freight collaboration, customs and border control, and possibly as many as 8,000 cargo planes to deliver just one vaccine dose to multiple countries.<sup class=\"reference\" id=\"cite_ref-unicef_232-3\"><a href=\"#cite_note-unicef-232\">[224]</a></sup><sup class=\"reference\" id=\"cite_ref-iata_249-3\"><a href=\"#cite_note-iata-249\">[241]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"Security_and_corruption\">Security and corruption</span></h3>\n",
            "<p>Medicines are the world's largest fraud market, worth some $200 billion per year, making the widespread demand for a COVID-19 vaccine vulnerable to <a href=\"/wiki/Counterfeit\" title=\"Counterfeit\">counterfeit</a>, theft, <a href=\"/wiki/Confidence_trick\" title=\"Confidence trick\">scams</a>, and <a href=\"/wiki/Cyberattack\" title=\"Cyberattack\">cyberattacks</a> throughout the supply chain.<sup class=\"reference\" id=\"cite_ref-pharmiweb_229-2\"><a href=\"#cite_note-pharmiweb-229\">[221]</a></sup><sup class=\"reference\" id=\"cite_ref-unodc_250-0\"><a href=\"#cite_note-unodc-250\">[242]</a></sup> <a class=\"mw-redirect\" href=\"/wiki/Anticorruption\" title=\"Anticorruption\">Anticorruption</a>, transparency, and accountability  safeguards are being established to reduce and eliminate corruption of COVID-19 vaccine supplies.<sup class=\"reference\" id=\"cite_ref-unodc_250-1\"><a href=\"#cite_note-unodc-250\">[242]</a></sup><sup class=\"reference\" id=\"cite_ref-kohler_251-0\"><a href=\"#cite_note-kohler-251\">[243]</a></sup> Absence of harmonized regulatory frameworks among countries, including low technical capacity, constrained access, and ineffective capability to identify and track genuine vs. counterfeit vaccines, may be life-threatening for vaccine recipients, and would potentially perpetuate the COVID-19 pandemic.<sup class=\"reference\" id=\"cite_ref-unodc_250-2\"><a href=\"#cite_note-unodc-250\">[242]</a></sup> <a href=\"/wiki/Tracking_system\" title=\"Tracking system\">Tracking system</a> technologies for packaging are being used by manufacturers to trace vaccine vials across the supply chain,<sup class=\"reference\" id=\"cite_ref-pharmiweb_229-3\"><a href=\"#cite_note-pharmiweb-229\">[221]</a></sup> and to use digital and <a class=\"mw-redirect\" href=\"/wiki/Biometric\" title=\"Biometric\">biometric</a> tools to assure security for vaccination teams.<sup class=\"reference\" id=\"cite_ref-kaplan_244-1\"><a href=\"#cite_note-kaplan-244\">[236]</a></sup><sup class=\"reference\" id=\"cite_ref-subra_252-0\"><a href=\"#cite_note-subra-252\">[244]</a></sup>\n",
            "</p>\n",
            "<h3><span class=\"mw-headline\" id=\"National_infrastructure\">National infrastructure</span></h3>\n",
            "<p>The WHO has implemented an \"Effective Vaccine Management\" system,<sup class=\"reference\" id=\"cite_ref-who-evm_253-0\"><a href=\"#cite_note-who-evm-253\">[245]</a></sup> which includes constructing priorities to prepare national and subnational personnel and facilities for vaccine distribution, including:\n",
            "</p>\n",
            "<ul><li>Trained staff to handle time- and temperature-sensitive vaccines</li>\n",
            "<li>Robust monitoring capabilities to ensure optimal vaccine storage and transport</li>\n",
            "<li>Temperature-controlled facilities and equipment</li>\n",
            "<li>Traceability</li>\n",
            "<li>Security</li></ul>\n",
            "<p>Border processes for efficient handling and customs clearance within individual countries may include:<sup class=\"reference\" id=\"cite_ref-hessel_234-1\"><a href=\"#cite_note-hessel-234\">[226]</a></sup><sup class=\"reference\" id=\"cite_ref-who-evm_253-1\"><a href=\"#cite_note-who-evm-253\">[245]</a></sup>\n",
            "</p>\n",
            "<ul><li>Facilitating flight and landing permits</li>\n",
            "<li>Exempting flight crews from <a href=\"/wiki/Quarantine\" title=\"Quarantine\">quarantine</a> requirements</li>\n",
            "<li>Facilitating flexible operations for efficient national deployment</li>\n",
            "<li>Granting arrival priority to maintain vaccine temperature requirements</li></ul>\n",
            "<h2><span class=\"mw-headline\" id=\"Liability\">Liability</span></h2>\n",
            "<p>On February 4, 2020, US Secretary of Health and Human Services <a href=\"/wiki/Alex_Azar\" title=\"Alex Azar\">Alex Azar</a> published a notice of declaration under the <a href=\"/wiki/Public_Readiness_and_Emergency_Preparedness_Act\" title=\"Public Readiness and Emergency Preparedness Act\">Public Readiness and Emergency Preparedness Act</a> for medical countermeasures against COVID‑19, covering \"any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID‑19, or the transmission of SARS-CoV-2 or a virus mutating therefrom\", and stating that the declaration precludes \"liability claims alleging negligence by a manufacturer in creating a vaccine, or negligence by a health care provider in prescribing the wrong dose, absent willful misconduct\".<sup class=\"reference\" id=\"cite_ref-254\"><a href=\"#cite_note-254\">[246]</a></sup> The declaration is effective in the United States through 1 October 2024.\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"Misinformation\">Misinformation</span></h2>\n",
            "<div class=\"hatnote navigation-not-searchable\" role=\"note\">Main article: <a href=\"/wiki/Misinformation_related_to_the_COVID-19_pandemic\" title=\"Misinformation related to the COVID-19 pandemic\">Misinformation related to the COVID-19 pandemic</a></div>\n",
            "<p>Social media posts have promoted a <a href=\"/wiki/Conspiracy_theory\" title=\"Conspiracy theory\">conspiracy theory</a> that a COVID‑19 vaccine is already available. The patents cited by various <a href=\"/wiki/Social_media\" title=\"Social media\">social media</a> posts have references to existing patents for <a class=\"mw-redirect\" href=\"/wiki/Genetic_sequence\" title=\"Genetic sequence\">genetic sequences</a> and vaccines for other strains such as the <a class=\"mw-redirect\" href=\"/wiki/Severe_acute_respiratory_syndrome-related_coronavirus\" title=\"Severe acute respiratory syndrome-related coronavirus\">SARS coronavirus</a>, but not for COVID‑19.<sup class=\"reference\" id=\"cite_ref-255\"><a href=\"#cite_note-255\">[247]</a></sup><sup class=\"reference\" id=\"cite_ref-20200124factcheckA_256-0\"><a href=\"#cite_note-20200124factcheckA-256\">[248]</a></sup>\n",
            "</p><p>On 21 May 2020, the FDA made public the cease-and-desist notice it had sent to North Coast Biologics, a Seattle-based company that had been selling a purported \"nCoV19 spike protein vaccine\".<sup class=\"reference\" id=\"cite_ref-257\"><a href=\"#cite_note-257\">[249]</a></sup>\n",
            "</p>\n",
            "<h2><span class=\"mw-headline\" id=\"See_also\">See also</span></h2>\n",
            "<style data-mw-deduplicate=\"TemplateStyles:r936637989\">.mw-parser-output .portal{border:solid #aaa 1px;padding:0}.mw-parser-output .portal.tleft{margin:0.5em 1em 0.5em 0}.mw-parser-output .portal.tright{margin:0.5em 0 0.5em 1em}.mw-parser-output .portal>ul{display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold}.mw-parser-output .portal>ul>li{display:table-row}.mw-parser-output .portal>ul>li>span:first-child{display:table-cell;padding:0.2em;vertical-align:middle;text-align:center}.mw-parser-output .portal>ul>li>span:last-child{display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle}</style><div aria-label=\"Portals\" class=\"noprint portal plainlist tright\" role=\"navigation\">\n",
            "<ul>\n",
            "<li><span><a class=\"image\" href=\"/wiki/File:SARS-CoV-2_(Wikimedia_colors).svg\"><img alt=\"virus icon\" class=\"noviewer\" data-file-height=\"666\" data-file-width=\"666\" decoding=\"async\" height=\"28\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/28px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/42px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/56px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 2x\" width=\"28\"/></a></span><span><a href=\"/wiki/Portal:Coronavirus_disease_2019\" title=\"Portal:Coronavirus disease 2019\">Coronavirus disease 2019 portal</a></span></li>\n",
            "<li><span><img alt=\"icon\" class=\"noviewer\" data-file-height=\"250\" data-file-width=\"107\" decoding=\"async\" height=\"28\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/12px-WHO_Rod.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/18px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/24px-WHO_Rod.svg.png 2x\" width=\"12\"/></span><span><a href=\"/wiki/Portal:Medicine\" title=\"Portal:Medicine\">Medicine portal</a></span></li>\n",
            "<li><span><img alt=\"icon\" class=\"noviewer\" data-file-height=\"275\" data-file-width=\"244\" decoding=\"async\" height=\"28\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Klepsydra-pt.svg/25px-Klepsydra-pt.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Klepsydra-pt.svg/37px-Klepsydra-pt.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Klepsydra-pt.svg/50px-Klepsydra-pt.svg.png 2x\" width=\"25\"/></span><span><a href=\"/wiki/Portal:Modern_history\" title=\"Portal:Modern history\">Modern history portal</a></span></li>\n",
            "<li><span><a class=\"image\" href=\"/wiki/File:Sida-aids.png\"><img alt=\"icon\" class=\"noviewer\" data-file-height=\"290\" data-file-width=\"290\" decoding=\"async\" height=\"28\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Sida-aids.png/28px-Sida-aids.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Sida-aids.png/42px-Sida-aids.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Sida-aids.png/56px-Sida-aids.png 2x\" width=\"28\"/></a></span><span><a href=\"/wiki/Portal:Viruses\" title=\"Portal:Viruses\">Viruses portal</a></span></li>\n",
            "<li><span><img alt=\"\" class=\"noviewer\" data-file-height=\"512\" data-file-width=\"512\" decoding=\"async\" height=\"28\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e2/Ambox_globe.svg/28px-Ambox_globe.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e2/Ambox_globe.svg/42px-Ambox_globe.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e2/Ambox_globe.svg/56px-Ambox_globe.svg.png 2x\" width=\"28\"/></span><span><a href=\"/wiki/Portal:Current_events\" title=\"Portal:Current events\">Current events portal</a></span></li></ul></div>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a></li>\n",
            "<li><a href=\"/wiki/Coronavirus_disease_2019\" title=\"Coronavirus disease 2019\">Coronavirus disease 2019</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_drug_repurposing_research\" title=\"COVID-19 drug repurposing research\">COVID-19 drug repurposing research</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_drug_development\" title=\"COVID-19 drug development\">COVID-19 drug development</a></li>\n",
            "<li><a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">Severe acute respiratory syndrome coronavirus 2</a></li>\n",
            "<li><a href=\"/wiki/Respiratory_disease\" title=\"Respiratory disease\">Respiratory disease</a></li>\n",
            "<li><a href=\"/wiki/Phases_of_clinical_research\" title=\"Phases of clinical research\">Phases of clinical research</a></li>\n",
            "<li><a href=\"/wiki/2009_swine_flu_pandemic_vaccine\" title=\"2009 swine flu pandemic vaccine\">2009 swine flu pandemic vaccine</a></li></ul>\n",
            "<h2><span class=\"mw-headline\" id=\"References\">References</span></h2>\n",
            "<div class=\"reflist\" style=\"list-style-type: decimal;\">\n",
            "<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n",
            "<li id=\"cite_note-diamond-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-diamond_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-diamond_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-diamond_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-diamond_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-diamond_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-diamond_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-diamond_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-diamond_1-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFDiamondPierson2020\">Diamond MS, Pierson TC (13 May 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7219397\" rel=\"nofollow\">\"The challenges of vaccine development against a new virus during a pandemic\"</a>. <i>Cell Host and Microbe</i>. <b>27</b> (5): 699–703. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.chom.2020.04.021\" rel=\"nofollow\">10.1016/j.chom.2020.04.021</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7219397\" rel=\"nofollow\">7219397</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32407708\" rel=\"nofollow\">32407708</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Host+and+Microbe&amp;rft.atitle=The+challenges+of+vaccine+development+against+a+new+virus+during+a+pandemic&amp;rft.volume=27&amp;rft.issue=5&amp;rft.pages=699-703&amp;rft.date=2020-05-13&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7219397&amp;rft_id=info%3Apmid%2F32407708&amp;rft_id=info%3Adoi%2F10.1016%2Fj.chom.2020.04.021&amp;rft.aulast=Diamond&amp;rft.aufirst=Michael+S&amp;rft.au=Pierson%2C+Theodore+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7219397&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><style data-mw-deduplicate=\"TemplateStyles:r982806391\">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:\"\\\"\"\"\\\"\"\"'\"\"'\"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg\")right 0.1em center/12px no-repeat}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style></span>\n",
            "</li>\n",
            "<li id=\"cite_note-thanh2-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-thanh2_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-16\"><sup><i><b>q</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-17\"><sup><i><b>r</b></i></sup></a> <a href=\"#cite_ref-thanh2_2-18\"><sup><i><b>s</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFLeCramerChenMayhew2020\">Le, Tung Thanh; Cramer, Jakob P.; Chen, Robert; Mayhew, Stephen (4 September 2020). <a class=\"external text\" href=\"https://www.nature.com/articles/d41573-020-00151-8\" rel=\"nofollow\">\"Evolution of the COVID-19 vaccine development landscape\"</a>. <i>Nature Reviews Drug Discovery</i>. <b>19</b> (10): 667–68. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fd41573-020-00151-8\" rel=\"nofollow\">10.1038/d41573-020-00151-8</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/1474-1776\" rel=\"nofollow\">1474-1776</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32887942\" rel=\"nofollow\">32887942</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221503034\" rel=\"nofollow\">221503034</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Drug+Discovery&amp;rft.atitle=Evolution+of+the+COVID-19+vaccine+development+landscape&amp;rft.volume=19&amp;rft.issue=10&amp;rft.pages=667-68&amp;rft.date=2020-09-04&amp;rft.issn=1474-1776&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221503034&amp;rft_id=info%3Apmid%2F32887942&amp;rft_id=info%3Adoi%2F10.1038%2Fd41573-020-00151-8&amp;rft.aulast=Le&amp;rft.aufirst=Tung+Thanh&amp;rft.au=Cramer%2C+Jakob+P.&amp;rft.au=Chen%2C+Robert&amp;rft.au=Mayhew%2C+Stephen&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41573-020-00151-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-london-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-london_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-london_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-london_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-london_3-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-london_3-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/\" rel=\"nofollow\">\"COVID-19 vaccine development pipeline (Refresh URL to update)\"</a>. Vaccine Centre, London School of Hygiene and Tropical Medicine. 14 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVID-19+vaccine+development+pipeline+%28Refresh+URL+to+update%29&amp;rft.pub=Vaccine+Centre%2C+London+School+of+Hygiene+and+Tropical+Medicine&amp;rft.date=2020-09-14&amp;rft_id=https%3A%2F%2Fvac-lshtm.shinyapps.io%2Fncov_vaccine_landscape%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-milken-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-milken_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-milken_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-milken_4-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://airtable.com/shrSAi6t5WFwqo3GM/tblEzPQS5fnc0FHYR/viwDBH7b6FjmIBX5x?blocks=hide\" rel=\"nofollow\">\"COVID-19 vaccine tracker (Choose vaccines tab, apply filters to view select data)\"</a>. Milken Institute. 17 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>. <a class=\"external text\" href=\"https://milkeninstitute.org/covid-19-tracker\" rel=\"nofollow\">Lay summary</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVID-19+vaccine+tracker+%28Choose+vaccines+tab%2C+apply+filters+to+view+select+data%29&amp;rft.pub=Milken+Institute&amp;rft.date=2020-09-17&amp;rft_id=https%3A%2F%2Fairtable.com%2FshrSAi6t5WFwqo3GM%2FtblEzPQS5fnc0FHYR%2FviwDBH7b6FjmIBX5x%3Fblocks%3Dhide&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-tracker-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-tracker_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-tracker_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-who-tracker_5-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-who-tracker_5-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines\" rel=\"nofollow\">\"Draft landscape of COVID 19 candidate vaccines\"</a>. World Health Organization. 17 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Draft+landscape+of+COVID+19+candidate+vaccines&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-09-17&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fwho-documents-detail%2Fdraft-landscape-of-covid-19-candidate-vaccines&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-gates2-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gates2_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gates2_6-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-gates2_6-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-gates2_6-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-gates2_6-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-gates2_6-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-gates2_6-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-gates2_6-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-gates2_6-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-gates2_6-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-gates2_6-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-gates2_6-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-gates2_6-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-gates2_6-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-gates2_6-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-gates2_6-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-gates2_6-16\"><sup><i><b>q</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFGates2020\">Gates B (30 April 2020). <a class=\"external text\" href=\"https://www.gatesnotes.com/Health/What-you-need-to-know-about-the-COVID-19-vaccine\" rel=\"nofollow\">\"The vaccine race explained: What you need to know about the COVID-19 vaccine\"</a>. The Gates Notes. <a class=\"external text\" href=\"https://web.archive.org/web/20200514010012/https://www.gatesnotes.com/Health/What-you-need-to-know-about-the-COVID-19-vaccine\" rel=\"nofollow\">Archived</a> from the original on 14 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+vaccine+race+explained%3A+What+you+need+to+know+about+the+COVID-19+vaccine&amp;rft.pub=The+Gates+Notes&amp;rft.date=2020-04-30&amp;rft.aulast=Gates&amp;rft.aufirst=Bill&amp;rft_id=https%3A%2F%2Fwww.gatesnotes.com%2FHealth%2FWhat-you-need-to-know-about-the-COVID-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cepi-fund-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cepi-fund_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cepi-fund_7-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://cepi.net/news_cepi/2-billion-required-to-develop-a-vaccine-against-the-covid-19-virus/\" rel=\"nofollow\">\"CEPI welcomes UK Government's funding and highlights need for $2 billion to develop a vaccine against COVID-19\"</a>. Coalition for Epidemic Preparedness Innovations, Oslo, Norway. 6 March 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200322170547/https://cepi.net/news_cepi/2-billion-required-to-develop-a-vaccine-against-the-covid-19-virus/\" rel=\"nofollow\">Archived</a> from the original on 22 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CEPI+welcomes+UK+Government%27s+funding+and+highlights+need+for+%242+billion+to+develop+a+vaccine+against+COVID-19&amp;rft.pub=Coalition+for+Epidemic+Preparedness+Innovations%2C+Oslo%2C+Norway&amp;rft.date=2020-03-06&amp;rft_id=https%3A%2F%2Fcepi.net%2Fnews_cepi%2F2-billion-required-to-develop-a-vaccine-against-the-covid-19-virus%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-waked-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-waked_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-waked_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-waked_8-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-waked_8-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFWake2020\">Wake D (4 May 2020). <a class=\"external text\" href=\"https://finance.yahoo.com/news/eu-hosts-virus-telethon-seeking-first-7-5-003500556.html\" rel=\"nofollow\">\"EU spearheads $8 billion virus fundraiser\"</a>. Yahoo Finance. <a class=\"external text\" href=\"https://web.archive.org/web/20200629033556if_/https://finance.yahoo.com/news/eu-hosts-virus-telethon-seeking-first-7-5-003500556.html\" rel=\"nofollow\">Archived</a> from the original on 29 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=EU+spearheads+%248+billion+virus+fundraiser&amp;rft.pub=Yahoo+Finance&amp;rft.date=2020-05-04&amp;rft.aulast=Wake&amp;rft.aufirst=Damon&amp;rft_id=https%3A%2F%2Ffinance.yahoo.com%2Fnews%2Feu-hosts-virus-telethon-seeking-first-7-5-003500556.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-accel-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-accel_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-who-accel_9-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-trial-accelerating-a-safe-and-effective-covid-19-vaccine\" rel=\"nofollow\">\"Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine\"</a>. World Health Organization. 27 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200430185550/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-trial-accelerating-a-safe-and-effective-covid-19-vaccine\" rel=\"nofollow\">Archived</a> from the original on 30 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>. <q>It is vital that we evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success (given the high level of attrition during vaccine development), we must test all candidate vaccines until they fail. [The] WHO is working to ensure that all of them have the chance of being tested at the initial stage of development. The results for the efficacy of each vaccine are expected within three to six months and this evidence, combined with data on safety, will inform decisions about whether it can be used on a wider scale.</q></cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Update+on+WHO+Solidarity+Trial+%E2%80%93+Accelerating+a+safe+and+effective+COVID-19+vaccine&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-04-27&amp;rft_id=https%3A%2F%2Fwww.who.int%2Femergencies%2Fdiseases%2Fnovel-coronavirus-2019%2Fglobal-research-on-novel-coronavirus-2019-ncov%2Fsolidarity-trial-accelerating-a-safe-and-effective-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFCavanagh2003\">Cavanagh D (December 2003). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7154303\" rel=\"nofollow\">\"Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus\"</a>. <i>Avian Pathology</i>. <b>32</b> (6): 567–82. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1080%2F03079450310001621198\" rel=\"nofollow\">10.1080/03079450310001621198</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7154303\" rel=\"nofollow\">7154303</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/14676007\" rel=\"nofollow\">14676007</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Avian+Pathology&amp;rft.atitle=Severe+acute+respiratory+syndrome+vaccine+development%3A+experiences+of+vaccination+against+avian+infectious+bronchitis+coronavirus&amp;rft.volume=32&amp;rft.issue=6&amp;rft.pages=567-82&amp;rft.date=2003-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7154303&amp;rft_id=info%3Apmid%2F14676007&amp;rft_id=info%3Adoi%2F10.1080%2F03079450310001621198&amp;rft.aulast=Cavanagh&amp;rft.aufirst=D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7154303&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFGaoTaminSoloffD'Aiuto2003\">Gao W, Tamin A, Soloff A, D'Aiuto L, Nwanegbo E, Robbins PD,  et al. (December 2003). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7112457\" rel=\"nofollow\">\"Effects of a SARS-associated coronavirus vaccine in monkeys\"</a>. <i>Lancet</i>. <b>362</b> (9399): 1895–96. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS0140-6736%2803%2914962-8\" rel=\"nofollow\">10.1016/S0140-6736(03)14962-8</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7112457\" rel=\"nofollow\">7112457</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/14667748\" rel=\"nofollow\">14667748</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Effects+of+a+SARS-associated+coronavirus+vaccine+in+monkeys&amp;rft.volume=362&amp;rft.issue=9399&amp;rft.pages=1895-96&amp;rft.date=2003-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112457&amp;rft_id=info%3Apmid%2F14667748&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2803%2914962-8&amp;rft.aulast=Gao&amp;rft.aufirst=W&amp;rft.au=Tamin%2C+A&amp;rft.au=Soloff%2C+A&amp;rft.au=D%27Aiuto%2C+L&amp;rft.au=Nwanegbo%2C+E&amp;rft.au=Robbins%2C+PD&amp;rft.au=Bellini%2C+WJ&amp;rft.au=Barratt-Boyes%2C+S&amp;rft.au=Gambotto%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112457&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFKimOkadaKennistonRaj2014\">Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA,  et al. (October 2014). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7115510\" rel=\"nofollow\">\"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice\"</a>. <i>Vaccine</i>. <b>32</b> (45): 5975–82. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.vaccine.2014.08.058\" rel=\"nofollow\">10.1016/j.vaccine.2014.08.058</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7115510\" rel=\"nofollow\">7115510</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/25192975\" rel=\"nofollow\">25192975</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Immunogenicity+of+an+adenoviral-based+Middle+East+Respiratory+Syndrome+coronavirus+vaccine+in+BALB%2Fc+mice&amp;rft.volume=32&amp;rft.issue=45&amp;rft.pages=5975-82&amp;rft.date=2014-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7115510&amp;rft_id=info%3Apmid%2F25192975&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2014.08.058&amp;rft.aulast=Kim&amp;rft.aufirst=E&amp;rft.au=Okada%2C+K&amp;rft.au=Kenniston%2C+T&amp;rft.au=Raj%2C+VS&amp;rft.au=AlHajri%2C+MM&amp;rft.au=Farag%2C+EA&amp;rft.au=AlHajri%2C+F&amp;rft.au=Osterhaus%2C+AD&amp;rft.au=Haagmans%2C+BL&amp;rft.au=Gambotto%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7115510&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-PMID_15655773-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PMID_15655773_13-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFGreenoughBabcockRobertsHernandez2005\">Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA,  et al. (February 2005). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7110081\" rel=\"nofollow\">\"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice\"</a>. <i>The Journal of Infectious Diseases</i>. <b>191</b> (4): 507–14. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1086%2F427242\" rel=\"nofollow\">10.1086/427242</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7110081\" rel=\"nofollow\">7110081</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/15655773\" rel=\"nofollow\">15655773</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Infectious+Diseases&amp;rft.atitle=Development+and+characterization+of+a+severe+acute+respiratory+syndrome-associated+coronavirus-neutralizing+human+monoclonal+antibody+that+provides+effective+immunoprophylaxis+in+mice&amp;rft.volume=191&amp;rft.issue=4&amp;rft.pages=507-14&amp;rft.date=2005-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7110081&amp;rft_id=info%3Apmid%2F15655773&amp;rft_id=info%3Adoi%2F10.1086%2F427242&amp;rft.aulast=Greenough&amp;rft.aufirst=TC&amp;rft.au=Babcock%2C+GJ&amp;rft.au=Roberts%2C+A&amp;rft.au=Hernandez%2C+HJ&amp;rft.au=Thomas%2C+WD&amp;rft.au=Coccia%2C+JA&amp;rft.au=Graziano%2C+RF&amp;rft.au=Srinivasan%2C+M&amp;rft.au=Lowy%2C+I&amp;rft.au=Finberg%2C+RW&amp;rft.au=Subbarao%2C+K&amp;rft.au=Vogel%2C+L&amp;rft.au=Somasundaran%2C+M&amp;rft.au=Luzuriaga%2C+K&amp;rft.au=Sullivan%2C+JL&amp;rft.au=Ambrosino%2C+DM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7110081&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-PMID_15885812-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PMID_15885812_14-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFTrippHaynesMooreAnderson2005\">Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH,  et al. (September 2005). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7112802\" rel=\"nofollow\">\"Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins\"</a>. <i>Journal of Virological Methods</i>. <b>128</b> (1–2): 21–28. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.jviromet.2005.03.021\" rel=\"nofollow\">10.1016/j.jviromet.2005.03.021</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7112802\" rel=\"nofollow\">7112802</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/15885812\" rel=\"nofollow\">15885812</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virological+Methods&amp;rft.atitle=Monoclonal+antibodies+to+SARS-associated+coronavirus+%28SARS-CoV%29%3A+identification+of+neutralizing+and+antibodies+reactive+to+S%2C+N%2C+M+and+E+viral+proteins&amp;rft.volume=128&amp;rft.issue=1%E2%80%932&amp;rft.pages=21-28&amp;rft.date=2005-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112802&amp;rft_id=info%3Apmid%2F15885812&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jviromet.2005.03.021&amp;rft.aulast=Tripp&amp;rft.aufirst=RA&amp;rft.au=Haynes%2C+LM&amp;rft.au=Moore%2C+D&amp;rft.au=Anderson%2C+B&amp;rft.au=Tamin%2C+A&amp;rft.au=Harcourt%2C+BH&amp;rft.au=Jones%2C+LP&amp;rft.au=Yilla%2C+M&amp;rft.au=Babcock%2C+GJ&amp;rft.au=Greenough%2C+T&amp;rft.au=Ambrosino%2C+DM&amp;rft.au=Alvarez%2C+R&amp;rft.au=Callaway%2C+J&amp;rft.au=Cavitt%2C+S&amp;rft.au=Kamrud%2C+K&amp;rft.au=Alterson%2C+H&amp;rft.au=Smith%2C+J&amp;rft.au=Harcourt%2C+JL&amp;rft.au=Miao%2C+C&amp;rft.au=Razdan%2C+R&amp;rft.au=Comer%2C+JA&amp;rft.au=Rollin%2C+PE&amp;rft.au=Ksiazek%2C+TG&amp;rft.au=Sanchez%2C+A&amp;rft.au=Rota%2C+PA&amp;rft.au=Bellini%2C+WJ&amp;rft.au=Anderson%2C+LJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7112802&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-PMID_16453264-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PMID_16453264_15-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFRobertsThomasGuarnerLamirande2006\">Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC,  et al. (March 2006). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7109703\" rel=\"nofollow\">\"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters\"</a>. <i>The Journal of Infectious Diseases</i>. <b>193</b> (5): 685–92. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1086%2F500143\" rel=\"nofollow\">10.1086/500143</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7109703\" rel=\"nofollow\">7109703</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/16453264\" rel=\"nofollow\">16453264</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Infectious+Diseases&amp;rft.atitle=Therapy+with+a+severe+acute+respiratory+syndrome-associated+coronavirus-neutralizing+human+monoclonal+antibody+reduces+disease+severity+and+viral+burden+in+golden+Syrian+hamsters&amp;rft.volume=193&amp;rft.issue=5&amp;rft.pages=685-92&amp;rft.date=2006-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7109703&amp;rft_id=info%3Apmid%2F16453264&amp;rft_id=info%3Adoi%2F10.1086%2F500143&amp;rft.aulast=Roberts&amp;rft.aufirst=A&amp;rft.au=Thomas%2C+WD&amp;rft.au=Guarner%2C+J&amp;rft.au=Lamirande%2C+EW&amp;rft.au=Babcock%2C+GJ&amp;rft.au=Greenough%2C+TC&amp;rft.au=Vogel%2C+L&amp;rft.au=Hayes%2C+N&amp;rft.au=Sullivan%2C+JL&amp;rft.au=Zaki%2C+S&amp;rft.au=Subbarao%2C+K&amp;rft.au=Ambrosino%2C+DM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7109703&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-JiangFutureVirology-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-JiangFutureVirology_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-JiangFutureVirology_16-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFJiangLuDu2013\">Jiang S, Lu L, Du L (January 2013). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7079997\" rel=\"nofollow\">\"Development of SARS vaccines and therapeutics is still needed\"</a>. <i>Future Virology</i>. <b>8</b> (1): 1–2. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.2217%2Ffvl.12.126\" rel=\"nofollow\">10.2217/fvl.12.126</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7079997\" rel=\"nofollow\">7079997</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32201503\" rel=\"nofollow\">32201503</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Future+Virology&amp;rft.atitle=Development+of+SARS+vaccines+and+therapeutics+is+still+needed&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=1-2&amp;rft.date=2013-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7079997&amp;rft_id=info%3Apmid%2F32201503&amp;rft_id=info%3Adoi%2F10.2217%2Ffvl.12.126&amp;rft.aulast=Jiang&amp;rft.aufirst=S&amp;rft.au=Lu%2C+L&amp;rft.au=Du%2C+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7079997&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.nhs.uk/conditions/sars/\" rel=\"nofollow\">\"SARS (severe acute respiratory syndrome)\"</a>. <a href=\"/wiki/National_Health_Service\" title=\"National Health Service\">National Health Service</a>. 5 March 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200309174230/https://www.nhs.uk/conditions/sars/\" rel=\"nofollow\">Archived</a> from the original on 9 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">31 January</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=SARS+%28severe+acute+respiratory+syndrome%29&amp;rft.pub=National+Health+Service&amp;rft.date=2020-03-05&amp;rft_id=https%3A%2F%2Fwww.nhs.uk%2Fconditions%2Fsars%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFShehataGomaaAliKayali2016\">Shehata MM, Gomaa MR, Ali MA, Kayali G (20 January 2016). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7089261\" rel=\"nofollow\">\"Middle East respiratory syndrome coronavirus: a comprehensive review\"</a>. <i>Frontiers of Medicine</i>. <b>10</b> (2): 120–36. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1007%2Fs11684-016-0430-6\" rel=\"nofollow\">10.1007/s11684-016-0430-6</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7089261\" rel=\"nofollow\">7089261</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26791756\" rel=\"nofollow\">26791756</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+of+Medicine&amp;rft.atitle=Middle+East+respiratory+syndrome+coronavirus%3A+a+comprehensive+review&amp;rft.volume=10&amp;rft.issue=2&amp;rft.pages=120-36&amp;rft.date=2016-01-20&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7089261&amp;rft_id=info%3Apmid%2F26791756&amp;rft_id=info%3Adoi%2F10.1007%2Fs11684-016-0430-6&amp;rft.aulast=Shehata&amp;rft.aufirst=Mahmoud+M.&amp;rft.au=Gomaa%2C+Mokhtar+R.&amp;rft.au=Ali%2C+Mohamed+A.&amp;rft.au=Kayali%2C+Ghazi&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7089261&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-Butler3oct2013-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Butler3oct2013_19-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFButler2012\">Butler D (October 2012). <a class=\"external text\" href=\"https://doi.org/10.1038%2F490020a\" rel=\"nofollow\">\"SARS veterans tackle coronavirus\"</a>. <i>Nature</i>. <b>490</b> (7418): 20. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2012Natur.490...20B\" rel=\"nofollow\">2012Natur.490...20B</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2F490020a\" rel=\"nofollow\">10.1038/490020a</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/23038444\" rel=\"nofollow\">23038444</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=SARS+veterans+tackle+coronavirus&amp;rft.volume=490&amp;rft.issue=7418&amp;rft.pages=20&amp;rft.date=2012-10&amp;rft_id=info%3Apmid%2F23038444&amp;rft_id=info%3Adoi%2F10.1038%2F490020a&amp;rft_id=info%3Abibcode%2F2012Natur.490...20B&amp;rft.aulast=Butler&amp;rft.aufirst=D&amp;rft_id=%2F%2Fdoi.org%2F10.1038%252F490020a&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFModjarradRobertsMillsCastellano2019\">Modjarrad K, Roberts CC, Mills KT, Castellano AR, Paolino K, Muthumani K,  et al. (September 2019). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7185789\" rel=\"nofollow\">\"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial\"</a>. <i>The Lancet. Infectious Diseases</i>. <b>19</b> (9): 1013–22. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS1473-3099%2819%2930266-X\" rel=\"nofollow\">10.1016/S1473-3099(19)30266-X</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7185789\" rel=\"nofollow\">7185789</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/31351922\" rel=\"nofollow\">31351922</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Infectious+Diseases&amp;rft.atitle=Safety+and+immunogenicity+of+an+anti-Middle+East+respiratory+syndrome+coronavirus+DNA+vaccine%3A+a+phase+1%2C+open-label%2C+single-arm%2C+dose-escalation+trial&amp;rft.volume=19&amp;rft.issue=9&amp;rft.pages=1013-22&amp;rft.date=2019-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7185789&amp;rft_id=info%3Apmid%2F31351922&amp;rft_id=info%3Adoi%2F10.1016%2FS1473-3099%2819%2930266-X&amp;rft.aulast=Modjarrad&amp;rft.aufirst=K&amp;rft.au=Roberts%2C+CC&amp;rft.au=Mills%2C+KT&amp;rft.au=Castellano%2C+AR&amp;rft.au=Paolino%2C+K&amp;rft.au=Muthumani%2C+K&amp;rft.au=Reuschel%2C+EL&amp;rft.au=Robb%2C+ML&amp;rft.au=Racine%2C+T&amp;rft.au=Oh%2C+MD&amp;rft.au=Lamarre%2C+C&amp;rft.au=Zaidi%2C+FI&amp;rft.au=Boyer%2C+J&amp;rft.au=Kudchodkar%2C+SB&amp;rft.au=Jeong%2C+M&amp;rft.au=Darden%2C+JM&amp;rft.au=Park%2C+YK&amp;rft.au=Scott%2C+PT&amp;rft.au=Remigio%2C+C&amp;rft.au=Parikh%2C+AP&amp;rft.au=Wise%2C+MC&amp;rft.au=Patel%2C+A&amp;rft.au=Duperret%2C+EK&amp;rft.au=Kim%2C+KY&amp;rft.au=Choi%2C+H&amp;rft.au=White%2C+S&amp;rft.au=Bagarazzi%2C+M&amp;rft.au=May%2C+JM&amp;rft.au=Kane%2C+D&amp;rft.au=Lee%2C+H&amp;rft.au=Kobinger%2C+G&amp;rft.au=Michael%2C+NL&amp;rft.au=Weiner%2C+DB&amp;rft.au=Thomas%2C+SJ&amp;rft.au=Maslow%2C+JN&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7185789&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFYongOngYeapHo2019\">Yong CY, Ong HK, Yeap SK, Ho KL, Tan WS (2019). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6688523\" rel=\"nofollow\">\"Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus\"</a>. <i>Frontiers in Microbiology</i>. <b>10</b>: 1781. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.3389%2Ffmicb.2019.01781\" rel=\"nofollow\">10.3389/fmicb.2019.01781</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6688523\" rel=\"nofollow\">6688523</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/31428074\" rel=\"nofollow\">31428074</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Microbiology&amp;rft.atitle=Recent+Advances+in+the+Vaccine+Development+Against+Middle+East+Respiratory+Syndrome-Coronavirus&amp;rft.volume=10&amp;rft.pages=1781&amp;rft.date=2019&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6688523&amp;rft_id=info%3Apmid%2F31428074&amp;rft_id=info%3Adoi%2F10.3389%2Ffmicb.2019.01781&amp;rft.aulast=Yong&amp;rft.aufirst=CY&amp;rft.au=Ong%2C+HK&amp;rft.au=Yeap%2C+SK&amp;rft.au=Ho%2C+KL&amp;rft.au=Tan%2C+WS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6688523&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-time-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-time_22-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19\" rel=\"nofollow\">\"World Health Organization timeline – COVID-19\"</a>. World Health Organization. 27 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200429012212/https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19\" rel=\"nofollow\">Archived</a> from the original on 29 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=World+Health+Organization+timeline+%E2%80%93+COVID-19&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-04-27&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fdetail%2F27-04-2020-who-timeline---covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-thanh-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-thanh_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-thanh_23-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-thanh_23-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-thanh_23-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-thanh_23-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-thanh_23-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-thanh_23-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-thanh_23-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-thanh_23-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-thanh_23-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-thanh_23-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-thanh_23-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-thanh_23-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-thanh_23-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-thanh_23-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-thanh_23-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-thanh_23-16\"><sup><i><b>q</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFThanh_LeAndreadakisKumarGómez_Román2020\">Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M,  et al. (9 April 2020). <a class=\"external text\" href=\"https://www.nature.com/articles/d41573-020-00073-5\" rel=\"nofollow\">\"The COVID-19 vaccine development landscape\"</a>. <i>Nature Reviews Drug Discovery</i>. <b>19</b> (5): 305–06. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fd41573-020-00073-5\" rel=\"nofollow\">10.1038/d41573-020-00073-5</a></span>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/1474-1776\" rel=\"nofollow\">1474-1776</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32273591\" rel=\"nofollow\">32273591</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200510135439/https://www.nature.com/articles/d41573-020-00073-5\" rel=\"nofollow\">Archived</a> from the original on 10 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Drug+Discovery&amp;rft.atitle=The+COVID-19+vaccine+development+landscape&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=305-06&amp;rft.date=2020-04-09&amp;rft.issn=1474-1776&amp;rft_id=info%3Apmid%2F32273591&amp;rft_id=info%3Adoi%2F10.1038%2Fd41573-020-00073-5&amp;rft.aulast=Thanh+Le&amp;rft.aufirst=Tung&amp;rft.au=Andreadakis%2C+Zacharias&amp;rft.au=Kumar%2C+Arun&amp;rft.au=G%C3%B3mez+Rom%C3%A1n%2C+Ra%C3%BAl&amp;rft.au=Tollefsen%2C+Stig&amp;rft.au=Saville%2C+Melanie&amp;rft.au=Mayhew%2C+Stephen&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41573-020-00073-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-gates1-24\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gates1_24-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gates1_24-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-gates1_24-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-gates1_24-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-gates1_24-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-gates1_24-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-gates1_24-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-gates1_24-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFGates2020\">Gates B (February 2020). <a class=\"external text\" href=\"https://doi.org/10.1056%2Fnejmp2003762\" rel=\"nofollow\">\"Responding to Covid-19: A once-in-a-century pandemic?\"</a>. <i>The New England Journal of Medicine</i>. <b>382</b> (18): 1677–79. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1056%2Fnejmp2003762\" rel=\"nofollow\">10.1056/nejmp2003762</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32109012\" rel=\"nofollow\">32109012</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Responding+to+Covid-19%3A+A+once-in-a-century+pandemic%3F&amp;rft.volume=382&amp;rft.issue=18&amp;rft.pages=1677-79&amp;rft.date=2020-02&amp;rft_id=info%3Adoi%2F10.1056%2Fnejmp2003762&amp;rft_id=info%3Apmid%2F32109012&amp;rft.aulast=Gates&amp;rft.aufirst=B&amp;rft_id=%2F%2Fdoi.org%2F10.1056%252Fnejmp2003762&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-Fauci-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Fauci_25-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFFauciLaneRedfield2020\">Fauci AS, Lane HC, Redfield RR (March 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7121221\" rel=\"nofollow\">\"Covid-19: Navigating the uncharted\"</a>. <i>The New England Journal of Medicine</i>. <b>382</b> (13): 1268–69. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1056%2Fnejme2002387\" rel=\"nofollow\">10.1056/nejme2002387</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7121221\" rel=\"nofollow\">7121221</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32109011\" rel=\"nofollow\">32109011</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Covid-19%3A+Navigating+the+uncharted&amp;rft.volume=382&amp;rft.issue=13&amp;rft.pages=1268-69&amp;rft.date=2020-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7121221&amp;rft_id=info%3Apmid%2F32109011&amp;rft_id=info%3Adoi%2F10.1056%2Fnejme2002387&amp;rft.aulast=Fauci&amp;rft.aufirst=AS&amp;rft.au=Lane%2C+HC&amp;rft.au=Redfield%2C+RR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7121221&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFGrenfellDrew2020\">Grenfell R, Drew T (17 February 2020). <a class=\"external text\" href=\"https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away\" rel=\"nofollow\">\"Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus\"</a>. <i>ScienceAlert</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200228010631/https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away\" rel=\"nofollow\">Archived</a> from the original on 28 February 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 February</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ScienceAlert&amp;rft.atitle=Here%27s+Why+It%27s+Taking+So+Long+to+Develop+a+Vaccine+for+the+New+Coronavirus&amp;rft.date=2020-02-17&amp;rft.aulast=Grenfell&amp;rft.aufirst=Rob&amp;rft.au=Drew%2C+Trevor&amp;rft_id=https%3A%2F%2Fwww.sciencealert.com%2Fwho-says-a-coronavirus-vaccine-is-18-months-away&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-yamey-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-yamey_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-yamey_27-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-yamey_27-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-yamey_27-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-yamey_27-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-yamey_27-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFYameySchäferhoffHatchettPate2020\">Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, McDade KK (May 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7271264\" rel=\"nofollow\">\"Ensuring global access to COVID-19 vaccines\"</a>. <i>Lancet</i>. <b>395</b> (10234): 1405–06. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0140-6736%2820%2930763-7\" rel=\"nofollow\">10.1016/S0140-6736(20)30763-7</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7271264\" rel=\"nofollow\">7271264</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32243778\" rel=\"nofollow\">32243778</a>. <q>CEPI estimates that developing up to three vaccines in the next 12–18 months will require an investment of at least <span style=\"white-space: nowrap\">US$2</span><span class=\"nowrap\"> </span>billion. This estimate includes Phase<span class=\"nowrap\"> </span>1 clinical trials of eight vaccine candidates, progression of up to six candidates through Phase<span class=\"nowrap\"> </span>2 and<span class=\"nowrap\"> </span>3 trials, completion of regulatory and quality requirements for at least three vaccines, and enhancing global manufacturing capacity for three vaccines.</q></cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Ensuring+global+access+to+COVID-19+vaccines&amp;rft.volume=395&amp;rft.issue=10234&amp;rft.pages=1405-06&amp;rft.date=2020-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7271264&amp;rft_id=info%3Apmid%2F32243778&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2820%2930763-7&amp;rft.aulast=Yamey&amp;rft.aufirst=G&amp;rft.au=Sch%C3%A4ferhoff%2C+M&amp;rft.au=Hatchett%2C+R&amp;rft.au=Pate%2C+M&amp;rft.au=Zhao%2C+F&amp;rft.au=McDade%2C+KK&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7271264&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cepi-landmark-28\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cepi-landmark_28-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cepi-landmark_28-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://cepi.net/news_cepi/landmark-global-collaboration-launched-to-defeat-covid-19-pandemic/\" rel=\"nofollow\">\"Landmark global collaboration launched to defeat COVID-19 pandemic\"</a>. CEPI. 24 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200502023137/https://cepi.net/news_cepi/landmark-global-collaboration-launched-to-defeat-covid-19-pandemic/\" rel=\"nofollow\">Archived</a> from the original on 2 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>. <q>The global nature of a pandemic means that any vaccine or medicine that is successfully developed will be needed immediately all over the world. That means that the challenge we face is not only one of R&amp;D but one of manufacturing at scale, and equitable access.</q></cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Landmark+global+collaboration+launched+to+defeat+COVID-19+pandemic&amp;rft.pub=CEPI&amp;rft.date=2020-04-24&amp;rft_id=https%3A%2F%2Fcepi.net%2Fnews_cepi%2Flandmark-global-collaboration-launched-to-defeat-covid-19-pandemic%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cssa-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cssa_29-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFSchmidt2020\">Schmidt, Charles (1 June 2020). <a class=\"external text\" href=\"https://www.scientificamerican.com/article/genetic-engineering-could-make-a-covid-19-vaccine-in-months-rather-than-years1/\" rel=\"nofollow\">\"Genetic Engineering Could Make a COVID-19 Vaccine in Months Rather Than Years\"</a>. Scientific American.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Genetic+Engineering+Could+Make+a+COVID-19+Vaccine+in+Months+Rather+Than+Years&amp;rft.date=2020-06-01&amp;rft.aulast=Schmidt&amp;rft.aufirst=Charles&amp;rft_id=https%3A%2F%2Fwww.scientificamerican.com%2Farticle%2Fgenetic-engineering-could-make-a-covid-19-vaccine-in-months-rather-than-years1%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFFoxKelion2020\">Fox C, Kelion L (16 July 2020). <a class=\"external text\" href=\"https://www.bbc.com/news/technology-53429506\" rel=\"nofollow\">\"Russian spies 'target coronavirus vaccine<span class=\"cs1-kern-right\">'</span>\"</a>. <i>BBC News Online</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News+Online&amp;rft.atitle=Russian+spies+%27target+coronavirus+vaccine%27&amp;rft.date=2020-07-16&amp;rft.aulast=Fox&amp;rft.aufirst=Chris&amp;rft.au=Kelion%2C+Leo&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Ftechnology-53429506&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-covax-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-covax_31-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/initiatives/act-accelerator\" rel=\"nofollow\">\"The Access to COVID-19 Tools (ACT) Accelerator\"</a>. World Health Organization. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">29 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Access+to+COVID-19+Tools+%28ACT%29+Accelerator&amp;rft.pub=World+Health+Organization&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.who.int%2Finitiatives%2Fact-accelerator&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-covax-gavi-32\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-covax-gavi_32-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-covax-gavi_32-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.gavi.org/covid19/covax-facility\" rel=\"nofollow\">\"COVAX: Ensuring global equitable access to COVID-19 vaccines\"</a>. GAVI. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVAX%3A+Ensuring+global+equitable+access+to+COVID-19+vaccines&amp;rft.pub=GAVI&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.gavi.org%2Fcovid19%2Fcovax-facility&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-covax-33\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-covax_33-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-covax_33-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/news-room/detail/15-07-2020-more-than-150-countries-engaged-in-covid-19-vaccine-global-access-facility\" rel=\"nofollow\">\"More than 150 countries engaged in COVID-19 vaccine global access facility\"</a>. World Health Organization. 15 July 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 July</span> 2020</span>. <q>COVAX is the only truly global solution to the COVID-19 pandemic. For the vast majority of countries, whether they can afford to pay for their own doses or require assistance, it means receiving a guaranteed share of doses and avoiding being pushed to the back of the queue, as we saw during the H1N1 pandemic a decade ago. Even for those countries that are able to secure their own agreements with vaccine manufacturers, this mechanism represents, through its world-leading portfolio of vaccine candidates, a means of reducing the risks associated with individual candidates failing to show efficacy or gain licensure.</q></cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=More+than+150+countries+engaged+in+COVID-19+vaccine+global+access+facility&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-07-15&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fdetail%2F15-07-2020-more-than-150-countries-engaged-in-covid-19-vaccine-global-access-facility&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-reuters-34\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-reuters_34-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-reuters_34-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-reuters_34-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-reuters_34-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-reuters_34-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-reuters_34-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-reuters_34-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-reuters_34-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-reuters_34-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-reuters_34-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-reuters_34-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-reuters_34-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-reuters_34-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-reuters_34-13\"><sup><i><b>n</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFSteenhuysenEislerMartellNebehay2020\">Steenhuysen J, Eisler P, Martell A, Nebehay S (27 April 2020). <a class=\"external text\" href=\"https://www.reuters.com/article/health-coronavirus-vaccine-idUSL2N2CF0JG\" rel=\"nofollow\">\"Special Report: Countries, companies risk billions in race for coronavirus vaccine\"</a>. <i>Reuters</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200515031817/https://www.reuters.com/article/health-coronavirus-vaccine-idUSL2N2CF0JG\" rel=\"nofollow\">Archived</a> from the original on 15 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Special+Report%3A+Countries%2C+companies+risk+billions+in+race+for+coronavirus+vaccine&amp;rft.date=2020-04-27&amp;rft.aulast=Steenhuysen&amp;rft.aufirst=Julie&amp;rft.au=Eisler%2C+Peter&amp;rft.au=Martell%2C+Allison&amp;rft.au=Nebehay%2C+Stephanie&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fhealth-coronavirus-vaccine-idUSL2N2CF0JG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-sanger-35\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-sanger_35-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-sanger_35-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-sanger_35-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-sanger_35-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-sanger_35-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-sanger_35-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-sanger_35-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-sanger_35-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-sanger_35-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-sanger_35-9\"><sup><i><b>j</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFSangerKirkpatrickZimmerThomas2020\">Sanger DE, Kirkpatrick DD, Zimmer C, Thomas K, Wee S (2 May 2020). <a class=\"external text\" href=\"https://www.nytimes.com/2020/05/02/us/politics/vaccines-coronavirus-research.html\" rel=\"nofollow\">\"With Pressure Growing, Global Race for a Vaccine Intensifies\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\" rel=\"nofollow\">0362-4331</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200511003506/https://www.nytimes.com/2020/05/02/us/politics/vaccines-coronavirus-research.html\" rel=\"nofollow\">Archived</a> from the original on 11 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=With+Pressure+Growing%2C+Global+Race+for+a+Vaccine+Intensifies&amp;rft.date=2020-05-02&amp;rft.issn=0362-4331&amp;rft.aulast=Sanger&amp;rft.aufirst=David+E.&amp;rft.au=Kirkpatrick%2C+David+D.&amp;rft.au=Zimmer%2C+Carl&amp;rft.au=Thomas%2C+Katie&amp;rft.au=Wee%2C+Sui-Lee&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F05%2F02%2Fus%2Fpolitics%2Fvaccines-coronavirus-research.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFHamilton2020\">Hamilton IA (1 May 2020). <a class=\"external text\" href=\"https://www.businessinsider.com/bill-gates-10-promising-coronavirus-vaccine-candidates-2020-5\" rel=\"nofollow\">\"Bill Gates thinks there are 8 to 10 promising coronavirus vaccine candidates and one could be ready in as little as 9 months\"</a>. <i>Business Insider</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200516101559/https://www.businessinsider.com/bill-gates-10-promising-coronavirus-vaccine-candidates-2020-5\" rel=\"nofollow\">Archived</a> from the original on 16 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+Insider&amp;rft.atitle=Bill+Gates+thinks+there+are+8+to+10+promising+coronavirus+vaccine+candidates+and+one+could+be+ready+in+as+little+as+9+months&amp;rft.date=2020-05-01&amp;rft.aulast=Hamilton&amp;rft.aufirst=Isobel+Asher&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fbill-gates-10-promising-coronavirus-vaccine-candidates-2020-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.glopid-r.org/our-work/novel-coronavirus-covid-19\" rel=\"nofollow\">\"GloPID: Novel coronavirus COVID-19\"</a>. <i>glopid-r.org</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200502035337/https://www.glopid-r.org/our-work/novel-coronavirus-covid-19/\" rel=\"nofollow\">Archived</a> from the original on 2 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>. <q>GloPID-R Members and other major players involved in infectious disease outbreaks worldwide reacted rapidly to this emerging epidemic, working closely with WHO to identify the specific funding research priorities needed to tackle the disease.</q></cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=glopid-r.org&amp;rft.atitle=GloPID%3A+Novel+coronavirus+COVID-19&amp;rft_id=https%3A%2F%2Fwww.glopid-r.org%2Four-work%2Fnovel-coronavirus-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-can-research-38\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-can-research_38-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-can-research_38-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.canada.ca/en/public-health/services/publications/diseases-conditions/covid-19-government-canada-research-response.html\" rel=\"nofollow\">\"Government of Canada's research response to COVID-19\"</a>. Government of Canada. 23 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200513135919/https://www.canada.ca/en/public-health/services/publications/diseases-conditions/covid-19-government-canada-research-response.html\" rel=\"nofollow\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Government+of+Canada%27s+research+response+to+COVID-19&amp;rft.pub=Government+of+Canada&amp;rft.date=2020-04-23&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Fpublic-health%2Fservices%2Fpublications%2Fdiseases-conditions%2Fcovid-19-government-canada-research-response.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-isaric-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-isaric_39-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://isaric.tghn.org/covid-19-clinical-research-resources/\" rel=\"nofollow\">\"ISARIC: COVID-19 clinical research resources\"</a>. ISARIC. 27 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200330135638/https://isaric.tghn.org/covid-19-clinical-research-resources/\" rel=\"nofollow\">Archived</a> from the original on 30 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ISARIC%3A+COVID-19+clinical+research+resources&amp;rft.pub=ISARIC&amp;rft.date=2020-04-27&amp;rft_id=https%3A%2F%2Fisaric.tghn.org%2Fcovid-19-clinical-research-resources%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-gavi-summit-40\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gavi-summit_40-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gavi-summit_40-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-gavi-summit_40-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.gavi.org/news/media-room/world-leaders-make-historic-commitments-provide-equal-access-vaccines-all\" rel=\"nofollow\">\"Global Vaccine Summit 2020: World leaders make historic commitments to provide equal access to vaccines for all\"</a>. Global Alliance for Vaccines and Immunisation. 4 June 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200606161748/https://www.gavi.org/news/media-room/world-leaders-make-historic-commitments-provide-equal-access-vaccines-all\" rel=\"nofollow\">Archived</a> from the original on 6 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Global+Vaccine+Summit+2020%3A+World+leaders+make+historic+commitments+to+provide+equal+access+to+vaccines+for+all&amp;rft.pub=Global+Alliance+for+Vaccines+and+Immunisation&amp;rft.date=2020-06-04&amp;rft_id=https%3A%2F%2Fwww.gavi.org%2Fnews%2Fmedia-room%2Fworld-leaders-make-historic-commitments-provide-equal-access-vaccines-all&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease cs1\"><a class=\"external text\" href=\"https://www.prnewswire.com/news-releases/bill--melinda-gates-foundation-pledges-1-6-billion-to-gavi-the-vaccine-alliance-to-protect-the-next-generation-with-lifesaving-vaccines-301070878.html\" rel=\"nofollow\">\"Bill &amp; Melinda Gates Foundation pledges <span style=\"white-space: nowrap\">US$1.6</span><span class=\"nowrap\"> </span>billion to Gavi, the Vaccine Alliance, to protect the next generation with lifesaving vaccines\"</a> (Press release). The Bill &amp; Melinda Gates Foundation. 4 June 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200604165907/https://www.prnewswire.com/news-releases/bill--melinda-gates-foundation-pledges-1-6-billion-to-gavi-the-vaccine-alliance-to-protect-the-next-generation-with-lifesaving-vaccines-301070878.html\" rel=\"nofollow\">Archived</a> from the original on 4 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 June</span> 2020</span> – via PR Newswire.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bill+%26+Melinda+Gates+Foundation+pledges+%3Cspan+style%3D%22white-space%3A+nowrap%22%3EUS%241.6%3C%2Fspan%3E%3Cspan+class%3D%22nowrap%22%3E+%3C%2Fspan%3Ebillion+to+Gavi%2C+the+Vaccine+Alliance%2C+to+protect+the+next+generation+with+lifesaving+vaccines&amp;rft.pub=The+Bill+%26+Melinda+Gates+Foundation&amp;rft.date=2020-06-04&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fbill--melinda-gates-foundation-pledges-1-6-billion-to-gavi-the-vaccine-alliance-to-protect-the-next-generation-with-lifesaving-vaccines-301070878.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-abedi-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-abedi_42-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFAbedi2020\">Abedi M (23 March 2020). <a class=\"external text\" href=\"https://globalnews.ca/news/6717883/coronavirus-canada-vaccine-spending/\" rel=\"nofollow\">\"Canada to spend $192M on developing COVID-19 vaccine\"</a>. <i>Global News</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200409200638/https://globalnews.ca/news/6717883/coronavirus-canada-vaccine-spending/\" rel=\"nofollow\">Archived</a> from the original on 9 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 March</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Global+News&amp;rft.atitle=Canada+to+spend+%24192M+on+developing+COVID-19+vaccine&amp;rft.date=2020-03-23&amp;rft.aulast=Abedi&amp;rft.aufirst=Maham&amp;rft_id=https%3A%2F%2Fglobalnews.ca%2Fnews%2F6717883%2Fcoronavirus-canada-vaccine-spending%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-can-funding-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-can-funding_43-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html\" rel=\"nofollow\">\"Government of Canada funds 49 additional COVID-19 research projects – Details of the funded projects\"</a>. Government of Canada. 23 March 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200322163807/https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html\" rel=\"nofollow\">Archived</a> from the original on 22 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Government+of+Canada+funds+49+additional+COVID-19+research+projects+%E2%80%93+Details+of+the+funded+projects&amp;rft.pub=Government+of+Canada&amp;rft.date=2020-03-23&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Finstitutes-health-research%2Fnews%2F2020%2F03%2Fgovernment-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-aiello-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-aiello_44-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFAiello2020\">Aiello R (4 May 2020). <a class=\"external text\" href=\"https://www.ctvnews.ca/health/coronavirus/a-global-challenge-pm-trudeau-commits-850-million-to-global-fight-against-covid-19-1.4923565\" rel=\"nofollow\">\"<span class=\"cs1-kern-left\">'</span>A global challenge': PM Trudeau commits $850 million to global fight against COVID-19\"</a>. <i>CTV News</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200510070903/https://www.ctvnews.ca/health/coronavirus/a-global-challenge-pm-trudeau-commits-850-million-to-global-fight-against-covid-19-1.4923565\" rel=\"nofollow\">Archived</a> from the original on 10 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CTV+News&amp;rft.atitle=%27A+global+challenge%27%3A+PM+Trudeau+commits+%24850+million+to+global+fight+against+COVID-19&amp;rft.date=2020-05-04&amp;rft.aulast=Aiello&amp;rft.aufirst=Rachel&amp;rft_id=https%3A%2F%2Fwww.ctvnews.ca%2Fhealth%2Fcoronavirus%2Fa-global-challenge-pm-trudeau-commits-850-million-to-global-fight-against-covid-19-1.4923565&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-takada-45\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-takada_45-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-takada_45-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFTakadaSatake2020\">Takada N, Satake M (2 May 2020). <a class=\"external text\" href=\"https://asia.nikkei.com/Spotlight/Coronavirus/US-and-China-unleash-wallets-in-race-for-coronavirus-vaccine\" rel=\"nofollow\">\"US and China unleash wallets in race for coronavirus vaccine\"</a>. <i>Nikkei Asian Review</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200510111134/https://asia.nikkei.com/Spotlight/Coronavirus/US-and-China-unleash-wallets-in-race-for-coronavirus-vaccine\" rel=\"nofollow\">Archived</a> from the original on 10 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nikkei+Asian+Review&amp;rft.atitle=US+and+China+unleash+wallets+in+race+for+coronavirus+vaccine&amp;rft.date=2020-05-02&amp;rft.aulast=Takada&amp;rft.aufirst=Noriyuki&amp;rft.au=Satake%2C+Minoru&amp;rft_id=https%3A%2F%2Fasia.nikkei.com%2FSpotlight%2FCoronavirus%2FUS-and-China-unleash-wallets-in-race-for-coronavirus-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\">Yuliya Talmazan, Keir Simmons, Laura Saravia (18 May 2020). <a class=\"external text\" href=\"https://www.nbcnews.com/news/world/coronavirus-who-faces-global-call-investigation-general-assembly-n1209061\" rel=\"nofollow\">\"China's Xi announces $2B for coronavirus response as WHO faces calls for investigation\"</a>. <i>NBC News</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200518171737/https://www.nbcnews.com/news/world/coronavirus-who-faces-global-call-investigation-general-assembly-n1209061\" rel=\"nofollow\">Archived</a> from the original on 18 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">18 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NBC+News&amp;rft.atitle=China%27s+Xi+announces+%242B+for+coronavirus+response+as+WHO+faces+calls+for+investigation&amp;rft.date=2020-05-18&amp;rft_id=https%3A%2F%2Fwww.nbcnews.com%2Fnews%2Fworld%2Fcoronavirus-who-faces-global-call-investigation-general-assembly-n1209061&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFOre2020\">Ore, Diego (23 July 2020). <a class=\"external text\" href=\"https://www.reuters.com/article/us-health-coronavirus-mexico-china/mexico-says-china-plans-1-billion-loan-to-ease-latam-access-to-virus-vaccine-idUSKCN24O08L\" rel=\"nofollow\">\"Mexico says China plans $1 billion loan to ease Latam access to virus vaccine\"</a>. <i>Reuters</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Mexico+says+China+plans+%241+billion+loan+to+ease+Latam+access+to+virus+vaccine&amp;rft.date=2020-07-23&amp;rft.aulast=Ore&amp;rft.aufirst=Diego&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-health-coronavirus-mexico-china%2Fmexico-says-china-plans-1-billion-loan-to-ease-latam-access-to-virus-vaccine-idUSKCN24O08L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.scmp.com/news/china/diplomacy/article/3098610/china-promises-its-mekong-neighbours-priority-access\" rel=\"nofollow\">\"China promises Mekong neighbours access to Chinese Covid-19 vaccine\"</a>. <i>South China Morning Post</i>. 24 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=South+China+Morning+Post&amp;rft.atitle=China+promises+Mekong+neighbours+access+to+Chinese+Covid-19+vaccine&amp;rft.date=2020-08-24&amp;rft_id=https%3A%2F%2Fwww.scmp.com%2Fnews%2Fchina%2Fdiplomacy%2Farticle%2F3098610%2Fchina-promises-its-mekong-neighbours-priority-access&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cepi-4-30-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cepi-4-30_49-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://cepi.net/research_dev/our-portfolio/\" rel=\"nofollow\">\"CEPI: Our vaccine and platform portfolio\"</a>. Coalition for Epidemic Preparedness Innovation (CEPI). 30 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200507133020/https://cepi.net/research_dev/our-portfolio/\" rel=\"nofollow\">Archived</a> from the original on 7 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CEPI%3A+Our+vaccine+and+platform+portfolio&amp;rft.pub=Coalition+for+Epidemic+Preparedness+Innovation+%28CEPI%29&amp;rft.date=2020-04-30&amp;rft_id=https%3A%2F%2Fcepi.net%2Fresearch_dev%2Four-portfolio%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cepi3-19-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cepi3-19_50-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://cepi.net/news_cepi/cepi-collaborates-with-the-institut-pasteur-in-a-consortium-to-develop-covid-19-vaccine/\" rel=\"nofollow\">\"CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine\"</a>. Coalition for Epidemic Preparedness Innovations. 19 March 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200322233816/https://cepi.net/news_cepi/cepi-collaborates-with-the-institut-pasteur-in-a-consortium-to-develop-covid-19-vaccine/\" rel=\"nofollow\">Archived</a> from the original on 22 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CEPI+collaborates+with+the+Institut+Pasteur+in+a+consortium+to+develop+COVID-19+vaccine&amp;rft.pub=Coalition+for+Epidemic+Preparedness+Innovations&amp;rft.date=2020-03-19&amp;rft_id=https%3A%2F%2Fcepi.net%2Fnews_cepi%2Fcepi-collaborates-with-the-institut-pasteur-in-a-consortium-to-develop-covid-19-vaccine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-curevac-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-curevac_51-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://ec.europa.eu/commission/presscorner/detail/en/ip_20_474\" rel=\"nofollow\">\"Coronavirus: Commission offers financing to innovative vaccines company CureVac\"</a>. European Commission. 16 March 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200319161432/https://ec.europa.eu/commission/presscorner/detail/en/ip_20_474\" rel=\"nofollow\">Archived</a> from the original on 19 March 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 March</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus%3A+Commission+offers+financing+to+innovative+vaccines+company+CureVac&amp;rft.pub=European+Commission&amp;rft.date=2020-03-16&amp;rft_id=https%3A%2F%2Fec.europa.eu%2Fcommission%2Fpresscorner%2Fdetail%2Fen%2Fip_20_474&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.spiegel.de/wirtschaft/bundesregierung-beteiligt-sich-an-impfstoffhersteller-curevac-a-2c915a65-5e89-407c-91d0-8fa2200efa00\" rel=\"nofollow\">\"Corona-Impfstoff: Bundesregierung beteiligt sich an Impfstoffhersteller CureVac\"</a>. <i>www.spiegel.de</i> (in German). Der Spiegel. <a class=\"external text\" href=\"https://web.archive.org/web/20200616073818/https://www.spiegel.de/wirtschaft/bundesregierung-beteiligt-sich-an-impfstoffhersteller-curevac-a-2c915a65-5e89-407c-91d0-8fa2200efa00\" rel=\"nofollow\">Archived</a> from the original on 16 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.spiegel.de&amp;rft.atitle=Corona-Impfstoff%3A+Bundesregierung+beteiligt+sich+an+Impfstoffhersteller+CureVac&amp;rft_id=https%3A%2F%2Fwww.spiegel.de%2Fwirtschaft%2Fbundesregierung-beteiligt-sich-an-impfstoffhersteller-curevac-a-2c915a65-5e89-407c-91d0-8fa2200efa00&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-morriss-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-morriss_53-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFMorriss2020\">Morriss E (22 April 2020). <a class=\"external text\" href=\"https://pharmafield.co.uk/pharma_news/government-launches-coronavirus-vaccine-taskforce-as-human-clinical-trials-start/\" rel=\"nofollow\">\"Government launches coronavirus vaccine taskforce as human clinical trials start\"</a>. Pharmafield<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Government+launches+coronavirus+vaccine+taskforce+as+human+clinical+trials+start&amp;rft.pub=Pharmafield&amp;rft.date=2020-04-22&amp;rft.aulast=Morriss&amp;rft.aufirst=Emma&amp;rft_id=https%3A%2F%2Fpharmafield.co.uk%2Fpharma_news%2Fgovernment-launches-coronavirus-vaccine-taskforce-as-human-clinical-trials-start%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-gartner-54\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gartner_54-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gartner_54-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFGartnerRoberts2020\">Gartner A, Roberts L (3 May 2020). <a class=\"external text\" href=\"https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-vaccine-uk-trials-news-latest-update-covid-19/\" rel=\"nofollow\">\"How close are we to a coronavirus vaccine? Latest news on UK trials\"</a>. <i>The Telegraph</i>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0307-1235\" rel=\"nofollow\">0307-1235</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200504203335/https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-vaccine-uk-trials-news-latest-update-covid-19/\" rel=\"nofollow\">Archived</a> from the original on 4 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Telegraph&amp;rft.atitle=How+close+are+we+to+a+coronavirus+vaccine%3F+Latest+news+on+UK+trials&amp;rft.date=2020-05-03&amp;rft.issn=0307-1235&amp;rft.aulast=Gartner&amp;rft.aufirst=Annelies&amp;rft.au=Roberts%2C+Lizzie&amp;rft_id=https%3A%2F%2Fwww.telegraph.co.uk%2Fglobal-health%2Fscience-and-disease%2Fcoronavirus-vaccine-uk-trials-news-latest-update-covid-19%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-oxford-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-oxford_55-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.ox.ac.uk/news/2020-04-30-landmark-partnership-announced-development-covid-19-vaccine\" rel=\"nofollow\">\"Landmark partnership announced for development of COVID-19 vaccine\"</a>. University of Oxford. 30 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200513010438/http://www.ox.ac.uk/news/2020-04-30-landmark-partnership-announced-development-covid-19-vaccine\" rel=\"nofollow\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Landmark+partnership+announced+for+development+of+COVID-19+vaccine&amp;rft.pub=University+of+Oxford&amp;rft.date=2020-04-30&amp;rft_id=http%3A%2F%2Fwww.ox.ac.uk%2Fnews%2F2020-04-30-landmark-partnership-announced-development-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-kuznia-56\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-kuznia_56-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-kuznia_56-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFKuzniaPolglaseMezzofiore2020\">Kuznia R, Polglase K, Mezzofiore G (1 May 2020). <a class=\"external text\" href=\"https://www.cnn.com/2020/05/01/us/coronavirus-moderna-vaccine-invs/index.html\" rel=\"nofollow\">\"In quest for vaccine, US makes 'big bet' on company with unproven technology\"</a>. <i>CNN</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200513005730/https://www.cnn.com/2020/05/01/us/coronavirus-moderna-vaccine-invs/index.html\" rel=\"nofollow\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=In+quest+for+vaccine%2C+US+makes+%27big+bet%27+on+company+with+unproven+technology&amp;rft.date=2020-05-01&amp;rft.aulast=Kuznia&amp;rft.aufirst=Robert&amp;rft.au=Polglase%2C+Katie&amp;rft.au=Mezzofiore%2C+Gianluca&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2020%2F05%2F01%2Fus%2Fcoronavirus-moderna-vaccine-invs%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-lee-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-lee_57-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFLeeWelkerPerlmutter-Gumbiner2020\">Lee CE, Welker K, Perlmutter-Gumbiner E (1 May 2020). <a class=\"external text\" href=\"https://www.nbcnews.com/politics/white-house/health-officials-eyeing-least-one-14-potential-coronavirus-vaccines-fast-n1198326\" rel=\"nofollow\">\"Health officials eyeing at least one of 14 potential coronavirus vaccines to fast-track\"</a>. <i>NBC News</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200511104127/https://www.nbcnews.com/politics/white-house/health-officials-eyeing-least-one-14-potential-coronavirus-vaccines-fast-n1198326\" rel=\"nofollow\">Archived</a> from the original on 11 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NBC+News&amp;rft.atitle=Health+officials+eyeing+at+least+one+of+14+potential+coronavirus+vaccines+to+fast-track&amp;rft.date=2020-05-01&amp;rft.aulast=Lee&amp;rft.aufirst=Carol+E&amp;rft.au=Welker%2C+Kristen&amp;rft.au=Perlmutter-Gumbiner%2C+Elyse&amp;rft_id=https%3A%2F%2Fwww.nbcnews.com%2Fpolitics%2Fwhite-house%2Fhealth-officials-eyeing-least-one-14-potential-coronavirus-vaccines-fast-n1198326&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-58\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFCohen2020\">Cohen J (15 May 2020). <a class=\"external text\" href=\"https://science.sciencemag.org/content/368/6492/692\" rel=\"nofollow\">\"U.S. 'Warp Speed' vaccine effort comes out of the shadows\"</a>. <i>Science</i>. <b>368</b> (6492): 692–93. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Sci...368..692C\" rel=\"nofollow\">2020Sci...368..692C</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.368.6492.692\" rel=\"nofollow\">10.1126/science.368.6492.692</a></span>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0036-8075\" rel=\"nofollow\">0036-8075</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32409451\" rel=\"nofollow\">32409451</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200519111116/https://science.sciencemag.org/content/368/6492/692\" rel=\"nofollow\">Archived</a> from the original on 19 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=U.S.+%27Warp+Speed%27+vaccine+effort+comes+out+of+the+shadows&amp;rft.volume=368&amp;rft.issue=6492&amp;rft.pages=692-93&amp;rft.date=2020-05-15&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.368.6492.692&amp;rft.issn=0036-8075&amp;rft_id=info%3Apmid%2F32409451&amp;rft_id=info%3Abibcode%2F2020Sci...368..692C&amp;rft.aulast=Cohen&amp;rft.aufirst=Jon&amp;rft_id=https%3A%2F%2Fscience.sciencemag.org%2Fcontent%2F368%2F6492%2F692&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\">Justin Sink, Jordan Fabian, Riley Griffin (15 May 2020). <a class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2020-05-15/trump-to-introduce-warp-speed-leaders-after-vaccine-criticism\" rel=\"nofollow\">\"Trump introduces 'Warp Speed' leaders to hasten COVID-19 vaccine\"</a>. <i>Bloomberg</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200521231515/https://www.bloomberg.com/news/articles/2020-05-15/trump-to-introduce-warp-speed-leaders-after-vaccine-criticism\" rel=\"nofollow\">Archived</a> from the original on 21 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=Trump+introduces+%27Warp+Speed%27+leaders+to+hasten+COVID-19+vaccine&amp;rft.date=2020-05-15&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2020-05-15%2Ftrump-to-introduce-warp-speed-leaders-after-vaccine-criticism&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-60\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\">Riley Griffith, Jennifer Jacobs (3 June 2020). <a class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2020-06-03/white-house-working-with-seven-drugmakers-in-warp-speed-push\" rel=\"nofollow\">\"White House Works With Seven Drugmakers in 'Warp Speed' Push\"</a>. <i>Bloomberg</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200603220008/https://www.bloomberg.com/news/articles/2020-06-03/white-house-working-with-seven-drugmakers-in-warp-speed-push\" rel=\"nofollow\">Archived</a> from the original on 3 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=White+House+Works+With+Seven+Drugmakers+in+%27Warp+Speed%27+Push&amp;rft.date=2020-06-03&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2020-06-03%2Fwhite-house-working-with-seven-drugmakers-in-warp-speed-push&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-solidarity-vacc-61\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-solidarity-vacc_61-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-solidarity-vacc_61-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-solidarity-vacc_61-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-solidarity-vacc_61-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-solidarity-vacc_61-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/blueprint/priority-diseases/key-action/Outline_CoreProtocol_vaccine_trial_09042020.pdf\" rel=\"nofollow\">\"An international randomised trial of candidate vaccines against COVID-19: Outline of Solidarity vaccine trial\"</a> <span class=\"cs1-format\">(PDF)</span>. World Health Organization. 9 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200512115627/https://www.who.int/blueprint/priority-diseases/key-action/Outline_CoreProtocol_vaccine_trial_09042020.pdf\" rel=\"nofollow\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 12 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=An+international+randomised+trial+of+candidate+vaccines+against+COVID-19%3A+Outline+of+Solidarity+vaccine+trial&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-04-09&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fblueprint%2Fpriority-diseases%2Fkey-action%2FOutline_CoreProtocol_vaccine_trial_09042020.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-pallmann-62\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pallmann_62-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pallmann_62-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFPallmannBeddingChoodari-OskooeiDimairo2018\">Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV,  et al. (February 2018). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5830330\" rel=\"nofollow\">\"Adaptive designs in clinical trials: why use them, and how to run and report them\"</a>. <i>BMC Medicine</i>. <b>16</b> (1): 29. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1186%2Fs12916-018-1017-7\" rel=\"nofollow\">10.1186/s12916-018-1017-7</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5830330\" rel=\"nofollow\">5830330</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/29490655\" rel=\"nofollow\">29490655</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Medicine&amp;rft.atitle=Adaptive+designs+in+clinical+trials%3A+why+use+them%2C+and+how+to+run+and+report+them&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=29&amp;rft.date=2018-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5830330&amp;rft_id=info%3Apmid%2F29490655&amp;rft_id=info%3Adoi%2F10.1186%2Fs12916-018-1017-7&amp;rft.aulast=Pallmann&amp;rft.aufirst=P&amp;rft.au=Bedding%2C+AW&amp;rft.au=Choodari-Oskooei%2C+B&amp;rft.au=Dimairo%2C+M&amp;rft.au=Flight%2C+L&amp;rft.au=Hampson%2C+LV&amp;rft.au=Holmes%2C+J&amp;rft.au=Mander%2C+AP&amp;rft.au=Odondi%2C+L&amp;rft.au=Sydes%2C+MR&amp;rft.au=Villar%2C+SS&amp;rft.au=Wason%2C+JM&amp;rft.au=Weir%2C+CJ&amp;rft.au=Wheeler%2C+GM&amp;rft.au=Yap%2C+C&amp;rft.au=Jaki%2C+T&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5830330&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-fda-adaptive-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-fda-adaptive_63-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.fda.gov/media/78495/download\" rel=\"nofollow\">\"Adaptive designs for clinical trials of drugs and biologics: Guidance for industry\"</a>. U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA). 1 November 2019. <a class=\"external text\" href=\"https://web.archive.org/web/20191213234438/https://www.fda.gov/media/78495/download\" rel=\"nofollow\">Archived</a> from the original on 13 December 2019<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Adaptive+designs+for+clinical+trials+of+drugs+and+biologics%3A+Guidance+for+industry&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2019-11-01&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F78495%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-64\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFMcGrail2020\">McGrail S (15 April 2020). <a class=\"external text\" href=\"https://pharmanewsintel.com/news/sanofi-gsk-partner-to-develop-adjuvanted-covid-19-vaccine\" rel=\"nofollow\">\"Sanofi, GSK partner to develop adjuvanted COVID-19 vaccine\"</a>. PharmaNewsIntelligence. <a class=\"external text\" href=\"https://web.archive.org/web/20200509223306/https://pharmanewsintel.com/news/sanofi-gsk-partner-to-develop-adjuvanted-covid-19-vaccine\" rel=\"nofollow\">Archived</a> from the original on 9 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Sanofi%2C+GSK+partner+to+develop+adjuvanted+COVID-19+vaccine&amp;rft.pub=PharmaNewsIntelligence&amp;rft.date=2020-04-15&amp;rft.aulast=McGrail&amp;rft.aufirst=Samantha&amp;rft_id=https%3A%2F%2Fpharmanewsintel.com%2Fnews%2Fsanofi-gsk-partner-to-develop-adjuvanted-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-blueprint-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-blueprint_65-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/blueprint/priority-diseases/key-action/Coronavirus_Roadmap_V9.pdf?ua=1\" rel=\"nofollow\">\"R&amp;D Blueprint: A coordinated global research roadmap – 2019 novel coronavirus\"</a> <span class=\"cs1-format\">(PDF)</span>. World Health Organization. 1 March 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200515101822/https://www.who.int/blueprint/priority-diseases/key-action/Coronavirus_Roadmap_V9.pdf?ua=1\" rel=\"nofollow\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 15 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=R%26D+Blueprint%3A+A+coordinated+global+research+roadmap+%E2%80%93+2019+novel+coronavirus&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-03-01&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fblueprint%2Fpriority-diseases%2Fkey-action%2FCoronavirus_Roadmap_V9.pdf%3Fua%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-66\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFJeong-hoZhengZhou2020\">Jeong-ho L, Zheng W, Zhou L (26 January 2020). <a class=\"external text\" href=\"https://www.scmp.com/news/china/society/article/3047676/number-coronavirus-cases-china-doubles-spread-rate-accelerates\" rel=\"nofollow\">\"Chinese scientists race to develop vaccine as coronavirus death toll jumps\"</a>. <i><a href=\"/wiki/South_China_Morning_Post\" title=\"South China Morning Post\">South China Morning Post</a></i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200126073453/https://www.scmp.com/news/china/society/article/3047676/number-coronavirus-cases-china-doubles-spread-rate-accelerates\" rel=\"nofollow\">Archived</a> from the original on 26 January 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 January</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=South+China+Morning+Post&amp;rft.atitle=Chinese+scientists+race+to+develop+vaccine+as+coronavirus+death+toll+jumps&amp;rft.date=2020-01-26&amp;rft.aulast=Jeong-ho&amp;rft.aufirst=Lee&amp;rft.au=Zheng%2C+William&amp;rft.au=Zhou%2C+Laura&amp;rft_id=https%3A%2F%2Fwww.scmp.com%2Fnews%2Fchina%2Fsociety%2Farticle%2F3047676%2Fnumber-coronavirus-cases-china-doubles-spread-rate-accelerates&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-wee-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-wee_67-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFWee2020\">Wee S (4 May 2020). <a class=\"external text\" href=\"https://www.nytimes.com/2020/05/04/business/coronavirus-china-vaccine.html\" rel=\"nofollow\">\"China's coronavirus vaccine drive empowers a troubled industry\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\" rel=\"nofollow\">0362-4331</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200504175312/https://www.nytimes.com/2020/05/04/business/coronavirus-china-vaccine.html\" rel=\"nofollow\">Archived</a> from the original on 4 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=China%27s+coronavirus+vaccine+drive+empowers+a+troubled+industry&amp;rft.date=2020-05-04&amp;rft.issn=0362-4331&amp;rft.aulast=Wee&amp;rft.aufirst=Sui-Lee&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F05%2F04%2Fbusiness%2Fcoronavirus-china-vaccine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-simpson-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-simpson_68-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFSimpsonKaufmannGlozmanChakrabarti2020\">Simpson S, Kaufmann MC, Glozman V, Chakrabarti A (May 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7158580\" rel=\"nofollow\">\"Disease X: accelerating the development of medical countermeasures for the next pandemic\"</a>. <i>The Lancet. Infectious Diseases</i>. <b>20</b> (5): e108–15. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS1473-3099%2820%2930123-7\" rel=\"nofollow\">10.1016/S1473-3099(20)30123-7</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/1474-4457\" rel=\"nofollow\">1474-4457</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7158580\" rel=\"nofollow\">7158580</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32197097\" rel=\"nofollow\">32197097</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Infectious+Diseases&amp;rft.atitle=Disease+X%3A+accelerating+the+development+of+medical+countermeasures+for+the+next+pandemic&amp;rft.volume=20&amp;rft.issue=5&amp;rft.pages=e108-15&amp;rft.date=2020-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7158580&amp;rft.issn=1474-4457&amp;rft_id=info%3Apmid%2F32197097&amp;rft_id=info%3Adoi%2F10.1016%2FS1473-3099%2820%2930123-7&amp;rft.aulast=Simpson&amp;rft.aufirst=Shmona&amp;rft.au=Kaufmann%2C+Michael+C.&amp;rft.au=Glozman%2C+Vitaly&amp;rft.au=Chakrabarti%2C+Ajoy&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7158580&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-bio-69\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-bio_69-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-bio_69-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-bio_69-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-bio_69-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf\" rel=\"nofollow\">\"Clinical Development Success Rates 2006–2015\"</a> <span class=\"cs1-format\">(PDF)</span>. BIO Industry Analysis. June 2016. <a class=\"external text\" href=\"https://web.archive.org/web/20190912220246/https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf\" rel=\"nofollow\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 12 September 2019<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Clinical+Development+Success+Rates+2006%E2%80%932015&amp;rft.pub=BIO+Industry+Analysis&amp;rft.date=2016-06&amp;rft_id=https%3A%2F%2Fwww.bio.org%2Fsites%2Fdefault%2Ffiles%2FClinical%2520Development%2520Success%2520Rates%25202006-2015%2520-%2520BIO%2C%2520Biomedtracker%2C%2520Amplion%25202016.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-70\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFBlackwell2020\">Blackwell T (20 April 2020). <a class=\"external text\" href=\"https://nationalpost.com/news/covid-19-vaccine-researchers-say-pandemic-lockdown-placing-many-serious-obstacles-to-their-work\" rel=\"nofollow\">\"COVID-19 vaccine researchers say pandemic lockdown placing many serious obstacles to their work\"</a>. <i>National Post</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=National+Post&amp;rft.atitle=COVID-19+vaccine+researchers+say+pandemic+lockdown+placing+many+serious+obstacles+to+their+work&amp;rft.date=2020-04-20&amp;rft.aulast=Blackwell&amp;rft.aufirst=Tom&amp;rft_id=https%3A%2F%2Fnationalpost.com%2Fnews%2Fcovid-19-vaccine-researchers-say-pandemic-lockdown-placing-many-serious-obstacles-to-their-work&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-71\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFChen2020\">Chen J (4 May 2020). <a class=\"external text\" href=\"https://www.statnews.com/2020/05/04/coronavirus-lab-shutdowns-impact-on-scientists-research-delays/\" rel=\"nofollow\">\"Covid-19 has shuttered labs. It could put a generation of researchers at risk\"</a>. STAT. <a class=\"external text\" href=\"https://web.archive.org/web/20200506072301/https://www.statnews.com/2020/05/04/coronavirus-lab-shutdowns-impact-on-scientists-research-delays/\" rel=\"nofollow\">Archived</a> from the original on 6 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Covid-19+has+shuttered+labs.+It+could+put+a+generation+of+researchers+at+risk&amp;rft.pub=STAT&amp;rft.date=2020-05-04&amp;rft.aulast=Chen&amp;rft.aufirst=Justin&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F05%2F04%2Fcoronavirus-lab-shutdowns-impact-on-scientists-research-delays%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-Vaccines.gov-73\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Vaccines.gov_73-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Vaccines.gov_73-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.vaccines.gov/basics/safety\" rel=\"nofollow\">\"Vaccine Safety – Vaccines\"</a>. <i>vaccines.gov</i>. US Department of Health and Human Services. <a class=\"external text\" href=\"https://web.archive.org/web/20200422073442/https://www.vaccines.gov/basics/safety\" rel=\"nofollow\">Archived</a> from the original on 22 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=vaccines.gov&amp;rft.atitle=Vaccine+Safety+%E2%80%93+Vaccines&amp;rft_id=https%3A%2F%2Fwww.vaccines.gov%2Fbasics%2Fsafety&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-fda-ddp-74\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-fda-ddp_74-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-fda-ddp_74-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-fda-ddp_74-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process\" rel=\"nofollow\">\"The drug development process\"</a>. U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA). 4 January 2018. <a class=\"external text\" href=\"https://web.archive.org/web/20200222182002/https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process\" rel=\"nofollow\">Archived</a> from the original on 22 February 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">12 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+drug+development+process&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2018-01-04&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fpatients%2Flearn-about-drug-and-device-approvals%2Fdrug-development-process&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cohen6-19-75\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cohen6-19_75-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cohen6-19_75-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-cohen6-19_75-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-cohen6-19_75-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-cohen6-19_75-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFCohen2020\">Cohen J (19 June 2020). <a class=\"external text\" href=\"https://science.sciencemag.org/content/368/6497/1295\" rel=\"nofollow\">\"Pandemic vaccines are about to face the real test\"</a>. <i>Science</i>. <b>368</b> (6497): 1295–96. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Sci...368.1295C\" rel=\"nofollow\">2020Sci...368.1295C</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.368.6497.1295\" rel=\"nofollow\">10.1126/science.368.6497.1295</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32554572\" rel=\"nofollow\">32554572</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200621082652/https://science.sciencemag.org/content/368/6497/1295\" rel=\"nofollow\">Archived</a> from the original on 21 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Pandemic+vaccines+are+about+to+face+the+real+test&amp;rft.volume=368&amp;rft.issue=6497&amp;rft.pages=1295-96&amp;rft.date=2020-06-19&amp;rft_id=info%3Apmid%2F32554572&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.368.6497.1295&amp;rft_id=info%3Abibcode%2F2020Sci...368.1295C&amp;rft.aulast=Cohen&amp;rft.aufirst=Jon&amp;rft_id=https%3A%2F%2Fscience.sciencemag.org%2Fcontent%2F368%2F6497%2F1295&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cdc-eff-76\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cdc-eff_76-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.cdc.gov/flu/vaccines-work/effectivenessqa.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Fvaccination%2Feffectivenessqa.htm\" rel=\"nofollow\">\"How flu vaccine effectiveness and efficacy are measured\"</a>. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, US Department of Health and Human Services. 29 January 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=How+flu+vaccine+effectiveness+and+efficacy+are+measured&amp;rft.pub=Centers+for+Disease+Control+and+Prevention%2C+National+Center+for+Immunization+and+Respiratory+Diseases%2C+US+Department+of+Health+and+Human+Services&amp;rft.date=2016-01-29&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fvaccines-work%2Feffectivenessqa.htm%3FCDC_AA_refVal%3Dhttps%253A%252F%252Fwww.cdc.gov%252Fflu%252Fprofessionals%252Fvaccination%252Feffectivenessqa.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-77\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section8.html\" rel=\"nofollow\">\"Principles of epidemiology, Section 8: Concepts of disease occurrence\"</a>. Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services, US Department of Health and Human Services. 18 May 2012. <a class=\"external text\" href=\"https://web.archive.org/web/20200406212227/https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section8.html\" rel=\"nofollow\">Archived</a> from the original on 6 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Principles+of+epidemiology%2C+Section+8%3A+Concepts+of+disease+occurrence&amp;rft.pub=Centers+for+Disease+Control+and+Prevention%2C+Center+for+Surveillance%2C+Epidemiology%2C+and+Laboratory+Services%2C+US+Department+of+Health+and+Human+Services&amp;rft.date=2012-05-18&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fcsels%2Fdsepd%2Fss1978%2Flesson1%2Fsection8.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-80\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-80\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFWalshShelleyDuweBonnett2020\">Walsh N, Shelley J, Duwe E, Bonnett W (27 July 2020). <a class=\"external text\" href=\"https://edition.cnn.com/2020/07/27/americas/brazil-covid-19-sinovac-vaccine-intl/index.html\" rel=\"nofollow\">\"The world's hopes for a coronavirus vaccine may run in these health care workers' veins\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>. <a href=\"/wiki/S%C3%A3o_Paulo\" title=\"São Paulo\">São Paulo</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=The+world%27s+hopes+for+a+coronavirus+vaccine+may+run+in+these+health+care+workers%27+veins&amp;rft.date=2020-07-27&amp;rft.aulast=Walsh&amp;rft.aufirst=Nick&amp;rft.au=Shelley%2C+Jo&amp;rft.au=Duwe%2C+Eduardo&amp;rft.au=Bonnett%2C+William&amp;rft_id=https%3A%2F%2Fedition.cnn.com%2F2020%2F07%2F27%2Famericas%2Fbrazil-covid-19-sinovac-vaccine-intl%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04400838-82\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04400838_82-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04400838\" rel=\"nofollow\">\"Investigating a Vaccine Against COVID-19\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 26 May 2020. NCT04400838<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Investigating+a+Vaccine+Against+COVID-19&amp;rft.date=2020-05-26&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04400838&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-EudraCT-2020-001228-32-83\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EudraCT-2020-001228-32_83-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB\" rel=\"nofollow\">\"A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19\"</a>. <i>EU Clinical Trials Register</i> (Registry). European Union. 21 April 2020. <a href=\"/wiki/EudraCT\" title=\"EudraCT\">EudraCT</a> 2020-001228-32<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EU+Clinical+Trials+Register&amp;rft.atitle=A+Phase+2%2F3+study+to+determine+the+efficacy%2C+safety+and+immunogenicity+of+the+candidate+Coronavirus+Disease+%28COVID-19%29+vaccine+ChAdOx1+nCoV-19&amp;rft.date=2020-04-21&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsregister.eu%2Fctr-search%2Ftrial%2F2020-001228-32%2FGB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-ISRCTN89951424-84\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ISRCTN89951424_84-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFO'Reilly2020\">O'Reilly P (26 May 2020). <a class=\"external text\" href=\"http://www.isrctn.com/ISRCTN89951424\" rel=\"nofollow\">\"A Phase III study to investigate a vaccine against COVID-19\"</a>. <i>ISRCTN</i> (Registry). <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1186%2FISRCTN89951424\" rel=\"nofollow\">10.1186/ISRCTN89951424</a>. ISRCTN89951424<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ISRCTN&amp;rft.atitle=A+Phase+III+study+to+investigate+a+vaccine+against+COVID-19&amp;rft.date=2020-05-26&amp;rft_id=info%3Adoi%2F10.1186%2FISRCTN89951424&amp;rft.aulast=O%27Reilly&amp;rft.aufirst=Peter&amp;rft_id=http%3A%2F%2Fwww.isrctn.com%2FISRCTN89951424&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04516746-85\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04516746_85-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04516746\" rel=\"nofollow\">\"A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 12 May 2020. NCT04383574<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Phase+III+Randomized%2C+Double-blind%2C+Placebo-controlled+Multicenter+Study+in+Adults+to+Determine+the+Safety%2C+Efficacy%2C+and+Immunogenicity+of+AZD1222%2C+a+Non-replicating+ChAdOx1+Vector+Vaccine%2C+for+the+Prevention+of+COVID-19&amp;rft.date=2020-05-12&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04516746&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-86\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-86\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://covid19vaccinetrial.co.uk/brazil-trial-launch\" rel=\"nofollow\">\"Trial of Oxford COVID-19 vaccine starts in Brazil\"</a>. <a href=\"/wiki/Jenner_Institute\" title=\"Jenner Institute\">Jenner Institute</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Trial+of+Oxford+COVID-19+vaccine+starts+in+Brazil&amp;rft.pub=Jenner+Institute&amp;rft_id=https%3A%2F%2Fcovid19vaccinetrial.co.uk%2Fbrazil-trial-launch&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-phillips-87\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-phillips_87-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFPhillipsCyranoskiMallapaty2020\">Phillips, Nicky; Cyranoski, David; Mallapaty, Smriti (9 September 2020). <a class=\"external text\" href=\"https://www.nature.com/articles/d41586-020-02594-w\" rel=\"nofollow\">\"A leading coronavirus vaccine trial is on hold: scientists react\"</a>. <i>Nature</i>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fd41586-020-02594-w\" rel=\"nofollow\">10.1038/d41586-020-02594-w</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0028-0836\" rel=\"nofollow\">0028-0836</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32908295\" rel=\"nofollow\">32908295</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221620587\" rel=\"nofollow\">221620587</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=A+leading+coronavirus+vaccine+trial+is+on+hold%3A+scientists+react&amp;rft.date=2020-09-09&amp;rft.issn=0028-0836&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221620587&amp;rft_id=info%3Apmid%2F32908295&amp;rft_id=info%3Adoi%2F10.1038%2Fd41586-020-02594-w&amp;rft.aulast=Phillips&amp;rft.aufirst=Nicky&amp;rft.au=Cyranoski%2C+David&amp;rft.au=Mallapaty%2C+Smriti&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-02594-w&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-88\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-88\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFAdam_Feuerstein2020\">Adam Feuerstein (9 September 2020). <a class=\"external text\" href=\"https://www.statnews.com/2020/09/09/astrazeneca-covid19-vaccine-trial-hold-patient-report/\" rel=\"nofollow\">\"Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says\"</a>. STAT<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Covid-19+vaccine+trial+participant+had+serious+neurological+symptoms%2C+but+could+be+discharged+today%2C+AstraZeneca+CEO+says&amp;rft.pub=STAT&amp;rft.date=2020-09-09&amp;rft.au=Adam+Feuerstein&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F09%2F09%2Fastrazeneca-covid19-vaccine-trial-hold-patient-report%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-89\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-89\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a class=\"external text\" href=\"https://nos.nl/artikel/2347931-astrazeneca-en-universiteit-oxford-hervatten-vaccintest.html\" rel=\"nofollow\">\"AstraZeneca en universiteit Oxford hervatten vaccintest\"</a>. <i><a href=\"/wiki/Nederlandse_Omroep_Stichting\" title=\"Nederlandse Omroep Stichting\">NOS</a></i> (in Dutch). 12 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">12 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NOS&amp;rft.atitle=AstraZeneca+en+universiteit+Oxford+hervatten+vaccintest&amp;rft.date=2020-09-12&amp;rft_id=https%3A%2F%2Fnos.nl%2Fartikel%2F2347931-astrazeneca-en-universiteit-oxford-hervatten-vaccintest.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-folegatti-90\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-folegatti_90-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFFolegattiEwerAleyAngus2020\">Folegatti PM, <a href=\"/wiki/Katie_Ewer\" title=\"Katie Ewer\">Ewer KJ</a>, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S,  et al. (July 2020). <a class=\"external text\" href=\"https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931604-4\" rel=\"nofollow\">\"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Lancet</i>. <b>396</b> (10249): 467–78. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2FS0140-6736%2820%2931604-4\" rel=\"nofollow\">10.1016/S0140-6736(20)31604-4</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7445431\" rel=\"nofollow\">7445431</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32702298\" rel=\"nofollow\">32702298</a>. <a class=\"external text\" href=\"https://blogs.sciencemag.org/pipeline/archives/2020/07/20/new-data-on-the-oxford-az-vaccine\" rel=\"nofollow\">Lay summary</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Safety+and+immunogenicity+of+the+ChAdOx1+nCoV-19+vaccine+against+SARS-CoV-2%3A+a+preliminary+report+of+a+phase+1%2F2%2C+single-blind%2C+randomised+controlled+trial&amp;rft.volume=396&amp;rft.issue=10249&amp;rft.pages=467-78&amp;rft.date=2020-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7445431&amp;rft_id=info%3Apmid%2F32702298&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2820%2931604-4&amp;rft.aulast=Folegatti&amp;rft.aufirst=Pedro+M&amp;rft.au=Ewer%2C+Katie+J&amp;rft.au=Aley%2C+Parvinder+K&amp;rft.au=Angus%2C+Brian&amp;rft.au=Becker%2C+Stephan&amp;rft.au=Belij-Rammerstorfer%2C+Sandra&amp;rft.au=Bellamy%2C+Duncan&amp;rft.au=Bibi%2C+Sagida&amp;rft.au=Bittaye%2C+Mustapha&amp;rft.au=Clutterbuck%2C+Elizabeth+A&amp;rft.au=Dold%2C+Christina&amp;rft.au=Faust%2C+Saul+N&amp;rft.au=Finn%2C+Adam&amp;rft.au=Flaxman%2C+Amy+L&amp;rft.au=Hallis%2C+Bassam&amp;rft.au=Heath%2C+Paul&amp;rft.au=Jenkin%2C+Daniel&amp;rft.au=Lazarus%2C+Rajeka&amp;rft.au=Makinson%2C+Rebecca&amp;rft.au=Minassian%2C+Angela+M&amp;rft.au=Pollock%2C+Katrina+M&amp;rft.au=Ramasamy%2C+Maheshi&amp;rft.au=Robinson%2C+Hannah&amp;rft.au=Snape%2C+Matthew&amp;rft.au=Tarrant%2C+Richard&amp;rft.au=Voysey%2C+Merryn&amp;rft.au=Green%2C+Catherine&amp;rft.au=Douglas%2C+Alexander+D&amp;rft.au=Hill%2C+Adrian+V+S&amp;rft.au=Lambe%2C+Teresa&amp;rft.au=Gilbert%2C+Sarah+C&amp;rft.au=Pollard%2C+Andrew+J&amp;rft_id=https%3A%2F%2Fwww.thelancet.com%2Faction%2FshowPdf%3Fpii%3DS0140-6736%252820%252931604-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-ChiCTR2000034780-91\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ChiCTR2000034780_91-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFChenAl_Kaabi2020\">Chen, Wei; Al Kaabi, Nawal (18 July 2020). <a class=\"external text\" href=\"http://www.chictr.org.cn/showprojen.aspx?proj=56651\" rel=\"nofollow\">\"A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)\"</a>. <i>Chinese Clinical Trial Registry</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chinese+Clinical+Trial+Registry&amp;rft.atitle=A+Phase+III+clinical+trial+for+inactivated+novel+coronavirus+pneumonia+%28COVID-19%29+vaccine+%28Vero+cells%29&amp;rft.date=2020-07-18&amp;rft.aulast=Chen&amp;rft.aufirst=Wei&amp;rft.au=Al+Kaabi%2C+Nawal&amp;rft_id=http%3A%2F%2Fwww.chictr.org.cn%2Fshowprojen.aspx%3Fproj%3D56651&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-92\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-92\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFYang\">Yang, Yunkai. <a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04510207\" rel=\"nofollow\">\"A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above\"</a>. <i>clinicaltrials.gov</i>. Clinical Trials<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=A+Study+to+Evaluate+The+Efficacy%2C+Safety+and+Immunogenicity+of+Inactivated+SARS-CoV-2+Vaccines+%28Vero+Cell%29+in+Healthy+Population+Aged+18+Years+Old+and+Above&amp;rft.aulast=Yang&amp;rft.aufirst=Yunkai&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04510207&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-93\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-93\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04560881?term=vaccine&amp;cond=covid-19&amp;draw=2&amp;rank=3\" rel=\"nofollow\">\"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)\"</a>. <i>clinicaltrials.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=Clinical+Trial+to+Evaluate+the+Efficacy%2C+Immunogenicity+and+Safety+of+the+Inactivated+SARS-CoV-2+Vaccine+%28COVID-19%29&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04560881%3Fterm%3Dvaccine%26cond%3Dcovid-19%26draw%3D2%26rank%3D3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-UAE_approval-94\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-UAE_approval_94-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFMaxwell\">Maxwell, Chris. <a class=\"external text\" href=\"https://www.thenational.ae/uae/health/coronavirus-uae-authorises-emergency-use-of-vaccine-for-frontline-workers-1.1077680\" rel=\"nofollow\">\"Coronavirus: UAE authorises emergency use of vaccine for frontline workers\"</a>. The National<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus%3A+UAE+authorises+emergency+use+of+vaccine+for+frontline+workers&amp;rft.pub=The+National&amp;rft.aulast=Maxwell&amp;rft.aufirst=Chris&amp;rft_id=https%3A%2F%2Fwww.thenational.ae%2Fuae%2Fhealth%2Fcoronavirus-uae-authorises-emergency-use-of-vaccine-for-frontline-workers-1.1077680&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-95\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-95\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFXiaDuanZhangZhao2020\">Xia S, Duan K, Zhang Y, Zhao D,  et al. (13 August 2020). <a class=\"external text\" href=\"https://jamanetwork.com/journals/jama/fullarticle/2769612\" rel=\"nofollow\">\"Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials\"</a>. <i>JAMA</i>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1001%2Fjama.2020.15543\" rel=\"nofollow\">10.1001/jama.2020.15543</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7426884\" rel=\"nofollow\">7426884</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32789505\" rel=\"nofollow\">32789505</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Effect+of+an+Inactivated+Vaccine+Against+SARS-CoV-2+on+Safety+and+Immunogenicity+Outcomes%3A+Interim+Analysis+of+2+Randomized+Clinical+Trials&amp;rft.date=2020-08-13&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7426884&amp;rft_id=info%3Apmid%2F32789505&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2020.15543&amp;rft.aulast=Xia&amp;rft.aufirst=S&amp;rft.au=Duan%2C+K&amp;rft.au=Zhang%2C+Y&amp;rft.au=Zhao%2C+D&amp;rft_id=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjama%2Ffullarticle%2F2769612&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-96\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-96\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.canada.ca/en/national-research-council/news/2020/05/the-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19.html\" rel=\"nofollow\">\"The National Research Council of Canada and CanSino Biologics Inc. announce collaboration to advance vaccine against COVID-19\"</a>. National Research Council, Government of Canada. 12 May 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200522153344/https://www.canada.ca/en/national-research-council/news/2020/05/the-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19.html\" rel=\"nofollow\">Archived</a> from the original on 22 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+National+Research+Council+of+Canada+and+CanSino+Biologics+Inc.+announce+collaboration+to+advance+vaccine+against+COVID-19&amp;rft.pub=National+Research+Council%2C+Government+of+Canada&amp;rft.date=2020-05-12&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Fnational-research-council%2Fnews%2F2020%2F05%2Fthe-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-98\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-98\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFGou\">Gou, Jinbo. <a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04526990\" rel=\"nofollow\">\"Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above\"</a>. clinicaltrials.gov<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Phase+III+Trial+of+A+COVID-19+Vaccine+of+Adenovirus+Vector+in+Adults+18+Years+Old+and+Above&amp;rft.pub=clinicaltrials.gov&amp;rft.aulast=Gou&amp;rft.aufirst=Jinbo&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04526990&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-zhu7-20-99\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-zhu7-20_99-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFZhuGuanLiHuang2020\">Zhu F, Guan X, Li Y, Huang J, Jiang T, Hou L,  et al. (July 2020). <a class=\"external text\" href=\"https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931605-6\" rel=\"nofollow\">\"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Lancet</i>. <b>396</b> (10249): 479–88. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2Fs0140-6736%2820%2931605-6\" rel=\"nofollow\">10.1016/s0140-6736(20)31605-6</a></span>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0140-6736\" rel=\"nofollow\">0140-6736</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32702299\" rel=\"nofollow\">32702299</a>. <a class=\"external text\" href=\"https://blogs.sciencemag.org/pipeline/archives/2020/07/20/new-data-on-the-cansino-vaccine\" rel=\"nofollow\">Lay summary</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Immunogenicity+and+safety+of+a+recombinant+adenovirus+type-5-vectored+COVID-19+vaccine+in+healthy+adults+aged+18+years+or+older%3A+a+randomised%2C+double-blind%2C+placebo-controlled%2C+phase+2+trial&amp;rft.volume=396&amp;rft.issue=10249&amp;rft.pages=479-88&amp;rft.date=2020-07&amp;rft.issn=0140-6736&amp;rft_id=info%3Apmid%2F32702299&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2820%2931605-6&amp;rft.aulast=Zhu&amp;rft.aufirst=Feng-Cai&amp;rft.au=Guan%2C+Xu-Hua&amp;rft.au=Li%2C+Yu-Hua&amp;rft.au=Huang%2C+Jian-Ying&amp;rft.au=Jiang%2C+Tao&amp;rft.au=Hou%2C+Li-Hua&amp;rft.au=Li%2C+Jing-Xin&amp;rft.au=Yang%2C+Bei-Fang&amp;rft.au=Wang%2C+Ling&amp;rft.au=Wang%2C+Wen-Juan&amp;rft.au=Wu%2C+Shi-Po&amp;rft.au=Wang%2C+Zhao&amp;rft.au=Wu%2C+Xiao-Hong&amp;rft.au=Xu%2C+Jun-Jie&amp;rft.au=Zhang%2C+Zhe&amp;rft.au=Jia%2C+Si-Yue&amp;rft.au=Wang%2C+Bu-Sen&amp;rft.au=Hu%2C+Yi&amp;rft.au=Liu%2C+Jing-Jing&amp;rft.au=Zhang%2C+Jun&amp;rft.au=Qian%2C+Xiao-Ai&amp;rft.au=Li%2C+Qiong&amp;rft.au=Pan%2C+Hong-Xing&amp;rft.au=Jiang%2C+Hu-Dachuan&amp;rft.au=Deng%2C+Peng&amp;rft.au=Gou%2C+Jin-Bo&amp;rft.au=Wang%2C+Xue-Wen&amp;rft.au=Wang%2C+Xing-Huan&amp;rft.au=Chen%2C+Wei&amp;rft_id=https%3A%2F%2Fwww.thelancet.com%2Faction%2FshowPdf%3Fpii%3DS0140-6736%252820%252931605-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04383574-100\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04383574_100-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04383574\" rel=\"nofollow\">\"Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 12 May 2020. NCT04383574<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety+and+Immunogenicity+Study+of+Inactivated+Vaccine+for+Prevention+of+SARS-CoV-2+Infection+%28COVID-19%29+%28Renqiu%29&amp;rft.date=2020-05-12&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04383574&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCname=_nct04456595=-101\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCname=_nct04456595=_101-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04456595\" rel=\"nofollow\">\"Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 2 July 2020. NCT04456595<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Clinical+Trial+of+Efficacy+and+Safety+of+Sinovac%27s+Adsorbed+COVID-19+%28Inactivated%29+Vaccine+in+Healthcare+Professionals+%28PROFISCOV%29&amp;rft.date=2020-07-02&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04456595&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-102\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-102\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFPT._Bio_Farma2020\">PT. Bio Farma (10 August 2020). <a class=\"external text\" href=\"https://www.ina-registry.org/index.php?act=registry_trial_detail&amp;code_trial=16202009080721WXFM0YX\" rel=\"nofollow\">\"A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia\"</a>. <i>Registri Penyakit Indonesia</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Registri+Penyakit+Indonesia&amp;rft.atitle=A+Phase+III%2C+observer-blind%2C+randomized%2C+placebo-controlled+study+of+the+efficacy%2C+safety%2C+and+immunogenicity+of+SARS-COV-2+inactivated+vaccine+in+healthy+adults+aged+18%E2%80%9359+years+in+Indonesia&amp;rft.date=2020-08-10&amp;rft.au=PT.+Bio+Farma&amp;rft_id=https%3A%2F%2Fwww.ina-registry.org%2Findex.php%3Fact%3Dregistry_trial_detail%26code_trial%3D16202009080721WXFM0YX&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-103\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-103\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\">Zhang Y-J, Zeng G, Pan H-X, Li C-G, others (10 August 2020). \"Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18–59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial\". <i>MedRxiv</i>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1101%2F2020.07.31.20161216\" rel=\"nofollow\">10.1101/2020.07.31.20161216</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221089937\" rel=\"nofollow\">221089937</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MedRxiv&amp;rft.atitle=Immunogenicity+and+Safety+of+a+SARS-CoV-2+Inactivated+Vaccine+in+Healthy+Adults+Aged+18%E2%80%9359+years%3A+Report+of+the+Randomized%2C+Double-blind%2C+and+Placebo-controlled+Phase+2+Clinical+Trial&amp;rft.date=2020-08-10&amp;rft_id=info%3Adoi%2F10.1101%2F2020.07.31.20161216&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221089937&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-104\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-104\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFIndonesia\">Indonesia, C. N. N. <a class=\"external text\" href=\"https://www.cnnindonesia.com/teknologi/20200805023946-199-532230/fakta-terbaru-uji-klinis-vaksin-covid-19-di-bandung\" rel=\"nofollow\">\"Fakta Terbaru Uji Klinis Vaksin Covid-19 di Bandung\"</a>. <i>teknologi</i> (in Indonesian)<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=teknologi&amp;rft.atitle=Fakta+Terbaru+Uji+Klinis+Vaksin+Covid-19+di+Bandung&amp;rft.aulast=Indonesia&amp;rft.aufirst=C.+N.+N.&amp;rft_id=https%3A%2F%2Fwww.cnnindonesia.com%2Fteknologi%2F20200805023946-199-532230%2Ffakta-terbaru-uji-klinis-vaksin-covid-19-di-bandung&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04368728-106\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04368728_106-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04368728\" rel=\"nofollow\">\"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 30 April 2020. NCT04368728<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Study+to+Describe+the+Safety%2C+Tolerability%2C+Immunogenicity%2C+and+Efficacy+of+RNA+Vaccine+Candidates+Against+COVID-19+in+Healthy+Adults&amp;rft.date=2020-04-30&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04368728&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-EudraCT-2020-001038-36-107\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EudraCT-2020-001038-36_107-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE\" rel=\"nofollow\">\"A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults\"</a>. <i>EU Clinical Trials Register</i> (Registry). European Union. 14 April 2020. <a href=\"/wiki/EudraCT\" title=\"EudraCT\">EudraCT</a> 2020-001038-36. <a class=\"external text\" href=\"https://web.archive.org/web/20200422111024/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE\" rel=\"nofollow\">Archived</a> from the original on 22 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EU+Clinical+Trials+Register&amp;rft.atitle=A+Multi-site+Phase+I%2FII%2C+2-Part%2C+Dose-Escalation+Trial+Investigating+the+Safety+and+Immunogenicity+of+four+Prophylactic+SARS-CoV-2+RNA+Vaccines+Against+COVID-19+Using+Different+Dosing+Regimens+in+Healthy+Adults&amp;rft.date=2020-04-14&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsregister.eu%2Fctr-search%2Ftrial%2F2020-001038-36%2FDE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-108\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-108\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFLovelace_Jr.2020\">Lovelace Jr B (27 July 2020). <a class=\"external text\" href=\"https://www.cnbc.com/2020/07/27/pfizer-and-biontech-began-late-stage-human-trial-for-coronavirus-vaccine-monday.html\" rel=\"nofollow\">\"Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday\"</a>. <i><a href=\"/wiki/CNBC\" title=\"CNBC\">CNBC</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNBC&amp;rft.atitle=Pfizer+and+BioNTech+began+late-stage+human+trial+for+coronavirus+vaccine+Monday&amp;rft.date=2020-07-27&amp;rft.aulast=Lovelace+Jr.&amp;rft.aufirst=Berkeley&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2F2020%2F07%2F27%2Fpfizer-and-biontech-began-late-stage-human-trial-for-coronavirus-vaccine-monday.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-109\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-109\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFMulliganLykeKitchinAbsalon2020\">Mulligan M, Lyke K, Kitchin N, Absalon J, Gurtman A, Lockhart S,  et al. (1 July 2020). <a class=\"external text\" href=\"https://www.medrxiv.org/content/10.1101/2020.06.30.20142570v1.full.pdf\" rel=\"nofollow\">\"Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>MedRxiv</i> (<a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>). <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1101%2F2020.06.30.20142570\" rel=\"nofollow\">10.1101/2020.06.30.20142570</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:220266992\" rel=\"nofollow\">220266992</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MedRxiv&amp;rft.atitle=Phase+1%2F2+Study+to+Describe+the+Safety+and+Immunogenicity+of+a+COVID-19+RNA+Vaccine+Candidate+%28BNT162b1%29+in+Adults+18+to+55+Years+of+Age%3A+Interim+Report&amp;rft.date=2020-07-01&amp;rft_id=info%3Adoi%2F10.1101%2F2020.06.30.20142570&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A220266992&amp;rft.aulast=Mulligan&amp;rft.aufirst=Mark&amp;rft.au=Lyke%2C+Kirsten&amp;rft.au=Kitchin%2C+Nicholas&amp;rft.au=Absalon%2C+Judith&amp;rft.au=Gurtman%2C+Alejandra&amp;rft.au=Lockhart%2C+Stephen&amp;rft.au=Neuzil%2C+Kathleen&amp;rft.au=Raabe%2C+Vanessa&amp;rft.au=Bailey%2C+Ruth&amp;rft.au=Swanson%2C+Kena&amp;rft.au=Li%2C+Ping&amp;rft.au=Koury%2C+Kenneth&amp;rft.au=Kalina%2C+Warren&amp;rft.au=Cooper%2C+David&amp;rft.au=Fonter-Garfias%2C+Camila&amp;rft.au=Shi%2C+Pei-Yong&amp;rft.au=Tuereci%2C+Ozlem&amp;rft.au=Tompkins%2C+Kristin&amp;rft.au=Walsh%2C+Edward&amp;rft.au=Frenck%2C+Robert&amp;rft.au=Falsey%2C+Ann&amp;rft.au=Dormitzer%2C+Philip&amp;rft.au=Gruber%2C+William&amp;rft.au=Sahin%2C+Ugur&amp;rft.au=Jansen%2C+Kathrin&amp;rft_id=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2020.06.30.20142570v1.full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-110\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-110\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFSahinMuikDerhovanessianVogler2020\">Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M,  et al. (2020). <a class=\"external text\" href=\"https://www.medrxiv.org/content/10.1101/2020.07.17.20140533v1.full.pdf\" rel=\"nofollow\">\"Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>MedRxiv</i> (<a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>). <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1101%2F2020.07.17.20140533\" rel=\"nofollow\">10.1101/2020.07.17.20140533</a></span>. <a class=\"external text\" href=\"https://blogs.sciencemag.org/pipeline/archives/2020/07/20/more-pfizer-phase-i-results-antibodies-viral-mutations-and-t-cells\" rel=\"nofollow\">Lay summary</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MedRxiv&amp;rft.atitle=Concurrent+human+antibody+and+TH1+type+T-cell+responses+elicited+by+a+COVID-19+RNA+vaccine&amp;rft.date=2020&amp;rft_id=info%3Adoi%2F10.1101%2F2020.07.17.20140533&amp;rft.aulast=Sahin&amp;rft.aufirst=Ugur&amp;rft.au=Muik%2C+Alexander&amp;rft.au=Derhovanessian%2C+Evelyna&amp;rft.au=Vogler%2C+Isabel&amp;rft.au=Kranz%2C+Lena+M&amp;rft.au=Vormehr%2C+Mathias&amp;rft.au=Baum%2C+Alina&amp;rft.au=Pascal%2C+Kristen&amp;rft.au=Quandt%2C+Jasmin&amp;rft.au=Maurus%2C+Daniel&amp;rft.au=Brachtendorf%2C+Sebastian&amp;rft.au=Loerks%2C+Verena+L&amp;rft.au=Sikorski%2C+Julian&amp;rft.au=Hilker%2C+Rolf&amp;rft.au=Becker%2C+Dirk&amp;rft.au=Eller%2C+Ann-Kathrin&amp;rft.au=Gruetzner%2C+Jan&amp;rft.au=Boesler%2C+Carsten&amp;rft.au=Rosenbaum%2C+Corinna&amp;rft.au=Kuehnle%2C+Marie-Cristine&amp;rft.au=Luxemburger%2C+Ulrich&amp;rft.au=Kemmer-Brueck%2C+Alexandra&amp;rft.au=Langer%2C+David&amp;rft.au=Bexon%2C+Martin&amp;rft.au=Bolte%2C+Stefanie&amp;rft.au=Kariko%2C+Katalin&amp;rft.au=Palanche%2C+Tania&amp;rft.au=Fischer%2C+Boris&amp;rft.au=Schultz%2C+Armin&amp;rft.au=Shi%2C+Pei-Yong&amp;rft.au=Fontes-Garfias%2C+Camila&amp;rft.au=Perez%2C+John+L&amp;rft.au=Swanson%2C+Kena+A&amp;rft.au=Loschko%2C+Jakob&amp;rft.au=Scully%2C+Ingrid+L&amp;rft.au=Cutler%2C+Mark&amp;rft.au=Kalina%2C+Warren&amp;rft.au=Kyratsous%2C+Christos+A&amp;rft.au=Cooper%2C+David&amp;rft.au=Dormitzer%2C+Philip+R&amp;rft.au=Jansen%2C+Kathrin+U&amp;rft.au=Tuereci%2C+Oezlem&amp;rft_id=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2020.07.17.20140533v1.full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04470427-111\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04470427_111-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04470427\" rel=\"nofollow\">\"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 14 July 2020. NCT04470427<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Study+to+Evaluate+Efficacy%2C+Safety%2C+and+Immunogenicity+of+mRNA-1273+Vaccine+in+Adults+Aged+18+Years+and+Older+to+Prevent+COVID-19&amp;rft.date=2020-07-14&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04470427&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-palca-112\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-palca_112-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFPalca2020\">Palca J (27 July 2020). <a class=\"external text\" href=\"https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people\" rel=\"nofollow\">\"COVID-19 vaccine candidate heads to widespread testing in U.S.\"</a> <i>NPR</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NPR&amp;rft.atitle=COVID-19+vaccine+candidate+heads+to+widespread+testing+in+U.S.&amp;rft.date=2020-07-27&amp;rft.aulast=Palca&amp;rft.aufirst=Joe&amp;rft_id=https%3A%2F%2Fwww.npr.org%2Fsections%2Fcoronavirus-live-updates%2F2020%2F07%2F27%2F895672859%2Fus-vaccine-candidate-heads-to-widespread-testing-in-people&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-jackson-113\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-jackson_113-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFJacksonAndersonRouphaelRoberts2020\">Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN,  et al. (mRNA-1273 Study Group) (July 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7377258\" rel=\"nofollow\">\"An mRNA Vaccine against SARS-CoV-2 – Preliminary Report\"</a>. <i>New England Journal of Medicine</i>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1056%2FNEJMoa2022483\" rel=\"nofollow\">10.1056/NEJMoa2022483</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7377258\" rel=\"nofollow\">7377258</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32663912\" rel=\"nofollow\">32663912</a>. <a class=\"external text\" href=\"https://www.statnews.com/2020/07/14/moderna-covid19-vaccine-first-data-show-spurs-immune-response/\" rel=\"nofollow\">Lay summary</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=An+mRNA+Vaccine+against+SARS-CoV-2+%E2%80%93+Preliminary+Report&amp;rft.date=2020-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7377258&amp;rft_id=info%3Apmid%2F32663912&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa2022483&amp;rft.aulast=Jackson&amp;rft.aufirst=LA&amp;rft.au=Anderson%2C+EJ&amp;rft.au=Rouphael%2C+NG&amp;rft.au=Roberts%2C+PC&amp;rft.au=Makhene%2C+M&amp;rft.au=Coler%2C+RN&amp;rft.au=McCullough%2C+MP&amp;rft.au=Chappell%2C+JD&amp;rft.au=Denison%2C+MR&amp;rft.au=Stevens%2C+LJ&amp;rft.au=Pruijssers%2C+AJ&amp;rft.au=McDermott%2C+A&amp;rft.au=Flach%2C+B&amp;rft.au=Doria-Rose%2C+NA&amp;rft.au=Corbett%2C+KS&amp;rft.au=Morabito%2C+KM&amp;rft.au=O%27Dell%2C+S&amp;rft.au=Schmidt%2C+SD&amp;rft.au=Swanson%2C+PA&amp;rft.au=Padilla%2C+M&amp;rft.au=Mascola%2C+JR&amp;rft.au=Neuzil%2C+KM&amp;rft.au=Bennett%2C+H&amp;rft.au=Sun%2C+W&amp;rft.au=Peters%2C+E&amp;rft.au=Makowski%2C+M&amp;rft.au=Albert%2C+J&amp;rft.au=Cross%2C+K&amp;rft.au=Buchanan%2C+W&amp;rft.au=Pikaart-Tautges%2C+R&amp;rft.au=Ledgerwood%2C+JE&amp;rft.au=Graham%2C+BS&amp;rft.au=Beigel%2C+JH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7377258&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-jackson-app-114\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-jackson-app_114-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFJacksonAndersonRouphaelRoberts2020\">Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN,  et al. (mRNA-1273 Study Group) (July 2020). <a class=\"external text\" href=\"https://www.nejm.org/doi/suppl/10.1056/NEJMoa2022483/suppl_file/nejmoa2022483_appendix.pdf\" rel=\"nofollow\">\"An mRNA Vaccine against SARS-CoV-2 – Preliminary Report Supplementary appendix\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>New England Journal of Medicine</i>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1056%2FNEJMoa2022483\" rel=\"nofollow\">10.1056/NEJMoa2022483</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32663912\" rel=\"nofollow\">32663912</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=An+mRNA+Vaccine+against+SARS-CoV-2+%E2%80%93+Preliminary+Report+Supplementary+appendix&amp;rft.date=2020-07&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa2022483&amp;rft_id=info%3Apmid%2F32663912&amp;rft.aulast=Jackson&amp;rft.aufirst=LA&amp;rft.au=Anderson%2C+EJ&amp;rft.au=Rouphael%2C+NG&amp;rft.au=Roberts%2C+PC&amp;rft.au=Makhene%2C+M&amp;rft.au=Coler%2C+RN&amp;rft.au=McCullough%2C+MP&amp;rft.au=Chappell%2C+JD&amp;rft.au=Denison%2C+MR&amp;rft.au=Stevens%2C+LJ&amp;rft.au=Pruijssers%2C+AJ&amp;rft.au=McDermott%2C+A&amp;rft.au=Flach%2C+B&amp;rft.au=Doria-Rose%2C+NA&amp;rft.au=Corbett%2C+KS&amp;rft.au=Morabito%2C+KM&amp;rft.au=O%27Dell%2C+S&amp;rft.au=Schmidt%2C+SD&amp;rft.au=Swanson%2C+PA&amp;rft.au=Padilla%2C+M&amp;rft.au=Mascola%2C+JR&amp;rft.au=Neuzil%2C+KM&amp;rft.au=Bennett%2C+H&amp;rft.au=Sun%2C+W&amp;rft.au=Peters%2C+E&amp;rft.au=Makowski%2C+M&amp;rft.au=Albert%2C+J&amp;rft.au=Cross%2C+K&amp;rft.au=Buchanan%2C+W&amp;rft.au=Pikaart-Tautges%2C+R&amp;rft.au=Ledgerwood%2C+JE&amp;rft.au=Graham%2C+BS&amp;rft.au=Beigel%2C+JH&amp;rft_id=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Fsuppl%2F10.1056%2FNEJMoa2022483%2Fsuppl_file%2Fnejmoa2022483_appendix.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-115\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-115\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04530396?term=vaccine&amp;cond=covid-19&amp;draw=3\" rel=\"nofollow\">\"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19\"</a>. <i>clinicaltrials.gov</i>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=Clinical+Trial+of+Efficacy%2C+Safety%2C+and+Immunogenicity+of+Gam-COVID-Vac+Vaccine+Against+COVID-19&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04530396%3Fterm%3Dvaccine%26cond%3Dcovid-19%26draw%3D3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-logunov-116\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-logunov_116-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFLogunovDolzhikovaothers2020\">Logunov, Denis Y; Dolzhikova, Inna V; others (2020). <a class=\"external text\" href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31866-3/fulltext\" rel=\"nofollow\">\"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia\"</a>. <i>The Lancet</i>. <b>396</b> (10255): 887–97. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2Fs0140-6736%2820%2931866-3\" rel=\"nofollow\">10.1016/s0140-6736(20)31866-3</a></span>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0140-6736\" rel=\"nofollow\">0140-6736</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32896291\" rel=\"nofollow\">32896291</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221472251\" rel=\"nofollow\">221472251</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Safety+and+immunogenicity+of+an+rAd26+and+rAd5+vector-based+heterologous+prime-boost+COVID-19+vaccine+in+two+formulations%3A+two+open%2C+non-randomised+phase+1%2F2+studies+from+Russia&amp;rft.volume=396&amp;rft.issue=10255&amp;rft.pages=887-97&amp;rft.date=2020&amp;rft.issn=0140-6736&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221472251&amp;rft_id=info%3Apmid%2F32896291&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2820%2931866-3&amp;rft.aulast=Logunov&amp;rft.aufirst=Denis+Y&amp;rft.au=Dolzhikova%2C+Inna+V&amp;rft.au=others&amp;rft_id=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2820%2931866-3%2Ffulltext&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-117\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-117\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04436276\" rel=\"nofollow\">\"A Study of Ad26.COV2.S in Adults\"</a>. ClinicalTrials.gov, US National Library of Medicine. 4 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Study+of+Ad26.COV2.S+in+Adults&amp;rft.pub=ClinicalTrials.gov%2C+US+National+Library+of+Medicine&amp;rft.date=2020-08-04&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04436276&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-118\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-118\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFSadoffLe_GarsShukarevHeerwegh2020\">Sadoff, Jerry; Le Gars, Mathieu; Shukarev, Georgi; Heerwegh, Dirk; Truyers, Carla; de Groot, Anna Marit; Stoop, Jeroen; Tete, Sarah; Van Damme, Wim; Leroux-Roels, Isabel; Berghmans, Pieter-Jan (25 September 2020). <a class=\"external text\" href=\"http://medrxiv.org/lookup/doi/10.1101/2020.09.23.20199604\" rel=\"nofollow\">\"Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial\"</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1101%2F2020.09.23.20199604\" rel=\"nofollow\">10.1101/2020.09.23.20199604</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221882008\" rel=\"nofollow\">221882008</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Safety+and+immunogenicity+of+the+Ad26.COV2.S+COVID-19+vaccine+candidate%3A+interim+results+of+a+phase+1%2F2a%2C+double-blind%2C+randomized%2C+placebo-controlled+trial&amp;rft.date=2020-09-25&amp;rft_id=info%3Adoi%2F10.1101%2F2020.09.23.20199604&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221882008&amp;rft.aulast=Sadoff&amp;rft.aufirst=Jerry&amp;rft.au=Le+Gars%2C+Mathieu&amp;rft.au=Shukarev%2C+Georgi&amp;rft.au=Heerwegh%2C+Dirk&amp;rft.au=Truyers%2C+Carla&amp;rft.au=de+Groot%2C+Anna+Marit&amp;rft.au=Stoop%2C+Jeroen&amp;rft.au=Tete%2C+Sarah&amp;rft.au=Van+Damme%2C+Wim&amp;rft.au=Leroux-Roels%2C+Isabel&amp;rft.au=Berghmans%2C+Pieter-Jan&amp;rft_id=http%3A%2F%2Fmedrxiv.org%2Flookup%2Fdoi%2F10.1101%2F2020.09.23.20199604&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span> <span class=\"cs1-hidden-error error citation-comment\">Cite journal requires <code class=\"cs1-code\">|journal=</code> (<a href=\"/wiki/Help:CS1_errors#missing_periodical\" title=\"Help:CS1 errors\">help</a>)</span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-119\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-119\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04505722\" rel=\"nofollow\">\"A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants\"</a>. <i>ClinicalTrials.gov</i>. US National Library of Medicine.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Study+of+Ad26.COV2.S+for+the+Prevention+of+SARS-CoV-2-Mediated+COVID-19+in+Adult+Participants&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04505722&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-120\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-120\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.jnj.com/our-company/johnson-johnson-temporarily-pauses-all-dosing-in-our-janssen-covid-19-vaccine-candidate-clinical-trials\" rel=\"nofollow\">\"Johnson &amp; Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials\"</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+Temporarily+Pauses+All+Dosing+in+Our+Janssen+COVID-19+Vaccine+Candidate+Clinical+Trials&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Four-company%2Fjohnson-johnson-temporarily-pauses-all-dosing-in-our-janssen-covid-19-vaccine-candidate-clinical-trials&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04445194-121\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04445194_121-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04445194\" rel=\"nofollow\">\"Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 24 June 2020. NCT04445194<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Phase+I+Clinical+Study+of+Recombinant+Novel+Coronavirus+Vaccine&amp;rft.date=2020-06-24&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04445194&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04466085-122\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04466085_122-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04466085\" rel=\"nofollow\">\"A Randomized, Blinded, Placebo-controlled Trial to Evaluate the Immunogenicity and Safety of a Recombinant New Coronavirus Vaccine (CHO Cell) With Different Doses and Different Immunization Procedures in Healthy People Aged 18 to 59 Years\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 10 July 2020. NCT04466085<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Randomized%2C+Blinded%2C+Placebo-controlled+Trial+to+Evaluate+the+Immunogenicity+and+Safety+of+a+Recombinant+New+Coronavirus+Vaccine+%28CHO+Cell%29+With+Different+Doses+and+Different+Immunization+Procedures+in+Healthy+People+Aged+18+to+59+Years&amp;rft.date=2020-07-10&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04466085&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04449276-123\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04449276_123-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04449276\" rel=\"nofollow\">\"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults\"</a>. ClinicalTrials.gov, US National Library of Medicine. 26 June 2020. NCT04449276<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Study+to+Evaluate+the+Safety%2C+Reactogenicity+and+Immunogenicity+of+Vaccine+CVnCoV+in+Healthy+Adults&amp;rft.pub=ClinicalTrials.gov%2C+US+National+Library+of+Medicine&amp;rft.date=2020-06-26&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04449276&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04515147-124\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04515147_124-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04515147\" rel=\"nofollow\">\"A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults\"</a>. ClinicalTrials.gov, US National Library of Medicine. 17 August 2020. NCT04515147<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Dose-Confirmation+Study+to+Evaluate+the+Safety%2C+Reactogenicity+and+Immunogenicity+of+Vaccine+CVnCoV+in+Healthy+Adults&amp;rft.pub=ClinicalTrials.gov%2C+US+National+Library+of+Medicine&amp;rft.date=2020-08-17&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04515147&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04368988-125\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04368988_125-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04368988\" rel=\"nofollow\">\"Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 30 April 2020. NCT04368988<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Evaluation+of+the+Safety+and+Immunogenicity+of+a+SARS-CoV-2+rS+%28COVID-19%29+Nanoparticle+Vaccine+With%2FWithout+Matrix-M+Adjuvant&amp;rft.date=2020-04-30&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04368988&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-126\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-126\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.novavax.com/download/files/2020.08.04NVXCoV2373Phase1ClinicalResults.pdf\" rel=\"nofollow\">\"NVX-CoV2373 COVID-19 Vaccine Candidate Phase 1/2, Part 1, Clinical Trial Results\"</a> <span class=\"cs1-format\">(PDF)</span>. 4 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 August</span> 2020</span>. <a class=\"external text\" href=\"https://www.nytimes.com/2020/08/04/health/covid-19-vaccine-novavax.html?searchResultPosition=4\" rel=\"nofollow\">Lay summary</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NVX-CoV2373+COVID-19+Vaccine+Candidate+Phase+1%2F2%2C+Part+1%2C+Clinical+Trial+Results&amp;rft.date=2020-08-04&amp;rft_id=https%3A%2F%2Fwww.novavax.com%2Fdownload%2Ffiles%2F2020.08.04NVXCoV2373Phase1ClinicalResults.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-127\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-127\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFKeechAlbertReedNeal2020\">Keech, Cheryl; Albert, Gary; Reed, Patricia; Neal, Susan; Plested, Joyce; Zhu, Mingzhu;  et al. (6 August 2020). <a class=\"external text\" href=\"https://www.medrxiv.org/content/10.1101/2020.08.05.20168435v1.full.pdf\" rel=\"nofollow\">\"First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>MedRxiv</i> (<a href=\"/wiki/Preprint\" title=\"Preprint\">Preprint</a>). <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1101%2F2020.08.05.20168435\" rel=\"nofollow\">10.1101/2020.08.05.20168435</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221004959\" rel=\"nofollow\">221004959</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">7 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MedRxiv&amp;rft.atitle=First-in-Human+Trial+of+a+SARS+CoV+2+Recombinant+Spike+Protein+Nanoparticle+Vaccine&amp;rft.date=2020-08-06&amp;rft_id=info%3Adoi%2F10.1101%2F2020.08.05.20168435&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221004959&amp;rft.aulast=Keech&amp;rft.aufirst=Cheryl&amp;rft.au=Albert%2C+Gary&amp;rft.au=Reed%2C+Patricia&amp;rft.au=Neal%2C+Susan&amp;rft.au=Plested%2C+Joyce&amp;rft.au=Zhu%2C+Mingzhu&amp;rft.au=Cloney-Clark%2C+Shane&amp;rft.au=Zhou%2C+Haixia&amp;rft.au=Patel%2C+Nita&amp;rft.au=Frieman%2C+Matthew&amp;rft.au=Haupt%2C+Robert&amp;rft.au=Logue%2C+James&amp;rft.au=McGrath%2C+Marisa&amp;rft.au=Weston%2C+Stuart&amp;rft.au=Piedra%2C+Pedro&amp;rft.au=Cho%2C+Iksung&amp;rft.au=Robertson%2C+Andreana&amp;rft.au=Desai%2C+Chinar&amp;rft.au=Callahan%2C+Kathleen&amp;rft.au=Lewis%2C+Maggie&amp;rft.au=Price-Abbott%2C+Patricia&amp;rft.au=Formica%2C+Neil&amp;rft.au=Shinde%2C+Vivek&amp;rft.au=Fries%2C+Louis&amp;rft.au=Linkliter%2C+Jason&amp;rft.au=Griffin%2C+Paul&amp;rft.au=Wilkinson%2C+Bethanie&amp;rft.au=Smith%2C+Gale&amp;rft.au=Glenn%2C+Gregory&amp;rft_id=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2020.08.05.20168435v1.full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04336410-129\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04336410_129-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04336410\" rel=\"nofollow\">\"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 7 April 2020. NCT04336410<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety%2C+Tolerability+and+Immunogenicity+of+INO-4800+for+COVID-19+in+Healthy+Volunteers&amp;rft.date=2020-04-07&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04336410&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-130\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-130\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.ivi.int/ivi-inovio-and-knih-to-partner-with-cepi-in-a-phase-i-ii-clinical-trial-of-inovios-covid-19-dna-vaccine-in-south-korea/\" rel=\"nofollow\">\"IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO's COVID-19 DNA vaccine in South Korea\"</a>. International Vaccine Institute. 16 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=IVI%2C+INOVIO%2C+and+KNIH+to+partner+with+CEPI+in+a+Phase+I%2FII+clinical+trial+of+INOVIO%27s+COVID-19+DNA+vaccine+in+South+Korea&amp;rft.pub=International+Vaccine+Institute&amp;rft.date=2020-04-16&amp;rft_id=https%3A%2F%2Fwww.ivi.int%2Fivi-inovio-and-knih-to-partner-with-cepi-in-a-phase-i-ii-clinical-trial-of-inovios-covid-19-dna-vaccine-in-south-korea%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04412538-131\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04412538_131-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04412538\" rel=\"nofollow\">\"Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 2 June 2020. NCT04412538<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety+and+Immunogenicity+Study+of+an+Inactivated+SARS-CoV-2+Vaccine+for+Preventing+Against+COVID-19&amp;rft.date=2020-06-02&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04412538&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04463472-132\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04463472_132-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04463472\" rel=\"nofollow\">\"Study of COVID-19 DNA Vaccine (AG0301-COVID19)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 9 July 2020. NCT04463472<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Study+of+COVID-19+DNA+Vaccine+%28AG0301-COVID19%29&amp;rft.date=2020-07-09&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04463472&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-anges-inc-133\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-anges-inc_133-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.anges.co.jp/en/company/index.html\" rel=\"nofollow\">\"About AnGes – Introduction\"</a>. <i>AnGes, Inc</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=AnGes%2C+Inc.&amp;rft.atitle=About+AnGes+%E2%80%93+Introduction&amp;rft_id=https%3A%2F%2Fwww.anges.co.jp%2Fen%2Fcompany%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-134\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-134\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.bioindustry.org/news-listing/cti-and-arcturus-therapeutics-announce-initiation-of-dosing-of-covid-19-starr-mrna-vaccine-candidate-lunar-cov19-arct-021-in-a-phase-12-study.html\" rel=\"nofollow\">\"CTI and Arcturus Therapeutics Announce Initiation of Dosing of COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study\"</a>. UK BioIndustry Association. 13 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CTI+and+Arcturus+Therapeutics+Announce+Initiation+of+Dosing+of+COVID-19+STARR%E2%84%A2+mRNA+Vaccine+Candidate%2C+LUNAR-COV19+%28ARCT-021%29+in+a+Phase+1%2F2+study&amp;rft.pub=UK+BioIndustry+Association&amp;rft.date=2020-08-13&amp;rft_id=https%3A%2F%2Fwww.bioindustry.org%2Fnews-listing%2Fcti-and-arcturus-therapeutics-announce-initiation-of-dosing-of-covid-19-starr-mrna-vaccine-candidate-lunar-cov19-arct-021-in-a-phase-12-study.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-135\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-135\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04480957\" rel=\"nofollow\">\"Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects\"</a>. <i>clinicaltrials.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=Ascending+Dose+Study+of+Investigational+SARS-CoV-2+Vaccine+ARCT-021+in+Healthy+Adult+Subjects&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04480957&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04299724-136\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04299724_136-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04299724\" rel=\"nofollow\">\"Safety and Immunity of Covid-19 aAPC Vaccine\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 9 March 2020. NCT04299724<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety+and+Immunity+of+Covid-19+aAPC+Vaccine&amp;rft.date=2020-03-09&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04299724&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-shenzhen-genoimmune-medical-institute-137\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-shenzhen-genoimmune-medical-institute_137-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-shenzhen-genoimmune-medical-institute_137-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.szgimi.org/en/about.php\" rel=\"nofollow\">\"About Us\"</a>. <i>Shenzhen Genoimmune Medical Institute</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Shenzhen+Genoimmune+Medical+Institute&amp;rft.atitle=About+Us&amp;rft_id=http%3A%2F%2Fwww.szgimi.org%2Fen%2Fabout.php&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04276896-138\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04276896_138-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04276896\" rel=\"nofollow\">\"Immunity and Safety of Covid-19 Synthetic Minigene Vaccine\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 19 February 2020. NCT04276896<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Immunity+and+Safety+of+Covid-19+Synthetic+Minigene+Vaccine&amp;rft.date=2020-02-19&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04276896&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-ISRCTN17072692-139\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ISRCTN17072692_139-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFWardMcCormack2020\">Ward D, McCormack S (22 May 2020). <a class=\"external text\" href=\"https://www.isrctn.com/ISRCTN17072692\" rel=\"nofollow\">\"Clinical trial to assess the safety of a coronavirus vaccine in healthy men and women\"</a>. <i>ISRCTN</i> (Registry). <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1186%2FISRCTN17072692\" rel=\"nofollow\">10.1186/ISRCTN17072692</a></span>. ISRCTN17072692<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ISRCTN&amp;rft.atitle=Clinical+trial+to+assess+the+safety+of+a+coronavirus+vaccine+in+healthy+men+and+women&amp;rft.date=2020-05-22&amp;rft_id=info%3Adoi%2F10.1186%2FISRCTN17072692&amp;rft.aulast=Ward&amp;rft.aufirst=Denise&amp;rft.au=McCormack%2C+Sheena&amp;rft_id=https%3A%2F%2Fwww.isrctn.com%2FISRCTN17072692&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04445389-140\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04445389_140-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04445389\" rel=\"nofollow\">\"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 24 June 2020. NCT04445389<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety+and+Immunogenicity+Study+of+GX-19%2C+a+COVID-19+Preventive+DNA+Vaccine+in+Healthy+Adults&amp;rft.date=2020-06-24&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04445389&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-gen-reut-141\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-gen-reut_141-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a class=\"external text\" href=\"https://www.reuters.com/article/health-coronavirus-genexine-vaccine-idUSL4N2DW1T3\" rel=\"nofollow\">\"S. Korea's Genexine begins human trial of coronavirus vaccine\"</a>. <i>Reuters</i>. 19 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=S.+Korea%27s+Genexine+begins+human+trial+of+coronavirus+vaccine&amp;rft.date=2020-06-19&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fhealth-coronavirus-genexine-vaccine-idUSL4N2DW1T3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-142\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-142\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a class=\"external text\" href=\"https://www.ivi.int/genexine-consortiums-covid-19-vaccine-acquires-approval-for-clinical-trails-in-korea/\" rel=\"nofollow\">\"Genexine consortium's Covid-19 vaccine acquires approval for clinical trails in Korea\"</a>. 11 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Genexine+consortium%27s+Covid-19+vaccine+acquires+approval+for+clinical+trails+in+Korea&amp;rft.date=2020-06-11&amp;rft_id=https%3A%2F%2Fwww.ivi.int%2Fgenexine-consortiums-covid-19-vaccine-acquires-approval-for-clinical-trails-in-korea%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04405908-143\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04405908_143-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04405908\" rel=\"nofollow\">\"SCB-2019 as COVID-19 Vaccine\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 28 May 2020. NCT04405908<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=SCB-2019+as+COVID-19+Vaccine&amp;rft.date=2020-05-28&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04405908&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-clover-cta-144\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-clover-cta_144-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.clinicaltrialsarena.com/news/clover-vaccine-covid-19-trial/\" rel=\"nofollow\">\"Clover Biopharmaceuticals starts Phase I Covid-19 vaccine trial\"</a>. Clinical Trials Arena. 20 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Clover+Biopharmaceuticals+starts+Phase+I+Covid-19+vaccine+trial&amp;rft.pub=Clinical+Trials+Arena&amp;rft.date=2020-06-20&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsarena.com%2Fnews%2Fclover-vaccine-covid-19-trial%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-clover-biopharma-145\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-clover-biopharma_145-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.cloverbiopharma.com/index.php?m=content&amp;c=index&amp;a=lists&amp;catid=12\" rel=\"nofollow\">\"About Us\"</a>. <i>Clover Biopharmaceuticals</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Clover+Biopharmaceuticals&amp;rft.atitle=About+Us&amp;rft_id=http%3A%2F%2Fwww.cloverbiopharma.com%2Findex.php%3Fm%3Dcontent%26c%3Dindex%26a%3Dlists%26catid%3D12&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04453852-146\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04453852_146-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04453852\" rel=\"nofollow\">\"Monovalent Recombinant COVID19 Vaccine (COVAX19)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 1 July 2020. NCT04453852<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Monovalent+Recombinant+COVID19+Vaccine+%28COVAX19%29&amp;rft.date=2020-07-01&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04453852&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-vaxine-pty-147\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-vaxine-pty_147-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://vaxine.net/\" rel=\"nofollow\">\"Vaxine\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaxine&amp;rft_id=http%3A%2F%2Fvaxine.net%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-ChiCTR2000034112-148\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ChiCTR2000034112_148-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.chictr.org.cn/showprojen.aspx?proj=55524\" rel=\"nofollow\">\"A Phase I clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a SARS-CoV-2 mRNA vaccine in population aged 18–59 years and 60 years and above\"</a>. <i>Chinese Clinical Trial Register</i> (Registry). 24 June 2020. ChiCTR2000034112<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Chinese+Clinical+Trial+Register&amp;rft.atitle=A+Phase+I+clinical+trial+to+evaluate+the+safety%2C+tolerance+and+preliminary+immunogenicity+of+different+doses+of+a+SARS-CoV-2+mRNA+vaccine+in+population+aged+18%E2%80%9359+years+and+60+years+and+above&amp;rft.date=2020-06-24&amp;rft_id=http%3A%2F%2Fwww.chictr.org.cn%2Fshowprojen.aspx%3Fproj%3D55524&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-walvax-149\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-walvax_149-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.walvax.com/wosen/28.aspx\" rel=\"nofollow\">\"Company introduction\"</a>. <i>Walvax Biotechnology</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Walvax+Biotechnology&amp;rft.atitle=Company+introduction&amp;rft_id=http%3A%2F%2Fwww.walvax.com%2Fwosen%2F28.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04450004-150\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04450004_150-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04450004\" rel=\"nofollow\">\"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 29 June 2020. NCT04450004<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Safety%2C+Tolerability+and+Immunogenicinity+of+a+Coronavirus-Like+Particle+COVID-19+Vaccine+in+Adults+Aged+18-55+Years&amp;rft.date=2020-06-29&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04450004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-ctv-medicago-151\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ctv-medicago_151-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFSt._PhilipFavaroMacLeod2020\">St Philip E, Favaro A, MacLeod M (14 July 2020). <a class=\"external text\" href=\"https://www.ctvnews.ca/health/coronavirus/the-hunt-for-a-vaccine-canadian-company-begins-human-testing-of-covid-19-candidate-1.5022960\" rel=\"nofollow\">\"The hunt for a vaccine: Canadian company begins human testing of COVID-19 candidate\"</a>. <i>CTV News</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CTV+News&amp;rft.atitle=The+hunt+for+a+vaccine%3A+Canadian+company+begins+human+testing+of+COVID-19+candidate&amp;rft.date=2020-07-14&amp;rft.aulast=St.+Philip&amp;rft.aufirst=Elizabeth&amp;rft.au=Favaro%2C+Avis&amp;rft.au=MacLeod%2C+Meredith&amp;rft_id=https%3A%2F%2Fwww.ctvnews.ca%2Fhealth%2Fcoronavirus%2Fthe-hunt-for-a-vaccine-canadian-company-begins-human-testing-of-covid-19-candidate-1.5022960&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-medicago-about-152\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-medicago-about_152-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.medicago.com/en/about-us/\" rel=\"nofollow\">\"About Us\"</a>. <i>Medicago</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medicago&amp;rft.atitle=About+Us&amp;rft_id=https%3A%2F%2Fwww.medicago.com%2Fen%2Fabout-us%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-np-medicago-153\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-np-medicago_153-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFChander2020\">Chander V (14 July 2020). <a class=\"external text\" href=\"https://nationalpost.com/news/canada/canadas-medicago-begins-human-trials-of-plant-based-covid-19-vaccine\" rel=\"nofollow\">\"Canada's Medicago begins human trials of plant-based COVID-19 vaccine\"</a>. <i>National Post</i>. Reuters<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 July</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=National+Post&amp;rft.atitle=Canada%27s+Medicago+begins+human+trials+of+plant-based+COVID-19+vaccine&amp;rft.date=2020-07-14&amp;rft.aulast=Chander&amp;rft.aufirst=Vishwadha&amp;rft_id=https%3A%2F%2Fnationalpost.com%2Fnews%2Fcanada%2Fcanadas-medicago-begins-human-trials-of-plant-based-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04495933-155\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04495933_155-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04495933\" rel=\"nofollow\">\"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 3 August 2020. NCT04495933<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=A+Study+on+the+Safety%2C+Tolerability+and+Immune+Response+of+SARS-CoV-2+Sclamp+%28COVID-19%29+Vaccine+in+Healthy+Adults&amp;rft.date=2020-08-03&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04495933&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-scientists-156\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-scientists_156-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development\" rel=\"nofollow\">\"Public statement for collaboration on COVID-19 vaccine development\"</a>. World Health Organization. 13 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200420214124/https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development\" rel=\"nofollow\">Archived</a> from the original on 20 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Public+statement+for+collaboration+on+COVID-19+vaccine+development&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-04-13&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fdetail%2F13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-gouglas-157\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gouglas_157-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gouglas_157-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-gouglas_157-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-gouglas_157-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFGouglasThanh_LeHendersonKaloudis2018\">Gouglas D, Thanh Le T, Henderson K, Kaloudis A, Danielsen T, Hammersland NC, Robinson JM, Heaton PM, Røttingen JA (December 2018). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7164811\" rel=\"nofollow\">\"Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study\"</a>. <i>Lancet Global Health</i>. <b>6</b> (12): e1386–96. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS2214-109X%2818%2930346-2\" rel=\"nofollow\">10.1016/S2214-109X(18)30346-2</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7164811\" rel=\"nofollow\">7164811</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/30342925\" rel=\"nofollow\">30342925</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet+Global+Health&amp;rft.atitle=Estimating+the+cost+of+vaccine+development+against+epidemic+infectious+diseases%3A+a+cost+minimisation+study&amp;rft.volume=6&amp;rft.issue=12&amp;rft.pages=e1386-96&amp;rft.date=2018-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7164811&amp;rft_id=info%3Apmid%2F30342925&amp;rft_id=info%3Adoi%2F10.1016%2FS2214-109X%2818%2930346-2&amp;rft.aulast=Gouglas&amp;rft.aufirst=D&amp;rft.au=Thanh+Le%2C+T&amp;rft.au=Henderson%2C+K&amp;rft.au=Kaloudis%2C+A&amp;rft.au=Danielsen%2C+T&amp;rft.au=Hammersland%2C+NC&amp;rft.au=Robinson%2C+JM&amp;rft.au=Heaton%2C+PM&amp;rft.au=R%C3%B8ttingen%2C+JA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7164811&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-strovel-158\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-strovel_158-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book cs1\" id=\"CITEREFStrovelSittampalamCoussensHughes2016\">Strovel J, Sittampalam S, Coussens NP, Hughes M, Inglese J, Kurtz A,  et al. (1 July 2016). <a class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK92015/\" rel=\"nofollow\">\"Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies\"</a>. <i>Assay Guidance Manual</i>. Eli Lilly &amp; Company and the National Center for Advancing Translational Sciences. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/22553881\" rel=\"nofollow\">22553881</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Early+Drug+Discovery+and+Development+Guidelines%3A+For+Academic+Researchers%2C+Collaborators%2C+and+Start-up+Companies&amp;rft.btitle=Assay+Guidance+Manual&amp;rft.pub=Eli+Lilly+%26+Company+and+the+National+Center+for+Advancing+Translational+Sciences&amp;rft.date=2016-07-01&amp;rft_id=info%3Apmid%2F22553881&amp;rft.aulast=Strovel&amp;rft.aufirst=J&amp;rft.au=Sittampalam%2C+S&amp;rft.au=Coussens%2C+NP&amp;rft.au=Hughes%2C+M&amp;rft.au=Inglese%2C+J&amp;rft.au=Kurtz%2C+A&amp;rft.au=Andalibi%2C+A&amp;rft.au=Patton%2C+L&amp;rft.au=Austin%2C+C&amp;rft.au=Baltezor%2C+M&amp;rft.au=Beckloff%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK92015%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-dimasi-159\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-dimasi_159-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFDiMasiGrabowskiHansen2016\">DiMasi JA, Grabowski HG, Hansen RW (May 2016). <a class=\"external text\" href=\"https://dukespace.lib.duke.edu/dspace/bitstream/handle/10161/12742/DiMasi-Grabowski-Hansen-RnD-JHE-2016.pdf;sequence=1\" rel=\"nofollow\">\"Innovation in the pharmaceutical industry: New estimates of R&amp;D costs\"</a>. <i>Journal of Health Economics</i>. <b>47</b>: 20–33. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.jhealeco.2016.01.012\" rel=\"nofollow\">10.1016/j.jhealeco.2016.01.012</a>. <a class=\"mw-redirect\" href=\"/wiki/Hdl_(identifier)\" title=\"Hdl (identifier)\">hdl</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//hdl.handle.net/10161%2F12742\" rel=\"nofollow\">10161/12742</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26928437\" rel=\"nofollow\">26928437</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20191205042228/https://dukespace.lib.duke.edu/dspace/bitstream/handle/10161/12742/DiMasi-Grabowski-Hansen-RnD-JHE-2016.pdf;sequence=1\" rel=\"nofollow\">Archived</a> from the original on 5 December 2019<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">21 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Health+Economics&amp;rft.atitle=Innovation+in+the+pharmaceutical+industry%3A+New+estimates+of+R%26D+costs&amp;rft.volume=47&amp;rft.pages=20-33&amp;rft.date=2016-05&amp;rft_id=info%3Ahdl%2F10161%2F12742&amp;rft_id=info%3Apmid%2F26928437&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhealeco.2016.01.012&amp;rft.aulast=DiMasi&amp;rft.aufirst=JA&amp;rft.au=Grabowski%2C+HG&amp;rft.au=Hansen%2C+RW&amp;rft_id=https%3A%2F%2Fdukespace.lib.duke.edu%2Fdspace%2Fbitstream%2Fhandle%2F10161%2F12742%2FDiMasi-Grabowski-Hansen-RnD-JHE-2016.pdf%3Bsequence%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-Kleinnijenhuis_2015-160\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Kleinnijenhuis_2015_160-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFKleinnijenhuisvan_CrevelNetea2015\">Kleinnijenhuis J, van Crevel R, Netea MG (January 2015). \"Trained immunity: consequences for the heterologous effects of BCG vaccination\". <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>. <b>109</b> (1): 29–35. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1093%2Ftrstmh%2Ftru168\" rel=\"nofollow\">10.1093/trstmh/tru168</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/25573107\" rel=\"nofollow\">25573107</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transactions+of+the+Royal+Society+of+Tropical+Medicine+and+Hygiene&amp;rft.atitle=Trained+immunity%3A+consequences+for+the+heterologous+effects+of+BCG+vaccination.&amp;rft.volume=109&amp;rft.issue=1&amp;rft.pages=29-35&amp;rft.date=2015-01&amp;rft_id=info%3Adoi%2F10.1093%2Ftrstmh%2Ftru168&amp;rft_id=info%3Apmid%2F25573107&amp;rft.aulast=Kleinnijenhuis&amp;rft.aufirst=J&amp;rft.au=van+Crevel%2C+R&amp;rft.au=Netea%2C+MG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-deVrieze-April-161\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-deVrieze-April_161-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFde_Vrieze2020\">de Vrieze J (23 March 2020). \"Can a century-old TB vaccine steel the immune system against the new coronavirus?\". <i>Science</i>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abb8297\" rel=\"nofollow\">10.1126/science.abb8297</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:216359131\" rel=\"nofollow\">216359131</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Can+a+century-old+TB+vaccine+steel+the+immune+system+against+the+new+coronavirus%3F&amp;rft.date=2020-03-23&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abb8297&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A216359131&amp;rft.aulast=de+Vrieze&amp;rft.aufirst=Jop&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-162\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-162\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFO'NeillNetea2020\">O'Neill LA, Netea MG (June 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7212510\" rel=\"nofollow\">\"BCG-induced trained immunity: can it offer protection against COVID-19?\"</a>. <i>Nat. Rev. Immunol</i>. <b>20</b> (6): 335–37. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fs41577-020-0337-y\" rel=\"nofollow\">10.1038/s41577-020-0337-y</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7212510\" rel=\"nofollow\">7212510</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32393823\" rel=\"nofollow\">32393823</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Rev.+Immunol.&amp;rft.atitle=BCG-induced+trained+immunity%3A+can+it+offer+protection+against+COVID-19%3F&amp;rft.volume=20&amp;rft.issue=6&amp;rft.pages=335-37&amp;rft.date=2020-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7212510&amp;rft_id=info%3Apmid%2F32393823&amp;rft_id=info%3Adoi%2F10.1038%2Fs41577-020-0337-y&amp;rft.aulast=O%27Neill&amp;rft.aufirst=LA&amp;rft.au=Netea%2C+MG&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7212510&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-163\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-163\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFEscobarMolina-CruzBarillas-Mury2020\">Escobar LE, Molina-Cruz A, Barillas-Mury C (July 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7395502\" rel=\"nofollow\">\"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>117</b> (30): 17720–26. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1073%2Fpnas.2008410117\" rel=\"nofollow\">10.1073/pnas.2008410117</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7395502\" rel=\"nofollow\">7395502</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32647056\" rel=\"nofollow\">32647056</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=BCG+vaccine+protection+from+severe+coronavirus+disease+2019+%28COVID-19%29&amp;rft.volume=117&amp;rft.issue=30&amp;rft.pages=17720-26&amp;rft.date=2020-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7395502&amp;rft_id=info%3Apmid%2F32647056&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.2008410117&amp;rft.aulast=Escobar&amp;rft.aufirst=LE&amp;rft.au=Molina-Cruz%2C+A&amp;rft.au=Barillas-Mury%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7395502&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-164\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-164\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFKotiMoralesGrahamSiemens2020\">Koti M, Morales A, Graham CH, Siemens DR (July 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7342862\" rel=\"nofollow\">\"BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy\"</a>. <i>J Immunother Cancer</i>. <b>8</b> (2): e001119. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1136%2Fjitc-2020-001119\" rel=\"nofollow\">10.1136/jitc-2020-001119</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7342862\" rel=\"nofollow\">7342862</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32636240\" rel=\"nofollow\">32636240</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Immunother+Cancer&amp;rft.atitle=BCG+vaccine+and+COVID-19%3A+implications+for+infection+prophylaxis+and+cancer+immunotherapy&amp;rft.volume=8&amp;rft.issue=2&amp;rft.pages=e001119&amp;rft.date=2020-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7342862&amp;rft_id=info%3Apmid%2F32636240&amp;rft_id=info%3Adoi%2F10.1136%2Fjitc-2020-001119&amp;rft.aulast=Koti&amp;rft.aufirst=M&amp;rft.au=Morales%2C+A&amp;rft.au=Graham%2C+CH&amp;rft.au=Siemens%2C+DR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7342862&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-165\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-165\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/news-room/commentaries/detail/bacille-calmette-gu%C3%A9rin-(bcg)-vaccination-and-covid-19\" rel=\"nofollow\">\"Bacille Calmette-Guérin (BCG) vaccination and COVID-19\"</a>. <i><a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> (WHO)</i>. 12 April 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200430121126/https://www.who.int/news-room/commentaries/detail/bacille-calmette-gu%C3%A9rin-(bcg)-vaccination-and-covid-19\" rel=\"nofollow\">Archived</a> from the original on 30 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization+%28WHO%29&amp;rft.atitle=Bacille+Calmette-Gu%C3%A9rin+%28BCG%29+vaccination+and+COVID-19&amp;rft.date=2020-04-12&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fcommentaries%2Fdetail%2Fbacille-calmette-gu%25C3%25A9rin-%28bcg%29-vaccination-and-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-EudraCT-2020-000919-69-166\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EudraCT-2020-000919-69_166-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000919-69/NL\" rel=\"nofollow\">\"Reducing health care workers absenteeism in SARS-CoV-2 pandemic by enhanced trained immune responses through Bacillus Calmette-Guérin vaccination, a randomized controlled trial (COVID-19)\"</a>. <i>EU Clinical Trials Register</i> (Registry). European Union. 17 March 2020. <a href=\"/wiki/EudraCT\" title=\"EudraCT\">EudraCT</a> 2020-000919-69. <a class=\"external text\" href=\"https://web.archive.org/web/20200404104902/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000919-69/NL\" rel=\"nofollow\">Archived</a> from the original on 4 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EU+Clinical+Trials+Register&amp;rft.atitle=Reducing+health+care+workers+absenteeism+in+SARS-CoV-2+pandemic+by+enhanced+trained+immune+responses+through+Bacillus+Calmette-Gu%C3%A9rin+vaccination%2C+a+randomized+controlled+trial+%28COVID-19%29&amp;rft.date=2020-03-17&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsregister.eu%2Fctr-search%2Ftrial%2F2020-000919-69%2FNL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-MCRI-BCG-trial-167\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-MCRI-BCG-trial_167-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.mcri.edu.au/news/murdoch-children%E2%80%99s-research-institute-trial-preventative-vaccine-covid-19-healthcare-workers\" rel=\"nofollow\">\"Murdoch Children's Research Institute to trial preventative vaccine for COVID-19 healthcare workers\"</a>. <i>Murdoch Children's Research Institute</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200413230625/https://www.mcri.edu.au/news/murdoch-children%2525E2%252580%252599s-research-institute-trial-preventative-vaccine-covid-19-healthcare-workers\" rel=\"nofollow\">Archived</a> from the original on 13 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Murdoch+Children%27s+Research+Institute&amp;rft.atitle=Murdoch+Children%27s+Research+Institute+to+trial+preventative+vaccine+for+COVID-19+healthcare+workers&amp;rft_id=https%3A%2F%2Fwww.mcri.edu.au%2Fnews%2Fmurdoch-children%25E2%2580%2599s-research-institute-trial-preventative-vaccine-covid-19-healthcare-workers&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04327206-168\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04327206_168-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04327206\" rel=\"nofollow\">\"BCG Vaccination to Protect Healthcare Workers Against COVID-19 (BRACE)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 31 March 2020. NCT04327206. <a class=\"external text\" href=\"https://web.archive.org/web/20200411045454/https://clinicaltrials.gov/ct2/show/NCT04327206\" rel=\"nofollow\">Archived</a> from the original on 11 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=BCG+Vaccination+to+Protect+Healthcare+Workers+Against+COVID-19+%28BRACE%29&amp;rft.date=2020-03-31&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04327206&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-NCT04357028-169\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NCT04357028_169-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT04357028\" rel=\"nofollow\">\"Measles Vaccine in HCW (MV-COVID19)\"</a>. <i><a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></i> (Registry). <a href=\"/wiki/United_States_National_Library_of_Medicine\" title=\"United States National Library of Medicine\">United States National Library of Medicine</a>. 22 April 2020. NCT04357028. <a class=\"external text\" href=\"https://web.archive.org/web/20200507053436/https://clinicaltrials.gov/ct2/show/NCT04357028\" rel=\"nofollow\">Archived</a> from the original on 7 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Measles+Vaccine+in+HCW+%28MV-COVID19%29&amp;rft.date=2020-04-22&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04357028&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-tregoning-170\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-tregoning_170-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-tregoning_170-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-tregoning_170-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-tregoning_170-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-tregoning_170-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFTregoningRussellKinnear2018\">Tregoning, John S.; Russell, Ryan F.; Kinnear, Ekaterina (25 January 2018). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5861793\" rel=\"nofollow\">\"Adjuvanted influenza vaccines\"</a>. <i>Human Vaccines and Immunotherapeutics</i>. <b>14</b> (3): 550–64. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1080%2F21645515.2017.1415684\" rel=\"nofollow\">10.1080/21645515.2017.1415684</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/2164-5515\" rel=\"nofollow\">2164-5515</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5861793\" rel=\"nofollow\">5861793</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/29232151\" rel=\"nofollow\">29232151</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Vaccines+and+Immunotherapeutics&amp;rft.atitle=Adjuvanted+influenza+vaccines&amp;rft.volume=14&amp;rft.issue=3&amp;rft.pages=550-64&amp;rft.date=2018-01-25&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5861793&amp;rft.issn=2164-5515&amp;rft_id=info%3Apmid%2F29232151&amp;rft_id=info%3Adoi%2F10.1080%2F21645515.2017.1415684&amp;rft.aulast=Tregoning&amp;rft.aufirst=John+S.&amp;rft.au=Russell%2C+Ryan+F.&amp;rft.au=Kinnear%2C+Ekaterina&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5861793&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-wang-171\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wang_171-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wang_171-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wang_171-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wang_171-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-wang_171-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFWangPengXuCui2020\">Wang, Jieliang; Peng, Ying; Xu, Haiyue; Cui, Zhengrong; Williams, Robert O. (5 August 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7405756\" rel=\"nofollow\">\"The COVID-19 vaccine race: Challenges and opportunities in vaccine formulation\"</a>. <i>AAPS PharmSciTech</i>. <b>21</b> (6): 225. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1208%2Fs12249-020-01744-7\" rel=\"nofollow\">10.1208/s12249-020-01744-7</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/1530-9932\" rel=\"nofollow\">1530-9932</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7405756\" rel=\"nofollow\">7405756</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32761294\" rel=\"nofollow\">32761294</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=AAPS+PharmSciTech&amp;rft.atitle=The+COVID-19+vaccine+race%3A+Challenges+and+opportunities+in+vaccine+formulation&amp;rft.volume=21&amp;rft.issue=6&amp;rft.pages=225&amp;rft.date=2020-08-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7405756&amp;rft.issn=1530-9932&amp;rft_id=info%3Apmid%2F32761294&amp;rft_id=info%3Adoi%2F10.1208%2Fs12249-020-01744-7&amp;rft.aulast=Wang&amp;rft.aufirst=Jieliang&amp;rft.au=Peng%2C+Ying&amp;rft.au=Xu%2C+Haiyue&amp;rft.au=Cui%2C+Zhengrong&amp;rft.au=Williams%2C+Robert+O.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7405756&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-Thorp-172\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Thorp_172-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFThorp2020\">Thorp HH (27 March 2020). <a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abb8492\" rel=\"nofollow\">\"Underpromise, overdeliver\"</a>. <i>Science</i>. <b>367</b> (6485): 1405. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Sci...367.1405T\" rel=\"nofollow\">2020Sci...367.1405T</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abb8492\" rel=\"nofollow\">10.1126/science.abb8492</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32205459\" rel=\"nofollow\">32205459</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Underpromise%2C+overdeliver&amp;rft.volume=367&amp;rft.issue=6485&amp;rft.pages=1405&amp;rft.date=2020-03-27&amp;rft_id=info%3Apmid%2F32205459&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abb8492&amp;rft_id=info%3Abibcode%2F2020Sci...367.1405T&amp;rft.aulast=Thorp&amp;rft.aufirst=H.+Holden&amp;rft_id=%2F%2Fdoi.org%2F10.1126%252Fscience.abb8492&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-threat-173\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-threat_173-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/emergencies/ten-threats-to-global-health-in-2019\" rel=\"nofollow\">\"Ten health issues WHO will tackle this year\"</a>. World Health Organization. 2019. <a class=\"external text\" href=\"https://web.archive.org/web/20191111212640/https://www.who.int/emergencies/ten-threats-to-global-health-in-2019\" rel=\"nofollow\">Archived</a> from the original on 11 November 2019<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Ten+health+issues+WHO+will+tackle+this+year&amp;rft.pub=World+Health+Organization&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.who.int%2Femergencies%2Ften-threats-to-global-health-in-2019&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-dube-174\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-dube_174-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-dube_174-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFDubéLabergeGuayBramadat2013\">Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J (1 August 2013). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3906279\" rel=\"nofollow\">\"Vaccine hesitancy: an overview\"</a>. <i>Human Vaccines and Immunotherapeutics</i>. <b>9</b> (8): 1763–73. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.4161%2Fhv.24657\" rel=\"nofollow\">10.4161/hv.24657</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/2164-554X\" rel=\"nofollow\">2164-554X</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3906279\" rel=\"nofollow\">3906279</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/23584253\" rel=\"nofollow\">23584253</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Vaccines+and+Immunotherapeutics&amp;rft.atitle=Vaccine+hesitancy%3A+an+overview&amp;rft.volume=9&amp;rft.issue=8&amp;rft.pages=1763-73&amp;rft.date=2013-08-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3906279&amp;rft.issn=2164-554X&amp;rft_id=info%3Apmid%2F23584253&amp;rft_id=info%3Adoi%2F10.4161%2Fhv.24657&amp;rft.aulast=Dub%C3%A9&amp;rft.aufirst=Eve&amp;rft.au=Laberge%2C+Caroline&amp;rft.au=Guay%2C+Maryse&amp;rft.au=Bramadat%2C+Paul&amp;rft.au=Roy%2C+R%C3%A9al&amp;rft.au=Bettinger%2C+Julie&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3906279&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-malik-175\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-malik_175-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-malik_175-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-malik_175-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFMalikMcFaddenElharakeOmer2020\">Malik, Amyn A; McFadden, SarahAnn M; Elharake, Jad; Omer, Saad B (2020). <a class=\"external text\" href=\"https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30239-X/fulltext\" rel=\"nofollow\">\"Determinants of COVID-19 vaccine acceptance in the US\"</a>. <i>EClinicalMedicine, the Lancet</i>. <b>26</b>: 100495. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.eclinm.2020.100495\" rel=\"nofollow\">10.1016/j.eclinm.2020.100495</a></span>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/2589-5370\" rel=\"nofollow\">2589-5370</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7423333\" rel=\"nofollow\">7423333</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32838242\" rel=\"nofollow\">32838242</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EClinicalMedicine%2C+the+Lancet&amp;rft.atitle=Determinants+of+COVID-19+vaccine+acceptance+in+the+US&amp;rft.volume=26&amp;rft.pages=100495&amp;rft.date=2020&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7423333&amp;rft.issn=2589-5370&amp;rft_id=info%3Apmid%2F32838242&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eclinm.2020.100495&amp;rft.aulast=Malik&amp;rft.aufirst=Amyn+A&amp;rft.au=McFadden%2C+SarahAnn+M&amp;rft.au=Elharake%2C+Jad&amp;rft.au=Omer%2C+Saad+B&amp;rft_id=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Feclinm%2Farticle%2FPIIS2589-5370%2820%2930239-X%2Ffulltext&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-176\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-176\">^</a></b></span> <span class=\"reference-text\">Linda Thunström, Madison Ashworth, David Finnoff, and Stephen C. Newbold. 2020. Hesitancy towards a COVID-19 vaccine and prospects for herd immunity. <a class=\"external text\" href=\"https://cepr.org/file/9287/download?token=Ba6cin7P\" rel=\"nofollow\"><i>Covid Economics</i> 35</a>: 7 July 2020</span>\n",
            "</li>\n",
            "<li id=\"cite_note-iwasaki-177\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-iwasaki_177-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-iwasaki_177-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-iwasaki_177-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFIwasakiYang2020\">Iwasaki A, Yang Y (21 April 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7187142\" rel=\"nofollow\">\"The potential danger of suboptimal antibody responses in COVID-19\"</a>. <i>Nature Reviews Immunology</i>. <b>20</b> (6): 339–41. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fs41577-020-0321-6\" rel=\"nofollow\">10.1038/s41577-020-0321-6</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/1474-1733\" rel=\"nofollow\">1474-1733</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7187142\" rel=\"nofollow\">7187142</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32317716\" rel=\"nofollow\">32317716</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Immunology&amp;rft.atitle=The+potential+danger+of+suboptimal+antibody+responses+in+COVID-19&amp;rft.volume=20&amp;rft.issue=6&amp;rft.pages=339-41&amp;rft.date=2020-04-21&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7187142&amp;rft.issn=1474-1733&amp;rft_id=info%3Apmid%2F32317716&amp;rft_id=info%3Adoi%2F10.1038%2Fs41577-020-0321-6&amp;rft.aulast=Iwasaki&amp;rft.aufirst=Akiko&amp;rft.au=Yang%2C+Yexin&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7187142&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-wied-178\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wied_178-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wied_178-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wied_178-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wied_178-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFWiedermannGarner-SpitzerWagner2016\">Wiedermann U, Garner-Spitzer E, Wagner A (2016). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4962729\" rel=\"nofollow\">\"Primary vaccine failure to routine vaccines: Why and what to do?\"</a>. <i>Human Vaccines and Immunotherapeutics</i>. <b>12</b> (1): 239–43. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1080%2F21645515.2015.1093263\" rel=\"nofollow\">10.1080/21645515.2015.1093263</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/2164-554X\" rel=\"nofollow\">2164-554X</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4962729\" rel=\"nofollow\">4962729</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26836329\" rel=\"nofollow\">26836329</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Vaccines+and+Immunotherapeutics&amp;rft.atitle=Primary+vaccine+failure+to+routine+vaccines%3A+Why+and+what+to+do%3F&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=239-43&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4962729&amp;rft.issn=2164-554X&amp;rft_id=info%3Apmid%2F26836329&amp;rft_id=info%3Adoi%2F10.1080%2F21645515.2015.1093263&amp;rft.aulast=Wiedermann&amp;rft.aufirst=Ursula&amp;rft.au=Garner-Spitzer%2C+Erika&amp;rft.au=Wagner%2C+Angelika&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4962729&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-zumla-179\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-zumla_179-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFZumlaHuiPerlman2015\">Zumla A, Hui DS, Perlman S (11 September 2015). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4721578\" rel=\"nofollow\">\"Middle East respiratory syndrome\"</a>. <i>Lancet</i>. <b>386</b> (9997): 995–1007. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2FS0140-6736%2815%2960454-8\" rel=\"nofollow\">10.1016/S0140-6736(15)60454-8</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4721578\" rel=\"nofollow\">4721578</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26049252\" rel=\"nofollow\">26049252</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Middle+East+respiratory+syndrome&amp;rft.volume=386&amp;rft.issue=9997&amp;rft.pages=995-1007&amp;rft.date=2015-09-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4721578&amp;rft_id=info%3Apmid%2F26049252&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2815%2960454-8&amp;rft.aulast=Zumla&amp;rft.aufirst=Alimuddin&amp;rft.au=Hui%2C+David+S&amp;rft.au=Perlman%2C+Stanley&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4721578&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-garcia-180\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-garcia_180-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFGarcia_de_Jesus2020\">Garcia de Jesus E (26 May 2020). <a class=\"external text\" href=\"https://www.sciencenews.org/article/coronavirus-covid19-mutations-strains-variants\" rel=\"nofollow\">\"Is the coronavirus mutating? Yes. But here's why you don't need to panic\"</a>. Science News. <a class=\"external text\" href=\"https://web.archive.org/web/20200621235243/https://www.sciencenews.org/article/coronavirus-covid19-mutations-strains-variants\" rel=\"nofollow\">Archived</a> from the original on 21 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">21 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Is+the+coronavirus+mutating%3F+Yes.+But+here%27s+why+you+don%27t+need+to+panic&amp;rft.pub=Science+News&amp;rft.date=2020-05-26&amp;rft.aulast=Garcia+de+Jesus&amp;rft.aufirst=Erin&amp;rft_id=https%3A%2F%2Fwww.sciencenews.org%2Farticle%2Fcoronavirus-covid19-mutations-strains-variants&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-howard-cnn-181\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-howard-cnn_181-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFHowardStracqualursi2020\">Howard J, Stracqualursi V (18 June 2020). <a class=\"external text\" href=\"https://www.cnn.com/2020/06/18/politics/anthony-fauci-coronavirus-anti-science-bias/index.html\" rel=\"nofollow\">\"Fauci warns of 'anti-science bias' being a problem in US\"</a>. <i>CNN</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200621003117/https://www.cnn.com/2020/06/18/politics/anthony-fauci-coronavirus-anti-science-bias/index.html\" rel=\"nofollow\">Archived</a> from the original on 21 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">21 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Fauci+warns+of+%27anti-science+bias%27+being+a+problem+in+US&amp;rft.date=2020-06-18&amp;rft.aulast=Howard&amp;rft.aufirst=Jacqueline&amp;rft.au=Stracqualursi%2C+Veronica&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2020%2F06%2F18%2Fpolitics%2Fanthony-fauci-coronavirus-anti-science-bias%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-winter-182\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-winter_182-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFWinterPage-ReevesPageHaozous2018\">Winter, SS; Page-Reeves, JM; Page, KA; Haozous, E; Solares, A; Nicole Cordova, C; Larson, RS (28 May 2018). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6410628\" rel=\"nofollow\">\"Inclusion of special populations in clinical research: important considerations and guidelines\"</a>. <i>Journal of Clinical and Translational Research</i> (Review). <b>4</b> (1): 56–69. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/2382-6533\" rel=\"nofollow\">2382-6533</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6410628\" rel=\"nofollow\">6410628</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/30873495\" rel=\"nofollow\">30873495</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+and+Translational+Research&amp;rft.atitle=Inclusion+of+special+populations+in+clinical+research%3A+important+considerations+and+guidelines&amp;rft.volume=4&amp;rft.issue=1&amp;rft.pages=56-69&amp;rft.date=2018-05-28&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6410628&amp;rft.issn=2382-6533&amp;rft_id=info%3Apmid%2F30873495&amp;rft.aulast=Winter&amp;rft.aufirst=SS&amp;rft.au=Page-Reeves%2C+JM&amp;rft.au=Page%2C+KA&amp;rft.au=Haozous%2C+E&amp;rft.au=Solares%2C+A&amp;rft.au=Nicole+Cordova%2C+C&amp;rft.au=Larson%2C+RS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6410628&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-gates3-183\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-gates3_183-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFGates2020\">Gates B (23 April 2020). <a class=\"external text\" href=\"https://www.gatesnotes.com/Health/Pandemic-Innovation\" rel=\"nofollow\">\"The first modern pandemic: The scientific advances we need to stop COVID-19\"</a>. The Gates Notes. <a class=\"external text\" href=\"https://web.archive.org/web/20200513122415/https://www.gatesnotes.com/Health/Pandemic-Innovation\" rel=\"nofollow\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+first+modern+pandemic%3A+The+scientific+advances+we+need+to+stop+COVID-19&amp;rft.pub=The+Gates+Notes&amp;rft.date=2020-04-23&amp;rft.aulast=Gates&amp;rft.aufirst=Bill&amp;rft_id=https%3A%2F%2Fwww.gatesnotes.com%2FHealth%2FPandemic-Innovation&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-184\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-184\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFStevis-GridneffJakes2020\">Stevis-Gridneff M, Jakes L (4 May 2020). <a class=\"external text\" href=\"https://www.nytimes.com/2020/05/04/world/europe/eu-coronavirus-vaccine.html\" rel=\"nofollow\">\"World Leaders Join to Pledge $8 Billion for Vaccine as U.S. Goes It Alone\"</a>. <i>The New York Times</i>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\" rel=\"nofollow\">0362-4331</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200513041549/https://www.nytimes.com/2020/05/04/world/europe/eu-coronavirus-vaccine.html\" rel=\"nofollow\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=World+Leaders+Join+to+Pledge+%248+Billion+for+Vaccine+as+U.S.+Goes+It+Alone&amp;rft.date=2020-05-04&amp;rft.issn=0362-4331&amp;rft.aulast=Stevis-Gridneff&amp;rft.aufirst=Matina&amp;rft.au=Jakes%2C+Lara&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F05%2F04%2Fworld%2Feurope%2Feu-coronavirus-vaccine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-185\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-185\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFBlanchfield2020\">Blanchfield M (30 April 2020). <a class=\"external text\" href=\"https://www.thestar.com/news/canada/2020/04/30/global-philanthropists-experts-call-for-covid-19-vaccine-distribution-plan.html\" rel=\"nofollow\">\"Global philanthropists, experts call for COVID-19 vaccine distribution plan\"</a>. <i>The Toronto Star</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200507230428/https://www.thestar.com/news/canada/2020/04/30/global-philanthropists-experts-call-for-covid-19-vaccine-distribution-plan.html\" rel=\"nofollow\">Archived</a> from the original on 7 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Toronto+Star&amp;rft.atitle=Global+philanthropists%2C+experts+call+for+COVID-19+vaccine+distribution+plan&amp;rft.date=2020-04-30&amp;rft.aulast=Blanchfield&amp;rft.aufirst=Mike&amp;rft_id=https%3A%2F%2Fwww.thestar.com%2Fnews%2Fcanada%2F2020%2F04%2F30%2Fglobal-philanthropists-experts-call-for-covid-19-vaccine-distribution-plan.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-186\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-186\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.statnews.com/2020/10/09/7-looming-questions-about-the-rollout-of-a-covid-19-vaccine/\" rel=\"nofollow\">\"7 looming questions about the rollout of a Covid-19 vaccine\"</a>. <i>STAT</i>. 9 October 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 October</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=STAT&amp;rft.atitle=7+looming+questions+about+the+rollout+of+a+Covid-19+vaccine&amp;rft.date=2020-10-09&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F10%2F09%2F7-looming-questions-about-the-rollout-of-a-covid-19-vaccine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-eyal-187\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-eyal_187-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-eyal_187-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-eyal_187-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-eyal_187-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-eyal_187-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-eyal_187-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-eyal_187-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-eyal_187-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFEyalLipsitchSmith2020\">Eyal N, Lipsitch M, Smith PG (31 March 2020). <a class=\"external text\" href=\"https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa152/5814216\" rel=\"nofollow\">\"Human challenge studies to accelerate coronavirus vaccine licensure\"</a>. <i>The Journal of Infectious Diseases</i>. <b>221</b> (11): 1752–56. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1093%2Finfdis%2Fjiaa152\" rel=\"nofollow\">10.1093/infdis/jiaa152</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7184325\" rel=\"nofollow\">7184325</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32232474\" rel=\"nofollow\">32232474</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200424095527/https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa152/5814216\" rel=\"nofollow\">Archived</a> from the original on 24 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Infectious+Diseases&amp;rft.atitle=Human+challenge+studies+to+accelerate+coronavirus+vaccine+licensure&amp;rft.volume=221&amp;rft.issue=11&amp;rft.pages=1752-56&amp;rft.date=2020-03-31&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7184325&amp;rft_id=info%3Apmid%2F32232474&amp;rft_id=info%3Adoi%2F10.1093%2Finfdis%2Fjiaa152&amp;rft.aulast=Eyal&amp;rft.aufirst=Nir&amp;rft.au=Lipsitch%2C+Marc&amp;rft.au=Smith%2C+Peter+G.&amp;rft_id=https%3A%2F%2Facademic.oup.com%2Fjid%2Fadvance-article%2Fdoi%2F10.1093%2Finfdis%2Fjiaa152%2F5814216&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-callaway-188\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-callaway_188-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-callaway_188-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-callaway_188-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-callaway_188-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-callaway_188-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-callaway_188-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-callaway_188-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFCallaway2020\">Callaway E (April 2020). <a class=\"external text\" href=\"https://www.nature.com/articles/d41586-020-00927-3\" rel=\"nofollow\">\"Should scientists infect healthy people with the coronavirus to test vaccines?\"</a>. <i>Nature</i>. <b>580</b> (7801): 17. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Natur.580...17C\" rel=\"nofollow\">2020Natur.580...17C</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fd41586-020-00927-3\" rel=\"nofollow\">10.1038/d41586-020-00927-3</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32218549\" rel=\"nofollow\">32218549</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200414035045/https://www.nature.com/articles/d41586-020-00927-3\" rel=\"nofollow\">Archived</a> from the original on 14 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Should+scientists+infect+healthy+people+with+the+coronavirus+to+test+vaccines%3F&amp;rft.volume=580&amp;rft.issue=7801&amp;rft.pages=17&amp;rft.date=2020-04&amp;rft_id=info%3Apmid%2F32218549&amp;rft_id=info%3Adoi%2F10.1038%2Fd41586-020-00927-3&amp;rft_id=info%3Abibcode%2F2020Natur.580...17C&amp;rft.aulast=Callaway&amp;rft.aufirst=E&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-00927-3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-boodman-189\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-boodman_189-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFBoodman2020\">Boodman E (13 March 2020). <a class=\"external text\" href=\"https://www.statnews.com/2020/03/11/researchers-rush-to-start-moderna-coronavirus-vaccine-trial-without-usual-animal-testing/\" rel=\"nofollow\">\"Coronavirus vaccine clinical trial starting without usual animal data\"</a>. STAT. <a class=\"external text\" href=\"https://web.archive.org/web/20200417060301/https://www.statnews.com/2020/03/11/researchers-rush-to-start-moderna-coronavirus-vaccine-trial-without-usual-animal-testing/\" rel=\"nofollow\">Archived</a> from the original on 17 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus+vaccine+clinical+trial+starting+without+usual+animal+data&amp;rft.pub=STAT&amp;rft.date=2020-03-13&amp;rft.aulast=Boodman&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F03%2F11%2Fresearchers-rush-to-start-moderna-coronavirus-vaccine-trial-without-usual-animal-testing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cohen-190\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cohen_190-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cohen_190-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-cohen_190-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-cohen_190-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFCohen2020\">Cohen J (31 March 2020). <a class=\"external text\" href=\"https://www.sciencemag.org/news/2020/03/speed-coronavirus-vaccine-testing-deliberately-infecting-volunteers-not-so-fast-some\" rel=\"nofollow\">\"Speed coronavirus vaccine testing by deliberately infecting volunteers? Not so fast, some scientists warn\"</a>. <i>Science</i>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abc0006\" rel=\"nofollow\">10.1126/science.abc0006</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200414031310/https://www.sciencemag.org/news/2020/03/speed-coronavirus-vaccine-testing-deliberately-infecting-volunteers-not-so-fast-some\" rel=\"nofollow\">Archived</a> from the original on 14 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Speed+coronavirus+vaccine+testing+by+deliberately+infecting+volunteers%3F+Not+so+fast%2C+some+scientists+warn&amp;rft.date=2020-03-31&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abc0006&amp;rft.aulast=Cohen&amp;rft.aufirst=Jon&amp;rft_id=https%3A%2F%2Fwww.sciencemag.org%2Fnews%2F2020%2F03%2Fspeed-coronavirus-vaccine-testing-deliberately-infecting-volunteers-not-so-fast-some&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-191\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-191\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFWalkerWhittakerWatsonBaguelin2020\">Walker P, Whittaker C, Watson O, Baguelin M, Ainslie K, Bhatia S,  et al. (26 March 2020). <a class=\"external text\" href=\"https://spiral.imperial.ac.uk:8443/bitstream/10044/1/77735/10/2020-03-26-COVID19-Report-12.pdf\" rel=\"nofollow\">\"The global impact of COVID-19 and strategies for mitigation and suppression\"</a> <span class=\"cs1-format\">(PDF)</span>. Imperial College COVID-19 Response Team. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.25561%2F77735\" rel=\"nofollow\">10.25561/77735</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200421013007/https://spiral.imperial.ac.uk:8443/bitstream/10044/1/77735/10/2020-03-26-COVID19-Report-12.pdf\" rel=\"nofollow\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 21 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+global+impact+of+COVID-19+and+strategies+for+mitigation+and+suppression&amp;rft.date=2020-03-26&amp;rft_id=info%3Adoi%2F10.25561%2F77735&amp;rft.aulast=Walker&amp;rft.aufirst=P.&amp;rft.au=Whittaker%2C+C.&amp;rft.au=Watson%2C+O.&amp;rft.au=Baguelin%2C+M.&amp;rft.au=Ainslie%2C+K.&amp;rft.au=Bhatia%2C+S.&amp;rft.au=Bhatt%2C+S.&amp;rft.au=Boonyasiri%2C+A.&amp;rft.au=Boyd%2C+O.&amp;rft.au=Cattarino%2C+L.&amp;rft.au=Cucunuba+Perez%2C+Z.&amp;rft.au=Cuomo-Dannenburg%2C+G.&amp;rft.au=Dighe%2C+A.&amp;rft.au=Donnelly%2C+C.&amp;rft.au=Dorigatti%2C+I.&amp;rft.au=Van+Elsland%2C+S.&amp;rft.au=Fitzjohn%2C+R.&amp;rft.au=Flaxman%2C+S.&amp;rft.au=Fu%2C+H.&amp;rft.au=Gaythorpe%2C+K.&amp;rft.au=Geidelberg%2C+L.&amp;rft.au=Grassly%2C+N.&amp;rft.au=Green%2C+W.&amp;rft.au=Hamlet%2C+A.&amp;rft.au=Hauck%2C+K.&amp;rft.au=Haw%2C+D.&amp;rft.au=Hayes%2C+S.&amp;rft.au=Hinsley%2C+W.&amp;rft.au=Imai%2C+N.&amp;rft.au=Jorgensen%2C+D.&amp;rft_id=https%3A%2F%2Fspiral.imperial.ac.uk%3A8443%2Fbitstream%2F10044%2F1%2F77735%2F10%2F2020-03-26-COVID19-Report-12.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span> <span class=\"cs1-hidden-error error citation-comment\">Cite journal requires <code class=\"cs1-code\">|journal=</code> (<a href=\"/wiki/Help:CS1_errors#missing_periodical\" title=\"Help:CS1 errors\">help</a>)</span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-challenge-192\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who-challenge_192-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://apps.who.int/iris/bitstream/handle/10665/331976/WHO-2019-nCoV-Ethics_criteria-2020.1-eng.pdf\" rel=\"nofollow\">\"Key criteria for the ethical acceptability of COVID-19 human challenge studies\"</a> <span class=\"cs1-format\">(PDF)</span>. World Health Organization. 6 May 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200508153855/https://apps.who.int/iris/bitstream/handle/10665/331976/WHO-2019-nCoV-Ethics_criteria-2020.1-eng.pdf\" rel=\"nofollow\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on 8 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">12 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Key+criteria+for+the+ethical+acceptability+of+COVID-19+human+challenge+studies&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-05-06&amp;rft_id=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F331976%2FWHO-2019-nCoV-Ethics_criteria-2020.1-eng.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-vacc-193\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-vacc_193-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-who-vacc_193-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://apps.who.int/iris/bitstream/handle/10665/111548/9789241506892_eng.pdf\" rel=\"nofollow\">\"Principles and considerations for adding a vaccine to a national immunization programme\"</a> <span class=\"cs1-format\">(PDF)</span>. World Health Organization. 1 April 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Principles+and+considerations+for+adding+a+vaccine+to+a+national+immunization+programme&amp;rft.pub=World+Health+Organization&amp;rft.date=2014-04-01&amp;rft_id=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F111548%2F9789241506892_eng.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-wijnans-194\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wijnans_194-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wijnans_194-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wijnans_194-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wijnans_194-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFWijnansVoordouw2015\">Wijnans, Leonoor; Voordouw, Bettie (11 December 2015). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4687503\" rel=\"nofollow\">\"A review of the changes to the licensing of influenza vaccines in Europe\"</a>. <i>Influenza and Other Respiratory Viruses</i>. <b>10</b> (1): 2–8. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1111%2Firv.12351\" rel=\"nofollow\">10.1111/irv.12351</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/1750-2640\" rel=\"nofollow\">1750-2640</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4687503\" rel=\"nofollow\">4687503</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26439108\" rel=\"nofollow\">26439108</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Influenza+and+Other+Respiratory+Viruses&amp;rft.atitle=A+review+of+the+changes+to+the+licensing+of+influenza+vaccines+in+Europe&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=2-8&amp;rft.date=2015-12-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4687503&amp;rft.issn=1750-2640&amp;rft_id=info%3Apmid%2F26439108&amp;rft_id=info%3Adoi%2F10.1111%2Firv.12351&amp;rft.aulast=Wijnans&amp;rft.aufirst=Leonoor&amp;rft.au=Voordouw%2C+Bettie&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4687503&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-chop-195\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-chop_195-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFPaul_A._Offit2020\">Paul A. Offit (2020). <a class=\"external text\" href=\"https://www.chop.edu/centers-programs/vaccine-education-center/making-vaccines/licensure-recommendations-and-requirements\" rel=\"nofollow\">\"Making vaccines: Licensure, recommendations and requirements\"</a>. Children's Hospital of Philadelphia<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Making+vaccines%3A+Licensure%2C+recommendations+and+requirements&amp;rft.pub=Children%27s+Hospital+of+Philadelphia&amp;rft.date=2020&amp;rft.au=Paul+A.+Offit&amp;rft_id=https%3A%2F%2Fwww.chop.edu%2Fcenters-programs%2Fvaccine-education-center%2Fmaking-vaccines%2Flicensure-recommendations-and-requirements&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-toner-196\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-toner_196-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-toner_196-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-toner_196-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFTonerBarnillKrubinerothers2020\">Toner E, Barnill A, Krubiner C, others (19 August 2020). <a class=\"external text\" href=\"https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200819-vaccine-allocation.pdf\" rel=\"nofollow\">\"Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States\"</a> <span class=\"cs1-format\">(PDF)</span>. Baltimore, MD: Johns Hopkins University Center for Health Security<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Interim+Framework+for+COVID-19+Vaccine+Allocation+and+Distribution+in+the+United+States&amp;rft.place=Baltimore%2C+MD&amp;rft.pub=Johns+Hopkins+University+Center+for+Health+Security&amp;rft.date=2020-08-19&amp;rft.aulast=Toner&amp;rft.aufirst=E&amp;rft.au=Barnill%2C+A&amp;rft.au=Krubiner%2C+C&amp;rft.au=others&amp;rft_id=https%3A%2F%2Fwww.centerforhealthsecurity.org%2Four-work%2Fpubs_archive%2Fpubs-pdfs%2F2020%2F200819-vaccine-allocation.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-197\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-197\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease cs1\"><a class=\"external text\" href=\"https://www.ema.europa.eu/en/news/ema-starts-first-rolling-review-covid-19-vaccine-eu\" rel=\"nofollow\">\"EMA starts first rolling review of a COVID-19 vaccine in the EU\"</a>. <i><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA)</i> (Press release). 1 October 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 October</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=EMA+starts+first+rolling+review+of+a+COVID-19+vaccine+in+the+EU&amp;rft.date=2020-10-01&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fnews%2Fema-starts-first-rolling-review-covid-19-vaccine-eu&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-198\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-198\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-vaccines-key-facts\" rel=\"nofollow\">\"COVID-19 vaccines: key facts\"</a>. <i><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA)</i>. 14 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 October</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=European+Medicines+Agency+%28EMA%29&amp;rft.atitle=COVID-19+vaccines%3A+key+facts&amp;rft.date=2020-09-14&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fhuman-regulatory%2Foverview%2Fpublic-health-threats%2Fcoronavirus-disease-covid-19%2Fcovid-19-vaccines-key-facts&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-199\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-199\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease cs1\"><a class=\"external text\" href=\"https://www.ema.europa.eu/en/news/ema-starts-second-rolling-review-covid-19-vaccine\" rel=\"nofollow\">\"EMA starts second rolling review of a COVID-19 vaccine\"</a>. <i><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA)</i> (Press release). 5 October 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">6 October</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=EMA+starts+second+rolling+review+of+a+COVID-19+vaccine&amp;rft.date=2020-10-05&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fnews%2Fema-starts-second-rolling-review-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-fda-vacc-200\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-fda-vacc_200-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-fda-vacc_200-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-fda-vacc_200-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-fda-vacc_200-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-fda-vacc_200-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/vaccine-product-approval-process\" rel=\"nofollow\">\"Vaccine product approval process\"</a>. US Food and Drug Administration. 30 January 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccine+product+approval+process&amp;rft.pub=US+Food+and+Drug+Administration&amp;rft.date=2020-01-30&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fvaccines-blood-biologics%2Fdevelopment-approval-process-cber%2Fvaccine-product-approval-process&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-corey-201\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-corey_201-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFCoreyMascolaFauciCollins2020\">Corey, Lawrence; Mascola, John R; Fauci, Anthony S; Collins, Francis S (11 May 2020). <a class=\"external text\" href=\"https://science.sciencemag.org/content/368/6494/948.long\" rel=\"nofollow\">\"A strategic approach to COVID-19 vaccine R&amp;D\"</a>. <i>Science</i>. <b>368</b> (6494): 948–50. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abc5312\" rel=\"nofollow\">10.1126/science.abc5312</a></span>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0036-8075\" rel=\"nofollow\">0036-8075</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32393526\" rel=\"nofollow\">32393526</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=A+strategic+approach+to+COVID-19+vaccine+R%26D&amp;rft.volume=368&amp;rft.issue=6494&amp;rft.pages=948-50&amp;rft.date=2020-05-11&amp;rft.issn=0036-8075&amp;rft_id=info%3Apmid%2F32393526&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abc5312&amp;rft.aulast=Corey&amp;rft.aufirst=Lawrence&amp;rft.au=Mascola%2C+John+R&amp;rft.au=Fauci%2C+Anthony+S&amp;rft.au=Collins%2C+Francis+S&amp;rft_id=https%3A%2F%2Fscience.sciencemag.org%2Fcontent%2F368%2F6494%2F948.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-eul-202\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-eul_202-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-eul_202-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/news-room/detail/09-01-2020-emergency-use-listing-procedure-and-roadmap-health-emergencies\" rel=\"nofollow\">\"WHO publishes Emergency Use Listing procedure and roadmap to make new medical products more readily available during health emergencies\"</a>. World Health Organization. 9 January 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=WHO+publishes+Emergency+Use+Listing+procedure+and+roadmap+to+make+new+medical+products+more+readily+available+during+health+emergencies&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-01-09&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Fdetail%2F09-01-2020-emergency-use-listing-procedure-and-roadmap-health-emergencies&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-ema-eau-203\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ema-eau_203-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.ema.europa.eu/en/authorisation-procedures\" rel=\"nofollow\">\"Vaccines: The Emergency Authorisation Procedure\"</a>. European Medicines Agency. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">21 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccines%3A+The+Emergency+Authorisation+Procedure&amp;rft.pub=European+Medicines+Agency&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fauthorisation-procedures&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-204\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-204\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.scmp.com/news/china/society/article/3103121/coronavirus-who-backed-chinas-emergency-use-experimental\" rel=\"nofollow\">\"WHO 'backed China's emergency use' of experimental Covid-19 vaccines\"</a>. <i>South China Morning Post</i>. 25 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=South+China+Morning+Post&amp;rft.atitle=WHO+%27backed+China%27s+emergency+use%27+of+experimental+Covid-19+vaccines&amp;rft.date=2020-09-25&amp;rft_id=https%3A%2F%2Fwww.scmp.com%2Fnews%2Fchina%2Fsociety%2Farticle%2F3103121%2Fcoronavirus-who-backed-chinas-emergency-use-experimental&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-205\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-205\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFKramer2020\">Kramer, Andrew E. (19 September 2020). <a class=\"external text\" href=\"https://www.nytimes.com/2020/09/19/world/europe/russia-coronavirus-vaccine.html\" rel=\"nofollow\">\"Russia Is Slow to Administer Virus Vaccine Despite Kremlin's Approval\"</a>. <i>The New York Times</i>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\" rel=\"nofollow\">0362-4331</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Russia+Is+Slow+to+Administer+Virus+Vaccine+Despite+Kremlin%27s+Approval&amp;rft.date=2020-09-19&amp;rft.issn=0362-4331&amp;rft.aulast=Kramer&amp;rft.aufirst=Andrew+E.&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F09%2F19%2Fworld%2Feurope%2Frussia-coronavirus-vaccine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-206\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-206\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.clinicaltrialsarena.com/comment/fda-covid-19-vaccines/\" rel=\"nofollow\">\"FDA may be risk-averse to grant emergency use for a Covid-19 vaccine; political pressure and hazy EUA standards are factors\"</a>. ClinicalTrials Arena, Verdict Media, Ltd. 2 July 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+may+be+risk-averse+to+grant+emergency+use+for+a+Covid-19+vaccine%3B+political+pressure+and+hazy+EUA+standards+are+factors&amp;rft.pub=ClinicalTrials+Arena%2C+Verdict+Media%2C+Ltd.&amp;rft.date=2020-07-02&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsarena.com%2Fcomment%2Ffda-covid-19-vaccines%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-hoffman-207\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-hoffman_207-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFJan_Hoffman2020\">Jan Hoffman (18 July 2020). <a class=\"external text\" href=\"https://www.nytimes.com/2020/07/18/health/coronavirus-anti-vaccine.html\" rel=\"nofollow\">\"Mistrust of a coronavirus vaccine could imperil widespread immunity\"</a>. <i>The New York Times</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 August</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Mistrust+of+a+coronavirus+vaccine+could+imperil+widespread+immunity&amp;rft.date=2020-07-18&amp;rft.au=Jan+Hoffman&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F07%2F18%2Fhealth%2Fcoronavirus-anti-vaccine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-208\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-208\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"http://www.news.sanofi.us/2020-09-08-Biopharma-leaders-unite-to-stand-with-science\" rel=\"nofollow\">\"Biopharma leaders unite to stand with science\"</a>. SANOFI. 8 September 2020.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Biopharma+leaders+unite+to+stand+with+science&amp;rft.pub=SANOFI&amp;rft.date=2020-09-08&amp;rft_id=http%3A%2F%2Fwww.news.sanofi.us%2F2020-09-08-Biopharma-leaders-unite-to-stand-with-science&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-hbr-209\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-hbr_209-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-hbr_209-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-hbr_209-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-hbr_209-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFWeintraubYadavBerkley2020\">Weintraub R, Yadav P, Berkley S (2 April 2020). <a class=\"external text\" href=\"https://hbr.org/2020/04/a-covid-19-vaccine-will-need-equitable-global-distribution\" rel=\"nofollow\">\"A COVID-19 vaccine will need equitable, global distribution\"</a>. <i>Harvard Business Review</i>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0017-8012\" rel=\"nofollow\">0017-8012</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200609173105/https://hbr.org/2020/04/a-covid-19-vaccine-will-need-equitable-global-distribution\" rel=\"nofollow\">Archived</a> from the original on 9 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Harvard+Business+Review&amp;rft.atitle=A+COVID-19+vaccine+will+need+equitable%2C+global+distribution&amp;rft.date=2020-04-02&amp;rft.issn=0017-8012&amp;rft.aulast=Weintraub&amp;rft.aufirst=Rebecca&amp;rft.au=Yadav%2C+Prashant&amp;rft.au=Berkley%2C+Seth&amp;rft_id=https%3A%2F%2Fhbr.org%2F2020%2F04%2Fa-covid-19-vaccine-will-need-equitable-global-distribution&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cbcr-210\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cbcr_210-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cbcr_210-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-cbcr_210-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-cbcr_210-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-cbcr_210-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a class=\"external text\" href=\"https://www.cbc.ca/radio/thesundayedition/the-sunday-edition-for-may-10-2020-1.5554451/covid-19-pandemic-reveals-the-risks-of-relying-on-private-sector-for-life-saving-vaccines-says-expert-1.5554463\" rel=\"nofollow\">\"COVID-19 pandemic reveals the risks of relying on private sector for life-saving vaccines, says expert\"</a>. <i>CBC Radio</i>. 8 May 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200513172525/https://www.cbc.ca/radio/thesundayedition/the-sunday-edition-for-may-10-2020-1.5554451/covid-19-pandemic-reveals-the-risks-of-relying-on-private-sector-for-life-saving-vaccines-says-expert-1.5554463\" rel=\"nofollow\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBC+Radio&amp;rft.atitle=COVID-19+pandemic+reveals+the+risks+of+relying+on+private+sector+for+life-saving+vaccines%2C+says+expert&amp;rft.date=2020-05-08&amp;rft_id=https%3A%2F%2Fwww.cbc.ca%2Fradio%2Fthesundayedition%2Fthe-sunday-edition-for-may-10-2020-1.5554451%2Fcovid-19-pandemic-reveals-the-risks-of-relying-on-private-sector-for-life-saving-vaccines-says-expert-1.5554463&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-ahmed-211\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ahmed_211-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ahmed_211-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ahmed_211-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ahmed_211-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFAhmed2020\">Ahmed DD (4 June 2020). <a class=\"external text\" href=\"https://www.statnews.com/2020/06/04/oxford-astrazeneca-covid-19-deal-reinforces-vaccine-sovereignty/\" rel=\"nofollow\">\"Oxford, AstraZeneca COVID-19 deal reinforces 'vaccine sovereignty<span class=\"cs1-kern-right\">'</span>\"</a>. STAT. <a class=\"external text\" href=\"https://web.archive.org/web/20200612125335/https://www.statnews.com/2020/06/04/oxford-astrazeneca-covid-19-deal-reinforces-vaccine-sovereignty/\" rel=\"nofollow\">Archived</a> from the original on 12 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Oxford%2C+AstraZeneca+COVID-19+deal+reinforces+%27vaccine+sovereignty%27&amp;rft.pub=STAT&amp;rft.date=2020-06-04&amp;rft.aulast=Ahmed&amp;rft.aufirst=Darius+D.&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F06%2F04%2Foxford-astrazeneca-covid-19-deal-reinforces-vaccine-sovereignty%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-kyle-212\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-kyle_212-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-kyle_212-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFBlankenship2020\">Blankenship K (4 June 2020). <a class=\"external text\" href=\"https://www.fiercepharma.com/manufacturing/astrazeneca-unveils-massive-750m-deal-effort-to-produce-billions-covid-19-shots\" rel=\"nofollow\">\"AstraZeneca unveils massive $750M deal in effort to produce billions of COVID-19 shots\"</a>. FiercePharma. <a class=\"external text\" href=\"https://web.archive.org/web/20200610191605/https://www.fiercepharma.com/manufacturing/astrazeneca-unveils-massive-750m-deal-effort-to-produce-billions-covid-19-shots\" rel=\"nofollow\">Archived</a> from the original on 10 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=AstraZeneca+unveils+massive+%24750M+deal+in+effort+to+produce+billions+of+COVID-19+shots&amp;rft.pub=FiercePharma&amp;rft.date=2020-06-04&amp;rft.aulast=Blankenship&amp;rft.aufirst=Kyle&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fmanufacturing%2Fastrazeneca-unveils-massive-750m-deal-effort-to-produce-billions-covid-19-shots&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cohen6-4-213\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-cohen6-4_213-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-cohen6-4_213-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFCohen2020\">Cohen J (4 June 2020). <a class=\"external text\" href=\"https://www.sciencemag.org/news/2020/06/top-us-scientists-left-out-white-house-selection-covid-19-vaccine-shortlist\" rel=\"nofollow\">\"Top U.S. scientists left out of White House selection of COVID-19 vaccine short list\"</a>. <i>Science</i>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1126%2Fscience.abd1719\" rel=\"nofollow\">10.1126/science.abd1719</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0036-8075\" rel=\"nofollow\">0036-8075</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200609203807/https://www.sciencemag.org/news/2020/06/top-us-scientists-left-out-white-house-selection-covid-19-vaccine-shortlist\" rel=\"nofollow\">Archived</a> from the original on 9 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Top+U.S.+scientists+left+out+of+White+House+selection+of+COVID-19+vaccine+short+list&amp;rft.date=2020-06-04&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.abd1719&amp;rft.issn=0036-8075&amp;rft.aulast=Cohen&amp;rft.aufirst=Jon&amp;rft_id=https%3A%2F%2Fwww.sciencemag.org%2Fnews%2F2020%2F06%2Ftop-us-scientists-left-out-white-house-selection-covid-19-vaccine-shortlist&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-bolly-214\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-bolly_214-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-bolly_214-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-bolly_214-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-bolly_214-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFBollykyGostinHamburg2020\">Bollyky TJ, Gostin LO, Hamburg MA (7 May 2020). <a class=\"external text\" href=\"https://jamanetwork.com/journals/jama/fullarticle/2765944\" rel=\"nofollow\">\"The equitable distribution of COVID-19 therapeutics and vaccines\"</a>. <i>JAMA</i>. <b>323</b> (24): 2462–63. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1001%2Fjama.2020.6641\" rel=\"nofollow\">10.1001/jama.2020.6641</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32379268\" rel=\"nofollow\">32379268</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200512234709/https://jamanetwork.com/journals/jama/fullarticle/2765944\" rel=\"nofollow\">Archived</a> from the original on 12 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=The+equitable+distribution+of+COVID-19+therapeutics+and+vaccines&amp;rft.volume=323&amp;rft.issue=24&amp;rft.pages=2462-63&amp;rft.date=2020-05-07&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2020.6641&amp;rft_id=info%3Apmid%2F32379268&amp;rft.aulast=Bollyky&amp;rft.aufirst=Thomas+J.&amp;rft.au=Gostin%2C+Lawrence+O.&amp;rft.au=Hamburg%2C+Margaret+A.&amp;rft_id=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjama%2Ffullarticle%2F2765944&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-215\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-215\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFAakashFaulconbridgeHolton2020\">Aakash B, Faulconbridge G, Holton K (22 May 2020). <a class=\"external text\" href=\"https://www.theguardian.pe.ca/news/world/astrazeneca-gets-first-supply-agreements-for-covid-19-vaccine-452225/\" rel=\"nofollow\">\"U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine\"</a>. <i>The Guardian</i>. Reuters. <a class=\"external text\" href=\"https://web.archive.org/web/20200610002524/http://www.theguardian.pe.ca/news/world/astrazeneca-gets-first-supply-agreements-for-covid-19-vaccine-452225/\" rel=\"nofollow\">Archived</a> from the original on 10 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Guardian&amp;rft.atitle=U.S.+secures+300+million+doses+of+potential+AstraZeneca+COVID-19+vaccine&amp;rft.date=2020-05-22&amp;rft.aulast=Aakash&amp;rft.aufirst=B&amp;rft.au=Faulconbridge%2C+Guy&amp;rft.au=Holton%2C+Kate&amp;rft_id=https%3A%2F%2Fwww.theguardian.pe.ca%2Fnews%2Fworld%2Fastrazeneca-gets-first-supply-agreements-for-covid-19-vaccine-452225%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-paton-216\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-paton_216-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFPatonGriffinKoons\">Paton J, Griffin R, Koons C. <a class=\"external text\" href=\"https://www.bloombergquint.com/business/u-s-to-get-sanofi-covid-vaccine-first-if-it-succeeds-ceo-says\" rel=\"nofollow\">\"U.S. likely to get Sanofi vaccine first if it succeeds\"</a>. <i>Bloomberg</i>. <a class=\"external text\" href=\"https://web.archive.org/web/20200608182905/https://www.bloombergquint.com/business/u-s-to-get-sanofi-covid-vaccine-first-if-it-succeeds-ceo-says\" rel=\"nofollow\">Archived</a> from the original on 8 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=U.S.+likely+to+get+Sanofi+vaccine+first+if+it+succeeds&amp;rft.aulast=Paton&amp;rft.aufirst=James&amp;rft.au=Griffin%2C+Riley&amp;rft.au=Koons%2C+Cynthia&amp;rft_id=https%3A%2F%2Fwww.bloombergquint.com%2Fbusiness%2Fu-s-to-get-sanofi-covid-vaccine-first-if-it-succeeds-ceo-says&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-unequal-217\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-unequal_217-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-unequal_217-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-unequal_217-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-unequal_217-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-unequal_217-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-unequal_217-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-unequal_217-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-unequal_217-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFCallaway2020\">Callaway, Ewen (27 August 2020). <a class=\"external text\" href=\"https://www.nature.com/articles/d41586-020-02450-x\" rel=\"nofollow\">\"The unequal scramble for coronavirus vaccines – by the numbers\"</a>. <i>Nature</i>. <b>584</b> (7822): 506–07. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Natur.584..506C\" rel=\"nofollow\">2020Natur.584..506C</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1038%2Fd41586-020-02450-x\" rel=\"nofollow\">10.1038/d41586-020-02450-x</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32839593\" rel=\"nofollow\">32839593</a>. <a class=\"mw-redirect\" href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a> <a class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:221285160\" rel=\"nofollow\">221285160</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=The+unequal+scramble+for+coronavirus+vaccines+%E2%80%93+by+the+numbers&amp;rft.volume=584&amp;rft.issue=7822&amp;rft.pages=506-07&amp;rft.date=2020-08-27&amp;rft_id=info%3Adoi%2F10.1038%2Fd41586-020-02450-x&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221285160&amp;rft_id=info%3Apmid%2F32839593&amp;rft_id=info%3Abibcode%2F2020Natur.584..506C&amp;rft.aulast=Callaway&amp;rft.aufirst=Ewen&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-02450-x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-khamsi-218\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-khamsi_218-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFKhamsi2020\">Khamsi R (9 April 2020). <a class=\"external text\" href=\"https://www.nature.com/articles/d41586-020-01063-8\" rel=\"nofollow\">\"If a coronavirus vaccine arrives, can the world make enough?\"</a>. <i>Nature</i>. <b>580</b> (7805): 578–80. <a class=\"mw-redirect\" href=\"/wiki/Bibcode_(identifier)\" title=\"Bibcode (identifier)\">Bibcode</a>:<a class=\"external text\" href=\"https://ui.adsabs.harvard.edu/abs/2020Natur.580..578K\" rel=\"nofollow\">2020Natur.580..578K</a>. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.1038%2Fd41586-020-01063-8\" rel=\"nofollow\">10.1038/d41586-020-01063-8</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32273621\" rel=\"nofollow\">32273621</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200513023042/https://www.nature.com/articles/d41586-020-01063-8\" rel=\"nofollow\">Archived</a> from the original on 13 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=If+a+coronavirus+vaccine+arrives%2C+can+the+world+make+enough%3F&amp;rft.volume=580&amp;rft.issue=7805&amp;rft.pages=578-80&amp;rft.date=2020-04-09&amp;rft_id=info%3Apmid%2F32273621&amp;rft_id=info%3Adoi%2F10.1038%2Fd41586-020-01063-8&amp;rft_id=info%3Abibcode%2F2020Natur.580..578K&amp;rft.aulast=Khamsi&amp;rft.aufirst=Roxanne&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-01063-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-219\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-219\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFGretler2020\">Gretler C (18 May 2020). <a class=\"external text\" href=\"https://nationalpost.com/news/world/china-pledges-to-make-its-coronavirus-vaccine-a-public-good\" rel=\"nofollow\">\"China pledges to make its coronavirus vaccine a 'public good<span class=\"cs1-kern-right\">'</span>\"</a>. <i>The National Post</i>. Bloomberg<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+National+Post&amp;rft.atitle=China+pledges+to+make+its+coronavirus+vaccine+a+%27public+good%27&amp;rft.date=2020-05-18&amp;rft.aulast=Gretler&amp;rft.aufirst=Corinne&amp;rft_id=https%3A%2F%2Fnationalpost.com%2Fnews%2Fworld%2Fchina-pledges-to-make-its-coronavirus-vaccine-a-public-good&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-huney-220\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-huney_220-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-huney_220-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-huney_220-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-huney_220-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFHuneycuttLurieRotenbergWilder2020\">Huneycutt B, Lurie N, Rotenberg S, Wilder R, Hatchett R (24 February 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7130943\" rel=\"nofollow\">\"Finding equipoise: CEPI revises its equitable access policy\"</a>. <i>Vaccine</i>. <b>38</b> (9): 2144–48. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.vaccine.2019.12.055\" rel=\"nofollow\">10.1016/j.vaccine.2019.12.055</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7130943\" rel=\"nofollow\">7130943</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32005536\" rel=\"nofollow\">32005536</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Finding+equipoise%3A+CEPI+revises+its+equitable+access+policy&amp;rft.volume=38&amp;rft.issue=9&amp;rft.pages=2144-48&amp;rft.date=2020-02-24&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7130943&amp;rft_id=info%3Apmid%2F32005536&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2019.12.055&amp;rft.aulast=Huneycutt&amp;rft.aufirst=Brenda&amp;rft.au=Lurie%2C+Nicole&amp;rft.au=Rotenberg%2C+Sara&amp;rft.au=Wilder%2C+Richard&amp;rft.au=Hatchett%2C+Richard&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7130943&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-221\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-221\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://c4aa.org/2020/03/join-us-free-the-vaccine-for-covid-19\" rel=\"nofollow\">\"Vaccine for COVID-19\"</a>. The Center for Artistic Activism. 22 March 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200609001355/https://c4aa.org/2020/03/join-us-free-the-vaccine-for-covid-19\" rel=\"nofollow\">Archived</a> from the original on 9 June 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccine+for+COVID-19&amp;rft.pub=The+Center+for+Artistic+Activism&amp;rft.date=2020-03-22&amp;rft_id=https%3A%2F%2Fc4aa.org%2F2020%2F03%2Fjoin-us-free-the-vaccine-for-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-222\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-222\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://uaem.org/\" rel=\"nofollow\">\"UAEM response to COVID-19\"</a>. Universities Allied for Essential Medicines. 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200421083204/https://uaem.org/\" rel=\"nofollow\">Archived</a> from the original on 21 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 June</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=UAEM+response+to+COVID-19&amp;rft.pub=Universities+Allied+for+Essential+Medicines&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fuaem.org%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-223\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-223\">^</a></b></span> <span class=\"reference-text\">Ferrucci A. (05 MAY 2020). <a class=\"external text\" href=\"https://www.edc-online.org/en/home-en/news/16033-more-than-100-scientists-call-for-covid-19-vaccines-to-be-in-the-public-domain.html\" rel=\"nofollow\">\"More than 100 scientists call for Covid 19 vaccines to be in the public domain\"</a>. <i>edc.online.org.</i> Retrieved July 21, 2020.</span>\n",
            "</li>\n",
            "<li id=\"cite_note-wef-224\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wef_224-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wef_224-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wef_224-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wef_224-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-wef_224-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.weforum.org/agenda/2020/07/blockchain-role-in-distributing-covid-19-vaccine-could-make-history/\" rel=\"nofollow\">\"How the massive plan to deliver the COVID-19 vaccine could make history – and leverage blockchain like never before\"</a>. World Economic Forum. 17 July 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=How+the+massive+plan+to+deliver+the+COVID-19+vaccine+could+make+history+%E2%80%93+and+leverage+blockchain+like+never+before&amp;rft.pub=World+Economic+Forum&amp;rft.date=2020-07-17&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Fagenda%2F2020%2F07%2Fblockchain-role-in-distributing-covid-19-vaccine-could-make-history%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-murray-225\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-murray_225-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-murray_225-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-murray_225-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-murray_225-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-murray_225-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-murray_225-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\">Brendan Murray and Riley Griffin (24 July 2020). <a class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2020-07-25/the-supply-chain-to-save-the-world-is-unprepared-for-a-vaccine\" rel=\"nofollow\">\"The world's supply chain isn't ready for a Covid-19 vaccine\"</a>. <i>Bloomberg World</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+World&amp;rft.atitle=The+world%27s+supply+chain+isn%27t+ready+for+a+Covid-19+vaccine&amp;rft.date=2020-07-24&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2020-07-25%2Fthe-supply-chain-to-save-the-world-is-unprepared-for-a-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><span class=\"cs1-maint citation-comment\">CS1 maint: uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">link</a>)</span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-scott-226\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-scott_226-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-scott_226-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-scott_226-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-scott_226-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFScott_Duke_KominersAlex_Tabarrok2020\">Scott Duke Kominers; Alex Tabarrok (18 August 2020). <a class=\"external text\" href=\"https://www.bloomberg.com/opinion/articles/2020-08-18/a-resilient-covid-19-vaccine-supply-chain-starts-now\" rel=\"nofollow\">\"Vaccines use bizarre stuff. We need a supply chain now\"</a>. <i>Bloomberg Business</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Business&amp;rft.atitle=Vaccines+use+bizarre+stuff.+We+need+a+supply+chain+now&amp;rft.date=2020-08-18&amp;rft.au=Scott+Duke+Kominers&amp;rft.au=Alex+Tabarrok&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fopinion%2Farticles%2F2020-08-18%2Fa-resilient-covid-19-vaccine-supply-chain-starts-now&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-unicef-now-227\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-unicef-now_227-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-unicef-now_227-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.unicef.org/press-releases/time-prepare-covid-19-vaccine-transport-now\" rel=\"nofollow\">\"The time to prepare for COVID-19 vaccine transport is now\"</a>. UNICEF. 10 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+time+to+prepare+for+COVID-19+vaccine+transport+is+now&amp;rft.pub=UNICEF&amp;rft.date=2020-09-10&amp;rft_id=https%3A%2F%2Fwww.unicef.org%2Fpress-releases%2Ftime-prepare-covid-19-vaccine-transport-now&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-desai-228\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-desai_228-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-desai_228-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFDevika_Desai2020\">Devika Desai (10 September 2020). <a class=\"external text\" href=\"https://nationalpost.com/news/transporting-one-single-dose-of-covid-19-vaccine-could-take-up-to-8000-jumbo-planes-says-aviation-body\" rel=\"nofollow\">\"Transporting one single dose of COVID-19 vaccine could take up to 8,000 jumbo planes, says aviation body\"</a>. <i>National Post</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>. <q>The IATA estimated that 8,000 747 cargo planes, at minimum, would be needed to transport a single dose of the vaccine worldwide, but more equipment could be required as administering the vaccine might mean several doses. Vaccines would also have to be stored at a temperature range between two and eight degrees Celsius, which could rule out the use of some types of planes.</q></cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=National+Post&amp;rft.atitle=Transporting+one+single+dose+of+COVID-19+vaccine+could+take+up+to+8%2C000+jumbo+planes%2C+says+aviation+body&amp;rft.date=2020-09-10&amp;rft.au=Devika+Desai&amp;rft_id=https%3A%2F%2Fnationalpost.com%2Fnews%2Ftransporting-one-single-dose-of-covid-19-vaccine-could-take-up-to-8000-jumbo-planes-says-aviation-body&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-pharmiweb-229\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pharmiweb_229-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pharmiweb_229-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pharmiweb_229-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pharmiweb_229-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFQuelch2020\">Quelch, Rich (14 August 2020). <a class=\"external text\" href=\"https://www.pharmiweb.com/article/covid-19-vaccine-delivery-overcoming-the-supply-chain-challenges\" rel=\"nofollow\">\"COVID-19 vaccine delivery – overcoming the supply chain challenges\"</a>. PharmiWeb.com<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>. <q>Delivering a new vaccine for COVID-19 worldwide will be one of the greatest challenges faced by modern pharma. The difficulties are intensified by pre-existing shortcomings in the supply chain.</q></cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVID-19+vaccine+delivery+%E2%80%93+overcoming+the+supply+chain+challenges&amp;rft.pub=PharmiWeb.com&amp;rft.date=2020-08-14&amp;rft.aulast=Quelch&amp;rft.aufirst=Rich&amp;rft_id=https%3A%2F%2Fwww.pharmiweb.com%2Farticle%2Fcovid-19-vaccine-delivery-overcoming-the-supply-chain-challenges&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-seidman-230\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-seidman_230-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFSeidmanAtun2017\">Seidman, Gabriel; Atun, Rifat (2017). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5435270\" rel=\"nofollow\">\"Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries\"</a>. <i>BMJ Global Health</i>. <b>2</b> (2): e000243. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1136%2Fbmjgh-2016-000243\" rel=\"nofollow\">10.1136/bmjgh-2016-000243</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/2059-7908\" rel=\"nofollow\">2059-7908</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5435270\" rel=\"nofollow\">5435270</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/28589028\" rel=\"nofollow\">28589028</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ+Global+Health&amp;rft.atitle=Do+changes+to+supply+chains+and+procurement+processes+yield+cost+savings+and+improve+availability+of+pharmaceuticals%2C+vaccines+or+health+products%3F+A+systematic+review+of+evidence+from+low-income+and+middle-income+countries&amp;rft.volume=2&amp;rft.issue=2&amp;rft.pages=e000243&amp;rft.date=2017&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5435270&amp;rft.issn=2059-7908&amp;rft_id=info%3Apmid%2F28589028&amp;rft_id=info%3Adoi%2F10.1136%2Fbmjgh-2016-000243&amp;rft.aulast=Seidman&amp;rft.aufirst=Gabriel&amp;rft.au=Atun%2C+Rifat&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5435270&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-gavi9-4-231\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-gavi9-4_231-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-gavi9-4_231-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.gavi.org/news/media-room/172-countries-multiple-candidate-vaccines-engaged-covid-19-vaccine-global-access\" rel=\"nofollow\">\"172 countries and multiple candidate vaccines engaged in COVID-19 Vaccine Global Access Facility\"</a>. GAVI. 4 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=172+countries+and+multiple+candidate+vaccines+engaged+in+COVID-19+Vaccine+Global+Access+Facility&amp;rft.pub=GAVI&amp;rft.date=2020-09-04&amp;rft_id=https%3A%2F%2Fwww.gavi.org%2Fnews%2Fmedia-room%2F172-countries-multiple-candidate-vaccines-engaged-covid-19-vaccine-global-access&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-unicef-232\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-unicef_232-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-unicef_232-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-unicef_232-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-unicef_232-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.unicef.org/press-releases/unicef-lead-procurement-and-supply-covid-19-vaccines-worlds-largest-and-fastest-ever\" rel=\"nofollow\">\"UNICEF to lead procurement and supply of COVID-19 vaccines in world's largest and fastest ever operation of its kind\"</a>. UNICEF. 4 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=UNICEF+to+lead+procurement+and+supply+of+COVID-19+vaccines+in+world%27s+largest+and+fastest+ever+operation+of+its+kind&amp;rft.pub=UNICEF&amp;rft.date=2020-09-04&amp;rft_id=https%3A%2F%2Fwww.unicef.org%2Fpress-releases%2Funicef-lead-procurement-and-supply-covid-19-vaccines-worlds-largest-and-fastest-ever&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-cook-233\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cook_233-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFEmily_Cook2020\">Emily Cook (4 September 2020). <a class=\"external text\" href=\"https://www.manufacturingglobal.com/procurement-and-supply-chain/unicef-lead-supply-chain-covid-19-vaccine\" rel=\"nofollow\">\"UNICEF to lead supply chain for COVID-19 vaccine\"</a>. Manufacturing<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=UNICEF+to+lead+supply+chain+for+COVID-19+vaccine&amp;rft.pub=Manufacturing&amp;rft.date=2020-09-04&amp;rft.au=Emily+Cook&amp;rft_id=https%3A%2F%2Fwww.manufacturingglobal.com%2Fprocurement-and-supply-chain%2Funicef-lead-supply-chain-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-hessel-234\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-hessel_234-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-hessel_234-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFHessel2009\">Hessel, Luc (2009). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4634681\" rel=\"nofollow\">\"Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges\"</a>. <i>Influenza and Other Respiratory Viruses</i>. <b>3</b> (4): 165–70. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1750-2659.2009.00085.x\" rel=\"nofollow\">10.1111/j.1750-2659.2009.00085.x</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/1750-2640\" rel=\"nofollow\">1750-2640</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4634681\" rel=\"nofollow\">4634681</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/19627373\" rel=\"nofollow\">19627373</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Influenza+and+Other+Respiratory+Viruses&amp;rft.atitle=Pandemic+influenza+vaccines%3A+meeting+the+supply%2C+distribution+and+deployment+challenges&amp;rft.volume=3&amp;rft.issue=4&amp;rft.pages=165-70&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4634681&amp;rft.issn=1750-2640&amp;rft_id=info%3Apmid%2F19627373&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1750-2659.2009.00085.x&amp;rft.aulast=Hessel&amp;rft.aufirst=Luc&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4634681&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-log-235\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-log_235-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-log_235-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/immunization/programmes_systems/supply_chain/resources/tools/en/\" rel=\"nofollow\">\"Vaccine management and logistics support\"</a>. World Health Organization. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccine+management+and+logistics+support&amp;rft.pub=World+Health+Organization&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fimmunization%2Fprogrammes_systems%2Fsupply_chain%2Fresources%2Ftools%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-jarrett-236\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-jarrett_236-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFJarrettYangPagliusi2020\">Jarrett, Stephen; Yang, Lingjiang; Pagliusi, Sonia (9 June 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7394771\" rel=\"nofollow\">\"Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectives\"</a>. <i>Vaccine X</i>. <b>5</b>: 100068. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.jvacx.2020.100068\" rel=\"nofollow\">10.1016/j.jvacx.2020.100068</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/2590-1362\" rel=\"nofollow\">2590-1362</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7394771\" rel=\"nofollow\">7394771</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32775997\" rel=\"nofollow\">32775997</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine+X&amp;rft.atitle=Roadmap+for+strengthening+the+vaccine+supply+chain+in+emerging+countries%3A+Manufacturers%27+perspectives&amp;rft.volume=5&amp;rft.pages=100068&amp;rft.date=2020-06-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7394771&amp;rft.issn=2590-1362&amp;rft_id=info%3Apmid%2F32775997&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jvacx.2020.100068&amp;rft.aulast=Jarrett&amp;rft.aufirst=Stephen&amp;rft.au=Yang%2C+Lingjiang&amp;rft.au=Pagliusi%2C+Sonia&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7394771&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-lloyd-237\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-lloyd_237-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-lloyd_237-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFLloydCheyne2017\">Lloyd, John; Cheyne, James (2017). <a class=\"external text\" href=\"https://www.sciencedirect.com/science/article/pii/S0264410X17300476/\" rel=\"nofollow\">\"The origins of the vaccine cold chain and a glimpse of the future\"</a>. <i>Vaccine</i>. <b>35</b> (17): 2115–20. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.vaccine.2016.11.097\" rel=\"nofollow\">10.1016/j.vaccine.2016.11.097</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0264-410X\" rel=\"nofollow\">0264-410X</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/28364918\" rel=\"nofollow\">28364918</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=The+origins+of+the+vaccine+cold+chain+and+a+glimpse+of+the+future&amp;rft.volume=35&amp;rft.issue=17&amp;rft.pages=2115-20&amp;rft.date=2017&amp;rft.issn=0264-410X&amp;rft_id=info%3Apmid%2F28364918&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2016.11.097&amp;rft.aulast=Lloyd&amp;rft.aufirst=John&amp;rft.au=Cheyne%2C+James&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0264410X17300476%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-wef-manuf-238\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wef-manuf_238-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wef-manuf_238-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wef-manuf_238-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-wef-manuf_238-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.weforum.org/agenda/2020/08/covid-vaccine-manufacture-distribute-2-billion-doses/\" rel=\"nofollow\">\"How can we make enough vaccine for 2 billion people?\"</a>. World Economic Forum. 25 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=How+can+we+make+enough+vaccine+for+2+billion+people%3F&amp;rft.pub=World+Economic+Forum&amp;rft.date=2020-08-25&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Fagenda%2F2020%2F08%2Fcovid-vaccine-manufacture-distribute-2-billion-doses%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-239\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-239\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\"><a class=\"external text\" href=\"https://www.japantimes.co.jp/news/2020/08/12/world/science-health-world/pre-orders-coronavirus-vaccines/\" rel=\"nofollow\">\"Coronavirus vaccine pre-orders worldwide top 5 billion\"</a>. <i>The Japan Times</i>. 12 August 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Japan+Times&amp;rft.atitle=Coronavirus+vaccine+pre-orders+worldwide+top+5+billion&amp;rft.date=2020-08-12&amp;rft_id=https%3A%2F%2Fwww.japantimes.co.jp%2Fnews%2F2020%2F08%2F12%2Fworld%2Fscience-health-world%2Fpre-orders-coronavirus-vaccines%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-240\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-240\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFC2020\">C, Hannah (10 October 2020). <a class=\"external text\" href=\"https://www.sciencetimes.com/articles/27653/20201010/china-producing-600-million-vaccine-2020.htm\" rel=\"nofollow\">\"China Commits to Producing 600 Million Vaccine Doses by the End of 2020\"</a>. <i>Science Times</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 October</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Science+Times&amp;rft.atitle=China+Commits+to+Producing+600+Million+Vaccine+Doses+by+the+End+of+2020&amp;rft.date=2020-10-10&amp;rft.aulast=C&amp;rft.aufirst=Hannah&amp;rft_id=https%3A%2F%2Fwww.sciencetimes.com%2Farticles%2F27653%2F20201010%2Fchina-producing-600-million-vaccine-2020.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-molteni-241\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-molteni_241-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFMegan_Molteni2020\">Megan Molteni (26 June 2020). <a class=\"external text\" href=\"https://www.wired.com/story/vaccine-makers-turn-to-microchip-tech-to-beat-glass-shortages/\" rel=\"nofollow\">\"Vaccine makers turn to microchip tech to beat glass shortages\"</a>. Wired<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Vaccine+makers+turn+to+microchip+tech+to+beat+glass+shortages&amp;rft.pub=Wired&amp;rft.date=2020-06-26&amp;rft.au=Megan+Molteni&amp;rft_id=https%3A%2F%2Fwww.wired.com%2Fstory%2Fvaccine-makers-turn-to-microchip-tech-to-beat-glass-shortages%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-glass-242\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-glass_242-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFFraiser_Kansteiner2020\">Fraiser Kansteiner (8 July 2020). <a class=\"external text\" href=\"https://www.fiercepharma.com/manufacturing/sio2-injects-163-million-into-glass-vial-production-plant\" rel=\"nofollow\">\"With COVID-19 vaccines coming, SiO2 injects $163M into vial production plant\"</a>. FiercePharma, Questex LLC<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=With+COVID-19+vaccines+coming%2C+SiO2+injects+%24163M+into+vial+production+plant&amp;rft.pub=FiercePharma%2C+Questex+LLC&amp;rft.date=2020-07-08&amp;rft.au=Fraiser+Kansteiner&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fmanufacturing%2Fsio2-injects-163-million-into-glass-vial-production-plant&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-burger-243\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-burger_243-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFLudwig_BurgerMatthias_Blamont2020\">Ludwig Burger; Matthias Blamont (11 June 2020). <a class=\"external text\" href=\"https://www.reuters.com/article/us-health-coronavirus-schott-exclusive-idUSKBN23J0SN\" rel=\"nofollow\">\"Bottlenecks? Glass vial makers prepare for COVID-19 vaccine\"</a>. <i>Reuters</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Bottlenecks%3F+Glass+vial+makers+prepare+for+COVID-19+vaccine&amp;rft.date=2020-06-11&amp;rft.au=Ludwig+Burger&amp;rft.au=Matthias+Blamont&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-health-coronavirus-schott-exclusive-idUSKBN23J0SN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-kaplan-244\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-kaplan_244-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-kaplan_244-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFDeborah_Abrams_Kaplan2020\">Deborah Abrams Kaplan (7 July 2020). <a class=\"external text\" href=\"https://www.supplychaindive.com/news/coronavirus-rfid-sensor-tracking-hospital-supply-chain/581066/\" rel=\"nofollow\">\"3 applications for RFID in the fight against COVID-19\"</a>. Supply Chain Dive<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=3+applications+for+RFID+in+the+fight+against+COVID-19&amp;rft.pub=Supply+Chain+Dive&amp;rft.date=2020-07-07&amp;rft.au=Deborah+Abrams+Kaplan&amp;rft_id=https%3A%2F%2Fwww.supplychaindive.com%2Fnews%2Fcoronavirus-rfid-sensor-tracking-hospital-supply-chain%2F581066%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-karto-245\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-karto_245-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-karto_245-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-karto_245-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFKartogluMilstien2014\">Kartoglu, Umit; Milstien, Julie (28 May 2014). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4743593\" rel=\"nofollow\">\"Tools and approaches to ensure quality of vaccines throughout the cold chain\"</a>. <i>Expert Review of Vaccines</i>. <b>13</b> (7): 843–54. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1586%2F14760584.2014.923761\" rel=\"nofollow\">10.1586/14760584.2014.923761</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/1476-0584\" rel=\"nofollow\">1476-0584</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4743593\" rel=\"nofollow\">4743593</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/24865112\" rel=\"nofollow\">24865112</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Review+of+Vaccines&amp;rft.atitle=Tools+and+approaches+to+ensure+quality+of+vaccines+throughout+the+cold+chain&amp;rft.volume=13&amp;rft.issue=7&amp;rft.pages=843-54&amp;rft.date=2014-05-28&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4743593&amp;rft.issn=1476-0584&amp;rft_id=info%3Apmid%2F24865112&amp;rft_id=info%3Adoi%2F10.1586%2F14760584.2014.923761&amp;rft.aulast=Kartoglu&amp;rft.aufirst=Umit&amp;rft.au=Milstien%2C+Julie&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4743593&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-hanson-246\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-hanson_246-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFHansonGeorgeSawadogoSchreiber2017\">Hanson, Celina M.; George, Anupa M.; Sawadogo, Adama; Schreiber, Benjamin (19 April 2017). <a class=\"external text\" href=\"https://www.sciencedirect.com/science/article/pii/S0264410X16309471/\" rel=\"nofollow\">\"Is freezing in the vaccine cold chain an ongoing issue? A literature review\"</a>. <i>Vaccine</i>. <b>35</b> (17): 2127–33. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1016%2Fj.vaccine.2016.09.070\" rel=\"nofollow\">10.1016/j.vaccine.2016.09.070</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/0264-410X\" rel=\"nofollow\">0264-410X</a>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/28364920\" rel=\"nofollow\">28364920</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Is+freezing+in+the+vaccine+cold+chain+an+ongoing+issue%3F+A+literature+review&amp;rft.volume=35&amp;rft.issue=17&amp;rft.pages=2127-33&amp;rft.date=2017-04-19&amp;rft.issn=0264-410X&amp;rft_id=info%3Apmid%2F28364920&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2016.09.070&amp;rft.aulast=Hanson&amp;rft.aufirst=Celina+M.&amp;rft.au=George%2C+Anupa+M.&amp;rft.au=Sawadogo%2C+Adama&amp;rft.au=Schreiber%2C+Benjamin&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0264410X16309471%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-weise-247\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-weise_247-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-weise_247-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-weise_247-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFElizabeth_Weise2020\">Elizabeth Weise (6 September 2020). <a class=\"external text\" href=\"https://www.usatoday.com/story/news/health/2020/09/06/covid-vaccine-complex-distribution-supply-chain-follow-approval/5712053002/\" rel=\"nofollow\">\"<span class=\"cs1-kern-left\">'</span>Mind-bogglingly complex': Here's what we know about how COVID-19 vaccine will be distributed when it's approved\"</a>. <i>USA Today</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=%27Mind-bogglingly+complex%27%3A+Here%27s+what+we+know+about+how+COVID-19+vaccine+will+be+distributed+when+it%27s+approved&amp;rft.date=2020-09-06&amp;rft.au=Elizabeth+Weise&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fhealth%2F2020%2F09%2F06%2Fcovid-vaccine-complex-distribution-supply-chain-follow-approval%2F5712053002%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-durbha-248\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-durbha_248-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFMadhav_Durbha2020\">Madhav Durbha (29 June 2020). <a class=\"external text\" href=\"https://www.europeanpharmaceuticalreview.com/article/122358/the-extra-mile-preparing-a-supply-chain-for-a-covid-19-vaccine/\" rel=\"nofollow\">\"The extra mile: preparing a supply chain for a COVID-19 vaccine\"</a>. European Pharmaceutical Review<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+extra+mile%3A+preparing+a+supply+chain+for+a+COVID-19+vaccine&amp;rft.pub=European+Pharmaceutical+Review&amp;rft.date=2020-06-29&amp;rft.au=Madhav+Durbha&amp;rft_id=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Farticle%2F122358%2Fthe-extra-mile-preparing-a-supply-chain-for-a-covid-19-vaccine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-iata-249\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-iata_249-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-iata_249-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-iata_249-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-iata_249-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.iata.org/en/pressroom/pr/2020-09-09-01/\" rel=\"nofollow\">\"The time to prepare for COVID-19 vaccine transport is now\"</a>. International Air Transport Association. 9 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+time+to+prepare+for+COVID-19+vaccine+transport+is+now&amp;rft.pub=International+Air+Transport+Association&amp;rft.date=2020-09-09&amp;rft_id=https%3A%2F%2Fwww.iata.org%2Fen%2Fpressroom%2Fpr%2F2020-09-09-01%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-unodc-250\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-unodc_250-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-unodc_250-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-unodc_250-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.unodc.org/documents/data-and-analysis/covid/COVID-19_research_brief_trafficking_medical_products.pdf\" rel=\"nofollow\">\"COVID-19-related trafficking of medical products as a threat to public health\"</a> <span class=\"cs1-format\">(PDF)</span>. United Nations Office on Drugs and Crime. 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=COVID-19-related+trafficking+of+medical+products+as+a+threat+to+public+health&amp;rft.pub=United+Nations+Office+on+Drugs+and+Crime&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.unodc.org%2Fdocuments%2Fdata-and-analysis%2Fcovid%2FCOVID-19_research_brief_trafficking_medical_products.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-kohler-251\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-kohler_251-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal cs1\" id=\"CITEREFKohlerDimancesco2020\">Kohler, Jillian Clare; Dimancesco, Deirdre (3 February 2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7170361\" rel=\"nofollow\">\"The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk\"</a>. <i>Global Health Action</i>. <b>13</b> (sup1): 1694745. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a class=\"external text\" href=\"https://doi.org/10.1080%2F16549716.2019.1694745\" rel=\"nofollow\">10.1080/16549716.2019.1694745</a>. <a class=\"mw-redirect\" href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a> <a class=\"external text\" href=\"//www.worldcat.org/issn/1654-9716\" rel=\"nofollow\">1654-9716</a>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7170361\" rel=\"nofollow\">7170361</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32194011\" rel=\"nofollow\">32194011</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Global+Health+Action&amp;rft.atitle=The+risk+of+corruption+in+public+pharmaceutical+procurement%3A+how+anti-corruption%2C+transparency+and+accountability+measures+may+reduce+this+risk&amp;rft.volume=13&amp;rft.issue=sup1&amp;rft.pages=1694745&amp;rft.date=2020-02-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7170361&amp;rft.issn=1654-9716&amp;rft_id=info%3Apmid%2F32194011&amp;rft_id=info%3Adoi%2F10.1080%2F16549716.2019.1694745&amp;rft.aulast=Kohler&amp;rft.aufirst=Jillian+Clare&amp;rft.au=Dimancesco%2C+Deirdre&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7170361&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-subra-252\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-subra_252-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news cs1\" id=\"CITEREFSamanth_Subramanian2020\">Samanth Subramanian (13 August 2020). <a class=\"external text\" href=\"https://www.bloomberg.com/features/2020-covid-vaccine-tracking-biometric/\" rel=\"nofollow\">\"Biometric tracking can ensure billions have immunity against Covid-19\"</a>. <i>Bloomberg Businessweek</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft.atitle=Biometric+tracking+can+ensure+billions+have+immunity+against+Covid-19&amp;rft.date=2020-08-13&amp;rft.au=Samanth+Subramanian&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Ffeatures%2F2020-covid-vaccine-tracking-biometric%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-who-evm-253\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who-evm_253-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who-evm_253-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.who.int/immunization/programmes_systems/supply_chain/evm/en/index5.html\" rel=\"nofollow\">\"Effective Vaccine Management (EVM) Initiative:Vaccine Management Handbook\"</a>. World Health Organization. 9 September 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 September</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Effective+Vaccine+Management+%28EVM%29+Initiative%3AVaccine+Management+Handbook&amp;rft.pub=World+Health+Organization&amp;rft.date=2020-09-09&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fimmunization%2Fprogrammes_systems%2Fsupply_chain%2Fevm%2Fen%2Findex5.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-254\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-254\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFAzar2020\">Azar A (4 February 2020). <a class=\"external text\" href=\"https://www.phe.gov/Preparedness/legal/prepact/Pages/COVID19.aspx\" rel=\"nofollow\">\"Notice of Declaration under the Public Readiness and Emergency Preparedness Act for medical countermeasures against COVID-19\"</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200425015411/https://www.phe.gov/Preparedness/legal/prepact/Pages/COVID19.aspx\" rel=\"nofollow\">Archived</a> from the original on 25 April 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 April</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Notice+of+Declaration+under+the+Public+Readiness+and+Emergency+Preparedness+Act+for+medical+countermeasures+against+COVID-19&amp;rft.date=2020-02-04&amp;rft.aulast=Azar&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.phe.gov%2FPreparedness%2Flegal%2Fprepact%2FPages%2FCOVID19.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-255\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-255\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFKertscher2020\">Kertscher T (23 January 2020). <a class=\"external text\" href=\"https://www.politifact.com/factchecks/2020/jan/23/facebook-posts/there-outbreak-china-wuhan-coronavirus-there-not-v/\" rel=\"nofollow\">\"No, there is no vaccine for the Wuhan coronavirus\"</a>. <i><a href=\"/wiki/PolitiFact\" title=\"PolitiFact\">PolitiFact</a></i>. <a href=\"/wiki/Poynter_Institute\" title=\"Poynter Institute\">Poynter Institute</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200207133056/https://www.politifact.com/factchecks/2020/jan/23/facebook-posts/there-outbreak-china-wuhan-coronavirus-there-not-v/\" rel=\"nofollow\">Archived</a> from the original on 7 February 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">7 February</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PolitiFact&amp;rft.atitle=No%2C+there+is+no+vaccine+for+the+Wuhan+coronavirus&amp;rft.date=2020-01-23&amp;rft.aulast=Kertscher&amp;rft.aufirst=Tom&amp;rft_id=https%3A%2F%2Fwww.politifact.com%2Ffactchecks%2F2020%2Fjan%2F23%2Ffacebook-posts%2Fthere-outbreak-china-wuhan-coronavirus-there-not-v%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-20200124factcheckA-256\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20200124factcheckA_256-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\" id=\"CITEREFMcDonald2020\">McDonald J (24 January 2020). <a class=\"external text\" href=\"https://www.factcheck.org/2020/01/social-media-posts-spread-bogus-coronavirus-conspiracy-theory/\" rel=\"nofollow\">\"Social Media Posts Spread Bogus Coronavirus Conspiracy Theory\"</a>. <i><a href=\"/wiki/FactCheck.org\" title=\"FactCheck.org\">FactCheck.org</a></i>. <a href=\"/wiki/Annenberg_Public_Policy_Center\" title=\"Annenberg Public Policy Center\">Annenberg Public Policy Center</a>. <a class=\"external text\" href=\"https://web.archive.org/web/20200206102802/https://www.factcheck.org/2020/01/social-media-posts-spread-bogus-coronavirus-conspiracy-theory/\" rel=\"nofollow\">Archived</a> from the original on 6 February 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 February</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FactCheck.org&amp;rft.atitle=Social+Media+Posts+Spread+Bogus+Coronavirus+Conspiracy+Theory&amp;rft.date=2020-01-24&amp;rft.aulast=McDonald&amp;rft.aufirst=Jessica&amp;rft_id=https%3A%2F%2Fwww.factcheck.org%2F2020%2F01%2Fsocial-media-posts-spread-bogus-coronavirus-conspiracy-theory%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "<li id=\"cite_note-257\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-257\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/north-coast-biologics-607532-05212020\" rel=\"nofollow\">\"Warning Letter – North Coast Biologics – MARCS-CMS 607532\"</a>. U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA). 21 May 2020. <a class=\"external text\" href=\"https://web.archive.org/web/20200526221432/https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/north-coast-biologics-607532-05212020\" rel=\"nofollow\">Archived</a> from the original on 26 May 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 May</span> 2020</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Warning+Letter+%E2%80%93+North+Coast+Biologics+%E2%80%93+MARCS-CMS+607532&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2020-05-21&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Finspections-compliance-enforcement-and-criminal-investigations%2Fwarning-letters%2Fnorth-coast-biologics-607532-05212020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></span>\n",
            "</li>\n",
            "</ol></div></div>\n",
            "<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span></h2>\n",
            "<ul><li><cite class=\"citation journal cs1\" id=\"CITEREFFunkLaferrièreArdakani2020\">Funk CD, Laferrière C, Ardakani A (2020). <a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7317023\" rel=\"nofollow\">\"A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic\"</a>. <i>Front Pharmacol</i>. <b>11</b>: 937. <a class=\"mw-redirect\" href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"https://doi.org/10.3389%2Ffphar.2020.00937\" rel=\"nofollow\">10.3389/fphar.2020.00937</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a> <span class=\"cs1-lock-free\" title=\"Freely accessible\"><a class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7317023\" rel=\"nofollow\">7317023</a></span>. <a class=\"mw-redirect\" href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a> <a class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/32636754\" rel=\"nofollow\">32636754</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Front+Pharmacol&amp;rft.atitle=A+Snapshot+of+the+Global+Race+for+Vaccines+Targeting+SARS-CoV-2+and+the+COVID-19+Pandemic&amp;rft.volume=11&amp;rft.pages=937&amp;rft.date=2020&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7317023&amp;rft_id=info%3Apmid%2F32636754&amp;rft_id=info%3Adoi%2F10.3389%2Ffphar.2020.00937&amp;rft.aulast=Funk&amp;rft.aufirst=CD&amp;rft.au=Laferri%C3%A8re%2C+C&amp;rft.au=Ardakani%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7317023&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li>\n",
            "<li><cite class=\"citation web cs1\" id=\"CITEREFJohnsonMufson2020\">Johnson CY, Mufson S (11 June 2020). <a class=\"external text\" href=\"https://www.washingtonpost.com/health/2020/06/11/can-old-vaccines-sciences-medicine-cabinet-ward-off-coronavirus/\" rel=\"nofollow\">\"Can old vaccines from science's medicine cabinet ward off coronavirus?\"</a>. <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=Can+old+vaccines+from+science%27s+medicine+cabinet+ward+off+coronavirus%3F&amp;rft.date=2020-06-11&amp;rft.aulast=Johnson&amp;rft.aufirst=Carolyn+Y.&amp;rft.au=Mufson%2C+Steven&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fhealth%2F2020%2F06%2F11%2Fcan-old-vaccines-sciences-medicine-cabinet-ward-off-coronavirus%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li>\n",
            "<li><cite class=\"citation web cs1\" id=\"CITEREFZimmerSheikhWeiland2020\">Zimmer C, Sheikh K, Weiland N (20 May 2020). <a class=\"external text\" href=\"https://www.nytimes.com/2020/05/20/health/coronavirus-vaccines.html\" rel=\"nofollow\">\"A New Entry in the Race for a Coronavirus Vaccine: Hope\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+New+Entry+in+the+Race+for+a+Coronavirus+Vaccine%3A+Hope&amp;rft.date=2020-05-20&amp;rft.aulast=Zimmer&amp;rft.aufirst=Carl&amp;rft.au=Sheikh%2C+Knvul&amp;rft.au=Weiland%2C+Noah&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F05%2F20%2Fhealth%2Fcoronavirus-vaccines.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li>\n",
            "<li><cite class=\"citation journal cs1\"><a class=\"external text\" href=\"https://www.fda.gov/media/139638/download\" rel=\"nofollow\">\"Development and Licensure of Vaccines to Prevent COVID-19\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>U.S. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA)</i>. June 2020. <a class=\"external text\" href=\"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19\" rel=\"nofollow\">Lay summary</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=Development+and+Licensure+of+Vaccines+to+Prevent+COVID-19&amp;rft.date=2020-06&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F139638%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li></ul>\n",
            "<h2><span class=\"mw-headline\" id=\"External_links\">External links</span></h2>\n",
            "<table class=\"mbox-small plainlinks sistersitebox\" role=\"presentation\" style=\"background-color:#f9f9f9;border:1px solid #aaa;color:#000\">\n",
            "<tbody><tr>\n",
            "<td class=\"mbox-image\"><img alt=\"\" class=\"noviewer\" data-file-height=\"355\" data-file-width=\"300\" decoding=\"async\" height=\"40\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/34px-Wikiquote-logo.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/51px-Wikiquote-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/68px-Wikiquote-logo.svg.png 2x\" width=\"34\"/></td>\n",
            "<td class=\"mbox-text plainlist\">Wikiquote has quotations related to: <i><b><a class=\"extiw\" href=\"https://en.wikiquote.org/wiki/Special:Search/COVID-19_vaccine\" title=\"q:Special:Search/COVID-19 vaccine\">COVID-19 vaccine</a></b></i></td></tr>\n",
            "</tbody></table>\n",
            "<ul><li><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html\" rel=\"nofollow\">\"Coronavirus Vaccine Tracker\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Coronavirus+Vaccine+Tracker&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2Finteractive%2F2020%2Fscience%2Fcoronavirus-vaccine-tracker.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li>\n",
            "<li><a class=\"external text\" href=\"https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker\" rel=\"nofollow\">COVID-19 vaccine tracker, Regulatory Focus</a></li>\n",
            "<li><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.statnews.com/feature/coronavirus/drugs-vaccines-tracker/#vaccines\" rel=\"nofollow\">\"STAT's Covid-19 Drugs and Vaccines Tracker\"</a>. <i><a href=\"/wiki/Stat_(website)\" title=\"Stat (website)\">Stat</a></i>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Stat&amp;rft.atitle=STAT%27s+Covid-19+Drugs+and+Vaccines+Tracker&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2Ffeature%2Fcoronavirus%2Fdrugs-vaccines-tracker%2F%23vaccines&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li>\n",
            "<li><cite class=\"citation pressrelease cs1\"><a class=\"external text\" href=\"https://www.businesswire.com/news/home/20200908005282/en/\" rel=\"nofollow\">\"Biopharma Leaders Unite to Stand with Science\"</a> (Press release). 8 September 2020 – via Business Wire.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Biopharma+Leaders+Unite+to+Stand+with+Science&amp;rft.date=2020-09-08&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20200908005282%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li>\n",
            "<li><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.modernatx.com/sites/default/files/mRNA-1273-P301-Protocol.pdf\" rel=\"nofollow\">\"Protocol mRNA-1273-P301\"</a> <span class=\"cs1-format\">(PDF)</span>. <a href=\"/wiki/Moderna\" title=\"Moderna\">Moderna</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protocol+mRNA-1273-P301&amp;rft.pub=Moderna&amp;rft_id=https%3A%2F%2Fwww.modernatx.com%2Fsites%2Fdefault%2Ffiles%2FmRNA-1273-P301-Protocol.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li>\n",
            "<li><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-09/C4591001_Clinical_Protocol.pdf\" rel=\"nofollow\">\"Protocol C4591001 PF-07302048 (BNT162 RNA-Based COVID-19 Vaccines)\"</a> <span class=\"cs1-format\">(PDF)</span>. <a href=\"/wiki/Pfizer\" title=\"Pfizer\">Pfizer</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protocol+C4591001+PF-07302048+%28BNT162+RNA-Based+COVID-19+Vaccines%29&amp;rft.pub=Pfizer&amp;rft_id=https%3A%2F%2Fpfe-pfizercom-d8-prod.s3.amazonaws.com%2F2020-09%2FC4591001_Clinical_Protocol.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li>\n",
            "<li><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://s3.amazonaws.com/ctr-med-7111/D8110C00001/52bec400-80f6-4c1b-8791-0483923d0867/c8070a4e-6a9d-46f9-8c32-cece903592b9/D8110C00001_CSP-v2.pdf\" rel=\"nofollow\">\"Protocol AZD1222 – D8110C00001\"</a> <span class=\"cs1-format\">(PDF)</span>. <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protocol+AZD1222+%E2%80%93+D8110C00001&amp;rft.pub=AstraZeneca&amp;rft_id=https%3A%2F%2Fs3.amazonaws.com%2Fctr-med-7111%2FD8110C00001%2F52bec400-80f6-4c1b-8791-0483923d0867%2Fc8070a4e-6a9d-46f9-8c32-cece903592b9%2FD8110C00001_CSP-v2.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li>\n",
            "<li><cite class=\"citation web cs1\"><a class=\"external text\" href=\"https://www.jnj.com/coronavirus/covid-19-phase-3-study-clinical-protocol\" rel=\"nofollow\">\"Protocol VAC31518COV3001; Phase 3\"</a> <span class=\"cs1-format\">(PDF)</span>. <a href=\"/wiki/Janssen_Pharmaceutica\" title=\"Janssen Pharmaceutica\">Janssen Vaccines &amp; Prevention</a>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protocol+VAC31518COV3001%3B+Phase+3&amp;rft.pub=Janssen+Vaccines+%26+Prevention&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fcoronavirus%2Fcovid-19-phase-3-study-clinical-protocol&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACOVID-19+vaccine\"></span><link href=\"mw-data:TemplateStyles:r982806391\" rel=\"mw-deduplicated-inline-style\"/></li></ul>\n",
            "<div aria-labelledby=\"COVID-19_pandemic\" class=\"navbox\" role=\"navigation\" style=\"padding:3px\"><table class=\"nowraplinks hlist mw-collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:COVID-19_pandemic\" title=\"Template:COVID-19 pandemic\"><abbr style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\" title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:COVID-19_pandemic\" title=\"Template talk:COVID-19 pandemic\"><abbr style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\" title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:COVID-19_pandemic&amp;action=edit\"><abbr style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\" title=\"Edit this template\">e</abbr></a></li></ul></div><div id=\"COVID-19_pandemic\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a></div></th></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div id=\"*_SARS-CoV-2_(virus)_*_COVID-19_(disease)\">\n",
            "<ul><li><b><a href=\"/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\" title=\"Severe acute respiratory syndrome coronavirus 2\">SARS-CoV-2</a> (virus)</b></li>\n",
            "<li><b><a href=\"/wiki/Coronavirus_disease_2019\" title=\"Coronavirus disease 2019\">COVID-19</a> (disease)</b></li></ul>\n",
            "</div></td></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><div id=\"Timeline\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic\" title=\"Timeline of the COVID-19 pandemic\">Timeline</a></div></th></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Pandemic_predictions_and_preparations_prior_to_the_COVID-19_pandemic\" title=\"Pandemic predictions and preparations prior to the COVID-19 pandemic\">Pre-pandemic</a>\n",
            "<ul><li><a href=\"/wiki/Crimson_Contagion\" title=\"Crimson Contagion\">Crimson Contagion</a></li>\n",
            "<li><a href=\"/wiki/Disease_X\" title=\"Disease X\">Disease X</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Event_201\" title=\"Event 201\">Event 201</a></li>\n",
            "<li><a href=\"/wiki/Exercise_Cygnus\" title=\"Exercise Cygnus\">Exercise Cygnus</a></li></ul></li></ul>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_2019\" title=\"Timeline of the COVID-19 pandemic in 2019\">2019</a>\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_December_2019\" title=\"Timeline of the COVID-19 pandemic in December 2019\">December</a></li></ul></li>\n",
            "<li>2020\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_January_2020\" title=\"Timeline of the COVID-19 pandemic in January 2020\">January</a></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_February_2020\" title=\"Timeline of the COVID-19 pandemic in February 2020\">February</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_February_2020\" title=\"Responses to the COVID-19 pandemic in February 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_March_2020\" title=\"Timeline of the COVID-19 pandemic in March 2020\">March</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_March_2020\" title=\"Responses to the COVID-19 pandemic in March 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_April_2020\" title=\"Timeline of the COVID-19 pandemic in April 2020\">April</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_April_2020\" title=\"Responses to the COVID-19 pandemic in April 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_May_2020\" title=\"Timeline of the COVID-19 pandemic in May 2020\">May</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_May_2020\" title=\"Responses to the COVID-19 pandemic in May 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_June_2020\" title=\"Timeline of the COVID-19 pandemic in June 2020\">June</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_June_2020\" title=\"Responses to the COVID-19 pandemic in June 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_July_2020\" title=\"Timeline of the COVID-19 pandemic in July 2020\">July</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_July_2020\" title=\"Responses to the COVID-19 pandemic in July 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_August_2020\" title=\"Timeline of the COVID-19 pandemic in August 2020\">August</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_August_2020\" title=\"Responses to the COVID-19 pandemic in August 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_September_2020\" title=\"Timeline of the COVID-19 pandemic in September 2020\">September</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_September_2020\" title=\"Responses to the COVID-19 pandemic in September 2020\">responses</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_October_2020\" title=\"Timeline of the COVID-19 pandemic in October 2020\">October</a>\n",
            "<ul><li><a href=\"/wiki/Responses_to_the_COVID-19_pandemic_in_October_2020\" title=\"Responses to the COVID-19 pandemic in October 2020\">responses</a></li></ul></li></ul></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><div id=\"Locations\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/COVID-19_pandemic_by_country_and_territory\" title=\"COVID-19 pandemic by country and territory\">Locations</a></div></th></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Africa\" title=\"COVID-19 pandemic in Africa\">Africa</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">Northern</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Algeria\" title=\"COVID-19 pandemic in Algeria\">Algeria</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Canary_Islands\" title=\"COVID-19 pandemic in the Canary Islands\">Canary Islands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ceuta\" title=\"COVID-19 pandemic in Ceuta\">Ceuta</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Egypt\" title=\"COVID-19 pandemic in Egypt\">Egypt</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Libya\" title=\"COVID-19 pandemic in Libya\">Libya</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mauritania\" title=\"COVID-19 pandemic in Mauritania\">Mauritania</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Melilla\" title=\"COVID-19 pandemic in Melilla\">Melilla</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Morocco\" title=\"COVID-19 pandemic in Morocco\">Morocco</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sudan\" title=\"COVID-19 pandemic in Sudan\">Sudan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Tunisia\" title=\"COVID-19 pandemic in Tunisia\">Tunisia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Western_Sahara\" title=\"COVID-19 pandemic in Western Sahara\">Western Sahara</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Sahrawi_Arab_Democratic_Republic\" title=\"COVID-19 pandemic in the Sahrawi Arab Democratic Republic\">Sahrawi Arab Democratic Republic</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">Eastern</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Burundi\" title=\"COVID-19 pandemic in Burundi\">Burundi</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Comoros\" title=\"COVID-19 pandemic in the Comoros\">Comoros</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Djibouti\" title=\"COVID-19 pandemic in Djibouti\">Djibouti</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Eritrea\" title=\"COVID-19 pandemic in Eritrea\">Eritrea</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ethiopia\" title=\"COVID-19 pandemic in Ethiopia\">Ethiopia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Kenya\" title=\"COVID-19 pandemic in Kenya\">Kenya</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Madagascar\" title=\"COVID-19 pandemic in Madagascar\">Madagascar</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mauritius\" title=\"COVID-19 pandemic in Mauritius\">Mauritius</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mayotte\" title=\"COVID-19 pandemic in Mayotte\">Mayotte</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_R%C3%A9union\" title=\"COVID-19 pandemic in Réunion\">Réunion</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Rwanda\" title=\"COVID-19 pandemic in Rwanda\">Rwanda</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Seychelles\" title=\"COVID-19 pandemic in Seychelles\">Seychelles</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Somalia\" title=\"COVID-19 pandemic in Somalia\">Somalia</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Puntland\" title=\"COVID-19 pandemic in Puntland\">Puntland</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Somaliland\" title=\"COVID-19 pandemic in Somaliland\">Somaliland</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_South_Sudan\" title=\"COVID-19 pandemic in South Sudan\">South Sudan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Tanzania\" title=\"COVID-19 pandemic in Tanzania\">Tanzania</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Uganda\" title=\"COVID-19 pandemic in Uganda\">Uganda</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">Southern</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Angola\" title=\"COVID-19 pandemic in Angola\">Angola</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Botswana\" title=\"COVID-19 pandemic in Botswana\">Botswana</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Eswatini\" title=\"COVID-19 pandemic in Eswatini\">Eswatini</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Lesotho\" title=\"COVID-19 pandemic in Lesotho\">Lesotho</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Malawi\" title=\"COVID-19 pandemic in Malawi\">Malawi</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mozambique\" title=\"COVID-19 pandemic in Mozambique\">Mozambique</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Namibia\" title=\"COVID-19 pandemic in Namibia\">Namibia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_South_Africa\" title=\"COVID-19 pandemic in South Africa\">South Africa</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Zambia\" title=\"COVID-19 pandemic in Zambia\">Zambia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Zimbabwe\" title=\"COVID-19 pandemic in Zimbabwe\">Zimbabwe</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">Central</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Cameroon\" title=\"COVID-19 pandemic in Cameroon\">Cameroon</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Central_African_Republic\" title=\"COVID-19 pandemic in the Central African Republic\">Central African Republic</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Chad\" title=\"COVID-19 pandemic in Chad\">Chad</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Democratic_Republic_of_the_Congo\" title=\"COVID-19 pandemic in the Democratic Republic of the Congo\">Democratic Republic of the Congo</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Republic_of_the_Congo\" title=\"COVID-19 pandemic in the Republic of the Congo\">Republic of the Congo</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Gabon\" title=\"COVID-19 pandemic in Gabon\">Gabon</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_S%C3%A3o_Tom%C3%A9_and_Pr%C3%ADncipe\" title=\"COVID-19 pandemic in São Tomé and Príncipe\">São Tomé and Príncipe</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">Western</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Benin\" title=\"COVID-19 pandemic in Benin\">Benin</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Burkina_Faso\" title=\"COVID-19 pandemic in Burkina Faso\">Burkina Faso</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Cape_Verde\" title=\"COVID-19 pandemic in Cape Verde\">Cape Verde</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Equatorial_Guinea\" title=\"COVID-19 pandemic in Equatorial Guinea\">Equatorial Guinea</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Gambia\" title=\"COVID-19 pandemic in the Gambia\">Gambia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ghana\" title=\"COVID-19 pandemic in Ghana\">Ghana</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Ghana\" title=\"Timeline of the COVID-19 pandemic in Ghana\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Guinea\" title=\"COVID-19 pandemic in Guinea\">Guinea</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Guinea-Bissau\" title=\"COVID-19 pandemic in Guinea-Bissau\">Guinea-Bissau</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ivory_Coast\" title=\"COVID-19 pandemic in Ivory Coast\">Ivory Coast</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Liberia\" title=\"COVID-19 pandemic in Liberia\">Liberia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mali\" title=\"COVID-19 pandemic in Mali\">Mali</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Niger\" title=\"COVID-19 pandemic in Niger\">Niger</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Nigeria\" title=\"COVID-19 pandemic in Nigeria\">Nigeria</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Senegal\" title=\"COVID-19 pandemic in Senegal\">Senegal</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sierra_Leone\" title=\"COVID-19 pandemic in Sierra Leone\">Sierra Leone</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Togo\" title=\"COVID-19 pandemic in Togo\">Togo</a></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Asia\" title=\"COVID-19 pandemic in Asia\">Asia</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">Central / <a href=\"/wiki/COVID-19_pandemic_in_North_Asia\" title=\"COVID-19 pandemic in North Asia\">North</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Kazakhstan\" title=\"COVID-19 pandemic in Kazakhstan\">Kazakhstan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Kyrgyzstan\" title=\"COVID-19 pandemic in Kyrgyzstan\">Kyrgyzstan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Russia\" title=\"COVID-19 pandemic in Russia\">Russia</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Russia\" title=\"Timeline of the COVID-19 pandemic in Russia\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Tajikistan\" title=\"COVID-19 pandemic in Tajikistan\">Tajikistan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Turkmenistan\" title=\"COVID-19 pandemic in Turkmenistan\">Turkmenistan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Uzbekistan\" title=\"COVID-19 pandemic in Uzbekistan\">Uzbekistan</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">East</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Hong_Kong\" title=\"COVID-19 pandemic in Hong Kong\">Hong Kong</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Japan\" title=\"COVID-19 pandemic in Japan\">Japan</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Japan\" title=\"Timeline of the COVID-19 pandemic in Japan\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_North_Korea\" title=\"COVID-19 pandemic in North Korea\">North Korea</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_South_Korea\" title=\"COVID-19 pandemic in South Korea\">South Korea</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Macau\" title=\"COVID-19 pandemic in Macau\">Macau</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mongolia\" title=\"COVID-19 pandemic in Mongolia\">Mongolia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Taiwan\" title=\"COVID-19 pandemic in Taiwan\">Taiwan</a></li></ul>\n",
            "</div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"China\" scope=\"row\" style=\"width:6em\"><a href=\"/wiki/COVID-19_pandemic_in_mainland_China\" title=\"COVID-19 pandemic in mainland China\">China</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Beijing\" title=\"COVID-19 pandemic in Beijing\">Beijing</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Heilongjiang\" title=\"COVID-19 pandemic in Heilongjiang\">Heilongjiang</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Henan\" title=\"COVID-19 pandemic in Henan\">Henan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Hubei\" title=\"COVID-19 pandemic in Hubei\">Hubei</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_lockdown_in_Hubei\" title=\"COVID-19 pandemic lockdown in Hubei\">lockdown</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Inner_Mongolia\" title=\"COVID-19 pandemic in Inner Mongolia\">Inner Mongolia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Liaoning\" title=\"COVID-19 pandemic in Liaoning\">Liaoning</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Shanghai\" title=\"COVID-19 pandemic in Shanghai\">Shanghai</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sichuan\" title=\"COVID-19 pandemic in Sichuan\">Sichuan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Tibet\" title=\"COVID-19 pandemic in Tibet\">Tibet</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Xinjiang\" title=\"COVID-19 pandemic in Xinjiang\"> Xinjiang</a></li></ul>\n",
            "</div></td></tr></tbody></table><div>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\"><a href=\"/wiki/COVID-19_pandemic_in_South_Asia\" title=\"COVID-19 pandemic in South Asia\">South</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Afghanistan\" title=\"COVID-19 pandemic in Afghanistan\">Afghanistan</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Afghanistan\" title=\"Timeline of the COVID-19 pandemic in Afghanistan\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Bangladesh\" title=\"COVID-19 pandemic in Bangladesh\">Bangladesh</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Bhutan\" title=\"COVID-19 pandemic in Bhutan\">Bhutan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Maldives\" title=\"COVID-19 pandemic in the Maldives\">Maldives</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Nepal\" title=\"COVID-19 pandemic in Nepal\">Nepal</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Nepal\" title=\"Timeline of the COVID-19 pandemic in Nepal\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Pakistan\" title=\"COVID-19 pandemic in Pakistan\">Pakistan</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Pakistan\" title=\"Timeline of the COVID-19 pandemic in Pakistan\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sri_Lanka\" title=\"COVID-19 pandemic in Sri Lanka\">Sri Lanka</a></li></ul>\n",
            "</div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"India\" scope=\"row\" style=\"width:6em\"><a href=\"/wiki/COVID-19_pandemic_in_India\" title=\"COVID-19 pandemic in India\">India</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li>(<a class=\"mw-redirect\" href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_India\" title=\"Timeline of the COVID-19 pandemic in India\">timeline</a></li>\n",
            "<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_India\" title=\"Economic impact of the COVID-19 pandemic in India\">economic impact</a></li>\n",
            "<li><a href=\"/wiki/Evacuations_by_India_related_to_the_COVID-19_pandemic\" title=\"Evacuations by India related to the COVID-19 pandemic\">evacuations</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_lockdown_in_India\" title=\"COVID-19 pandemic lockdown in India\">lockdown</a></li>\n",
            "<li><a href=\"/wiki/Indian_migrant_workers_during_the_COVID-19_pandemic\" title=\"Indian migrant workers during the COVID-19 pandemic\">migrant workers' crisis</a></li>\n",
            "<li><a href=\"/wiki/Indian_government_response_to_the_COVID-19_pandemic\" title=\"Indian government response to the COVID-19 pandemic\">Indian government response</a>\n",
            "<ul><li><a href=\"/wiki/Operation_Namaste\" title=\"Operation Namaste\">Operation Namaste</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Indian_state_government_responses_to_the_COVID-19_pandemic\" title=\"Indian state government responses to the COVID-19 pandemic\">state government responses</a>)</li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Andaman_and_Nicobar_Islands\" title=\"COVID-19 pandemic in the Andaman and Nicobar Islands\">Andaman and Nicobar Islands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Andhra_Pradesh\" title=\"COVID-19 pandemic in Andhra Pradesh\">Andhra Pradesh</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Arunachal_Pradesh\" title=\"COVID-19 pandemic in Arunachal Pradesh\">Arunachal Pradesh</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Assam\" title=\"COVID-19 pandemic in Assam\">Assam</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Bihar\" title=\"COVID-19 pandemic in Bihar\">Bihar</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Chandigarh\" title=\"COVID-19 pandemic in Chandigarh\">Chandigarh</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Chhattisgarh\" title=\"COVID-19 pandemic in Chhattisgarh\">Chhattisgarh</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Dadra_and_Nagar_Haveli_and_Daman_and_Diu\" title=\"COVID-19 pandemic in Dadra and Nagar Haveli and Daman and Diu\">Dadra and Nagar Haveli and Daman and Diu</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Delhi\" title=\"COVID-19 pandemic in Delhi\">Delhi</a>\n",
            "<ul><li><a href=\"/wiki/2020_Tablighi_Jamaat_coronavirus_hotspot_in_Delhi\" title=\"2020 Tablighi Jamaat coronavirus hotspot in Delhi\">Tablighi Jamaat hotspot</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Goa\" title=\"COVID-19 pandemic in Goa\">Goa</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Gujarat\" title=\"COVID-19 pandemic in Gujarat\">Gujarat</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Haryana\" title=\"COVID-19 pandemic in Haryana\">Haryana</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Himachal_Pradesh\" title=\"COVID-19 pandemic in Himachal Pradesh\">Himachal Pradesh</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Jammu_and_Kashmir\" title=\"COVID-19 pandemic in Jammu and Kashmir\">Jammu and Kashmir</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Jharkhand\" title=\"COVID-19 pandemic in Jharkhand\">Jharkhand</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Karnataka\" title=\"COVID-19 pandemic in Karnataka\">Karnataka</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Kerala\" title=\"COVID-19 pandemic in Kerala\">Kerala</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ladakh\" title=\"COVID-19 pandemic in Ladakh\">Ladakh</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Madhya_Pradesh\" title=\"COVID-19 pandemic in Madhya Pradesh\">Madhya Pradesh</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Maharashtra\" title=\"COVID-19 pandemic in Maharashtra\">Maharashtra</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Manipur\" title=\"COVID-19 pandemic in Manipur\">Manipur</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Meghalaya\" title=\"COVID-19 pandemic in Meghalaya\">Meghalaya</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mizoram\" title=\"COVID-19 pandemic in Mizoram\">Mizoram</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Nagaland\" title=\"COVID-19 pandemic in Nagaland\">Nagaland</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Odisha\" title=\"COVID-19 pandemic in Odisha\">Odisha</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Puducherry\" title=\"COVID-19 pandemic in Puducherry\">Puducherry</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Punjab,_India\" title=\"COVID-19 pandemic in Punjab, India\">Punjab</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Rajasthan\" title=\"COVID-19 pandemic in Rajasthan\">Rajasthan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sikkim\" title=\"COVID-19 pandemic in Sikkim\">Sikkim</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Tamil_Nadu\" title=\"COVID-19 pandemic in Tamil Nadu\">Tamil Nadu</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Telangana\" title=\"COVID-19 pandemic in Telangana\">Telangana</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Tripura\" title=\"COVID-19 pandemic in Tripura\">Tripura</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Uttar_Pradesh\" title=\"COVID-19 pandemic in Uttar Pradesh\">Uttar Pradesh</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Uttarakhand\" title=\"COVID-19 pandemic in Uttarakhand\">Uttarakhand</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_West_Bengal\" title=\"COVID-19 pandemic in West Bengal\">West Bengal</a></li></ul>\n",
            "</div></td></tr></tbody></table><div>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\"><a href=\"/wiki/COVID-19_pandemic_in_Southeast_Asia\" title=\"COVID-19 pandemic in Southeast Asia\">Southeast</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Brunei\" title=\"COVID-19 pandemic in Brunei\">Brunei</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Cambodia\" title=\"COVID-19 pandemic in Cambodia\">Cambodia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_East_Timor\" title=\"COVID-19 pandemic in East Timor\">East Timor</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Indonesia\" title=\"COVID-19 pandemic in Indonesia\">Indonesia</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Indonesia\" title=\"Timeline of the COVID-19 pandemic in Indonesia\">timeline</a></li>\n",
            "<li><a href=\"/wiki/2020_Indonesia_large-scale_social_restrictions\" title=\"2020 Indonesia large-scale social restrictions\">social restrictions</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Laos\" title=\"COVID-19 pandemic in Laos\">Laos</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Malaysia\" title=\"COVID-19 pandemic in Malaysia\">Malaysia</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Malaysia\" title=\"Timeline of the COVID-19 pandemic in Malaysia\">timeline</a></li>\n",
            "<li><a href=\"/wiki/2020_Malaysia_movement_control_order\" title=\"2020 Malaysia movement control order\">movement control order</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Johor\" title=\"COVID-19 pandemic in Johor\">Johor</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Kuala_Lumpur\" title=\"COVID-19 pandemic in Kuala Lumpur\">Kuala Lumpur</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sabah\" title=\"COVID-19 pandemic in Sabah\">Sabah</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sarawak\" title=\"COVID-19 pandemic in Sarawak\">Sarawak</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Selangor\" title=\"COVID-19 pandemic in Selangor\">Selangor</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Myanmar\" title=\"COVID-19 pandemic in Myanmar\">Myanmar</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Singapore\" title=\"COVID-19 pandemic in Singapore\">Singapore</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Singapore\" title=\"Timeline of the COVID-19 pandemic in Singapore\">timeline</a></li>\n",
            "<li><a href=\"/wiki/2020_Singapore_circuit_breaker_measures\" title=\"2020 Singapore circuit breaker measures\">circuit breaker response</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Thailand\" title=\"COVID-19 pandemic in Thailand\">Thailand</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Nonthaburi_Province\" title=\"COVID-19 pandemic in Nonthaburi Province\">Nonthaburi</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Vietnam\" title=\"COVID-19 pandemic in Vietnam\">Vietnam</a></li></ul>\n",
            "</div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" id=\"Philippines\" scope=\"row\" style=\"width:6em\"><a href=\"/wiki/COVID-19_pandemic_in_the_Philippines\" title=\"COVID-19 pandemic in the Philippines\">Philippines</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li>(<a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_Philippines\" title=\"Timeline of the COVID-19 pandemic in the Philippines\">timeline</a></li>\n",
            "<li><a href=\"/wiki/Philippine_government_response_to_the_COVID-19_pandemic\" title=\"Philippine government response to the COVID-19 pandemic\">government response</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_community_quarantines_in_the_Philippines\" title=\"COVID-19 community quarantines in the Philippines\">community quarantines</a>\n",
            "<ul><li><a href=\"/wiki/Enhanced_community_quarantine_in_Luzon\" title=\"Enhanced community quarantine in Luzon\">Luzon</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Evacuations_by_the_Philippines_related_to_the_COVID-19_pandemic\" title=\"Evacuations by the Philippines related to the COVID-19 pandemic\">evacuations</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_testing_controversy_in_the_Philippines\" title=\"COVID-19 testing controversy in the Philippines\">testing controversy</a>)</li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Bangsamoro\" title=\"COVID-19 pandemic in Bangsamoro\">Bangsamoro</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Bicol_Region\" title=\"COVID-19 pandemic in the Bicol Region\">Bicol Region</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Cagayan_Valley\" title=\"COVID-19 pandemic in Cagayan Valley\">Cagayan Valley</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Calabarzon\" title=\"COVID-19 pandemic in Calabarzon\">Calabarzon</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Caraga\" title=\"COVID-19 pandemic in Caraga\">Caraga</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Central_Luzon\" title=\"COVID-19 pandemic in Central Luzon\">Central Luzon</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Central_Visayas\" title=\"COVID-19 pandemic in Central Visayas\">Central Visayas</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Cordillera_Administrative_Region\" title=\"COVID-19 pandemic in the Cordillera Administrative Region\">Cordillera</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Davao_Region\" title=\"COVID-19 pandemic in the Davao Region\">Davao Region</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Eastern_Visayas\" title=\"COVID-19 pandemic in Eastern Visayas\">Eastern Visayas</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Ilocos_Region\" title=\"COVID-19 pandemic in the Ilocos Region\">Ilocos Region</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Metro_Manila\" title=\"COVID-19 pandemic in Metro Manila\">Metro Manila</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mimaropa\" title=\"COVID-19 pandemic in Mimaropa\">Mimaropa</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Northern_Mindanao\" title=\"COVID-19 pandemic in Northern Mindanao\">Northern Mindanao</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Soccsksargen\" title=\"COVID-19 pandemic in Soccsksargen\">Soccsksargen</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Western_Visayas\" title=\"COVID-19 pandemic in Western Visayas\">Western Visayas</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Zamboanga_Peninsula\" title=\"COVID-19 pandemic in Zamboanga Peninsula\">Zamboanga Peninsula</a></li>\n",
            "<li><a href=\"/wiki/Overseas_Filipinos_during_the_COVID-19_pandemic\" title=\"Overseas Filipinos during the COVID-19 pandemic\">Overseas Filipinos</a></li></ul>\n",
            "</div></td></tr></tbody></table><div>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">West</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Armenia\" title=\"COVID-19 pandemic in Armenia\">Armenia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Azerbaijan\" title=\"COVID-19 pandemic in Azerbaijan\">Azerbaijan</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Republic_of_Artsakh\" title=\"COVID-19 pandemic in the Republic of Artsakh\">Artsakh</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Bahrain\" title=\"COVID-19 pandemic in Bahrain\">Bahrain</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Georgia_(country)\" title=\"COVID-19 pandemic in Georgia (country)\">Georgia</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Abkhazia\" title=\"COVID-19 pandemic in Abkhazia\">Abkhazia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_South_Ossetia\" title=\"COVID-19 pandemic in South Ossetia\">South Ossetia</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Iran\" title=\"COVID-19 pandemic in Iran\">Iran</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Iraq\" title=\"COVID-19 pandemic in Iraq\">Iraq</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Kurdistan_Region\" title=\"COVID-19 pandemic in the Kurdistan Region\">Kurdistan</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Israel\" title=\"COVID-19 pandemic in Israel\">Israel</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Jordan\" title=\"COVID-19 pandemic in Jordan\">Jordan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Kuwait\" title=\"COVID-19 pandemic in Kuwait\">Kuwait</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Lebanon\" title=\"COVID-19 pandemic in Lebanon\">Lebanon</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Oman\" title=\"COVID-19 pandemic in Oman\">Oman</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_State_of_Palestine\" title=\"COVID-19 pandemic in the State of Palestine\">Palestine</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Qatar\" title=\"COVID-19 pandemic in Qatar\">Qatar</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Saudi_Arabia\" title=\"COVID-19 pandemic in Saudi Arabia\">Saudi Arabia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Syria\" title=\"COVID-19 pandemic in Syria\">Syria</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Turkey\" title=\"COVID-19 pandemic in Turkey\">Turkey</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Turkey\" title=\"Timeline of the COVID-19 pandemic in Turkey\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_United_Arab_Emirates\" title=\"COVID-19 pandemic in the United Arab Emirates\">United Arab Emirates</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Yemen\" title=\"COVID-19 pandemic in Yemen\">Yemen</a></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Europe\" title=\"COVID-19 pandemic in Europe\">Europe</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\"><a href=\"/wiki/COVID-19_pandemic_in_the_United_Kingdom\" title=\"COVID-19 pandemic in the United Kingdom\">United Kingdom</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li class=\"mw-empty-elt\"></li>\n",
            "<li>timeline\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_United_Kingdom_(January%E2%80%93June_2020)\" title=\"Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020)\">January–June 2020</a></li>\n",
            "<li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_United_Kingdom_(July%E2%80%93December_2020)\" title=\"Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020)\">July–December 2020</a></li></ul></li>\n",
            "<li><a href=\"/wiki/British_government_response_to_the_COVID-19_pandemic\" title=\"British government response to the COVID-19 pandemic\">government response</a>\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Criticism_of_the_British_government_response_to_the_COVID-19_pandemic\" title=\"Criticism of the British government response to the COVID-19 pandemic\">criticism</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_United_Kingdom\" title=\"Social impact of the COVID-19 pandemic in the United Kingdom\">social impact</a></li>\n",
            "<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_the_United_Kingdom\" title=\"Economic impact of the COVID-19 pandemic in the United Kingdom\">economic impact</a></li>\n",
            "<li><a href=\"/wiki/2020_United_Kingdom_education_shutdown\" title=\"2020 United Kingdom education shutdown\">education shutdown</a></li>\n",
            "<li><a href=\"/wiki/Operation_Rescript\" title=\"Operation Rescript\">Operation Rescript</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_England\" title=\"COVID-19 pandemic in England\">England</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_England\" title=\"Timeline of the COVID-19 pandemic in England\">timeline</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_London\" title=\"COVID-19 pandemic in London\">London</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Northern_Ireland\" title=\"COVID-19 pandemic in Northern Ireland\">Northern Ireland</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Northern_Ireland\" title=\"Timeline of the COVID-19 pandemic in Northern Ireland\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Scotland\" title=\"COVID-19 pandemic in Scotland\">Scotland</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Scotland\" title=\"Timeline of the COVID-19 pandemic in Scotland\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Wales\" title=\"COVID-19 pandemic in Wales\">Wales</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Wales\" title=\"Timeline of the COVID-19 pandemic in Wales\">timeline</a></li></ul></li>\n",
            "<li>Crown dependencies\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Isle_of_Man\" title=\"COVID-19 pandemic in the Isle of Man\">Isle of Man</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Jersey\" title=\"COVID-19 pandemic in Jersey\">Jersey</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Guernsey\" title=\"COVID-19 pandemic in Guernsey\">Guernsey</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_British_Overseas_Territories\" title=\"COVID-19 pandemic in the British Overseas Territories\">Overseas territories</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Akrotiri_and_Dhekelia\" title=\"COVID-19 pandemic in Akrotiri and Dhekelia\">Akrotiri and Dhekelia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Gibraltar\" title=\"COVID-19 pandemic in Gibraltar\">Gibraltar</a></li>\n",
            "<li><a href=\"/wiki/Operation_Broadshare\" title=\"Operation Broadshare\">response</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">Eastern</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Armenia\" title=\"COVID-19 pandemic in Armenia\">Armenia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Azerbaijan\" title=\"COVID-19 pandemic in Azerbaijan\">Azerbaijan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Belarus\" title=\"COVID-19 pandemic in Belarus\">Belarus</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Georgia_(country)\" title=\"COVID-19 pandemic in Georgia (country)\">Georgia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Kazakhstan\" title=\"COVID-19 pandemic in Kazakhstan\">Kazakhstan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Moldova\" title=\"COVID-19 pandemic in Moldova\">Moldova</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Gagauzia\" title=\"COVID-19 pandemic in Gagauzia\">Gagauzia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Transnistria\" title=\"COVID-19 pandemic in Transnistria\">Transnistria</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Russia\" title=\"COVID-19 pandemic in Russia\">Russia</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Russia\" title=\"Timeline of the COVID-19 pandemic in Russia\">timeline</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Russian_government_responses_to_the_COVID-19_pandemic\" title=\"Russian government responses to the COVID-19 pandemic\">government responses</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Crimea\" title=\"COVID-19 pandemic in Crimea\">Crimea</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sevastopol\" title=\"COVID-19 pandemic in Sevastopol\">Sevastopol</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ukraine\" title=\"COVID-19 pandemic in Ukraine\">Ukraine</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Crimea\" title=\"COVID-19 pandemic in Crimea\">Crimea</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sevastopol\" title=\"COVID-19 pandemic in Sevastopol\">Sevastopol</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Donetsk_People%27s_Republic\" title=\"COVID-19 pandemic in the Donetsk People's Republic\">Donetsk</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Luhansk_People%27s_Republic\" title=\"COVID-19 pandemic in the Luhansk People's Republic\">Luhansk</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">Balkans</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Albania\" title=\"COVID-19 pandemic in Albania\">Albania</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Bosnia_and_Herzegovina\" title=\"COVID-19 pandemic in Bosnia and Herzegovina\">Bosnia and Herzegovina</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Montenegro\" title=\"COVID-19 pandemic in Montenegro\">Montenegro</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_North_Macedonia\" title=\"COVID-19 pandemic in North Macedonia\">North Macedonia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Serbia\" title=\"COVID-19 pandemic in Serbia\">Serbia</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_protests_and_riots_in_Serbia\" title=\"COVID-19 protests and riots in Serbia\">protests and riots</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Kosovo\" title=\"COVID-19 pandemic in Kosovo\">Kosovo</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Turkey\" title=\"COVID-19 pandemic in Turkey\">Turkey</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Turkey\" title=\"Timeline of the COVID-19 pandemic in Turkey\">timeline</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\">Microstates</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Andorra\" title=\"COVID-19 pandemic in Andorra\">Andorra</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_San_Marino\" title=\"COVID-19 pandemic in San Marino\">San Marino</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Vatican_City\" title=\"COVID-19 pandemic in Vatican City\">Vatican City</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Monaco\" title=\"COVID-19 pandemic in Monaco\">Monaco</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:8em\"><a href=\"/wiki/European_Union_response_to_the_COVID-19_pandemic\" title=\"European Union response to the COVID-19 pandemic\">European Union</a><br/>EFTA countries</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Austria\" title=\"COVID-19 pandemic in Austria\">Austria</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Belgium\" title=\"COVID-19 pandemic in Belgium\">Belgium</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Bulgaria\" title=\"COVID-19 pandemic in Bulgaria\">Bulgaria</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Croatia\" title=\"COVID-19 pandemic in Croatia\">Croatia</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Croatia\" title=\"Timeline of the COVID-19 pandemic in Croatia\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Cyprus\" title=\"COVID-19 pandemic in Cyprus\">Cyprus</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Northern_Cyprus\" title=\"COVID-19 pandemic in Northern Cyprus\">Northern Cyprus</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Czech_Republic\" title=\"COVID-19 pandemic in the Czech Republic\">Czech Republic</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Denmark\" title=\"COVID-19 pandemic in Denmark\">Denmark</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Faroe_Islands\" title=\"COVID-19 pandemic in the Faroe Islands\">Faroe Islands</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Estonia\" title=\"COVID-19 pandemic in Estonia\">Estonia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Finland\" title=\"COVID-19 pandemic in Finland\">Finland</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_%C3%85land_Islands\" title=\"COVID-19 pandemic in the Åland Islands\">Åland Islands</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_France\" title=\"COVID-19 pandemic in France\">France</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Guadeloupe\" title=\"COVID-19 pandemic in Guadeloupe\">Guadeloupe</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_French_Guiana\" title=\"COVID-19 pandemic in French Guiana\">French Guiana</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_R%C3%A9union\" title=\"COVID-19 pandemic in Réunion\">Réunion</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Martinique\" title=\"COVID-19 pandemic in Martinique\">Martinique</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mayotte\" title=\"COVID-19 pandemic in Mayotte\">Mayotte</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_French_Saint_Martin\" title=\"COVID-19 pandemic in French Saint Martin\">Saint Martin</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Germany\" title=\"COVID-19 pandemic in Germany\">Germany</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_North_Rhine-Westphalia\" title=\"COVID-19 pandemic in North Rhine-Westphalia\">North Rhine-Westphalia</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Greece\" title=\"COVID-19 pandemic in Greece\">Greece</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Hungary\" title=\"COVID-19 pandemic in Hungary\">Hungary</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Iceland\" title=\"COVID-19 pandemic in Iceland\">Iceland</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Republic_of_Ireland\" title=\"COVID-19 pandemic in the Republic of Ireland\">Ireland</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_Republic_of_Ireland\" title=\"Timeline of the COVID-19 pandemic in the Republic of Ireland\">timeline</a></li>\n",
            "<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_Republic_of_Ireland\" title=\"Social impact of the COVID-19 pandemic in the Republic of Ireland\">social impact</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Italy\" title=\"COVID-19 pandemic in Italy\">Italy</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_lockdown_in_Italy\" title=\"COVID-19 pandemic lockdown in Italy\">lockdown</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Latvia\" title=\"COVID-19 pandemic in Latvia\">Latvia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Liechtenstein\" title=\"COVID-19 pandemic in Liechtenstein\">Liechtenstein</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Lithuania\" title=\"COVID-19 pandemic in Lithuania\">Lithuania</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Luxembourg\" title=\"COVID-19 pandemic in Luxembourg\">Luxembourg</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Malta\" title=\"COVID-19 pandemic in Malta\">Malta</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Netherlands\" title=\"COVID-19 pandemic in the Netherlands\">Netherlands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Norway\" title=\"COVID-19 pandemic in Norway\">Norway</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Poland\" title=\"COVID-19 pandemic in Poland\">Poland</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Portugal\" title=\"COVID-19 pandemic in Portugal\">Portugal</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Romania\" title=\"COVID-19 pandemic in Romania\">Romania</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Romania\" title=\"Timeline of the COVID-19 pandemic in Romania\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Slovakia\" title=\"COVID-19 pandemic in Slovakia\">Slovakia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Slovenia\" title=\"COVID-19 pandemic in Slovenia\">Slovenia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Spain\" title=\"COVID-19 pandemic in Spain\">Spain</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Spain\" title=\"Timeline of the COVID-19 pandemic in Spain\">timeline</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Asturias\" title=\"COVID-19 pandemic in Asturias\">Asturias</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Canary_Islands\" title=\"COVID-19 pandemic in the Canary Islands\">Canary Islands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ceuta\" title=\"COVID-19 pandemic in Ceuta\">Ceuta</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Community_of_Madrid\" title=\"COVID-19 pandemic in the Community of Madrid\">Community of Madrid</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Melilla\" title=\"COVID-19 pandemic in Melilla\">Melilla</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sweden\" title=\"COVID-19 pandemic in Sweden\">Sweden</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Sweden\" title=\"Timeline of the COVID-19 pandemic in Sweden\">timeline</a></li>\n",
            "<li><a href=\"/wiki/Swedish_government_response_to_the_COVID-19_pandemic\" title=\"Swedish government response to the COVID-19 pandemic\">government response</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Switzerland\" title=\"COVID-19 pandemic in Switzerland\">Switzerland</a></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_North_America\" title=\"COVID-19 pandemic in North America\">North America</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Mexico\" title=\"COVID-19 pandemic in Mexico\">Mexico</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Mexico\" title=\"Timeline of the COVID-19 pandemic in Mexico\">timeline</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Central America</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Belize\" title=\"COVID-19 pandemic in Belize\">Belize</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Costa_Rica\" title=\"COVID-19 pandemic in Costa Rica\">Costa Rica</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_El_Salvador\" title=\"COVID-19 pandemic in El Salvador\">El Salvador</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Guatemala\" title=\"COVID-19 pandemic in Guatemala\">Guatemala</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Honduras\" title=\"COVID-19 pandemic in Honduras\">Honduras</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Nicaragua\" title=\"COVID-19 pandemic in Nicaragua\">Nicaragua</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Panama\" title=\"COVID-19 pandemic in Panama\">Panama</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Canada\" title=\"COVID-19 pandemic in Canada\">Canada</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Canada\" title=\"Timeline of the COVID-19 pandemic in Canada\">timeline</a></li>\n",
            "<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_Canada\" title=\"Economic impact of the COVID-19 pandemic in Canada\">economic impact</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Alberta\" title=\"COVID-19 pandemic in Alberta\">Alberta</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_British_Columbia\" title=\"COVID-19 pandemic in British Columbia\">British Columbia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Manitoba\" title=\"COVID-19 pandemic in Manitoba\">Manitoba</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_New_Brunswick\" title=\"COVID-19 pandemic in New Brunswick\">New Brunswick</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Newfoundland_and_Labrador\" title=\"COVID-19 pandemic in Newfoundland and Labrador\">Newfoundland and Labrador</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Northwest_Territories\" title=\"COVID-19 pandemic in the Northwest Territories\">Northwest Territories</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Nova_Scotia\" title=\"COVID-19 pandemic in Nova Scotia\">Nova Scotia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Nunavut\" title=\"COVID-19 pandemic in Nunavut\">Nunavut</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ontario\" title=\"COVID-19 pandemic in Ontario\">Ontario</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Regional_Municipality_of_Peel\" title=\"COVID-19 pandemic in the Regional Municipality of Peel\">Peel Region</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Toronto\" title=\"COVID-19 pandemic in Toronto\">Toronto</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Prince_Edward_Island\" title=\"COVID-19 pandemic in Prince Edward Island\">Prince Edward Island</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Quebec\" title=\"COVID-19 pandemic in Quebec\">Quebec</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Montreal\" title=\"COVID-19 pandemic in Montreal\">Montreal</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Saskatchewan\" title=\"COVID-19 pandemic in Saskatchewan\">Saskatchewan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Yukon\" title=\"COVID-19 pandemic in Yukon\">Yukon</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Caribbean</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Antigua_and_Barbuda\" title=\"COVID-19 pandemic in Antigua and Barbuda\">Antigua and Barbuda</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Bahamas\" title=\"COVID-19 pandemic in the Bahamas\">Bahamas</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Barbados\" title=\"COVID-19 pandemic in Barbados\">Barbados</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_British_Overseas_Territories\" title=\"COVID-19 pandemic in the British Overseas Territories\">British Overseas Territories</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Anguilla\" title=\"COVID-19 pandemic in Anguilla\">Anguilla</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_British_Virgin_Islands\" title=\"COVID-19 pandemic in the British Virgin Islands\">British Virgin Islands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Cayman_Islands\" title=\"COVID-19 pandemic in the Cayman Islands\">Cayman Islands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Montserrat\" title=\"COVID-19 pandemic in Montserrat\">Montserrat</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Turks_and_Caicos_Islands\" title=\"COVID-19 pandemic in the Turks and Caicos Islands\">Turks and Caicos Islands</a></li>\n",
            "<li><a href=\"/wiki/Operation_Broadshare\" title=\"Operation Broadshare\">response</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Cuba\" title=\"COVID-19 pandemic in Cuba\">Cuba</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Guantanamo_Bay_Naval_Base\" title=\"COVID-19 pandemic in the Guantanamo Bay Naval Base\">Guantanamo Bay Naval Base</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Dominica\" title=\"COVID-19 pandemic in Dominica\">Dominica</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Dominican_Republic\" title=\"COVID-19 pandemic in the Dominican Republic\">Dominican Republic</a></li>\n",
            "<li>Dutch Caribbean\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Aruba\" title=\"COVID-19 pandemic in Aruba\">Aruba</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Cura%C3%A7ao\" title=\"COVID-19 pandemic in Curaçao\">Curaçao</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sint_Maarten\" title=\"COVID-19 pandemic in Sint Maarten\">Sint Maarten</a></li>\n",
            "<li>Caribbean Netherlands\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Bonaire\" title=\"COVID-19 pandemic in Bonaire\">Bonaire</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Saba\" title=\"COVID-19 pandemic in Saba\">Saba</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Sint_Eustatius\" title=\"COVID-19 pandemic in Sint Eustatius\">Sint Eustatius</a></li></ul></li></ul></li>\n",
            "<li>French West Indies\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Guadeloupe\" title=\"COVID-19 pandemic in Guadeloupe\">Guadeloupe</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Martinique\" title=\"COVID-19 pandemic in Martinique\">Martinique</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Barth%C3%A9lemy\" title=\"COVID-19 pandemic in Saint Barthélemy\">Saint Barthélemy</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_French_Saint_Martin\" title=\"COVID-19 pandemic in French Saint Martin\">Saint Martin</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Grenada\" title=\"COVID-19 pandemic in Grenada\">Grenada</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Haiti\" title=\"COVID-19 pandemic in Haiti\">Haiti</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Jamaica\" title=\"COVID-19 pandemic in Jamaica\">Jamaica</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Kitts_and_Nevis\" title=\"COVID-19 pandemic in Saint Kitts and Nevis\">Saint Kitts and Nevis</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Lucia\" title=\"COVID-19 pandemic in Saint Lucia\">Saint Lucia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Vincent_and_the_Grenadines\" title=\"COVID-19 pandemic in Saint Vincent and the Grenadines\">Saint Vincent and the Grenadines</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Trinidad_and_Tobago\" title=\"COVID-19 pandemic in Trinidad and Tobago\">Trinidad and Tobago</a></li>\n",
            "<li>US insular areas\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Puerto_Rico\" title=\"COVID-19 pandemic in Puerto Rico\">Puerto Rico</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_United_States_Virgin_Islands\" title=\"COVID-19 pandemic in the United States Virgin Islands\">U.S. Virgin Islands</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_the_United_States\" title=\"COVID-19 pandemic in the United States\">United States</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Timeline of the COVID-19 pandemic in the United States\">timeline</a></li>\n",
            "<li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Social impact of the COVID-19 pandemic in the United States\">social impact</a></li>\n",
            "<li><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic_in_the_United_States\" title=\"Economic impact of the COVID-19 pandemic in the United States\">economic impact</a></li>\n",
            "<li><a href=\"/wiki/U.S._federal_government_response_to_the_COVID-19_pandemic\" title=\"U.S. federal government response to the COVID-19 pandemic\">federal government response</a></li>\n",
            "<li><a href=\"/wiki/U.S._state_and_local_government_responses_to_the_COVID-19_pandemic\" title=\"U.S. state and local government responses to the COVID-19 pandemic\">state and local government responses</a></li>\n",
            "<li>Regional responses\n",
            "<ul><li><a href=\"/wiki/Eastern_States_Multi-state_Council\" title=\"Eastern States Multi-state Council\">Eastern States Multi-state Council</a></li>\n",
            "<li><a href=\"/wiki/Midwest_Governors_Regional_Pact\" title=\"Midwest Governors Regional Pact\">Midwest Governors Regional Pact</a></li>\n",
            "<li><a href=\"/wiki/Western_States_Pact\" title=\"Western States Pact\">Western States Pact</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Trump_administration_communication_during_the_COVID-19_pandemic\" title=\"Trump administration communication during the COVID-19 pandemic\">Trump administration communication</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Alabama\" title=\"COVID-19 pandemic in Alabama\">Alabama</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Alaska\" title=\"COVID-19 pandemic in Alaska\">Alaska</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Arizona\" title=\"COVID-19 pandemic in Arizona\">Arizona</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Navajo_Nation\" title=\"COVID-19 pandemic in the Navajo Nation\">Navajo Nation</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Arkansas\" title=\"COVID-19 pandemic in Arkansas\">Arkansas</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_California\" title=\"COVID-19 pandemic in California\">California</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_San_Francisco_Bay_Area\" title=\"COVID-19 pandemic in the San Francisco Bay Area\">S.F. Bay Area</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Colorado\" title=\"COVID-19 pandemic in Colorado\">Colorado</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Connecticut\" title=\"COVID-19 pandemic in Connecticut\">Connecticut</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Delaware\" title=\"COVID-19 pandemic in Delaware\">Delaware</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Florida\" title=\"COVID-19 pandemic in Florida\">Florida</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Georgia_(U.S._state)\" title=\"COVID-19 pandemic in Georgia (U.S. state)\">Georgia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Guam\" title=\"COVID-19 pandemic in Guam\">Guam</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Hawaii\" title=\"COVID-19 pandemic in Hawaii\">Hawaii</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Idaho\" title=\"COVID-19 pandemic in Idaho\">Idaho</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Illinois\" title=\"COVID-19 pandemic in Illinois\">Illinois</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Indiana\" title=\"COVID-19 pandemic in Indiana\">Indiana</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Iowa\" title=\"COVID-19 pandemic in Iowa\">Iowa</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Kansas\" title=\"COVID-19 pandemic in Kansas\">Kansas</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Kentucky\" title=\"COVID-19 pandemic in Kentucky\">Kentucky</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Louisiana\" title=\"COVID-19 pandemic in Louisiana\">Louisiana</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Maine\" title=\"COVID-19 pandemic in Maine\">Maine</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Maryland\" title=\"COVID-19 pandemic in Maryland\">Maryland</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Massachusetts\" title=\"COVID-19 pandemic in Massachusetts\">Massachusetts</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Massachusetts\" title=\"Timeline of the COVID-19 pandemic in Massachusetts\">timeline</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Boston\" title=\"COVID-19 pandemic in Boston\">Boston</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Boston\" title=\"Timeline of the COVID-19 pandemic in Boston\">timeline</a></li></ul></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Michigan\" title=\"COVID-19 pandemic in Michigan\">Michigan</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Minnesota\" title=\"COVID-19 pandemic in Minnesota\">Minnesota</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Mississippi\" title=\"COVID-19 pandemic in Mississippi\">Mississippi</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Missouri\" title=\"COVID-19 pandemic in Missouri\">Missouri</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Montana\" title=\"COVID-19 pandemic in Montana\">Montana</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Nebraska\" title=\"COVID-19 pandemic in Nebraska\">Nebraska</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Nevada\" title=\"COVID-19 pandemic in Nevada\">Nevada</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_New_Hampshire\" title=\"COVID-19 pandemic in New Hampshire\">New Hampshire</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_New_Jersey\" title=\"COVID-19 pandemic in New Jersey\">New Jersey</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_New_Mexico\" title=\"COVID-19 pandemic in New Mexico\">New Mexico</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_New_York_(state)\" title=\"COVID-19 pandemic in New York (state)\">New York</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_New_York_City\" title=\"COVID-19 pandemic in New York City\">New York City</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_North_Carolina\" title=\"COVID-19 pandemic in North Carolina\">North Carolina</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_North_Dakota\" title=\"COVID-19 pandemic in North Dakota\">North Dakota</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Northern_Mariana_Islands\" title=\"COVID-19 pandemic in the Northern Mariana Islands\">Northern Mariana Islands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ohio\" title=\"COVID-19 pandemic in Ohio\">Ohio</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_in_Ohio\" title=\"Impact of the COVID-19 pandemic in Ohio\">impact</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Columbus,_Ohio\" title=\"COVID-19 pandemic in Columbus, Ohio\">Columbus</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Oklahoma\" title=\"COVID-19 pandemic in Oklahoma\">Oklahoma</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Oregon\" title=\"COVID-19 pandemic in Oregon\">Oregon</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Portland,_Oregon\" title=\"COVID-19 pandemic in Portland, Oregon\">Portland</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Pennsylvania\" title=\"COVID-19 pandemic in Pennsylvania\">Pennsylvania</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Philadelphia\" title=\"COVID-19 pandemic in Philadelphia\">Philadelphia</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Puerto_Rico\" title=\"COVID-19 pandemic in Puerto Rico\">Puerto Rico</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Rhode_Island\" title=\"COVID-19 pandemic in Rhode Island\">Rhode Island</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_South_Carolina\" title=\"COVID-19 pandemic in South Carolina\">South Carolina</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_South_Dakota\" title=\"COVID-19 pandemic in South Dakota\">South Dakota</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Tennessee\" title=\"COVID-19 pandemic in Tennessee\">Tennessee</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Texas\" title=\"COVID-19 pandemic in Texas\">Texas</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_United_States_Virgin_Islands\" title=\"COVID-19 pandemic in the United States Virgin Islands\">U.S. Virgin Islands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Utah\" title=\"COVID-19 pandemic in Utah\">Utah</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Vermont\" title=\"COVID-19 pandemic in Vermont\">Vermont</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Virginia\" title=\"COVID-19 pandemic in Virginia\">Virginia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Washington_(state)\" title=\"COVID-19 pandemic in Washington (state)\">Washington</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Washington,_D.C.\" title=\"COVID-19 pandemic in Washington, D.C.\">Washington, D.C.</a>\n",
            "<ul><li><a href=\"/wiki/White_House_COVID-19_outbreak\" title=\"White House COVID-19 outbreak\">White House</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_West_Virginia\" title=\"COVID-19 pandemic in West Virginia\">West Virginia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Wisconsin\" title=\"COVID-19 pandemic in Wisconsin\">Wisconsin</a>\n",
            "<ul><li><a href=\"/wiki/Statistics_of_the_COVID-19_pandemic_in_Wisconsin\" title=\"Statistics of the COVID-19 pandemic in Wisconsin\">statistics</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Door_County,_Wisconsin\" title=\"COVID-19 pandemic in Door County, Wisconsin\">Door County</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Wyoming\" title=\"COVID-19 pandemic in Wyoming\">Wyoming</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Atlantic</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Bermuda\" title=\"COVID-19 pandemic in Bermuda\">Bermuda</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Greenland\" title=\"COVID-19 pandemic in Greenland\">Greenland</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Saint_Pierre_and_Miquelon\" title=\"COVID-19 pandemic in Saint Pierre and Miquelon\">Saint Pierre and Miquelon</a></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_Oceania\" title=\"COVID-19 pandemic in Oceania\">Oceania</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Australia\" title=\"COVID-19 pandemic in Australia\">Australia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Easter_Island\" title=\"COVID-19 pandemic in Easter Island\">Easter Island</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Fiji\" title=\"COVID-19 pandemic in Fiji\">Fiji</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_French_Polynesia\" title=\"COVID-19 pandemic in French Polynesia\">French Polynesia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Guam\" title=\"COVID-19 pandemic in Guam\">Guam</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Hawaii\" title=\"COVID-19 pandemic in Hawaii\">Hawaii</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_New_Caledonia\" title=\"COVID-19 pandemic in New Caledonia\">New Caledonia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_New_Zealand\" title=\"COVID-19 pandemic in New Zealand\">New Zealand</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_New_Zealand\" title=\"Timeline of the COVID-19 pandemic in New Zealand\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Northern_Mariana_Islands\" title=\"COVID-19 pandemic in the Northern Mariana Islands\">Northern Mariana Islands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Papua_New_Guinea\" title=\"COVID-19 pandemic in Papua New Guinea\">Papua New Guinea</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_the_Autonomous_Region_of_Bougainville\" title=\"COVID-19 pandemic in the Autonomous Region of Bougainville\">Bougainville</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Solomon_Islands\" title=\"COVID-19 pandemic in the Solomon Islands\">Solomon Islands</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/COVID-19_pandemic_in_South_America\" title=\"COVID-19 pandemic in South America\">South America</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Argentina\" title=\"COVID-19 pandemic in Argentina\">Argentina</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Argentina\" title=\"Timeline of the COVID-19 pandemic in Argentina\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Bolivia\" title=\"COVID-19 pandemic in Bolivia\">Bolivia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Brazil\" title=\"COVID-19 pandemic in Brazil\">Brazil</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_S%C3%A3o_Paulo_(state)\" title=\"COVID-19 pandemic in São Paulo (state)\">São Paulo</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Chile\" title=\"COVID-19 pandemic in Chile\">Chile</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Easter_Island\" title=\"COVID-19 pandemic in Easter Island\">Easter Island</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Colombia\" title=\"COVID-19 pandemic in Colombia\">Colombia</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Ecuador\" title=\"COVID-19 pandemic in Ecuador\">Ecuador</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_the_Falkland_Islands\" title=\"COVID-19 pandemic in the Falkland Islands\">Falkland Islands</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_French_Guiana\" title=\"COVID-19 pandemic in French Guiana\">French Guiana</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Guyana\" title=\"COVID-19 pandemic in Guyana\">Guyana</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Paraguay\" title=\"COVID-19 pandemic in Paraguay\">Paraguay</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Peru\" title=\"COVID-19 pandemic in Peru\">Peru</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Suriname\" title=\"COVID-19 pandemic in Suriname\">Suriname</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Uruguay\" title=\"COVID-19 pandemic in Uruguay\">Uruguay</a>\n",
            "<ul><li><a href=\"/wiki/Timeline_of_the_COVID-19_pandemic_in_Uruguay\" title=\"Timeline of the COVID-19 pandemic in Uruguay\">timeline</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_Venezuela\" title=\"COVID-19 pandemic in Venezuela\">Venezuela</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_Antarctica\" title=\"COVID-19 pandemic in Antarctica\">Antarctica</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_on_cruise_ships\" title=\"COVID-19 pandemic on cruise ships\">Cruise ships</a>\n",
            "<ul><li><i><a href=\"/wiki/COVID-19_pandemic_on_Diamond_Princess\" title=\"COVID-19 pandemic on Diamond Princess\">Diamond Princess</a></i></li>\n",
            "<li><i><a href=\"/wiki/COVID-19_pandemic_on_Grand_Princess\" title=\"COVID-19 pandemic on Grand Princess\">Grand Princess</a></i></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_on_naval_ships\" title=\"COVID-19 pandemic on naval ships\">Naval ships</a>\n",
            "<ul><li><i><a href=\"/wiki/COVID-19_pandemic_on_Charles_de_Gaulle\" title=\"COVID-19 pandemic on Charles de Gaulle\">Charles de Gaulle</a></i></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_on_USS_Theodore_Roosevelt\" title=\"COVID-19 pandemic on USS Theodore Roosevelt\">USS <i>Theodore Roosevelt</i></a></li></ul></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><div id=\"Impacts\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Impact_of_the_COVID-19_pandemic\" title=\"Impact of the COVID-19 pandemic\">Impacts</a></div></th></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Culture and<br/>entertainment</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_arts_and_cultural_heritage\" title=\"Impact of the COVID-19 pandemic on the arts and cultural heritage\">Arts and cultural heritage</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_cinema\" title=\"Impact of the COVID-19 pandemic on cinema\">Cinema</a>\n",
            "<ul><li><a href=\"/wiki/List_of_films_impacted_by_the_COVID-19_pandemic\" title=\"List of films impacted by the COVID-19 pandemic\">films affected</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_The_Walt_Disney_Company\" title=\"Impact of the COVID-19 pandemic on The Walt Disney Company\">Disney</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_education\" title=\"Impact of the COVID-19 pandemic on education\">Education</a></li>\n",
            "<li><a href=\"/wiki/List_of_events_affected_by_the_COVID-19_pandemic\" title=\"List of events affected by the COVID-19 pandemic\">Events affected</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_fashion_industry\" title=\"Impact of the COVID-19 pandemic on the fashion industry\">Fashion industry</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_music_industry\" title=\"Impact of the COVID-19 pandemic on the music industry\">Music industry</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_performing_arts\" title=\"Impact of the COVID-19 pandemic on the performing arts\">Performing arts</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_sports\" title=\"Impact of the COVID-19 pandemic on sports\">Sports</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_association_football\" title=\"Impact of the COVID-19 pandemic on association football\">association football</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_cricket\" title=\"Impact of the COVID-19 pandemic on cricket\">cricket</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_disc_golf\" title=\"Impact of the COVID-19 pandemic on disc golf\">disc golf</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_motorsport\" title=\"Impact of the COVID-19 pandemic on motorsport\">motorsport</a></li>\n",
            "<li><a href=\"/wiki/Suspension_of_the_2019%E2%80%9320_NBA_season\" title=\"Suspension of the 2019–20 NBA season\">NBA</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_television\" title=\"Impact of the COVID-19 pandemic on television\">Television</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_television_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on television in the United States\">U.S.</a>\n",
            "<ul><li><a href=\"/wiki/List_of_American_television_series_impacted_by_the_COVID-19_pandemic\" title=\"List of American television series impacted by the COVID-19 pandemic\">programs affected</a></li></ul></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_video_game_industry\" title=\"Impact of the COVID-19 pandemic on the video game industry\">Video games</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Society<br/> and rights</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Social_impact_of_the_COVID-19_pandemic\" title=\"Social impact of the COVID-19 pandemic\">Social</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_social_media\" title=\"Impact of the COVID-19 pandemic on social media\">social media</a></li>\n",
            "<li><a href=\"/wiki/Social_stigma_associated_with_COVID-19\" title=\"Social stigma associated with COVID-19\">stigma</a></li>\n",
            "<li><a href=\"/wiki/Coronavirus_party\" title=\"Coronavirus party\">COVID-19 parties</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_children\" title=\"Impact of the COVID-19 pandemic on children\">Children</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_foster_care_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on foster care in the United States\">foster care in the United States</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Gendered_impact_of_the_COVID-19_pandemic\" title=\"Gendered impact of the COVID-19 pandemic\">Gender</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_healthcare_workers\" title=\"Impact of the COVID-19 pandemic on healthcare workers\">Healthcare workers</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_hospitals\" title=\"Impact of the COVID-19 pandemic on hospitals\">Hospitals</a></li>\n",
            "<li><a href=\"/wiki/Human_rights_issues_related_to_the_COVID-19_pandemic\" title=\"Human rights issues related to the COVID-19 pandemic\">Human rights</a></li>\n",
            "<li>Legal\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_abortion_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on abortion in the United States\">abortion in the U.S.</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_crime\" title=\"Impact of the COVID-19 pandemic on crime\">crime</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_domestic_violence\" title=\"Impact of the COVID-19 pandemic on domestic violence\">domestic violence</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_prisons\" title=\"Impact of the COVID-19 pandemic on prisons\">prisons</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_in_US_immigration_detention\" title=\"COVID-19 pandemic in US immigration detention\">U.S. immigration detention</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_LGBT_community\" title=\"Impact of the COVID-19 pandemic on the LGBT community\">LGBT community</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_long-term_care_facilities\" title=\"Impact of the COVID-19 pandemic on long-term care facilities\">Long-term care facilities</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_public_transport\" title=\"Impact of the COVID-19 pandemic on public transport\">Public transport</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_religion\" title=\"Impact of the COVID-19 pandemic on religion\">Religion</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_Catholic_Church\" title=\"Impact of the COVID-19 pandemic on the Catholic Church\">Catholic Church</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_Hajj\" title=\"Impact of the COVID-19 pandemic on Hajj\">Hajj</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Strikes_during_the_COVID-19_pandemic\" title=\"Strikes during the COVID-19 pandemic\">Strikes</a></li>\n",
            "<li><a href=\"/wiki/List_of_incidents_of_xenophobia_and_racism_related_to_the_COVID-19_pandemic\" title=\"List of incidents of xenophobia and racism related to the COVID-19 pandemic\">Xenophobia and racism</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Economic_impact_of_the_COVID-19_pandemic\" title=\"Economic impact of the COVID-19 pandemic\">Economic</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_aviation\" title=\"Impact of the COVID-19 pandemic on aviation\">Aviation</a>\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_airlines\" title=\"Impact of the COVID-19 pandemic on airlines\">Airlines</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_cannabis_industry\" title=\"Impact of the COVID-19 pandemic on the cannabis industry\">Cannabis industry</a></li>\n",
            "<li><a href=\"/wiki/Charitable_activities_related_to_the_COVID-19_pandemic\" title=\"Charitable activities related to the COVID-19 pandemic\">Charitable activity</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_recession\" title=\"COVID-19 recession\">COVID-19 recession</a></li>\n",
            "<li><a href=\"/wiki/Financial_market_impact_of_the_COVID-19_pandemic\" title=\"Financial market impact of the COVID-19 pandemic\">Financial markets</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_food_industry\" title=\"Impact of the COVID-19 pandemic on the food industry\">Food industry</a>\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_meat_industry_in_Canada\" title=\"Impact of the COVID-19 pandemic on the meat industry in Canada\">meat industry in Canada</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_meat_industry_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on the meat industry in the United States\">meat industry in the U.S.</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_restaurant_industry_in_the_United_States\" title=\"Impact of the COVID-19 pandemic on the restaurant industry in the United States\">restaurant industry in the U.S.</a></li></ul></li>\n",
            "<li><a href=\"/wiki/2020_stock_market_crash\" title=\"2020 stock market crash\">Global stock market crash</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_hospitals\" title=\"Impact of the COVID-19 pandemic on hospitals\">Hospitals</a></li>\n",
            "<li><a href=\"/wiki/2020_Russia%E2%80%93Saudi_Arabia_oil_price_war\" title=\"2020 Russia–Saudi Arabia oil price war\">Oil price war</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_retail\" title=\"Impact of the COVID-19 pandemic on retail\">Retail</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_tourism\" title=\"Impact of the COVID-19 pandemic on tourism\">Tourism</a></li>\n",
            "<li><a href=\"/wiki/Travel_restrictions_related_to_the_COVID-19_pandemic\" title=\"Travel restrictions related to the COVID-19 pandemic\">Travel restrictions</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Information</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_journalism\" title=\"Impact of the COVID-19 pandemic on journalism\">Journalism</a></li>\n",
            "<li><a href=\"/wiki/Media_coverage_of_the_COVID-19_pandemic\" title=\"Media coverage of the COVID-19 pandemic\">Media coverage</a></li>\n",
            "<li><a href=\"/wiki/Misinformation_related_to_the_COVID-19_pandemic\" title=\"Misinformation related to the COVID-19 pandemic\">Misinformation</a></li>\n",
            "<li><a href=\"/wiki/Wikipedia%27s_response_to_the_COVID-19_pandemic\" title=\"Wikipedia's response to the COVID-19 pandemic\">Wikipedia's response</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_politics\" title=\"Impact of the COVID-19 pandemic on politics\">Politics</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/National_responses_to_the_COVID-19_pandemic\" title=\"National responses to the COVID-19 pandemic\">National responses</a></li>\n",
            "<li><a href=\"/wiki/List_of_COVID-19_pandemic_legislation\" title=\"List of COVID-19 pandemic legislation\">Legislation</a></li>\n",
            "<li><a href=\"/wiki/Protests_over_responses_to_the_COVID-19_pandemic\" title=\"Protests over responses to the COVID-19 pandemic\">Protests</a>\n",
            "<ul><li><a href=\"/wiki/2020_United_States_anti-lockdown_protests\" title=\"2020 United States anti-lockdown protests\">U.S.</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_international_relations\" title=\"Impact of the COVID-19 pandemic on international relations\">International relations</a>\n",
            "<ul><li><a href=\"/wiki/International_aid_related_to_the_COVID-19_pandemic\" title=\"International aid related to the COVID-19 pandemic\">Aid</a></li></ul></li>\n",
            "<li><a href=\"/wiki/European_Union_response_to_the_COVID-19_pandemic\" title=\"European Union response to the COVID-19 pandemic\">European Union</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Others</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Anthropause\" title=\"Anthropause\">Anthropause</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_environment\" title=\"Impact of the COVID-19 pandemic on the environment\">Environment</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_the_military\" title=\"Impact of the COVID-19 pandemic on the military\">Military</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_science_and_technology\" title=\"Impact of the COVID-19 pandemic on science and technology\">Science and technology</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/COVID-19_pandemic-related_famines\" title=\"COVID-19 pandemic-related famines\">Famine</a></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><div id=\"Health_issues\" style=\"font-size:114%;margin:0 4em\">Health issues</div></th></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Problems and<br/>restrictions</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Transmission_of_COVID-19\" title=\"Transmission of COVID-19\">Transmission</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_death_rates_by_country\" title=\"COVID-19 pandemic death rates by country\">Death rates by country</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_and_cancer\" title=\"COVID-19 and cancer\">Cancer</a></li>\n",
            "<li><a href=\"/wiki/Evacuations_related_to_the_COVID-19_pandemic\" title=\"Evacuations related to the COVID-19 pandemic\">Evacuations</a></li>\n",
            "<li><a href=\"/wiki/List_of_unproven_methods_against_COVID-19\" title=\"List of unproven methods against COVID-19\">Falsified medical methods</a></li>\n",
            "<li><a href=\"/wiki/Management_of_COVID-19\" title=\"Management of COVID-19\">Management</a></li>\n",
            "<li><a href=\"/wiki/Mental_health_during_the_COVID-19_pandemic\" title=\"Mental health during the COVID-19 pandemic\">Mental health</a></li>\n",
            "<li><a href=\"/wiki/Shortages_related_to_the_COVID-19_pandemic\" title=\"Shortages related to the COVID-19 pandemic\">Shortages</a>\n",
            "<ul><li><a href=\"/wiki/Oxygen_therapy\" title=\"Oxygen therapy\">medical oxygen</a></li>\n",
            "<li><a href=\"/wiki/Mechanical_ventilation\" title=\"Mechanical ventilation\">ventilator</a></li>\n",
            "<li><a href=\"/wiki/Open-source_ventilator\" title=\"Open-source ventilator\">open-source ventilator</a></li>\n",
            "<li><a href=\"/wiki/Extracorporeal_membrane_oxygenation\" title=\"Extracorporeal membrane oxygenation\">extracorporeal membrane oxygenation</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Flattening_the_curve#Raise_the_line\" title=\"Flattening the curve\">Raise the line</a></li>\n",
            "<li><a href=\"/wiki/Impact_of_the_COVID-19_pandemic_on_other_health_issues\" title=\"Impact of the COVID-19 pandemic on other health issues\">Non-COVID-19-related health issues</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Prevention</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Pandemic_Severity_Assessment_Framework\" title=\"Pandemic Severity Assessment Framework\">Pandemic Severity Assessment Framework</a></li>\n",
            "<li><a href=\"/wiki/Public_Health_Emergency_of_International_Concern\" title=\"Public Health Emergency of International Concern\">Public Health Emergency of International Concern</a></li>\n",
            "<li><a href=\"/wiki/Non-pharmaceutical_intervention\" title=\"Non-pharmaceutical intervention\">Non-pharmaceutical intervention</a>\n",
            "<ul><li><a href=\"/wiki/Great_Barrington_Declaration\" title=\"Great Barrington Declaration\">Great Barrington Declaration</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Social_distancing\" title=\"Social distancing\">Social distancing</a>\n",
            "<ul><li><a href=\"/wiki/Social_distancing_measures_related_to_the_COVID-19_pandemic\" title=\"Social distancing measures related to the COVID-19 pandemic\">Measures</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Face_masks_during_the_COVID-19_pandemic\" title=\"Face masks during the COVID-19 pandemic\">Face masks</a>\n",
            "<ul><li><a href=\"/wiki/Face_masks_during_the_COVID-19_pandemic_in_the_United_States\" title=\"Face masks during the COVID-19 pandemic in the United States\">United States</a></li>\n",
            "<li><a href=\"/wiki/N95_mask\" title=\"N95 mask\">N95</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Flattening_the_curve\" title=\"Flattening the curve\">Flattening the curve</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_testing\" title=\"COVID-19 testing\">Disease testing</a>\n",
            "<ul><li><a href=\"/wiki/Coronavirus_breathalyzer\" title=\"Coronavirus breathalyzer\">breathalyzer</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_datasets\" title=\"COVID-19 datasets\">Datasets</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_apps\" title=\"COVID-19 apps\">Coronavirus apps</a>\n",
            "<ul><li><a href=\"/wiki/COVID_Alert\" title=\"COVID Alert\">COVID Alert</a></li>\n",
            "<li><a href=\"/wiki/COVIDSafe\" title=\"COVIDSafe\">COVIDSafe</a></li>\n",
            "<li><a href=\"/wiki/COVID_Tracker_Ireland\" title=\"COVID Tracker Ireland\">COVID Tracker Ireland</a></li>\n",
            "<li><a href=\"/wiki/Coronavirus_Australia\" title=\"Coronavirus Australia\">Coronavirus Australia</a></li>\n",
            "<li><a href=\"/wiki/Aarogya_Setu\" title=\"Aarogya Setu\">Aarogya Setu</a></li>\n",
            "<li><a href=\"/wiki/NZ_COVID_Tracer\" title=\"NZ COVID Tracer\">NZ COVID Tracer</a></li>\n",
            "<li><a href=\"/wiki/TraceTogether\" title=\"TraceTogether\">TraceTogether</a></li>\n",
            "<li><a href=\"/wiki/BlueTrace\" title=\"BlueTrace\">BlueTrace</a></li>\n",
            "<li><a href=\"/wiki/Decentralized_Privacy-Preserving_Proximity_Tracing\" title=\"Decentralized Privacy-Preserving Proximity Tracing\">Decentralized Privacy-Preserving Proximity Tracing</a></li>\n",
            "<li><a href=\"/wiki/NHS_COVID-19\" title=\"NHS COVID-19\">NHS COVID-19</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Nearby_Spot\" title=\"Nearby Spot\">Nearby Spot</a></li>\n",
            "<li><a href=\"/wiki/TCN_Protocol\" title=\"TCN Protocol\">TCN Protocol</a></li>\n",
            "<li><a href=\"/wiki/Exposure_Notification\" title=\"Exposure Notification\">Exposure Notification</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Workplace_hazard_controls_for_COVID-19\" title=\"Workplace hazard controls for COVID-19\">Workplace hazard controls</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_surveillance\" title=\"COVID-19 surveillance\">Surveillance</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_lockdowns\" title=\"COVID-19 pandemic lockdowns\">Lockdowns</a></li>\n",
            "<li><a href=\"/wiki/Immunity_passport\" title=\"Immunity passport\">Immunity passports</a></li>\n",
            "<li><a href=\"/wiki/International_aid_related_to_the_COVID-19_pandemic\" title=\"International aid related to the COVID-19 pandemic\">International aid</a></li>\n",
            "<li><a href=\"/wiki/Safe_Hands_Challenge\" title=\"Safe Hands Challenge\">Safe Hands Challenge</a></li>\n",
            "<li><a href=\"/wiki/Wastewater_surveillance\" title=\"Wastewater surveillance\">Wastewater surveillance</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Treatments<br/>and research</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_in_pregnancy\" title=\"COVID-19 in pregnancy\">Pregnancy</a></li>\n",
            "<li><a href=\"/wiki/Coronavirus_disease_2019#Post-infection_treatments\" title=\"Coronavirus disease 2019\">Treatment research</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_drug_repurposing_research\" title=\"COVID-19 drug repurposing research\">Drug repurposing research</a>\n",
            "<ul><li><a href=\"/wiki/Dexamethasone\" title=\"Dexamethasone\">Dexamethasone</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_drug_development\" title=\"COVID-19 drug development\">Drug development</a></li>\n",
            "<li><a class=\"mw-selflink selflink\">Vaccine research</a>\n",
            "<ul><li><a href=\"/wiki/Gam-COVID-Vac\" title=\"Gam-COVID-Vac\">Sputnik V</a> (Russia)</li>\n",
            "<li><a href=\"/wiki/CoronaVac\" title=\"CoronaVac\">CoronaVac</a></li>\n",
            "<li><a href=\"/wiki/Operation_Warp_Speed\" title=\"Operation Warp Speed\">Operation Warp Speed</a> (U.S.)</li>\n",
            "<li><a href=\"/wiki/Solidarity_trial\" title=\"Solidarity trial\">Solidarity trial</a> (WHO)</li>\n",
            "<li><a href=\"/wiki/RECOVERY_Trial\" title=\"RECOVERY Trial\">RECOVERY Trial</a> (UK)</li></ul></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><div id=\"Institutions\" style=\"font-size:114%;margin:0 4em\">Institutions</div></th></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Hospitals and<br/>related</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Hospital_ships_designated_for_the_COVID-19_pandemic\" title=\"Hospital ships designated for the COVID-19 pandemic\">Hospital ships</a></li>\n",
            "<li><a href=\"/wiki/Central_Hospital_of_Wuhan\" title=\"Central Hospital of Wuhan\">Central Hospital of Wuhan</a></li>\n",
            "<li><a href=\"/wiki/Dabie_Mountain_Regional_Medical_Centre\" title=\"Dabie Mountain Regional Medical Centre\">Dabie Mountain Regional Medical Centre</a></li>\n",
            "<li><a href=\"/wiki/Fangcang_Hospital\" title=\"Fangcang Hospital\">Fangcang Hospitals</a></li>\n",
            "<li><a href=\"/wiki/Huoshenshan_Hospital\" title=\"Huoshenshan Hospital\">Huoshenshan Hospital</a></li>\n",
            "<li><a href=\"/wiki/Wuhan_Jinyintan_Hospital\" title=\"Wuhan Jinyintan Hospital\">Wuhan Jinyintan Hospital</a></li>\n",
            "<li><a href=\"/wiki/Leishenshan_Hospital\" title=\"Leishenshan Hospital\">Leishenshan Hospital</a></li>\n",
            "<li><a href=\"/wiki/Collapse_of_Xinjia_Express_Hotel\" title=\"Collapse of Xinjia Express Hotel\">Xinjia Express Hotel</a></li>\n",
            "<li><a href=\"/wiki/SevenHills_Hospital#COVID-19_hospital\" title=\"SevenHills Hospital\">COVID-19 Hospital in Mumbai</a></li>\n",
            "<li><a href=\"/wiki/Kemayoran_Athletes_Village\" title=\"Kemayoran Athletes Village\">Kemayoran Athletes Village</a></li>\n",
            "<li><a href=\"/wiki/Malaysia_Agro_Exposition_Park_Serdang\" title=\"Malaysia Agro Exposition Park Serdang\">Malaysia Agro Exposition Park Serdang</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_hospitals_in_the_United_Kingdom\" title=\"COVID-19 hospitals in the United Kingdom\">COVID-19 hospitals in the United Kingdom</a></li>\n",
            "<li><a href=\"/wiki/Canberra_Coronavirus_Field_Hospital\" title=\"Canberra Coronavirus Field Hospital\">Canberra Coronavirus Field Hospital</a></li>\n",
            "<li><a href=\"/wiki/Hospital_El_Salvador\" title=\"Hospital El Salvador\">Hospital El Salvador</a></li>\n",
            "<li><a href=\"/wiki/Pyongyang_General_Hospital\" title=\"Pyongyang General Hospital\">Pyongyang General Hospital</a></li>\n",
            "<li><a href=\"/wiki/Sancaktepe_Prof._Dr._Feriha_%C3%96z_Emergency_Hospital\" title=\"Sancaktepe Prof. Dr. Feriha Öz Emergency Hospital\">Sancaktepe Prof. Dr. Feriha Öz Emergency Hospital</a></li>\n",
            "<li><a href=\"/wiki/Ye%C5%9Filk%C3%B6y_Prof._Dr._Murat_Dilmener_Emergency_Hospital\" title=\"Yeşilköy Prof. Dr. Murat Dilmener Emergency Hospital\">Yeşilköy Prof. Dr. Murat Dilmener Emergency Hospital</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/We_Heal_As_One_Center\" title=\"We Heal As One Center\">We Heal As One Center</a></li>\n",
            "<li><a href=\"/wiki/Dragon%27s_Heart_Hospital\" title=\"Dragon's Heart Hospital\">Dragon's Heart Hospital</a></li>\n",
            "<li><a href=\"/wiki/NHS_Nightingale_Hospitals\" title=\"NHS Nightingale Hospitals\">NHS Nightingale Hospitals</a>\n",
            "<ul><li><a href=\"/wiki/NHS_Nightingale_Hospital_Birmingham\" title=\"NHS Nightingale Hospital Birmingham\">NHS Nightingale Hospital Birmingham</a></li>\n",
            "<li><a href=\"/wiki/NHS_Nightingale_Hospital_London\" title=\"NHS Nightingale Hospital London\">NHS Nightingale Hospital London</a></li>\n",
            "<li><a href=\"/wiki/NHS_Nightingale_Hospital_North_East\" title=\"NHS Nightingale Hospital North East\">NHS Nightingale Hospital North East</a></li>\n",
            "<li><a href=\"/wiki/NHS_Nightingale_Hospital_North_West\" title=\"NHS Nightingale Hospital North West\">NHS Nightingale Hospital North West</a></li>\n",
            "<li><a href=\"/wiki/NHS_Nightingale_Hospital_Yorkshire_and_the_Humber\" title=\"NHS Nightingale Hospital Yorkshire and the Humber\">NHS Nightingale Hospital Yorkshire and the Humber</a></li></ul></li>\n",
            "<li><a href=\"/wiki/NHS_Louisa_Jordan_Hospital\" title=\"NHS Louisa Jordan Hospital\">NHS Louisa Jordan Hospital</a></li>\n",
            "<li><a href=\"/wiki/Kandakadu_Treatment_and_Rehabilitation_Centre\" title=\"Kandakadu Treatment and Rehabilitation Centre\">Kandakadu Treatment and Rehabilitation Centre</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Organizations</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Coalition_for_Epidemic_Preparedness_Innovations\" title=\"Coalition for Epidemic Preparedness Innovations\">Coalition for Epidemic Preparedness Innovations</a></li>\n",
            "<li><a href=\"/wiki/World_Health_Organization%27s_response_to_the_COVID-19_pandemic\" title=\"World Health Organization's response to the COVID-19 pandemic\">World Health Organization</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/United_Nations%27_response_to_the_COVID-19_pandemic\" title=\"United Nations' response to the COVID-19 pandemic\">United Nations</a>\n",
            "<ul><li><a href=\"/wiki/List_of_United_Nations_resolutions_in_response_to_the_COVID-19_pandemic\" title=\"List of United Nations resolutions in response to the COVID-19 pandemic\">resolutions</a></li></ul></li>\n",
            "<li><a href=\"/wiki/International_Committee_on_Taxonomy_of_Viruses\" title=\"International Committee on Taxonomy of Viruses\">International Committee on Taxonomy of Viruses</a></li>\n",
            "<li><a href=\"/wiki/Wuhan_Institute_of_Virology\" title=\"Wuhan Institute of Virology\">Wuhan Institute of Virology</a> (China)</li>\n",
            "<li><a href=\"/wiki/Central_Epidemic_Command_Center\" title=\"Central Epidemic Command Center\">Central Epidemic Command Center</a> (Taiwan)</li>\n",
            "<li><a href=\"/wiki/Taiwan_Centers_for_Disease_Control\" title=\"Taiwan Centers for Disease Control\">Taiwan Centers for Disease Control</a> (Taiwan)</li>\n",
            "<li><a href=\"/wiki/COVID-19_Response_Acceleration_Task_Force\" title=\"COVID-19 Response Acceleration Task Force\">COVID-19 Response Acceleration Task Force</a> (Indonesia)</li>\n",
            "<li><a href=\"/wiki/White_House_Coronavirus_Task_Force\" title=\"White House Coronavirus Task Force\">White House Coronavirus Task Force</a> (United States)</li>\n",
            "<li><a href=\"/wiki/Great_American_Economic_Revival_Industry_Groups\" title=\"Great American Economic Revival Industry Groups\">Great American Economic Revival Industry Groups</a> (United States)</li>\n",
            "<li><a href=\"/wiki/Coronavirus_Tech_Handbook\" title=\"Coronavirus Tech Handbook\">Coronavirus Tech Handbook</a></li>\n",
            "<li><a href=\"/wiki/Inter-Agency_Task_Force_on_Emerging_Infectious_Diseases\" title=\"Inter-Agency Task Force on Emerging Infectious Diseases\">Inter-Agency Task Force on Emerging Infectious Diseases</a> (Philippines)</li>\n",
            "<li><a href=\"/wiki/PM_CARES_Fund\" title=\"PM CARES Fund\">PM CARES Fund</a> (India)</li>\n",
            "<li><a href=\"/wiki/Artist_Relief\" title=\"Artist Relief\">Artist Relief</a> (United States)</li>\n",
            "<li><a href=\"/wiki/Covid_Watch\" title=\"Covid Watch\">Covid Watch</a></li>\n",
            "<li><a href=\"/wiki/SAARC_COVID-19_Emergency_Fund\" title=\"SAARC COVID-19 Emergency Fund\">SAARC COVID-19 Emergency Fund</a> (India)</li>\n",
            "<li><a href=\"/wiki/COVID-19_Solidarity_Response_Fund\" title=\"COVID-19 Solidarity Response Fund\">COVID-19 Solidarity Response Fund</a></li>\n",
            "<li><a href=\"/wiki/MusiCares_COVID-19_Relief_Fund\" title=\"MusiCares COVID-19 Relief Fund\">MusiCares COVID-19 Relief Fund</a></li>\n",
            "<li><a href=\"/wiki/Imperial_College_COVID-19_Response_Team\" title=\"Imperial College COVID-19 Response Team\">Imperial College COVID-19 Response Team</a> (UK)</li>\n",
            "<li><a href=\"/wiki/Scientific_Advisory_Group_for_Emergencies\" title=\"Scientific Advisory Group for Emergencies\">SAGE</a> (UK)</li>\n",
            "<li><a href=\"/wiki/National_Cabinet_(Australia)\" title=\"National Cabinet (Australia)\">National Cabinet (Australia)</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/National_COVID-19_Coordination_Commission\" title=\"National COVID-19 Coordination Commission\">National COVID-19 Coordination Commission</a> (Australia)</li>\n",
            "<li><a href=\"/wiki/UN_COVID-19_Supply_Chain_Task_Force\" title=\"UN COVID-19 Supply Chain Task Force\">UN COVID-19 Supply Chain Task Force</a> (WHO)</li>\n",
            "<li><a href=\"/wiki/COVID-19_Supply_Council\" title=\"COVID-19 Supply Council\">COVID-19 Supply Council</a> (Canada)</li>\n",
            "<li><a href=\"/wiki/PREPARE\" title=\"PREPARE\">PREPARE</a> (European Union)</li>\n",
            "<li><a href=\"/wiki/National_Public_Health_Emergency_Team_(2020)\" title=\"National Public Health Emergency Team (2020)\">National Public Health Emergency Team</a> (Ireland)</li>\n",
            "<li><a href=\"/wiki/Africa_Centres_for_Disease_Control_and_Prevention\" title=\"Africa Centres for Disease Control and Prevention\">Africa Centres for Disease Control and Prevention</a> (African Union)</li>\n",
            "<li><a href=\"/wiki/Ghana_Infectious_Disease_Centre\" title=\"Ghana Infectious Disease Centre\">Ghana Infectious Disease Centre</a> (Ghana)</li>\n",
            "<li><a href=\"/wiki/COVID-19_Immunity_Task_Force\" title=\"COVID-19 Immunity Task Force\">COVID-19 Immunity Task Force</a> (Canada)</li>\n",
            "<li><a href=\"/wiki/Novel_Coronavirus_Expert_Meeting\" title=\"Novel Coronavirus Expert Meeting\">Novel Coronavirus Expert Meeting</a> (Japan)</li>\n",
            "<li><a href=\"/wiki/Coronavirus_Scientific_Advisory_Board_(Turkey)\" title=\"Coronavirus Scientific Advisory Board (Turkey)\">Coronavirus Scientific Advisory Board (Turkey)</a></li>\n",
            "<li><a href=\"/wiki/Crisis_Preparedness_and_Response_Centre\" title=\"Crisis Preparedness and Response Centre\">Crisis Preparedness and Response Centre</a> (Malaysia)</li>\n",
            "<li><a href=\"/wiki/Korea_Disease_Control_and_Prevention_Agency\" title=\"Korea Disease Control and Prevention Agency\">Korea Disease Control and Prevention Agency</a> (Korea)</li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><div id=\"People\" style=\"font-size:114%;margin:0 4em\">People</div></th></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Medical professionals</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Ai_Fen\" title=\"Ai Fen\">Ai Fen</a></li>\n",
            "<li><a href=\"/wiki/Li_Wenliang\" title=\"Li Wenliang\">Li Wenliang</a></li>\n",
            "<li><a href=\"/wiki/Liu_Wen_(doctor)\" title=\"Liu Wen (doctor)\">Liu Wen</a></li>\n",
            "<li><a href=\"/wiki/Corona_Rintawan\" title=\"Corona Rintawan\">Corona Rintawan</a></li>\n",
            "<li><a href=\"/wiki/Xie_Linka\" title=\"Xie Linka\">Xie Linka</a></li>\n",
            "<li><a href=\"/wiki/Zhang_Wenhong\" title=\"Zhang Wenhong\">Zhang Wenhong</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Researchers</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Roberto_Burioni\" title=\"Roberto Burioni\">Roberto Burioni</a></li>\n",
            "<li><a href=\"/wiki/Awang_Bulgiba_Awang_Mahmud\" title=\"Awang Bulgiba Awang Mahmud\">Awang Bulgiba Awang Mahmud</a></li>\n",
            "<li><a href=\"/wiki/Chen_Wei_(medical_scientist)\" title=\"Chen Wei (medical scientist)\">Chen Wei</a></li>\n",
            "<li><a href=\"/wiki/Andrea_Crisanti_(scientist)\" title=\"Andrea Crisanti (scientist)\">Andrea Crisanti</a></li>\n",
            "<li><a href=\"/wiki/Christian_Drosten\" title=\"Christian Drosten\">Christian Drosten</a></li>\n",
            "<li><a href=\"/wiki/Neil_Ferguson_(epidemiologist)\" title=\"Neil Ferguson (epidemiologist)\">Neil Ferguson</a></li>\n",
            "<li><a href=\"/wiki/George_F._Gao\" title=\"George F. Gao\">George F. Gao</a></li>\n",
            "<li><a href=\"/wiki/Azra_Ghani\" title=\"Azra Ghani\">Azra Ghani</a></li>\n",
            "<li><a href=\"/wiki/Sarah_Gilbert\" title=\"Sarah Gilbert\">Sarah Gilbert</a></li>\n",
            "<li><a href=\"/wiki/Guan_Yi\" title=\"Guan Yi\">Guan Yi</a></li>\n",
            "<li><a href=\"/wiki/Kentaro_Iwata\" title=\"Kentaro Iwata\">Kentaro Iwata</a></li>\n",
            "<li><a href=\"/wiki/Trudie_Lang\" title=\"Trudie Lang\">Trudie Lang</a></li>\n",
            "<li><a href=\"/wiki/Li_Lanjuan\" title=\"Li Lanjuan\">Li Lanjuan</a></li>\n",
            "<li><a href=\"/wiki/W._Ian_Lipkin\" title=\"W. Ian Lipkin\">W. Ian Lipkin</a></li>\n",
            "<li><a href=\"/wiki/Ma_Xiaowei\" title=\"Ma Xiaowei\">Ma Xiaowei</a></li>\n",
            "<li><a href=\"/wiki/Allison_McGeer\" title=\"Allison McGeer\">Allison McGeer</a></li>\n",
            "<li><a href=\"/wiki/Luc_Montagnier\" title=\"Luc Montagnier\">Luc Montagnier</a></li>\n",
            "<li><a href=\"/wiki/Shi_Zhengli\" title=\"Shi Zhengli\">Shi Zhengli</a></li>\n",
            "<li><a href=\"/wiki/Moncef_Slaoui\" title=\"Moncef Slaoui\">Moncef Slaoui</a></li>\n",
            "<li><a href=\"/wiki/John_Todd_(British_biologist)\" title=\"John Todd (British biologist)\">John Todd</a></li>\n",
            "<li><a href=\"/wiki/Wang_Chen_(physician)\" title=\"Wang Chen (physician)\">Wang Chen</a></li>\n",
            "<li><a href=\"/wiki/Wang_Guangfa\" title=\"Wang Guangfa\">Wang Guangfa</a></li></ul>\n",
            "<ul><li><a href=\"/wiki/Yuen_Kwok-yung\" title=\"Yuen Kwok-yung\">Yuen Kwok-yung</a></li>\n",
            "<li><a href=\"/wiki/Zeng_Guang\" title=\"Zeng Guang\">Zeng Guang</a></li>\n",
            "<li><a href=\"/wiki/Zhong_Nanshan\" title=\"Zhong Nanshan\">Zhong Nanshan</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Officials</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">WHO</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Tedros_Adhanom\" title=\"Tedros Adhanom\">Tedros Adhanom</a> (Director-General of the WHO)</li>\n",
            "<li><a href=\"/wiki/Bruce_Aylward\" title=\"Bruce Aylward\">Bruce Aylward</a> (Team lead of WHO-China COVID-19 mission)</li>\n",
            "<li><a href=\"/wiki/Maria_Van_Kerkhove\" title=\"Maria Van Kerkhove\">Maria Van Kerkhove</a> (Technical Lead for COVID-19 response)</li>\n",
            "<li><a href=\"/wiki/Michael_J._Ryan_(doctor)\" title=\"Michael J. Ryan (doctor)\">Michael J. Ryan</a> (Executive Director of the WHO Health Emergencies Programme)</li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Countries</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Frank_Atherton\" title=\"Frank Atherton\">Frank Atherton</a> (Wales)</li>\n",
            "<li><a href=\"/wiki/Scott_Atlas\" title=\"Scott Atlas\">Scott Atlas</a> (United States)</li>\n",
            "<li><a href=\"/wiki/Deborah_Birx\" title=\"Deborah Birx\">Deborah Birx</a> (United States)</li>\n",
            "<li><a href=\"/wiki/Ashley_Bloomfield\" title=\"Ashley Bloomfield\">Ashley Bloomfield</a> (New Zealand)</li>\n",
            "<li><a href=\"/wiki/Angelo_Borrelli\" title=\"Angelo Borrelli\">Angelo Borrelli</a> (Italy)</li>\n",
            "<li><a href=\"/wiki/Catherine_Calderwood\" title=\"Catherine Calderwood\">Catherine Calderwood</a> (Scotland)</li>\n",
            "<li><a href=\"/wiki/Carmen_Deseda\" title=\"Carmen Deseda\">Carmen Deseda</a> (Puerto Rico)</li>\n",
            "<li><a href=\"/wiki/Jaap_van_Dissel\" title=\"Jaap van Dissel\">Jaap van Dissel</a> (the Netherlands)</li>\n",
            "<li><a href=\"/wiki/Shan-chwen_Chang\" title=\"Shan-chwen Chang\">Shan-chwen Chang</a> (Taiwan)</li>\n",
            "<li><a href=\"/wiki/Chen_Shih-chung\" title=\"Chen Shih-chung\">Chen Shih-chung</a> (Taiwan)</li>\n",
            "<li><a href=\"/wiki/Chuang_Yin-ching\" title=\"Chuang Yin-ching\">Chuang Yin-ching</a> (Taiwan)</li>\n",
            "<li><a href=\"/wiki/Francisco_Duque_III\" title=\"Francisco Duque III\">Francisco Duque</a> (Philippines)</li>\n",
            "<li><a href=\"/wiki/Anthony_Fauci\" title=\"Anthony Fauci\">Anthony Fauci</a> (United States)</li>\n",
            "<li><a href=\"/wiki/Ronan_Glynn\" title=\"Ronan Glynn\">Ronan Glynn</a> (Ireland)</li>\n",
            "<li><a href=\"/wiki/Jeong_Eun-kyeong\" title=\"Jeong Eun-kyeong\">Jeong Eun-kyeong</a> (South Korea)</li>\n",
            "<li><a href=\"/wiki/Fahrettin_Koca\" title=\"Fahrettin Koca\">Fahrettin Koca</a> (Turkey)</li>\n",
            "<li><a href=\"/wiki/Li_Keqiang\" title=\"Li Keqiang\">Li Keqiang</a> (China)</li>\n",
            "<li><a href=\"/wiki/Michael_McBride_(doctor)\" title=\"Michael McBride (doctor)\">Michael McBride</a> (Northern Ireland)</li>\n",
            "<li><a href=\"/wiki/Oriol_Mitj%C3%A0\" title=\"Oriol Mitjà\">Oriol Mitjà</a> (Andorra)</li>\n",
            "<li><a href=\"/wiki/Doni_Monardo\" title=\"Doni Monardo\">Doni Monardo</a> (Indonesia)</li>\n",
            "<li><a href=\"/wiki/Noor_Hisham_Abdullah\" title=\"Noor Hisham Abdullah\">Noor Hisham Abdullah</a> (Malaysia)</li>\n",
            "<li><a href=\"/wiki/J%C3%A9r%C3%B4me_Salomon\" title=\"Jérôme Salomon\">Jérôme Salomon</a> (France)</li>\n",
            "<li><a href=\"/wiki/Fernando_Sim%C3%B3n\" title=\"Fernando Simón\">Fernando Simón</a> (Spain)</li>\n",
            "<li><a href=\"/wiki/Gregor_Smith\" title=\"Gregor Smith\">Gregor Smith</a> (Scotland)</li>\n",
            "<li><a href=\"/wiki/Ih-Jen_Su\" title=\"Ih-Jen Su\">Ih-Jen Su</a> (Taiwan)</li>\n",
            "<li><a href=\"/wiki/%C5%81ukasz_Szumowski\" title=\"Łukasz Szumowski\">Łukasz Szumowski</a> (Poland)</li>\n",
            "<li><a href=\"/wiki/Anders_Tegnell\" title=\"Anders Tegnell\">Anders Tegnell</a> (Sweden)</li>\n",
            "<li><a href=\"/wiki/Theresa_Tam\" title=\"Theresa Tam\">Theresa Tam</a> (Canada)</li>\n",
            "<li><a href=\"/wiki/Sotiris_Tsiodras\" title=\"Sotiris Tsiodras\">Sotiris Tsiodras</a> (Greece)</li>\n",
            "<li><a href=\"/wiki/Chris_Whitty\" title=\"Chris Whitty\">Chris Whitty</a> (United Kingdom)</li>\n",
            "<li><a href=\"/wiki/Lawrence_Wong\" title=\"Lawrence Wong\">Lawrence Wong</a> (Singapore)</li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Others</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Chen_Qiushi\" title=\"Chen Qiushi\">Chen Qiushi</a></li>\n",
            "<li><a href=\"/wiki/Brett_Crozier\" title=\"Brett Crozier\">Brett Crozier</a></li>\n",
            "<li><a href=\"/wiki/Fang_Bin\" title=\"Fang Bin\">Fang Bin</a></li>\n",
            "<li><a href=\"/wiki/Fang_Fang\" title=\"Fang Fang\">Fang Fang</a></li>\n",
            "<li><a href=\"/wiki/Li_Zehua\" title=\"Li Zehua\">Li Zehua</a></li>\n",
            "<li><a href=\"/wiki/Qiu_Menghuang\" title=\"Qiu Menghuang\">Qiu Menghuang</a></li>\n",
            "<li><a href=\"/wiki/Ren_Zhiqiang\" title=\"Ren Zhiqiang\">Ren Zhiqiang</a></li>\n",
            "<li><a href=\"/wiki/Captain_Tom\" title=\"Captain Tom\">Captain Tom</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Deaths</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"><a href=\"/wiki/List_of_deaths_due_to_COVID-19\" title=\"List of deaths due to COVID-19\">List</a></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks mw-collapsible mw-collapsed navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><div id=\"Data_(templates)\" style=\"font-size:114%;margin:0 4em\">Data (templates)</div></th></tr><tr><td class=\"navbox-list navbox-odd\" colspan=\"2\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Global</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_by_country_and_territory#Statistics\" title=\"COVID-19 pandemic by country and territory\">Cases, deaths, recoveries by country</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_testing#Virus_testing_statistics_by_country\" title=\"COVID-19 testing\">Tests, cases, tests per capita, cases per capita by country</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_testing#Virus_testing_statistics_by_country_subdivision\" title=\"COVID-19 testing\">Tests, cases, tests per capita, cases per capita by country subdivision</a></li>\n",
            "<li>WHO situation reports\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_cases\" title=\"COVID-19 pandemic cases\">cases</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_deaths\" title=\"COVID-19 pandemic deaths\">deaths</a></li></ul></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">World map by countries: confirmed per capita</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_in_mainland_China#Graphics\" title=\"COVID-19 pandemic in mainland China\">China</a></li></ul></li>\n",
            "<li><a href=\"/wiki/List_of_countries_by_hospital_beds#Numbers\" title=\"List of countries by hospital beds\">Hospital beds by country</a></li>\n",
            "<li><a href=\"/wiki/COVID-19_pandemic_lockdowns#Table_of_pandemic_lockdowns\" title=\"COVID-19 pandemic lockdowns\">Lockdowns</a>\n",
            "<ul><li><a href=\"/wiki/COVID-19_pandemic_lockdowns#China\" title=\"COVID-19 pandemic lockdowns\">Mainland China</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Africa</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Algeria_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Algeria medical cases (page does not exist)\">Algeria</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Algeria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Algeria medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Angola_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Angola medical cases (page does not exist)\">Angola</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Angola_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Angola medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Burkina_Faso_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Burkina Faso medical cases (page does not exist)\">Burkina Faso</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Burkina_Faso_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Burkina Faso medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Burundi_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Burundi medical cases (page does not exist)\">Burundi</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Burundi_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Burundi medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Cameroon_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Cameroon medical cases (page does not exist)\">Cameroon</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cameroon_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Cameroon medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Egypt_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Egypt medical cases (page does not exist)\">Egypt</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Egypt_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Egypt medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Eswatini_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Eswatini medical cases (page does not exist)\">Eswatini</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Eswatini_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Eswatini medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Ethiopia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Ethiopia medical cases (page does not exist)\">Ethiopia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ethiopia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ethiopia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ghana_medical_cases\" title=\"Template:COVID-19 pandemic data/Ghana medical cases\">Ghana</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ghana_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ghana medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Ivory_Coast_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Ivory Coast medical cases (page does not exist)\">Ivory Coast</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ivory_Coast_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ivory Coast medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Kenya_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Kenya medical cases (page does not exist)\">Kenya</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kenya_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kenya medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Libya_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Libya medical cases (page does not exist)\">Libya</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Libya_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Libya medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Malawi_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Malawi medical cases (page does not exist)\">Malawi</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Malawi_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Malawi medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Mali_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Mali medical cases (page does not exist)\">Mali</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mali_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mali medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Mauritania_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Mauritania medical cases (page does not exist)\">Mauritania</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mauritania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mauritania medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Mauritius_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Mauritius medical cases (page does not exist)\">Mauritius</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mauritius_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mauritius medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Morocco_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Morocco medical cases (page does not exist)\">Morocco</a>\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Template:COVID-19_pandemic_data/Morocco_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Morocco medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nigeria_medical_cases\" title=\"Template:COVID-19 pandemic data/Nigeria medical cases\">Nigeria</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nigeria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Nigeria medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Senegal_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Senegal medical cases (page does not exist)\">Senegal</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Senegal_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Senegal medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Sierra_Leone_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Sierra Leone medical cases (page does not exist)\">Sierra Leone</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sierra_Leone_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Sierra Leone medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Africa_medical_cases\" title=\"Template:COVID-19 pandemic data/South Africa medical cases\">South Africa</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Africa_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/South Africa medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/South_Sudan_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/South Sudan medical cases (page does not exist)\">South Sudan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Sudan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/South Sudan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Sudan_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Sudan medical cases (page does not exist)\">Sudan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sudan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Sudan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Tanzania_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Tanzania medical cases (page does not exist)\">Tanzania</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Tanzania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Tanzania medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Togo_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Togo medical cases (page does not exist)\">Togo</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Togo_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Togo medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Tunisia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Tunisia medical cases (page does not exist)\">Tunisia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Tunisia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Tunisia medical cases chart\">chart</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Americas</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Argentina_medical_cases\" title=\"Template:COVID-19 pandemic data/Argentina medical cases\">Argentina</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Argentina_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Argentina medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bolivia_medical_cases\" title=\"Template:COVID-19 pandemic data/Bolivia medical cases\">Bolivia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bolivia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bolivia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Brazil_medical_cases\" title=\"Template:COVID-19 pandemic data/Brazil medical cases\">Brazil</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Brazil_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Brazil medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Canada_medical_cases\" title=\"Template:COVID-19 pandemic data/Canada medical cases\">Canada</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Canada_medical_cases_by_province\" title=\"Template:COVID-19 pandemic data/Canada medical cases by province\">by province</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Canada_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Canada medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Chile_medical_cases\" title=\"Template:COVID-19 pandemic data/Chile medical cases\">Chile</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Chile_medical_cases_by_commune\" title=\"Template:COVID-19 pandemic data/Chile medical cases by commune\">by commune</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Chile_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Chile medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Colombia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Colombia medical cases (page does not exist)\">Colombia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Colombia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Colombia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Costa_Rica_medical_cases\" title=\"Template:COVID-19 pandemic data/Costa Rica medical cases\">Costa Rica</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Costa_Rica_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Costa Rica medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Cuba_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Cuba medical cases (page does not exist)\">Cuba</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cuba_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Cuba medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Dominican_Republic_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Dominican Republic medical cases (page does not exist)\">Dominican Republic</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Dominican_Republic_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Dominican Republic medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Ecuador_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Ecuador medical cases (page does not exist)\">Ecuador</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ecuador_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ecuador medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/El_Salvador_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/El Salvador medical cases (page does not exist)\">El Salvador</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/El_Salvador_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/El Salvador medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Guatemala_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Guatemala medical cases (page does not exist)\">Guatemala</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Guatemala_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Guatemala medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Haiti_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Haiti medical cases (page does not exist)\">Haiti</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Haiti_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Haiti medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Honduras_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Honduras medical cases (page does not exist)\">Honduras</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Honduras_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Honduras medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mexico_medical_cases\" title=\"Template:COVID-19 pandemic data/Mexico medical cases\">Mexico</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mexico_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mexico medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Nicaragua_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Nicaragua medical cases (page does not exist)\">Nicaragua</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nicaragua_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Nicaragua medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Panama_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Panama medical cases (page does not exist)\">Panama</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Panama_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Panama medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Paraguay_medical_cases\" title=\"Template:COVID-19 pandemic data/Paraguay medical cases\">Paraguay</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Paraguay_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Paraguay medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Peru_medical_cases\" title=\"Template:COVID-19 pandemic data/Peru medical cases\">Peru</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Peru_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Peru medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_States_medical_cases\" title=\"Template:COVID-19 pandemic data/United States medical cases\">United States</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_States_medical_cases_by_state\" title=\"Template:COVID-19 pandemic data/United States medical cases by state\">by state</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_States_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/United States medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Uruguay_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Uruguay medical cases (page does not exist)\">Uruguay</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Uruguay_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Uruguay medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Venezuela_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Venezuela medical cases (page does not exist)\">Venezuela</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Venezuela_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Venezuela medical cases chart\">chart</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Asia</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Afghanistan_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Afghanistan medical cases (page does not exist)\">Afghanistan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Afghanistan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Afghanistan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Armenia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Armenia medical cases (page does not exist)\">Armenia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Armenia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Armenia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Azerbaijan_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Azerbaijan medical cases (page does not exist)\">Azerbaijan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Azerbaijan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Azerbaijan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Bahrain_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Bahrain medical cases (page does not exist)\">Bahrain</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bahrain_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bahrain medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Bangladesh_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Bangladesh medical cases (page does not exist)\">Bangladesh</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bangladesh_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bangladesh medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bhutan_medical_cases\" title=\"Template:COVID-19 pandemic data/Bhutan medical cases\">Bhutan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bhutan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bhutan medical cases chart\">chart</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bhutan_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/Bhutan medical cases summary\">summary</a></li></ul></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Template:COVID-19_pandemic_data/Brunei_medical_cases\" title=\"Template:COVID-19 pandemic data/Brunei medical cases\">Brunei</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Brunei_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Brunei medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Cambodia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Cambodia medical cases (page does not exist)\">Cambodia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cambodia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Cambodia medical cases chart\">chart</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cambodia_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/Cambodia medical cases summary\">summary</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/China_medical_cases_by_province\" title=\"Template:COVID-19 pandemic data/China medical cases by province\">Mainland China</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mainland_China_medical_cases\" title=\"Template:COVID-19 pandemic data/Mainland China medical cases\">aggregate</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Mainland_China_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Mainland China medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Georgia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Georgia medical cases (page does not exist)\">Georgia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Georgia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Georgia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Hong_Kong_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Hong Kong medical cases (page does not exist)\">Hong Kong</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Hong_Kong_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Hong Kong medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/India_medical_cases_by_state_and_union_territory\" title=\"Template:COVID-19 pandemic data/India medical cases by state and union territory\">India</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/India_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/India medical cases chart\">chart</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/India_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/India medical cases summary\">summary</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Indonesia_medical_cases\" title=\"Template:COVID-19 pandemic data/Indonesia medical cases\">Indonesia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Indonesia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Indonesia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iran_medical_cases\" title=\"Template:COVID-19 pandemic data/Iran medical cases\">Iran</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iran_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Iran medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Iraq_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Iraq medical cases (page does not exist)\">Iraq</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iraq_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Iraq medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Israel_medical_cases\" title=\"Template:COVID-19 pandemic data/Israel medical cases\">Israel</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Israel_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Israel medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Japan_medical_cases\" title=\"Template:COVID-19 pandemic data/Japan medical cases\">Japan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Japan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Japan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Jordan_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Jordan medical cases (page does not exist)\">Jordan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Jordan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Jordan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_dat/Kazakhstan_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic dat/Kazakhstan medical cases (page does not exist)\">Kazakhstan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kazakhstan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kazakhstan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Korea_medical_cases\" title=\"Template:COVID-19 pandemic data/South Korea medical cases\">South Korea</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/South_Korea_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/South Korea medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kuwait_medical_cases\" title=\"Template:COVID-19 pandemic data/Kuwait medical cases\">Kuwait</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data_in_Kuwait/Charts\" title=\"Template:COVID-19 pandemic data in Kuwait/Charts\">graph</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kuwait_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kuwait medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Kyrgyzstan_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Kyrgyzstan medical cases (page does not exist)\">Kyrgyzstan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kyrgyzstan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kyrgyzstan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Laos_medical_cases\" title=\"Template:COVID-19 pandemic data/Laos medical cases\">Laos</a>\n",
            "<ul><li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Laos_medical_cases_chart&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Laos medical cases chart (page does not exist)\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Lebanon_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Lebanon medical cases (page does not exist)\">Lebanon</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Lebanon_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Lebanon medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Malaysia_medical_cases\" title=\"Template:COVID-19 pandemic data/Malaysia medical cases\">Malaysia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Malaysia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Malaysia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Myanmar_medical_cases\" title=\"Template:COVID-19 pandemic data/Myanmar medical cases\">Myanmar</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Myanmar_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Myanmar medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nepal_medical_cases\" title=\"Template:COVID-19 pandemic data/Nepal medical cases\">Nepal</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nepal_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Nepal medical cases chart\">chart</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nepal_medical_cases_by_province_and_district\" title=\"Template:COVID-19 pandemic data/Nepal medical cases by province and district\">by district</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Nepal_PCR_tests_by_laboratory\" title=\"Template:COVID-19 pandemic data/Nepal PCR tests by laboratory\">PCR tests</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Oman_medical_cases\" title=\"Template:COVID-19 pandemic data/Oman medical cases\">Oman</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Oman_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Oman medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Pakistan_medical_cases\" title=\"Template:COVID-19 pandemic data/Pakistan medical cases\">Pakistan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Pakistan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Pakistan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Palestine_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Palestine medical cases (page does not exist)\">Palestine</a>\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Template:COVID-19_pandemic_data/Palestine_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Palestine medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Philippines_medical_cases\" title=\"Template:COVID-19 pandemic data/Philippines medical cases\">Philippines</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Philippines_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Philippines medical cases chart\">chart</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Philippines_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/Philippines medical cases summary\">summary</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Template:COVID-19_pandemic_data/Philippines_coronavirus_quarantines\" title=\"Template:COVID-19 pandemic data/Philippines coronavirus quarantines\">areas of quarantine</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Qatar_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Qatar medical cases (page does not exist)\">Qatar</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Qatar_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Qatar medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/North_Asia_medical_cases\" title=\"Template:COVID-19 pandemic data/North Asia medical cases\">Russia/North Asia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases_by_federal_subject\" title=\"Template:COVID-19 pandemic data/Russia medical cases by federal subject\">by federal subject</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Russia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Saudi_Arabia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Saudi Arabia medical cases (page does not exist)\">Saudi Arabia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Saudi_Arabia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Saudi Arabia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Singapore_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Singapore medical cases (page does not exist)\">Singapore</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Singapore_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Singapore medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Sri_Lanka_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Sri Lanka medical cases (page does not exist)\">Sri Lanka</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sri_Lanka_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Sri Lanka medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Syria_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Syria medical cases (page does not exist)\">Syria</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Syria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Syria medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Taiwan_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Taiwan medical cases (page does not exist)\">Taiwan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Taiwan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Taiwan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Tajikistan_medical_cases\" title=\"Template:COVID-19 pandemic data/Tajikistan medical cases\">Tajikistan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Tajikistan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Tajikistan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Thailand_medical_cases\" title=\"Template:COVID-19 pandemic data/Thailand medical cases\">Thailand</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Thailand_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Thailand medical cases chart\">chart</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Thailand_medical_cases_summary\" title=\"Template:COVID-19 pandemic data/Thailand medical cases summary\">summary</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases\" title=\"Template:COVID-19 pandemic data/Turkey medical cases\">Turkey</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases_by_province\" title=\"Template:COVID-19 pandemic data/Turkey medical cases by province\">by province</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Turkey medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Arab_Emirates_medical_cases\" title=\"Template:COVID-19 pandemic data/United Arab Emirates medical cases\">United Arab Emirates</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Arab_Emirates_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/United Arab Emirates medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Uzbekistan_medical_cases\" title=\"Template:COVID-19 pandemic data/Uzbekistan medical cases\">Uzbekistan</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Uzbekistan_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Uzbekistan medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Vietnam_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Vietnam medical cases (page does not exist)\">Vietnam</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Vietnam_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Vietnam medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Yemen_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Yemen medical cases (page does not exist)\">Yemen</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Yemen_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Yemen medical cases chart\">chart</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Template:COVID-19_pandemic_data/Europe_medical_cases\" title=\"Template:COVID-19 pandemic data/Europe medical cases\">Europe</a><br/><span style=\"font-weight:normal;\">(<a href=\"/wiki/Template:COVID-19_pandemic_data/Europe_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Europe medical cases chart\">chart</a>)</span></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Albania_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Albania medical cases (page does not exist)\">Albania</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Albania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Albania medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Austria_medical_cases\" title=\"Template:COVID-19 pandemic data/Austria medical cases\">Austria</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Austria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Austria medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Belarus_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Belarus medical cases (page does not exist)\">Belarus</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Belarus_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Belarus medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Belgium_medical_cases\" title=\"Template:COVID-19 pandemic data/Belgium medical cases\">Belgium</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Belgium_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Belgium medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Bosnia_and_Herzegovina_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Bosnia and Herzegovina medical cases (page does not exist)\">Bosnia and Herzegovina</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bosnia_and_Herzegovina_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bosnia and Herzegovina medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bulgaria_medical_cases\" title=\"Template:COVID-19 pandemic data/Bulgaria medical cases\">Bulgaria</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Bulgaria_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Bulgaria medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Croatia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Croatia medical cases (page does not exist)\">Croatia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Croatia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Croatia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Cyprus_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Cyprus medical cases (page does not exist)\">Cyprus</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Cyprus_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Cyprus medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Czech_Republic_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Czech Republic medical cases (page does not exist)\">Czech Republic</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Czech_Republic_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Czech Republic medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Denmark_medical_cases\" title=\"Template:COVID-19 pandemic data/Denmark medical cases\">Denmark</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Denmark_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Denmark medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Estonia_medical_cases\" title=\"Template:COVID-19 pandemic data/Estonia medical cases\">Estonia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Estonia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Estonia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Faroe_Islands_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Faroe Islands medical cases (page does not exist)\">Faroe Islands</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Faroe_Islands_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Faroe Islands medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Finland_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Finland medical cases (page does not exist)\">Finland</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Finland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Finland medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/France_medical_cases\" title=\"Template:COVID-19 pandemic data/France medical cases\">France</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/France_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/France medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Germany_medical_cases\" title=\"Template:COVID-19 pandemic data/Germany medical cases\">Germany</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Germany_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Germany medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Greece_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Greece medical cases (page does not exist)\">Greece</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Greece_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Greece medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Hungary_medical_cases\" title=\"Template:COVID-19 pandemic data/Hungary medical cases\">Hungary</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Hungary_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Hungary medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iceland_medical_cases\" title=\"Template:COVID-19 pandemic data/Iceland medical cases\">Iceland</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Iceland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Iceland medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Republic_of_Ireland_medical_cases\" title=\"Template:COVID-19 pandemic data/Republic of Ireland medical cases\">Ireland</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Republic_of_Ireland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Republic of Ireland medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Italy_medical_cases\" title=\"Template:COVID-19 pandemic data/Italy medical cases\">Italy</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Italy_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Italy medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Kosovo_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Kosovo medical cases (page does not exist)\">Kosovo</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Kosovo_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Kosovo medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Latvia_medical_cases\" title=\"Template:COVID-19 pandemic data/Latvia medical cases\">Latvia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Latvia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Latvia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Lithuania_medical_cases\" title=\"Template:COVID-19 pandemic data/Lithuania medical cases\">Lithuania</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Lithuania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Lithuania medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Luxembourg_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Luxembourg medical cases (page does not exist)\">Luxembourg</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Luxembourg_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Luxembourg medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Malta_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Malta medical cases (page does not exist)\">Malta</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Malta_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Malta medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Moldova_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Moldova medical cases (page does not exist)\">Moldova</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Moldova_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Moldova medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Monaco_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Monaco medical cases (page does not exist)\">Monaco</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Monaco_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Monaco medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Montenegro_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Montenegro medical cases (page does not exist)\">Montenegro</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Montenegro_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Montenegro medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Netherlands_medical_cases\" title=\"Template:COVID-19 pandemic data/Netherlands medical cases\">Netherlands</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Netherlands_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Netherlands medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/North_Macedonia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/North Macedonia medical cases (page does not exist)\">North Macedonia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/North_Macedonia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/North Macedonia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Norway_medical_cases\" title=\"Template:COVID-19 pandemic data/Norway medical cases\">Norway</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Norway_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Norway medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Poland_medical_cases\" title=\"Template:COVID-19 pandemic data/Poland medical cases\">Poland</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Poland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Poland medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Portugal_medical_cases\" title=\"Template:COVID-19 pandemic data/Portugal medical cases\">Portugal</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Portugal_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Portugal medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Romania_medical_cases\" title=\"Template:COVID-19 pandemic data/Romania medical cases\">Romania</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Romania_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Romania medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases\" title=\"Template:COVID-19 pandemic data/Russia medical cases\">Russia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases_by_federal_subject\" title=\"Template:COVID-19 pandemic data/Russia medical cases by federal subject\">by federal subject</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Russia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Russia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/San_Marino_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/San Marino medical cases (page does not exist)\">San Marino</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/San_Marino_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/San Marino medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Serbia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Serbia medical cases (page does not exist)\">Serbia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Serbia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Serbia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovakia_medical_cases\" title=\"Template:COVID-19 pandemic data/Slovakia medical cases\">Slovakia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovakia_medical_cases_by_region\" title=\"Template:COVID-19 pandemic data/Slovakia medical cases by region\">by region</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovakia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Slovakia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovenia_medical_cases\" title=\"Template:COVID-19 pandemic data/Slovenia medical cases\">Slovenia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Slovenia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Slovenia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Spain_medical_cases\" title=\"Template:COVID-19 pandemic data/Spain medical cases\">Spain</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Spain_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Spain medical cases chart\">chart</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Asturias_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Asturias medical cases chart\">Asturias</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Community_of_Madrid_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Community of Madrid medical cases chart\">Community of Madrid</a></li></ul></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sweden_medical_cases\" title=\"Template:COVID-19 pandemic data/Sweden medical cases\">Sweden</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Sweden_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Sweden medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Switzerland_medical_cases\" title=\"Template:COVID-19 pandemic data/Switzerland medical cases\">Switzerland</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Switzerland_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Switzerland medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases\" title=\"Template:COVID-19 pandemic data/Turkey medical cases\">Turkey</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases_by_province\" title=\"Template:COVID-19 pandemic data/Turkey medical cases by province\">by province</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Turkey_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Turkey medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Ukraine_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Ukraine medical cases (page does not exist)\">Ukraine</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Ukraine_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Ukraine medical cases chart\">chart</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Donetsk_People%27s_Republic_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Donetsk People's Republic medical cases chart\">Donetsk People's Republic</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Luhansk_People%27s_Republic_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Luhansk People's Republic medical cases chart\">Luhansk People's Republic</a></li></ul></li></ul></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Kingdom_medical_cases\" title=\"Template:COVID-19 pandemic data/United Kingdom medical cases\">United Kingdom</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Kingdom/Scotland_medical_cases\" title=\"Template:COVID-19 pandemic data/United Kingdom/Scotland medical cases\">Scotland</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/United_Kingdom_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/United Kingdom medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Vatican_City_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Vatican City medical cases (page does not exist)\">Vatican City</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Vatican_City_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Vatican City medical cases chart\">chart</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Oceania</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Australia_medical_cases\" title=\"Template:COVID-19 pandemic data/Australia medical cases\">Australia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Australia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Australia medical cases chart\">chart</a></li>\n",
            "<li><a href=\"/wiki/Template:COVID-19_pandemic_data/Australia_cases_by_state/territory\" title=\"Template:COVID-19 pandemic data/Australia cases by state/territory\">by state/territory</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Fiji_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Fiji medical cases (page does not exist)\">Fiji</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Fiji_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Fiji medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/French_Polynesia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/French Polynesia medical cases (page does not exist)\">French Polynesia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/French_Polynesia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/French Polynesia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/New_Caledonia_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/New Caledonia medical cases (page does not exist)\">New Caledonia</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/New_Caledonia_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/New Caledonia medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/New_Zealand_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/New Zealand medical cases (page does not exist)\">New Zealand</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/New_Zealand_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/New Zealand medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Papua_New_Guinea_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Papua New Guinea medical cases (page does not exist)\">Papua New Guinea</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Papua_New_Guinea_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Papua New Guinea medical cases chart\">chart</a></li></ul></li>\n",
            "<li><a class=\"new\" href=\"/w/index.php?title=Template:COVID-19_pandemic_data/Solomon_Islands_medical_cases&amp;action=edit&amp;redlink=1\" title=\"Template:COVID-19 pandemic data/Solomon Islands medical cases (page does not exist)\">Solomon Islands</a>\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Solomon_Islands_medical_cases_chart\" title=\"Template:COVID-19 pandemic data/Solomon Islands medical cases chart\">Solomon Islands</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Others</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li>Cruise ships\n",
            "<ul><li><a href=\"/wiki/Template:COVID-19_pandemic_data/Diamond_Princess_medical_cases\" title=\"Template:COVID-19 pandemic data/Diamond Princess medical cases\">Diamond Princess</a></li></ul></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\n",
            "<ul><li><img alt=\"Category\" data-file-height=\"31\" data-file-width=\"36\" decoding=\"async\" height=\"14\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/24px-Folder_Hexagonal_Icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/32px-Folder_Hexagonal_Icon.svg.png 2x\" title=\"Category\" width=\"16\"/> <b><a href=\"/wiki/Category:COVID-19_pandemic\" title=\"Category:COVID-19 pandemic\">Category</a></b></li>\n",
            "<li><img alt=\"Portal\" data-file-height=\"28\" data-file-width=\"32\" decoding=\"async\" height=\"14\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/16px-Portal-puzzle.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/24px-Portal-puzzle.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/32px-Portal-puzzle.svg.png 2x\" title=\"Portal\" width=\"16\"/> <b><a href=\"/wiki/Portal:Coronavirus_disease_2019\" title=\"Portal:Coronavirus disease 2019\">Portal</a></b></li></ul>\n",
            "</div></td></tr></tbody></table></div>\n",
            "<div aria-labelledby=\"Artificial_induction_of_immunity_/_Immunization:_Vaccines,_Vaccination,_Infection,_Inoculation_(J07)\" class=\"navbox\" role=\"navigation\" style=\"padding:3px\"><table class=\"nowraplinks hlist mw-collapsible mw-collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th class=\"navbox-title\" colspan=\"2\" scope=\"col\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Vaccines\" title=\"Template:Vaccines\"><abbr style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\" title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Vaccines\" title=\"Template talk:Vaccines\"><abbr style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\" title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:Vaccines&amp;action=edit\"><abbr style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\" title=\"Edit this template\">e</abbr></a></li></ul></div><div id=\"Artificial_induction_of_immunity_/_Immunization:_Vaccines,_Vaccination,_Infection,_Inoculation_(J07)\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Artificial_induction_of_immunity\" title=\"Artificial induction of immunity\">Artificial induction of immunity</a> / <a href=\"/wiki/Immunization\" title=\"Immunization\">Immunization</a>: <a href=\"/wiki/Vaccine\" title=\"Vaccine\">Vaccines</a>, <a href=\"/wiki/Vaccination\" title=\"Vaccination\">Vaccination</a>, <a href=\"/wiki/Infection\" title=\"Infection\">Infection</a>, <a href=\"/wiki/Inoculation\" title=\"Inoculation\">Inoculation</a> (<a href=\"/wiki/ATC_code_J07\" title=\"ATC code J07\">J07</a>)</div></th></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Development</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Immunologic_adjuvant\" title=\"Immunologic adjuvant\">Adjuvants</a></li>\n",
            "<li><a href=\"/wiki/List_of_vaccine_ingredients\" title=\"List of vaccine ingredients\">List of vaccine ingredients</a></li>\n",
            "<li><a href=\"/wiki/Mathematical_modelling_of_infectious_disease\" title=\"Mathematical modelling of infectious disease\">Mathematical modelling</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Timeline_of_vaccines\" title=\"Timeline of vaccines\">Timeline</a></li>\n",
            "<li><a href=\"/wiki/Vaccine_trial\" title=\"Vaccine trial\">Trials</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Classes</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Conjugate_vaccine\" title=\"Conjugate vaccine\">Conjugate vaccine</a></li>\n",
            "<li><a href=\"/wiki/DNA_vaccination\" title=\"DNA vaccination\">DNA vaccination</a></li>\n",
            "<li><a href=\"/wiki/Inactivated_vaccine\" title=\"Inactivated vaccine\">Inactivated vaccine</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Live_vector_vaccine\" title=\"Live vector vaccine\">Live vector vaccine</a>\n",
            "<ul><li><a href=\"/wiki/Attenuated_vaccine\" title=\"Attenuated vaccine\">Attenuated vaccine</a></li>\n",
            "<li><a href=\"/wiki/Heterologous_vaccine\" title=\"Heterologous vaccine\">Heterologous vaccine</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Protein_subunit\" title=\"Protein subunit\">Subunit/component</a> / <a href=\"/wiki/Peptide_vaccine\" title=\"Peptide vaccine\">Peptide</a> / <a href=\"/wiki/Virus-like_particle\" title=\"Virus-like particle\">Virus-like particle</a></li>\n",
            "<li><a href=\"/wiki/Toxoid\" title=\"Toxoid\">Toxoid</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Administration</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li>Global:\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/GAVI_Alliance\" title=\"GAVI Alliance\">GAVI Alliance</a></li>\n",
            "<li><a href=\"/wiki/National_Immunization_Technical_Advisory_Group\" title=\"National Immunization Technical Advisory Group\">NITAG</a></li>\n",
            "<li><a href=\"/wiki/Vaccination_policy\" title=\"Vaccination policy\">Policy</a></li>\n",
            "<li><a href=\"/wiki/Vaccination_schedule\" title=\"Vaccination schedule\">Schedule</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Vaccine_injury\" title=\"Vaccine injury\">Vaccine injury</a></li></ul></li>\n",
            "<li>USA:\n",
            "<ul><li><a href=\"/wiki/Advisory_Committee_on_Immunization_Practices\" title=\"Advisory Committee on Immunization Practices\">ACIP</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Vaccine_court\" title=\"Vaccine court\">Vaccine court</a></li>\n",
            "<li><a href=\"/wiki/Vaccines_for_Children_Program\" title=\"Vaccines for Children Program\">Vaccines for Children Program</a></li>\n",
            "<li><a href=\"/wiki/Vaccine_Adverse_Event_Reporting_System\" title=\"Vaccine Adverse Event Reporting System\">VAERS</a></li>\n",
            "<li><a href=\"/wiki/Vaccine_Safety_Datalink\" title=\"Vaccine Safety Datalink\">VSD</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Vaccines</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Bacterial</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Anthrax_vaccines\" title=\"Anthrax vaccines\">Anthrax</a></li>\n",
            "<li><a href=\"/wiki/Brucellosis_vaccine\" title=\"Brucellosis vaccine\">Brucellosis</a></li>\n",
            "<li><a href=\"/wiki/Cholera_vaccine\" title=\"Cholera vaccine\">Cholera</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Diphtheria_vaccine\" title=\"Diphtheria vaccine\">Diphtheria</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Hib_vaccine\" title=\"Hib vaccine\">Hib</a><sup>#</sup></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Leptospirosis_vaccine\" title=\"Leptospirosis vaccine\">Leptospirosis</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Lyme_disease_vaccine\" title=\"Lyme disease vaccine\">Lyme disease</a><sup>‡</sup></li>\n",
            "<li><a href=\"/wiki/Meningococcal_vaccine\" title=\"Meningococcal vaccine\">Meningococcus</a><sup>#</sup>\n",
            "<ul><li><a href=\"/wiki/MeNZB\" title=\"MeNZB\">MeNZB</a></li>\n",
            "<li><a href=\"/wiki/NmVac4-A/C/Y/W-135\" title=\"NmVac4-A/C/Y/W-135\">NmVac4-A/C/Y/W-135</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Pertussis_vaccine\" title=\"Pertussis vaccine\">Pertussis</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Plague_vaccine\" title=\"Plague vaccine\">Plague</a></li>\n",
            "<li><a href=\"/wiki/Pneumococcal_vaccine\" title=\"Pneumococcal vaccine\">Pneumococcal</a><sup>#</sup>\n",
            "<ul><li><a href=\"/wiki/Pneumococcal_conjugate_vaccine\" title=\"Pneumococcal conjugate vaccine\">PCV</a></li>\n",
            "<li><a href=\"/wiki/Pneumococcal_polysaccharide_vaccine\" title=\"Pneumococcal polysaccharide vaccine\">PPSV</a></li></ul></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Q_fever_vaccine\" title=\"Q fever vaccine\">Q fever</a></li>\n",
            "<li><a href=\"/wiki/Tetanus_vaccine\" title=\"Tetanus vaccine\">Tetanus</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Tuberculosis_vaccines\" title=\"Tuberculosis vaccines\">Tuberculosis</a>\n",
            "<ul><li><a href=\"/wiki/BCG_vaccine\" title=\"BCG vaccine\">BCG</a><sup>#</sup></li></ul></li>\n",
            "<li><a href=\"/wiki/Typhoid_vaccine\" title=\"Typhoid vaccine\">Typhoid</a><sup>#</sup>\n",
            "<ul><li><a href=\"/wiki/Ty21a\" title=\"Ty21a\">Ty21a</a></li>\n",
            "<li><a href=\"/wiki/Vi_capsular_polysaccharide_vaccine\" title=\"Vi capsular polysaccharide vaccine\">ViCPS</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Typhus_vaccine\" title=\"Typhus vaccine\">Typhus</a></li>\n",
            "<li>combination: <a href=\"/wiki/DPT_vaccine\" title=\"DPT vaccine\">DTwP/DTaP</a></li>\n",
            "<li>research:\n",
            "<ul><li><a href=\"/wiki/Clostridioides_difficile_infection#Research\" title=\"Clostridioides difficile infection\">Clostridioides difficile</a></li>\n",
            "<li><a href=\"/wiki/Group_B_streptococcal_infection#Vaccine\" title=\"Group B streptococcal infection\">Group B streptococcal disease</a></li>\n",
            "<li><a href=\"/wiki/Shigellosis#Vaccine\" title=\"Shigellosis\">Shigellosis</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Viral</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Adenovirus_vaccine\" title=\"Adenovirus vaccine\">Adenovirus</a></li>\n",
            "<li><a href=\"/wiki/RVSV-ZEBOV_vaccine\" title=\"RVSV-ZEBOV vaccine\">Ebola</a></li>\n",
            "<li><a href=\"/wiki/Influenza_vaccine\" title=\"Influenza vaccine\">Flu</a><sup>#</sup>\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/2009_flu_pandemic_vaccine\" title=\"2009 flu pandemic vaccine\">H1N1</a> (<a href=\"/wiki/Pandemrix\" title=\"Pandemrix\">Pandemrix</a>)</li>\n",
            "<li><a href=\"/wiki/Live_attenuated_influenza_vaccine\" title=\"Live attenuated influenza vaccine\">LAIV</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Hantavirus_vaccine\" title=\"Hantavirus vaccine\">Hantavirus</a></li>\n",
            "<li><a href=\"/wiki/Hepatitis_A_vaccine\" title=\"Hepatitis A vaccine\">Hepatitis A</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Hepatitis_B_vaccine\" title=\"Hepatitis B vaccine\">Hepatitis B</a><sup>#</sup></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Hepatitis_E_vaccine\" title=\"Hepatitis E vaccine\">Hepatitis E</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/HPV_vaccines\" title=\"HPV vaccines\">HPV</a>\n",
            "<ul><li><a href=\"/wiki/Cervarix\" title=\"Cervarix\">Cervarix</a></li>\n",
            "<li><a href=\"/wiki/Gardasil\" title=\"Gardasil\">Gardasil</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Japanese_encephalitis_vaccine\" title=\"Japanese encephalitis vaccine\">Japanese encephalitis</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Measles_vaccine\" title=\"Measles vaccine\">Measles</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Mumps_vaccine\" title=\"Mumps vaccine\">Mumps</a><sup>#</sup>\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Mumpsvax\" title=\"Mumpsvax\">Mumpsvax</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Polio_vaccine\" title=\"Polio vaccine\">Polio</a><sup>#</sup>\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Sabin_polio_vaccine\" title=\"Sabin polio vaccine\">Sabin</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Salk_polio_vaccine\" title=\"Salk polio vaccine\">Salk</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Rabies_vaccine\" title=\"Rabies vaccine\">Rabies</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Rotavirus_vaccine\" title=\"Rotavirus vaccine\">Rotavirus</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Rubella_vaccine\" title=\"Rubella vaccine\">Rubella</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Smallpox_vaccine\" title=\"Smallpox vaccine\">Smallpox</a>\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Dryvax\" title=\"Dryvax\">Dryvax</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Tick-borne_encephalitis_vaccine\" title=\"Tick-borne encephalitis vaccine\">Tick-borne encephalitis</a></li>\n",
            "<li>Varicella zoster\n",
            "<ul><li><a href=\"/wiki/Varicella_vaccine\" title=\"Varicella vaccine\">chicken pox</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Zoster_vaccine\" title=\"Zoster vaccine\">Zoster vaccine</a></li></ul></li>\n",
            "<li><a href=\"/wiki/Yellow_fever_vaccine\" title=\"Yellow fever vaccine\">Yellow fever</a><sup>#</sup></li>\n",
            "<li>combination:\n",
            "<ul><li><a href=\"/wiki/MMR_vaccine\" title=\"MMR vaccine\">MMR</a></li>\n",
            "<li><a href=\"/wiki/MMRV_vaccine\" title=\"MMRV vaccine\">MMRV</a></li></ul></li>\n",
            "<li>research:\n",
            "<ul><li><a href=\"/wiki/Chikungunya#Vaccine\" title=\"Chikungunya\">Chikungunya</a></li>\n",
            "<li><a class=\"mw-selflink selflink\">COVID-19</a></li>\n",
            "<li><a href=\"/wiki/Cytomegalovirus_vaccine\" title=\"Cytomegalovirus vaccine\">Cytomegalovirus</a></li>\n",
            "<li><a href=\"/wiki/Dengue_vaccine\" title=\"Dengue vaccine\">Dengue</a></li>\n",
            "<li><a href=\"/wiki/Ebola_vaccine\" title=\"Ebola vaccine\">Ebola</a></li>\n",
            "<li><a href=\"/wiki/Epstein%E2%80%93Barr_virus_vaccine\" title=\"Epstein–Barr virus vaccine\">Epstein–Barr virus</a></li>\n",
            "<li><a href=\"/wiki/Hepatitis_C_vaccine\" title=\"Hepatitis C vaccine\">Hepatitis C</a></li>\n",
            "<li><a href=\"/wiki/Herpes_simplex_research\" title=\"Herpes simplex research\">Herpes simplex</a></li>\n",
            "<li><a href=\"/wiki/HIV_vaccine\" title=\"HIV vaccine\">HIV</a></li>\n",
            "<li><a href=\"/wiki/Respiratory_syncytial_virus_vaccine\" title=\"Respiratory syncytial virus vaccine\">Respiratory syncytial virus</a></li>\n",
            "<li><a href=\"/wiki/Zika_virus_vaccine\" title=\"Zika virus vaccine\">Zika</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Protozoan</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Malaria_vaccine\" title=\"Malaria vaccine\">Malaria</a>\n",
            "<ul><li><a href=\"/wiki/RTS,S\" title=\"RTS,S\">RTS,S</a></li></ul></li>\n",
            "<li>research:\n",
            "<ul><li><a href=\"/wiki/Trypanosomiasis_vaccine\" title=\"Trypanosomiasis vaccine\">Trypanosomiasis</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\"><a href=\"/wiki/Helminthiasis\" title=\"Helminthiasis\">Helminthiasis</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li>research:\n",
            "<ul><li><a href=\"/wiki/Hookworm_vaccine\" title=\"Hookworm vaccine\">Hookworm</a></li>\n",
            "<li><a href=\"/wiki/Schistosomiasis_vaccine\" title=\"Schistosomiasis vaccine\">Schistosomiasis</a></li></ul></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Androvax\" title=\"Androvax\">Androvax (androstenedione albumin)</a></li>\n",
            "<li><a href=\"/wiki/Cancer_vaccine\" title=\"Cancer vaccine\">Cancer vaccines</a>\n",
            "<ul><li><a href=\"/wiki/ALVAC-CEA_vaccine\" title=\"ALVAC-CEA vaccine\">ALVAC-CEA</a></li>\n",
            "<li><a href=\"/wiki/BCG_vaccine\" title=\"BCG vaccine\">BCG</a><sup>#</sup></li>\n",
            "<li><a href=\"/wiki/Hepatitis_B_vaccine\" title=\"Hepatitis B vaccine\">Hepatitis B</a><sup>#</sup></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/HPV_vaccines\" title=\"HPV vaccines\">HPV</a>\n",
            "<ul><li><a href=\"/wiki/Cervarix\" title=\"Cervarix\">Cervarix</a></li>\n",
            "<li><a href=\"/wiki/Gardasil\" title=\"Gardasil\">Gardasil</a></li></ul></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/PROSTVAC\" title=\"PROSTVAC\">PROSTVAC</a></li></ul></li>\n",
            "<li><a href=\"/wiki/NicVAX\" title=\"NicVAX\">NicVAX</a></li>\n",
            "<li><a href=\"/wiki/Ovandrotone_albumin\" title=\"Ovandrotone albumin\">Ovandrotone albumin (Fecundin)</a></li>\n",
            "<li><a href=\"/wiki/TA-CD\" title=\"TA-CD\">TA-CD</a></li>\n",
            "<li><a href=\"/wiki/TA-NIC\" title=\"TA-NIC\">TA-NIC</a></li>\n",
            "<li>combination\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/DTaP-IPV/Hib\" title=\"DTaP-IPV/Hib\">DTaP-IPV/Hib</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/DTaP-IPV-HepB\" title=\"DTaP-IPV-HepB\">DTaP-IPV-HepB</a></li>\n",
            "<li><a href=\"/wiki/Hexavalent_vaccine\" title=\"Hexavalent vaccine\">Hexavalent vaccine</a></li>\n",
            "<li><a href=\"/wiki/Pentavalent_vaccine\" title=\"Pentavalent vaccine\">Pentavalent vaccine</a></li></ul></li></ul>\n",
            "</div></td></tr></tbody></table><div></div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Inventors/researchers</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Edward_Jenner\" title=\"Edward Jenner\">Edward Jenner</a></li>\n",
            "<li><a href=\"/wiki/Louis_Pasteur\" title=\"Louis Pasteur\">Louis Pasteur</a></li>\n",
            "<li><a href=\"/wiki/Hilary_Koprowski\" title=\"Hilary Koprowski\">Hilary Koprowski</a></li>\n",
            "<li><a href=\"/wiki/Jonas_Salk\" title=\"Jonas Salk\">Jonas Salk</a></li>\n",
            "<li><a href=\"/wiki/John_Franklin_Enders\" title=\"John Franklin Enders\">John Franklin Enders</a></li>\n",
            "<li><a href=\"/wiki/Stanley_Plotkin\" title=\"Stanley Plotkin\">Stanley Plotkin</a></li>\n",
            "<li><a href=\"/wiki/H._Fred_Clark\" title=\"H. Fred Clark\">H. Fred Clark</a></li>\n",
            "<li><a href=\"/wiki/Paul_Offit\" title=\"Paul Offit\">Paul Offit</a></li>\n",
            "<li><a href=\"/wiki/Anthony_Fauci\" title=\"Anthony Fauci\">Anthony Fauci</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Controversy</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a class=\"mw-redirect\" href=\"/wiki/Vaccine_controversies\" title=\"Vaccine controversies\">General</a></li>\n",
            "<li><a href=\"/wiki/MMR_vaccine_and_autism\" title=\"MMR vaccine and autism\">MMR</a></li>\n",
            "<li><a href=\"/wiki/National_Childhood_Vaccine_Injury_Act\" title=\"National Childhood Vaccine Injury Act\">NCVIA</a></li>\n",
            "<li>Infection party\n",
            "<ul><li><a href=\"/wiki/Pox_party\" title=\"Pox party\">Pox</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Flu_party\" title=\"Flu party\">Flu</a></li>\n",
            "<li><a href=\"/wiki/Coronavirus_party\" title=\"Coronavirus party\">CoV</a></li></ul></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Thiomersal_controversy\" title=\"Thiomersal controversy\">Thiomersal</a></li>\n",
            "<li><a href=\"/wiki/Vaccines_and_SIDS\" title=\"Vaccines and SIDS\">Vaccines and SIDS</a></li>\n",
            "<li><a href=\"/wiki/Lancet_MMR_autism_fraud\" title=\"Lancet MMR autism fraud\"><i>Lancet</i> MMR autism fraud</a></li>\n",
            "<li><i><a href=\"/wiki/Cedillo_v._Secretary_of_Health_and_Human_Services\" title=\"Cedillo v. Secretary of Health and Human Services\">Cedillo v. Secretary of Health and Human Services</a></i></li>\n",
            "<li><a href=\"/wiki/Alternative_vaccination_schedule\" title=\"Alternative vaccination schedule\">Alternative vaccination schedule</a></li></ul>\n",
            "</div></td></tr><tr><th class=\"navbox-group\" scope=\"row\" style=\"width:1%\">Related</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n",
            "<ul><li><a href=\"/wiki/Epidemiology\" title=\"Epidemiology\">Epidemiology</a></li>\n",
            "<li><a href=\"/wiki/Eradication_of_infectious_diseases\" title=\"Eradication of infectious diseases\">Eradication of infectious diseases</a></li>\n",
            "<li><a class=\"mw-redirect\" href=\"/wiki/Every_Child_by_Two\" title=\"Every Child by Two\">Every Child by Two</a></li>\n",
            "<li><a href=\"/wiki/List_of_vaccine_topics\" title=\"List of vaccine topics\">List of vaccine topics</a></li></ul>\n",
            "</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\" style=\"background: transparent; padding: 0px;\"><div><div class=\"hlist\">\n",
            "<ul><li><sup>#</sup><a href=\"/wiki/WHO_Model_List_of_Essential_Medicines\" title=\"WHO Model List of Essential Medicines\">WHO-EM</a></li>\n",
            "<li><sup>‡</sup><a href=\"/wiki/List_of_withdrawn_drugs\" title=\"List of withdrawn drugs\">Withdrawn</a> from market</li>\n",
            "<li><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trials</a>:\n",
            "<ul><li><sup>†</sup><a href=\"/wiki/Phases_of_clinical_research#Phase_III\" title=\"Phases of clinical research\">Phase III</a></li>\n",
            "<li><sup>§</sup>Never to phase III</li></ul></li></ul>\n",
            "</div></div></td></tr></tbody></table></div>\n",
            "<!-- \n",
            "NewPP limit report\n",
            "Parsed by mw2365\n",
            "Cached time: 20201017063903\n",
            "Cache expiry: 2592000\n",
            "Dynamic content: false\n",
            "Complications: [vary‐revision‐sha1]\n",
            "CPU time usage: 2.708 seconds\n",
            "Real time usage: 2.979 seconds\n",
            "Preprocessor visited node count: 21382/1000000\n",
            "Post‐expand include size: 1041476/2097152 bytes\n",
            "Template argument size: 22318/2097152 bytes\n",
            "Highest expansion depth: 13/40\n",
            "Expensive parser function count: 9/500\n",
            "Unstrip recursion depth: 1/20\n",
            "Unstrip post‐expand size: 958437/5000000 bytes\n",
            "Lua time usage: 1.378/10.000 seconds\n",
            "Lua memory usage: 10.61 MB/50 MB\n",
            "Lua Profile:\n",
            "    ?                                                                220 ms       15.3%\n",
            "    Scribunto_LuaSandboxCallback::match                              160 ms       11.1%\n",
            "    Scribunto_LuaSandboxCallback::find                               140 ms        9.7%\n",
            "    Scribunto_LuaSandboxCallback::gsub                               120 ms        8.3%\n",
            "    dataWrapper <mw.lua:661>                                         120 ms        8.3%\n",
            "    Scribunto_LuaSandboxCallback::callParserFunction                 120 ms        8.3%\n",
            "    recursiveClone <mwInit.lua:41>                                    80 ms        5.6%\n",
            "    <mw.lua:683>                                                      60 ms        4.2%\n",
            "    Scribunto_LuaSandboxCallback::plain                               60 ms        4.2%\n",
            "    <Module:Citation/CS1:815>                                         40 ms        2.8%\n",
            "    [others]                                                         320 ms       22.2%\n",
            "Number of Wikibase entities loaded: 0/400\n",
            "-->\n",
            "<!--\n",
            "Transclusion expansion time report (%,ms,calls,template)\n",
            "100.00% 2364.278      1 -total\n",
            " 63.72% 1506.406      3 Template:Reflist\n",
            " 24.40%  576.900    138 Template:Cite_web\n",
            " 21.55%  509.472     71 Template:Cite_journal\n",
            "  7.62%  180.272     41 Template:Cite_news\n",
            "  3.95%   93.432      1 Template:Pp-semi\n",
            "  2.99%   70.710      1 Template:COVID-19_pandemic\n",
            "  2.34%   55.234      1 Template:Short_description\n",
            "  2.29%   54.155     48 Template:ClinicalStudyInfo\n",
            "  1.53%   36.071     28 Template:US$\n",
            "-->\n",
            "<!-- Saved in parser cache with key enwiki:pcache:idhash:63319438-0!canonical and timestamp 20201017063900 and revision id 983748222\n",
            " -->\n",
            "</div><noscript><img alt=\"\" height=\"1\" src=\"//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1\" style=\"border: none; position: absolute;\" title=\"\" width=\"1\"/></noscript>\n",
            "<div class=\"printfooter\">Retrieved from \"<a dir=\"ltr\" href=\"https://en.wikipedia.org/w/index.php?title=COVID-19_vaccine&amp;oldid=983748222\">https://en.wikipedia.org/w/index.php?title=COVID-19_vaccine&amp;oldid=983748222</a>\"</div></div>\n",
            "<div class=\"catlinks\" data-mw=\"interface\" id=\"catlinks\"><div class=\"mw-normal-catlinks\" id=\"mw-normal-catlinks\"><a href=\"/wiki/Help:Category\" title=\"Help:Category\">Categories</a>: <ul><li><a href=\"/wiki/Category:COVID-19_vaccines\" title=\"Category:COVID-19 vaccines\">COVID-19 vaccines</a></li><li><a href=\"/wiki/Category:Medical_research\" title=\"Category:Medical research\">Medical research</a></li><li><a href=\"/wiki/Category:Medical_responses_to_the_COVID-19_pandemic\" title=\"Category:Medical responses to the COVID-19 pandemic\">Medical responses to the COVID-19 pandemic</a></li></ul></div><div class=\"mw-hidden-catlinks mw-hidden-cats-hidden\" id=\"mw-hidden-catlinks\">Hidden categories: <ul><li><a href=\"/wiki/Category:Pages_with_non-numeric_formatnum_arguments\" title=\"Category:Pages with non-numeric formatnum arguments\">Pages with non-numeric formatnum arguments</a></li><li><a href=\"/wiki/Category:CS1_maint:_uses_authors_parameter\" title=\"Category:CS1 maint: uses authors parameter\">CS1 maint: uses authors parameter</a></li><li><a href=\"/wiki/Category:CS1_German-language_sources_(de)\" title=\"Category:CS1 German-language sources (de)\">CS1 German-language sources (de)</a></li><li><a href=\"/wiki/Category:CS1_Dutch-language_sources_(nl)\" title=\"Category:CS1 Dutch-language sources (nl)\">CS1 Dutch-language sources (nl)</a></li><li><a href=\"/wiki/Category:CS1_Indonesian-language_sources_(id)\" title=\"Category:CS1 Indonesian-language sources (id)\">CS1 Indonesian-language sources (id)</a></li><li><a href=\"/wiki/Category:CS1_errors:_missing_periodical\" title=\"Category:CS1 errors: missing periodical\">CS1 errors: missing periodical</a></li><li><a href=\"/wiki/Category:Wikipedia_indefinitely_semi-protected_pages\" title=\"Category:Wikipedia indefinitely semi-protected pages\">Wikipedia indefinitely semi-protected pages</a></li><li><a href=\"/wiki/Category:Articles_with_short_description\" title=\"Category:Articles with short description\">Articles with short description</a></li><li><a href=\"/wiki/Category:Short_description_is_different_from_Wikidata\" title=\"Category:Short description is different from Wikidata\">Short description is different from Wikidata</a></li><li><a href=\"/wiki/Category:Use_dmy_dates_from_March_2020\" title=\"Category:Use dmy dates from March 2020\">Use dmy dates from March 2020</a></li><li><a href=\"/wiki/Category:Pages_using_left_with_no_arguments\" title=\"Category:Pages using left with no arguments\">Pages using left with no arguments</a></li></ul></div></div>\n",
            "</div>\n",
            "</div>\n",
            "<div id=\"mw-data-after-content\">\n",
            "<div class=\"read-more-container\"></div>\n",
            "</div>\n",
            "<div id=\"mw-navigation\">\n",
            "<h2>Navigation menu</h2>\n",
            "<div id=\"mw-head\">\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-personal-label\" class=\"mw-portlet mw-portlet-personal vector-menu\" id=\"p-personal\" role=\"navigation\">\n",
            "<h3 id=\"p-personal-label\">\n",
            "<span>Personal tools</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"><li id=\"pt-anonuserpage\">Not logged in</li><li id=\"pt-anontalk\"><a accesskey=\"n\" href=\"/wiki/Special:MyTalk\" title=\"Discussion about edits from this IP address [n]\">Talk</a></li><li id=\"pt-anoncontribs\"><a accesskey=\"y\" href=\"/wiki/Special:MyContributions\" title=\"A list of edits made from this IP address [y]\">Contributions</a></li><li id=\"pt-createaccount\"><a href=\"/w/index.php?title=Special:CreateAccount&amp;returnto=COVID-19+vaccine\" title=\"You are encouraged to create an account and log in; however, it is not mandatory\">Create account</a></li><li id=\"pt-login\"><a accesskey=\"o\" href=\"/w/index.php?title=Special:UserLogin&amp;returnto=COVID-19+vaccine\" title=\"You're encouraged to log in; however, it's not mandatory. [o]\">Log in</a></li></ul>\n",
            "</div>\n",
            "</nav>\n",
            "<div id=\"left-navigation\">\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-namespaces-label\" class=\"mw-portlet mw-portlet-namespaces vector-menu vector-menu-tabs\" id=\"p-namespaces\" role=\"navigation\">\n",
            "<h3 id=\"p-namespaces-label\">\n",
            "<span>Namespaces</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"><li class=\"selected\" id=\"ca-nstab-main\"><a accesskey=\"c\" href=\"/wiki/COVID-19_vaccine\" title=\"View the content page [c]\">Article</a></li><li id=\"ca-talk\"><a accesskey=\"t\" href=\"/wiki/Talk:COVID-19_vaccine\" rel=\"discussion\" title=\"Discuss improvements to the content page [t]\">Talk</a></li></ul>\n",
            "</div>\n",
            "</nav>\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-variants-label\" class=\"mw-portlet mw-portlet-variants emptyPortlet vector-menu vector-menu-dropdown\" id=\"p-variants\" role=\"navigation\">\n",
            "<input aria-labelledby=\"p-variants-label\" class=\"vector-menu-checkbox\" type=\"checkbox\"/>\n",
            "<h3 id=\"p-variants-label\">\n",
            "<span>Variants</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"></ul>\n",
            "</div>\n",
            "</nav>\n",
            "</div>\n",
            "<div id=\"right-navigation\">\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-views-label\" class=\"mw-portlet mw-portlet-views vector-menu vector-menu-tabs\" id=\"p-views\" role=\"navigation\">\n",
            "<h3 id=\"p-views-label\">\n",
            "<span>Views</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"><li class=\"selected\" id=\"ca-view\"><a href=\"/wiki/COVID-19_vaccine\">Read</a></li><li id=\"ca-viewsource\"><a accesskey=\"e\" href=\"/w/index.php?title=COVID-19_vaccine&amp;action=edit\" title=\"This page is protected.\n",
            "You can view its source [e]\">View source</a></li><li id=\"ca-history\"><a accesskey=\"h\" href=\"/w/index.php?title=COVID-19_vaccine&amp;action=history\" title=\"Past revisions of this page [h]\">View history</a></li></ul>\n",
            "</div>\n",
            "</nav>\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-cactions-label\" class=\"mw-portlet mw-portlet-cactions emptyPortlet vector-menu vector-menu-dropdown\" id=\"p-cactions\" role=\"navigation\">\n",
            "<input aria-labelledby=\"p-cactions-label\" class=\"vector-menu-checkbox\" type=\"checkbox\"/>\n",
            "<h3 id=\"p-cactions-label\">\n",
            "<span>More</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"></ul>\n",
            "</div>\n",
            "</nav>\n",
            "<div id=\"p-search\" role=\"search\">\n",
            "<h3>\n",
            "<label for=\"searchInput\">Search</label>\n",
            "</h3>\n",
            "<form action=\"/w/index.php\" id=\"searchform\">\n",
            "<div data-search-loc=\"header-navigation\" id=\"simpleSearch\">\n",
            "<input accesskey=\"f\" id=\"searchInput\" name=\"search\" placeholder=\"Search Wikipedia\" title=\"Search Wikipedia [f]\" type=\"search\"/>\n",
            "<input name=\"title\" type=\"hidden\" value=\"Special:Search\"/>\n",
            "<input class=\"searchButton mw-fallbackSearchButton\" id=\"mw-searchButton\" name=\"fulltext\" title=\"Search Wikipedia for this text\" type=\"submit\" value=\"Search\"/>\n",
            "<input class=\"searchButton\" id=\"searchButton\" name=\"go\" title=\"Go to a page with this exact name if it exists\" type=\"submit\" value=\"Go\"/>\n",
            "</div>\n",
            "</form>\n",
            "</div>\n",
            "</div>\n",
            "</div>\n",
            "<div id=\"mw-panel\">\n",
            "<div id=\"p-logo\" role=\"banner\">\n",
            "<a class=\"mw-wiki-logo\" href=\"/wiki/Main_Page\" title=\"Visit the main page\"></a>\n",
            "</div>\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-navigation-label\" class=\"mw-portlet mw-portlet-navigation vector-menu vector-menu-portal portal portal-first\" id=\"p-navigation\" role=\"navigation\">\n",
            "<h3 id=\"p-navigation-label\">\n",
            "<span>Navigation</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"><li id=\"n-mainpage-description\"><a accesskey=\"z\" href=\"/wiki/Main_Page\" title=\"Visit the main page [z]\">Main page</a></li><li id=\"n-contents\"><a href=\"/wiki/Wikipedia:Contents\" title=\"Guides to browsing Wikipedia\">Contents</a></li><li id=\"n-currentevents\"><a href=\"/wiki/Portal:Current_events\" title=\"Articles related to current events\">Current events</a></li><li id=\"n-randompage\"><a accesskey=\"x\" href=\"/wiki/Special:Random\" title=\"Visit a randomly selected article [x]\">Random article</a></li><li id=\"n-aboutsite\"><a href=\"/wiki/Wikipedia:About\" title=\"Learn about Wikipedia and how it works\">About Wikipedia</a></li><li id=\"n-contactpage\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\" title=\"How to contact Wikipedia\">Contact us</a></li><li id=\"n-sitesupport\"><a href=\"https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en\" title=\"Support us by donating to the Wikimedia Foundation\">Donate</a></li></ul>\n",
            "</div>\n",
            "</nav>\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-interaction-label\" class=\"mw-portlet mw-portlet-interaction vector-menu vector-menu-portal portal\" id=\"p-interaction\" role=\"navigation\">\n",
            "<h3 id=\"p-interaction-label\">\n",
            "<span>Contribute</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"><li id=\"n-help\"><a href=\"/wiki/Help:Contents\" title=\"Guidance on how to use and edit Wikipedia\">Help</a></li><li id=\"n-introduction\"><a href=\"/wiki/Help:Introduction\" title=\"Learn how to edit Wikipedia\">Learn to edit</a></li><li id=\"n-portal\"><a href=\"/wiki/Wikipedia:Community_portal\" title=\"The hub for editors\">Community portal</a></li><li id=\"n-recentchanges\"><a accesskey=\"r\" href=\"/wiki/Special:RecentChanges\" title=\"A list of recent changes to Wikipedia [r]\">Recent changes</a></li><li id=\"n-upload\"><a href=\"/wiki/Wikipedia:File_Upload_Wizard\" title=\"Add images or other media for use on Wikipedia\">Upload file</a></li></ul>\n",
            "</div>\n",
            "</nav>\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-tb-label\" class=\"mw-portlet mw-portlet-tb vector-menu vector-menu-portal portal\" id=\"p-tb\" role=\"navigation\">\n",
            "<h3 id=\"p-tb-label\">\n",
            "<span>Tools</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"><li id=\"t-whatlinkshere\"><a accesskey=\"j\" href=\"/wiki/Special:WhatLinksHere/COVID-19_vaccine\" title=\"List of all English Wikipedia pages containing links to this page [j]\">What links here</a></li><li id=\"t-recentchangeslinked\"><a accesskey=\"k\" href=\"/wiki/Special:RecentChangesLinked/COVID-19_vaccine\" rel=\"nofollow\" title=\"Recent changes in pages linked from this page [k]\">Related changes</a></li><li id=\"t-upload\"><a accesskey=\"u\" href=\"/wiki/Wikipedia:File_Upload_Wizard\" title=\"Upload files [u]\">Upload file</a></li><li id=\"t-specialpages\"><a accesskey=\"q\" href=\"/wiki/Special:SpecialPages\" title=\"A list of all special pages [q]\">Special pages</a></li><li id=\"t-permalink\"><a href=\"/w/index.php?title=COVID-19_vaccine&amp;oldid=983748222\" title=\"Permanent link to this revision of this page\">Permanent link</a></li><li id=\"t-info\"><a href=\"/w/index.php?title=COVID-19_vaccine&amp;action=info\" title=\"More information about this page\">Page information</a></li><li id=\"t-cite\"><a href=\"/w/index.php?title=Special:CiteThisPage&amp;page=COVID-19_vaccine&amp;id=983748222&amp;wpFormIdentifier=titleform\" title=\"Information on how to cite this page\">Cite this page</a></li><li id=\"t-wikibase\"><a accesskey=\"g\" href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q87719492\" title=\"Structured data on this page hosted by Wikidata [g]\">Wikidata item</a></li></ul>\n",
            "</div>\n",
            "</nav>\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-coll-print_export-label\" class=\"mw-portlet mw-portlet-coll-print_export vector-menu vector-menu-portal portal\" id=\"p-coll-print_export\" role=\"navigation\">\n",
            "<h3 id=\"p-coll-print_export-label\">\n",
            "<span>Print/export</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"><li id=\"coll-download-as-rl\"><a href=\"/w/index.php?title=Special:DownloadAsPdf&amp;page=COVID-19_vaccine&amp;action=show-download-screen\" title=\"Download this page as a PDF file\">Download as PDF</a></li><li id=\"t-print\"><a accesskey=\"p\" href=\"/w/index.php?title=COVID-19_vaccine&amp;printable=yes\" title=\"Printable version of this page [p]\">Printable version</a></li></ul>\n",
            "</div>\n",
            "</nav>\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-wikibase-otherprojects-label\" class=\"mw-portlet mw-portlet-wikibase-otherprojects vector-menu vector-menu-portal portal\" id=\"p-wikibase-otherprojects\" role=\"navigation\">\n",
            "<h3 id=\"p-wikibase-otherprojects-label\">\n",
            "<span>In other projects</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"><li class=\"wb-otherproject-link wb-otherproject-commons\"><a href=\"https://commons.wikimedia.org/wiki/Category:COVID-19_vaccines\" hreflang=\"en\">Wikimedia Commons</a></li></ul>\n",
            "</div>\n",
            "</nav>\n",
            "<!-- Please do not use role attribute as CSS selector, it is deprecated. -->\n",
            "<nav aria-labelledby=\"p-lang-label\" class=\"mw-portlet mw-portlet-lang vector-menu vector-menu-portal portal\" id=\"p-lang\" role=\"navigation\">\n",
            "<h3 id=\"p-lang-label\">\n",
            "<span>Languages</span>\n",
            "</h3>\n",
            "<div class=\"vector-menu-content\">\n",
            "<ul class=\"vector-menu-content-list\"><li class=\"interlanguage-link interwiki-ar\"><a class=\"interlanguage-link-target\" href=\"https://ar.wikipedia.org/wiki/%D9%84%D9%82%D8%A7%D8%AD_%D9%83%D9%88%D9%81%D9%8A%D8%AF-19\" hreflang=\"ar\" lang=\"ar\" title=\"لقاح كوفيد-19 – Arabic\">العربية</a></li><li class=\"interlanguage-link interwiki-bn\"><a class=\"interlanguage-link-target\" href=\"https://bn.wikipedia.org/wiki/%E0%A6%95%E0%A7%8B%E0%A6%AD%E0%A6%BF%E0%A6%A1-%E0%A7%A7%E0%A7%AF_%E0%A6%9F%E0%A6%BF%E0%A6%95%E0%A6%BE\" hreflang=\"bn\" lang=\"bn\" title=\"কোভিড-১৯ টিকা – Bangla\">বাংলা</a></li><li class=\"interlanguage-link interwiki-bs\"><a class=\"interlanguage-link-target\" href=\"https://bs.wikipedia.org/wiki/Vakcina_protiv_bolesti_COVID-19\" hreflang=\"bs\" lang=\"bs\" title=\"Vakcina protiv bolesti COVID-19 – Bosnian\">Bosanski</a></li><li class=\"interlanguage-link interwiki-ca\"><a class=\"interlanguage-link-target\" href=\"https://ca.wikipedia.org/wiki/Vacuna_contra_la_COVID-19\" hreflang=\"ca\" lang=\"ca\" title=\"Vacuna contra la COVID-19 – Catalan\">Català</a></li><li class=\"interlanguage-link interwiki-da\"><a class=\"interlanguage-link-target\" href=\"https://da.wikipedia.org/wiki/COVID-19-vaccine\" hreflang=\"da\" lang=\"da\" title=\"COVID-19-vaccine – Danish\">Dansk</a></li><li class=\"interlanguage-link interwiki-de\"><a class=\"interlanguage-link-target\" href=\"https://de.wikipedia.org/wiki/SARS-CoV-2-Impfstoff\" hreflang=\"de\" lang=\"de\" title=\"SARS-CoV-2-Impfstoff – German\">Deutsch</a></li><li class=\"interlanguage-link interwiki-el\"><a class=\"interlanguage-link-target\" href=\"https://el.wikipedia.org/wiki/%CE%95%CE%BC%CE%B2%CF%8C%CE%BB%CE%B9%CE%BF_COVID-19\" hreflang=\"el\" lang=\"el\" title=\"Εμβόλιο COVID-19 – Greek\">Ελληνικά</a></li><li class=\"interlanguage-link interwiki-es\"><a class=\"interlanguage-link-target\" href=\"https://es.wikipedia.org/wiki/Vacuna_contra_COVID-19\" hreflang=\"es\" lang=\"es\" title=\"Vacuna contra COVID-19 – Spanish\">Español</a></li><li class=\"interlanguage-link interwiki-eu\"><a class=\"interlanguage-link-target\" href=\"https://eu.wikipedia.org/wiki/COVID-19aren_aurkako_txertoa\" hreflang=\"eu\" lang=\"eu\" title=\"COVID-19aren aurkako txertoa – Basque\">Euskara</a></li><li class=\"interlanguage-link interwiki-fa\"><a class=\"interlanguage-link-target\" href=\"https://fa.wikipedia.org/wiki/%D9%88%D8%A7%DA%A9%D8%B3%D9%86_%DA%A9%D9%88%D9%88%DB%8C%D8%AF-%DB%B1%DB%B9\" hreflang=\"fa\" lang=\"fa\" title=\"واکسن کووید-۱۹ – Persian\">فارسی</a></li><li class=\"interlanguage-link interwiki-fr\"><a class=\"interlanguage-link-target\" href=\"https://fr.wikipedia.org/wiki/Vaccin_contre_la_Covid-19\" hreflang=\"fr\" lang=\"fr\" title=\"Vaccin contre la Covid-19 – French\">Français</a></li><li class=\"interlanguage-link interwiki-gl\"><a class=\"interlanguage-link-target\" href=\"https://gl.wikipedia.org/wiki/Vacina_da_COVID-19\" hreflang=\"gl\" lang=\"gl\" title=\"Vacina da COVID-19 – Galician\">Galego</a></li><li class=\"interlanguage-link interwiki-ko\"><a class=\"interlanguage-link-target\" href=\"https://ko.wikipedia.org/wiki/%EC%BD%94%EB%A1%9C%EB%82%9819_%EB%B0%B1%EC%8B%A0\" hreflang=\"ko\" lang=\"ko\" title=\"코로나19 백신 – Korean\">한국어</a></li><li class=\"interlanguage-link interwiki-hi\"><a class=\"interlanguage-link-target\" href=\"https://hi.wikipedia.org/wiki/%E0%A4%95%E0%A5%8B%E0%A4%B5%E0%A4%BF%E0%A4%A1-19_%E0%A4%95%E0%A4%BE_%E0%A4%9F%E0%A5%80%E0%A4%95%E0%A4%BE\" hreflang=\"hi\" lang=\"hi\" title=\"कोविड-19 का टीका – Hindi\">हिन्दी</a></li><li class=\"interlanguage-link interwiki-hr\"><a class=\"interlanguage-link-target\" href=\"https://hr.wikipedia.org/wiki/Cjepivo_protiv_COVID-19\" hreflang=\"hr\" lang=\"hr\" title=\"Cjepivo protiv COVID-19 – Croatian\">Hrvatski</a></li><li class=\"interlanguage-link interwiki-id\"><a class=\"interlanguage-link-target\" href=\"https://id.wikipedia.org/wiki/Vaksin_COVID-19\" hreflang=\"id\" lang=\"id\" title=\"Vaksin COVID-19 – Indonesian\">Bahasa Indonesia</a></li><li class=\"interlanguage-link interwiki-it\"><a class=\"interlanguage-link-target\" href=\"https://it.wikipedia.org/wiki/Vaccino_contro_il_COVID-19\" hreflang=\"it\" lang=\"it\" title=\"Vaccino contro il COVID-19 – Italian\">Italiano</a></li><li class=\"interlanguage-link interwiki-kn\"><a class=\"interlanguage-link-target\" href=\"https://kn.wikipedia.org/wiki/%E0%B2%95%E0%B3%8B%E0%B2%B5%E0%B2%BF%E0%B2%A1%E0%B3%8D-%E0%B3%A7%E0%B3%AF_%E0%B2%B2%E0%B2%B8%E0%B2%BF%E0%B2%95%E0%B3%86\" hreflang=\"kn\" lang=\"kn\" title=\"ಕೋವಿಡ್-೧೯ ಲಸಿಕೆ – Kannada\">ಕನ್ನಡ</a></li><li class=\"interlanguage-link interwiki-lt\"><a class=\"interlanguage-link-target\" href=\"https://lt.wikipedia.org/wiki/COVID-19_vakcina\" hreflang=\"lt\" lang=\"lt\" title=\"COVID-19 vakcina – Lithuanian\">Lietuvių</a></li><li class=\"interlanguage-link interwiki-hu\"><a class=\"interlanguage-link-target\" href=\"https://hu.wikipedia.org/wiki/COVID%E2%80%9319-vakcina\" hreflang=\"hu\" lang=\"hu\" title=\"COVID–19-vakcina – Hungarian\">Magyar</a></li><li class=\"interlanguage-link interwiki-ml\"><a class=\"interlanguage-link-target\" href=\"https://ml.wikipedia.org/wiki/%E0%B4%95%E0%B5%8A%E0%B4%B1%E0%B5%8B%E0%B4%A3%E0%B4%B5%E0%B5%88%E0%B4%B1%E0%B4%B8%E0%B5%8D_%E0%B4%B0%E0%B5%8B%E0%B4%97%E0%B4%82_2019_%E0%B4%B5%E0%B4%BE%E0%B4%95%E0%B5%8D%E0%B4%B8%E0%B4%BF%E0%B5%BB\" hreflang=\"ml\" lang=\"ml\" title=\"കൊറോണവൈറസ് രോഗം 2019 വാക്സിൻ – Malayalam\">മലയാളം</a></li><li class=\"interlanguage-link interwiki-ms\"><a class=\"interlanguage-link-target\" href=\"https://ms.wikipedia.org/wiki/Vaksin_COVID-19\" hreflang=\"ms\" lang=\"ms\" title=\"Vaksin COVID-19 – Malay\">Bahasa Melayu</a></li><li class=\"interlanguage-link interwiki-nl\"><a class=\"interlanguage-link-target\" href=\"https://nl.wikipedia.org/wiki/COVID-19-vaccin\" hreflang=\"nl\" lang=\"nl\" title=\"COVID-19-vaccin – Dutch\">Nederlands</a></li><li class=\"interlanguage-link interwiki-ja\"><a class=\"interlanguage-link-target\" href=\"https://ja.wikipedia.org/wiki/COVID-19%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3\" hreflang=\"ja\" lang=\"ja\" title=\"COVID-19ワクチン – Japanese\">日本語</a></li><li class=\"interlanguage-link interwiki-no\"><a class=\"interlanguage-link-target\" href=\"https://no.wikipedia.org/wiki/Covid-19-vaksiner\" hreflang=\"nb\" lang=\"nb\" title=\"Covid-19-vaksiner – Norwegian Bokmål\">Norsk bokmål</a></li><li class=\"interlanguage-link interwiki-pt\"><a class=\"interlanguage-link-target\" href=\"https://pt.wikipedia.org/wiki/Pesquisa_de_vacina_para_COVID-19\" hreflang=\"pt\" lang=\"pt\" title=\"Pesquisa de vacina para COVID-19 – Portuguese\">Português</a></li><li class=\"interlanguage-link interwiki-ro\"><a class=\"interlanguage-link-target\" href=\"https://ro.wikipedia.org/wiki/Vaccin_anti-COVID-19\" hreflang=\"ro\" lang=\"ro\" title=\"Vaccin anti-COVID-19 – Romanian\">Română</a></li><li class=\"interlanguage-link interwiki-ru\"><a class=\"interlanguage-link-target\" href=\"https://ru.wikipedia.org/wiki/%D0%92%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D0%B0_%D0%BF%D1%80%D0%BE%D1%82%D0%B8%D0%B2_COVID-19\" hreflang=\"ru\" lang=\"ru\" title=\"Вакцина против COVID-19 – Russian\">Русский</a></li><li class=\"interlanguage-link interwiki-sq\"><a class=\"interlanguage-link-target\" href=\"https://sq.wikipedia.org/wiki/Vaksina_p%C3%ABr_COVID-19\" hreflang=\"sq\" lang=\"sq\" title=\"Vaksina për COVID-19 – Albanian\">Shqip</a></li><li class=\"interlanguage-link interwiki-si\"><a class=\"interlanguage-link-target\" href=\"https://si.wikipedia.org/wiki/%E0%B6%9A%E0%B7%9C%E0%B7%80%E0%B7%92%E0%B6%A9%E0%B7%8A-19_%E0%B6%91%E0%B6%B1%E0%B7%8A%E0%B6%B1%E0%B6%AD\" hreflang=\"si\" lang=\"si\" title=\"කොවිඩ්-19 එන්නත – Sinhala\">සිංහල</a></li><li class=\"interlanguage-link interwiki-simple\"><a class=\"interlanguage-link-target\" href=\"https://simple.wikipedia.org/wiki/COVID-19_vaccine\" hreflang=\"en-simple\" lang=\"en-simple\" title=\"COVID-19 vaccine – Simple English\">Simple English</a></li><li class=\"interlanguage-link interwiki-sd\"><a class=\"interlanguage-link-target\" href=\"https://sd.wikipedia.org/wiki/%DA%AA%D9%88%D9%88%DA%8A-%D9%A1%D9%A9_%D9%88%D9%8A%DA%AA%D8%B3%D9%8A%D9%86\" hreflang=\"sd\" lang=\"sd\" title=\"ڪووڊ-١٩ ويڪسين – Sindhi\">سنڌي</a></li><li class=\"interlanguage-link interwiki-sk\"><a class=\"interlanguage-link-target\" href=\"https://sk.wikipedia.org/wiki/Vakc%C3%ADna_proti_chorobe_COVID-19\" hreflang=\"sk\" lang=\"sk\" title=\"Vakcína proti chorobe COVID-19 – Slovak\">Slovenčina</a></li><li class=\"interlanguage-link interwiki-sr\"><a class=\"interlanguage-link-target\" href=\"https://sr.wikipedia.org/wiki/%D0%98%D1%81%D1%82%D1%80%D0%B0%D0%B6%D0%B8%D0%B2%D0%B0%D1%9A%D0%B5_%D0%B2%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D0%B5_%D0%BF%D1%80%D0%BE%D1%82%D0%B8%D0%B2_%D0%BA%D0%BE%D0%B2%D0%B8%D0%B4%D0%B0_19\" hreflang=\"sr\" lang=\"sr\" title=\"Истраживање вакцине против ковида 19 – Serbian\">Српски / srpski</a></li><li class=\"interlanguage-link interwiki-fi\"><a class=\"interlanguage-link-target\" href=\"https://fi.wikipedia.org/wiki/SARS-CoV-2-rokote\" hreflang=\"fi\" lang=\"fi\" title=\"SARS-CoV-2-rokote – Finnish\">Suomi</a></li><li class=\"interlanguage-link interwiki-sv\"><a class=\"interlanguage-link-target\" href=\"https://sv.wikipedia.org/wiki/Covid-19-vaccin\" hreflang=\"sv\" lang=\"sv\" title=\"Covid-19-vaccin – Swedish\">Svenska</a></li><li class=\"interlanguage-link interwiki-ta\"><a class=\"interlanguage-link-target\" href=\"https://ta.wikipedia.org/wiki/%E0%AE%95%E0%AF%8A%E0%AE%B0%E0%AF%8B%E0%AE%A9%E0%AE%BE%E0%AE%B5%E0%AF%88%E0%AE%B0%E0%AE%9A%E0%AF%81%E0%AE%A4%E0%AF%8D_%E0%AE%A4%E0%AF%8A%E0%AE%B1%E0%AF%8D%E0%AE%B1%E0%AF%81_2019_%E0%AE%A4%E0%AE%9F%E0%AF%81%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%82%E0%AE%9A%E0%AE%BF_%E0%AE%86%E0%AE%AF%E0%AF%8D%E0%AE%B5%E0%AF%81\" hreflang=\"ta\" lang=\"ta\" title=\"கொரோனாவைரசுத் தொற்று 2019 தடுப்பூசி ஆய்வு – Tamil\">தமிழ்</a></li><li class=\"interlanguage-link interwiki-kab\"><a class=\"interlanguage-link-target\" href=\"https://kab.wikipedia.org/wiki/Tigezt_mgal_Covid-19\" hreflang=\"kab\" lang=\"kab\" title=\"Tigezt mgal Covid-19 – Kabyle\">Taqbaylit</a></li><li class=\"interlanguage-link interwiki-th\"><a class=\"interlanguage-link-target\" href=\"https://th.wikipedia.org/wiki/%E0%B8%A7%E0%B8%B1%E0%B8%84%E0%B8%8B%E0%B8%B5%E0%B8%99%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B8%95%E0%B8%B4%E0%B8%94%E0%B9%80%E0%B8%8A%E0%B8%B7%E0%B9%89%E0%B8%AD%E0%B9%84%E0%B8%A7%E0%B8%A3%E0%B8%B1%E0%B8%AA%E0%B9%82%E0%B8%84%E0%B9%82%E0%B8%A3%E0%B8%99%E0%B8%B2_2019\" hreflang=\"th\" lang=\"th\" title=\"วัคซีนโรคติดเชื้อไวรัสโคโรนา 2019 – Thai\">ไทย</a></li><li class=\"interlanguage-link interwiki-tr\"><a class=\"interlanguage-link-target\" href=\"https://tr.wikipedia.org/wiki/COVID-19_a%C5%9F%C4%B1s%C4%B1\" hreflang=\"tr\" lang=\"tr\" title=\"COVID-19 aşısı – Turkish\">Türkçe</a></li><li class=\"interlanguage-link interwiki-uk\"><a class=\"interlanguage-link-target\" href=\"https://uk.wikipedia.org/wiki/%D0%92%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D0%B0_%D0%BF%D1%80%D0%BE%D1%82%D0%B8_COVID-19\" hreflang=\"uk\" lang=\"uk\" title=\"Вакцина проти COVID-19 – Ukrainian\">Українська</a></li><li class=\"interlanguage-link interwiki-ur\"><a class=\"interlanguage-link-target\" href=\"https://ur.wikipedia.org/wiki/%DA%A9%D9%88%D9%88%DA%88-%D9%A1%D9%A9_%D9%88%DB%8C%DA%A9%D8%B3%DB%8C%D9%86\" hreflang=\"ur\" lang=\"ur\" title=\"کووڈ-١٩ ویکسین – Urdu\">اردو</a></li><li class=\"interlanguage-link interwiki-ug\"><a class=\"interlanguage-link-target\" href=\"https://ug.wikipedia.org/wiki/%D9%8A%DB%90%DA%AD%D9%89_%D8%AA%D9%89%D9%BE%D8%AA%D9%89%D9%83%D9%89_%D8%AA%D8%A7%D8%AC%D8%B3%D9%89%D9%85%D8%A7%D9%86_%DB%8B%D9%89%D8%B1%DB%87%D8%B3_%D9%83%DB%90%D8%B3%D9%89%D9%84%D9%89_%DB%8B%D8%A7%D9%83%D8%B3%D9%89%D9%86%D9%89%D8%B3%D9%89(%D9%83%D9%88%DB%8B%D9%89%D8%AF-19_%D9%83%DB%90%D8%B3%D9%89%D9%84%D9%89_%DB%8B%D8%A7%D9%83%D8%B3%D9%89%D9%86%D9%89%D8%B3%D9%89)\" hreflang=\"ug\" lang=\"ug\" title=\"يېڭى تىپتىكى تاجسىمان ۋىرۇس كېسىلى ۋاكسىنىسى(كوۋىد-19 كېسىلى ۋاكسىنىسى) – Uyghur\">ئۇيغۇرچە / Uyghurche</a></li><li class=\"interlanguage-link interwiki-vi\"><a class=\"interlanguage-link-target\" href=\"https://vi.wikipedia.org/wiki/V%E1%BA%AFc-xin_COVID-19\" hreflang=\"vi\" lang=\"vi\" title=\"Vắc-xin COVID-19 – Vietnamese\">Tiếng Việt</a></li><li class=\"interlanguage-link interwiki-zh\"><a class=\"interlanguage-link-target\" href=\"https://zh.wikipedia.org/wiki/2019%E5%86%A0%E7%8A%B6%E7%97%85%E6%AF%92%E7%97%85%E7%96%AB%E8%8B%97\" hreflang=\"zh\" lang=\"zh\" title=\"2019冠状病毒病疫苗 – Chinese\">中文</a></li></ul>\n",
            "<div class=\"after-portlet after-portlet-lang\"><span class=\"wb-langlinks-edit wb-langlinks-link\"><a class=\"wbc-editpage\" href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q87719492#sitelinks-wikipedia\" title=\"Edit interlanguage links\">Edit links</a></span></div>\n",
            "</div>\n",
            "</nav>\n",
            "</div>\n",
            "</div>\n",
            "<footer class=\"mw-footer\" id=\"footer\" role=\"contentinfo\">\n",
            "<ul id=\"footer-info\">\n",
            "<li id=\"footer-info-lastmod\"> This page was last edited on 16 October 2020, at 01:04<span class=\"anonymous-show\"> (UTC)</span>.</li>\n",
            "<li id=\"footer-info-copyright\">Text is available under the <a href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License\" rel=\"license\">Creative Commons Attribution-ShareAlike License</a><a href=\"//creativecommons.org/licenses/by-sa/3.0/\" rel=\"license\" style=\"display:none;\"></a>;\n",
            "additional terms may apply.  By using this site, you agree to the <a href=\"//foundation.wikimedia.org/wiki/Terms_of_Use\">Terms of Use</a> and <a href=\"//foundation.wikimedia.org/wiki/Privacy_policy\">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href=\"//www.wikimediafoundation.org/\">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>\n",
            "</ul>\n",
            "<ul id=\"footer-places\">\n",
            "<li id=\"footer-places-privacy\"><a class=\"extiw\" href=\"https://foundation.wikimedia.org/wiki/Privacy_policy\" title=\"wmf:Privacy policy\">Privacy policy</a></li>\n",
            "<li id=\"footer-places-about\"><a href=\"/wiki/Wikipedia:About\" title=\"Wikipedia:About\">About Wikipedia</a></li>\n",
            "<li id=\"footer-places-disclaimer\"><a href=\"/wiki/Wikipedia:General_disclaimer\" title=\"Wikipedia:General disclaimer\">Disclaimers</a></li>\n",
            "<li id=\"footer-places-contact\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\">Contact Wikipedia</a></li>\n",
            "<li id=\"footer-places-mobileview\"><a class=\"noprint stopMobileRedirectToggle\" href=\"//en.m.wikipedia.org/w/index.php?title=COVID-19_vaccine&amp;mobileaction=toggle_view_mobile\">Mobile view</a></li>\n",
            "<li id=\"footer-places-developers\"><a href=\"https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute\">Developers</a></li>\n",
            "<li id=\"footer-places-statslink\"><a href=\"https://stats.wikimedia.org/#/en.wikipedia.org\">Statistics</a></li>\n",
            "<li id=\"footer-places-cookiestatement\"><a href=\"https://foundation.wikimedia.org/wiki/Cookie_statement\">Cookie statement</a></li>\n",
            "</ul>\n",
            "<ul class=\"noprint\" id=\"footer-icons\">\n",
            "<li id=\"footer-copyrightico\"><a href=\"https://wikimediafoundation.org/\"><img alt=\"Wikimedia Foundation\" height=\"31\" loading=\"lazy\" src=\"/static/images/footer/wikimedia-button.png\" srcset=\"/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x\" width=\"88\"/></a></li>\n",
            "<li id=\"footer-poweredbyico\"><a href=\"https://www.mediawiki.org/\"><img alt=\"Powered by MediaWiki\" height=\"31\" loading=\"lazy\" src=\"/static/images/footer/poweredby_mediawiki_88x31.png\" srcset=\"/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x\" width=\"88\"/></a></li>\n",
            "</ul>\n",
            "<div style=\"clear: both;\"></div>\n",
            "</footer>\n",
            "<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgPageParseReport\":{\"limitreport\":{\"cputime\":\"2.708\",\"walltime\":\"2.979\",\"ppvisitednodes\":{\"value\":21382,\"limit\":1000000},\"postexpandincludesize\":{\"value\":1041476,\"limit\":2097152},\"templateargumentsize\":{\"value\":22318,\"limit\":2097152},\"expansiondepth\":{\"value\":13,\"limit\":40},\"expensivefunctioncount\":{\"value\":9,\"limit\":500},\"unstrip-depth\":{\"value\":1,\"limit\":20},\"unstrip-size\":{\"value\":958437,\"limit\":5000000},\"entityaccesscount\":{\"value\":0,\"limit\":400},\"timingprofile\":[\"100.00% 2364.278      1 -total\",\" 63.72% 1506.406      3 Template:Reflist\",\" 24.40%  576.900    138 Template:Cite_web\",\" 21.55%  509.472     71 Template:Cite_journal\",\"  7.62%  180.272     41 Template:Cite_news\",\"  3.95%   93.432      1 Template:Pp-semi\",\"  2.99%   70.710      1 Template:COVID-19_pandemic\",\"  2.34%   55.234      1 Template:Short_description\",\"  2.29%   54.155     48 Template:ClinicalStudyInfo\",\"  1.53%   36.071     28 Template:US$\"]},\"scribunto\":{\"limitreport-timeusage\":{\"value\":\"1.378\",\"limit\":\"10.000\"},\"limitreport-memusage\":{\"value\":11127045,\"limit\":52428800},\"limitreport-logs\":\"table#1 {\\n  [\\\"size\\\"] = \\\"tiny\\\",\\n  [\\\"text\\\"] = \\\"COVID-19 Portal\\\",\\n}\\n\",\"limitreport-profile\":[[\"?\",\"220\",\"15.3\"],[\"Scribunto_LuaSandboxCallback::match\",\"160\",\"11.1\"],[\"Scribunto_LuaSandboxCallback::find\",\"140\",\"9.7\"],[\"Scribunto_LuaSandboxCallback::gsub\",\"120\",\"8.3\"],[\"dataWrapper \\u003Cmw.lua:661\\u003E\",\"120\",\"8.3\"],[\"Scribunto_LuaSandboxCallback::callParserFunction\",\"120\",\"8.3\"],[\"recursiveClone \\u003CmwInit.lua:41\\u003E\",\"80\",\"5.6\"],[\"\\u003Cmw.lua:683\\u003E\",\"60\",\"4.2\"],[\"Scribunto_LuaSandboxCallback::plain\",\"60\",\"4.2\"],[\"\\u003CModule:Citation/CS1:815\\u003E\",\"40\",\"2.8\"],[\"[others]\",\"320\",\"22.2\"]]},\"cachereport\":{\"origin\":\"mw2365\",\"timestamp\":\"20201017063903\",\"ttl\":2592000,\"transientcontent\":false}}});});</script>\n",
            "<script type=\"application/ld+json\">{\"@context\":\"https:\\/\\/schema.org\",\"@type\":\"Article\",\"name\":\"COVID-19 vaccine\",\"url\":\"https:\\/\\/en.wikipedia.org\\/wiki\\/COVID-19_vaccine\",\"sameAs\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q87719492\",\"mainEntity\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q87719492\",\"author\":{\"@type\":\"Organization\",\"name\":\"Contributors to Wikimedia projects\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Wikimedia Foundation, Inc.\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\/\\/www.wikimedia.org\\/static\\/images\\/wmf-hor-googpub.png\"}},\"datePublished\":\"2020-03-08T17:51:40Z\",\"dateModified\":\"2020-10-16T01:04:52Z\",\"image\":\"https:\\/\\/upload.wikimedia.org\\/wikipedia\\/commons\\/8\\/82\\/SARS-CoV-2_without_background.png\",\"headline\":\"hypothetical vaccine against coronavirus\"}</script>\n",
            "<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgBackendResponseTime\":152,\"wgHostname\":\"mw2355\"});});</script>\n",
            "</body></html>\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "2k3guSCJS8b8"
      },
      "source": [
        "text = \" \"\n",
        "for paragraph in obj2.find_all('p'):\n",
        "  text += paragraph.text"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "NIIkF1hRZz_F",
        "outputId": "982b5a22-c2e0-4e16-aab8-cda535873f4f",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        }
      },
      "source": [
        "print(text)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            " \n",
            "\n",
            "A COVID‑19 vaccine is any of several different vaccines intended to  provide acquired immunity against coronavirus disease 2019 (COVID‑19). Previous work to develop a vaccine against the coronavirus diseases SARS and MERS established knowledge about the structure and function of coronaviruses – which accelerated development during early 2020 of varied technology platforms for a COVID‑19 vaccine.[1] As of October 2020, there were 321 vaccine candidates in development, a 2.5 fold increase since April. However, no candidate has completed clinical trials to prove its safety and efficacy.[2] In October, some 42 vaccine candidates were in clinical research: namely 33 in Phase I–II trials and 9 in Phase II–III trials.[2][3][4][5]\n",
            "The World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and the Gates Foundation (GF) are committing money and organizational resources for the prospect that several vaccines will be needed to prevent continuing COVID‑19 infection.[6] The CEPI, which is organizing a US$2 billion worldwide fund for rapid investment and development of vaccine candidates,[7] indicated in September that clinical data to support licensure may be available by the end of 2020.[2] On 4 May 2020, the WHO organized a telethon which received US$8.1 billion in pledges from forty countries to support rapid development of vaccines to prevent COVID‑19 infections.[8] At the same time, the WHO also announced the deployment of an international \"Solidarity trial\" for simultaneous evaluation of several vaccine candidates reaching Phase II–III clinical trials.[9]\n",
            "Vaccines have been produced against several animal diseases caused by coronaviruses, including as of 2003 infectious bronchitis virus in birds, canine coronavirus, and feline coronavirus.[10] Previous projects to develop vaccines for viruses in the family Coronaviridae that affect humans have been aimed at severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Vaccines against SARS[11] and MERS[12] have been tested in non-human animals.\n",
            "According to studies published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and public health agencies around the world at that time.[13][14][15] As of 2020, there is no cure or protective vaccine proven to be safe and effective against SARS in humans.[16][17]\n",
            "There is also no proven vaccine against MERS.[18] When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.[16][19] As of March 2020, there was one (DNA based) MERS vaccine which completed Phase I clinical trials in humans,[20] and three others in progress, all of which are viral-vectored vaccines: two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), and one MVA-vectored (MVA-MERS-S).[21]\n",
            "A vaccine for an infectious disease has never before been produced in less than several years, and no vaccine exists for preventing a coronavirus infection in humans.[6] After the coronavirus was detected in December 2019,[22] the genetic sequence of COVID‑19 was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten development of a preventive vaccine.[23][24][25]\n",
            "In February 2020, the World Health Organization (WHO) said it did not expect a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus, to become available in less than 18 months.[26] The rapidly growing infection rate of COVID‑19 worldwide during early 2020 stimulated international alliances and government efforts to urgently organize resources to make multiple vaccines on shortened timelines,[9] with four vaccine candidates entering human evaluation in March (see the table of clinical trials started in 2020, below).[23][27]\n",
            "In April 2020, the WHO estimated a total cost of US$8 billion to develop a suite of three or more vaccines having different technologies and distribution.[9][28]\n",
            "By April 2020, \"almost 80 companies and institutes in 19 countries\" were working on this virtual gold rush.[29] Also in April, CEPI estimated that as many as six of the vaccine candidates against COVID‑19 should be chosen by international coalitions for development through Phase II–III trials, and three should be streamlined through regulatory and quality assurance for eventual licensing at a total cost of at least US$2 billion.[2][27][6] Another analysis estimates 10 candidates will need simultaneous initial development, before a select few are chosen for the final path to licensing.[6]\n",
            "In July 2020, Anglo-American intelligence and security organisations of the respective governments and armed forces, as the UK's National Cyber Security Centre, together with the Canadian Communications Security Establishment, the United States Department for Homeland Security Cybersecurity Infrastructure Security Agency, and the US National Security Agency (NSA) alleged that Russian state-backed hackers may have been trying to steal COVID-19 treatment and vaccine research from academic and pharmaceutical institutions in other countries; Russia has denied it.[30]\n",
            "During 2020, major changes in the overall effort of developing COVID-19 vaccines since early in the year have been the increasing number of collaborations of the multinational pharmaceutical industry with national governments, and the diversity and growing number of biotechnology companies in many countries focusing on a COVID-19 vaccine.[2] According to CEPI, the general geographic distribution of COVID‑19 vaccine development involves organizations in North America having about 40% of the world's COVID-19 vaccine research, compared with 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.[2][23]\n",
            "Organizations have formed international alliances to expedite vaccine development and prepare for distribution, including the WHO which is facilitating collaboration, accelerated research, and international communications on a scale unprecedented in history, beginning in early May by raising US$8.1 billion in pledges.[8] The WHO also implemented Covid-19 Vaccines Global Access (COVAX) for coordinating global vaccine development, the vaccine pillar of Access to COVID-19 Tools (ACT) Accelerator in collaboration with GAVI and the Coalition for Epidemic Preparedness Innovations (CEPI).[2][31][32] In July, the WHO announced that 165 countries, representing up to 60% of the world population, had agreed to a WHO COVAX plan for fair and equitable distribution of an eventual licensed vaccine, assuring that each participating country would receive a guaranteed share of doses to vaccinate the most vulnerable 20% of its population by the end of 2021.[33] COVAX has the goal to accelerate the development and manufacturing of COVID-19 vaccines, and to assure that access to licensed vaccines is equitably provided to all countries.[32]\n",
            "CEPI is working with international health authorities and vaccine developers to create another US$2 billion fund in a global partnership between public, private, philanthropic, and civil society organizations for accelerated research and clinical testing of eight vaccine candidates, with the 2020–21 goal of supporting several candidates for full development to licensing.[2][27][28] The United Kingdom, Canada, Belgium, Norway, Switzerland, Germany and the Netherlands had already donated US$915 million to CEPI by early May.[8][34] The Bill & Melinda Gates Foundation (Gates Foundation), a private charitable organization dedicated to vaccine research and distribution, is donating US$250 million in support of CEPI for research and public educational support on COVID‑19 vaccines.[35][36]\n",
            "The Global Research Collaboration for Infectious Disease Preparedness (GLoPID-R) is working closely with the WHO and member states to identify priorities for funding specific researches needed for a COVID‑19 vaccine, coordinating among the international funding and research organizations to maintain updated information on vaccine progress and avoid duplicate funding.[37][38]\n",
            "The International Severe Acute Respiratory and Emerging Infection Consortium is organizing and disseminating clinical information on COVID‑19 research to inform public health policy on eventual vaccine distribution.[39]\n",
            "On 4 June, a virtual summit was coordinated from London, UK, among private and government representatives of 52 countries, including 35 heads of state from G7 and G20 nations, to raise US$8.8 billion in support of the Global Alliance for Vaccines and Immunisation (GAVI) to prepare for COVID‑19 vaccinations of 300 million children in under-developed countries through 2025.[40] Major contributions were US$1.6 billion from The Gates Foundation[41] and GB£330 million per year over five years by the UK government (approximately US$2.1 billion in June 2020).[40]\n",
            "National governments dedicating resources for national or international investments in vaccine research, development, and manufacturing beginning in 2020 included the Canadian government which announced CA$275 million in funding for 96 research vaccine research projects at Canadian companies and universities, with plans to establish a \"vaccine bank\" of several new vaccines that could be used if another coronavirus outbreak occurs.[42][43] A further investment of CA$1.1 billion was added to support clinical trials in Canada and develop manufacturing and supply chains for vaccines.[38] On 4 May, the Canadian government committed CA$850 million to the WHO's live streaming effort to raise US$8 billion for COVID‑19 vaccines and preparedness.[44]\n",
            "In China, the government is providing low-rate loans to a vaccine developer through its central bank, and has \"quickly made land available for the company\" to build production plants.[34] As of June 2020, six of the eleven COVID‑19 vaccine candidates in early-stage human testing were developed by Chinese organizations.[35] Three Chinese vaccine companies and research institutes are supported by the government for financing research, conducting clinical trials, and manufacturing the most promising vaccine candidates, while prioritizing rapid evidence of efficacy over safety.[45] On 18 May, China had pledged US$2 billion to support overall efforts by the WHO for programs against COVID‑19.[46] On 22 July, China additionally announced that it plans to provide a US$1 billion loan to make its vaccine accessible for countries in Latin America and the Caribbean.[47] On August 24, Chinese Premier Li Keqiang announced it would provide five Southeast Asian countries of Cambodia, Laos, Myanmar, Thailand and Vietnam priority access to the vaccine once it was fully developed.[48]\n",
            "Among European Union countries, France announced a US$4.9 million investment in a COVID‑19 vaccine research consortium via CEPI involving the Institut Pasteur, Themis Bioscience (Vienna, Austria), and the University of Pittsburgh, bringing CEPI's total investment in COVID‑19 vaccine development to US$480 million by May.[49][50] In March, the European Commission made an €80 million investment in CureVac, a German biotechnology company, to develop a mRNA vaccine.[51] The German government announced a separate €300 million investment in CureVac in June.[52] Belgium, Norway, Switzerland, Germany, and the Netherlands have been major contributors to the CEPI effort for COVID‑19 vaccine research in Europe.[34]\n",
            "In April, the UK government formed a COVID‑19 vaccine task force to stimulate British efforts for rapidly developing a vaccine through collaborations of industry, universities, and government agencies across the vaccine development pipeline, including clinical trial placement at UK hospitals, regulations for approval, and eventual manufacturing.[53] The vaccine development initiatives at the University of Oxford and Imperial College of London were financed with GB£44 million in April.[54][55]\n",
            "The United States Biomedical Advanced Research and Development Authority (BARDA), a federal agency that funds disease-fighting technology, announced investments of nearly US$1 billion to support American COVID‑19 vaccine development, and preparation for manufacturing the most promising candidates. On 16 April, BARDA made a US$483 million investment in the vaccine developer, Moderna and its partner, Johnson & Johnson.[34][56] BARDA has an additional US$4 billion to spend on vaccine development, and will have roles in other American investment for development of six to eight vaccine candidates to be in clinical studies over 2020–21 by companies such as Sanofi Pasteur and Regeneron.[56][57] On 15 May, the US government announced federal funding for a fast-track program called Operation Warp Speed, which has the goals of placing diverse vaccine candidates in clinical trials by the fall of 2020, and manufacturing 300 million doses of a licensed vaccine by January 2021. The project chief advisor is Moncef Slaoui and its Chief Operating Officer is Army General Gustave Perna.[58][59] In June, the Warp Speed team said it would work with seven companies developing COVID‑19 vaccine candidates: Moderna, Johnson & Johnson, Merck, Pfizer, and the University of Oxford in collaboration with AstraZeneca, as well as two others.[60]\n",
            "In April 2020, the WHO published an \"R&D Blueprint (for the) novel Coronavirus\" (Blueprint). The Blueprint documented a \"large, international, multi-site, individually randomized controlled clinical trial\" to allow \"the concurrent evaluation of the benefits and risks of each promising candidate vaccine within 3-6 months of it being made available for the trial.\" The Blueprint listed a Global Target Product Profile (TPP) for COVID‑19, identifying favorable attributes of safe and effective vaccines under two broad categories: \"vaccines for the long-term protection of people at higher risk of COVID‑19, such as healthcare workers\", and other vaccines to provide rapid-response immunity for new outbreaks.[9] The international TPP team was formed to 1) assess the development of the most promising candidate vaccines; 2) map candidate vaccines and their clinical trial worldwide, publishing a frequently-updated \"landscape\" of vaccines in development;[5] 3) rapidly evaluate and screen for the most promising candidate vaccines simultaneously before they are tested in humans; and 4) design and coordinate a multiple-site, international randomized controlled trial – the \"Solidarity trial\" for vaccines[9][61] – to enable simultaneous evaluation of the benefits and risks of different vaccine candidates under clinical trials in countries where there are high rates of COVID‑19 disease, ensuring fast interpretation and sharing of results around the world.[9] The WHO vaccine coalition will prioritize which vaccines should go into Phase II and III clinical trials, and determine harmonized Phase III protocols for all vaccines achieving the pivotal trial stage.[9]\n",
            "A clinical trial design in progress may be modified as an \"adaptive design\" if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment.[62][63] The WHO Solidarity trial of multiple vaccines in clinical studies during 2020 will apply adaptive design to rapidly alter trial parameters across all study sites as results emerge.[61] Candidate vaccines may be added to the Solidarity trial as they become available if priority criteria are met, while vaccine candidates showing poor evidence of safety or efficacy compared to placebo or other vaccines will be dropped from the international trial.[61]\n",
            "Adaptive designs within ongoing Phase II–III clinical trials on candidate vaccines may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, avoiding duplication of research efforts, and enhancing coordination of design changes for the Solidarity trial across its international locations.[61][62]\n",
            "Large pharmaceutical companies with experience in making vaccines at scale, including Johnson & Johnson, AstraZeneca, and GlaxoSmithKline (GSK), are forming alliances with biotechnology companies, national governments, and universities to accelerate progression to an effective vaccine.[34][35] To combine financial and manufacturing capabilities for a pandemic adjuvanted vaccine technology, GSK joined with Sanofi in an uncommon partnership of multinational companies to support accelerated vaccine development.[64]\n",
            "During a pandemic on the rapid timeline and scale of COVID‑19 infections during 2020, international organizations like the WHO and CEPI, vaccine developers, governments, and industry are evaluating distribution of the eventual vaccine(s).[9] Individual countries producing a vaccine may be persuaded to favor the highest bidder for manufacturing or provide first-service to their own country.[6][24][34] Experts emphasize that licensed vaccines should be available and affordable for people at the frontline of healthcare and having the greatest need.[6][24][34] Under their agreement with AstraZeneca, the University of Oxford vaccine development team and UK government agreed that UK citizens would not get preferential access to a new COVID‑19 vaccine developed by the taxpayer-funded university, but rather consented to having a licensed vaccine distributed multinationally in cooperation with the WHO.[54] Several companies plan to initially manufacture a vaccine at low cost, then increase costs for profitability later if annual vaccinations are needed and as countries build stock for future needs.[34]\n",
            "The WHO and CEPI are developing financial resources and guidelines for global deployment of several safe, effective COVID‑19 vaccines, recognizing the need is different across countries and population segments.[2][9][27][61] For example, successful COVID‑19 vaccines would likely be allocated first to healthcare personnel and populations at greatest risk of severe illness and death from COVID‑19 infection, such as the elderly or densely-populated impoverished people.[32][65] The WHO, CEPI, and GAVI have expressed concerns that affluent countries should not receive priority access to the global supply of eventual COVID‑19 vaccines, but rather protecting healthcare personnel and people at high risk of infection are needed to address public health concerns and reduce economic impact of the pandemic.[23][27][32]\n",
            "Geopolitical issues, safety concerns for vulnerable populations, and manufacturing challenges for producing billions of doses are compressing schedules to shorten the standard vaccine development timeline, in some cases combining clinical trial steps over months, a process typically conducted sequentially over years.[35] As an example, Chinese vaccine developers and the government Chinese Center for Disease Control and Prevention began their efforts in January 2020,[66] and by March were pursuing numerous candidates on short timelines, with the goal to showcase Chinese technology strengths over those of the United States, and to reassure the Chinese people about the quality of vaccines produced in China.[35][67]\n",
            "In the haste to provide a vaccine on a rapid timeline for the COVID‑19 pandemic, developers and governments are accepting a high risk of \"short-circuiting\" the vaccine development process,[34] with one industry executive saying: \"The crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop\".[34] Multiple steps along the entire development path are evaluated, including the level of acceptable toxicity of the vaccine (its safety), targeting vulnerable populations, the need for vaccine efficacy breakthroughs, the duration of vaccination protection, special delivery systems (such as oral or nasal, rather than by injection), dose regimen, stability and storage characteristics, emergency use authorization before formal licensing, optimal manufacturing for scaling to billions of doses, and dissemination of the licensed vaccine.[6][68] From Phase I clinical trials, 84–90%[23][69]of vaccine candidates fail to make it to final approval during development, and from Phase III, 25.7% fail[69] – the investment by a manufacturer in a vaccine candidate may exceed US$1 billion and end with millions of useless doses.[6][34][35] In the case of COVID‑19 specifically, a vaccine efficacy of 70% may be enough to stop the pandemic, but if it has only 60% efficacy, outbreaks may continue; an efficacy of less than 60% will not provide enough herd immunity to stop the spread of the virus alone.[6]\n",
            "As the pandemic expands during 2020, research at universities is obstructed by physical distancing and closing of laboratories.[70][71] Globally, supplies critical to vaccine research and development are increasingly scarce due to international competition or national sequestration.[45] Timelines for conducting clinical research – normally a sequential process requiring years – are being compressed into safety, efficacy, and dosing trials running simultaneously over months, potentially compromising safety assurance.[34][35]\n",
            "CEPI scientists reported in September 2020 that nine different technology platforms  –  with the technology of numerous candidates remaining undefined  –  were under research and development during 2020 to create an effective vaccine against COVID‑19.[2] According to CEPI, most of the platforms of vaccine candidates in clinical trials as of September are focused on the coronavirus spike protein and its variants as the primary antigen of COVID-19 infection.[2] Platforms being developed in 2020 involve nucleic acid technologies (RNA and DNA), non-replicating viral vectors, peptides, recombinant proteins, live attenuated viruses, and inactivated viruses.[2][1][6][23]\n",
            "Many vaccine technologies being developed for COVID‑19 are not like vaccines already in use to prevent influenza, but rather are using \"next-generation\" strategies for precision on COVID‑19 infection mechanisms.[2][1][23] Vaccine platforms in development may improve flexibility for antigen manipulation and effectiveness for targeting mechanisms of COVID‑19 infection in susceptible population subgroups, such as healthcare workers, the elderly, children, pregnant women, and people with existing weakened immune systems.[2][23]\n",
            "^ technologies for dozens of candidates are unannounced or \"unknown\"[3]\n",
            "\n",
            "CEPI classifies development stages for vaccines as \"exploratory\" (planning and designing a candidate, having no evaluation in vivo), \"preclinical\" (in vivo evaluation with preparation for manufacturing a compound to test in humans), or initiation of Phase I safety studies in healthy people.[2] Some 321 total vaccine candidates are in development as either confirmed projects in clinical trials or in early-stage \"exploratory\" or \"preclinical\" development, as of September.[2]\n",
            "Phase I trials test primarily for safety and preliminary dosing in a few dozen healthy subjects, while Phase II trials – following success in Phase I – evaluate immunogenicity, dose levels (efficacy based on biomarkers) and adverse effects of the candidate vaccine, typically in hundreds of people.[72][73] A Phase I–II trial consists of preliminary safety and immunogenicity testing, is typically randomized, placebo-controlled, while determining more precise, effective doses.[73]  Phase III trials typically involve more participants at multiple sites, include a control group, and test effectiveness of the vaccine to prevent the disease (an \"interventional\" or \"pivotal\" trial), while monitoring for adverse effects at the optimal dose.[72][73] Definition of vaccine safety, efficacy, and clinical endpoints in a Phase III trial may vary between the trials of different companies, such as defining the degree of side effects, infection or amount of transmission, and whether the vaccine prevents moderate or severe COVID‑19 infection.[74][75][76]\n",
            "On September 14, UAE approved Sinopharm's vaccine for emergency use by front-line healthcare workers following successful interim results in the Phase III trials.[90]\n",
            "Pakistan\n",
            "Sep 2020 – December 2021 in Pakistan\n",
            "Janssen Pharmaceutica (Johnson & Johnson), BIDMC\n",
            "Temporarily paused on October 13 2020 due to an unexplained illness in a participant.[114]\n",
            "Arcturus Therapeutics\n",
            "In April 2020, the WHO issued a statement representing dozens of vaccine scientists around the world, pledging collaboration to speed development of a vaccine against COVID‑19.[148] The WHO coalition is encouraging international cooperation between organizations developing vaccine candidates, national regulatory and policy agencies, financial contributors, public health associations, and governments, for eventual manufacturing of a successful vaccine in quantities sufficient to supply all affected regions, particularly low-resource countries.[23]\n",
            "Industry analysis of past vaccine development shows failure rates of 84–90%.[23][69] Because COVID‑19 is a novel virus target with properties still being discovered and requiring innovative vaccine technologies and development strategies, the risks associated with developing a successful vaccine across all steps of preclinical and clinical research are high.[23]\n",
            "To assess potential for vaccine efficacy, unprecedented computer simulations and new COVID‑19-specific animal models are being developed multinationally during 2020, but these methods remain untested by unknown characteristics of the COVID‑19 virus.[23] Of the confirmed active vaccine candidates, about 70% are being developed by private companies, with the remaining projects under development by academic, government coalitions, and health organizations.[2]\n",
            "Most of the vaccine developers are small firms or university research teams with little experience in successful vaccine design and limited capacity for advanced clinical trial costs and manufacturing without partnership by multinational pharmaceutical companies.[2][23]\n",
            "Many vaccine candidates under design or preclinical development for COVID‑19 will not gain approval for human studies in 2020 due to toxicity, ineffectiveness to induce immune responses or dosing failures in laboratory animals, or because of underfunding.[149][150] The probability of success for an infectious disease vaccine candidate to pass preclinical barriers and reach Phase I of human testing is 41-57%.[149]\n",
            "Commitment to first-in-human testing of a vaccine candidate represents a substantial capital cost for vaccine developers, estimated to be from US$14 million to US$25 million for a typical Phase I trial program, but possibly as much as US$70 million.[149][151] For comparison, during the Ebola virus epidemic of 2013-16, there were 37 vaccine candidates in urgent development, but only one eventually succeeded as a licensed vaccine, involving a total cost to confirm efficacy in Phase II–III trials of about US$1 billion.[149]\n",
            "Some vaccines have non-specific effects beyond the disease they prevent.[152]\n",
            "Assertions have been made that COVID‑19 mortality has been lower in countries having routine BCG vaccine administered against tuberculosis,[153][154][155][156] though the World Health Organization (WHO) has said there is no evidence that this vaccine is effective against the COVID‑19 virus.[157] In March 2020, a randomized trial of BCG vaccine to reduce COVID‑19 illness began in the Netherlands, seeking to recruit 1,000 healthcare workers.[158] A further randomized trial in Australia is seeking to enroll 4,170 healthcare workers.[159][160]\n",
            "In June 2020, a randomized placebo-controlled trial to test whether the measles-mumps-rubella vaccine (MMR) can protect healthcare workers from COVID‑19 began with 200 participants in Cairo.[161]\n",
            "In September 2020, eleven of the vaccine candidates in clinical development used adjuvants to enhance immunogenicity.[2] An immunological adjuvant is a substance formulated with a vaccine to elevate the immune response to an antigen, such as the COVID-19 virus or influenza virus.[162] Specifically, an adjuvant may be used in formulating a COVID-19 vaccine candidate to boost its immunogenicity and efficacy to reduce or prevent COVID-19 infection in vaccinated individuals.[162][163] Adjuvants used in COVID-19 vaccine formulation may be particularly effective for technologies using the inactivated COVID-19 virus and recombinant protein-based or vector-based vaccines.[163] Aluminum salts, known as \"alum\", were the first adjuvant used for licensed vaccines, and are the adjuvant of choice in some 80% of adjuvanted vaccines.[163] The alum adjuvant initiates diverse molecular and cellular mechanisms to enhance immunogenicity, including release of proinflammatory cytokines.[162][163] A potential drawback of adjuvanted vaccines is that the virus evolves in a way to avoid the induced vaccine response, making the adjuvant-vaccine technology misdesigned against a changed virus.[162] Such a change would require revised manufacturing and increased costs that discourage the routine use of adjuvants.[162][163]\n",
            "The rapid development and urgency of producing a vaccine for the COVID‑19 pandemic may increase the risks and failure rate of delivering a safe, effective vaccine.[1][23][164] One study found that between 2006 and 2015, the success rate of obtaining approval from Phase I to successful Phase III trials was 16.2% for vaccines,[69] and CEPI indicates a potential success rate of only 10% for vaccine candidates in 2020 development.[23]\n",
            "An April 2020 CEPI report stated: \"Strong international coordination and cooperation between vaccine developers, regulators, policymakers, funders, public health bodies and governments will be needed to ensure that promising late-stage vaccine candidates can be manufactured in sufficient quantities and equitably supplied to all affected areas, particularly low-resource regions.\"[23] However, some 10% of the public perceives vaccines as unsafe or unnecessary, refusing vaccination – a global health threat called vaccine hesitancy[165] – which increases the risk of further viral spread that could lead to COVID‑19 outbreaks.[166] In mid-2020, estimates from two surveys were that 67% or 80% of people in the U.S. would accept a new vaccination against COVID-19, with wide disparity by education level, employment status, race, and geography.[167][168]\n",
            "Early research to assess vaccine efficacy using COVID‑19-specific animal models, such as ACE2-transgenic mice, other laboratory animals, and non-human primates, indicates a need for biosafety-level 3 containment measures for handling live viruses, and international coordination to ensure standardized safety procedures.[1][23]\n",
            "Although the quality and quantity of antibody production by a potential vaccine is intended to neutralize the COVID‑19 infection, a vaccine may have an unintended opposite effect by causing antibody-dependent disease enhancement (ADE), which increases the virus attachment to its target cells and might trigger the cytokine storm when the person will be infected by the virus after vaccination.[1][169] The vaccine technology platform (for example, viral vector vaccine, spike (S) protein vaccine or protein subunit vaccine), vaccine dose, timing of repeat vaccinations for the possible recurrence of COVID‑19 infection, and elderly age are factors determining the risk and extent of ADE.[1][169] The antibody response to a vaccine is a variable of vaccine technologies in development, including whether the vaccine has precision in its mechanism,[1] and choice of the route for how it is given (intramuscular, intradermal, oral, or nasal).[169][170]\n",
            "The effectiveness of new vaccine is defined by its efficacy. The efficacy of less than 60% may result in failure to create herd immunity.[6][170] Host-(\"vaccinee\")-related determinants that render a person susceptible to infection, such as genetics, health status (underlying disease, nutrition, pregnancy, sensitivities or allergies), immune competence, age, and economic impact or cultural environment can be primary or secondary factors affecting the severity of infection and response to a vaccine.[170] Elderly (above age 60), allergen-hypersensitive, and obese people have susceptibility to compromised immunogenicity, which prevents or inhibits vaccine effectiveness, possibly requiring separate vaccine technologies for these specific populations or repetitive booster vaccinations to limit virus transmission.[170] Further, mutations of the virus can alter its structure targeted by the vaccine, thus making the vaccine ineffective.[171][172]\n",
            "Vaccine developers have to invest resources internationally to find enough participants for Phase II–III clinical trials when the virus has proved to be a \"moving target\" of changing transmission rate across and within countries, forcing companies to compete for trial participants.[74] As an example in June, the Chinese vaccine developer Sinovac formed alliances in Malaysia, Canada, the UK, and Brazil among its plans to recruit trial participants and manufacture enough vaccine doses for a possible Phase III study in Brazil where COVID‑19 transmission was accelerating during June.[74] As the COVID‑19 pandemic within China became more isolated and controlled, Chinese vaccine developers sought international relationships to conduct advanced human studies in several countries, creating competition for trial participants with other manufacturers and the international Solidarity trial organized by the WHO.[74] In addition to competition over recruiting participants, clinical trial organizers may encounter  people unwilling to be vaccinated due to vaccine hesitancy[166] or disbelieving the science of the vaccine technology and its ability to prevent infection.[173]\n",
            "Having an insufficient number of skilled team members to administer vaccinations may hinder clinical trials that must overcome risks for trial failure, such as recruiting participants in rural or low-density geographic regions, and variations of age, race, ethnicity, or underlying medical conditions.[74][174]\n",
            "An effective vaccine for COVID-19 could save trillions of dollars in global economic impact, according to one expert, and would, therefore, make any price tag in the billions look small in comparison.[175] It is not yet known if it is possible to create a safe, reliable and affordable vaccine for this virus, and it is not yet known exactly how much the vaccine development will cost.[6][24][35] It is possible that billions of dollars could be invested without success.[34]\n",
            "The European Commission organized and held a video conference of world leaders on 4 May 2020, at which US$8 billion was raised for COVID-19 vaccine development.[176]\n",
            "After a vaccine is created, billions of doses will need to be manufactured and distributed worldwide. In April 2020, the Gates Foundation estimated that manufacturing and distribution could cost as much as US$25 billion.[177]\n",
            "Different vaccines have different shipping and handling requirements. For example, the Pfizer/BioNTech vaccine BNT162 must be shipped and stored at −70 °C (−94 °F), must be used within five days of thawing, and has a minimum order of 975 doses, making it unlikely to be rolled out in settings other than large, well-equipped hospitals.[178]\n",
            "Strategies are being considered for fast-tracking the licensing of a vaccine against COVID‑19, especially by compressing (to a few months) the usually lengthy duration of Phase II–III trials (typically many years).[179][180][181] Challenge studies have been implemented previously for diseases less deadly than COVID‑19 infection, such as common influenza, typhoid fever, cholera, and malaria.[180][182] Following preliminary proof of safety and efficacy of a candidate vaccine in laboratory animals and healthy humans, controlled challenge studies might be implemented to bypass typical Phase III research, providing an accelerated path to license a COVID‑19 vaccine.[179][182][180]\n",
            "A challenge study begins by simultaneously testing a vaccine candidate for immunogenicity and safety in laboratory animals and healthy adult volunteers (100 or fewer), something normally a sequential process using animals first.[179][180] If the initial tests are promising, the study proceeds by rapidly advancing the effective dose into a large-scale Phase II–III trial in previously-uninfected, low-risk volunteers (such as young adults), who would then be deliberately infected with COVID‑19 for comparison with a placebo control group.[179][180][182] Following the challenge, the volunteers would be monitored closely in clinics with life-saving resources, if needed.[179][180] Volunteering for a vaccine challenge study during the COVID‑19 pandemic is likened to the emergency service of healthcare personnel for COVID‑19-infected people, firefighters, or organ donors.[179]\n",
            "Although challenge studies are ethically questionable due to the unknown hazards for the volunteers of possible COVID‑19 disease enhancement and whether the vaccine received has long-term safety (among other cautions), challenge studies may be the only option to rapidly produce an effective vaccine that will minimize the projected millions of deaths worldwide from COVID‑19 infection,[179][183] according to some infectious disease experts.[179][180][182] The World Health Organization has developed a guidance document with criteria for conducting COVID‑19 challenge studies in healthy people, including scientific and ethical evaluation, public consultation and coordination, selection and informed consent of the participants, and monitoring by independent experts.[184]\n",
            "A vaccine licensure occurs after the successful conclusion of the clinical trials program through Phases I–III demonstrating safety, immunogenicity at a specific dose, effectiveness at preventing infection in target populations, and enduring preventive effect.[185] As part of a multinational licensure for a vaccine, the World Health Organization Expert Committee on Biological Standardization developed guidelines of international standards for manufacturing and quality control of vaccines, a process intended as a platform for national regulatory agencies to apply for their own licensure process.[185] Vaccine manufacturers do not receive licensure until a complete clinical package proves the vaccine is safe and has long-term effectiveness, following scientific review by a multinational or national regulatory organization, such as the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA).[186][187]\n",
            "Upon developing countries adopting WHO guidelines for vaccine development and licensure, each country has its own responsibility to issue a national licensure, and to manage, deploy, and monitor the vaccine throughout its use in each nation.[185] Building trust and acceptance of a licensed vaccine among the public is a task of communication by governments and healthcare personnel to ensure a vaccination campaign proceeds smoothly, saves lives, and enables economic recovery.[188] When a vaccine is licensed, it will initially be in limited supply due to variable manufacturing, distribution, and logistical factors, requiring an allocation plan for the limited supply and which population segments should be prioritized to first receive the vaccine.[188]\n",
            "Vaccines developed for multinational distribution via the United Nations Children's Fund (UNICEF) require pre-qualification by\n",
            "WHO to ensure international standards of quality, safety, immunogenicity, and efficacy for adoption by numerous countries.[185]\n",
            "The process requires manufacturing consistency at WHO-contracted laboratories following GMP practices.[185] When UN agencies are involved in vaccine licensure, individual nations collaborate by 1) issuing marketing authorization and a national license for the vaccine, its manufacturers, and distribution partners; and 2) conducting postmarketing surveillance, including records for adverse events after the vaccination program. WHO works with national agencies to monitor inspections of manufacturing facilities and distributors for compliance with GMP and regulatory oversight.[185]\n",
            "Some countries choose to buy vaccines licensed by reputable national organizations, such as EMA, FDA, or national agencies in other\n",
            "affluent countries, but such purchases typically are more expensive and may not have distribution resources suitable to local conditions in developing countries.[185]\n",
            "In the European Union (EU), vaccines for pandemic pathogens, such as seasonal influenza, are licensed EU-wide where all of the member states comply (\"centralized\"), are licensed for only some member states (\"decentralized\"), or are licensed on an individual national level.[186] Generally, all EU states follow regulatory guidance and clinical programs defined by the European Committee for Medicinal Products for Human Use (CHMP), a scientific panel of the European Medicines Agency (EMA) responsible for vaccine licensure.[186] The CHMP is supported by several expert groups who assess and monitor the progress of a vaccine before and after licensure and distribution.[186]\n",
            "In October 2020, the CHMP started 'rolling reviews' of the vaccines known as COVID-19 Vaccine AstraZeneca and BNT162b2.[189][190][191]\n",
            "Under the FDA, the process of establishing evidence for vaccine clinical safety and efficacy is the same as for the approval process for prescription drugs.[192] If successful through the stages of clinical development, the vaccine licensing process is followed by a Biologics License Application which must provide a scientific review team (from diverse disciplines, such as physicians, statisticians, microbiologists, chemists) a comprehensive documentation for the vaccine candidate having efficacy and safety throughout its development. Also during this stage, the proposed manufacturing facility is examined by expert reviewers for GMP compliance, and the label must have compliant description to enable health care providers definition of vaccine specific use, including its possible risks, to communicate and deliver the vaccine to the public.[192]\n",
            "As of August 2020 in the United States, there is no national strategy for how a successful vaccine will be ethically prioritized or distributed to vulnerable population segments, such as homeless and incarcerated people and the elderly.[167][188][193] After licensure, monitoring of the vaccine and its production, including periodic inspections for GMP compliance, continue as long as the manufacturer retains its license, which may include additional submissions to the FDA of tests for potency, safety, and purity for each vaccine manufacturing step.[192]\n",
            "At the beginning of the COVID-19 pandemic in early 2020, the WHO issued a guideline as an Emergency Use Listing of new vaccines, a process derived from the 2013-16 Ebola epidemic.[194] It required that a vaccine candidate developed for a life-threatening emergency be manufactured using GMP and that it complete development according to WHO prequalification procedures.[194]\n",
            "Even as new vaccines are developed during the COVID-19 pandemic, licensure of COVID-19 vaccine candidates requires submission of a full dossier of information on development and manufacturing quality. In the EU, companies may use a rolling review process, supplying data as they become available during Phase III trials, rather than developing the full documentation over months or years at the end of clinical research, as is typical. This rolling process allows the European CHMP to evaluate clinical data in real time, enabling a promising vaccine candidate to be approved on a rapid timeline by the EMA.[195]\n",
            "On June 24, 2020, China approved the CanSino vaccine for limited use in the military and two inactivated virus vaccines for emergency use in high-risk occupations.[196] On August 11, 2020, Russia announced the approval of its Sputnik V vaccine for emergency use, though one month later only small amounts of the vaccine had been distributed for use outside of the phase 3 trial.[197]\n",
            "In the United States, the FDA may grant Emergency Use Authorization for a promising COVID-19 vaccine before full evidence is available about its safety and efficacy, but this hastened process has been criticized for its political misuse, potential for lowered standards, and increased antivaccine sentiment in the US population during 2020.[167][198][199] On September 8, 2020, nine leading pharma companies involved in COVID-19 vaccine research signed a letter, pledging that they would submit their vaccines for emergency use authorization only after phase 3 trials had demonstrated safety and efficacy.[200]\n",
            "Until a vaccine is in use for the general population, all potential adverse events from the vaccine may not be known, requiring manufacturers to conduct Phase IV studies for postmarketing surveillance of the vaccine while it is used widely in the public.[185][192] The WHO works with UN member states to implement postlicensing surveillance.[185] The FDA relies on a Vaccine Adverse Event Reporting System to monitor safety concerns about a vaccine throughout its use in the American public.[192]\n",
            "By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection.[24][201][202][203] The corporate investment and need to generate value for public shareholders raised concerns about a \"market-based approach\" in vaccine development, costly pricing of eventual licensed vaccines, preferred access for distribution first to affluent countries, and sparse or no distribution to where the pandemic is most aggressive, as predicted for densely-populated, impoverished countries unable to afford vaccinations.[24][35][202] The collaboration of the University of Oxford with AstraZeneca (a global pharmaceutical company based in the UK) raised concerns about price and sharing of eventual profits from international vaccine sales, arising from whether the UK government and university as public partners had commercialization rights.[203] AstraZeneca stated that initial pricing of its vaccine would not include a profit margin for the company while the pandemic was still expanding.[203]\n",
            "In early June, AstraZeneca made a USD$750 millon deal allowing CEPI and GAVI to manufacture and distribute 300 million doses if its Oxford vaccine candidate proves safe and effective, reportedly increasing the company's total production capacity to over 2 billion doses per year.[204] Commercialization of pandemic vaccines is a high-risk business venture, potentially losing billions of dollars in development and pre-market manufacturing costs if the candidate vaccines fail to be safe and effective.[24][34][35][201] The multinational pharmaceutical company Pfizer indicated it was not interested in a government partnership, which would be a \"third party\" slowing progress in Pfizer's vaccine program.[205] Further, there are concerns that rapid-development programs – like the Operation Warp Speed plan of the United States – are choosing vaccine candidates mainly for their manufacturing advantages to shorten the development timeline, rather than for the most promising vaccine technology having safety and efficacy.[205]\n",
            "Favored distribution of vaccines within one or a few select countries, called \"vaccine sovereignty\", is a criticism of some of the vaccine development partnerships,[202][206] such as for the AstraZeneca-University of Oxford vaccine candidate, concerning whether there may be prioritized distribution first within the UK and to the \"highest bidder\" – the United States, which made an advance payment of US$1.2 billion to secure 300 million vaccine doses for Americans, even before the AstraZeneca-Oxford vaccine or a Sanofi vaccine is proved safe or effective.[203][207][208] Concerns exist about whether some countries producing vaccines may impose protectionist controls by export restrictions that would stockpile a COVID‑19 vaccine for their own population.[206]\n",
            "In June, the Serum Institute of India (SII) – a major manufacturer of global vaccines – reached a licensing agreement with AstraZeneca to make 1 billion doses of vaccine for low-and-middle income countries;[204] of which half of the doses would go to India.[209] Similar preferential homeland distribution may exist if a vaccine is manufactured in Australia.[210] The Chinese government pledged in May that a successful Chinese vaccine would become a \"global, public good,\" implying enough doses would be manufactured for both national and global distribution.[211]\n",
            "As many of the efforts on vaccine candidates have open-ended outcomes, including a high potential for failure during human testing, CEPI, WHO, and charitable vaccine organizations, such as the Gates Foundation and GAVI, raised over US$20 billion during the first half of 2020 to fund vaccine development and preparedness for vaccinations, particularly for children in under-developed countries.[7][8][40][201] CEPI had stated that governments should ensure implementation of a globally-fair allocation system for eventual vaccines, using a coordinated system of manufacturing capacity, financing and purchasing, and indemnification from liability to offset risks taken by vaccine developers.[27]\n",
            "Having been created to monitor fair distribution of infectious disease vaccines to low- and middle-income countries,[206][212] CEPI revised its equitable access policy that was published in February to apply to its COVID-19 vaccine funding: 1) \"prices for vaccines will be set as low as possible for territories that are or may be affected by an outbreak of a disease for which CEPI funding was used to develop a vaccine;\" 2) \"information, know-how and materials related to vaccine development must be shared with (or transferred to) CEPI\" so that it can assume responsibility for vaccine development if a company discontinues expenditures for a promising vaccine candidate; 3) CEPI would have access to, and possible management of, intellectual property rights (i.e., patents) for promising vaccines; 4) \"CEPI would receive a share of financial benefits that might accrue from CEPI-sponsored vaccine development, to re-invest in support of its mission to provide global public health benefit\"; and 5) data transparency among development partners should maintain the WHO Statement on Public Disclosure of Clinical Trial Results, and require results to be published in open-access publications.[212] Some vaccine manufacturers opposed parts of these proposals.[202][212]\n",
            "International groups, such as the Centre for Artistic Activism and Universities Allied for Essential Medicines, advocate for equitable access to licensed COVID‑19 vaccines.[213][214] Scientists have encouraged that the WHO, CEPI, corporations, and governments collaborate to assure evidence-based allocation of eventual COVID‑19 vaccines determined on infection risk,[206][212] particularly urgent vaccinations provided first for healthcare workers, vulnerable populations, and children.[24][201][202]\n",
            "During 2020, the WHO, GAVI, and CEPI combined resources to form COVAX – a program for coordination of global equitable access to a licensed vaccine.[32][33]\n",
            "Over 100 international scientists and concerned individuals (including those associated with religious organizations) have called for releasing COVID‑19 vaccines to the public domain. Similar to the development of the first polio vaccine that was never patented, an effective COVID-19 vaccine would be available for production and approval by a number of countries and pharmaceutical manufacturing centers worldwide, therefore allowing for a more even and cost-effective distribution on a global scale.[215]\n",
            "During and after 2021, deploying a COVID-19 vaccine may require worldwide transport and tracking of 10-19 billion vial doses, an effort readily becoming the largest supply chain challenge in history.[6][216][209] As of September 2020, supply chain and logistics experts expressed concern that international and national networks for distributing a licensed vaccine were not ready for the volume and urgency, due mainly to deterioration of resources during 2020 pandemic lockdowns and downsizing that degraded supply capabilities.[216][217][218] Addressing the worldwide challenge faced by coordinating numerous organizations – the COVAX partnership, global pharmaceutical companies, contract vaccine manufacturers, inter- and intranational transport, storage facilities, and health organizations in individual countries – Seth Berkley, chief executive of GAVI, stated: \"Delivering billions of doses of vaccine to the entire world efficiently will involve hugely complex logistical and programmatic obstacles all the way along the supply chain.\"[219]\n",
            "As an example highlighting the immensity of the challenge, the International Air Transport Association stated that 8,000 747 cargo planes – implemented with equipment for precision vaccine cold storage – would be needed to transport just one dose for people in the more than 200 countries experiencing the COVID-19 pandemic.[220] GAVI states that \"with a fast-moving pandemic, no one is safe, unless everyone is safe.\"[32]\n",
            "In contrast to the multibillion dollar investment in vaccine technologies and early-stage clinical research, the post-licensing supply chain for a vaccine has not received the same planning, coordination, security or investment.[216][217][221] A major concern is that resources for vaccine distribution in low- to middle-income countries, particularly for vaccinating children, are inadequate or non-existent, but could be improved with cost efficiencies if procurement and distribution were centralized regionally or nationally.[32][222] In September, the COVAX partnership included 172 countries coordinating plans to optimize the supply chain for a COVID-19 vaccine,[223] and the United Nations Children's Fund joined with COVAX to prepare the financing and supply chain for vaccinations of children in 92 developing countries.[224][225]\n",
            "Logistics vaccination services assure necessary equipment, staff, and supply of licensed vaccines across international borders.[226] Central logistics include vaccine handling and monitoring, cold chain management, and safety of distribution within the vaccination network.[227] The purpose of the COVAX Facility is to centralize and equitably administer logistics resources among participating countries, merging manufacturing, transport, and overall supply chain infrastructure.[32][221] Included are logistics tools for vaccine forecasting and needs estimation, in-country vaccine management, potential for wastage, and stock management.[227]\n",
            "Other logistics factors conducted internationally during distribution of a COVID-19 vaccine may include:[216][228][229]\n",
            "A logistics shortage in any one step may derail the whole supply chain, according to one vaccine developer.[230] If the vaccine supply chain fails, the economic and human costs of the pandemic may be extended for years.[218]\n",
            "By August 2020 when only a few vaccine candidates were in Phase III trials many months from establishing safety and efficacy, numerous governments pre-ordered more than two billion doses at a cost of more than US$5 billion.[209][230][231] Pre-orders from the UK government for 2021 were for five vaccine doses per person, a number dispiriting organizations like the WHO and GAVI which are promoting fair and equitable access worldwide, especially for developing countries.[209] In September, CEPI was financially supporting basic and clinical research for nine vaccine candidates, with nine more in evaluation, under financing commitments to manufacture two billion doses of three licensed vaccines by the end of 2021.[223] Overall before 2022, 7-10 billion COVID-19 vaccine doses may be manufactured worldwide, but the sizable pre-orders by affluent countries – called \"vaccine nationalism\" – threaten vaccine availability for poorer nations.[6][230][209] Brazil and Indonesia had pre-ordered millions of vaccine doses that are undergoing phase III trials in their countries The Serum Institute of India plans to produce at least one billion vaccine doses, although the Institute has stated that half the doses will be used in India.[209] After joining COVAX in October, China shared that it would produce 600 million vaccine doses before the end of 2020 and another one billion doses in 2021, although it was unsure how many would be for the country's own population of 1.4 billion.[232]\n",
            "AstraZeneca CEO, Pascal Soriot, stated: \"The challenge is not making the vaccine itself, it's filling vials. There just aren't enough vials in the world.\"[233] Preparing for high demand in manufacturing vials, an American glass producer invested $163 million in July for a vial factory.[234] Glass availability for vial manufacturing and contaminant control are issues of concern,[235] indicating higher production costs with lower profit potential for developers amid demands for vaccines to be affordable.[32][209][218]\n",
            "Vaccines must be handled and transported using international regulations, be maintained at controlled temperatures that vary across vaccine technologies, and be used for immunization before deterioration in storage.[209][230] The scale of the COVID-19 vaccine supply chain is expected to be vast to ensure delivery worldwide to vulnerable populations.[6][217] Priorities for preparing facilities for such distribution include temperature-controlled facilities and equipment, optimizing infrastructure, training immunization staff, and rigorous monitoring.[217][219][224] RFID technologies are being implemented to track and authenticate a vaccine dose from the manufacturer along the entire supply chain to the vaccination.[236]\n",
            "Vaccines (and adjuvants) are inherently unstable during temperature changes, requiring cold chain management throughout the entire supply chain, typically at temperatures of 2–8 °C (36–46 °F).[229][237] Because COVID-19 vaccine technologies are varied among several novel technologies, there are new challenges for cold chain management, with some vaccines that are stable while frozen but labile to heat, while others should not be frozen at all, and some are stable across temperatures.[237] Freezing damage and inadequate training of personnel in the local vaccination process are major concerns.[238] If more than one COVID-19 vaccine is approved, the vaccine cold chain may have to accommodate all these temperature sensitivities across different countries with variable climate conditions and local resources for temperature maintenance.[237]\n",
            "DNA and RNA vaccine technologies are in development, but may be difficult to manufacture at scale and control degradation during cold storage and transport.[218] As examples, Moderna's RNA vaccine candidate requires cold chain management just above freezing temperatures with limited storage duration, but the BioNTech-Pfizer RNA candidate requires storage at -70°C (-94°F) or colder throughout deployment until vaccination.[6][239]\n",
            "After a vaccine vial is punctured to administer a dose, it is viable for only six hours, then must be discarded, requiring attention to local management of cold storage and vaccination processes.[239] Because the COVID-19 vaccine will likely be in short supply for many locations during early deployment, vaccination staff will have to avoid spoilage and waste, which typically are as much as 30% of the supply.[216][239] The cold chain is further challenged by the type of local transportation for the vaccines in rural communities, such as by motorcycle or delivery drone, need for booster doses, use of diluents, and access to vulnerable populations, such as healthcare staff, children and the elderly.[6][224][240]\n",
            "Coordination of international air cargo is an essential component of time- and temperature-sensitive distribution of COVID-19 vaccines, but, as of September 2020, the air freight network is not prepared for multinational deployment.[217][220][241] \"Safely delivering COVID-19 vaccines will be the mission of the century for the global air cargo industry. But it won't happen without careful advance planning. And the time for that is now. We urge governments to take the lead in facilitating cooperation across the logistics chain so that the facilities, security arrangements and border processes are ready for the mammoth and complex task ahead,\" said IATA's Director General and CEO, Alexandre de Juniac, in September 2020.[241]\n",
            "For the severe reduction in passenger air traffic during 2020, airlines downsized personnel, trimmed destination networks, and put aircraft into long-term storage.[217][241] As the lead agencies for procurement and supply of the COVID-19 vaccine within the WHO COVAX Facility, GAVI and UNICEF are preparing for the largest and fastest vaccine deployment ever, necessitating international air freight collaboration, customs and border control, and possibly as many as 8,000 cargo planes to deliver just one vaccine dose to multiple countries.[224][241]\n",
            "Medicines are the world's largest fraud market, worth some $200 billion per year, making the widespread demand for a COVID-19 vaccine vulnerable to counterfeit, theft, scams, and cyberattacks throughout the supply chain.[221][242] Anticorruption, transparency, and accountability  safeguards are being established to reduce and eliminate corruption of COVID-19 vaccine supplies.[242][243] Absence of harmonized regulatory frameworks among countries, including low technical capacity, constrained access, and ineffective capability to identify and track genuine vs. counterfeit vaccines, may be life-threatening for vaccine recipients, and would potentially perpetuate the COVID-19 pandemic.[242] Tracking system technologies for packaging are being used by manufacturers to trace vaccine vials across the supply chain,[221] and to use digital and biometric tools to assure security for vaccination teams.[236][244]\n",
            "The WHO has implemented an \"Effective Vaccine Management\" system,[245] which includes constructing priorities to prepare national and subnational personnel and facilities for vaccine distribution, including:\n",
            "Border processes for efficient handling and customs clearance within individual countries may include:[226][245]\n",
            "On February 4, 2020, US Secretary of Health and Human Services Alex Azar published a notice of declaration under the Public Readiness and Emergency Preparedness Act for medical countermeasures against COVID‑19, covering \"any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID‑19, or the transmission of SARS-CoV-2 or a virus mutating therefrom\", and stating that the declaration precludes \"liability claims alleging negligence by a manufacturer in creating a vaccine, or negligence by a health care provider in prescribing the wrong dose, absent willful misconduct\".[246] The declaration is effective in the United States through 1 October 2024.\n",
            "Social media posts have promoted a conspiracy theory that a COVID‑19 vaccine is already available. The patents cited by various social media posts have references to existing patents for genetic sequences and vaccines for other strains such as the SARS coronavirus, but not for COVID‑19.[247][248]\n",
            "On 21 May 2020, the FDA made public the cease-and-desist notice it had sent to North Coast Biologics, a Seattle-based company that had been selling a purported \"nCoV19 spike protein vaccine\".[249]\n",
            "\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "9IJdQLkxajhA"
      },
      "source": [
        "text = re.sub(r'\\[[0-9]*\\]',' ',text)"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "YgDbGmHZnYSr",
        "outputId": "84ddbd8b-88bf-4ee3-c39b-a877bd57eb42",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        }
      },
      "source": [
        "print(text)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            " \n",
            "\n",
            "A COVID‑19 vaccine is any of several different vaccines intended to  provide acquired immunity against coronavirus disease 2019 (COVID‑19). Previous work to develop a vaccine against the coronavirus diseases SARS and MERS established knowledge about the structure and function of coronaviruses – which accelerated development during early 2020 of varied technology platforms for a COVID‑19 vaccine.  As of October 2020, there were 321 vaccine candidates in development, a 2.5 fold increase since April. However, no candidate has completed clinical trials to prove its safety and efficacy.  In October, some 42 vaccine candidates were in clinical research: namely 33 in Phase I–II trials and 9 in Phase II–III trials.    \n",
            "The World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and the Gates Foundation (GF) are committing money and organizational resources for the prospect that several vaccines will be needed to prevent continuing COVID‑19 infection.  The CEPI, which is organizing a US$2 billion worldwide fund for rapid investment and development of vaccine candidates,  indicated in September that clinical data to support licensure may be available by the end of 2020.  On 4 May 2020, the WHO organized a telethon which received US$8.1 billion in pledges from forty countries to support rapid development of vaccines to prevent COVID‑19 infections.  At the same time, the WHO also announced the deployment of an international \"Solidarity trial\" for simultaneous evaluation of several vaccine candidates reaching Phase II–III clinical trials. \n",
            "Vaccines have been produced against several animal diseases caused by coronaviruses, including as of 2003 infectious bronchitis virus in birds, canine coronavirus, and feline coronavirus.  Previous projects to develop vaccines for viruses in the family Coronaviridae that affect humans have been aimed at severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Vaccines against SARS  and MERS  have been tested in non-human animals.\n",
            "According to studies published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and public health agencies around the world at that time.    As of 2020, there is no cure or protective vaccine proven to be safe and effective against SARS in humans.  \n",
            "There is also no proven vaccine against MERS.  When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.   As of March 2020, there was one (DNA based) MERS vaccine which completed Phase I clinical trials in humans,  and three others in progress, all of which are viral-vectored vaccines: two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), and one MVA-vectored (MVA-MERS-S). \n",
            "A vaccine for an infectious disease has never before been produced in less than several years, and no vaccine exists for preventing a coronavirus infection in humans.  After the coronavirus was detected in December 2019,  the genetic sequence of COVID‑19 was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten development of a preventive vaccine.   \n",
            "In February 2020, the World Health Organization (WHO) said it did not expect a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus, to become available in less than 18 months.  The rapidly growing infection rate of COVID‑19 worldwide during early 2020 stimulated international alliances and government efforts to urgently organize resources to make multiple vaccines on shortened timelines,  with four vaccine candidates entering human evaluation in March (see the table of clinical trials started in 2020, below).  \n",
            "In April 2020, the WHO estimated a total cost of US$8 billion to develop a suite of three or more vaccines having different technologies and distribution.  \n",
            "By April 2020, \"almost 80 companies and institutes in 19 countries\" were working on this virtual gold rush.  Also in April, CEPI estimated that as many as six of the vaccine candidates against COVID‑19 should be chosen by international coalitions for development through Phase II–III trials, and three should be streamlined through regulatory and quality assurance for eventual licensing at a total cost of at least US$2 billion.    Another analysis estimates 10 candidates will need simultaneous initial development, before a select few are chosen for the final path to licensing. \n",
            "In July 2020, Anglo-American intelligence and security organisations of the respective governments and armed forces, as the UK's National Cyber Security Centre, together with the Canadian Communications Security Establishment, the United States Department for Homeland Security Cybersecurity Infrastructure Security Agency, and the US National Security Agency (NSA) alleged that Russian state-backed hackers may have been trying to steal COVID-19 treatment and vaccine research from academic and pharmaceutical institutions in other countries; Russia has denied it. \n",
            "During 2020, major changes in the overall effort of developing COVID-19 vaccines since early in the year have been the increasing number of collaborations of the multinational pharmaceutical industry with national governments, and the diversity and growing number of biotechnology companies in many countries focusing on a COVID-19 vaccine.  According to CEPI, the general geographic distribution of COVID‑19 vaccine development involves organizations in North America having about 40% of the world's COVID-19 vaccine research, compared with 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.  \n",
            "Organizations have formed international alliances to expedite vaccine development and prepare for distribution, including the WHO which is facilitating collaboration, accelerated research, and international communications on a scale unprecedented in history, beginning in early May by raising US$8.1 billion in pledges.  The WHO also implemented Covid-19 Vaccines Global Access (COVAX) for coordinating global vaccine development, the vaccine pillar of Access to COVID-19 Tools (ACT) Accelerator in collaboration with GAVI and the Coalition for Epidemic Preparedness Innovations (CEPI).    In July, the WHO announced that 165 countries, representing up to 60% of the world population, had agreed to a WHO COVAX plan for fair and equitable distribution of an eventual licensed vaccine, assuring that each participating country would receive a guaranteed share of doses to vaccinate the most vulnerable 20% of its population by the end of 2021.  COVAX has the goal to accelerate the development and manufacturing of COVID-19 vaccines, and to assure that access to licensed vaccines is equitably provided to all countries. \n",
            "CEPI is working with international health authorities and vaccine developers to create another US$2 billion fund in a global partnership between public, private, philanthropic, and civil society organizations for accelerated research and clinical testing of eight vaccine candidates, with the 2020–21 goal of supporting several candidates for full development to licensing.    The United Kingdom, Canada, Belgium, Norway, Switzerland, Germany and the Netherlands had already donated US$915 million to CEPI by early May.   The Bill & Melinda Gates Foundation (Gates Foundation), a private charitable organization dedicated to vaccine research and distribution, is donating US$250 million in support of CEPI for research and public educational support on COVID‑19 vaccines.  \n",
            "The Global Research Collaboration for Infectious Disease Preparedness (GLoPID-R) is working closely with the WHO and member states to identify priorities for funding specific researches needed for a COVID‑19 vaccine, coordinating among the international funding and research organizations to maintain updated information on vaccine progress and avoid duplicate funding.  \n",
            "The International Severe Acute Respiratory and Emerging Infection Consortium is organizing and disseminating clinical information on COVID‑19 research to inform public health policy on eventual vaccine distribution. \n",
            "On 4 June, a virtual summit was coordinated from London, UK, among private and government representatives of 52 countries, including 35 heads of state from G7 and G20 nations, to raise US$8.8 billion in support of the Global Alliance for Vaccines and Immunisation (GAVI) to prepare for COVID‑19 vaccinations of 300 million children in under-developed countries through 2025.  Major contributions were US$1.6 billion from The Gates Foundation  and GB£330 million per year over five years by the UK government (approximately US$2.1 billion in June 2020). \n",
            "National governments dedicating resources for national or international investments in vaccine research, development, and manufacturing beginning in 2020 included the Canadian government which announced CA$275 million in funding for 96 research vaccine research projects at Canadian companies and universities, with plans to establish a \"vaccine bank\" of several new vaccines that could be used if another coronavirus outbreak occurs.   A further investment of CA$1.1 billion was added to support clinical trials in Canada and develop manufacturing and supply chains for vaccines.  On 4 May, the Canadian government committed CA$850 million to the WHO's live streaming effort to raise US$8 billion for COVID‑19 vaccines and preparedness. \n",
            "In China, the government is providing low-rate loans to a vaccine developer through its central bank, and has \"quickly made land available for the company\" to build production plants.  As of June 2020, six of the eleven COVID‑19 vaccine candidates in early-stage human testing were developed by Chinese organizations.  Three Chinese vaccine companies and research institutes are supported by the government for financing research, conducting clinical trials, and manufacturing the most promising vaccine candidates, while prioritizing rapid evidence of efficacy over safety.  On 18 May, China had pledged US$2 billion to support overall efforts by the WHO for programs against COVID‑19.  On 22 July, China additionally announced that it plans to provide a US$1 billion loan to make its vaccine accessible for countries in Latin America and the Caribbean.  On August 24, Chinese Premier Li Keqiang announced it would provide five Southeast Asian countries of Cambodia, Laos, Myanmar, Thailand and Vietnam priority access to the vaccine once it was fully developed. \n",
            "Among European Union countries, France announced a US$4.9 million investment in a COVID‑19 vaccine research consortium via CEPI involving the Institut Pasteur, Themis Bioscience (Vienna, Austria), and the University of Pittsburgh, bringing CEPI's total investment in COVID‑19 vaccine development to US$480 million by May.   In March, the European Commission made an €80 million investment in CureVac, a German biotechnology company, to develop a mRNA vaccine.  The German government announced a separate €300 million investment in CureVac in June.  Belgium, Norway, Switzerland, Germany, and the Netherlands have been major contributors to the CEPI effort for COVID‑19 vaccine research in Europe. \n",
            "In April, the UK government formed a COVID‑19 vaccine task force to stimulate British efforts for rapidly developing a vaccine through collaborations of industry, universities, and government agencies across the vaccine development pipeline, including clinical trial placement at UK hospitals, regulations for approval, and eventual manufacturing.  The vaccine development initiatives at the University of Oxford and Imperial College of London were financed with GB£44 million in April.  \n",
            "The United States Biomedical Advanced Research and Development Authority (BARDA), a federal agency that funds disease-fighting technology, announced investments of nearly US$1 billion to support American COVID‑19 vaccine development, and preparation for manufacturing the most promising candidates. On 16 April, BARDA made a US$483 million investment in the vaccine developer, Moderna and its partner, Johnson & Johnson.   BARDA has an additional US$4 billion to spend on vaccine development, and will have roles in other American investment for development of six to eight vaccine candidates to be in clinical studies over 2020–21 by companies such as Sanofi Pasteur and Regeneron.   On 15 May, the US government announced federal funding for a fast-track program called Operation Warp Speed, which has the goals of placing diverse vaccine candidates in clinical trials by the fall of 2020, and manufacturing 300 million doses of a licensed vaccine by January 2021. The project chief advisor is Moncef Slaoui and its Chief Operating Officer is Army General Gustave Perna.   In June, the Warp Speed team said it would work with seven companies developing COVID‑19 vaccine candidates: Moderna, Johnson & Johnson, Merck, Pfizer, and the University of Oxford in collaboration with AstraZeneca, as well as two others. \n",
            "In April 2020, the WHO published an \"R&D Blueprint (for the) novel Coronavirus\" (Blueprint). The Blueprint documented a \"large, international, multi-site, individually randomized controlled clinical trial\" to allow \"the concurrent evaluation of the benefits and risks of each promising candidate vaccine within 3-6 months of it being made available for the trial.\" The Blueprint listed a Global Target Product Profile (TPP) for COVID‑19, identifying favorable attributes of safe and effective vaccines under two broad categories: \"vaccines for the long-term protection of people at higher risk of COVID‑19, such as healthcare workers\", and other vaccines to provide rapid-response immunity for new outbreaks.  The international TPP team was formed to 1) assess the development of the most promising candidate vaccines; 2) map candidate vaccines and their clinical trial worldwide, publishing a frequently-updated \"landscape\" of vaccines in development;  3) rapidly evaluate and screen for the most promising candidate vaccines simultaneously before they are tested in humans; and 4) design and coordinate a multiple-site, international randomized controlled trial – the \"Solidarity trial\" for vaccines   – to enable simultaneous evaluation of the benefits and risks of different vaccine candidates under clinical trials in countries where there are high rates of COVID‑19 disease, ensuring fast interpretation and sharing of results around the world.  The WHO vaccine coalition will prioritize which vaccines should go into Phase II and III clinical trials, and determine harmonized Phase III protocols for all vaccines achieving the pivotal trial stage. \n",
            "A clinical trial design in progress may be modified as an \"adaptive design\" if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment.   The WHO Solidarity trial of multiple vaccines in clinical studies during 2020 will apply adaptive design to rapidly alter trial parameters across all study sites as results emerge.  Candidate vaccines may be added to the Solidarity trial as they become available if priority criteria are met, while vaccine candidates showing poor evidence of safety or efficacy compared to placebo or other vaccines will be dropped from the international trial. \n",
            "Adaptive designs within ongoing Phase II–III clinical trials on candidate vaccines may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, avoiding duplication of research efforts, and enhancing coordination of design changes for the Solidarity trial across its international locations.  \n",
            "Large pharmaceutical companies with experience in making vaccines at scale, including Johnson & Johnson, AstraZeneca, and GlaxoSmithKline (GSK), are forming alliances with biotechnology companies, national governments, and universities to accelerate progression to an effective vaccine.   To combine financial and manufacturing capabilities for a pandemic adjuvanted vaccine technology, GSK joined with Sanofi in an uncommon partnership of multinational companies to support accelerated vaccine development. \n",
            "During a pandemic on the rapid timeline and scale of COVID‑19 infections during 2020, international organizations like the WHO and CEPI, vaccine developers, governments, and industry are evaluating distribution of the eventual vaccine(s).  Individual countries producing a vaccine may be persuaded to favor the highest bidder for manufacturing or provide first-service to their own country.    Experts emphasize that licensed vaccines should be available and affordable for people at the frontline of healthcare and having the greatest need.    Under their agreement with AstraZeneca, the University of Oxford vaccine development team and UK government agreed that UK citizens would not get preferential access to a new COVID‑19 vaccine developed by the taxpayer-funded university, but rather consented to having a licensed vaccine distributed multinationally in cooperation with the WHO.  Several companies plan to initially manufacture a vaccine at low cost, then increase costs for profitability later if annual vaccinations are needed and as countries build stock for future needs. \n",
            "The WHO and CEPI are developing financial resources and guidelines for global deployment of several safe, effective COVID‑19 vaccines, recognizing the need is different across countries and population segments.     For example, successful COVID‑19 vaccines would likely be allocated first to healthcare personnel and populations at greatest risk of severe illness and death from COVID‑19 infection, such as the elderly or densely-populated impoverished people.   The WHO, CEPI, and GAVI have expressed concerns that affluent countries should not receive priority access to the global supply of eventual COVID‑19 vaccines, but rather protecting healthcare personnel and people at high risk of infection are needed to address public health concerns and reduce economic impact of the pandemic.   \n",
            "Geopolitical issues, safety concerns for vulnerable populations, and manufacturing challenges for producing billions of doses are compressing schedules to shorten the standard vaccine development timeline, in some cases combining clinical trial steps over months, a process typically conducted sequentially over years.  As an example, Chinese vaccine developers and the government Chinese Center for Disease Control and Prevention began their efforts in January 2020,  and by March were pursuing numerous candidates on short timelines, with the goal to showcase Chinese technology strengths over those of the United States, and to reassure the Chinese people about the quality of vaccines produced in China.  \n",
            "In the haste to provide a vaccine on a rapid timeline for the COVID‑19 pandemic, developers and governments are accepting a high risk of \"short-circuiting\" the vaccine development process,  with one industry executive saying: \"The crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop\".  Multiple steps along the entire development path are evaluated, including the level of acceptable toxicity of the vaccine (its safety), targeting vulnerable populations, the need for vaccine efficacy breakthroughs, the duration of vaccination protection, special delivery systems (such as oral or nasal, rather than by injection), dose regimen, stability and storage characteristics, emergency use authorization before formal licensing, optimal manufacturing for scaling to billions of doses, and dissemination of the licensed vaccine.   From Phase I clinical trials, 84–90%  of vaccine candidates fail to make it to final approval during development, and from Phase III, 25.7% fail  – the investment by a manufacturer in a vaccine candidate may exceed US$1 billion and end with millions of useless doses.    In the case of COVID‑19 specifically, a vaccine efficacy of 70% may be enough to stop the pandemic, but if it has only 60% efficacy, outbreaks may continue; an efficacy of less than 60% will not provide enough herd immunity to stop the spread of the virus alone. \n",
            "As the pandemic expands during 2020, research at universities is obstructed by physical distancing and closing of laboratories.   Globally, supplies critical to vaccine research and development are increasingly scarce due to international competition or national sequestration.  Timelines for conducting clinical research – normally a sequential process requiring years – are being compressed into safety, efficacy, and dosing trials running simultaneously over months, potentially compromising safety assurance.  \n",
            "CEPI scientists reported in September 2020 that nine different technology platforms  –  with the technology of numerous candidates remaining undefined  –  were under research and development during 2020 to create an effective vaccine against COVID‑19.  According to CEPI, most of the platforms of vaccine candidates in clinical trials as of September are focused on the coronavirus spike protein and its variants as the primary antigen of COVID-19 infection.  Platforms being developed in 2020 involve nucleic acid technologies (RNA and DNA), non-replicating viral vectors, peptides, recombinant proteins, live attenuated viruses, and inactivated viruses.    \n",
            "Many vaccine technologies being developed for COVID‑19 are not like vaccines already in use to prevent influenza, but rather are using \"next-generation\" strategies for precision on COVID‑19 infection mechanisms.    Vaccine platforms in development may improve flexibility for antigen manipulation and effectiveness for targeting mechanisms of COVID‑19 infection in susceptible population subgroups, such as healthcare workers, the elderly, children, pregnant women, and people with existing weakened immune systems.  \n",
            "^ technologies for dozens of candidates are unannounced or \"unknown\" \n",
            "\n",
            "CEPI classifies development stages for vaccines as \"exploratory\" (planning and designing a candidate, having no evaluation in vivo), \"preclinical\" (in vivo evaluation with preparation for manufacturing a compound to test in humans), or initiation of Phase I safety studies in healthy people.  Some 321 total vaccine candidates are in development as either confirmed projects in clinical trials or in early-stage \"exploratory\" or \"preclinical\" development, as of September. \n",
            "Phase I trials test primarily for safety and preliminary dosing in a few dozen healthy subjects, while Phase II trials – following success in Phase I – evaluate immunogenicity, dose levels (efficacy based on biomarkers) and adverse effects of the candidate vaccine, typically in hundreds of people.   A Phase I–II trial consists of preliminary safety and immunogenicity testing, is typically randomized, placebo-controlled, while determining more precise, effective doses.   Phase III trials typically involve more participants at multiple sites, include a control group, and test effectiveness of the vaccine to prevent the disease (an \"interventional\" or \"pivotal\" trial), while monitoring for adverse effects at the optimal dose.   Definition of vaccine safety, efficacy, and clinical endpoints in a Phase III trial may vary between the trials of different companies, such as defining the degree of side effects, infection or amount of transmission, and whether the vaccine prevents moderate or severe COVID‑19 infection.   \n",
            "On September 14, UAE approved Sinopharm's vaccine for emergency use by front-line healthcare workers following successful interim results in the Phase III trials. \n",
            "Pakistan\n",
            "Sep 2020 – December 2021 in Pakistan\n",
            "Janssen Pharmaceutica (Johnson & Johnson), BIDMC\n",
            "Temporarily paused on October 13 2020 due to an unexplained illness in a participant. \n",
            "Arcturus Therapeutics\n",
            "In April 2020, the WHO issued a statement representing dozens of vaccine scientists around the world, pledging collaboration to speed development of a vaccine against COVID‑19.  The WHO coalition is encouraging international cooperation between organizations developing vaccine candidates, national regulatory and policy agencies, financial contributors, public health associations, and governments, for eventual manufacturing of a successful vaccine in quantities sufficient to supply all affected regions, particularly low-resource countries. \n",
            "Industry analysis of past vaccine development shows failure rates of 84–90%.   Because COVID‑19 is a novel virus target with properties still being discovered and requiring innovative vaccine technologies and development strategies, the risks associated with developing a successful vaccine across all steps of preclinical and clinical research are high. \n",
            "To assess potential for vaccine efficacy, unprecedented computer simulations and new COVID‑19-specific animal models are being developed multinationally during 2020, but these methods remain untested by unknown characteristics of the COVID‑19 virus.  Of the confirmed active vaccine candidates, about 70% are being developed by private companies, with the remaining projects under development by academic, government coalitions, and health organizations. \n",
            "Most of the vaccine developers are small firms or university research teams with little experience in successful vaccine design and limited capacity for advanced clinical trial costs and manufacturing without partnership by multinational pharmaceutical companies.  \n",
            "Many vaccine candidates under design or preclinical development for COVID‑19 will not gain approval for human studies in 2020 due to toxicity, ineffectiveness to induce immune responses or dosing failures in laboratory animals, or because of underfunding.   The probability of success for an infectious disease vaccine candidate to pass preclinical barriers and reach Phase I of human testing is 41-57%. \n",
            "Commitment to first-in-human testing of a vaccine candidate represents a substantial capital cost for vaccine developers, estimated to be from US$14 million to US$25 million for a typical Phase I trial program, but possibly as much as US$70 million.   For comparison, during the Ebola virus epidemic of 2013-16, there were 37 vaccine candidates in urgent development, but only one eventually succeeded as a licensed vaccine, involving a total cost to confirm efficacy in Phase II–III trials of about US$1 billion. \n",
            "Some vaccines have non-specific effects beyond the disease they prevent. \n",
            "Assertions have been made that COVID‑19 mortality has been lower in countries having routine BCG vaccine administered against tuberculosis,     though the World Health Organization (WHO) has said there is no evidence that this vaccine is effective against the COVID‑19 virus.  In March 2020, a randomized trial of BCG vaccine to reduce COVID‑19 illness began in the Netherlands, seeking to recruit 1,000 healthcare workers.  A further randomized trial in Australia is seeking to enroll 4,170 healthcare workers.  \n",
            "In June 2020, a randomized placebo-controlled trial to test whether the measles-mumps-rubella vaccine (MMR) can protect healthcare workers from COVID‑19 began with 200 participants in Cairo. \n",
            "In September 2020, eleven of the vaccine candidates in clinical development used adjuvants to enhance immunogenicity.  An immunological adjuvant is a substance formulated with a vaccine to elevate the immune response to an antigen, such as the COVID-19 virus or influenza virus.  Specifically, an adjuvant may be used in formulating a COVID-19 vaccine candidate to boost its immunogenicity and efficacy to reduce or prevent COVID-19 infection in vaccinated individuals.   Adjuvants used in COVID-19 vaccine formulation may be particularly effective for technologies using the inactivated COVID-19 virus and recombinant protein-based or vector-based vaccines.  Aluminum salts, known as \"alum\", were the first adjuvant used for licensed vaccines, and are the adjuvant of choice in some 80% of adjuvanted vaccines.  The alum adjuvant initiates diverse molecular and cellular mechanisms to enhance immunogenicity, including release of proinflammatory cytokines.   A potential drawback of adjuvanted vaccines is that the virus evolves in a way to avoid the induced vaccine response, making the adjuvant-vaccine technology misdesigned against a changed virus.  Such a change would require revised manufacturing and increased costs that discourage the routine use of adjuvants.  \n",
            "The rapid development and urgency of producing a vaccine for the COVID‑19 pandemic may increase the risks and failure rate of delivering a safe, effective vaccine.    One study found that between 2006 and 2015, the success rate of obtaining approval from Phase I to successful Phase III trials was 16.2% for vaccines,  and CEPI indicates a potential success rate of only 10% for vaccine candidates in 2020 development. \n",
            "An April 2020 CEPI report stated: \"Strong international coordination and cooperation between vaccine developers, regulators, policymakers, funders, public health bodies and governments will be needed to ensure that promising late-stage vaccine candidates can be manufactured in sufficient quantities and equitably supplied to all affected areas, particularly low-resource regions.\"  However, some 10% of the public perceives vaccines as unsafe or unnecessary, refusing vaccination – a global health threat called vaccine hesitancy  – which increases the risk of further viral spread that could lead to COVID‑19 outbreaks.  In mid-2020, estimates from two surveys were that 67% or 80% of people in the U.S. would accept a new vaccination against COVID-19, with wide disparity by education level, employment status, race, and geography.  \n",
            "Early research to assess vaccine efficacy using COVID‑19-specific animal models, such as ACE2-transgenic mice, other laboratory animals, and non-human primates, indicates a need for biosafety-level 3 containment measures for handling live viruses, and international coordination to ensure standardized safety procedures.  \n",
            "Although the quality and quantity of antibody production by a potential vaccine is intended to neutralize the COVID‑19 infection, a vaccine may have an unintended opposite effect by causing antibody-dependent disease enhancement (ADE), which increases the virus attachment to its target cells and might trigger the cytokine storm when the person will be infected by the virus after vaccination.   The vaccine technology platform (for example, viral vector vaccine, spike (S) protein vaccine or protein subunit vaccine), vaccine dose, timing of repeat vaccinations for the possible recurrence of COVID‑19 infection, and elderly age are factors determining the risk and extent of ADE.   The antibody response to a vaccine is a variable of vaccine technologies in development, including whether the vaccine has precision in its mechanism,  and choice of the route for how it is given (intramuscular, intradermal, oral, or nasal).  \n",
            "The effectiveness of new vaccine is defined by its efficacy. The efficacy of less than 60% may result in failure to create herd immunity.   Host-(\"vaccinee\")-related determinants that render a person susceptible to infection, such as genetics, health status (underlying disease, nutrition, pregnancy, sensitivities or allergies), immune competence, age, and economic impact or cultural environment can be primary or secondary factors affecting the severity of infection and response to a vaccine.  Elderly (above age 60), allergen-hypersensitive, and obese people have susceptibility to compromised immunogenicity, which prevents or inhibits vaccine effectiveness, possibly requiring separate vaccine technologies for these specific populations or repetitive booster vaccinations to limit virus transmission.  Further, mutations of the virus can alter its structure targeted by the vaccine, thus making the vaccine ineffective.  \n",
            "Vaccine developers have to invest resources internationally to find enough participants for Phase II–III clinical trials when the virus has proved to be a \"moving target\" of changing transmission rate across and within countries, forcing companies to compete for trial participants.  As an example in June, the Chinese vaccine developer Sinovac formed alliances in Malaysia, Canada, the UK, and Brazil among its plans to recruit trial participants and manufacture enough vaccine doses for a possible Phase III study in Brazil where COVID‑19 transmission was accelerating during June.  As the COVID‑19 pandemic within China became more isolated and controlled, Chinese vaccine developers sought international relationships to conduct advanced human studies in several countries, creating competition for trial participants with other manufacturers and the international Solidarity trial organized by the WHO.  In addition to competition over recruiting participants, clinical trial organizers may encounter  people unwilling to be vaccinated due to vaccine hesitancy  or disbelieving the science of the vaccine technology and its ability to prevent infection. \n",
            "Having an insufficient number of skilled team members to administer vaccinations may hinder clinical trials that must overcome risks for trial failure, such as recruiting participants in rural or low-density geographic regions, and variations of age, race, ethnicity, or underlying medical conditions.  \n",
            "An effective vaccine for COVID-19 could save trillions of dollars in global economic impact, according to one expert, and would, therefore, make any price tag in the billions look small in comparison.  It is not yet known if it is possible to create a safe, reliable and affordable vaccine for this virus, and it is not yet known exactly how much the vaccine development will cost.    It is possible that billions of dollars could be invested without success. \n",
            "The European Commission organized and held a video conference of world leaders on 4 May 2020, at which US$8 billion was raised for COVID-19 vaccine development. \n",
            "After a vaccine is created, billions of doses will need to be manufactured and distributed worldwide. In April 2020, the Gates Foundation estimated that manufacturing and distribution could cost as much as US$25 billion. \n",
            "Different vaccines have different shipping and handling requirements. For example, the Pfizer/BioNTech vaccine BNT162 must be shipped and stored at −70 °C (−94 °F), must be used within five days of thawing, and has a minimum order of 975 doses, making it unlikely to be rolled out in settings other than large, well-equipped hospitals. \n",
            "Strategies are being considered for fast-tracking the licensing of a vaccine against COVID‑19, especially by compressing (to a few months) the usually lengthy duration of Phase II–III trials (typically many years).    Challenge studies have been implemented previously for diseases less deadly than COVID‑19 infection, such as common influenza, typhoid fever, cholera, and malaria.   Following preliminary proof of safety and efficacy of a candidate vaccine in laboratory animals and healthy humans, controlled challenge studies might be implemented to bypass typical Phase III research, providing an accelerated path to license a COVID‑19 vaccine.   \n",
            "A challenge study begins by simultaneously testing a vaccine candidate for immunogenicity and safety in laboratory animals and healthy adult volunteers (100 or fewer), something normally a sequential process using animals first.   If the initial tests are promising, the study proceeds by rapidly advancing the effective dose into a large-scale Phase II–III trial in previously-uninfected, low-risk volunteers (such as young adults), who would then be deliberately infected with COVID‑19 for comparison with a placebo control group.    Following the challenge, the volunteers would be monitored closely in clinics with life-saving resources, if needed.   Volunteering for a vaccine challenge study during the COVID‑19 pandemic is likened to the emergency service of healthcare personnel for COVID‑19-infected people, firefighters, or organ donors. \n",
            "Although challenge studies are ethically questionable due to the unknown hazards for the volunteers of possible COVID‑19 disease enhancement and whether the vaccine received has long-term safety (among other cautions), challenge studies may be the only option to rapidly produce an effective vaccine that will minimize the projected millions of deaths worldwide from COVID‑19 infection,   according to some infectious disease experts.    The World Health Organization has developed a guidance document with criteria for conducting COVID‑19 challenge studies in healthy people, including scientific and ethical evaluation, public consultation and coordination, selection and informed consent of the participants, and monitoring by independent experts. \n",
            "A vaccine licensure occurs after the successful conclusion of the clinical trials program through Phases I–III demonstrating safety, immunogenicity at a specific dose, effectiveness at preventing infection in target populations, and enduring preventive effect.  As part of a multinational licensure for a vaccine, the World Health Organization Expert Committee on Biological Standardization developed guidelines of international standards for manufacturing and quality control of vaccines, a process intended as a platform for national regulatory agencies to apply for their own licensure process.  Vaccine manufacturers do not receive licensure until a complete clinical package proves the vaccine is safe and has long-term effectiveness, following scientific review by a multinational or national regulatory organization, such as the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA).  \n",
            "Upon developing countries adopting WHO guidelines for vaccine development and licensure, each country has its own responsibility to issue a national licensure, and to manage, deploy, and monitor the vaccine throughout its use in each nation.  Building trust and acceptance of a licensed vaccine among the public is a task of communication by governments and healthcare personnel to ensure a vaccination campaign proceeds smoothly, saves lives, and enables economic recovery.  When a vaccine is licensed, it will initially be in limited supply due to variable manufacturing, distribution, and logistical factors, requiring an allocation plan for the limited supply and which population segments should be prioritized to first receive the vaccine. \n",
            "Vaccines developed for multinational distribution via the United Nations Children's Fund (UNICEF) require pre-qualification by\n",
            "WHO to ensure international standards of quality, safety, immunogenicity, and efficacy for adoption by numerous countries. \n",
            "The process requires manufacturing consistency at WHO-contracted laboratories following GMP practices.  When UN agencies are involved in vaccine licensure, individual nations collaborate by 1) issuing marketing authorization and a national license for the vaccine, its manufacturers, and distribution partners; and 2) conducting postmarketing surveillance, including records for adverse events after the vaccination program. WHO works with national agencies to monitor inspections of manufacturing facilities and distributors for compliance with GMP and regulatory oversight. \n",
            "Some countries choose to buy vaccines licensed by reputable national organizations, such as EMA, FDA, or national agencies in other\n",
            "affluent countries, but such purchases typically are more expensive and may not have distribution resources suitable to local conditions in developing countries. \n",
            "In the European Union (EU), vaccines for pandemic pathogens, such as seasonal influenza, are licensed EU-wide where all of the member states comply (\"centralized\"), are licensed for only some member states (\"decentralized\"), or are licensed on an individual national level.  Generally, all EU states follow regulatory guidance and clinical programs defined by the European Committee for Medicinal Products for Human Use (CHMP), a scientific panel of the European Medicines Agency (EMA) responsible for vaccine licensure.  The CHMP is supported by several expert groups who assess and monitor the progress of a vaccine before and after licensure and distribution. \n",
            "In October 2020, the CHMP started 'rolling reviews' of the vaccines known as COVID-19 Vaccine AstraZeneca and BNT162b2.   \n",
            "Under the FDA, the process of establishing evidence for vaccine clinical safety and efficacy is the same as for the approval process for prescription drugs.  If successful through the stages of clinical development, the vaccine licensing process is followed by a Biologics License Application which must provide a scientific review team (from diverse disciplines, such as physicians, statisticians, microbiologists, chemists) a comprehensive documentation for the vaccine candidate having efficacy and safety throughout its development. Also during this stage, the proposed manufacturing facility is examined by expert reviewers for GMP compliance, and the label must have compliant description to enable health care providers definition of vaccine specific use, including its possible risks, to communicate and deliver the vaccine to the public. \n",
            "As of August 2020 in the United States, there is no national strategy for how a successful vaccine will be ethically prioritized or distributed to vulnerable population segments, such as homeless and incarcerated people and the elderly.    After licensure, monitoring of the vaccine and its production, including periodic inspections for GMP compliance, continue as long as the manufacturer retains its license, which may include additional submissions to the FDA of tests for potency, safety, and purity for each vaccine manufacturing step. \n",
            "At the beginning of the COVID-19 pandemic in early 2020, the WHO issued a guideline as an Emergency Use Listing of new vaccines, a process derived from the 2013-16 Ebola epidemic.  It required that a vaccine candidate developed for a life-threatening emergency be manufactured using GMP and that it complete development according to WHO prequalification procedures. \n",
            "Even as new vaccines are developed during the COVID-19 pandemic, licensure of COVID-19 vaccine candidates requires submission of a full dossier of information on development and manufacturing quality. In the EU, companies may use a rolling review process, supplying data as they become available during Phase III trials, rather than developing the full documentation over months or years at the end of clinical research, as is typical. This rolling process allows the European CHMP to evaluate clinical data in real time, enabling a promising vaccine candidate to be approved on a rapid timeline by the EMA. \n",
            "On June 24, 2020, China approved the CanSino vaccine for limited use in the military and two inactivated virus vaccines for emergency use in high-risk occupations.  On August 11, 2020, Russia announced the approval of its Sputnik V vaccine for emergency use, though one month later only small amounts of the vaccine had been distributed for use outside of the phase 3 trial. \n",
            "In the United States, the FDA may grant Emergency Use Authorization for a promising COVID-19 vaccine before full evidence is available about its safety and efficacy, but this hastened process has been criticized for its political misuse, potential for lowered standards, and increased antivaccine sentiment in the US population during 2020.    On September 8, 2020, nine leading pharma companies involved in COVID-19 vaccine research signed a letter, pledging that they would submit their vaccines for emergency use authorization only after phase 3 trials had demonstrated safety and efficacy. \n",
            "Until a vaccine is in use for the general population, all potential adverse events from the vaccine may not be known, requiring manufacturers to conduct Phase IV studies for postmarketing surveillance of the vaccine while it is used widely in the public.   The WHO works with UN member states to implement postlicensing surveillance.  The FDA relies on a Vaccine Adverse Event Reporting System to monitor safety concerns about a vaccine throughout its use in the American public. \n",
            "By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection.     The corporate investment and need to generate value for public shareholders raised concerns about a \"market-based approach\" in vaccine development, costly pricing of eventual licensed vaccines, preferred access for distribution first to affluent countries, and sparse or no distribution to where the pandemic is most aggressive, as predicted for densely-populated, impoverished countries unable to afford vaccinations.    The collaboration of the University of Oxford with AstraZeneca (a global pharmaceutical company based in the UK) raised concerns about price and sharing of eventual profits from international vaccine sales, arising from whether the UK government and university as public partners had commercialization rights.  AstraZeneca stated that initial pricing of its vaccine would not include a profit margin for the company while the pandemic was still expanding. \n",
            "In early June, AstraZeneca made a USD$750 millon deal allowing CEPI and GAVI to manufacture and distribute 300 million doses if its Oxford vaccine candidate proves safe and effective, reportedly increasing the company's total production capacity to over 2 billion doses per year.  Commercialization of pandemic vaccines is a high-risk business venture, potentially losing billions of dollars in development and pre-market manufacturing costs if the candidate vaccines fail to be safe and effective.     The multinational pharmaceutical company Pfizer indicated it was not interested in a government partnership, which would be a \"third party\" slowing progress in Pfizer's vaccine program.  Further, there are concerns that rapid-development programs – like the Operation Warp Speed plan of the United States – are choosing vaccine candidates mainly for their manufacturing advantages to shorten the development timeline, rather than for the most promising vaccine technology having safety and efficacy. \n",
            "Favored distribution of vaccines within one or a few select countries, called \"vaccine sovereignty\", is a criticism of some of the vaccine development partnerships,   such as for the AstraZeneca-University of Oxford vaccine candidate, concerning whether there may be prioritized distribution first within the UK and to the \"highest bidder\" – the United States, which made an advance payment of US$1.2 billion to secure 300 million vaccine doses for Americans, even before the AstraZeneca-Oxford vaccine or a Sanofi vaccine is proved safe or effective.    Concerns exist about whether some countries producing vaccines may impose protectionist controls by export restrictions that would stockpile a COVID‑19 vaccine for their own population. \n",
            "In June, the Serum Institute of India (SII) – a major manufacturer of global vaccines – reached a licensing agreement with AstraZeneca to make 1 billion doses of vaccine for low-and-middle income countries;  of which half of the doses would go to India.  Similar preferential homeland distribution may exist if a vaccine is manufactured in Australia.  The Chinese government pledged in May that a successful Chinese vaccine would become a \"global, public good,\" implying enough doses would be manufactured for both national and global distribution. \n",
            "As many of the efforts on vaccine candidates have open-ended outcomes, including a high potential for failure during human testing, CEPI, WHO, and charitable vaccine organizations, such as the Gates Foundation and GAVI, raised over US$20 billion during the first half of 2020 to fund vaccine development and preparedness for vaccinations, particularly for children in under-developed countries.     CEPI had stated that governments should ensure implementation of a globally-fair allocation system for eventual vaccines, using a coordinated system of manufacturing capacity, financing and purchasing, and indemnification from liability to offset risks taken by vaccine developers. \n",
            "Having been created to monitor fair distribution of infectious disease vaccines to low- and middle-income countries,   CEPI revised its equitable access policy that was published in February to apply to its COVID-19 vaccine funding: 1) \"prices for vaccines will be set as low as possible for territories that are or may be affected by an outbreak of a disease for which CEPI funding was used to develop a vaccine;\" 2) \"information, know-how and materials related to vaccine development must be shared with (or transferred to) CEPI\" so that it can assume responsibility for vaccine development if a company discontinues expenditures for a promising vaccine candidate; 3) CEPI would have access to, and possible management of, intellectual property rights (i.e., patents) for promising vaccines; 4) \"CEPI would receive a share of financial benefits that might accrue from CEPI-sponsored vaccine development, to re-invest in support of its mission to provide global public health benefit\"; and 5) data transparency among development partners should maintain the WHO Statement on Public Disclosure of Clinical Trial Results, and require results to be published in open-access publications.  Some vaccine manufacturers opposed parts of these proposals.  \n",
            "International groups, such as the Centre for Artistic Activism and Universities Allied for Essential Medicines, advocate for equitable access to licensed COVID‑19 vaccines.   Scientists have encouraged that the WHO, CEPI, corporations, and governments collaborate to assure evidence-based allocation of eventual COVID‑19 vaccines determined on infection risk,   particularly urgent vaccinations provided first for healthcare workers, vulnerable populations, and children.   \n",
            "During 2020, the WHO, GAVI, and CEPI combined resources to form COVAX – a program for coordination of global equitable access to a licensed vaccine.  \n",
            "Over 100 international scientists and concerned individuals (including those associated with religious organizations) have called for releasing COVID‑19 vaccines to the public domain. Similar to the development of the first polio vaccine that was never patented, an effective COVID-19 vaccine would be available for production and approval by a number of countries and pharmaceutical manufacturing centers worldwide, therefore allowing for a more even and cost-effective distribution on a global scale. \n",
            "During and after 2021, deploying a COVID-19 vaccine may require worldwide transport and tracking of 10-19 billion vial doses, an effort readily becoming the largest supply chain challenge in history.    As of September 2020, supply chain and logistics experts expressed concern that international and national networks for distributing a licensed vaccine were not ready for the volume and urgency, due mainly to deterioration of resources during 2020 pandemic lockdowns and downsizing that degraded supply capabilities.    Addressing the worldwide challenge faced by coordinating numerous organizations – the COVAX partnership, global pharmaceutical companies, contract vaccine manufacturers, inter- and intranational transport, storage facilities, and health organizations in individual countries – Seth Berkley, chief executive of GAVI, stated: \"Delivering billions of doses of vaccine to the entire world efficiently will involve hugely complex logistical and programmatic obstacles all the way along the supply chain.\" \n",
            "As an example highlighting the immensity of the challenge, the International Air Transport Association stated that 8,000 747 cargo planes – implemented with equipment for precision vaccine cold storage – would be needed to transport just one dose for people in the more than 200 countries experiencing the COVID-19 pandemic.  GAVI states that \"with a fast-moving pandemic, no one is safe, unless everyone is safe.\" \n",
            "In contrast to the multibillion dollar investment in vaccine technologies and early-stage clinical research, the post-licensing supply chain for a vaccine has not received the same planning, coordination, security or investment.    A major concern is that resources for vaccine distribution in low- to middle-income countries, particularly for vaccinating children, are inadequate or non-existent, but could be improved with cost efficiencies if procurement and distribution were centralized regionally or nationally.   In September, the COVAX partnership included 172 countries coordinating plans to optimize the supply chain for a COVID-19 vaccine,  and the United Nations Children's Fund joined with COVAX to prepare the financing and supply chain for vaccinations of children in 92 developing countries.  \n",
            "Logistics vaccination services assure necessary equipment, staff, and supply of licensed vaccines across international borders.  Central logistics include vaccine handling and monitoring, cold chain management, and safety of distribution within the vaccination network.  The purpose of the COVAX Facility is to centralize and equitably administer logistics resources among participating countries, merging manufacturing, transport, and overall supply chain infrastructure.   Included are logistics tools for vaccine forecasting and needs estimation, in-country vaccine management, potential for wastage, and stock management. \n",
            "Other logistics factors conducted internationally during distribution of a COVID-19 vaccine may include:   \n",
            "A logistics shortage in any one step may derail the whole supply chain, according to one vaccine developer.  If the vaccine supply chain fails, the economic and human costs of the pandemic may be extended for years. \n",
            "By August 2020 when only a few vaccine candidates were in Phase III trials many months from establishing safety and efficacy, numerous governments pre-ordered more than two billion doses at a cost of more than US$5 billion.    Pre-orders from the UK government for 2021 were for five vaccine doses per person, a number dispiriting organizations like the WHO and GAVI which are promoting fair and equitable access worldwide, especially for developing countries.  In September, CEPI was financially supporting basic and clinical research for nine vaccine candidates, with nine more in evaluation, under financing commitments to manufacture two billion doses of three licensed vaccines by the end of 2021.  Overall before 2022, 7-10 billion COVID-19 vaccine doses may be manufactured worldwide, but the sizable pre-orders by affluent countries – called \"vaccine nationalism\" – threaten vaccine availability for poorer nations.    Brazil and Indonesia had pre-ordered millions of vaccine doses that are undergoing phase III trials in their countries The Serum Institute of India plans to produce at least one billion vaccine doses, although the Institute has stated that half the doses will be used in India.  After joining COVAX in October, China shared that it would produce 600 million vaccine doses before the end of 2020 and another one billion doses in 2021, although it was unsure how many would be for the country's own population of 1.4 billion. \n",
            "AstraZeneca CEO, Pascal Soriot, stated: \"The challenge is not making the vaccine itself, it's filling vials. There just aren't enough vials in the world.\"  Preparing for high demand in manufacturing vials, an American glass producer invested $163 million in July for a vial factory.  Glass availability for vial manufacturing and contaminant control are issues of concern,  indicating higher production costs with lower profit potential for developers amid demands for vaccines to be affordable.   \n",
            "Vaccines must be handled and transported using international regulations, be maintained at controlled temperatures that vary across vaccine technologies, and be used for immunization before deterioration in storage.   The scale of the COVID-19 vaccine supply chain is expected to be vast to ensure delivery worldwide to vulnerable populations.   Priorities for preparing facilities for such distribution include temperature-controlled facilities and equipment, optimizing infrastructure, training immunization staff, and rigorous monitoring.    RFID technologies are being implemented to track and authenticate a vaccine dose from the manufacturer along the entire supply chain to the vaccination. \n",
            "Vaccines (and adjuvants) are inherently unstable during temperature changes, requiring cold chain management throughout the entire supply chain, typically at temperatures of 2–8 °C (36–46 °F).   Because COVID-19 vaccine technologies are varied among several novel technologies, there are new challenges for cold chain management, with some vaccines that are stable while frozen but labile to heat, while others should not be frozen at all, and some are stable across temperatures.  Freezing damage and inadequate training of personnel in the local vaccination process are major concerns.  If more than one COVID-19 vaccine is approved, the vaccine cold chain may have to accommodate all these temperature sensitivities across different countries with variable climate conditions and local resources for temperature maintenance. \n",
            "DNA and RNA vaccine technologies are in development, but may be difficult to manufacture at scale and control degradation during cold storage and transport.  As examples, Moderna's RNA vaccine candidate requires cold chain management just above freezing temperatures with limited storage duration, but the BioNTech-Pfizer RNA candidate requires storage at -70°C (-94°F) or colder throughout deployment until vaccination.  \n",
            "After a vaccine vial is punctured to administer a dose, it is viable for only six hours, then must be discarded, requiring attention to local management of cold storage and vaccination processes.  Because the COVID-19 vaccine will likely be in short supply for many locations during early deployment, vaccination staff will have to avoid spoilage and waste, which typically are as much as 30% of the supply.   The cold chain is further challenged by the type of local transportation for the vaccines in rural communities, such as by motorcycle or delivery drone, need for booster doses, use of diluents, and access to vulnerable populations, such as healthcare staff, children and the elderly.   \n",
            "Coordination of international air cargo is an essential component of time- and temperature-sensitive distribution of COVID-19 vaccines, but, as of September 2020, the air freight network is not prepared for multinational deployment.    \"Safely delivering COVID-19 vaccines will be the mission of the century for the global air cargo industry. But it won't happen without careful advance planning. And the time for that is now. We urge governments to take the lead in facilitating cooperation across the logistics chain so that the facilities, security arrangements and border processes are ready for the mammoth and complex task ahead,\" said IATA's Director General and CEO, Alexandre de Juniac, in September 2020. \n",
            "For the severe reduction in passenger air traffic during 2020, airlines downsized personnel, trimmed destination networks, and put aircraft into long-term storage.   As the lead agencies for procurement and supply of the COVID-19 vaccine within the WHO COVAX Facility, GAVI and UNICEF are preparing for the largest and fastest vaccine deployment ever, necessitating international air freight collaboration, customs and border control, and possibly as many as 8,000 cargo planes to deliver just one vaccine dose to multiple countries.  \n",
            "Medicines are the world's largest fraud market, worth some $200 billion per year, making the widespread demand for a COVID-19 vaccine vulnerable to counterfeit, theft, scams, and cyberattacks throughout the supply chain.   Anticorruption, transparency, and accountability  safeguards are being established to reduce and eliminate corruption of COVID-19 vaccine supplies.   Absence of harmonized regulatory frameworks among countries, including low technical capacity, constrained access, and ineffective capability to identify and track genuine vs. counterfeit vaccines, may be life-threatening for vaccine recipients, and would potentially perpetuate the COVID-19 pandemic.  Tracking system technologies for packaging are being used by manufacturers to trace vaccine vials across the supply chain,  and to use digital and biometric tools to assure security for vaccination teams.  \n",
            "The WHO has implemented an \"Effective Vaccine Management\" system,  which includes constructing priorities to prepare national and subnational personnel and facilities for vaccine distribution, including:\n",
            "Border processes for efficient handling and customs clearance within individual countries may include:  \n",
            "On February 4, 2020, US Secretary of Health and Human Services Alex Azar published a notice of declaration under the Public Readiness and Emergency Preparedness Act for medical countermeasures against COVID‑19, covering \"any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID‑19, or the transmission of SARS-CoV-2 or a virus mutating therefrom\", and stating that the declaration precludes \"liability claims alleging negligence by a manufacturer in creating a vaccine, or negligence by a health care provider in prescribing the wrong dose, absent willful misconduct\".  The declaration is effective in the United States through 1 October 2024.\n",
            "Social media posts have promoted a conspiracy theory that a COVID‑19 vaccine is already available. The patents cited by various social media posts have references to existing patents for genetic sequences and vaccines for other strains such as the SARS coronavirus, but not for COVID‑19.  \n",
            "On 21 May 2020, the FDA made public the cease-and-desist notice it had sent to North Coast Biologics, a Seattle-based company that had been selling a purported \"nCoV19 spike protein vaccine\". \n",
            "\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "9LGARwiGffto"
      },
      "source": [
        "cleaner_text = text.lower()\n",
        "cleaner_text = re.sub(r'\\d',' ',cleaner_text)#removes decimal digits\n",
        "cleaner_text = re.sub(r'\\W',' ',cleaner_text)#short form of re.sub [a-zA-Z0-9]\n",
        "cleaner_text = re.sub(r'\\s+',' ',cleaner_text) #remove extra spaces"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "qiGjIruiq8yY",
        "outputId": "df5c52ef-8834-4929-bac9-7abf6d94a15b",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 120
        }
      },
      "source": [
        "cleaner_text"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "' a covid vaccine is any of several different vaccines intended to provide acquired immunity against coronavirus disease covid previous work to develop a vaccine against the coronavirus diseases sars and mers established knowledge about the structure and function of coronaviruses which accelerated development during early of varied technology platforms for a covid vaccine as of october there were vaccine candidates in development a fold increase since april however no candidate has completed clinical trials to prove its safety and efficacy in october some vaccine candidates were in clinical research namely in phase i ii trials and in phase ii iii trials the world health organization who the coalition for epidemic preparedness innovations cepi and the gates foundation gf are committing money and organizational resources for the prospect that several vaccines will be needed to prevent continuing covid infection the cepi which is organizing a us billion worldwide fund for rapid investment and development of vaccine candidates indicated in september that clinical data to support licensure may be available by the end of on may the who organized a telethon which received us billion in pledges from forty countries to support rapid development of vaccines to prevent covid infections at the same time the who also announced the deployment of an international solidarity trial for simultaneous evaluation of several vaccine candidates reaching phase ii iii clinical trials vaccines have been produced against several animal diseases caused by coronaviruses including as of infectious bronchitis virus in birds canine coronavirus and feline coronavirus previous projects to develop vaccines for viruses in the family coronaviridae that affect humans have been aimed at severe acute respiratory syndrome sars and middle east respiratory syndrome mers vaccines against sars and mers have been tested in non human animals according to studies published in and the identification and development of novel vaccines and medicines to treat sars was a priority for governments and public health agencies around the world at that time as of there is no cure or protective vaccine proven to be safe and effective against sars in humans there is also no proven vaccine against mers when mers became prevalent it was believed that existing sars research may provide a useful template for developing vaccines and therapeutics against a mers cov infection as of march there was one dna based mers vaccine which completed phase i clinical trials in humans and three others in progress all of which are viral vectored vaccines two adenoviral vectored chadox mers bvrs gamvac and one mva vectored mva mers s a vaccine for an infectious disease has never before been produced in less than several years and no vaccine exists for preventing a coronavirus infection in humans after the coronavirus was detected in december the genetic sequence of covid was published on january triggering an urgent international response to prepare for an outbreak and hasten development of a preventive vaccine in february the world health organization who said it did not expect a vaccine against severe acute respiratory syndrome coronavirus sars cov the causative virus to become available in less than months the rapidly growing infection rate of covid worldwide during early stimulated international alliances and government efforts to urgently organize resources to make multiple vaccines on shortened timelines with four vaccine candidates entering human evaluation in march see the table of clinical trials started in below in april the who estimated a total cost of us billion to develop a suite of three or more vaccines having different technologies and distribution by april almost companies and institutes in countries were working on this virtual gold rush also in april cepi estimated that as many as six of the vaccine candidates against covid should be chosen by international coalitions for development through phase ii iii trials and three should be streamlined through regulatory and quality assurance for eventual licensing at a total cost of at least us billion another analysis estimates candidates will need simultaneous initial development before a select few are chosen for the final path to licensing in july anglo american intelligence and security organisations of the respective governments and armed forces as the uk s national cyber security centre together with the canadian communications security establishment the united states department for homeland security cybersecurity infrastructure security agency and the us national security agency nsa alleged that russian state backed hackers may have been trying to steal covid treatment and vaccine research from academic and pharmaceutical institutions in other countries russia has denied it during major changes in the overall effort of developing covid vaccines since early in the year have been the increasing number of collaborations of the multinational pharmaceutical industry with national governments and the diversity and growing number of biotechnology companies in many countries focusing on a covid vaccine according to cepi the general geographic distribution of covid vaccine development involves organizations in north america having about of the world s covid vaccine research compared with in asia and australia in europe and a few projects in south america and africa organizations have formed international alliances to expedite vaccine development and prepare for distribution including the who which is facilitating collaboration accelerated research and international communications on a scale unprecedented in history beginning in early may by raising us billion in pledges the who also implemented covid vaccines global access covax for coordinating global vaccine development the vaccine pillar of access to covid tools act accelerator in collaboration with gavi and the coalition for epidemic preparedness innovations cepi in july the who announced that countries representing up to of the world population had agreed to a who covax plan for fair and equitable distribution of an eventual licensed vaccine assuring that each participating country would receive a guaranteed share of doses to vaccinate the most vulnerable of its population by the end of covax has the goal to accelerate the development and manufacturing of covid vaccines and to assure that access to licensed vaccines is equitably provided to all countries cepi is working with international health authorities and vaccine developers to create another us billion fund in a global partnership between public private philanthropic and civil society organizations for accelerated research and clinical testing of eight vaccine candidates with the goal of supporting several candidates for full development to licensing the united kingdom canada belgium norway switzerland germany and the netherlands had already donated us million to cepi by early may the bill melinda gates foundation gates foundation a private charitable organization dedicated to vaccine research and distribution is donating us million in support of cepi for research and public educational support on covid vaccines the global research collaboration for infectious disease preparedness glopid r is working closely with the who and member states to identify priorities for funding specific researches needed for a covid vaccine coordinating among the international funding and research organizations to maintain updated information on vaccine progress and avoid duplicate funding the international severe acute respiratory and emerging infection consortium is organizing and disseminating clinical information on covid research to inform public health policy on eventual vaccine distribution on june a virtual summit was coordinated from london uk among private and government representatives of countries including heads of state from g and g nations to raise us billion in support of the global alliance for vaccines and immunisation gavi to prepare for covid vaccinations of million children in under developed countries through major contributions were us billion from the gates foundation and gb million per year over five years by the uk government approximately us billion in june national governments dedicating resources for national or international investments in vaccine research development and manufacturing beginning in included the canadian government which announced ca million in funding for research vaccine research projects at canadian companies and universities with plans to establish a vaccine bank of several new vaccines that could be used if another coronavirus outbreak occurs a further investment of ca billion was added to support clinical trials in canada and develop manufacturing and supply chains for vaccines on may the canadian government committed ca million to the who s live streaming effort to raise us billion for covid vaccines and preparedness in china the government is providing low rate loans to a vaccine developer through its central bank and has quickly made land available for the company to build production plants as of june six of the eleven covid vaccine candidates in early stage human testing were developed by chinese organizations three chinese vaccine companies and research institutes are supported by the government for financing research conducting clinical trials and manufacturing the most promising vaccine candidates while prioritizing rapid evidence of efficacy over safety on may china had pledged us billion to support overall efforts by the who for programs against covid on july china additionally announced that it plans to provide a us billion loan to make its vaccine accessible for countries in latin america and the caribbean on august chinese premier li keqiang announced it would provide five southeast asian countries of cambodia laos myanmar thailand and vietnam priority access to the vaccine once it was fully developed among european union countries france announced a us million investment in a covid vaccine research consortium via cepi involving the institut pasteur themis bioscience vienna austria and the university of pittsburgh bringing cepi s total investment in covid vaccine development to us million by may in march the european commission made an million investment in curevac a german biotechnology company to develop a mrna vaccine the german government announced a separate million investment in curevac in june belgium norway switzerland germany and the netherlands have been major contributors to the cepi effort for covid vaccine research in europe in april the uk government formed a covid vaccine task force to stimulate british efforts for rapidly developing a vaccine through collaborations of industry universities and government agencies across the vaccine development pipeline including clinical trial placement at uk hospitals regulations for approval and eventual manufacturing the vaccine development initiatives at the university of oxford and imperial college of london were financed with gb million in april the united states biomedical advanced research and development authority barda a federal agency that funds disease fighting technology announced investments of nearly us billion to support american covid vaccine development and preparation for manufacturing the most promising candidates on april barda made a us million investment in the vaccine developer moderna and its partner johnson johnson barda has an additional us billion to spend on vaccine development and will have roles in other american investment for development of six to eight vaccine candidates to be in clinical studies over by companies such as sanofi pasteur and regeneron on may the us government announced federal funding for a fast track program called operation warp speed which has the goals of placing diverse vaccine candidates in clinical trials by the fall of and manufacturing million doses of a licensed vaccine by january the project chief advisor is moncef slaoui and its chief operating officer is army general gustave perna in june the warp speed team said it would work with seven companies developing covid vaccine candidates moderna johnson johnson merck pfizer and the university of oxford in collaboration with astrazeneca as well as two others in april the who published an r d blueprint for the novel coronavirus blueprint the blueprint documented a large international multi site individually randomized controlled clinical trial to allow the concurrent evaluation of the benefits and risks of each promising candidate vaccine within months of it being made available for the trial the blueprint listed a global target product profile tpp for covid identifying favorable attributes of safe and effective vaccines under two broad categories vaccines for the long term protection of people at higher risk of covid such as healthcare workers and other vaccines to provide rapid response immunity for new outbreaks the international tpp team was formed to assess the development of the most promising candidate vaccines map candidate vaccines and their clinical trial worldwide publishing a frequently updated landscape of vaccines in development rapidly evaluate and screen for the most promising candidate vaccines simultaneously before they are tested in humans and design and coordinate a multiple site international randomized controlled trial the solidarity trial for vaccines to enable simultaneous evaluation of the benefits and risks of different vaccine candidates under clinical trials in countries where there are high rates of covid disease ensuring fast interpretation and sharing of results around the world the who vaccine coalition will prioritize which vaccines should go into phase ii and iii clinical trials and determine harmonized phase iii protocols for all vaccines achieving the pivotal trial stage a clinical trial design in progress may be modified as an adaptive design if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment the who solidarity trial of multiple vaccines in clinical studies during will apply adaptive design to rapidly alter trial parameters across all study sites as results emerge candidate vaccines may be added to the solidarity trial as they become available if priority criteria are met while vaccine candidates showing poor evidence of safety or efficacy compared to placebo or other vaccines will be dropped from the international trial adaptive designs within ongoing phase ii iii clinical trials on candidate vaccines may shorten trial durations and use fewer subjects possibly expediting decisions for early termination or success avoiding duplication of research efforts and enhancing coordination of design changes for the solidarity trial across its international locations large pharmaceutical companies with experience in making vaccines at scale including johnson johnson astrazeneca and glaxosmithkline gsk are forming alliances with biotechnology companies national governments and universities to accelerate progression to an effective vaccine to combine financial and manufacturing capabilities for a pandemic adjuvanted vaccine technology gsk joined with sanofi in an uncommon partnership of multinational companies to support accelerated vaccine development during a pandemic on the rapid timeline and scale of covid infections during international organizations like the who and cepi vaccine developers governments and industry are evaluating distribution of the eventual vaccine s individual countries producing a vaccine may be persuaded to favor the highest bidder for manufacturing or provide first service to their own country experts emphasize that licensed vaccines should be available and affordable for people at the frontline of healthcare and having the greatest need under their agreement with astrazeneca the university of oxford vaccine development team and uk government agreed that uk citizens would not get preferential access to a new covid vaccine developed by the taxpayer funded university but rather consented to having a licensed vaccine distributed multinationally in cooperation with the who several companies plan to initially manufacture a vaccine at low cost then increase costs for profitability later if annual vaccinations are needed and as countries build stock for future needs the who and cepi are developing financial resources and guidelines for global deployment of several safe effective covid vaccines recognizing the need is different across countries and population segments for example successful covid vaccines would likely be allocated first to healthcare personnel and populations at greatest risk of severe illness and death from covid infection such as the elderly or densely populated impoverished people the who cepi and gavi have expressed concerns that affluent countries should not receive priority access to the global supply of eventual covid vaccines but rather protecting healthcare personnel and people at high risk of infection are needed to address public health concerns and reduce economic impact of the pandemic geopolitical issues safety concerns for vulnerable populations and manufacturing challenges for producing billions of doses are compressing schedules to shorten the standard vaccine development timeline in some cases combining clinical trial steps over months a process typically conducted sequentially over years as an example chinese vaccine developers and the government chinese center for disease control and prevention began their efforts in january and by march were pursuing numerous candidates on short timelines with the goal to showcase chinese technology strengths over those of the united states and to reassure the chinese people about the quality of vaccines produced in china in the haste to provide a vaccine on a rapid timeline for the covid pandemic developers and governments are accepting a high risk of short circuiting the vaccine development process with one industry executive saying the crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop multiple steps along the entire development path are evaluated including the level of acceptable toxicity of the vaccine its safety targeting vulnerable populations the need for vaccine efficacy breakthroughs the duration of vaccination protection special delivery systems such as oral or nasal rather than by injection dose regimen stability and storage characteristics emergency use authorization before formal licensing optimal manufacturing for scaling to billions of doses and dissemination of the licensed vaccine from phase i clinical trials of vaccine candidates fail to make it to final approval during development and from phase iii fail the investment by a manufacturer in a vaccine candidate may exceed us billion and end with millions of useless doses in the case of covid specifically a vaccine efficacy of may be enough to stop the pandemic but if it has only efficacy outbreaks may continue an efficacy of less than will not provide enough herd immunity to stop the spread of the virus alone as the pandemic expands during research at universities is obstructed by physical distancing and closing of laboratories globally supplies critical to vaccine research and development are increasingly scarce due to international competition or national sequestration timelines for conducting clinical research normally a sequential process requiring years are being compressed into safety efficacy and dosing trials running simultaneously over months potentially compromising safety assurance cepi scientists reported in september that nine different technology platforms with the technology of numerous candidates remaining undefined were under research and development during to create an effective vaccine against covid according to cepi most of the platforms of vaccine candidates in clinical trials as of september are focused on the coronavirus spike protein and its variants as the primary antigen of covid infection platforms being developed in involve nucleic acid technologies rna and dna non replicating viral vectors peptides recombinant proteins live attenuated viruses and inactivated viruses many vaccine technologies being developed for covid are not like vaccines already in use to prevent influenza but rather are using next generation strategies for precision on covid infection mechanisms vaccine platforms in development may improve flexibility for antigen manipulation and effectiveness for targeting mechanisms of covid infection in susceptible population subgroups such as healthcare workers the elderly children pregnant women and people with existing weakened immune systems technologies for dozens of candidates are unannounced or unknown cepi classifies development stages for vaccines as exploratory planning and designing a candidate having no evaluation in vivo preclinical in vivo evaluation with preparation for manufacturing a compound to test in humans or initiation of phase i safety studies in healthy people some total vaccine candidates are in development as either confirmed projects in clinical trials or in early stage exploratory or preclinical development as of september phase i trials test primarily for safety and preliminary dosing in a few dozen healthy subjects while phase ii trials following success in phase i evaluate immunogenicity dose levels efficacy based on biomarkers and adverse effects of the candidate vaccine typically in hundreds of people a phase i ii trial consists of preliminary safety and immunogenicity testing is typically randomized placebo controlled while determining more precise effective doses phase iii trials typically involve more participants at multiple sites include a control group and test effectiveness of the vaccine to prevent the disease an interventional or pivotal trial while monitoring for adverse effects at the optimal dose definition of vaccine safety efficacy and clinical endpoints in a phase iii trial may vary between the trials of different companies such as defining the degree of side effects infection or amount of transmission and whether the vaccine prevents moderate or severe covid infection on september uae approved sinopharm s vaccine for emergency use by front line healthcare workers following successful interim results in the phase iii trials pakistan sep december in pakistan janssen pharmaceutica johnson johnson bidmc temporarily paused on october due to an unexplained illness in a participant arcturus therapeutics in april the who issued a statement representing dozens of vaccine scientists around the world pledging collaboration to speed development of a vaccine against covid the who coalition is encouraging international cooperation between organizations developing vaccine candidates national regulatory and policy agencies financial contributors public health associations and governments for eventual manufacturing of a successful vaccine in quantities sufficient to supply all affected regions particularly low resource countries industry analysis of past vaccine development shows failure rates of because covid is a novel virus target with properties still being discovered and requiring innovative vaccine technologies and development strategies the risks associated with developing a successful vaccine across all steps of preclinical and clinical research are high to assess potential for vaccine efficacy unprecedented computer simulations and new covid specific animal models are being developed multinationally during but these methods remain untested by unknown characteristics of the covid virus of the confirmed active vaccine candidates about are being developed by private companies with the remaining projects under development by academic government coalitions and health organizations most of the vaccine developers are small firms or university research teams with little experience in successful vaccine design and limited capacity for advanced clinical trial costs and manufacturing without partnership by multinational pharmaceutical companies many vaccine candidates under design or preclinical development for covid will not gain approval for human studies in due to toxicity ineffectiveness to induce immune responses or dosing failures in laboratory animals or because of underfunding the probability of success for an infectious disease vaccine candidate to pass preclinical barriers and reach phase i of human testing is commitment to first in human testing of a vaccine candidate represents a substantial capital cost for vaccine developers estimated to be from us million to us million for a typical phase i trial program but possibly as much as us million for comparison during the ebola virus epidemic of there were vaccine candidates in urgent development but only one eventually succeeded as a licensed vaccine involving a total cost to confirm efficacy in phase ii iii trials of about us billion some vaccines have non specific effects beyond the disease they prevent assertions have been made that covid mortality has been lower in countries having routine bcg vaccine administered against tuberculosis though the world health organization who has said there is no evidence that this vaccine is effective against the covid virus in march a randomized trial of bcg vaccine to reduce covid illness began in the netherlands seeking to recruit healthcare workers a further randomized trial in australia is seeking to enroll healthcare workers in june a randomized placebo controlled trial to test whether the measles mumps rubella vaccine mmr can protect healthcare workers from covid began with participants in cairo in september eleven of the vaccine candidates in clinical development used adjuvants to enhance immunogenicity an immunological adjuvant is a substance formulated with a vaccine to elevate the immune response to an antigen such as the covid virus or influenza virus specifically an adjuvant may be used in formulating a covid vaccine candidate to boost its immunogenicity and efficacy to reduce or prevent covid infection in vaccinated individuals adjuvants used in covid vaccine formulation may be particularly effective for technologies using the inactivated covid virus and recombinant protein based or vector based vaccines aluminum salts known as alum were the first adjuvant used for licensed vaccines and are the adjuvant of choice in some of adjuvanted vaccines the alum adjuvant initiates diverse molecular and cellular mechanisms to enhance immunogenicity including release of proinflammatory cytokines a potential drawback of adjuvanted vaccines is that the virus evolves in a way to avoid the induced vaccine response making the adjuvant vaccine technology misdesigned against a changed virus such a change would require revised manufacturing and increased costs that discourage the routine use of adjuvants the rapid development and urgency of producing a vaccine for the covid pandemic may increase the risks and failure rate of delivering a safe effective vaccine one study found that between and the success rate of obtaining approval from phase i to successful phase iii trials was for vaccines and cepi indicates a potential success rate of only for vaccine candidates in development an april cepi report stated strong international coordination and cooperation between vaccine developers regulators policymakers funders public health bodies and governments will be needed to ensure that promising late stage vaccine candidates can be manufactured in sufficient quantities and equitably supplied to all affected areas particularly low resource regions however some of the public perceives vaccines as unsafe or unnecessary refusing vaccination a global health threat called vaccine hesitancy which increases the risk of further viral spread that could lead to covid outbreaks in mid estimates from two surveys were that or of people in the u s would accept a new vaccination against covid with wide disparity by education level employment status race and geography early research to assess vaccine efficacy using covid specific animal models such as ace transgenic mice other laboratory animals and non human primates indicates a need for biosafety level containment measures for handling live viruses and international coordination to ensure standardized safety procedures although the quality and quantity of antibody production by a potential vaccine is intended to neutralize the covid infection a vaccine may have an unintended opposite effect by causing antibody dependent disease enhancement ade which increases the virus attachment to its target cells and might trigger the cytokine storm when the person will be infected by the virus after vaccination the vaccine technology platform for example viral vector vaccine spike s protein vaccine or protein subunit vaccine vaccine dose timing of repeat vaccinations for the possible recurrence of covid infection and elderly age are factors determining the risk and extent of ade the antibody response to a vaccine is a variable of vaccine technologies in development including whether the vaccine has precision in its mechanism and choice of the route for how it is given intramuscular intradermal oral or nasal the effectiveness of new vaccine is defined by its efficacy the efficacy of less than may result in failure to create herd immunity host vaccinee related determinants that render a person susceptible to infection such as genetics health status underlying disease nutrition pregnancy sensitivities or allergies immune competence age and economic impact or cultural environment can be primary or secondary factors affecting the severity of infection and response to a vaccine elderly above age allergen hypersensitive and obese people have susceptibility to compromised immunogenicity which prevents or inhibits vaccine effectiveness possibly requiring separate vaccine technologies for these specific populations or repetitive booster vaccinations to limit virus transmission further mutations of the virus can alter its structure targeted by the vaccine thus making the vaccine ineffective vaccine developers have to invest resources internationally to find enough participants for phase ii iii clinical trials when the virus has proved to be a moving target of changing transmission rate across and within countries forcing companies to compete for trial participants as an example in june the chinese vaccine developer sinovac formed alliances in malaysia canada the uk and brazil among its plans to recruit trial participants and manufacture enough vaccine doses for a possible phase iii study in brazil where covid transmission was accelerating during june as the covid pandemic within china became more isolated and controlled chinese vaccine developers sought international relationships to conduct advanced human studies in several countries creating competition for trial participants with other manufacturers and the international solidarity trial organized by the who in addition to competition over recruiting participants clinical trial organizers may encounter people unwilling to be vaccinated due to vaccine hesitancy or disbelieving the science of the vaccine technology and its ability to prevent infection having an insufficient number of skilled team members to administer vaccinations may hinder clinical trials that must overcome risks for trial failure such as recruiting participants in rural or low density geographic regions and variations of age race ethnicity or underlying medical conditions an effective vaccine for covid could save trillions of dollars in global economic impact according to one expert and would therefore make any price tag in the billions look small in comparison it is not yet known if it is possible to create a safe reliable and affordable vaccine for this virus and it is not yet known exactly how much the vaccine development will cost it is possible that billions of dollars could be invested without success the european commission organized and held a video conference of world leaders on may at which us billion was raised for covid vaccine development after a vaccine is created billions of doses will need to be manufactured and distributed worldwide in april the gates foundation estimated that manufacturing and distribution could cost as much as us billion different vaccines have different shipping and handling requirements for example the pfizer biontech vaccine bnt must be shipped and stored at c f must be used within five days of thawing and has a minimum order of doses making it unlikely to be rolled out in settings other than large well equipped hospitals strategies are being considered for fast tracking the licensing of a vaccine against covid especially by compressing to a few months the usually lengthy duration of phase ii iii trials typically many years challenge studies have been implemented previously for diseases less deadly than covid infection such as common influenza typhoid fever cholera and malaria following preliminary proof of safety and efficacy of a candidate vaccine in laboratory animals and healthy humans controlled challenge studies might be implemented to bypass typical phase iii research providing an accelerated path to license a covid vaccine a challenge study begins by simultaneously testing a vaccine candidate for immunogenicity and safety in laboratory animals and healthy adult volunteers or fewer something normally a sequential process using animals first if the initial tests are promising the study proceeds by rapidly advancing the effective dose into a large scale phase ii iii trial in previously uninfected low risk volunteers such as young adults who would then be deliberately infected with covid for comparison with a placebo control group following the challenge the volunteers would be monitored closely in clinics with life saving resources if needed volunteering for a vaccine challenge study during the covid pandemic is likened to the emergency service of healthcare personnel for covid infected people firefighters or organ donors although challenge studies are ethically questionable due to the unknown hazards for the volunteers of possible covid disease enhancement and whether the vaccine received has long term safety among other cautions challenge studies may be the only option to rapidly produce an effective vaccine that will minimize the projected millions of deaths worldwide from covid infection according to some infectious disease experts the world health organization has developed a guidance document with criteria for conducting covid challenge studies in healthy people including scientific and ethical evaluation public consultation and coordination selection and informed consent of the participants and monitoring by independent experts a vaccine licensure occurs after the successful conclusion of the clinical trials program through phases i iii demonstrating safety immunogenicity at a specific dose effectiveness at preventing infection in target populations and enduring preventive effect as part of a multinational licensure for a vaccine the world health organization expert committee on biological standardization developed guidelines of international standards for manufacturing and quality control of vaccines a process intended as a platform for national regulatory agencies to apply for their own licensure process vaccine manufacturers do not receive licensure until a complete clinical package proves the vaccine is safe and has long term effectiveness following scientific review by a multinational or national regulatory organization such as the european medicines agency ema or the us food and drug administration fda upon developing countries adopting who guidelines for vaccine development and licensure each country has its own responsibility to issue a national licensure and to manage deploy and monitor the vaccine throughout its use in each nation building trust and acceptance of a licensed vaccine among the public is a task of communication by governments and healthcare personnel to ensure a vaccination campaign proceeds smoothly saves lives and enables economic recovery when a vaccine is licensed it will initially be in limited supply due to variable manufacturing distribution and logistical factors requiring an allocation plan for the limited supply and which population segments should be prioritized to first receive the vaccine vaccines developed for multinational distribution via the united nations children s fund unicef require pre qualification by who to ensure international standards of quality safety immunogenicity and efficacy for adoption by numerous countries the process requires manufacturing consistency at who contracted laboratories following gmp practices when un agencies are involved in vaccine licensure individual nations collaborate by issuing marketing authorization and a national license for the vaccine its manufacturers and distribution partners and conducting postmarketing surveillance including records for adverse events after the vaccination program who works with national agencies to monitor inspections of manufacturing facilities and distributors for compliance with gmp and regulatory oversight some countries choose to buy vaccines licensed by reputable national organizations such as ema fda or national agencies in other affluent countries but such purchases typically are more expensive and may not have distribution resources suitable to local conditions in developing countries in the european union eu vaccines for pandemic pathogens such as seasonal influenza are licensed eu wide where all of the member states comply centralized are licensed for only some member states decentralized or are licensed on an individual national level generally all eu states follow regulatory guidance and clinical programs defined by the european committee for medicinal products for human use chmp a scientific panel of the european medicines agency ema responsible for vaccine licensure the chmp is supported by several expert groups who assess and monitor the progress of a vaccine before and after licensure and distribution in october the chmp started rolling reviews of the vaccines known as covid vaccine astrazeneca and bnt b under the fda the process of establishing evidence for vaccine clinical safety and efficacy is the same as for the approval process for prescription drugs if successful through the stages of clinical development the vaccine licensing process is followed by a biologics license application which must provide a scientific review team from diverse disciplines such as physicians statisticians microbiologists chemists a comprehensive documentation for the vaccine candidate having efficacy and safety throughout its development also during this stage the proposed manufacturing facility is examined by expert reviewers for gmp compliance and the label must have compliant description to enable health care providers definition of vaccine specific use including its possible risks to communicate and deliver the vaccine to the public as of august in the united states there is no national strategy for how a successful vaccine will be ethically prioritized or distributed to vulnerable population segments such as homeless and incarcerated people and the elderly after licensure monitoring of the vaccine and its production including periodic inspections for gmp compliance continue as long as the manufacturer retains its license which may include additional submissions to the fda of tests for potency safety and purity for each vaccine manufacturing step at the beginning of the covid pandemic in early the who issued a guideline as an emergency use listing of new vaccines a process derived from the ebola epidemic it required that a vaccine candidate developed for a life threatening emergency be manufactured using gmp and that it complete development according to who prequalification procedures even as new vaccines are developed during the covid pandemic licensure of covid vaccine candidates requires submission of a full dossier of information on development and manufacturing quality in the eu companies may use a rolling review process supplying data as they become available during phase iii trials rather than developing the full documentation over months or years at the end of clinical research as is typical this rolling process allows the european chmp to evaluate clinical data in real time enabling a promising vaccine candidate to be approved on a rapid timeline by the ema on june china approved the cansino vaccine for limited use in the military and two inactivated virus vaccines for emergency use in high risk occupations on august russia announced the approval of its sputnik v vaccine for emergency use though one month later only small amounts of the vaccine had been distributed for use outside of the phase trial in the united states the fda may grant emergency use authorization for a promising covid vaccine before full evidence is available about its safety and efficacy but this hastened process has been criticized for its political misuse potential for lowered standards and increased antivaccine sentiment in the us population during on september nine leading pharma companies involved in covid vaccine research signed a letter pledging that they would submit their vaccines for emergency use authorization only after phase trials had demonstrated safety and efficacy until a vaccine is in use for the general population all potential adverse events from the vaccine may not be known requiring manufacturers to conduct phase iv studies for postmarketing surveillance of the vaccine while it is used widely in the public the who works with un member states to implement postlicensing surveillance the fda relies on a vaccine adverse event reporting system to monitor safety concerns about a vaccine throughout its use in the american public by june tens of billions of dollars were invested by corporations governments international health organizations and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against covid infection the corporate investment and need to generate value for public shareholders raised concerns about a market based approach in vaccine development costly pricing of eventual licensed vaccines preferred access for distribution first to affluent countries and sparse or no distribution to where the pandemic is most aggressive as predicted for densely populated impoverished countries unable to afford vaccinations the collaboration of the university of oxford with astrazeneca a global pharmaceutical company based in the uk raised concerns about price and sharing of eventual profits from international vaccine sales arising from whether the uk government and university as public partners had commercialization rights astrazeneca stated that initial pricing of its vaccine would not include a profit margin for the company while the pandemic was still expanding in early june astrazeneca made a usd millon deal allowing cepi and gavi to manufacture and distribute million doses if its oxford vaccine candidate proves safe and effective reportedly increasing the company s total production capacity to over billion doses per year commercialization of pandemic vaccines is a high risk business venture potentially losing billions of dollars in development and pre market manufacturing costs if the candidate vaccines fail to be safe and effective the multinational pharmaceutical company pfizer indicated it was not interested in a government partnership which would be a third party slowing progress in pfizer s vaccine program further there are concerns that rapid development programs like the operation warp speed plan of the united states are choosing vaccine candidates mainly for their manufacturing advantages to shorten the development timeline rather than for the most promising vaccine technology having safety and efficacy favored distribution of vaccines within one or a few select countries called vaccine sovereignty is a criticism of some of the vaccine development partnerships such as for the astrazeneca university of oxford vaccine candidate concerning whether there may be prioritized distribution first within the uk and to the highest bidder the united states which made an advance payment of us billion to secure million vaccine doses for americans even before the astrazeneca oxford vaccine or a sanofi vaccine is proved safe or effective concerns exist about whether some countries producing vaccines may impose protectionist controls by export restrictions that would stockpile a covid vaccine for their own population in june the serum institute of india sii a major manufacturer of global vaccines reached a licensing agreement with astrazeneca to make billion doses of vaccine for low and middle income countries of which half of the doses would go to india similar preferential homeland distribution may exist if a vaccine is manufactured in australia the chinese government pledged in may that a successful chinese vaccine would become a global public good implying enough doses would be manufactured for both national and global distribution as many of the efforts on vaccine candidates have open ended outcomes including a high potential for failure during human testing cepi who and charitable vaccine organizations such as the gates foundation and gavi raised over us billion during the first half of to fund vaccine development and preparedness for vaccinations particularly for children in under developed countries cepi had stated that governments should ensure implementation of a globally fair allocation system for eventual vaccines using a coordinated system of manufacturing capacity financing and purchasing and indemnification from liability to offset risks taken by vaccine developers having been created to monitor fair distribution of infectious disease vaccines to low and middle income countries cepi revised its equitable access policy that was published in february to apply to its covid vaccine funding prices for vaccines will be set as low as possible for territories that are or may be affected by an outbreak of a disease for which cepi funding was used to develop a vaccine information know how and materials related to vaccine development must be shared with or transferred to cepi so that it can assume responsibility for vaccine development if a company discontinues expenditures for a promising vaccine candidate cepi would have access to and possible management of intellectual property rights i e patents for promising vaccines cepi would receive a share of financial benefits that might accrue from cepi sponsored vaccine development to re invest in support of its mission to provide global public health benefit and data transparency among development partners should maintain the who statement on public disclosure of clinical trial results and require results to be published in open access publications some vaccine manufacturers opposed parts of these proposals international groups such as the centre for artistic activism and universities allied for essential medicines advocate for equitable access to licensed covid vaccines scientists have encouraged that the who cepi corporations and governments collaborate to assure evidence based allocation of eventual covid vaccines determined on infection risk particularly urgent vaccinations provided first for healthcare workers vulnerable populations and children during the who gavi and cepi combined resources to form covax a program for coordination of global equitable access to a licensed vaccine over international scientists and concerned individuals including those associated with religious organizations have called for releasing covid vaccines to the public domain similar to the development of the first polio vaccine that was never patented an effective covid vaccine would be available for production and approval by a number of countries and pharmaceutical manufacturing centers worldwide therefore allowing for a more even and cost effective distribution on a global scale during and after deploying a covid vaccine may require worldwide transport and tracking of billion vial doses an effort readily becoming the largest supply chain challenge in history as of september supply chain and logistics experts expressed concern that international and national networks for distributing a licensed vaccine were not ready for the volume and urgency due mainly to deterioration of resources during pandemic lockdowns and downsizing that degraded supply capabilities addressing the worldwide challenge faced by coordinating numerous organizations the covax partnership global pharmaceutical companies contract vaccine manufacturers inter and intranational transport storage facilities and health organizations in individual countries seth berkley chief executive of gavi stated delivering billions of doses of vaccine to the entire world efficiently will involve hugely complex logistical and programmatic obstacles all the way along the supply chain as an example highlighting the immensity of the challenge the international air transport association stated that cargo planes implemented with equipment for precision vaccine cold storage would be needed to transport just one dose for people in the more than countries experiencing the covid pandemic gavi states that with a fast moving pandemic no one is safe unless everyone is safe in contrast to the multibillion dollar investment in vaccine technologies and early stage clinical research the post licensing supply chain for a vaccine has not received the same planning coordination security or investment a major concern is that resources for vaccine distribution in low to middle income countries particularly for vaccinating children are inadequate or non existent but could be improved with cost efficiencies if procurement and distribution were centralized regionally or nationally in september the covax partnership included countries coordinating plans to optimize the supply chain for a covid vaccine and the united nations children s fund joined with covax to prepare the financing and supply chain for vaccinations of children in developing countries logistics vaccination services assure necessary equipment staff and supply of licensed vaccines across international borders central logistics include vaccine handling and monitoring cold chain management and safety of distribution within the vaccination network the purpose of the covax facility is to centralize and equitably administer logistics resources among participating countries merging manufacturing transport and overall supply chain infrastructure included are logistics tools for vaccine forecasting and needs estimation in country vaccine management potential for wastage and stock management other logistics factors conducted internationally during distribution of a covid vaccine may include a logistics shortage in any one step may derail the whole supply chain according to one vaccine developer if the vaccine supply chain fails the economic and human costs of the pandemic may be extended for years by august when only a few vaccine candidates were in phase iii trials many months from establishing safety and efficacy numerous governments pre ordered more than two billion doses at a cost of more than us billion pre orders from the uk government for were for five vaccine doses per person a number dispiriting organizations like the who and gavi which are promoting fair and equitable access worldwide especially for developing countries in september cepi was financially supporting basic and clinical research for nine vaccine candidates with nine more in evaluation under financing commitments to manufacture two billion doses of three licensed vaccines by the end of overall before billion covid vaccine doses may be manufactured worldwide but the sizable pre orders by affluent countries called vaccine nationalism threaten vaccine availability for poorer nations brazil and indonesia had pre ordered millions of vaccine doses that are undergoing phase iii trials in their countries the serum institute of india plans to produce at least one billion vaccine doses although the institute has stated that half the doses will be used in india after joining covax in october china shared that it would produce million vaccine doses before the end of and another one billion doses in although it was unsure how many would be for the country s own population of billion astrazeneca ceo pascal soriot stated the challenge is not making the vaccine itself it s filling vials there just aren t enough vials in the world preparing for high demand in manufacturing vials an american glass producer invested million in july for a vial factory glass availability for vial manufacturing and contaminant control are issues of concern indicating higher production costs with lower profit potential for developers amid demands for vaccines to be affordable vaccines must be handled and transported using international regulations be maintained at controlled temperatures that vary across vaccine technologies and be used for immunization before deterioration in storage the scale of the covid vaccine supply chain is expected to be vast to ensure delivery worldwide to vulnerable populations priorities for preparing facilities for such distribution include temperature controlled facilities and equipment optimizing infrastructure training immunization staff and rigorous monitoring rfid technologies are being implemented to track and authenticate a vaccine dose from the manufacturer along the entire supply chain to the vaccination vaccines and adjuvants are inherently unstable during temperature changes requiring cold chain management throughout the entire supply chain typically at temperatures of c f because covid vaccine technologies are varied among several novel technologies there are new challenges for cold chain management with some vaccines that are stable while frozen but labile to heat while others should not be frozen at all and some are stable across temperatures freezing damage and inadequate training of personnel in the local vaccination process are major concerns if more than one covid vaccine is approved the vaccine cold chain may have to accommodate all these temperature sensitivities across different countries with variable climate conditions and local resources for temperature maintenance dna and rna vaccine technologies are in development but may be difficult to manufacture at scale and control degradation during cold storage and transport as examples moderna s rna vaccine candidate requires cold chain management just above freezing temperatures with limited storage duration but the biontech pfizer rna candidate requires storage at c f or colder throughout deployment until vaccination after a vaccine vial is punctured to administer a dose it is viable for only six hours then must be discarded requiring attention to local management of cold storage and vaccination processes because the covid vaccine will likely be in short supply for many locations during early deployment vaccination staff will have to avoid spoilage and waste which typically are as much as of the supply the cold chain is further challenged by the type of local transportation for the vaccines in rural communities such as by motorcycle or delivery drone need for booster doses use of diluents and access to vulnerable populations such as healthcare staff children and the elderly coordination of international air cargo is an essential component of time and temperature sensitive distribution of covid vaccines but as of september the air freight network is not prepared for multinational deployment safely delivering covid vaccines will be the mission of the century for the global air cargo industry but it won t happen without careful advance planning and the time for that is now we urge governments to take the lead in facilitating cooperation across the logistics chain so that the facilities security arrangements and border processes are ready for the mammoth and complex task ahead said iata s director general and ceo alexandre de juniac in september for the severe reduction in passenger air traffic during airlines downsized personnel trimmed destination networks and put aircraft into long term storage as the lead agencies for procurement and supply of the covid vaccine within the who covax facility gavi and unicef are preparing for the largest and fastest vaccine deployment ever necessitating international air freight collaboration customs and border control and possibly as many as cargo planes to deliver just one vaccine dose to multiple countries medicines are the world s largest fraud market worth some billion per year making the widespread demand for a covid vaccine vulnerable to counterfeit theft scams and cyberattacks throughout the supply chain anticorruption transparency and accountability safeguards are being established to reduce and eliminate corruption of covid vaccine supplies absence of harmonized regulatory frameworks among countries including low technical capacity constrained access and ineffective capability to identify and track genuine vs counterfeit vaccines may be life threatening for vaccine recipients and would potentially perpetuate the covid pandemic tracking system technologies for packaging are being used by manufacturers to trace vaccine vials across the supply chain and to use digital and biometric tools to assure security for vaccination teams the who has implemented an effective vaccine management system which includes constructing priorities to prepare national and subnational personnel and facilities for vaccine distribution including border processes for efficient handling and customs clearance within individual countries may include on february us secretary of health and human services alex azar published a notice of declaration under the public readiness and emergency preparedness act for medical countermeasures against covid covering any vaccine used to treat diagnose cure prevent or mitigate covid or the transmission of sars cov or a virus mutating therefrom and stating that the declaration precludes liability claims alleging negligence by a manufacturer in creating a vaccine or negligence by a health care provider in prescribing the wrong dose absent willful misconduct the declaration is effective in the united states through october social media posts have promoted a conspiracy theory that a covid vaccine is already available the patents cited by various social media posts have references to existing patents for genetic sequences and vaccines for other strains such as the sars coronavirus but not for covid on may the fda made public the cease and desist notice it had sent to north coast biologics a seattle based company that had been selling a purported ncov spike protein vaccine '"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 13
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "LpbpUAtWdzQy",
        "outputId": "c8adb075-bcab-442c-e2f8-3102f070aa7f",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 67
        }
      },
      "source": [
        "nltk.download(\"punkt\") "
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Package punkt is already up-to-date!\n"
          ],
          "name": "stdout"
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 14
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "ja0Bb3vKgSTJ"
      },
      "source": [
        "sentences = nltk.sent_tokenize(text)"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "ca5z5NVfq5g-",
        "outputId": "a9d71d81-3953-41a7-b57f-fc7a3369342b",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        }
      },
      "source": [
        "sentences"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[' \\n\\nA COVID‑19 vaccine is any of several different vaccines intended to  provide acquired immunity against coronavirus disease 2019 (COVID‑19).',\n",
              " 'Previous work to develop a vaccine against the coronavirus diseases SARS and MERS established knowledge about the structure and function of coronaviruses\\xa0– which accelerated development during early 2020 of varied technology platforms for a COVID‑19 vaccine.',\n",
              " 'As of October 2020, there were 321 vaccine candidates in development, a 2.5 fold increase since April.',\n",
              " 'However, no candidate has completed clinical trials to prove its safety and efficacy.',\n",
              " 'In October, some 42 vaccine candidates were in clinical research: namely 33 in Phase I–II trials and 9 in Phase II–III trials.',\n",
              " 'The World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and the Gates Foundation (GF) are committing money and organizational resources for the prospect that several vaccines will be needed to prevent continuing COVID‑19 infection.',\n",
              " 'The CEPI, which is organizing a US$2\\xa0billion worldwide fund for rapid investment and development of vaccine candidates,  indicated in September that clinical data to support licensure may be available by the end of 2020.',\n",
              " 'On 4\\xa0May 2020, the WHO organized a telethon which received US$8.1\\xa0billion in pledges from forty countries to support rapid development of vaccines to prevent COVID‑19 infections.',\n",
              " 'At the same time, the WHO also announced the deployment of an international \"Solidarity trial\" for simultaneous evaluation of several vaccine candidates reaching Phase II–III clinical trials.',\n",
              " 'Vaccines have been produced against several animal diseases caused by coronaviruses, including as of 2003 infectious bronchitis virus in birds, canine coronavirus, and feline coronavirus.',\n",
              " 'Previous projects to develop vaccines for viruses in the family Coronaviridae that affect humans have been aimed at severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).',\n",
              " 'Vaccines against SARS  and MERS  have been tested in non-human animals.',\n",
              " 'According to studies published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and public health agencies around the world at that time.',\n",
              " 'As of 2020, there is no cure or protective vaccine proven to be safe and effective against SARS in humans.',\n",
              " 'There is also no proven vaccine against MERS.',\n",
              " 'When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.',\n",
              " 'As of March 2020, there was one (DNA based) MERS vaccine which completed Phase\\xa0I clinical trials in humans,  and three others in progress, all of which are viral-vectored vaccines: two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), and one MVA-vectored (MVA-MERS-S).',\n",
              " 'A vaccine for an infectious disease has never before been produced in less than several years, and no vaccine exists for preventing a coronavirus infection in humans.',\n",
              " 'After the coronavirus was detected in December 2019,  the genetic sequence of COVID‑19 was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten development of a preventive vaccine.',\n",
              " 'In February 2020, the World Health Organization (WHO) said it did not expect a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus, to become available in less than 18 months.',\n",
              " 'The rapidly growing infection rate of COVID‑19 worldwide during early 2020 stimulated international alliances and government efforts to urgently organize resources to make multiple vaccines on shortened timelines,  with four vaccine candidates entering human evaluation in March (see the table of clinical trials started in 2020, below).',\n",
              " 'In April 2020, the WHO estimated a total cost of US$8\\xa0billion to develop a suite of three or more vaccines having different technologies and distribution.',\n",
              " 'By April 2020, \"almost 80 companies and institutes in 19 countries\" were working on this virtual gold rush.',\n",
              " 'Also in April, CEPI estimated that as many as six of the vaccine candidates against COVID‑19 should be chosen by international coalitions for development through Phase\\xa0II–III trials, and three should be streamlined through regulatory and quality assurance for eventual licensing at a total cost of at least US$2\\xa0billion.',\n",
              " 'Another analysis estimates 10 candidates will need simultaneous initial development, before a select few are chosen for the final path to licensing.',\n",
              " \"In July 2020, Anglo-American intelligence and security organisations of the respective governments and armed forces, as the UK's National Cyber Security Centre, together with the Canadian Communications Security Establishment, the United States Department for Homeland Security Cybersecurity Infrastructure Security Agency, and the US National Security Agency (NSA) alleged that Russian state-backed hackers may have been trying to steal COVID-19 treatment and vaccine research from academic and pharmaceutical institutions in other countries; Russia has denied it.\",\n",
              " 'During 2020, major changes in the overall effort of developing COVID-19 vaccines since early in the year have been the increasing number of collaborations of the multinational pharmaceutical industry with national governments, and the diversity and growing number of biotechnology companies in many countries focusing on a COVID-19 vaccine.',\n",
              " \"According to CEPI, the general geographic distribution of COVID‑19 vaccine development involves organizations in North America having about 40% of the world's COVID-19 vaccine research, compared with 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.\",\n",
              " 'Organizations have formed international alliances to expedite vaccine development and prepare for distribution, including the WHO which is facilitating collaboration, accelerated research, and international communications on a scale unprecedented in history, beginning in early May by raising US$8.1\\xa0billion in pledges.',\n",
              " 'The WHO also implemented Covid-19 Vaccines Global Access (COVAX) for coordinating global vaccine development, the vaccine pillar of Access to COVID-19 Tools (ACT) Accelerator in collaboration with GAVI and the Coalition for Epidemic Preparedness Innovations (CEPI).',\n",
              " 'In July, the WHO announced that 165 countries, representing up to 60% of the world population, had agreed to a WHO COVAX plan for fair and equitable distribution of an eventual licensed vaccine, assuring that each participating country would receive a guaranteed share of doses to vaccinate the most vulnerable 20% of its population by the end of 2021.',\n",
              " 'COVAX has the goal to accelerate the development and manufacturing of COVID-19 vaccines, and to assure that access to licensed vaccines is equitably provided to all countries.',\n",
              " 'CEPI is working with international health authorities and vaccine developers to create another US$2\\xa0billion fund in a global partnership between public, private, philanthropic, and civil society organizations for accelerated research and clinical testing of eight vaccine candidates, with the 2020–21 goal of supporting several candidates for full development to licensing.',\n",
              " 'The United Kingdom, Canada, Belgium, Norway, Switzerland, Germany and the Netherlands had already donated US$915\\xa0million to CEPI by early May.',\n",
              " 'The Bill & Melinda Gates Foundation (Gates Foundation), a private charitable organization dedicated to vaccine research and distribution, is donating US$250\\xa0million in support of CEPI for research and public educational support on COVID‑19 vaccines.',\n",
              " 'The Global Research Collaboration for Infectious Disease Preparedness (GLoPID-R) is working closely with the WHO and member states to identify priorities for funding specific researches needed for a COVID‑19 vaccine, coordinating among the international funding and research organizations to maintain updated information on vaccine progress and avoid duplicate funding.',\n",
              " 'The International Severe Acute Respiratory and Emerging Infection Consortium is organizing and disseminating clinical information on COVID‑19 research to inform public health policy on eventual vaccine distribution.',\n",
              " 'On 4 June, a virtual summit was coordinated from London, UK, among private and government representatives of 52 countries, including 35 heads of state from G7 and G20 nations, to raise US$8.8\\xa0billion in support of the Global Alliance for Vaccines and Immunisation (GAVI) to prepare for COVID‑19 vaccinations of 300\\xa0million children in under-developed countries through 2025.',\n",
              " 'Major contributions were US$1.6\\xa0billion from The Gates Foundation  and GB£330\\xa0million per year over five years by the UK government (approximately US$2.1\\xa0billion in June 2020).',\n",
              " 'National governments dedicating resources for national or international investments in vaccine research, development, and manufacturing beginning in 2020 included the Canadian government which announced CA$275\\xa0million in funding for 96 research vaccine research projects at Canadian companies and universities, with plans to establish a \"vaccine bank\" of several new vaccines that could be used if another coronavirus outbreak occurs.',\n",
              " 'A further investment of CA$1.1\\xa0billion was added to support clinical trials in Canada and develop manufacturing and supply chains for vaccines.',\n",
              " \"On 4\\xa0May, the Canadian government committed CA$850\\xa0million to the WHO's live streaming effort to raise US$8\\xa0billion for COVID‑19 vaccines and preparedness.\",\n",
              " 'In China, the government is providing low-rate loans to a vaccine developer through its central bank, and has \"quickly made land available for the company\" to build production plants.',\n",
              " 'As of June 2020, six of the eleven COVID‑19 vaccine candidates in early-stage human testing were developed by Chinese organizations.',\n",
              " 'Three Chinese vaccine companies and research institutes are supported by the government for financing research, conducting clinical trials, and manufacturing the most promising vaccine candidates, while prioritizing rapid evidence of efficacy over safety.',\n",
              " 'On 18 May, China had pledged US$2\\xa0billion to support overall efforts by the WHO for programs against COVID‑19.',\n",
              " 'On 22 July, China additionally announced that it plans to provide a US$1 billion loan to make its vaccine accessible for countries in Latin America and the Caribbean.',\n",
              " 'On August 24, Chinese Premier Li Keqiang announced it would provide five Southeast Asian countries of Cambodia, Laos, Myanmar, Thailand and Vietnam priority access to the vaccine once it was fully developed.',\n",
              " \"Among European Union countries, France announced a US$4.9\\xa0million investment in a COVID‑19 vaccine research consortium via CEPI involving the Institut Pasteur, Themis Bioscience (Vienna, Austria), and the University of Pittsburgh, bringing CEPI's total investment in COVID‑19 vaccine development to US$480\\xa0million by May.\",\n",
              " 'In March, the European Commission made an €80\\xa0million investment in CureVac, a German biotechnology company, to develop a mRNA vaccine.',\n",
              " 'The German government announced a separate €300\\xa0million investment in CureVac in June.',\n",
              " 'Belgium, Norway, Switzerland, Germany, and the Netherlands have been major contributors to the CEPI effort for COVID‑19 vaccine research in Europe.',\n",
              " 'In April, the UK government formed a COVID‑19 vaccine task force to stimulate British efforts for rapidly developing a vaccine through collaborations of industry, universities, and government agencies across the vaccine development pipeline, including clinical trial placement at UK hospitals, regulations for approval, and eventual manufacturing.',\n",
              " 'The vaccine development initiatives at the University of Oxford and Imperial College of London were financed with GB£44\\xa0million in April.',\n",
              " 'The United States Biomedical Advanced Research and Development Authority (BARDA), a federal agency that funds disease-fighting technology, announced investments of nearly US$1\\xa0billion to support American COVID‑19 vaccine development, and preparation for manufacturing the most promising candidates.',\n",
              " 'On 16 April, BARDA made a US$483\\xa0million investment in the vaccine developer, Moderna and its partner, Johnson & Johnson.',\n",
              " 'BARDA has an additional US$4\\xa0billion to spend on vaccine development, and will have roles in other American investment for development of six to eight vaccine candidates to be in clinical studies over 2020–21 by companies such as Sanofi Pasteur and Regeneron.',\n",
              " 'On 15 May, the US government announced federal funding for a fast-track program called Operation Warp Speed, which has the goals of placing diverse vaccine candidates in clinical trials by the fall of 2020, and manufacturing 300\\xa0million doses of a licensed vaccine by January 2021.',\n",
              " 'The project chief advisor is Moncef Slaoui and its Chief Operating Officer is Army General Gustave Perna.',\n",
              " 'In June, the Warp Speed team said it would work with seven companies developing COVID‑19 vaccine candidates: Moderna, Johnson & Johnson, Merck, Pfizer, and the University of Oxford in collaboration with AstraZeneca, as well as two others.',\n",
              " 'In April 2020, the WHO published an \"R&D Blueprint (for the) novel Coronavirus\" (Blueprint).',\n",
              " 'The Blueprint documented a \"large, international, multi-site, individually randomized controlled clinical trial\" to allow \"the concurrent evaluation of the benefits and risks of each promising candidate vaccine within 3-6 months of it being made available for the trial.\"',\n",
              " 'The Blueprint listed a Global Target Product Profile (TPP) for COVID‑19, identifying favorable attributes of safe and effective vaccines under two broad categories: \"vaccines for the long-term protection of people at higher risk of COVID‑19, such as healthcare workers\", and other vaccines to provide rapid-response immunity for new outbreaks.',\n",
              " 'The international TPP team was formed to 1) assess the development of the most promising candidate vaccines; 2) map candidate vaccines and their clinical trial worldwide, publishing a frequently-updated \"landscape\" of vaccines in development;  3) rapidly evaluate and screen for the most promising candidate vaccines simultaneously before they are tested in humans; and 4) design and coordinate a multiple-site, international randomized controlled trial\\xa0– the \"Solidarity trial\" for vaccines  \\xa0– to enable simultaneous evaluation of the benefits and risks of different vaccine candidates under clinical trials in countries where there are high rates of COVID‑19 disease, ensuring fast interpretation and sharing of results around the world.',\n",
              " 'The WHO vaccine coalition will prioritize which vaccines should go into Phase\\xa0II and III clinical trials, and determine harmonized Phase\\xa0III protocols for all vaccines achieving the pivotal trial stage.',\n",
              " 'A clinical trial design in progress may be modified as an \"adaptive design\" if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment.',\n",
              " 'The WHO Solidarity trial of multiple vaccines in clinical studies during 2020 will apply adaptive design to rapidly alter trial parameters across all study sites as results emerge.',\n",
              " 'Candidate vaccines may be added to the Solidarity trial as they become available if priority criteria are met, while vaccine candidates showing poor evidence of safety or efficacy compared to placebo or other vaccines will be dropped from the international trial.',\n",
              " 'Adaptive designs within ongoing Phase\\xa0II–III clinical trials on candidate vaccines may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, avoiding duplication of research efforts, and enhancing coordination of design changes for the Solidarity trial across its international locations.',\n",
              " 'Large pharmaceutical companies with experience in making vaccines at scale, including Johnson & Johnson, AstraZeneca, and GlaxoSmithKline (GSK), are forming alliances with biotechnology companies, national governments, and universities to accelerate progression to an effective vaccine.',\n",
              " 'To combine financial and manufacturing capabilities for a pandemic adjuvanted vaccine technology, GSK joined with Sanofi in an uncommon partnership of multinational companies to support accelerated vaccine development.',\n",
              " 'During a pandemic on the rapid timeline and scale of COVID‑19 infections during 2020, international organizations like the WHO and CEPI, vaccine developers, governments, and industry are evaluating distribution of the eventual vaccine(s).',\n",
              " 'Individual countries producing a vaccine may be persuaded to favor the highest bidder for manufacturing or provide first-service to their own country.',\n",
              " 'Experts emphasize that licensed vaccines should be available and affordable for people at the frontline of healthcare and having the greatest need.',\n",
              " 'Under their agreement with AstraZeneca, the University of Oxford vaccine development team and UK government agreed that UK citizens would not get preferential access to a new COVID‑19 vaccine developed by the taxpayer-funded university, but rather consented to having a licensed vaccine distributed multinationally in cooperation with the WHO.',\n",
              " 'Several companies plan to initially manufacture a vaccine at low cost, then increase costs for profitability later if annual vaccinations are needed and as countries build stock for future needs.',\n",
              " 'The WHO and CEPI are developing financial resources and guidelines for global deployment of several safe, effective COVID‑19 vaccines, recognizing the need is different across countries and population segments.',\n",
              " 'For example, successful COVID‑19 vaccines would likely be allocated first to healthcare personnel and populations at greatest risk of severe illness and death from COVID‑19 infection, such as the elderly or densely-populated impoverished people.',\n",
              " 'The WHO, CEPI, and GAVI have expressed concerns that affluent countries should not receive priority access to the global supply of eventual COVID‑19 vaccines, but rather protecting healthcare personnel and people at high risk of infection are needed to address public health concerns and reduce economic impact of the pandemic.',\n",
              " 'Geopolitical issues, safety concerns for vulnerable populations, and manufacturing challenges for producing billions of doses are compressing schedules to shorten the standard vaccine development timeline, in some cases combining clinical trial steps over months, a process typically conducted sequentially over years.',\n",
              " 'As an example, Chinese vaccine developers and the government Chinese Center for Disease Control and Prevention began their efforts in January 2020,  and by March were pursuing numerous candidates on short timelines, with the goal to showcase Chinese technology strengths over those of the United States, and to reassure the Chinese people about the quality of vaccines produced in China.',\n",
              " 'In the haste to provide a vaccine on a rapid timeline for the COVID‑19 pandemic, developers and governments are accepting a high risk of \"short-circuiting\" the vaccine development process,  with one industry executive saying: \"The crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop\".',\n",
              " 'Multiple steps along the entire development path are evaluated, including the level of acceptable toxicity of the vaccine (its safety), targeting vulnerable populations, the need for vaccine efficacy breakthroughs, the duration of vaccination protection, special delivery systems (such as oral or nasal, rather than by injection), dose regimen, stability and storage characteristics, emergency use authorization before formal licensing, optimal manufacturing for scaling to billions of doses, and dissemination of the licensed vaccine.',\n",
              " 'From Phase I clinical trials, 84–90%  of vaccine candidates fail to make it to final approval during development, and from Phase III, 25.7% fail \\xa0– the investment by a manufacturer in a vaccine candidate may exceed US$1\\xa0billion and end with millions of useless doses.',\n",
              " 'In the case of COVID‑19 specifically, a vaccine efficacy of 70% may be enough to stop the pandemic, but if it has only 60% efficacy, outbreaks may continue; an efficacy of less than 60% will not provide enough herd immunity to stop the spread of the virus alone.',\n",
              " 'As the pandemic expands during 2020, research at universities is obstructed by physical distancing and closing of laboratories.',\n",
              " 'Globally, supplies critical to vaccine research and development are increasingly scarce due to international competition or national sequestration.',\n",
              " 'Timelines for conducting clinical research\\xa0– normally a sequential process requiring years\\xa0– are being compressed into safety, efficacy, and dosing trials running simultaneously over months, potentially compromising safety assurance.',\n",
              " 'CEPI scientists reported in September 2020 that nine different technology platforms \\xa0–  with the technology of numerous candidates remaining undefined \\xa0–  were under research and development during 2020 to create an effective vaccine against COVID‑19.',\n",
              " 'According to CEPI, most of the platforms of vaccine candidates in clinical trials as of September are focused on the coronavirus spike protein and its variants as the primary antigen of COVID-19 infection.',\n",
              " 'Platforms being developed in 2020 involve nucleic acid technologies (RNA and DNA), non-replicating viral vectors, peptides, recombinant proteins, live attenuated viruses, and inactivated viruses.',\n",
              " 'Many vaccine technologies being developed for COVID‑19 are not like vaccines already in use to prevent influenza, but rather are using \"next-generation\" strategies for precision on COVID‑19 infection mechanisms.',\n",
              " 'Vaccine platforms in development may improve flexibility for antigen manipulation and effectiveness for targeting mechanisms of COVID‑19 infection in susceptible population subgroups, such as healthcare workers, the elderly, children, pregnant women, and people with existing weakened immune systems.',\n",
              " '^ technologies for dozens of candidates are unannounced or \"unknown\" \\n\\nCEPI classifies development stages for vaccines as \"exploratory\" (planning and designing a candidate, having no evaluation in vivo), \"preclinical\" (in vivo evaluation with preparation for manufacturing a compound to test in humans), or initiation of Phase\\xa0I safety studies in healthy people.',\n",
              " 'Some 321 total vaccine candidates are in development as either confirmed projects in clinical trials or in early-stage \"exploratory\" or \"preclinical\" development, as of September.',\n",
              " 'Phase\\xa0I trials test primarily for safety and preliminary dosing in a few dozen healthy subjects, while Phase\\xa0II trials\\xa0– following success in Phase\\xa0I\\xa0– evaluate immunogenicity, dose levels (efficacy based on biomarkers) and adverse effects of the candidate vaccine, typically in hundreds of people.',\n",
              " 'A Phase\\xa0I–II trial consists of preliminary safety and immunogenicity testing, is typically randomized, placebo-controlled, while determining more precise, effective doses.',\n",
              " 'Phase\\xa0III trials typically involve more participants at multiple sites, include a control group, and test effectiveness of the vaccine to prevent the disease (an \"interventional\" or \"pivotal\" trial), while monitoring for adverse effects at the optimal dose.',\n",
              " 'Definition of vaccine safety, efficacy, and clinical endpoints in a Phase\\xa0III trial may vary between the trials of different companies, such as defining the degree of side effects, infection or amount of transmission, and whether the vaccine prevents moderate or severe COVID‑19 infection.',\n",
              " \"On September 14, UAE approved Sinopharm's vaccine for emergency use by front-line healthcare workers following successful interim results in the Phase III trials.\",\n",
              " 'Pakistan\\nSep 2020 – December 2021 in Pakistan\\nJanssen Pharmaceutica (Johnson & Johnson), BIDMC\\nTemporarily paused on October 13 2020 due to an unexplained illness in a participant.',\n",
              " 'Arcturus Therapeutics\\nIn April 2020, the WHO issued a statement representing dozens of vaccine scientists around the world, pledging collaboration to speed development of a vaccine against COVID‑19.',\n",
              " 'The WHO coalition is encouraging international cooperation between organizations developing vaccine candidates, national regulatory and policy agencies, financial contributors, public health associations, and governments, for eventual manufacturing of a successful vaccine in quantities sufficient to supply all affected regions, particularly low-resource countries.',\n",
              " 'Industry analysis of past vaccine development shows failure rates of 84–90%.',\n",
              " 'Because COVID‑19 is a novel virus target with properties still being discovered and requiring innovative vaccine technologies and development strategies, the risks associated with developing a successful vaccine across all steps of preclinical and clinical research are high.',\n",
              " 'To assess potential for vaccine efficacy, unprecedented computer simulations and new COVID‑19-specific animal models are being developed multinationally during 2020, but these methods remain untested by unknown characteristics of the COVID‑19 virus.',\n",
              " 'Of the confirmed active vaccine candidates, about 70% are being developed by private companies, with the remaining projects under development by academic, government coalitions, and health organizations.',\n",
              " 'Most of the vaccine developers are small firms or university research teams with little experience in successful vaccine design and limited capacity for advanced clinical trial costs and manufacturing without partnership by multinational pharmaceutical companies.',\n",
              " 'Many vaccine candidates under design or preclinical development for COVID‑19 will not gain approval for human studies in 2020 due to toxicity, ineffectiveness to induce immune responses or dosing failures in laboratory animals, or because of underfunding.',\n",
              " 'The probability of success for an infectious disease vaccine candidate to pass preclinical barriers and reach Phase\\xa0I of human testing is 41-57%.',\n",
              " 'Commitment to first-in-human testing of a vaccine candidate represents a substantial capital cost for vaccine developers, estimated to be from US$14\\xa0million to US$25\\xa0million for a typical Phase\\xa0I trial program, but possibly as much as US$70\\xa0million.',\n",
              " 'For comparison, during the Ebola virus epidemic of 2013-16, there were 37 vaccine candidates in urgent development, but only one eventually succeeded as a licensed vaccine, involving a total cost to confirm efficacy in Phase\\xa0II–III trials of about US$1\\xa0billion.',\n",
              " 'Some vaccines have non-specific effects beyond the disease they prevent.',\n",
              " 'Assertions have been made that COVID‑19 mortality has been lower in countries having routine BCG vaccine administered against tuberculosis,     though the World Health Organization (WHO) has said there is no evidence that this vaccine is effective against the COVID‑19 virus.',\n",
              " 'In March 2020, a randomized trial of BCG vaccine to reduce COVID‑19 illness began in the Netherlands, seeking to recruit 1,000 healthcare workers.',\n",
              " 'A further randomized trial in Australia is seeking to enroll 4,170 healthcare workers.',\n",
              " 'In June 2020, a randomized placebo-controlled trial to test whether the measles-mumps-rubella vaccine (MMR) can protect healthcare workers from COVID‑19 began with 200 participants in Cairo.',\n",
              " 'In September 2020, eleven of the vaccine candidates in clinical development used adjuvants to enhance immunogenicity.',\n",
              " 'An immunological adjuvant is a substance formulated with a vaccine to elevate the immune response to an antigen, such as the COVID-19 virus or influenza virus.',\n",
              " 'Specifically, an adjuvant may be used in formulating a COVID-19 vaccine candidate to boost its immunogenicity and efficacy to reduce or prevent COVID-19 infection in vaccinated individuals.',\n",
              " 'Adjuvants used in COVID-19 vaccine formulation may be particularly effective for technologies using the inactivated COVID-19 virus and recombinant protein-based or vector-based vaccines.',\n",
              " 'Aluminum salts, known as \"alum\", were the first adjuvant used for licensed vaccines, and are the adjuvant of choice in some 80% of adjuvanted vaccines.',\n",
              " 'The alum adjuvant initiates diverse molecular and cellular mechanisms to enhance immunogenicity, including release of proinflammatory cytokines.',\n",
              " 'A potential drawback of adjuvanted vaccines is that the virus evolves in a way to avoid the induced vaccine response, making the adjuvant-vaccine technology misdesigned against a changed virus.',\n",
              " 'Such a change would require revised manufacturing and increased costs that discourage the routine use of adjuvants.',\n",
              " 'The rapid development and urgency of producing a vaccine for the COVID‑19 pandemic may increase the risks and failure rate of delivering a safe, effective vaccine.',\n",
              " 'One study found that between 2006 and 2015, the success rate of obtaining approval from Phase\\xa0I to successful Phase\\xa0III trials was 16.2% for vaccines,  and CEPI indicates a potential success rate of only 10% for vaccine candidates in 2020 development.',\n",
              " 'An April 2020 CEPI report stated: \"Strong international coordination and cooperation between vaccine developers, regulators, policymakers, funders, public health bodies and governments will be needed to ensure that promising late-stage vaccine candidates can be manufactured in sufficient quantities and equitably supplied to all affected areas, particularly low-resource regions.\"',\n",
              " 'However, some 10% of the public perceives vaccines as unsafe or unnecessary, refusing vaccination\\xa0– a global health threat called vaccine hesitancy \\xa0– which increases the risk of further viral spread that could lead to COVID‑19 outbreaks.',\n",
              " 'In mid-2020, estimates from two surveys were that 67% or 80% of people in the U.S. would accept a new vaccination against COVID-19, with wide disparity by education level, employment status, race, and geography.',\n",
              " 'Early research to assess vaccine efficacy using COVID‑19-specific animal models, such as ACE2-transgenic mice, other laboratory animals, and non-human primates, indicates a need for biosafety-level\\xa03 containment measures for handling live viruses, and international coordination to ensure standardized safety procedures.',\n",
              " 'Although the quality and quantity of antibody production by a potential vaccine is intended to neutralize the COVID‑19 infection, a vaccine may have an unintended opposite effect by causing antibody-dependent disease enhancement (ADE), which increases the virus attachment to its target cells and might trigger the cytokine storm when the person will be infected by the virus after vaccination.',\n",
              " 'The vaccine technology platform (for example, viral vector vaccine, spike (S) protein vaccine or protein subunit vaccine), vaccine dose, timing of repeat vaccinations for the possible recurrence of COVID‑19 infection, and elderly age are factors determining the risk and extent of ADE.',\n",
              " 'The antibody response to a vaccine is a variable of vaccine technologies in development, including whether the vaccine has precision in its mechanism,  and choice of the route for how it is given (intramuscular, intradermal, oral, or nasal).',\n",
              " 'The effectiveness of new vaccine is defined by its efficacy.',\n",
              " 'The efficacy of less than 60% may result in failure to create herd immunity.',\n",
              " 'Host-(\"vaccinee\")-related determinants that render a person susceptible to infection, such as genetics, health status (underlying disease, nutrition, pregnancy, sensitivities or allergies), immune competence, age, and economic impact or cultural environment can be primary or secondary factors affecting the severity of infection and response to a vaccine.',\n",
              " 'Elderly (above age 60), allergen-hypersensitive, and obese people have susceptibility to compromised immunogenicity, which prevents or inhibits vaccine effectiveness, possibly requiring separate vaccine technologies for these specific populations or repetitive booster vaccinations to limit virus transmission.',\n",
              " 'Further, mutations of the virus can alter its structure targeted by the vaccine, thus making the vaccine ineffective.',\n",
              " 'Vaccine developers have to invest resources internationally to find enough participants for Phase\\xa0II–III clinical trials when the virus has proved to be a \"moving target\" of changing transmission rate across and within countries, forcing companies to compete for trial participants.',\n",
              " 'As an example in June, the Chinese vaccine developer Sinovac formed alliances in Malaysia, Canada, the UK, and Brazil among its plans to recruit trial participants and manufacture enough vaccine doses for a possible Phase\\xa0III study in Brazil where COVID‑19 transmission was accelerating during June.',\n",
              " 'As the COVID‑19 pandemic within China became more isolated and controlled, Chinese vaccine developers sought international relationships to conduct advanced human studies in several countries, creating competition for trial participants with other manufacturers and the international Solidarity trial organized by the WHO.',\n",
              " 'In addition to competition over recruiting participants, clinical trial organizers may encounter  people unwilling to be vaccinated due to vaccine hesitancy  or disbelieving the science of the vaccine technology and its ability to prevent infection.',\n",
              " 'Having an insufficient number of skilled team members to administer vaccinations may hinder clinical trials that must overcome risks for trial failure, such as recruiting participants in rural or low-density geographic regions, and variations of age, race, ethnicity, or underlying medical conditions.',\n",
              " 'An effective vaccine for COVID-19 could save trillions of dollars in global economic impact, according to one expert, and would, therefore, make any price tag in the billions look small in comparison.',\n",
              " 'It is not yet known if it is possible to create a safe, reliable and affordable vaccine for this virus, and it is not yet known exactly how much the vaccine development will cost.',\n",
              " 'It is possible that billions of dollars could be invested without success.',\n",
              " 'The European Commission organized and held a video conference of world leaders on 4 May 2020, at which US$8\\xa0billion was raised for COVID-19 vaccine development.',\n",
              " 'After a vaccine is created, billions of doses will need to be manufactured and distributed worldwide.',\n",
              " 'In April 2020, the Gates Foundation estimated that manufacturing and distribution could cost as much as US$25\\xa0billion.',\n",
              " 'Different vaccines have different shipping and handling requirements.',\n",
              " 'For example, the Pfizer/BioNTech vaccine BNT162 must be shipped and stored at −70\\xa0°C (−94\\xa0°F), must be used within five days of thawing, and has a minimum order of 975 doses, making it unlikely to be rolled out in settings other than large, well-equipped hospitals.',\n",
              " 'Strategies are being considered for fast-tracking the licensing of a vaccine against COVID‑19, especially by compressing (to a few months) the usually lengthy duration of Phase\\xa0II–III trials (typically many years).',\n",
              " 'Challenge studies have been implemented previously for diseases less deadly than COVID‑19 infection, such as common influenza, typhoid fever, cholera, and malaria.',\n",
              " 'Following preliminary proof of safety and efficacy of a candidate vaccine in laboratory animals and healthy humans, controlled challenge studies might be implemented to bypass typical Phase\\xa0III research, providing an accelerated path to license a COVID‑19 vaccine.',\n",
              " 'A challenge study begins by simultaneously testing a vaccine candidate for immunogenicity and safety in laboratory animals and healthy adult volunteers (100 or fewer), something normally a sequential process using animals first.',\n",
              " 'If the initial tests are promising, the study proceeds by rapidly advancing the effective dose into a large-scale Phase\\xa0II–III trial in previously-uninfected, low-risk volunteers (such as young adults), who would then be deliberately infected with COVID‑19 for comparison with a placebo control group.',\n",
              " 'Following the challenge, the volunteers would be monitored closely in clinics with life-saving resources, if needed.',\n",
              " 'Volunteering for a vaccine challenge study during the COVID‑19 pandemic is likened to the emergency service of healthcare personnel for COVID‑19-infected people, firefighters, or organ donors.',\n",
              " 'Although challenge studies are ethically questionable due to the unknown hazards for the volunteers of possible COVID‑19 disease enhancement and whether the vaccine received has long-term safety (among other cautions), challenge studies may be the only option to rapidly produce an effective vaccine that will minimize the projected millions of deaths worldwide from COVID‑19 infection,   according to some infectious disease experts.',\n",
              " 'The World Health Organization has developed a guidance document with criteria for conducting COVID‑19 challenge studies in healthy people, including scientific and ethical evaluation, public consultation and coordination, selection and informed consent of the participants, and monitoring by independent experts.',\n",
              " 'A vaccine licensure occurs after the successful conclusion of the clinical trials program through Phases I–III demonstrating safety, immunogenicity at a specific dose, effectiveness at preventing infection in target populations, and enduring preventive effect.',\n",
              " 'As part of a multinational licensure for a vaccine, the World Health Organization Expert Committee on Biological Standardization developed guidelines of international standards for manufacturing and quality control of vaccines, a process intended as a platform for national regulatory agencies to apply for their own licensure process.',\n",
              " 'Vaccine manufacturers do not receive licensure until a complete clinical package proves the vaccine is safe and has long-term effectiveness, following scientific review by a multinational or national regulatory organization, such as the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA).',\n",
              " 'Upon developing countries adopting WHO guidelines for vaccine development and licensure, each country has its own responsibility to issue a national licensure, and to manage, deploy, and monitor the vaccine throughout its use in each nation.',\n",
              " 'Building trust and acceptance of a licensed vaccine among the public is a task of communication by governments and healthcare personnel to ensure a vaccination campaign proceeds smoothly, saves lives, and enables economic recovery.',\n",
              " 'When a vaccine is licensed, it will initially be in limited supply due to variable manufacturing, distribution, and logistical factors, requiring an allocation plan for the limited supply and which population segments should be prioritized to first receive the vaccine.',\n",
              " \"Vaccines developed for multinational distribution via the United Nations Children's Fund (UNICEF) require pre-qualification by\\nWHO to ensure international standards of quality, safety, immunogenicity, and efficacy for adoption by numerous countries.\",\n",
              " 'The process requires manufacturing consistency at WHO-contracted laboratories following GMP practices.',\n",
              " 'When UN agencies are involved in vaccine licensure, individual nations collaborate by 1) issuing marketing authorization and a national license for the vaccine, its manufacturers, and distribution partners; and 2) conducting postmarketing surveillance, including records for adverse events after the vaccination program.',\n",
              " 'WHO works with national agencies to monitor inspections of manufacturing facilities and distributors for compliance with GMP and regulatory oversight.',\n",
              " 'Some countries choose to buy vaccines licensed by reputable national organizations, such as EMA, FDA, or national agencies in other\\naffluent countries, but such purchases typically are more expensive and may not have distribution resources suitable to local conditions in developing countries.',\n",
              " 'In the European Union (EU), vaccines for pandemic pathogens, such as seasonal influenza, are licensed EU-wide where all of the member states comply (\"centralized\"), are licensed for only some member states (\"decentralized\"), or are licensed on an individual national level.',\n",
              " 'Generally, all EU states follow regulatory guidance and clinical programs defined by the European Committee for Medicinal Products for Human Use (CHMP), a scientific panel of the European Medicines Agency (EMA) responsible for vaccine licensure.',\n",
              " 'The CHMP is supported by several expert groups who assess and monitor the progress of a vaccine before and after licensure and distribution.',\n",
              " \"In October 2020, the CHMP started 'rolling reviews' of the vaccines known as COVID-19 Vaccine AstraZeneca and BNT162b2.\",\n",
              " 'Under the FDA, the process of establishing evidence for vaccine clinical safety and efficacy is the same as for the approval process for prescription drugs.',\n",
              " 'If successful through the stages of clinical development, the vaccine licensing process is followed by a Biologics License Application which must provide a scientific review team (from diverse disciplines, such as physicians, statisticians, microbiologists, chemists) a comprehensive documentation for the vaccine candidate having efficacy and safety throughout its development.',\n",
              " 'Also during this stage, the proposed manufacturing facility is examined by expert reviewers for GMP compliance, and the label must have compliant description to enable health care providers definition of vaccine specific use, including its possible risks, to communicate and deliver the vaccine to the public.',\n",
              " 'As of August 2020 in the United States, there is no national strategy for how a successful vaccine will be ethically prioritized or distributed to vulnerable population segments, such as homeless and incarcerated people and the elderly.',\n",
              " 'After licensure, monitoring of the vaccine and its production, including periodic inspections for GMP compliance, continue as long as the manufacturer retains its license, which may include additional submissions to the FDA of tests for potency, safety, and purity for each vaccine manufacturing step.',\n",
              " 'At the beginning of the COVID-19 pandemic in early 2020, the WHO issued a guideline as an Emergency Use Listing of new vaccines, a process derived from the 2013-16 Ebola epidemic.',\n",
              " 'It required that a vaccine candidate developed for a life-threatening emergency be manufactured using GMP and that it complete development according to WHO prequalification procedures.',\n",
              " 'Even as new vaccines are developed during the COVID-19 pandemic, licensure of COVID-19 vaccine candidates requires submission of a full dossier of information on development and manufacturing quality.',\n",
              " 'In the EU, companies may use a rolling review process, supplying data as they become available during Phase III trials, rather than developing the full documentation over months or years at the end of clinical research, as is typical.',\n",
              " 'This rolling process allows the European CHMP to evaluate clinical data in real time, enabling a promising vaccine candidate to be approved on a rapid timeline by the EMA.',\n",
              " 'On June 24, 2020, China approved the CanSino vaccine for limited use in the military and two inactivated virus vaccines for emergency use in high-risk occupations.',\n",
              " 'On August 11, 2020, Russia announced the approval of its Sputnik V vaccine for emergency use, though one month later only small amounts of the vaccine had been distributed for use outside of the phase 3 trial.',\n",
              " 'In the United States, the FDA may grant Emergency Use Authorization for a promising COVID-19 vaccine before full evidence is available about its safety and efficacy, but this hastened process has been criticized for its political misuse, potential for lowered standards, and increased antivaccine sentiment in the US population during 2020.',\n",
              " 'On September 8, 2020, nine leading pharma companies involved in COVID-19 vaccine research signed a letter, pledging that they would submit their vaccines for emergency use authorization only after phase 3 trials had demonstrated safety and efficacy.',\n",
              " 'Until a vaccine is in use for the general population, all potential adverse events from the vaccine may not be known, requiring manufacturers to conduct Phase IV studies for postmarketing surveillance of the vaccine while it is used widely in the public.',\n",
              " 'The WHO works with UN member states to implement postlicensing surveillance.',\n",
              " 'The FDA relies on a Vaccine Adverse Event Reporting System to monitor safety concerns about a vaccine throughout its use in the American public.',\n",
              " 'By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection.',\n",
              " 'The corporate investment and need to generate value for public shareholders raised concerns about a \"market-based approach\" in vaccine development, costly pricing of eventual licensed vaccines, preferred access for distribution first to affluent countries, and sparse or no distribution to where the pandemic is most aggressive, as predicted for densely-populated, impoverished countries unable to afford vaccinations.',\n",
              " 'The collaboration of the University of Oxford with AstraZeneca (a global pharmaceutical company based in the UK) raised concerns about price and sharing of eventual profits from international vaccine sales, arising from whether the UK government and university as public partners had commercialization rights.',\n",
              " 'AstraZeneca stated that initial pricing of its vaccine would not include a profit margin for the company while the pandemic was still expanding.',\n",
              " \"In early June, AstraZeneca made a USD$750 millon deal allowing CEPI and GAVI to manufacture and distribute 300 million doses if its Oxford vaccine candidate proves safe and effective, reportedly increasing the company's total production capacity to over 2 billion doses per year.\",\n",
              " 'Commercialization of pandemic vaccines is a high-risk business venture, potentially losing billions of dollars in development and pre-market manufacturing costs if the candidate vaccines fail to be safe and effective.',\n",
              " 'The multinational pharmaceutical company Pfizer indicated it was not interested in a government partnership, which would be a \"third party\" slowing progress in Pfizer\\'s vaccine program.',\n",
              " 'Further, there are concerns that rapid-development programs – like the Operation Warp Speed plan of the United States – are choosing vaccine candidates mainly for their manufacturing advantages to shorten the development timeline, rather than for the most promising vaccine technology having safety and efficacy.',\n",
              " 'Favored distribution of vaccines within one or a few select countries, called \"vaccine sovereignty\", is a criticism of some of the vaccine development partnerships,   such as for the AstraZeneca-University of Oxford vaccine candidate, concerning whether there may be prioritized distribution first within the UK and to the \"highest bidder\" – the United States, which made an advance payment of US$1.2\\xa0billion to secure 300\\xa0million vaccine doses for Americans, even before the AstraZeneca-Oxford vaccine or a Sanofi vaccine is proved safe or effective.',\n",
              " 'Concerns exist about whether some countries producing vaccines may impose protectionist controls by export restrictions that would stockpile a COVID‑19 vaccine for their own population.',\n",
              " 'In June, the Serum Institute of India (SII) – a major manufacturer of global vaccines – reached a licensing agreement with AstraZeneca to make 1 billion doses of vaccine for low-and-middle income countries;  of which half of the doses would go to India.',\n",
              " 'Similar preferential homeland distribution may exist if a vaccine is manufactured in Australia.',\n",
              " 'The Chinese government pledged in May that a successful Chinese vaccine would become a \"global, public good,\" implying enough doses would be manufactured for both national and global distribution.',\n",
              " 'As many of the efforts on vaccine candidates have open-ended outcomes, including a high potential for failure during human testing, CEPI, WHO, and charitable vaccine organizations, such as the Gates Foundation and GAVI, raised over US$20\\xa0billion during the first half of 2020 to fund vaccine development and preparedness for vaccinations, particularly for children in under-developed countries.',\n",
              " 'CEPI had stated that governments should ensure implementation of a globally-fair allocation system for eventual vaccines, using a coordinated system of manufacturing capacity, financing and purchasing, and indemnification from liability to offset risks taken by vaccine developers.',\n",
              " 'Having been created to monitor fair distribution of infectious disease vaccines to low- and middle-income countries,   CEPI revised its equitable access policy that was published in February to apply to its COVID-19 vaccine funding: 1) \"prices for vaccines will be set as low as possible for territories that are or may be affected by an outbreak of a disease for which CEPI funding was used to develop a vaccine;\" 2) \"information, know-how and materials related to vaccine development must be shared with (or transferred to) CEPI\" so that it can assume responsibility for vaccine development if a company discontinues expenditures for a promising vaccine candidate; 3) CEPI would have access to, and possible management of, intellectual property rights (i.e., patents) for promising vaccines; 4) \"CEPI would receive a share of financial benefits that might accrue from CEPI-sponsored vaccine development, to re-invest in support of its mission to provide global public health benefit\"; and 5) data transparency among development partners should maintain the WHO Statement on Public Disclosure of Clinical Trial Results, and require results to be published in open-access publications.',\n",
              " 'Some vaccine manufacturers opposed parts of these proposals.',\n",
              " 'International groups, such as the Centre for Artistic Activism and Universities Allied for Essential Medicines, advocate for equitable access to licensed COVID‑19 vaccines.',\n",
              " 'Scientists have encouraged that the WHO, CEPI, corporations, and governments collaborate to assure evidence-based allocation of eventual COVID‑19 vaccines determined on infection risk,   particularly urgent vaccinations provided first for healthcare workers, vulnerable populations, and children.',\n",
              " 'During 2020, the WHO, GAVI, and CEPI combined resources to form COVAX – a program for coordination of global equitable access to a licensed vaccine.',\n",
              " 'Over 100 international scientists and concerned individuals (including those associated with religious organizations) have called for releasing COVID‑19 vaccines to the public domain.',\n",
              " 'Similar to the development of the first polio vaccine that was never patented, an effective COVID-19 vaccine would be available for production and approval by a number of countries and pharmaceutical manufacturing centers worldwide, therefore allowing for a more even and cost-effective distribution on a global scale.',\n",
              " 'During and after 2021, deploying a COVID-19 vaccine may require worldwide transport and tracking of 10-19 billion vial doses, an effort readily becoming the largest supply chain challenge in history.',\n",
              " 'As of September 2020, supply chain and logistics experts expressed concern that international and national networks for distributing a licensed vaccine were not ready for the volume and urgency, due mainly to deterioration of resources during 2020 pandemic lockdowns and downsizing that degraded supply capabilities.',\n",
              " 'Addressing the worldwide challenge faced by coordinating numerous organizations – the COVAX partnership, global pharmaceutical companies, contract vaccine manufacturers, inter- and intranational transport, storage facilities, and health organizations in individual countries – Seth Berkley, chief executive of GAVI, stated: \"Delivering billions of doses of vaccine to the entire world efficiently will involve hugely complex logistical and programmatic obstacles all the way along the supply chain.\"',\n",
              " 'As an example highlighting the immensity of the challenge, the International Air Transport Association stated that 8,000 747 cargo planes – implemented with equipment for precision vaccine cold storage – would be needed to transport just one dose for people in the more than 200 countries experiencing the COVID-19 pandemic.',\n",
              " 'GAVI states that \"with a fast-moving pandemic, no one is safe, unless everyone is safe.\"',\n",
              " 'In contrast to the multibillion dollar investment in vaccine technologies and early-stage clinical research, the post-licensing supply chain for a vaccine has not received the same planning, coordination, security or investment.',\n",
              " 'A major concern is that resources for vaccine distribution in low- to middle-income countries, particularly for vaccinating children, are inadequate or non-existent, but could be improved with cost efficiencies if procurement and distribution were centralized regionally or nationally.',\n",
              " \"In September, the COVAX partnership included 172 countries coordinating plans to optimize the supply chain for a COVID-19 vaccine,  and the United Nations Children's Fund joined with COVAX to prepare the financing and supply chain for vaccinations of children in 92 developing countries.\",\n",
              " 'Logistics vaccination services assure necessary equipment, staff, and supply of licensed vaccines across international borders.',\n",
              " 'Central logistics include vaccine handling and monitoring, cold chain management, and safety of distribution within the vaccination network.',\n",
              " 'The purpose of the COVAX Facility is to centralize and equitably administer logistics resources among participating countries, merging manufacturing, transport, and overall supply chain infrastructure.',\n",
              " 'Included are logistics tools for vaccine forecasting and needs estimation, in-country vaccine management, potential for wastage, and stock management.',\n",
              " 'Other logistics factors conducted internationally during distribution of a COVID-19 vaccine may include:   \\nA logistics shortage in any one step may derail the whole supply chain, according to one vaccine developer.',\n",
              " 'If the vaccine supply chain fails, the economic and human costs of the pandemic may be extended for years.',\n",
              " 'By August 2020 when only a few vaccine candidates were in Phase III trials many months from establishing safety and efficacy, numerous governments pre-ordered more than two billion doses at a cost of more than US$5 billion.',\n",
              " 'Pre-orders from the UK government for 2021 were for five vaccine doses per person, a number dispiriting organizations like the WHO and GAVI which are promoting fair and equitable access worldwide, especially for developing countries.',\n",
              " 'In September, CEPI was financially supporting basic and clinical research for nine vaccine candidates, with nine more in evaluation, under financing commitments to manufacture two billion doses of three licensed vaccines by the end of 2021.',\n",
              " 'Overall before 2022, 7-10 billion COVID-19 vaccine doses may be manufactured worldwide, but the sizable pre-orders by affluent countries – called \"vaccine nationalism\" – threaten vaccine availability for poorer nations.',\n",
              " 'Brazil and Indonesia had pre-ordered millions of vaccine doses that are undergoing phase III trials in their countries The Serum Institute of India plans to produce at least one billion vaccine doses, although the Institute has stated that half the doses will be used in India.',\n",
              " \"After joining COVAX in October, China shared that it would produce 600 million vaccine doses before the end of 2020 and another one billion doses in 2021, although it was unsure how many would be for the country's own population of 1.4 billion.\",\n",
              " 'AstraZeneca CEO, Pascal Soriot, stated: \"The challenge is not making the vaccine itself, it\\'s filling vials.',\n",
              " 'There just aren\\'t enough vials in the world.\"',\n",
              " 'Preparing for high demand in manufacturing vials, an American glass producer invested $163 million in July for a vial factory.',\n",
              " 'Glass availability for vial manufacturing and contaminant control are issues of concern,  indicating higher production costs with lower profit potential for developers amid demands for vaccines to be affordable.',\n",
              " 'Vaccines must be handled and transported using international regulations, be maintained at controlled temperatures that vary across vaccine technologies, and be used for immunization before deterioration in storage.',\n",
              " 'The scale of the COVID-19 vaccine supply chain is expected to be vast to ensure delivery worldwide to vulnerable populations.',\n",
              " 'Priorities for preparing facilities for such distribution include temperature-controlled facilities and equipment, optimizing infrastructure, training immunization staff, and rigorous monitoring.',\n",
              " 'RFID technologies are being implemented to track and authenticate a vaccine dose from the manufacturer along the entire supply chain to the vaccination.',\n",
              " 'Vaccines (and adjuvants) are inherently unstable during temperature changes, requiring cold chain management throughout the entire supply chain, typically at temperatures of 2–8\\xa0°C (36–46\\xa0°F).',\n",
              " 'Because COVID-19 vaccine technologies are varied among several novel technologies, there are new challenges for cold chain management, with some vaccines that are stable while frozen but labile to heat, while others should not be frozen at all, and some are stable across temperatures.',\n",
              " 'Freezing damage and inadequate training of personnel in the local vaccination process are major concerns.',\n",
              " 'If more than one COVID-19 vaccine is approved, the vaccine cold chain may have to accommodate all these temperature sensitivities across different countries with variable climate conditions and local resources for temperature maintenance.',\n",
              " 'DNA and RNA vaccine technologies are in development, but may be difficult to manufacture at scale and control degradation during cold storage and transport.',\n",
              " \"As examples, Moderna's RNA vaccine candidate requires cold chain management just above freezing temperatures with limited storage duration, but the BioNTech-Pfizer RNA candidate requires storage at -70°C (-94°F) or colder throughout deployment until vaccination.\",\n",
              " 'After a vaccine vial is punctured to administer a dose, it is viable for only six hours, then must be discarded, requiring attention to local management of cold storage and vaccination processes.',\n",
              " 'Because the COVID-19 vaccine will likely be in short supply for many locations during early deployment, vaccination staff will have to avoid spoilage and waste, which typically are as much as 30% of the supply.',\n",
              " 'The cold chain is further challenged by the type of local transportation for the vaccines in rural communities, such as by motorcycle or delivery drone, need for booster doses, use of diluents, and access to vulnerable populations, such as healthcare staff, children and the elderly.',\n",
              " 'Coordination of international air cargo is an essential component of time- and temperature-sensitive distribution of COVID-19 vaccines, but, as of September 2020, the air freight network is not prepared for multinational deployment.',\n",
              " '\"Safely delivering COVID-19 vaccines will be the mission of the century for the global air cargo industry.',\n",
              " \"But it won't happen without careful advance planning.\",\n",
              " 'And the time for that is now.',\n",
              " 'We urge governments to take the lead in facilitating cooperation across the logistics chain so that the facilities, security arrangements and border processes are ready for the mammoth and complex task ahead,\" said IATA\\'s Director General and CEO, Alexandre de Juniac, in September 2020.',\n",
              " 'For the severe reduction in passenger air traffic during 2020, airlines downsized personnel, trimmed destination networks, and put aircraft into long-term storage.',\n",
              " 'As the lead agencies for procurement and supply of the COVID-19 vaccine within the WHO COVAX Facility, GAVI and UNICEF are preparing for the largest and fastest vaccine deployment ever, necessitating international air freight collaboration, customs and border control, and possibly as many as 8,000 cargo planes to deliver just one vaccine dose to multiple countries.',\n",
              " \"Medicines are the world's largest fraud market, worth some $200 billion per year, making the widespread demand for a COVID-19 vaccine vulnerable to counterfeit, theft, scams, and cyberattacks throughout the supply chain.\",\n",
              " 'Anticorruption, transparency, and accountability  safeguards are being established to reduce and eliminate corruption of COVID-19 vaccine supplies.',\n",
              " 'Absence of harmonized regulatory frameworks among countries, including low technical capacity, constrained access, and ineffective capability to identify and track genuine vs. counterfeit vaccines, may be life-threatening for vaccine recipients, and would potentially perpetuate the COVID-19 pandemic.',\n",
              " 'Tracking system technologies for packaging are being used by manufacturers to trace vaccine vials across the supply chain,  and to use digital and biometric tools to assure security for vaccination teams.',\n",
              " 'The WHO has implemented an \"Effective Vaccine Management\" system,  which includes constructing priorities to prepare national and subnational personnel and facilities for vaccine distribution, including:\\nBorder processes for efficient handling and customs clearance within individual countries may include:  \\nOn February 4, 2020, US Secretary of Health and Human Services Alex Azar published a notice of declaration under the Public Readiness and Emergency Preparedness Act for medical countermeasures against COVID‑19, covering \"any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID‑19, or the transmission of SARS-CoV-2 or a virus mutating therefrom\", and stating that the declaration precludes \"liability claims alleging negligence by a manufacturer in creating a vaccine, or negligence by a health care provider in prescribing the wrong dose, absent willful misconduct\".',\n",
              " 'The declaration is effective in the United States through 1 October 2024.',\n",
              " 'Social media posts have promoted a conspiracy theory that a COVID‑19 vaccine is already available.',\n",
              " 'The patents cited by various social media posts have references to existing patents for genetic sequences and vaccines for other strains such as the SARS coronavirus, but not for COVID‑19.',\n",
              " 'On 21 May 2020, the FDA made public the cease-and-desist notice it had sent to North Coast Biologics, a Seattle-based company that had been selling a purported \"nCoV19 spike protein vaccine\".']"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 16
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "4C-ohrX6rTck",
        "outputId": "ce544bf6-b475-422a-9096-b8932a41c991",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 67
        }
      },
      "source": [
        "nltk.download(\"stopwords\")"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
            "[nltk_data]   Package stopwords is already up-to-date!\n"
          ],
          "name": "stdout"
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 17
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "9HT3reQErgRn"
      },
      "source": [
        "stopwords = nltk.corpus.stopwords.words('english')"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "c_FkHa_8sdgr"
      },
      "source": [
        "wordstoCount = {} #dictionary not list\n",
        "for word in nltk.word_tokenize(cleaner_text):\n",
        "  if word not in stopwords:\n",
        "    if word not in wordstoCount.keys():\n",
        "      wordstoCount[word] = 1\n",
        "    else:\n",
        "        wordstoCount[word]+= 1"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "cJ0ARvTBty4J",
        "outputId": "5ecce22b-bbc6-4ae5-cbf4-5595a3683670",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 54
        }
      },
      "source": [
        "print(wordstoCount)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "{'covid': 111, 'vaccine': 273, 'several': 12, 'different': 9, 'vaccines': 83, 'intended': 3, 'provide': 11, 'acquired': 1, 'immunity': 4, 'coronavirus': 11, 'disease': 16, 'previous': 2, 'work': 2, 'develop': 7, 'diseases': 3, 'sars': 9, 'mers': 9, 'established': 2, 'knowledge': 1, 'structure': 2, 'function': 1, 'coronaviruses': 2, 'accelerated': 5, 'development': 64, 'early': 14, 'varied': 2, 'technology': 10, 'platforms': 5, 'october': 6, 'candidates': 36, 'fold': 1, 'increase': 3, 'since': 2, 'april': 11, 'however': 2, 'candidate': 24, 'completed': 2, 'clinical': 42, 'trials': 32, 'prove': 1, 'safety': 26, 'efficacy': 25, 'research': 33, 'namely': 1, 'phase': 34, 'ii': 12, 'iii': 21, 'world': 15, 'health': 20, 'organization': 7, 'coalition': 4, 'epidemic': 4, 'preparedness': 6, 'innovations': 2, 'cepi': 31, 'gates': 6, 'foundation': 6, 'gf': 1, 'committing': 1, 'money': 1, 'organizational': 1, 'resources': 12, 'prospect': 1, 'needed': 7, 'prevent': 8, 'continuing': 1, 'infection': 23, 'organizing': 2, 'us': 35, 'billion': 32, 'worldwide': 11, 'fund': 5, 'rapid': 9, 'investment': 12, 'indicated': 2, 'september': 12, 'data': 5, 'support': 10, 'licensure': 12, 'may': 48, 'available': 10, 'end': 6, 'organized': 3, 'telethon': 1, 'received': 3, 'pledges': 2, 'forty': 1, 'countries': 46, 'infections': 2, 'time': 5, 'also': 5, 'announced': 10, 'deployment': 6, 'international': 34, 'solidarity': 6, 'trial': 34, 'simultaneous': 3, 'evaluation': 8, 'reaching': 1, 'produced': 3, 'animal': 3, 'caused': 1, 'including': 16, 'infectious': 6, 'bronchitis': 1, 'virus': 20, 'birds': 1, 'canine': 1, 'feline': 1, 'projects': 5, 'viruses': 4, 'family': 1, 'coronaviridae': 1, 'affect': 1, 'humans': 7, 'aimed': 1, 'severe': 6, 'acute': 3, 'respiratory': 4, 'syndrome': 3, 'middle': 4, 'east': 1, 'tested': 2, 'non': 5, 'human': 12, 'animals': 6, 'according': 7, 'studies': 12, 'published': 6, 'identification': 1, 'novel': 4, 'medicines': 5, 'treat': 2, 'priority': 4, 'governments': 15, 'public': 21, 'agencies': 8, 'around': 3, 'cure': 2, 'protective': 1, 'proven': 2, 'safe': 11, 'effective': 19, 'became': 2, 'prevalent': 1, 'believed': 1, 'existing': 3, 'useful': 1, 'template': 1, 'developing': 12, 'therapeutics': 2, 'cov': 3, 'march': 5, 'one': 16, 'dna': 3, 'based': 8, 'three': 5, 'others': 3, 'progress': 5, 'viral': 4, 'vectored': 3, 'two': 7, 'adenoviral': 1, 'chadox': 1, 'bvrs': 1, 'gamvac': 1, 'mva': 2, 'never': 2, 'less': 5, 'years': 7, 'exists': 1, 'preventing': 2, 'detected': 1, 'december': 2, 'genetic': 2, 'sequence': 1, 'january': 3, 'triggering': 1, 'urgent': 3, 'response': 6, 'prepare': 6, 'outbreak': 3, 'hasten': 1, 'preventive': 2, 'february': 3, 'said': 4, 'expect': 1, 'causative': 1, 'become': 4, 'months': 7, 'rapidly': 6, 'growing': 2, 'rate': 6, 'stimulated': 1, 'alliances': 4, 'government': 18, 'efforts': 6, 'urgently': 1, 'organize': 1, 'make': 5, 'multiple': 6, 'shortened': 1, 'timelines': 3, 'four': 1, 'entering': 1, 'see': 1, 'table': 1, 'started': 2, 'estimated': 4, 'total': 6, 'cost': 10, 'suite': 1, 'technologies': 15, 'distribution': 28, 'almost': 1, 'companies': 17, 'institutes': 2, 'working': 3, 'virtual': 2, 'gold': 1, 'rush': 1, 'many': 10, 'six': 4, 'chosen': 2, 'coalitions': 2, 'streamlined': 1, 'regulatory': 7, 'quality': 6, 'assurance': 2, 'eventual': 11, 'licensing': 8, 'least': 2, 'another': 4, 'analysis': 2, 'estimates': 2, 'need': 8, 'initial': 3, 'select': 2, 'final': 2, 'path': 3, 'july': 4, 'anglo': 1, 'american': 5, 'intelligence': 1, 'security': 9, 'organisations': 1, 'respective': 1, 'armed': 1, 'forces': 1, 'uk': 12, 'national': 20, 'cyber': 1, 'centre': 2, 'together': 1, 'canadian': 4, 'communications': 2, 'establishment': 1, 'united': 11, 'states': 14, 'department': 1, 'homeland': 2, 'cybersecurity': 1, 'infrastructure': 3, 'agency': 5, 'nsa': 1, 'alleged': 1, 'russian': 1, 'state': 2, 'backed': 1, 'hackers': 1, 'trying': 1, 'steal': 1, 'treatment': 2, 'academic': 2, 'pharmaceutical': 8, 'institutions': 1, 'russia': 2, 'denied': 1, 'major': 6, 'changes': 3, 'overall': 4, 'effort': 4, 'year': 4, 'increasing': 2, 'number': 5, 'collaborations': 2, 'multinational': 8, 'industry': 6, 'diversity': 1, 'biotechnology': 3, 'focusing': 1, 'general': 4, 'geographic': 2, 'involves': 1, 'organizations': 15, 'north': 2, 'america': 3, 'compared': 2, 'asia': 1, 'australia': 3, 'europe': 2, 'south': 1, 'africa': 1, 'formed': 4, 'expedite': 1, 'facilitating': 2, 'collaboration': 7, 'scale': 7, 'unprecedented': 2, 'history': 2, 'beginning': 3, 'raising': 1, 'implemented': 6, 'global': 20, 'access': 15, 'covax': 10, 'coordinating': 4, 'pillar': 1, 'tools': 3, 'act': 2, 'accelerator': 1, 'gavi': 10, 'representing': 2, 'population': 10, 'agreed': 2, 'plan': 4, 'fair': 4, 'equitable': 5, 'licensed': 20, 'assuring': 1, 'participating': 2, 'country': 5, 'would': 24, 'receive': 5, 'guaranteed': 1, 'share': 2, 'doses': 27, 'vaccinate': 1, 'vulnerable': 8, 'goal': 3, 'accelerate': 2, 'manufacturing': 30, 'assure': 4, 'equitably': 3, 'provided': 2, 'authorities': 1, 'developers': 11, 'create': 4, 'partnership': 6, 'private': 4, 'philanthropic': 1, 'civil': 1, 'society': 1, 'testing': 7, 'eight': 2, 'supporting': 2, 'full': 4, 'kingdom': 1, 'canada': 3, 'belgium': 2, 'norway': 2, 'switzerland': 2, 'germany': 2, 'netherlands': 3, 'already': 3, 'donated': 1, 'million': 20, 'bill': 1, 'melinda': 1, 'charitable': 2, 'dedicated': 1, 'donating': 1, 'educational': 1, 'glopid': 1, 'r': 2, 'closely': 2, 'member': 4, 'identify': 2, 'priorities': 3, 'funding': 7, 'specific': 7, 'researches': 1, 'among': 10, 'maintain': 2, 'updated': 2, 'information': 4, 'avoid': 3, 'duplicate': 1, 'emerging': 1, 'consortium': 2, 'disseminating': 1, 'inform': 1, 'policy': 3, 'june': 12, 'summit': 1, 'coordinated': 2, 'london': 2, 'representatives': 1, 'heads': 1, 'g': 2, 'nations': 5, 'raise': 2, 'alliance': 1, 'immunisation': 1, 'vaccinations': 9, 'children': 9, 'developed': 14, 'contributions': 1, 'gb': 2, 'per': 4, 'five': 4, 'approximately': 1, 'dedicating': 1, 'investments': 2, 'included': 3, 'ca': 3, 'universities': 5, 'plans': 5, 'establish': 1, 'bank': 2, 'new': 9, 'could': 6, 'used': 12, 'occurs': 2, 'added': 2, 'supply': 24, 'chains': 1, 'committed': 1, 'live': 3, 'streaming': 1, 'china': 7, 'providing': 2, 'low': 11, 'loans': 1, 'developer': 4, 'central': 2, 'quickly': 1, 'made': 8, 'land': 1, 'company': 8, 'build': 2, 'production': 6, 'plants': 1, 'eleven': 2, 'stage': 6, 'chinese': 11, 'supported': 2, 'financing': 4, 'conducting': 4, 'promising': 12, 'prioritizing': 1, 'evidence': 6, 'pledged': 2, 'programs': 4, 'additionally': 1, 'loan': 1, 'accessible': 1, 'latin': 1, 'caribbean': 1, 'august': 4, 'premier': 1, 'li': 1, 'keqiang': 1, 'southeast': 1, 'asian': 1, 'cambodia': 1, 'laos': 1, 'myanmar': 1, 'thailand': 1, 'vietnam': 1, 'fully': 1, 'european': 8, 'union': 2, 'france': 1, 'via': 2, 'involving': 2, 'institut': 1, 'pasteur': 2, 'themis': 1, 'bioscience': 1, 'vienna': 1, 'austria': 1, 'university': 10, 'pittsburgh': 1, 'bringing': 1, 'commission': 2, 'curevac': 2, 'german': 2, 'mrna': 1, 'separate': 2, 'contributors': 2, 'task': 3, 'force': 1, 'stimulate': 1, 'british': 1, 'across': 12, 'pipeline': 1, 'placement': 1, 'hospitals': 2, 'regulations': 2, 'approval': 7, 'initiatives': 1, 'oxford': 7, 'imperial': 1, 'college': 1, 'financed': 1, 'biomedical': 1, 'advanced': 3, 'authority': 1, 'barda': 3, 'federal': 2, 'funds': 1, 'fighting': 1, 'nearly': 1, 'preparation': 2, 'moderna': 3, 'partner': 1, 'johnson': 8, 'additional': 2, 'spend': 1, 'roles': 1, 'sanofi': 3, 'regeneron': 1, 'fast': 4, 'track': 3, 'program': 6, 'called': 5, 'operation': 2, 'warp': 3, 'speed': 4, 'goals': 1, 'placing': 1, 'diverse': 3, 'fall': 1, 'project': 1, 'chief': 3, 'advisor': 1, 'moncef': 1, 'slaoui': 1, 'operating': 1, 'officer': 1, 'army': 1, 'gustave': 1, 'perna': 1, 'team': 5, 'seven': 1, 'merck': 1, 'pfizer': 5, 'astrazeneca': 11, 'well': 2, 'blueprint': 4, 'documented': 1, 'large': 4, 'multi': 1, 'site': 2, 'individually': 1, 'randomized': 6, 'controlled': 8, 'allow': 1, 'concurrent': 1, 'benefits': 3, 'risks': 7, 'within': 10, 'listed': 1, 'target': 5, 'product': 1, 'profile': 1, 'tpp': 2, 'identifying': 1, 'favorable': 1, 'attributes': 1, 'broad': 1, 'categories': 1, 'long': 5, 'term': 4, 'protection': 2, 'people': 15, 'higher': 2, 'risk': 11, 'healthcare': 13, 'workers': 7, 'outbreaks': 3, 'assess': 4, 'map': 1, 'publishing': 1, 'frequently': 1, 'landscape': 1, 'evaluate': 3, 'screen': 1, 'simultaneously': 3, 'design': 7, 'coordinate': 1, 'enable': 2, 'high': 8, 'rates': 2, 'ensuring': 1, 'interpretation': 1, 'sharing': 2, 'results': 5, 'prioritize': 1, 'go': 2, 'determine': 1, 'harmonized': 2, 'protocols': 1, 'achieving': 1, 'pivotal': 2, 'modified': 1, 'adaptive': 3, 'accumulating': 1, 'insights': 1, 'positive': 1, 'negative': 1, 'apply': 3, 'alter': 2, 'parameters': 1, 'study': 6, 'sites': 2, 'emerge': 1, 'criteria': 2, 'met': 1, 'showing': 1, 'poor': 1, 'placebo': 4, 'dropped': 1, 'designs': 1, 'ongoing': 1, 'shorten': 3, 'durations': 1, 'use': 20, 'fewer': 2, 'subjects': 2, 'possibly': 4, 'expediting': 1, 'decisions': 1, 'termination': 1, 'success': 6, 'avoiding': 1, 'duplication': 1, 'enhancing': 1, 'coordination': 7, 'locations': 2, 'experience': 2, 'making': 6, 'glaxosmithkline': 1, 'gsk': 2, 'forming': 1, 'progression': 1, 'combine': 1, 'financial': 4, 'capabilities': 2, 'pandemic': 20, 'adjuvanted': 3, 'joined': 2, 'uncommon': 1, 'timeline': 5, 'like': 4, 'evaluating': 1, 'individual': 5, 'producing': 4, 'persuaded': 1, 'favor': 1, 'highest': 2, 'bidder': 2, 'first': 11, 'service': 2, 'experts': 4, 'emphasize': 1, 'affordable': 3, 'frontline': 1, 'greatest': 2, 'agreement': 2, 'citizens': 1, 'get': 1, 'preferential': 2, 'taxpayer': 1, 'funded': 1, 'rather': 6, 'consented': 1, 'distributed': 4, 'multinationally': 2, 'cooperation': 4, 'initially': 2, 'manufacture': 5, 'costs': 6, 'profitability': 1, 'later': 2, 'annual': 1, 'stock': 2, 'future': 1, 'needs': 2, 'guidelines': 3, 'recognizing': 1, 'segments': 3, 'example': 6, 'successful': 10, 'likely': 2, 'allocated': 1, 'personnel': 7, 'populations': 8, 'illness': 3, 'death': 1, 'elderly': 6, 'densely': 2, 'populated': 2, 'impoverished': 2, 'expressed': 2, 'concerns': 9, 'affluent': 4, 'protecting': 1, 'address': 1, 'reduce': 4, 'economic': 5, 'impact': 3, 'geopolitical': 1, 'issues': 2, 'challenges': 2, 'billions': 8, 'compressing': 2, 'schedules': 1, 'standard': 1, 'cases': 1, 'combining': 1, 'steps': 3, 'process': 15, 'typically': 8, 'conducted': 2, 'sequentially': 1, 'center': 1, 'control': 7, 'prevention': 1, 'began': 3, 'pursuing': 1, 'numerous': 5, 'short': 3, 'showcase': 1, 'strengths': 1, 'reassure': 1, 'haste': 1, 'accepting': 1, 'circuiting': 1, 'executive': 2, 'saying': 1, 'crisis': 1, 'big': 1, 'take': 2, 'maximum': 1, 'put': 2, 'stop': 3, 'along': 3, 'entire': 4, 'evaluated': 1, 'level': 4, 'acceptable': 1, 'toxicity': 2, 'targeting': 2, 'breakthroughs': 1, 'duration': 3, 'vaccination': 15, 'special': 1, 'delivery': 3, 'systems': 2, 'oral': 2, 'nasal': 2, 'injection': 1, 'dose': 11, 'regimen': 1, 'stability': 1, 'storage': 9, 'characteristics': 2, 'emergency': 10, 'authorization': 4, 'formal': 1, 'optimal': 2, 'scaling': 1, 'dissemination': 1, 'fail': 3, 'manufacturer': 5, 'exceed': 1, 'millions': 3, 'useless': 1, 'case': 1, 'specifically': 2, 'enough': 6, 'continue': 2, 'herd': 2, 'spread': 2, 'alone': 1, 'expands': 1, 'obstructed': 1, 'physical': 1, 'distancing': 1, 'closing': 1, 'laboratories': 2, 'globally': 2, 'supplies': 2, 'critical': 1, 'increasingly': 1, 'scarce': 1, 'due': 7, 'competition': 3, 'sequestration': 1, 'normally': 2, 'sequential': 2, 'requiring': 7, 'compressed': 1, 'dosing': 3, 'running': 1, 'potentially': 3, 'compromising': 1, 'scientists': 4, 'reported': 1, 'nine': 4, 'remaining': 2, 'undefined': 1, 'focused': 1, 'spike': 3, 'protein': 5, 'variants': 1, 'primary': 2, 'antigen': 3, 'involve': 3, 'nucleic': 1, 'acid': 1, 'rna': 4, 'replicating': 1, 'vectors': 1, 'peptides': 1, 'recombinant': 2, 'proteins': 1, 'attenuated': 1, 'inactivated': 3, 'influenza': 4, 'using': 7, 'next': 1, 'generation': 1, 'strategies': 3, 'precision': 3, 'mechanisms': 3, 'improve': 1, 'flexibility': 1, 'manipulation': 1, 'effectiveness': 6, 'susceptible': 2, 'subgroups': 1, 'pregnant': 1, 'women': 1, 'weakened': 1, 'immune': 4, 'dozens': 3, 'unannounced': 1, 'unknown': 3, 'classifies': 1, 'stages': 2, 'exploratory': 2, 'planning': 3, 'designing': 1, 'vivo': 2, 'preclinical': 5, 'compound': 1, 'test': 4, 'initiation': 1, 'healthy': 5, 'either': 1, 'confirmed': 2, 'primarily': 1, 'preliminary': 3, 'dozen': 1, 'following': 6, 'immunogenicity': 9, 'levels': 1, 'biomarkers': 1, 'adverse': 5, 'effects': 4, 'hundreds': 1, 'consists': 1, 'determining': 2, 'precise': 1, 'participants': 9, 'include': 7, 'group': 2, 'interventional': 1, 'monitoring': 5, 'definition': 2, 'endpoints': 1, 'vary': 2, 'defining': 1, 'degree': 1, 'side': 1, 'amount': 1, 'transmission': 5, 'whether': 7, 'prevents': 2, 'moderate': 1, 'uae': 1, 'approved': 4, 'sinopharm': 1, 'front': 1, 'line': 1, 'interim': 1, 'pakistan': 2, 'sep': 1, 'janssen': 1, 'pharmaceutica': 1, 'bidmc': 1, 'temporarily': 1, 'paused': 1, 'unexplained': 1, 'participant': 1, 'arcturus': 1, 'issued': 2, 'statement': 2, 'pledging': 2, 'encouraging': 1, 'associations': 1, 'quantities': 2, 'sufficient': 2, 'affected': 3, 'regions': 3, 'particularly': 6, 'resource': 2, 'past': 1, 'shows': 1, 'failure': 5, 'properties': 1, 'still': 2, 'discovered': 1, 'innovative': 1, 'associated': 2, 'potential': 9, 'computer': 1, 'simulations': 1, 'models': 2, 'methods': 1, 'remain': 1, 'untested': 1, 'active': 1, 'small': 3, 'firms': 1, 'teams': 2, 'little': 1, 'limited': 5, 'capacity': 4, 'without': 3, 'gain': 1, 'ineffectiveness': 1, 'induce': 1, 'responses': 1, 'failures': 1, 'laboratory': 4, 'underfunding': 1, 'probability': 1, 'pass': 1, 'barriers': 1, 'reach': 1, 'commitment': 1, 'represents': 1, 'substantial': 1, 'capital': 1, 'typical': 3, 'much': 4, 'comparison': 3, 'ebola': 2, 'eventually': 1, 'succeeded': 1, 'confirm': 1, 'beyond': 1, 'assertions': 1, 'mortality': 1, 'lower': 2, 'routine': 2, 'bcg': 2, 'administered': 1, 'tuberculosis': 1, 'though': 2, 'seeking': 2, 'recruit': 2, 'enroll': 1, 'measles': 1, 'mumps': 1, 'rubella': 1, 'mmr': 1, 'protect': 1, 'cairo': 1, 'adjuvants': 4, 'enhance': 2, 'immunological': 1, 'adjuvant': 6, 'substance': 1, 'formulated': 1, 'elevate': 1, 'formulating': 1, 'boost': 1, 'vaccinated': 2, 'individuals': 2, 'formulation': 1, 'vector': 2, 'aluminum': 1, 'salts': 1, 'known': 5, 'alum': 2, 'choice': 2, 'initiates': 1, 'molecular': 1, 'cellular': 1, 'release': 1, 'proinflammatory': 1, 'cytokines': 1, 'drawback': 1, 'evolves': 1, 'way': 2, 'induced': 1, 'misdesigned': 1, 'changed': 1, 'change': 1, 'require': 4, 'revised': 2, 'increased': 2, 'discourage': 1, 'urgency': 2, 'delivering': 3, 'found': 1, 'obtaining': 1, 'indicates': 2, 'report': 1, 'stated': 7, 'strong': 1, 'regulators': 1, 'policymakers': 1, 'funders': 1, 'bodies': 1, 'ensure': 6, 'late': 1, 'manufactured': 6, 'supplied': 1, 'areas': 1, 'perceives': 1, 'unsafe': 1, 'unnecessary': 1, 'refusing': 1, 'threat': 1, 'hesitancy': 2, 'increases': 2, 'lead': 3, 'mid': 1, 'surveys': 1, 'u': 1, 'accept': 1, 'wide': 2, 'disparity': 1, 'education': 1, 'employment': 1, 'status': 2, 'race': 2, 'geography': 1, 'ace': 1, 'transgenic': 1, 'mice': 1, 'primates': 1, 'biosafety': 1, 'containment': 1, 'measures': 1, 'handling': 4, 'standardized': 1, 'procedures': 2, 'although': 4, 'quantity': 1, 'antibody': 3, 'neutralize': 1, 'unintended': 1, 'opposite': 1, 'effect': 2, 'causing': 1, 'dependent': 1, 'enhancement': 2, 'ade': 2, 'attachment': 1, 'cells': 1, 'might': 3, 'trigger': 1, 'cytokine': 1, 'storm': 1, 'person': 3, 'infected': 3, 'platform': 2, 'subunit': 1, 'timing': 1, 'repeat': 1, 'possible': 8, 'recurrence': 1, 'age': 4, 'factors': 4, 'extent': 1, 'variable': 3, 'mechanism': 1, 'route': 1, 'given': 1, 'intramuscular': 1, 'intradermal': 1, 'defined': 2, 'result': 1, 'host': 1, 'vaccinee': 1, 'related': 2, 'determinants': 1, 'render': 1, 'genetics': 1, 'underlying': 2, 'nutrition': 1, 'pregnancy': 1, 'sensitivities': 2, 'allergies': 1, 'competence': 1, 'cultural': 1, 'environment': 1, 'secondary': 1, 'affecting': 1, 'severity': 1, 'allergen': 1, 'hypersensitive': 1, 'obese': 1, 'susceptibility': 1, 'compromised': 1, 'inhibits': 1, 'repetitive': 1, 'booster': 2, 'limit': 1, 'mutations': 1, 'targeted': 1, 'thus': 1, 'ineffective': 2, 'invest': 2, 'internationally': 2, 'find': 1, 'proved': 2, 'moving': 2, 'changing': 1, 'forcing': 1, 'compete': 1, 'sinovac': 1, 'malaysia': 1, 'brazil': 3, 'accelerating': 1, 'isolated': 1, 'sought': 1, 'relationships': 1, 'conduct': 2, 'creating': 2, 'manufacturers': 7, 'addition': 1, 'recruiting': 2, 'organizers': 1, 'encounter': 1, 'unwilling': 1, 'disbelieving': 1, 'science': 1, 'ability': 1, 'insufficient': 1, 'skilled': 1, 'members': 1, 'administer': 3, 'hinder': 1, 'must': 8, 'overcome': 1, 'rural': 2, 'density': 1, 'variations': 1, 'ethnicity': 1, 'medical': 2, 'conditions': 3, 'save': 1, 'trillions': 1, 'dollars': 4, 'expert': 4, 'therefore': 2, 'price': 2, 'tag': 1, 'look': 1, 'yet': 2, 'reliable': 1, 'exactly': 1, 'invested': 3, 'held': 1, 'video': 1, 'conference': 1, 'leaders': 1, 'raised': 4, 'created': 2, 'shipping': 1, 'requirements': 1, 'biontech': 2, 'bnt': 2, 'shipped': 1, 'stored': 1, 'c': 3, 'f': 3, 'days': 1, 'thawing': 1, 'minimum': 1, 'order': 1, 'unlikely': 1, 'rolled': 1, 'settings': 1, 'equipped': 1, 'considered': 1, 'tracking': 3, 'especially': 2, 'usually': 1, 'lengthy': 1, 'challenge': 12, 'previously': 2, 'deadly': 1, 'common': 1, 'typhoid': 1, 'fever': 1, 'cholera': 1, 'malaria': 1, 'proof': 1, 'bypass': 1, 'license': 4, 'begins': 1, 'adult': 1, 'volunteers': 4, 'something': 1, 'tests': 2, 'proceeds': 2, 'advancing': 1, 'uninfected': 1, 'young': 1, 'adults': 1, 'deliberately': 1, 'monitored': 1, 'clinics': 1, 'life': 3, 'saving': 1, 'volunteering': 1, 'likened': 1, 'firefighters': 1, 'organ': 1, 'donors': 1, 'ethically': 2, 'questionable': 1, 'hazards': 1, 'cautions': 1, 'option': 1, 'produce': 3, 'minimize': 1, 'projected': 1, 'deaths': 1, 'guidance': 2, 'document': 1, 'scientific': 4, 'ethical': 1, 'consultation': 1, 'selection': 1, 'informed': 1, 'consent': 1, 'independent': 1, 'conclusion': 1, 'phases': 1, 'demonstrating': 1, 'enduring': 1, 'part': 1, 'committee': 2, 'biological': 1, 'standardization': 1, 'standards': 3, 'complete': 2, 'package': 1, 'proves': 2, 'review': 3, 'ema': 4, 'food': 1, 'drug': 1, 'administration': 1, 'fda': 7, 'upon': 1, 'adopting': 1, 'responsibility': 2, 'issue': 1, 'manage': 1, 'deploy': 1, 'monitor': 5, 'throughout': 6, 'nation': 1, 'building': 1, 'trust': 1, 'acceptance': 1, 'communication': 1, 'campaign': 1, 'smoothly': 1, 'saves': 1, 'lives': 1, 'enables': 1, 'recovery': 1, 'logistical': 2, 'allocation': 3, 'prioritized': 3, 'unicef': 2, 'pre': 6, 'qualification': 1, 'adoption': 1, 'requires': 4, 'consistency': 1, 'contracted': 1, 'gmp': 5, 'practices': 1, 'un': 2, 'involved': 2, 'collaborate': 2, 'issuing': 1, 'marketing': 1, 'partners': 3, 'postmarketing': 2, 'surveillance': 3, 'records': 1, 'events': 2, 'works': 2, 'inspections': 2, 'facilities': 6, 'distributors': 1, 'compliance': 3, 'oversight': 1, 'choose': 1, 'buy': 1, 'reputable': 1, 'purchases': 1, 'expensive': 1, 'suitable': 1, 'local': 5, 'eu': 4, 'pathogens': 1, 'seasonal': 1, 'comply': 1, 'centralized': 2, 'decentralized': 1, 'generally': 1, 'follow': 1, 'medicinal': 1, 'products': 1, 'chmp': 4, 'panel': 1, 'responsible': 1, 'groups': 3, 'rolling': 3, 'reviews': 1, 'b': 1, 'establishing': 2, 'prescription': 1, 'drugs': 1, 'followed': 1, 'biologics': 2, 'application': 1, 'disciplines': 1, 'physicians': 1, 'statisticians': 1, 'microbiologists': 1, 'chemists': 1, 'comprehensive': 1, 'documentation': 2, 'proposed': 1, 'facility': 3, 'examined': 1, 'reviewers': 1, 'label': 1, 'compliant': 1, 'description': 1, 'care': 2, 'providers': 1, 'communicate': 1, 'deliver': 2, 'strategy': 1, 'homeless': 1, 'incarcerated': 1, 'periodic': 1, 'retains': 1, 'submissions': 1, 'potency': 1, 'purity': 1, 'step': 2, 'guideline': 1, 'listing': 1, 'derived': 1, 'required': 1, 'threatening': 2, 'prequalification': 1, 'even': 3, 'submission': 1, 'dossier': 1, 'supplying': 1, 'allows': 1, 'real': 1, 'enabling': 1, 'cansino': 1, 'military': 1, 'occupations': 1, 'sputnik': 1, 'v': 1, 'month': 1, 'amounts': 1, 'outside': 1, 'grant': 1, 'hastened': 1, 'criticized': 1, 'political': 1, 'misuse': 1, 'lowered': 1, 'antivaccine': 1, 'sentiment': 1, 'leading': 1, 'pharma': 1, 'signed': 1, 'letter': 1, 'submit': 1, 'demonstrated': 1, 'iv': 1, 'widely': 1, 'implement': 1, 'postlicensing': 1, 'relies': 1, 'event': 1, 'reporting': 1, 'system': 5, 'tens': 1, 'corporations': 2, 'immunize': 1, 'corporate': 1, 'generate': 1, 'value': 1, 'shareholders': 1, 'market': 3, 'approach': 1, 'costly': 1, 'pricing': 2, 'preferred': 1, 'sparse': 1, 'aggressive': 1, 'predicted': 1, 'unable': 1, 'afford': 1, 'profits': 1, 'sales': 1, 'arising': 1, 'commercialization': 2, 'rights': 2, 'profit': 2, 'margin': 1, 'expanding': 1, 'usd': 1, 'millon': 1, 'deal': 1, 'allowing': 2, 'distribute': 1, 'reportedly': 1, 'business': 1, 'venture': 1, 'losing': 1, 'interested': 1, 'third': 1, 'party': 1, 'slowing': 1, 'choosing': 1, 'mainly': 2, 'advantages': 1, 'favored': 1, 'sovereignty': 1, 'criticism': 1, 'partnerships': 1, 'concerning': 1, 'advance': 2, 'payment': 1, 'secure': 1, 'americans': 1, 'exist': 2, 'impose': 1, 'protectionist': 1, 'controls': 1, 'export': 1, 'restrictions': 1, 'stockpile': 1, 'serum': 2, 'institute': 3, 'india': 4, 'sii': 1, 'reached': 1, 'income': 3, 'half': 3, 'similar': 2, 'good': 1, 'implying': 1, 'open': 2, 'ended': 1, 'outcomes': 1, 'implementation': 1, 'purchasing': 1, 'indemnification': 1, 'liability': 2, 'offset': 1, 'taken': 1, 'prices': 1, 'set': 1, 'territories': 1, 'know': 1, 'materials': 1, 'shared': 2, 'transferred': 1, 'assume': 1, 'discontinues': 1, 'expenditures': 1, 'management': 9, 'intellectual': 1, 'property': 1, 'e': 1, 'patents': 3, 'accrue': 1, 'sponsored': 1, 'mission': 2, 'benefit': 1, 'transparency': 2, 'disclosure': 1, 'publications': 1, 'opposed': 1, 'parts': 1, 'proposals': 1, 'artistic': 1, 'activism': 1, 'allied': 1, 'essential': 2, 'advocate': 1, 'encouraged': 1, 'determined': 1, 'combined': 1, 'form': 1, 'concerned': 1, 'religious': 1, 'releasing': 1, 'domain': 1, 'polio': 1, 'patented': 1, 'centers': 1, 'deploying': 1, 'transport': 6, 'vial': 4, 'readily': 1, 'becoming': 1, 'largest': 3, 'chain': 21, 'logistics': 8, 'concern': 3, 'networks': 2, 'distributing': 1, 'ready': 2, 'volume': 1, 'deterioration': 2, 'lockdowns': 1, 'downsizing': 1, 'degraded': 1, 'addressing': 1, 'faced': 1, 'contract': 1, 'inter': 1, 'intranational': 1, 'seth': 1, 'berkley': 1, 'efficiently': 1, 'hugely': 1, 'complex': 2, 'programmatic': 1, 'obstacles': 1, 'highlighting': 1, 'immensity': 1, 'air': 6, 'association': 1, 'cargo': 4, 'planes': 2, 'equipment': 3, 'cold': 9, 'experiencing': 1, 'unless': 1, 'everyone': 1, 'contrast': 1, 'multibillion': 1, 'dollar': 1, 'post': 1, 'vaccinating': 1, 'inadequate': 2, 'existent': 1, 'improved': 1, 'efficiencies': 1, 'procurement': 2, 'regionally': 1, 'nationally': 1, 'optimize': 1, 'services': 2, 'necessary': 1, 'staff': 4, 'borders': 1, 'network': 2, 'purpose': 1, 'centralize': 1, 'merging': 1, 'forecasting': 1, 'estimation': 1, 'wastage': 1, 'shortage': 1, 'derail': 1, 'whole': 1, 'fails': 1, 'extended': 1, 'ordered': 2, 'orders': 2, 'dispiriting': 1, 'promoting': 1, 'financially': 1, 'basic': 1, 'commitments': 1, 'sizable': 1, 'nationalism': 1, 'threaten': 1, 'availability': 2, 'poorer': 1, 'indonesia': 1, 'undergoing': 1, 'joining': 1, 'unsure': 1, 'ceo': 2, 'pascal': 1, 'soriot': 1, 'filling': 1, 'vials': 4, 'preparing': 3, 'demand': 2, 'glass': 2, 'producer': 1, 'factory': 1, 'contaminant': 1, 'indicating': 1, 'amid': 1, 'demands': 1, 'handled': 1, 'transported': 1, 'maintained': 1, 'temperatures': 4, 'immunization': 2, 'expected': 1, 'vast': 1, 'temperature': 5, 'optimizing': 1, 'training': 2, 'rigorous': 1, 'rfid': 1, 'authenticate': 1, 'inherently': 1, 'unstable': 1, 'stable': 2, 'frozen': 2, 'labile': 1, 'heat': 1, 'freezing': 2, 'damage': 1, 'accommodate': 1, 'climate': 1, 'maintenance': 1, 'difficult': 1, 'degradation': 1, 'examples': 1, 'colder': 1, 'punctured': 1, 'viable': 1, 'hours': 1, 'discarded': 1, 'attention': 1, 'processes': 3, 'spoilage': 1, 'waste': 1, 'challenged': 1, 'type': 1, 'transportation': 1, 'communities': 1, 'motorcycle': 1, 'drone': 1, 'diluents': 1, 'component': 1, 'sensitive': 1, 'freight': 2, 'prepared': 1, 'safely': 1, 'century': 1, 'happen': 1, 'careful': 1, 'urge': 1, 'arrangements': 1, 'border': 3, 'mammoth': 1, 'ahead': 1, 'iata': 1, 'director': 1, 'alexandre': 1, 'de': 1, 'juniac': 1, 'reduction': 1, 'passenger': 1, 'traffic': 1, 'airlines': 1, 'downsized': 1, 'trimmed': 1, 'destination': 1, 'aircraft': 1, 'fastest': 1, 'ever': 1, 'necessitating': 1, 'customs': 2, 'fraud': 1, 'worth': 1, 'widespread': 1, 'counterfeit': 2, 'theft': 1, 'scams': 1, 'cyberattacks': 1, 'anticorruption': 1, 'accountability': 1, 'safeguards': 1, 'eliminate': 1, 'corruption': 1, 'absence': 1, 'frameworks': 1, 'technical': 1, 'constrained': 1, 'capability': 1, 'genuine': 1, 'vs': 1, 'recipients': 1, 'perpetuate': 1, 'packaging': 1, 'trace': 1, 'digital': 1, 'biometric': 1, 'includes': 1, 'constructing': 1, 'subnational': 1, 'efficient': 1, 'clearance': 1, 'secretary': 1, 'alex': 1, 'azar': 1, 'notice': 2, 'declaration': 3, 'readiness': 1, 'countermeasures': 1, 'covering': 1, 'diagnose': 1, 'mitigate': 1, 'mutating': 1, 'therefrom': 1, 'stating': 1, 'precludes': 1, 'claims': 1, 'alleging': 1, 'negligence': 2, 'provider': 1, 'prescribing': 1, 'wrong': 1, 'absent': 1, 'willful': 1, 'misconduct': 1, 'social': 2, 'media': 2, 'posts': 2, 'promoted': 1, 'conspiracy': 1, 'theory': 1, 'cited': 1, 'various': 1, 'references': 1, 'sequences': 1, 'strains': 1, 'cease': 1, 'desist': 1, 'sent': 1, 'coast': 1, 'seattle': 1, 'selling': 1, 'purported': 1, 'ncov': 1}\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "VOyve1z5utvI"
      },
      "source": [
        "maximum_count = max(wordstoCount.values())"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "sJ7HnE5zvE6Y",
        "outputId": "ca6701e9-2399-4859-e8c2-ff87512f66b1",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 34
        }
      },
      "source": [
        "print(maximum_count) #converting counts to weights"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "273\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Tt4-Q0bxvZGB"
      },
      "source": [
        "for key in wordstoCount.keys(): #converting counts to weights\n",
        "  wordstoCount[key] = wordstoCount[key]/maximum_count"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "KnowRYPYv8TP",
        "outputId": "b430d3b6-63ab-4c79-9db6-a5728ab0dfd7",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 34
        }
      },
      "source": [
        "print(wordstoCount[key])"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "0.003663003663003663\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "iVTqQtw92uks"
      },
      "source": [
        "sentscore = {} #taking wordto count score to sentence tokens\n",
        "for sentence in sentences:\n",
        "  for word in nltk.word_tokenize(sentence.lower()):\n",
        "    if word in wordstoCount.keys():\n",
        "      if len(sentence.split(\" \"))<25:\n",
        "        if sentence not in sentscore.keys():\n",
        "          sentscore[sentence] = wordstoCount[word]\n",
        "        else:\n",
        "           sentscore[sentence] += wordstoCount[word] \n"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "_raaqMTM5Oqr"
      },
      "source": [
        "import heapq\n",
        "best_sentences = heapq.nlargest(5,sentscore,key=sentscore.get)"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "5FIfKs2k5yxm",
        "outputId": "981a6b95-1e6f-469d-f293-db4d68c77e98",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 138
        }
      },
      "source": [
        "print(\"--------------------------------------------------\")\n",
        "for sentence in best_sentences:\n",
        "  print(sentence)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "--------------------------------------------------\n",
            "The FDA relies on a Vaccine Adverse Event Reporting System to monitor safety concerns about a vaccine throughout its use in the American public.\n",
            "Included are logistics tools for vaccine forecasting and needs estimation, in-country vaccine management, potential for wastage, and stock management.\n",
            "Further, mutations of the virus can alter its structure targeted by the vaccine, thus making the vaccine ineffective.\n",
            "In October, some 42 vaccine candidates were in clinical research: namely 33 in Phase I–II trials and 9 in Phase II–III trials.\n",
            "Adjuvants used in COVID-19 vaccine formulation may be particularly effective for technologies using the inactivated COVID-19 virus and recombinant protein-based or vector-based vaccines.\n"
          ],
          "name": "stdout"
        }
      ]
    }
  ]
}